PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	HOLDEN, C				HOLDEN, C			HOW TO WIN A WESTINGHOUSE	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					871	871						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847379				2022-12-28	WOS:A1991EY62900028
J	HOLDEN, C				HOLDEN, C			CAMPUS DRINKING	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					871	871						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY629	17847379				2022-12-28	WOS:A1991EY62900024
J	HOLDEN, C				HOLDEN, C			PUBLIC-ATTITUDES TOWARD GENE-SPLICING	SCIENCE			English	Editorial Material																		RABINO I, 1991, SCI TECHNOLOGY H WIN	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					871	871						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY629	17847379				2022-12-28	WOS:A1991EY62900026
J	HOLDEN, C				HOLDEN, C			PMA LAUNCHES AD CAMPAIGN	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					871	871						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847379				2022-12-28	WOS:A1991EY62900025
J	HOLDEN, C				HOLDEN, C			PHYSICISTS HURTING	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					871	871						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847379				2022-12-28	WOS:A1991EY62900027
J	CRAWFORD, MH				CRAWFORD, MH			PROSPECTORS CASH IN ON GEOLOGISTS FIND	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1298	1298						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843788				2022-12-28	WOS:A1990CU25300023
J	HOLDEN, C				HOLDEN, C			CRUISING THE DIGITAL HIGHWAY	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					870	870						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847373				2022-12-28	WOS:A1991EY62900022
J	CRAWFORD, MH				CRAWFORD, MH			TRANSGENIC CARP - POND-READY	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1298	1298						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843788				2022-12-28	WOS:A1990CU25300025
J	HOLDEN, C				HOLDEN, C			WORLD-BANK ENVIRONMENT FUND	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					870	870						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY629	17847373				2022-12-28	WOS:A1991EY62900020
J	CRAWFORD, MH				CRAWFORD, MH			TECHNOLOGY UNLOCKS LOST WRITINGS	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1298	1298						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU253	17843788				2022-12-28	WOS:A1990CU25300024
J	CRAWFORD, MH				CRAWFORD, MH			STANFORD PATENTS PAY	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1298	1298						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843788				2022-12-28	WOS:A1990CU25300026
J	HOLDEN, C				HOLDEN, C			PROVING EINSTEIN RIGHT (OR WRONG)	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					870	870						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847373				2022-12-28	WOS:A1991EY62900021
J	HOLDEN, C				HOLDEN, C			LOOKING FOR PLANETS	SCIENCE			English	Editorial Material																		STRATEGY DETECTION S	1	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					870	871						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847373				2022-12-28	WOS:A1991EY62900023
J	MAHONEY, RJ; LITTLEJOHN, SE				MAHONEY, RJ; LITTLEJOHN, SE			PUNITIVE DAMAGES AND INNOVATION - RESPONSE	SCIENCE			English	Letter											MAHONEY, RJ (corresponding author), MONSANTO CO, 800 N LINDBERGH BLVD, ST LOUIS, MO 63167 USA.							PRIEST GL, 1989, FORTUNE, V119, P323; WILLARD RK, 1987, UPDATE LIABILITY CRI, P50; 1989, PRODUCT LIABILITY VE, P69	3	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	1990	247	4948					1281	1281		10.1126/science.247.4948.1281	http://dx.doi.org/10.1126/science.247.4948.1281			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843777				2022-12-28	WOS:A1990CU25300007
J	RANDALL, RL				RANDALL, RL			PUNITIVE DAMAGES AND INNOVATION	SCIENCE			English	Letter											RANDALL, RL (corresponding author), US INT TRADE COMMISS, WASHINGTON, DC 20436 USA.								0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	1990	247	4948					1281	1281		10.1126/science.247.4948.1281	http://dx.doi.org/10.1126/science.247.4948.1281			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843777				2022-12-28	WOS:A1990CU25300006
J	BROWN, A				BROWN, A			PUNITIVE DAMAGES AND INNOVATION	SCIENCE			English	Letter											BROWN, A (corresponding author), WEINER EDRICH BROWN,200 E 33RD ST,NEW YORK,NY 10016, USA.								0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1281	1281		10.1126/science.247.4948.1281	http://dx.doi.org/10.1126/science.247.4948.1281			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843777				2022-12-28	WOS:A1990CU25300005
J	KERR, RA				KERR, RA			BUMPY ROAD TO A CLIMATE TREATY	SCIENCE			English	Editorial Material																			0	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					868	868		10.1126/science.251.4996.868	http://dx.doi.org/10.1126/science.251.4996.868			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847368				2022-12-28	WOS:A1991EY62900017
J	PALCA, J				PALCA, J			AAAS MEETING OPENS WITH VIEWS FROM THE TOP	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					869	869		10.1126/science.251.4996.869	http://dx.doi.org/10.1126/science.251.4996.869			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847369				2022-12-28	WOS:A1991EY62900018
J	Getz, G; Hofling, H; Mesirov, JP; Golub, TR; Meyerson, M; Tibshirani, R; Lander, ES				Getz, Gad; Hoefling, Holger; Mesirov, Jill P.; Golub, Todd R.; Meyerson, Matthew; Tibshirani, Robert; Lander, Eric S.			Comment on "The consensus coding sequences of human breast and colorectal cancers"	SCIENCE			English	Editorial Material									MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp Boston, Dept Med, Boston, MA 02115 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Getz, G (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	gadgetz@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Meyerson, Matthew L/E-7123-2012					BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; PARMIGIANI G, 2006, 126 J HOPK U DEP BIO; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427	4	109	113	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844								10.1126/science.1138764	http://dx.doi.org/10.1126/science.1138764			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872427				2022-12-28	WOS:000249467900020
J	PALCA, J				PALCA, J			LEDERMAN AND HIS CRITICS	SCIENCE			English	Editorial Material																		LEDERMAN, SCI END FRONTIER; 1991, SCIENCE, V251, P153	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					869	869		10.1126/science.251.4996.869	http://dx.doi.org/10.1126/science.251.4996.869			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847369				2022-12-28	WOS:A1991EY62900019
J	KERR, RA				KERR, RA			UNITED-STATES BITES GREENHOUSE BULLET AND GAGS	SCIENCE			English	Editorial Material																			0	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					868	868		10.1126/science.251.4996.868	http://dx.doi.org/10.1126/science.251.4996.868			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847368				2022-12-28	WOS:A1991EY62900016
J	Haines, A; Smith, KR; Anderson, D; Epstein, PR; McMichael, AJ; Roberts, I; Wilkinson, P; Woodcock, J; Woods, J				Haines, Andy; Smith, Kirk R.; Anderson, Dennis; Epstein, Paul R.; McMichael, Anthony J.; Roberts, Ian; Wilkinson, Paul; Woodcock, James; Woods, Jeremy			Energy and health 6 - Policies for accelerating access to clean energy, improving health, advancing development, and mitigating climate change	LANCET			English	Article							POPULATION-GROWTH; AIR-QUALITY; MORTALITY; IMPACTS; VULNERABILITY; BENEFITS; CARBON	The absence of reliable access to clean energy and the services it provides imposes a large disease burden on low-income populations and impedes prospects for development. Furthermore, current patterns of fossil-fuel use cause substantial ill-health from air pollution and occupational hazards. Impending climate change, mainly driven by energy use, now also threatens health. Policies to promote access to non-polluting and sustainable sources of energy have great potential both to improve public health and to mitigate (prevent) climate disruption. There are several technological options, policy levers, and economic instruments for sectors such as power generation, transport, agriculture, and the built environment. However, barriers to change include vested interests, political inertia, inability to take meaningful action, profound global inequalities, weak technology-transfer mechanisms, and knowledge gaps that must be addressed to transform global markets. The need for policies that prevent dangerous anthropogenic interference with the climate while addressing the energy needs of disadvantaged people is a central challenge of the current era. A comprehensive programme for clean energy should optimise mitigation and, simultaneously, adaption to climate change while maximising co-benefits for health-eg, through improved air, water, and food quality. Intersectoral research and concerted action, both nationally and internationally, will be required.	Univ London London Sch Hyg & Trop Med, Directors Off, London WC1E 7HT, England; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ London Imperial Coll Sci Technol & Med, London, England; Harvard Univ, Sch Med, Boston, MA USA; Australian Natl Univ, Canberra, ACT, Australia	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; Imperial College London; Harvard University; Harvard Medical School; Australian National University	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Directors Off, Keppel St, London WC1E 7HT, England.	andy.haines@lshtm.ac.uk	Woodcock, James/AAH-6753-2021	Woods, Jeremy/0000-0002-1542-8144; Woodcock, James/0000-0003-4769-5375; Wilkinson, Paul/0000-0001-7456-259X; Haines, Andy/0000-0002-8053-4605				[Anonymous], 1995, CONTRIBUTION WORKING; Arbex MA, 2007, J EPIDEMIOL COMMUN H, V61, P395, DOI 10.1136/jech.2005.044743; Aunan K, 2007, ENVIRON DEV ECON, V12, P471, DOI 10.1017/S1355770X07003610; Aunan K, 2006, ENVIRON SCI TECHNOL, V40, P4822, DOI 10.1021/es062994k; Beverland IJ, 2000, INT J ENVIRON HEAL R, V10, P229, DOI 10.1080/09603120050127176; BONGAARTS J, 1992, POPUL DEV REV, V18, P299, DOI 10.2307/1973681; Bruce N, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P793; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; *COMM COMM COUNC, 2007, LIM GLOB CLIM CHANG; Davis DL, 1997, LANCET, V350, P1341, DOI 10.1016/S0140-6736(97)10209-4; DENHAM J, 2001, NEW ENERGY EFFICIENC; *DEP HLTH, 2005, SUST DEV ENV STRAT N; *ENDS, 2005, ENDS REP, V370, P35; *ENDS, 2007, ENDS REPORT, V386, P15; *EUR COMM DIR GEN, EUR TECHN PLATF SMAR; *FAO, FAO NEWSR GLOB BIOEN; Finkelman RB, 1999, P NATL ACAD SCI USA, V96, P3427, DOI 10.1073/pnas.96.7.3427; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Global Commons Institute, CONTR CONV; GOW D, 2007, GUARDIAN        0403; Griffiths J, 2006, PUBLIC HEALTH, V120, P609, DOI 10.1016/j.puhe.2006.04.005; GROSS R, ASSESSMENT TECHNOLOG; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; HAINES A, 2000, GLOBAL CHANGE HUM HL, V1, P78; Hazell P., 2006, BIOENERGY AGR PROMIS; Heinrich J., 2005, HLTH EFFECTS TRANSPO; *INT AT E AUTH, STRUCT CONT AGR AG S; *INT EN AG, 30 KEY EN TRENDS IEA; *INT PAN CLIM CHAN, CLIM CHANG 2007 IMP; International Energy Agency, 2006, WORLD EN OUTL; Jacobson MZ, 2007, ENVIRON SCI TECHNOL, V41, P4150, DOI 10.1021/es062085v; KJELLSTROM B, RENEWABLE ENERGY TEC; KJORVEN O, ENERGISING MDGS GOIN; MACFARLANE A, 2007, INNOVATIONS, V1, P83; MARKANDYA A, 2007, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61253-7; McCully Patrick, 1996, SILENCED RIVERS ECOL; McMichael A J, 1993, PLANETARY OVERLOAD G; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; MCMICHAEL AJ, 2007, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61256-2; MCMICHAEL AJ, 2000, METHODOLOGICAL TECHN; MEINSHAUSEN M, 2006, AVOIDING DANGEROUS C; METZ B, 2005, SPECIAL REPORT WORKI; MODI V, ENERGY SERVICES MILL; Moreira J. R., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P313, DOI 10.1007/s11027-005-9003-8; *NAT HEART FOR COM, 2007, LIV STREETS BUILD HL; Njenga P, 2003, TRANSPORT REV, V23, P217, DOI 10.1080/01441640309889; Nuttall W. J., 2005, NUCL RENAISSANCE TEC; O'Neill BC., 2001, POPULATION CLIMATE C; Oreszczyn T, 2006, ENERG BUILDINGS, V38, P245, DOI 10.1016/j.enbuild.2005.06.006; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pedersen E, 2007, OCCUP ENVIRON MED, V64, P480, DOI 10.1136/oem.2006.031039; Potts M, 2007, LANCET, V369, P354, DOI 10.1016/S0140-6736(07)60158-5; *PRIM MIN STRAT UN, EN REV 2002 ASS TECH; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Reddy A., 2000, WORLD ENERGY ASSESSM, V2000, P41; ROCKSTROM J, SUSTAINABLE PATHWAYS; Rollin HB, 2004, INDOOR AIR, V14, P208, DOI 10.1111/j.1600-0668.2004.00238.x; Rosillo-Calle F., 1999, MULTIFUNCTIONAL CHAR, P44; ROSILLOCALLE F, 2006, BIOMASS ASSESSMENT H; *ROYAL SOC, GOV MUST SHOW POL CO; *ROYAL SOC, DEV UK POL MAN RAD W; Schneider S. H., 2006, AVOIDING DANGEROUS C; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Skeer J, 2002, AMBIO, V31, P28, DOI 10.1639/0044-7447(2002)031[0028:LBCAKA]2.0.CO;2; Smith KR, 2002, SCIENCE, V298, P1847, DOI 10.1126/science.298.5600.1847; SMITH KR, IN PRESS ANN REV PUB; SMITH KR, 2007, ENERGY SUSTAIN DEV, V15, P5; Socolow RH, 2006, SCI AM, V295, P50, DOI 10.1038/scientificamerican0906-50; Steinfield H, 2006, LIVESTOCKS LONG SHAD; Stern N. H., 2006, STERN REV EC CLIMATE; Stott R, 2006, BRIT MED J, V332, P1385, DOI 10.1136/bmj.332.7554.1385; *SUST DEV COMM, SDC POS PAP ROL NUCL; TAKADA M, ACHIEVING MILLENNIUM; TAKADA M, REV ENERGY NATL MDG; *UN, 2007, UN EN SUST BIOEN FRA; *UN, 1998, KYOT PROT UN FRAM CO, DOI [10.51663/pnz.58.2.07, DOI 10.51663/PNZ.58.2.07]; *UNDP, 2002, 25502 UNDP WORLD BAN; *UNFCCC, 2006, BACKG PAP IMP VULN A; United Nations, MILL DEV GOALS IND; Vandentorren S, 2004, AM J PUBLIC HEALTH, V94, P1518, DOI 10.2105/AJPH.94.9.1518; Vennemo H, 2006, CLIMATIC CHANGE, V75, P215, DOI 10.1007/s10584-006-1834-0; Viray F. L., 2000, WORLD ENERGY ASSESSM, P61; Wang X, 1999, WHOSDEPHE991; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a; *WHHO, 2002, WORLD HLTH REP 2002; *WHO, 2004, WORLD BANK WORLD REP; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; WILKINSON P, 2007, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61255-0; WILKINSON P, 2007, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61252-5; WOODCOCK J, 2007, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61254-9; WOODS J, 2007, ROYAL SOC INT BIOF O; *WORK GROUP 3 CONT, CLIM CHANG 2007; World Bank, 2006, CLEAN EN DEV INV FRA; *WORLD EN COUNC, WORLD EN 2006; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; CAP SHARE; 2007, AGE SPAINS WIND ENER	99	141	143	3	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1264	1281		10.1016/S0140-6736(07)61257-4	http://dx.doi.org/10.1016/S0140-6736(07)61257-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219NM	17868819				2022-12-28	WOS:000250091900027
J	Chou, R; Huffman, LH				Chou, Roger; Huffman, Laurie Hoyt			Medications for acute and chronic low back pain: a review of the evidence for an American pain Society/American college of physicians clinical practice guideline	ANNALS OF INTERNAL MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CHRONIC NONCANCER PAIN; SKELETAL-MUSCLE SPASM; DOUBLE-BLIND; CONSERVATIVE TREATMENT; RHEUMATOID-ARTHRITIS; ANALGESIC EFFICACY; CONTROLLED-RELEASE; ADVERSE EVENTS; HEALTH-CARE	Background: Medications are the most frequently prescribed therapy for low back pain. A challenge in choosing pharmacologic therapy is that each class of medication is associated with a unique balance of risks and benefits. Purpose: To assess benefits and harms of acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, benzo-diazepines, antiepileptic drugs, skeletal muscle relaxants, opioid analgesics, tramadol, and systemic corticosteroids for acute or chronic low back pain (with or without leg pain). Data Sources: English-language studies were identified through searches of MEDLINE (through November 2006) and the Cochrane Database of Systematic Reviews (2006, Issue 4). These electronic searches were supplemented by hand searching reference lists and additional citations suggested by experts. Study Selection: Systematic reviews and randomized trials of dual therapy or monotherapy with 1 or more of the preceding medications for acute or chronic low back pain that reported pain outcomes, back-specific function, general health status, work disability, or patient satisfaction. Data Extraction: We abstracted information about study design, population characteristics, interventions, outcomes, and adverse events. To grade methodological quality, we used the Oxman criteria for systematic reviews and the Cochrane Back Review Group criteria for individual trials. Data Synthesis: We found good evidence that NSAIDs, acetaminophen, skeletal muscle relaxants (for acute low back pain), and tricyclic antidepressants (for chronic low back pain) are effective for pain relief. The magnitude of benefit was moderate (effect size of 0.5 to 0.8, improvement of 10 to 20 points on a 100-point visual analogue pain scale, or relative risk of 1.25 to 2.00 for the proportion of patients experiencing clinically significant pain relief), except in the case of tricyclic antidepressants (for which the benefit was small to moderate). We also found fair evidence that opioids, tramadol, benzodiazepines, and gabapentin (for radiculopathy) are effective for pain relief. We found good evidence that systemic corticosteroids are ineffective. Adverse events, such as sedation, varied by medication, although reliable data on serious and long-term harms are sparse. Most trials were short term (<= 4 weeks). Few data address efficacy of dual-medication therapy compared with monotherapy, or beneficial effects on functional outcomes. Limitations: Our primary source of data was systematic reviews. We included non-English-language trials only if they were included in English-language systematic reviews. Conclusions: Medications with good evidence of short-term effectiveness for low back pain are NSAIDs, acetaminophen, skeletal muscle relaxants (for acute low back pain), and tricyclic antidepressants (for chronic low back pain). Evidence is insufficient to identify one medication as offering a clear overall net advantage because of complex tradeoffs between benefits and harms. Individual patients are likely to differ in how they weigh potential benefits, harms, and costs of various medications.	Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				Allan L, 2005, SPINE, V30, P2484, DOI 10.1097/01.brs.0000186860.23078.a8; ARBUS L, 1990, CLIN TRIALS J, V27, P258; Armstrong K, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(00)00263-4; Assendelft W, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000447.PUB2; BAMIGBADE TA, 1999, 9 WORLD C PAIN VIENN; BARATTA RR, 1976, CURR THER RES CLIN E, V20, P233; Bartleson JD, 2002, PAIN MED, V3, P260, DOI 10.1046/j.1526-4637.2002.02043.x; BASMAJIAN JV, 1978, ARCH PHYS MED REHAB, V59, P58; Bernstein E, 2004, SPINE, V29, P1346, DOI 10.1097/01.BRS.0000128258.49781.74; BERRY H, 1988, J INT MED RES, V16, P83, DOI 10.1177/030006058801600202; BERRY H, 1988, J INT MED RES, V16, P75, DOI 10.1177/030006058801600201; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Bombardier C, 1997, SPINE, V22, P837, DOI 10.1097/00007632-199704150-00001; BOYLES WF, 1983, TODAYS THERAPEUTIC T, V1, P1; *BRIT PAIN SOC, 2005, REC APPR US OP PERS; Brown R L, 1996, J Am Board Fam Pract, V9, P191; Browning R, 2001, ARCH INTERN MED, V161, P1613, DOI 10.1001/archinte.161.13.1613; *CAN PAIN SOC, 2003, PAIN RES MANAG SA, V8, pA3; Cherkin DC, 1998, SPINE, V23, P607, DOI 10.1097/00007632-199803010-00015; Chou R, 2004, J PAIN SYMPTOM MANAG, V28, P140, DOI 10.1016/j.jpainsymman.2004.05.002; CHOU R, 2007, IN PRESS AM PAIN SOC; *COCHR BACK REV GR, 2003, SPINE, V28, P1978; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Deyo RA, 1996, SPINE, V21, P2840, DOI 10.1097/00007632-199612150-00007; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; DORAN DML, 1975, BRIT MED J, V2, P161, DOI 10.1136/bmj.2.5964.161; *ED BOARD BACK REV, 2003, SPINE, V28, P1215; EVANS DP, 1980, CURR MED RES OPIN, V6, P540, DOI 10.1185/03007998009109484; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; Fishbain D, 2000, ANN MED, V32, P305, DOI 10.3109/07853890008995932; Friedman BW, 2006, J EMERG MED, V31, P365, DOI 10.1016/j.jemermed.2005.09.023; Furlan A D, 2001, Spine (Phila Pa 1976), V26, pE155, DOI 10.1097/00007632-200104010-00018; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; GOODKIN K, 1989, Annals of Behavioral Medicine, V11, P83, DOI 10.1207/s15324796abm1103_1; GOSTICK N, 1989, P ED S PAIN CONTR ME, P137; HACKETT GI, 1988, PRACTITIONER, V232, P163; Hagen KB, 2005, SPINE, V30, P542, DOI 10.1097/01.brs.0000154625.02586.95; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; HAIMOVIC IC, 1986, NEUROLOGY, V36, P1593, DOI 10.1212/WNL.36.12.1593; HALE M, 1997, PAIN RES MANAG, V2, P33; Hale ME, 2005, J PAIN, V6, P21, DOI 10.1016/j.jpain.2004.09.005; Hale ME, 1999, CLIN J PAIN, V15, P179, DOI 10.1097/00002508-199909000-00004; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; HENNIES OL, 1981, J INT MED RES, V9, P62, DOI 10.1177/030006058100900111; HICKEY RFJ, 1982, NEW ZEAL MED J, V95, P312; HINGORANI K, 1966, ANN PHYS MED, V12, P125; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jamison RN, 1998, SPINE, V23, P2591, DOI 10.1097/00007632-199812010-00014; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kalso E, 2003, EUR J PAIN, V7, P381, DOI 10.1016/S1090-3801(02)00143-X; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Koes BW, 1997, ANN RHEUM DIS, V56, P214, DOI 10.1136/ard.56.4.214; Lee C, 2004, ARTHRIT RHEUM-ARTHR, V51, P746, DOI 10.1002/art.20698; Luo XM, 2004, SPINE, V29, pE531, DOI 10.1097/01.brs.0000146453.76528.7c; Luo XM, 2004, SPINE, V29, P884, DOI 10.1097/00007632-200404150-00012; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; McCleane GJ, 2001, PAIN CLINIC, V13, P103, DOI 10.1163/156856901753420945; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Metscher B, 2001, Fortschr Med Orig, V118, P147; MILGROM C, 1993, J SPINAL DISORD, V6, P187, DOI 10.1097/00002517-199306030-00001; Moll W, 1973, Med Welt, V24, P1747; Moore N, 1999, CLIN DRUG INVEST, V18, P89, DOI 10.2165/00044011-199918020-00001; Moore RA, 2005, ARTHRITIS RES THER, V7, pR644, DOI 10.1186/ar1704; Muehlbacher M, 2006, CLIN J PAIN, V22, P526, DOI 10.1097/.ajp.0000192516.58578.a4; Muller FO, 1998, ARZNEIMITTEL-FORSCH, V48, P675; Mullican WS, 2001, CLIN THER, V23, P1429, DOI 10.1016/S0149-2918(01)80118-1; Nadler SF, 2002, SPINE, V27, P1012, DOI 10.1097/00007632-200205150-00003; NIBBELINK DW, 1978, CLIN THER, V1, P409; ONGHENA P, 1992, PAIN, V49, P205, DOI 10.1016/0304-3959(92)90144-Z; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; PORSMAN O, 1979, SCAND J RHEUMATOL, V8, P142, DOI 10.3109/03009747909114446; *PROT CAPSS 112 ST, 2003, CLIN THER, V25, P1123; *PROT TRP CAN 1 ST, 2004, J RHEUMATOL, V31, P2454; Raber M, 1999, CLIN DRUG INVEST, V17, P415, DOI 10.2165/00044011-199917060-00001; RELJA M, 1990, J NEUROLOGICAL SCI S, V98, P334; Roelofs P., 2008, COCHRANE DB SYST REV, V1, P1, DOI [10.1002/14651858.CD000396.pub3, 10.1002/14651858.00000396.pub3, DOI 10.1002/14651858.CD000396.PUB3, 10.1002/14651858.cd000396]; Rozenberg S, 1998, REV RHUM, V65, P649; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; Salzman RT, 1999, J PAIN SYMPTOM MANAG, V18, P271, DOI 10.1016/S0885-3924(99)00079-2; Salzmann E., 1992, Journal of Drug Development, V4, P219; Schnitzer TJ, 2000, J RHEUMATOL, V27, P772; Schnitzer TJ, 2004, J PAIN SYMPTOM MANAG, V28, P72, DOI 10.1016/j.jpainsymman.2003.10.015; Schreiber S, 2001, ISR J PSYCHIATR REL, V38, P88; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Sorge J, 1997, CLIN DRUG INVEST, V14, P157, DOI 10.2165/00044011-199714030-00001; Staiger TO, 2003, SPINE, V28, P2540, DOI 10.1097/01.BRS.0000092372.73527.BA; Stein D, 1996, PSYCHOSOMATICS, V37, P63, DOI 10.1016/S0033-3182(96)71600-6; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; TURNER JA, 1993, J FAM PRACTICE, V37, P545; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; van Tulder M W, 2003, Cochrane Database Syst Rev, pCD004252; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013; vanderWeide WE, 1997, SCAND J WORK ENV HEA, V23, P165, DOI 10.5271/sjweh.195; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; Vogt MT, 2005, SPINE, V30, P1075, DOI 10.1097/01.brs.0000160843.77091.07; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Wegman A, 2004, J RHEUMATOL, V31, P344; WIESEL SW, 1980, SPINE, V5, P324, DOI 10.1097/00007632-198007000-00006; Yildirim K, 2003, PAIN CLINIC, V15, P213, DOI 10.1163/156856903767650718; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	109	376	395	4	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					505	514		10.7326/0003-4819-147-7-200710020-00008	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909211				2022-12-28	WOS:000250214700007
J	Ng, WF; To, KF				Ng, Wai Fu; To, Ka Fai			Pathology of human H5N1 infection: new findings	LANCET			English	Editorial Material							INFLUENZA-A H5N1; CHILD		Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Yan Chai Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, State Key Lab Oncol S China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ng, WF (corresponding author), Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	ngwaifu@cuhk.edu.hk						Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chokephaibulkit K, 2005, PEDIATR INFECT DIS J, V24, P162, DOI 10.1097/01.inf.0000151037.25237.1e; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *WHO, 2007, COM NUMB CONF HUM CA	12	28	29	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1106	1108		10.1016/S0140-6736(07)61490-1	http://dx.doi.org/10.1016/S0140-6736(07)61490-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905148				2022-12-28	WOS:000250263700006
J	Collerson, KD; Weisler, MI				Collerson, Kenneth D.; Weisler, Marshall I.			Stone adze compositions and the extent of ancient Polynesian voyaging and trade	SCIENCE			English	Article							OCEAN ISLAND BASALTS; TRACE-ELEMENT; EVOLUTION; VOLCANO; HAWAII; LAVAS; DIFFERENTIATION; GEOCHEMISTRY; SOCIETY; PLUMES	The last region on Earth settled by humans during prehistory was East Polynesia. Hawaiian oral histories mention voyaging from Hawai'i to Tahiti and back via the Tuamotus, an open ocean journey of several thousands of kilometers. The trace element and isotope chemistries of a stone adze recovered from the Tuamotu Archipelago are unlike those of sources in central Polynesia but are similar to the Kaho'olawe Island hawaiite, in the Hawaiian Islands, supporting the oral histories. Other adzes collected from the low coral islands of the northwest Tuamotus have sources in the Marquesas, Austral and Society Islands, and the Pitcairn Group, confirming that trade was widespread within East Polynesia.	Univ Queensland, Sch Phys Sci Earth Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Social Sci Archaeol, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Collerson, KD (corresponding author), Univ Queensland, Sch Phys Sci Earth Sci, St Lucia, Qld 4072, Australia.	k.collerson@mailbox.uq.edu.au		Weisler, Marshall/0000-0002-2336-2544				Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; BASU AR, 1996, EARTH PROCESSES READ, P149; BEST S, 1992, J POLYNESIAN SOC, V101, P45; Bonneville A, 2006, EARTH PLANET SC LETT, V244, P251, DOI 10.1016/j.epsl.2005.12.037; BROUSSE R, 1986, CR ACAD SCI II, V303, P247; Cachola-Abad CK, 1993, EVOLUTION ORG PREHIS, P13; CHEN CY, 1990, CONTRIB MINERAL PETR, V105, P197, DOI 10.1007/BF00678986; CHEN JH, 1983, C LUN PLAN I, V1, P103; Dickinson WR, 2004, PALAEOGEOGR PALAEOCL, V213, P251, DOI 10.1016/j.palaeo.2004.07.012; Emory K.P., 1975, PACIFIC ANTHR RECORD, V22; FINNEY BR, 1977, SCIENCE, V196, P1277, DOI 10.1126/science.196.4296.1277; FINNEY BR, 1994, VOYAGE DISCOVERY CUL; Finney BR, 1967, POLYNESIAN CULTURE H, P141; FODOR RV, 1992, CONTRIB MINERAL PETR, V110, P442, DOI 10.1007/BF00344080; FREY FA, 1990, J GEOPHYS RES-SOLID, V95, P1271, DOI 10.1029/JB095iB02p01271; Geddes W.R., 1959, ANTHR S SEAS, P121; Grove TL, 2006, EARTH PLANET SC LETT, V249, P74, DOI 10.1016/j.epsl.2006.06.043; Grove TL, 2003, CONTRIB MINERAL PETR, V145, P515, DOI 10.1007/s00410-003-0448-z; HEMOND C, 1994, CHEM GEOL, V115, P7, DOI 10.1016/0009-2541(94)90143-0; Hofmann AW, 1996, J GEOPHYS RES-SOL EA, V101, P11831, DOI 10.1029/95JB03701; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Huang S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000756; Irwin G, 1998, J POLYNESIAN SOC, V107, P111; Irwin G., 1992, PREHISTORIC EXPLORAT; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; LEEMAN WP, 1994, CONTRIB MINERAL PETR, V116, P62, DOI 10.1007/BF00310690; Levison M., 1973, SETTLEMENT POLYNESIA; MORGAN WJ, 1972, AM ASSOC PETR GEOL B, V56, P203; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; PEARCE JA, 1973, EARTH PLANET SC LETT, V19, P290, DOI 10.1016/0012-821X(73)90129-5; Pfander JA, 2007, EARTH PLANET SC LETT, V254, P158, DOI 10.1016/j.epsl.2006.11.027; SHARP A, 1964, ANCIENT VOYAGES POLY; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Weisler MI, 2002, SCI ARCH MI, P257; WEISLER MI, 1997, NZ ARCHAEOL ASS MO, V21; WEST HB, 1987, EARTH PLANET SC LETT, V84, P211, DOI 10.1016/0012-821X(87)90087-2; White memo Walter, COMMUNICATION, P16; White W.M., 1996, EARTH PROCESSES READ, P183, DOI [10.1029/GM095p0183, DOI 10.1029/GM095P0183]; Xu GP, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001554; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	40	78	79	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1907	1911		10.1126/science.1147013	http://dx.doi.org/10.1126/science.1147013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901331				2022-12-28	WOS:000249764300036
J	Lester, B				Lester, Benjamin			2007 visualization challenge winners	SCIENCE			English	Editorial Material									Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China		Lester, B (corresponding author), Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China.			Ottesen, Andrea/0000-0002-6425-7943					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1858	1863		10.1126/science.317.5846.1858	http://dx.doi.org/10.1126/science.317.5846.1858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901312				2022-12-28	WOS:000249764300013
J	Cobaleda, C; Jochum, W; Busslinger, M				Cobaleda, Cesar; Jochum, Wolfram; Busslinger, Meinrad			Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors	NATURE			English	Article							IN-VIVO; GENE REARRANGEMENT; STEM-CELLS; PAX5; MICE; TRANSCRIPTION; RECONSTITUTION; INACTIVATION; MUTAGENESIS; COMMITMENT	Lineage commitment and differentiation to a mature cell type are considered to be unidirectional and irreversible processes under physiological conditions(1). The commitment of haematopoietic progenitors to the B-cell lineage(2,3) and their development to mature B lymphocytes(4,5) critically depend on the transcription factor encoded by the paired box gene 5 (Pax5). Here we show that conditional Pax5 deletion in mice allowed mature B cells from peripheral lymphoid organs to dedifferentiate in vivo back to early uncommitted progenitors in the bone marrow, which rescued T lymphopoiesis in the thymus of T-cell-deficient mice. These B-cell-derived T lymphocytes carried not only immunoglobulin heavy- and light-chain gene rearrangements but also participated as functional T cells in immune reactions. Mice lacking Pax5 in mature B cells also developed aggressive lymphomas, which were identified by their gene expression profile as progenitor cell tumours. Hence, the complete loss of Pax5 in late B cells could initiate lymphoma development and uncovered an extraordinary plasticity of mature peripheral B cells despite their advanced differentiation stage.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Zurich; University Zurich Hospital	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Busslinger, Meinrad J./J-1249-2016; Cobaleda, Cesar/D-4668-2011	Busslinger, Meinrad J./0000-0002-9111-9351; Cobaleda, Cesar/0000-0003-3807-9204				Batch MJ, 1997, AGT CYTOGENETIC LAB; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sato H, 2004, J IMMUNOL, V172, P4858, DOI 10.4049/jimmunol.172.8.4858; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	40	361	381	0	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					473	U8		10.1038/nature06159	http://dx.doi.org/10.1038/nature06159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851532				2022-12-28	WOS:000249724800043
J	Halpern, SD; Ubel, PA; Asch, DA				Halpern, Scott D.; Ubel, Peter A.; Asch, David A.			Harnessing the power of default options to improve health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LUNG INJURY; CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; RECOMMENDATIONS; PATERNALISM; DECISIONS; PNEUMONIA; CHOICE		Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Dept Med, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Vet Affairs Med Ctr, Dept Med, Ann Arbor, MI USA; Univ Michigan, Ctr Behav & Decis Sci Med, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Halpern, SD (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, 711 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	scott.halpern@uphs.upenn.edu		Asch, David/0000-0002-7970-286X				[Anonymous], MMWR RECOMM REP; Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; BARON J, 1994, ORGAN BEHAV HUM DEC, V59, P475, DOI 10.1006/obhd.1994.1070; BARRINGER MW, 1994, IND LABOR RELAT REV, V48, P141, DOI 10.2307/2524631; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Camerer C, 2003, U PENN LAW REV, V151, P1211, DOI 10.2307/3312889; *COMM INCR RAT ORG, 2006, ORG DON OPP ACT; Cornia PB, 2003, AM J MED, V114, P404, DOI 10.1016/S0002-9343(02)01568-1; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Fink MP, 2006, CRIT CARE MED, V34, P1811, DOI 10.1097/01.CCM.0000218410.20050.8B; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Gimbel Ronald W, 2003, Prog Transplant, V13, P17; Halpern SD, 2005, JAMA-J AM MED ASSOC, V294, P734, DOI 10.1001/jama.294.6.734; Johnson EJ, 2004, TRANSPLANTATION, V78, P1713, DOI 10.1097/01.TP.0000149788.10382.B2; Johnson EJ, 2002, MARKET LETT, V13, P5, DOI 10.1023/A:1015044207315; JOHNSON EJ, 1993, J RISK UNCERTAINTY, V7, P35, DOI 10.1007/BF01065313; Kane RS, 1997, J AM GERIATR SOC, V45, P154, DOI 10.1111/j.1532-5415.1997.tb04500.x; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Schnirring L., 2007, IDSA URGES REQUIRING; Schweitzer M, 1996, MED CARE, V34, P583, DOI 10.1097/00005650-199606000-00008; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Sunstein CR, 2003, U CHICAGO LAW REV, V70, P1159, DOI 10.2307/1600573; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Ubel PA, 2002, ARCH INTERN MED, V162, P977, DOI 10.1001/archinte.162.9.977; [No title captured]	30	213	216	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1340	1344		10.1056/NEJMsb071595	http://dx.doi.org/10.1056/NEJMsb071595			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898105				2022-12-28	WOS:000249711500013
J	Huxley, A; Green, AG				Huxley, Andrew; Green, Andrew G.			Electrons acquire a split personality in bismuth	SCIENCE			English	Editorial Material									Univ Edinburgh, Scottish Univ Phys Alliance, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ St Andrews, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland	University of Edinburgh; University of St Andrews	Huxley, A (corresponding author), Univ Edinburgh, Scottish Univ Phys Alliance, Edinburgh EH9 3JZ, Midlothian, Scotland.	ahuxley@ph.ed.ac.uk		Green, Andrew/0000-0002-3923-5291				Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; Jain JK, 2007, COMPOSITE FERMIONS, P1, DOI 10.1017/CBO9780511607561; Wang YY, 2003, SCIENCE, V299, P86, DOI 10.1126/science.1078422	5	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1694	1695		10.1126/science.1148554	http://dx.doi.org/10.1126/science.1148554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885120				2022-12-28	WOS:000249585900029
J	Seandel, M; James, D; Shmelkov, SV; Falciatori, I; Kim, J; Chavala, S; Scherr, DS; Zhang, F; Torres, R; Gale, NW; Yancopoulos, GD; Murphy, A; Valenzuela, DM; Hobbs, RM; Pandolfi, PP; Rafii, S				Seandel, Marco; James, Daylon; Shmelkov, Sergey V.; Falciatori, Ilaria; Kim, Jiyeon; Chavala, Sai; Scherr, Douglas S.; Zhang, Fan; Torres, Richard; Gale, Nicholas W.; Yancopoulos, George D.; Murphy, Andrew; Valenzuela, David M.; Hobbs, Robin M.; Pandolfi, Pier Paolo; Rafii, Shahin			Generation of functional multipotent adult stem cells from GPR125(+) germline progenitors	NATURE			English	Article							NEONATAL MOUSE TESTIS; IN-VIVO; PLURIPOTENCY; EXPRESSION; MICE; SPERMATOGENESIS; TRANSPLANTATION; RENEWAL; CULTURE; GENES	Adult mammalian testis is a source of pluripotent stem cells(1). However, the lack of specific surface markers has hampered identification and tracking of the unrecognized subset of germ cells that gives rise to multipotent cells(2). Although embryonic-like cells can be derived from adult testis cultures after only several weeks in vitro(1), it is not known whether adult self-renewing spermatogonia in long-term culture can generate such stem cells as well. Here, we show that highly proliferative adult spermatogonial progenitor cells (SPCs) can be efficiently obtained by cultivation on mitotically inactivated testicular feeders containing CD34(+) stromal cells. SPCs exhibit testicular repopulating activity in vivo and maintain the ability in long-term culture to give rise to multipotent adult spermatogonial-derived stem cells (MASCs). Furthermore, both SPCs and MASCs express GPR125, an orphan adhesion-type G-protein-coupled receptor. In knock-in mice bearing a GPR125-beta-galactosidase (LacZ) fusion protein under control of the native Gpr125 promoter (GPR125-LacZ), expression in the testis was detected exclusively in spermatogonia and not in differentiated germ cells. Primary GPR125-LacZ SPC lines retained GPR125 expression, underwent clonal expansion, maintained the phenotype of germline stem cells, and reconstituted spermatogenesis in busulphan-treated mice. Long-term cultures of GPR125(+) SPCs (GSPCs) also converted into GPR125(+) MASC colonies. GPR125(+) MASCs generated derivatives of the three germ layers and contributed to chimaeric embryos, with concomitant downregulation of GPR125 during differentiation into GPR125(+) cells. MASCs also differentiated into contractile cardiac tissue in vitro and formed functional blood vessels in vivo. Molecular bookmarking by GPR125 in the adult mouse and, ultimately, in the human testis could enrich for a population of SPCs for derivation of GPR125(+) MASCs, which may be employed for genetic manipulation, tissue regeneration and revascularization of ischaemic organs.	Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA; Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02115 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, Canc Biol & Genet Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Div Med Oncol, Dept Med, New York, NY 10065 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Regeneron; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu	Mordwinkin, Nicholas M/A-4347-2010; Hobbs, Robin/I-2577-2014; Scherr, Daniel/D-4098-2019	Hobbs, Robin/0000-0002-3853-2614; Murphy, Andrew/0000-0003-4152-4081; Scherr, Daniel/0000-0001-5868-5493	NATIONAL EYE INSTITUTE [K08EY021171] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952, R01HL061849, R01HL097797, P01HL059312, P01HL067839, R21HL083222, P50HL084936, R01HL058707, R01HL075234] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [K08 EY021171] Funding Source: Medline; NHLBI NIH HHS [P01 HL059312-100006, R01 HL097797-01, R01 HL061849-03S1, U01 HL066952-040002, R01 HL061849-03, P01 HL059312-080006, P01 HL059312, R01 HL075234, P50 HL084936-020003, R21 HL083222-01, R01 HL097797, R01 HL097797-02, P01 HL059312-060006, R01 HL058707-03, U01 HL066952-020002, R01 HL075234-03, P01 HL067839, P50 HL084936-030003, R21 HL083222-02, P50 HL084936-010003, U01 HL066952-030002, R01 HL058707-04, P50 HL084936, P01 HL067839-020004, R01 HL075234-04, U01 HL066952, P50 HL084936-040003, P01 HL067839-030004, P01 HL067839-050004, P01 HL067839-010004, R01 HL075234-01, R01 HL061849-02, U01 HL066952-050002, U01 HL066952-010002, P01 HL067839-040004, R21 HL083222, P01 HL059312-090006, P01 HL059312-070006, R01 HL061849-04, R01 HL061849-05, R01 HL075234-02, R01 HL097797-03, R01 HL061849] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baba S, 2007, STEM CELLS, V25, P1375, DOI 10.1634/stemcells.2006-0574; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Ehmcke J, 2006, REPROD FERT DEVELOP, V18, P7, DOI 10.1071/RD05119; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, NAT BIOTECHNOL, V24, P663, DOI 10.1038/nbt0606-663; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuroda N, 2004, HISTOL HISTOPATHOL, V19, P743, DOI 10.14670/HH-19.743; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schatten G, 2005, NAT METHODS, V2, P455, DOI 10.1038/nmeth0605-455; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tanaka SS, 2000, GENE DEV, V14, P841; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322	32	322	350	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					346	+		10.1038/nature06129	http://dx.doi.org/10.1038/nature06129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882221	Green Accepted			2022-12-28	WOS:000249557300046
J	Ives, ST				Ives, Samuel T.			Ghosts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												samuelives@yahoo.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1259	1259		10.1001/jama.298.11.1259	http://dx.doi.org/10.1001/jama.298.11.1259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878412				2022-12-28	WOS:000249524100001
J	Sheldon, T				Sheldon, Tony			Cosmetic surgery gets under Dutch skin	BRITISH MEDICAL JOURNAL			English	Editorial Material												Tonysheldon5@cs.com						2003, BMJ, V327, P295; 2004, BMJ, V328, P520	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					541	541		10.1136/bmj.39335.547442.59	http://dx.doi.org/10.1136/bmj.39335.547442.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855322	Green Published			2022-12-28	WOS:000249790200031
J	Subrahmanian, VS				Subrahmanian, V. S.			Cultural modeling in real time	SCIENCE			English	Editorial Material									Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Subrahmanian, VS (corresponding author), Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.	vs@cs.umd.edu	Subrahmanian, Venkatramanan/ABA-7399-2021					BOND J, 2004, INT STUD ASS CONV MO; Edwards DavidB., 2002, TALIBAN GENEALOGIES; Gelfand M.J., 2002, HDB RES METHODS IND, P216; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; SCHRODT P, 2006, COMPUTER AIDED METHO, P161; SCHRODT PA, 2001, HIGH LEV SCI C ID WA; Subrahmanian VS, 2007, IEEE INTELL SYST, V22, P12, DOI 10.1109/MIS.2007.25; WILKENFELD J, 2007, NAT CONS STUD TERR R	8	15	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1509	1510		10.1126/science.1148306	http://dx.doi.org/10.1126/science.1148306			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872433				2022-12-28	WOS:000249467900028
J	Kent, DM; Hayward, RA				Kent, David M.; Hayward, Rodney A.			Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR; PRIMARY ANGIOPLASTY; SUBGROUP ANALYSIS; BENEFIT; HETEROGENEITY; MORTALITY; CONSUMERS; GUIDE		Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Univ Michigan, Vet Affairs Ann Arbor Hlth Serv Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dev Serv Ctr Excellence, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Tufts Medical Center; Tufts University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kent, DM (corresponding author), Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, 750 Washington St,Box 63, Boston, MA 02111 USA.	dkent1@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS044929] Funding Source: NIH RePORTER; NIDDK NIH HHS [P60 DK-20572] Funding Source: Medline; NINDS NIH HHS [K23 NS44929-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; *FOOD DRUG ADM, 2001, XIGR DROTR ALF ACT P; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117; Ioannidis JPA, 1997, J CLIN EPIDEMIOL, V50, P1089, DOI 10.1016/S0895-4356(97)00149-2; Kent DM, 2007, J AM SOC NEPHROL, V18, P1959, DOI 10.1681/ASN.2006101081; Kent DM, 2007, AM J CARDIOL, V99, P1384, DOI 10.1016/j.amjcard.2006.12.068; Kent DM, 2003, STROKE, V34, P464, DOI 10.1161/01.STR.0000051506.43212.8B; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Morrow DA, 2002, EUR HEART J, V23, P223, DOI 10.1053/euhj.2001.2738; *OXF CTR DIAB END, UKDPS RISK ENG; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Rothwell PM, 2005, LANCET, V365, P256; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Selker HP, 1997, ANN INTERN MED, V127, P538, DOI 10.7326/0003-4819-127-7-199710010-00006; Thune JJ, 2005, CIRCULATION, V112, P2017, DOI 10.1161/CIRCULATIONAHA.105.558676; Vijan S, 2000, DIABETOLOGIA, V43, P125, DOI 10.1007/s001250050017	22	351	356	2	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1209	1212		10.1001/jama.298.10.1209	http://dx.doi.org/10.1001/jama.298.10.1209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848656				2022-12-28	WOS:000249374200027
J	KOSHLAND, DE				KOSHLAND, DE			A NEW APPROACH TO FACULTY SALARIES	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1533	1533		10.1126/science.243.4898.1533	http://dx.doi.org/10.1126/science.243.4898.1533			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847250				2022-12-28	WOS:A1989T795200001
J	Stommel, JM; Kimmelman, AC; Ying, HQ; Nabioullin, R; Ponugoti, AH; Wiedemeyer, R; Stegh, AH; Bradner, JE; Ligon, KL; Brennan, C; Chin, L; DePinho, RA				Stommel, Jayne M.; Kimmelman, Alec C.; Ying, Haoqiang; Nabioullin, Roustem; Ponugoti, Aditya H.; Wiedemeyer, Ruprecht; Stegh, Alexander H.; Bradner, James E.; Ligon, Keith L.; Brennan, Cameron; Chin, Lynda; DePinho, Ronald A.			Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies	SCIENCE			English	Article							CONFERS ENHANCED TUMORIGENICITY; DIFFUSE GLIOMAS; INHIBITORS; CANCER; GLIOBLASTOMA; MARKER; COMMON; BRAIN; GENE; MET	Targeted therapies that inhibit receptor tyrosine kinases (RTKs) and the downstream phosphatidylinositol 3-kinase (PI3K) signaling pathway have shown promising anticancer activity, but their efficacy in the brain tumor glioblastoma multiforme (GBM) and other solid tumors has been modest. We hypothesized that multiple RTKs are coactivated in these tumors and that redundant inputs drive and maintain downstream signaling, thereby limiting the efficacy of therapies targeting single RTKs. Tumor cell lines, xenotransplants, and primary tumors indeed show multiple concomitantly activated RTKs. Combinations of RTK inhibitors and/or RNA interference, but not single agents, decreased signaling, cell survival, and anchorage-independent growth even in glioma cells deficient in PTEN, a frequently inactivated inhibitor of PI3K. Thus, effective GBM therapy may require combined regimens targeting multiple RTKs.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA 02115 USA; Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci, Ctr Appl Canc Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Hematol Neoplasia, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Cornell Univ, Dept Neurosurg, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Brennan, Cameron/R-7082-2019; Ying, Haoqiang/AAK-4325-2020; Stommel, Jayne M/M-3439-2017	Brennan, Cameron/0000-0003-4064-8891; DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [R01CA099041, P01CA095616] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA99041, 5P01CA95616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; El-Obeid A, 1997, CANCER RES, V57, P5598; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nagane M, 1996, CANCER RES, V56, P5079; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sonoda Y, 2001, CANCER RES, V61, P4956; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; WULLICH B, 1994, ANTICANCER RES, V14, P577	20	715	770	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					287	290		10.1126/science.1142946	http://dx.doi.org/10.1126/science.1142946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17872411				2022-12-28	WOS:000250086100051
J	Muller, K; Faeh, C; Diederich, F				Mueller, Klaus; Faeh, Christoph; Diederich, Francois			Fluorine in pharmaceuticals: Looking beyond intuition	SCIENCE			English	Review							THROMBIN ACTIVE-SITE; C-F; MEDICINAL CHEMISTRY; MULTIPOLAR INTERACTIONS; ORGANIC FLUORINE; INHIBITORS; DRUG; DISCOVERY; AFFINITY; POTENT	Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents. Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound. Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines. In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun. Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.	F Hoffmann La Roche, Div Pharmaceut, Discovery Chem, CH-4070 Basel, Switzerland; ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Roche Holding; Swiss Federal Institutes of Technology Domain; ETH Zurich	Muller, K (corresponding author), F Hoffmann La Roche, Div Pharmaceut, Discovery Chem, CH-4070 Basel, Switzerland.	klaus.mueller@roche.com; diederich@org.chem.ethz.ch						Alberati D, 2006, BIOORG MED CHEM LETT, V16, P4311, DOI 10.1016/j.bmcl.2006.05.058; Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Biffinger JC, 2004, CHEMBIOCHEM, V5, P622, DOI 10.1002/cbic.200300910; Black WC, 2005, BIOORG MED CHEM LETT, V15, P4741, DOI 10.1016/j.bmcl.2005.07.071; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; *CAMBR CRYST DAT C, 2007, CSD VERS 5 28; *CAMBR CRYST DAT C, 2005, PDB SEARCH PERF US W; *DAYL CHEM INF SYS, MEDCHEM DAT VERS 06; DELANO WL, 2006, MACPYMOL V0 99; Dolbier WR, 2005, J FLUORINE CHEM, V126, P157, DOI 10.1016/j.jfluchem.2004.09.033; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Dunitz JD, 2006, CHEM-EUR J, V12, P6804, DOI 10.1002/chem.200600092; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Fischer H, 2000, CHIMIA, V54, P640; Harper DB, 2003, HANDB ENVIRON CHEM, V3, P141; Hayashi H, 2002, CHEM COMMUN, P1618, DOI 10.1039/b204471d; HernandezTrujillo J, 1996, J PHYS CHEM-US, V100, P6524, DOI 10.1021/jp953576x; Hof F, 2004, ANGEW CHEM INT EDIT, V43, P5056, DOI 10.1002/anie.200460781; Hoffmann-Roder A, 2006, CHEMMEDCHEM, V1, P1205, DOI 10.1002/cmdc.200600124; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; Jamieson C, 2006, J MED CHEM, V49, P5029, DOI 10.1021/jm060379l; Jensen HH, 2002, CHEM-EUR J, V8, P1218, DOI 10.1002/1521-3765(20020301)8:5<1218::AID-CHEM1218>3.0.CO;2-X; Joubert J, 2003, ANGEW CHEM INT EDIT, V42, P3133, DOI 10.1002/anie.200351301; Kim CY, 2001, J AM CHEM SOC, V123, P9620, DOI 10.1021/ja011034p; Kim CY, 2000, J AM CHEM SOC, V122, P12125, DOI 10.1021/ja002627n; Kirk KL, 2006, J FLUORINE CHEM, V127, P1013, DOI 10.1016/j.jfluchem.2006.06.007; Kirsch P., 2013, MODERN FLUOROORGANIC; Krishnamurthy VM, 2007, CHEM-ASIAN J, V2, P94, DOI 10.1002/asia.200600360; Lal GS, 1999, J ORG CHEM, V64, P7048, DOI 10.1021/jo990566+; Leroux F, 2005, CHEM REV, V105, P827, DOI 10.1021/cr040075b; Leroux F, 2004, CHEMBIOCHEM, V5, P644, DOI 10.1002/cbic.200300906; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; MAREN TH, 1993, J BIOL CHEM, V268, P26233; Martino R, 2006, CHEMOTHERAPY, V52, P215, DOI 10.1159/000094744; MATSUMOTO J, 1984, J MED CHEM, V27, P292, DOI 10.1021/jm00369a011; Matsushima A, 2000, J BIOCHEM-TOKYO, V128, P225, DOI 10.1093/oxfordjournals.jbchem.a022745; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; MIDDLETON WJ, 1975, J ORG CHEM, V40, P574, DOI 10.1021/jo00893a007; Morgenthaler M, 2007, CHEMMEDCHEM, V2, P1100, DOI 10.1002/cmdc.200700059; Obst U, 1997, CHEM BIOL, V4, P287, DOI 10.1016/S1074-5521(97)90072-7; Olsen J, 2004, ORG BIOMOL CHEM, V2, P1339, DOI 10.1039/b402515f; Olsen JA, 2003, ANGEW CHEM INT EDIT, V42, P2507, DOI 10.1002/anie.200351268; Olsen JA, 2004, CHEMBIOCHEM, V5, P666, DOI 10.1002/cbic.200300907; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Patani GA, 1996, CHEM REV, V96, P3147, DOI 10.1021/cr950066q; Paulini R, 2005, ANGEW CHEM INT EDIT, V44, P1788, DOI 10.1002/anie.200462213; Perrin D.D., 1981, PKA PREDICTION ORGAN; Roth BD, 2002, PROGR MED CHEM, V40, P1, DOI 10.1016/S0079-6468(08)70080-8; ROTH BD, 1990, J MED CHEM, V33, P21, DOI 10.1021/jm00163a005; Rowley M, 2001, J MED CHEM, V44, P1603, DOI 10.1021/jm0004998; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Schweizer E, 2006, CHEMMEDCHEM, V1, P611, DOI 10.1002/cmdc.200600015; Schweizer E, 2006, ORG BIOMOL CHEM, V4, P2364, DOI 10.1039/b602585d; Smart B. E., 1994, ORGANOFLUORINE CHEM, P57, DOI DOI 10.1007/978-1-4899-1202-2_3; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Snyder JP, 2000, J AM CHEM SOC, V122, P544, DOI 10.1021/ja9934504; Sun AM, 2005, CHEM-EUR J, V11, P1579, DOI 10.1002/chem.200400835; van Niel MB, 1999, J MED CHEM, V42, P2087, DOI 10.1021/jm981133m; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Wollin L, 2006, PULM PHARMACOL THER, V19, P343, DOI 10.1016/j.pupt.2005.09.002; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Zhao K, 2003, BIOORGAN MED CHEM, V11, P207, DOI 10.1016/S0968-0896(02)00384-X; 2006, INTEGRITY PROUS SCI	65	4662	4707	25	901	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1881	1886		10.1126/science.1131943	http://dx.doi.org/10.1126/science.1131943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901324				2022-12-28	WOS:000249764300028
J	Norrie, J				Norrie, John			Trials of venous thromboembolism prevention	LANCET			English	Editorial Material									Univ Aberdeen, CHaRT, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Norrie, J (corresponding author), Univ Aberdeen, CHaRT, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	j.norrie@abdn.ac.uk			Chief Scientist Office [HSRU1] Funding Source: Medline	Chief Scientist Office		Boudes PF, 2006, CONTEMP CLIN TRIALS, V27, P432, DOI 10.1016/j.cct.2006.04.005; Committee for Proprietary Medicinal Products (CPMP), 2003, POINTS CONS ADJ BAS; *CPMP, 2005, REC NEED REV GUID CL; *CPMP, 2006, DRAFT GUID CLIN INV; *CPMP, 2000, POINTS CONS CLIN INV; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Goodacre S, 2006, HEALTH TECHNOL ASSES, V10, P1; Kassai B, 2005, J CLIN EPIDEMIOL, V58, P1042, DOI 10.1016/j.jclinepi.2005.02.024; O'Donnell M, 2007, LANCET, V369, P1413, DOI 10.1016/S0140-6736(07)60647-3; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Thabut G, 2006, EUR HEART J, V27, P227, DOI 10.1093/eurheartj/ehi587	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					915	917		10.1016/S0140-6736(07)61425-1	http://dx.doi.org/10.1016/S0140-6736(07)61425-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17869620				2022-12-28	WOS:000249506500006
J	Wilkinson, P; Smith, KR; Joffe, M; Haines, A				Wilkinson, Paul; Smith, Kirk R.; Joffe, Michael; Haines, Andrew			Energy and Health 1 - A global perspective on energy: health effects and injustices	LANCET			English	Article							CLIMATE-CHANGE; IMPACT	The exploitation of fossil fuels is integral to modem living and has been a key element of the rapid technological, social, and cultural changes of the past 250 years. Although such changes have brought undeniable benefits, this exploitation has contributed to a burden of illness through pollution of local and regional environments, and is the dominant cause of climate change. This pattern of development is therefore unsustainable at a global level. At the same time, about 2.4 billion of the world's population, disadvantaged by lack of access to clean energy, are exposed to high levels of indoor air pollutants from the inefficient burning of biomass fuels. Even in high-income countries, many people live in fuel poverty, and throughout the world, increasingly sedentary lifestyles (to which fossil-fuel-dependent transport systems contribute) are leading to chronic disease and injuries. Energy security is also an issue of growing concern to many governments in both the developed and developing world, and a potential source of international tension and conflict. In this Series, we examine the opportunities to improve health, reduce climate effects, and promote development through realistic adjustments in the way energy and food are produced and consumed.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ London Imperial Coll Sci Technol & Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; Imperial College London	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X				*AIR QUAL EXP GROU, 2006, AIR QUAL CLIM CHANG; BIROL F, 2007, WORLD ENERGY OUTLOOK; BORROUGHS WJ, 2001, CLIMATE CHANGE MULTI; CASSIDY E, 2000, PROSPECTS SUSTAINABL; Chertow MR., 2000, J IND ECOL, V4, P13, DOI [DOI 10.1162/10881980052541927, 10.1162/10881980052541927]; Cohen JR, 2006, J BUS ETHICS, V68, P1, DOI 10.1007/s10551-006-9036-2; Concha-Barrientos M, 2004, COMP QUANTIFICATION, P1651; *DEFRA DTL, 2006, 4 DEFRADTL; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; *FOOD AGR ORG, CLIM CHANG; Global Commons Institute, CONTR CONV GLOB SOL; GOLDEMBERG J, 2005, WORLD ENERGY ASSESSM; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; HERBST AM, 2006, NUCL ENERGY TIME COM; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; HOLDREN JP, 2000, WORLD ENERGY ASSESSM; *INT EN AG, LIST SERV; Jaccard M, 2005, SUSTAINABLE FOSSIL FUELS: THE UNUSUAL SUSPECT IN THE QUEST FOR CLEAN AND ENDURING ENERGY, P1; Krzyzanowski M., 2004, COMP QUANTIFICATION, P1353; Marland G., 2003, GLOBAL REGIONAL NATL; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Mcmichael A.J., 2003, ATL HLTH CLIM; MEHTA S, 2006, ENERGY SUSTAIN DEV, V10, P36; O'Neill BC., 2001, POPULATION CLIMATE C; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Reddy A., 2000, WORLD ENERGY ASSESSM, V2000, P41; Rogner HH, 2000, WORLD ENERGY ASSESSM, P135; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Smil V, 2000, ANNU REV ENERG ENV, V25, P21, DOI 10.1146/annurev.energy.25.1.21; SMIL V, 2005, ENERGY CROSSROADS GL, P317; SMITH K, 2005, HOUSEHOLS FUELS ILL; SMITH K, 2005, ANN REV ENERGY RES, V30, P29; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith K. R, 1990, INT ENVIRON AFFAIR, V2, P227; SMITH KR, 1978, SCIENCE, V201, P609, DOI 10.1126/science.201.4356.609; SMITH KR, IN PRESS ANN REV PUB; SMITH KR, 2002, ENV CHANGE CLIMATE H, P52; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stern Nicholas, 2007, EC CLIMATE CHANGE; TANS P, 2006, NOAA ESRL TRENDS ATM; *UN DEV PROGR, HUM DEV REP 2006; *UNDP, 1997, EN RIO PROSP CHALL; *WHO, 2002, WHO USAID GLOB CONS; WHO Working Group, 2003, EUR035042688 WHO WOR; Wilkinson P, 2001, COLD COMFORT SOCIAL; *WORLD BANK, WORLD BANKS APPR CLE; *WORLD RES I, EN RES; *WORLD RES I, EARTH TRENDS; [No title captured]	51	127	128	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					965	978		10.1016/S0140-6736(07)61252-5	http://dx.doi.org/10.1016/S0140-6736(07)61252-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17876909				2022-12-28	WOS:000249506500029
J	Kefi, S; Rietkerk, M; Alados, CL; Pueyo, Y; Papanastasis, VP; ElAich, A; de Ruiter, PC				Kefi, Sonia; Rietkerk, Max; Alados, Concepcion L.; Pueyo, Yolanda; Papanastasis, Vasilios P.; ElAich, Ahmed; de Ruiter, Peter C.			Spatial vegetation patterns and imminent desertification in Mediterranean arid ecosystems	NATURE			English	Article							SELF-ORGANIZED PATCHINESS; CATASTROPHIC SHIFTS; GLOBAL DESERTIFICATION; FACILITATION; CRITICALITY; DISTURBANCE; COMPETITION; SIGNATURES; DYNAMICS; SYSTEMS	Humans and climate affect ecosystems and their services(1), which may involve continuous and discontinuous transitions from one stable state to another(2). Discontinuous transitions are abrupt, irreversible and among the most catastrophic changes of ecosystems identified(1). For terrestrial ecosystems, it has been hypothesized that vegetation patchiness could be used as a signature of imminent transitions(3,4). Here, we analyse how vegetation patchiness changes in arid ecosystems with different grazing pressures, using both field data and a modelling approach. In the modelling approach, we extrapolated our analysis to even higher grazing pressures to investigate the vegetation patchiness when desertification is imminent. In three arid Mediterranean ecosystems in Spain, Greece and Morocco, we found that the patch-size distribution of the vegetation follows a power law. Using a stochastic cellular automaton model, we show that local positive interactions among plants can explain such power-law distributions. Furthermore, with increasing grazing pressure, the field data revealed consistent deviations from power laws. Increased grazing pressure leads to similar deviations in the model. When grazing was further increased in the model, we found that these deviations always and only occurred close to transition to desert, independent of the type of transition, and regardless of the vegetation cover. Therefore, we propose that patch-size distributions may be a warning signal for the onset of desertification.	Univ Utrecht, Copernicus Inst, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands; Pyrenean Inst Ecol, Zaragoza 50192, Spain; Aristotle Univ Thessaloniki, Lab Rangeland Ecol, Thessaloniki 54006, Greece; Inst Agron & Vet Hassan II, Dept Anim Prod, Rabat, Morocco; Univ Wageningen & Res Ctr, Soil Ctr, NL-6708 PB Wageningen, Netherlands	Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Aristotle University of Thessaloniki; Wageningen University & Research	Kefi, S (corresponding author), Univ Utrecht, Copernicus Inst, Dept Environm Sci, POB 80115, NL-3508 TC Utrecht, Netherlands.	kefi@geo.uu.nl	Pueyo, Yolanda/I-4248-2015; Alados, Concepción L/K-8085-2014; Rietkerk, Max/H-6235-2011	Pueyo, Yolanda/0000-0001-6970-7790; Alados, Concepción L/0000-0002-6227-861X; Rietkerk, Max/0000-0002-2698-3848; Kefi, Sonia/0000-0002-9678-7770				Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; INGERSON TE, 1984, PHYSICA D, V10, P59, DOI 10.1016/0167-2789(84)90249-5; IWASA Y, 2000, GEOMETRY ECOLOGICAL, P227; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; KUTZNETSOV YA, 1997, CONTENT MULTIPLATFOR; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MATSUDA H, 1992, PROG THEOR PHYS, V88, P1035, DOI 10.1143/PTP.88.1035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Pueyo Y, 2007, BASIC APPL ECOL, V8, P158, DOI 10.1016/j.baae.2006.03.009; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; SCHABENBERGER O, 2002, CONT STAT MODELS PLA, P1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SOLE RV, 2006, SELF ORG COMPLEX ECO, P215; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; [No title captured]	30	682	714	20	508	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					213	U5		10.1038/nature06111	http://dx.doi.org/10.1038/nature06111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851524	Green Published			2022-12-28	WOS:000249394500049
J	Pearson, DG; Parman, SW; Nowell, GM				Pearson, D. G.; Parman, S. W.; Nowell, G. M.			A link between large mantle melting events and continent growth seen in osmium isotopes	NATURE			English	Article							RE-187-OS-187 SYSTEMATICS; ABYSSAL PERIDOTITES; OS ISOTOPES; EVOLUTION; CONSTRAINTS; CHONDRITES; TIME	Although Earth's continental crust is thought to have been derived from the mantle, the timing and mode of crust formation have proven to be elusive issues. The area of preserved crust diminishes markedly with age(1,2), and this can be interpreted as being the result of either the progressive accumulation of new crust(3) or the tectonic recycling of old crust(4). However, there is a disproportionate amount of crust of certain ages(1,2), with the main peaks being 1.2, 1.9, 2.7 and 3.3 billion years old; this has led to a third model in which the crust has grown through time in pulses(1,2,5-7), although peaks in continental crust ages could also record preferential preservation. The Re-187-Os-187 decay system is unique in its ability to track melt depletion events within the mantle and could therefore potentially link the crust and mantle differentiation records. Here we employ a laser ablation technique to analyse large numbers of osmium alloy grains to quantify the distribution of depletion ages in the Earth's upper mantle. Statistical analysis of these data, combined with other samples of the upper mantle, show that depletion ages are not evenly distributed but cluster in distinct periods, around 1.2, 1.9 and 2.7 billion years. These mantle depletion events coincide with peaks in the generation of continental crust and so provide evidence of coupled, global and pulsed mantle crust differentiation, lending strong support to pulsed models of continental growth by means of large-scale mantle melting events(6).	Univ Durham, Dept Earth Sci, No Ctr Isotop & Elemental Tracing, Durham DH1 4QE, England	Durham University	Pearson, DG (corresponding author), Univ Durham, Dept Earth Sci, No Ctr Isotop & Elemental Tracing, South Rd, Durham DH1 4QE, England.	d.g.pearson@durham.ac.uk	Pearson, Graham/AAN-5507-2020	Parman, Stephen/0000-0002-7523-8684; Nowell, Geoff/0000-0003-3229-128X				Alard O, 2005, NATURE, V436, P1005, DOI 10.1038/nature03902; ALLEGRE CJ, 1984, EARTH PLANET SC LETT, V67, P19, DOI 10.1016/0012-821X(84)90035-9; ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; Brandon AD, 2006, GEOCHIM COSMOCHIM AC, V70, P2093, DOI 10.1016/j.gca.2006.01.005; Brandon AD, 2000, EARTH PLANET SC LETT, V177, P319, DOI 10.1016/S0012-821X(00)00044-3; Brenker FE, 2003, AM MINERAL, V88, P1731, DOI 10.2138/am-2003-11-1214; Carlson RW, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000156; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; GASTIL G, 1960, AM J SCI, V258, P1; Goldstein S, 1997, CHEM GEOL, V139, P271, DOI 10.1016/S0009-2541(97)00039-9; Griffin WL, 2004, CHEM GEOL, V208, P89, DOI 10.1016/j.chemgeo.2004.04.007; Griffin WL, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000287; HARRIS DC, 1991, CAN MINERAL, V29, P231; Harvey J, 2006, EARTH PLANET SC LETT, V244, P606, DOI 10.1016/j.epsl.2006.02.031; HATTORI K, 1991, EARTH PLANET SC LETT, V107, P499, DOI 10.1016/0012-821X(91)90096-Z; HURLEY PM, 1969, SCIENCE, V164, P1229, DOI 10.1126/science.164.3885.1229; Jasra A, 2006, MATH GEOL, V38, P269, DOI 10.1007/s11004-005-9019-3; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; Ludwig KR, 1997, ISOPLOT PROGRAM DOCU; MATEEV S, 2002, EARTH PLANET SC LETT, V203, P235; Meibom A, 2002, NATURE, V419, P705, DOI 10.1038/nature01067; Meibom A, 2002, SCIENCE, V296, P516, DOI 10.1126/science.1069119; Parkinson IJ, 1998, SCIENCE, V281, P2011, DOI 10.1126/science.281.5385.2011; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; PEARSON DG, 1999, SPEC PUB GEOCHEM SOC, V6, P57; SAMBRIDGE MS, 1994, EARTH PLANET SC LETT, V128, P373, DOI 10.1016/0012-821X(94)90157-0; Shi RD, 2007, EARTH PLANET SC LETT, V261, P33, DOI 10.1016/j.epsl.2007.05.044; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Walker RJ, 2005, EARTH PLANET SC LETT, V230, P211, DOI 10.1016/j.epsl.2004.11.009; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P4187, DOI 10.1016/S0016-7037(02)01003-7	30	191	203	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					202	205		10.1038/nature06122	http://dx.doi.org/10.1038/nature06122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851521				2022-12-28	WOS:000249394500046
J	Tzedakis, PC; Hughen, KA; Cacho, I; Harvati, K				Tzedakis, P. C.; Hughen, K. A.; Cacho, I.; Harvati, K.			Placing late Neanderthals in a climatic context	NATURE			English	Article							RADIOCARBON AGE CALIBRATION; ALBORAN SEA; MARINE; SCALE; EVENT	Attempts to place Palaeolithic finds within a precise climatic framework are complicated by both uncertainty over the radiocarbon calibration beyond about 21,500 C-14 years BP1 and the absence of a master calendar chronology for climate events from reference archives such as Greenland ice cores or speleothems(2). Here we present an alternative approach, in which C-14 dates of interest are mapped directly onto the palaeoclimate record of the Cariaco Basin by means of its C-14 series(3), circumventing calendar age model and correlation uncertainties, and placing dated events in the millennial-scale climate context of the last glacial period. This is applied to different sets of dates from levels with Mousterian artefacts, presumably produced by late Neanderthals, from Gorham's Cave in Gibraltar: first, generally accepted estimates of about 32,000 C-14 years BP for the upper-most Mousterian levels(4,5); second, a possible extended Middle Palaeolithic occupation until about 28,000 C-14 years BP6; and third, more contentious evidence for persistence until about 24,000 C-14 years BP6. This study shows that the three sets translate to different scenarios on the role of climate in Neanderthal extinction. The first two correspond to intervals of general climatic instability between stadials and interstadials that characterized most of the Middle Pleniglacial and are not coeval with Heinrich Events. In contrast, if accepted, the youngest date indicates that late Neanderthals may have persisted up to the onset of a major environmental shift, which included an expansion in global ice volume and an increased latitudinal temperature gradient. More generally, our radiocarbon climatostratigraphic approach can be applied to any 'snapshot' date from discontinuous records in a variety of deposits and can become a powerful tool in evaluating the climatic signature of critical intervals in Late Pleistocene human evolution.	Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Aegean, Dept Environm, Mitilini 81100, Greece; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Barcelona, GRC Marine Geosci, E-08028 Barcelona, Spain; Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany	University of Leeds; University of Aegean; Woods Hole Oceanographic Institution; University of Barcelona; Max Planck Society	Tzedakis, PC (corresponding author), Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England.	p.c.tzedakis@leeds.ac.uk	Rohlf, F J/A-8710-2008; Harvati, Katerina/A-5197-2008; Cacho, Isabel/H-4402-2013; Tzedakis, Polychronis/J-1894-2012; Cacho, Isabel/AAX-2610-2021	Cacho, Isabel/0000-0002-6512-0770; Cacho, Isabel/0000-0002-6512-0770; Tzedakis, Polychronis/0000-0001-6072-1166				Bronk Ramsey Christopher, 2002, ARCHAEOMETRY, V44, P1, DOI DOI 10.1111/J.1475-4754.2002.TB01101.X; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Delson E, 2006, NATURE, V443, DOI 10.1038/nature05207; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Moreno A, 2005, QUATERNARY SCI REV, V24, P1623, DOI 10.1016/j.quascirev.2004.06.018; Nebout NC, 2002, GEOLOGY, V30, P863, DOI 10.1130/0091-7613(2002)030<0863:EAAAHP>2.0.CO;2; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pettitt P.B., 2000, NEANDERTHALS EDGE, P155; PONS A, 1988, PALAEOGEOGR PALAEOCL, V66, P243, DOI 10.1016/0031-0182(88)90202-7; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; SEVNSSON A, 2006, QUATERNARY SCI REV, V25, P3258; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; STRINGER C, 2003, NEANDERTHALS MODERN, P233; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Walker MJC, 1999, QUATERNARY SCI REV, V18, P1143, DOI 10.1016/S0277-3791(99)00023-2; Weinelt M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000772; ZILHAO J, 2006, BEFORE FARMING; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A	27	78	78	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					206	208		10.1038/nature06117	http://dx.doi.org/10.1038/nature06117			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851522	Green Published			2022-12-28	WOS:000249394500047
J	WEBSTER, OW				WEBSTER, OW			LIVING POLYMERIZATION METHODS	SCIENCE			English	Article							METHACRYLATE-TERMINATED POLYSTYRENE; ANIONIC-POLYMERIZATION; COORDINATION POLYMERIZATION; IMMORTAL POLYMERIZATION; RADICAL POLYMERIZATION; METHYL-METHACRYLATE; ALUMINUM PORPHYRIN; GRAFT POLYMERS; MODEL; MACROMONOMERS	Living polymerization techniques can be used to achieve a high degree of control over polymer chain architecture. Examples of the type of polymers that can be synthesized include block copolymers, comb-shaped polymers, multiarmed polymers, ladder polymers, and cyclic polymers. This control of structure, in turn, results in polymers with widely diverse physical properties, even though they are made from readily available low-cost monomers.			WEBSTER, OW (corresponding author), DUPONT CO,CENT RES & DEV,POB 80328,WILMINGTON,DE 19880, USA.							AIDA T, 1988, MACROMOLECULES, V21, P1195, DOI 10.1021/ma00183a001; ANDERSON BC, 1981, MACROMOLECULES, V14, P1599, DOI 10.1021/ma50006a093; ASANO S, 1985, J CHEM SOC CHEM COMM, P1148, DOI 10.1039/c39850001148; BAUER BJ, 1978, RUBBER CHEM TECHNOL, V51, P406, DOI 10.5254/1.3535747; BERCAW JE, 1989, NOV WORKSH HOM CAT A; BIGDELI E, 1978, MACROMOLECULES, V11, P493, DOI 10.1021/ma60063a013; BLEDZKI A, 1983, MAKROMOL CHEM, V184, P745; BOCHMANN M, 1990, ANGEW CHEM INT EDIT, V29, P780, DOI 10.1002/anie.199007801; BRODY H, 1958, CHEM IND REV, V45, P1473; CHO CG, 1990, MACROMOLECULES, V23, P1918, DOI 10.1021/ma00209a006; DOI Y, 1987, MAKROMOL CHEM, V188, P1273; DOI Y, 1985, MAKROMOL CHEM, V186, P11; DOI Y, 1979, MACROMOLECULES, V12, P814, DOI 10.1021/ma60071a004; FAUST R, 1986, POLYM BULL, V15, P317; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; GEISER D, 1980, POLYM B, V2, P59; GORMAN C, 1990, POLYM PREPR, V31, P386; GRUBBS RH, 1989, SCIENCE, V243, P907, DOI 10.1126/science.2645643; GRUBBS RH, 1986, J AM CHEM SOC, V108, P733; HADJIANDREOU P, 1984, MACROMOLECULES, V17, P2456; HIGASHIMURA T, 1988, MAKROMOL CHEM-M SYMP, V13-4, P457, DOI 10.1002/masy.19880130133; HILD G, 1980, EUR POLYM J, V16, P555; INOUE S, 1990, MAKROMOL CHEM-M SYMP, V32, P255, DOI 10.1002/masy.19900320120; ISHIHAMA Y, 1990, POLYM BULL, V24, P201, DOI 10.1007/BF00297318; ISHIHAMA Y, 1990, POLYM BULL, V23, P361, DOI 10.1007/BF00294864; IVAN B, 1990, POLYM PREPR AM CHEM, V33, P215; IVAN B, 1990, POLYM PREPR AM CHEM, V33, P217; KANAOKA S, 1990, J POLYM SCI POL CHEM, V28, P1127, DOI 10.1002/pola.1990.080280513; KASZAS G, 1990, MACROMOLECULES, V23, P3909, DOI 10.1021/ma00219a008; Kennedy J. P., 1982, CARBOCATIONIC POLYM; KENNEDY JP, 1990, MACROMOLECULES, V23, P3736, DOI 10.1021/ma00218a004; KENNEDY JP, 1982, ORGANIC COATINGS APP, V46, P182; KLAVETTER FL, 1988, J AM CHEM SOC, V110, P7807, DOI 10.1021/ja00231a036; KOBAYASHI S, 1984, RING OPENING POLYM, V2, pCH11; LAUTENSCHLAEGER F, 1972, J MACROMOL SCI CHEM, VA  6, P1089, DOI 10.1080/10601327208056887; LIN CH, 1990, POLYM PREPR AM CHEM, V31, P599; MASUDA T, 1989, MACROMOLECULES, V22, P3805; MILKOVICH R, 1981, ACS SYM SER, V166, P42; MISHRA MK, 1987, J MACROMOL SCI CHEM, VA24, P933, DOI 10.1080/00222338708076927; MIYAMOTO M, 1984, MACROMOLECULES, V17, P265, DOI 10.1021/ma00133a001; MOHAJER Y, 1982, POLYM BULL, V8, P47; Morton M., 1983, ANIONIC POLYM PRINCI; MURDZEK JS, 1987, MACROMOLECULES, V20, P2460; NOVAK BM, 1988, J AM CHEM SOC, V110, P7542, DOI 10.1021/ja00230a047; OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P133; OTSU T, 1989, EUR POLYM J, V25, P643, DOI 10.1016/0014-3057(89)90023-2; PENCZEK S, 1988, POLYM PREPR AM CHEM, V29, P38; PLESCH PH, 1990, MAKROMOL CHEM-M SYMP, V32, P299, DOI 10.1002/masy.19900320123; QUIRK RP, 1989, POLYM BULL, V22, P63; REETZ MT, 1988, ANGEW CHEM INT EDIT, V27, P1373, DOI 10.1002/anie.198813731; SAAM JC, 1970, MACROMOLECULES, V3, P1, DOI 10.1021/ma60013a001; SAEGUSA T, 1973, MACROMOLECULES, V6, P315, DOI 10.1021/ma60033a002; SAEGUSA T, 1988, MAKROMOL CHEM-M SYMP, V13-4, P111, DOI 10.1002/masy.19880130110; SAWAMOTO M, 1990, JUL MACR 90 INT UN P; SCHROCK RR, 1990, ACCOUNTS CHEM RES, V23, P158, DOI 10.1021/ar00173a007; SCHULZ GO, 1982, J APPL POLYM SCI, V27, P4773, DOI 10.1002/app.1982.070271222; SCHULZ GO, 1984, J POLYM SCI POL CHEM, V22, P1633, DOI 10.1002/pol.1984.170220711; SIMMS JA, 1987, J COATING TECHNOL, V59, P125; SMITH S, 1973, J MACROMOL SCI CHEM, VA  7, P1399, DOI 10.1080/10601327308060509; SOGAH DY, 1987, MACROMOLECULES, V20, P1473, DOI 10.1021/ma00173a006; SOGAH DY, 1985, ORGANOSILICON BIOORG, pCH20; SOGAH DY, 1988, POLYM PREPR AM CHEM, V33, P215; Solomon D.H., 1986, US Patent, Patent No. [4581429, 4 581 429]; SZWARC M, 1956, J AM CHEM SOC, V78, P2656, DOI 10.1021/ja01592a101; SZWARC M, 1968, CARBANIONS LIVING PO; TEYSSIE P, 1990, MAKROMOL CHEM-M SYMP, V32, P61, DOI 10.1002/masy.19900320107; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; VOLLMERT B, 1981, MAKROMOL CHEM-RAPID, V2, P467; WEBSTER OW, 1983, J AM CHEM SOC, V105, P5706, DOI 10.1021/ja00355a039; WORSFOLD DJ, 1969, CAN J CHEMISTRY, V47, P3379, DOI 10.1139/v69-560; YOSHIMURA T, 1988, MACROMOLECULES, V21, P1899, DOI 10.1021/ma00185a002; Ziegler K, 1936, ANGEW CHEM-GER EDIT, V49, P0499, DOI 10.1002/ange.19360493003	72	772	813	2	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					887	893		10.1126/science.251.4996.887	http://dx.doi.org/10.1126/science.251.4996.887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847382				2022-12-28	WOS:A1991EY62900033
J	Legg, L; Drummond, A; Leonardi-Bee, J; Gladman, JRF; Corr, S; Donkervoort, M; Edmans, J; Gilbertson, L; Jongboed, L; Logan, P; Sackley, C; Walker, M; Langhorne, P				Legg, Lynn; Drummond, Avril; Leonardi-Bee, Jo; Gladman, J. R. F.; Corr, Susan; Donkervoort, Mireille; Edmans, Judi; Gilbertson, Louise; Jongboed, Lyn; Logan, Pip; Sackley, Catherine; Walker, Marion; Langhorne, Peter			Occupational therapy for patients with problems in personal activities of daily living after stroke: systematic review of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REHABILITATION	Objective To determine whether occupational therapy focused specifically on personal activities of daily living improves recovery for patients after stroke. Design Systematic review and meta-analysis. Data sources The Cochrane stroke group trials register, the Cochrane central register of controlled trials, Medline, Embase, CINAHL, PsycLIT, AMED, Wilson Social Sciences Abstracts, Science Citation Index, Social Science Citation, Arts and Humanities Citation Index, Dissertations Abstracts register, Occupational Therapy Research Index, scanning reference lists, personal communication with authors, and hand searching. Review methods Trials were included if they evaluated the effect of occupational therapy focused on practice of personal activities of daily living or where performance in such activities was the target of the occupational therapy intervention in a stroke population. Original data were sought from trialists. Two reviewers independently reviewed each trial for methodological quality. Disagreements were resolved by consensus. Results Nine randomised controlled trials including 12 58 participants met the inclusion criteria. Occupational therapy delivered to patients after stroke and targeted towards personal activities of daily living increased performance scores (standardised mean difference 0. 18, 95% confidence interval 0.04 to 0.32, P=0.01) and reduced the risk of poor outcome (death, deterioration or dependency in personal activities of daily living) (odds ratio 0.67, 95% confidence interval 0.51 to 0.87, P=0.003). For every 100 people who received occupational therapy focused on personal activities of daily living, 11 (95% confidence interval 7 to 30) would be spared a poor outcome. Conclusions Occupational therapy focused on improving personal activities of daily living after stroke can improve performance and reduce the risk of deterioration in these abilities. Focused occupational therapy should be available to everyone who has had a stroke.	Glasgow Royal Infirm Univ NHS Trust, Acad Sect Geriatr Med, Glasgow G31 2ER, Lanark, Scotland; Queens Med Ctr, Sch Med, Div Rehabil & Ageing, Nottingham NG7 2UH, England; Univ Northampton, Sch Hlth, Div Occupat Therapy, Northampton NN2 7AL, England; Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Royal Haslar Hosp, Occupat Therapy Serv, Gosport PO12 2AA, Hants, England; Univ British Columbia, Sch Rehabil Sci, Online Programs, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V6T 2B5, Canada; Univ Birmingham, Sch Hlth Sci, Birmingham B15 2TT, W Midlands, England	University of Nottingham; University of Northampton; Erasmus University Rotterdam; Erasmus MC; University of British Columbia; University of Birmingham	Legg, L (corresponding author), Glasgow Royal Infirm Univ NHS Trust, Acad Sect Geriatr Med, Glasgow G31 2ER, Lanark, Scotland.	step@clinmed.ga.ac.uk	; Gladman, John/M-7429-2015	Logan, Philippa/0000-0002-6657-2381; Leonardi-Bee, Jo/0000-0003-0893-6068; Walker, Marion/0000-0002-3534-591X; Drummond, Avril/0000-0003-1220-8354; Corr, Susan/0000-0001-6018-5260; Gladman, John/0000-0002-8506-7786; sackley, catherine/0000-0002-8580-6622				*AM OCC THER ASS, 1994, AM J OCCUP THER, V48, P1072; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Collin C, 1988, Int Disabil Stud, V10, P61; De Wit L, 2006, STROKE, V37, P1483, DOI 10.1161/01.STR.0000221709.23293.c2; Granger CV, 1993, GUIDE UNIFORM DATA S; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIGGINS JPT, 2005, COCHRANE LIB; HOPSON S, 1981, PRACTICE OCCUPATIONA, P31; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Legg L, 2004, LANCET, V363, P352; Legg LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003585.pub2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray DM, 2001, STAT MED, V20, P1373, DOI 10.1002/sim.675; *NORD COCHR CTR CO, 2003, REV MAN REVMAN VERS; SANDERCOCK P, 2002, COCHRANE LIB; Steultjens EMJ, 2005, CLIN REHABIL, V19, P247, DOI 10.1191/0269215505cr870oa; Steultjens EMJ, 2003, STROKE, V34, P676, DOI 10.1161/01.STR.0000057576.77308.30; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Walker MF, 2004, STROKE, V35, P2226, DOI 10.1161/01.STR.0000137766.17092.fb; WHITING S, 1980, BR J OCCUP THER, V2, P44	22	91	95	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					922	925		10.1136/bmj.39343.466863.55	http://dx.doi.org/10.1136/bmj.39343.466863.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17901469	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000250848300032
J	Lande, R; Gregorio, J; Facchinetti, V; Chatterjee, B; Wang, YH; Homey, B; Cao, W; Wang, YH; Su, B; Nestle, FO; Zal, T; Mellman, I; Schroder, JM; Liu, YJ; Gilliet, M				Lande, Roberto; Gregorio, Josh; Facchinetti, Valeria; Chatterjee, Bithi; Wang, Yi-Hong; Homey, Bernhard; Cao, Wei; Wang, Yui-Hsi; Su, Bing; Nestle, Frank O.; Zal, Tomasz; Mellman, Ira; Schroeder, Jens-Michael; Liu, Yong-Jun; Gilliet, Michel			Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide	NATURE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; HUMAN SKIN; INNATE IMMUNITY; VERTEBRATE DNA; BACTERIAL-DNA; PSORIASIS; ALPHA; AUTOIMMUNITY; LL-37	Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Genentech Inc, San Francisco, CA 94080 USA; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Kings Coll London Sch Med, St Johns Inst Dermatol, London SE1 9RT, England; Univ Kiel, Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University; Roche Holding; Genentech; Heinrich Heine University Dusseldorf; University of London; King's College London; University of Kiel; Schleswig Holstein University Hospital	Gilliet, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	mgilliet@mdanderson.org	Lande, Roberto/B-9987-2016; Mellman, Ira/ABG-5896-2020; Schroeder, Jens M/B-3994-2009; Lande, Roberto/L-5803-2019	Lande, Roberto/0000-0001-8398-4567; Lande, Roberto/0000-0001-8398-4567; Zal, Tomasz/0000-0002-3469-4261; Cao, Wei/0000-0002-8952-9159				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dufourcq J, 1998, FEBS LETT, V421, P7, DOI 10.1016/S0014-5793(97)01522-6; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Griffiths CEM, 1996, J ROY SOC MED, V89, P315, DOI 10.1177/014107689608900604; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kubo T, 2001, NUCLEOS NUCLEOT NUCL, V20, P1313, DOI 10.1081/NCN-100002544; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Li XQ, 2005, BIOCHEMISTRY-US, V44, P14688, DOI 10.1021/bi051519g; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Niidome T, 2000, J PEPT SCI, V6, P271, DOI 10.1002/1099-1387(200006)6:6<271::AID-PSC249>3.3.CO;2-6; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zal T, 2006, TRAFFIC, V7, P1607, DOI 10.1111/j.1600-0854.2006.00498.x; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	42	1266	1336	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					564	U6		10.1038/nature06116	http://dx.doi.org/10.1038/nature06116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873860				2022-12-28	WOS:000249893500037
J	Victora, CG; Black, RE; Bryce, J				Victora, Cesar G.; Black, Robert E.; Bryce, Jennifer			Learning from new initiatives in maternal and child health	LANCET			English	Editorial Material									Univ Fed Pelotas, BR-96001 Pelotas, RS, Brazil; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Universidade Federal de Pelotas; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96001 Pelotas, RS, Brazil.	cvictora@terra.com.br	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Black, Robert/0000-0001-9926-7984				[Anonymous], DEM HLTH SURV; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Evaluation Gap Working Group, 2006, WHEN WILL WE EV LEAR; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; *UNICEF, MON SIT WOM MULT IND; World Health Organization, INT MAN CHILDH ILLN	9	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1113	1114		10.1016/S0140-6736(07)61492-5	http://dx.doi.org/10.1016/S0140-6736(07)61492-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221YQ	17905150				2022-12-28	WOS:000250263700010
J	Finney, B				Finney, Ben			Tracking Polynesian seafarers	SCIENCE			English	Editorial Material									Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA	University of Hawaii System	Finney, B (corresponding author), Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA.	bfinney@hawaii.edu						Collerson KD, 2007, SCIENCE, V317, P1907, DOI 10.1126/science.1147013; COOK J, 1955, VOYAGE ENDEAVOUR, P153; FINNEY BR, 1977, SCIENCE, V196, P1277, DOI 10.1126/science.196.4296.1277; FINNEY BR, 1967, POLYNESIAN CULTURE H, V56, P141; GREEN RC, 1996, B INDOPACIFIC PREHIS, V15, P119; IRWIN G, 1989, J POLYNESIAN SOC, V98, P167; Kirch P., 2001, HAWAIKI ANCESTRAL PO; Lewis D., 1972, WE NAVIGATORS; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; WEISLER MI, 1997, ARCHAEOL ASS MONOGR, V21; Wilson E. O., 1998, CONSILIENCE UNITY KN	11	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1873	1874		10.1126/science.1149035	http://dx.doi.org/10.1126/science.1149035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901319				2022-12-28	WOS:000249764300023
J	Holgate, S; Jevrejeva, S; Woodworth, P; Brewer, S				Holgate, Simon; Jevrejeva, Svetlana; Woodworth, Philip; Brewer, Simon			Comment on "A semi-empirical approach to projecting future sea-level rise"	SCIENCE			English	Editorial Material									Proudman Oceanog Lab, Permanent Serv Mean Sea Level, Liverpool L3 5DA, Merseyside, England; Irstea, F-13182 Aix En Provence, France	NERC National Oceanography Centre; INRAE	Holgate, S (corresponding author), Proudman Oceanog Lab, Permanent Serv Mean Sea Level, 6 Brownlow St, Liverpool L3 5DA, Merseyside, England.	simonh@pol.ac.uk	Holgate, Simon/A-5327-2009	Brewer, Simon/0000-0002-6810-1911; Woodworth, Philip/0000-0002-6681-239X	NERC [pol010001, pol010005] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bell R., 2005, EOS T AM GEOPHYS UNI, V86, P226, DOI [10.1029/2005eo240003, 10.1029/2005EO240003, DOI 10.1029/2005EO240003]; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Hansen J, 1996, GEOPHYS RES LETT, V23, P1665, DOI 10.1029/96GL01040; Holgate SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028492; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2	7	33	34	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846								10.1126/science.1140942	http://dx.doi.org/10.1126/science.1140942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901316	Green Accepted			2022-12-28	WOS:000249764300017
J	Partin, JW; Cobb, KM; Adkins, JF; Clark, B; Fernandez, DP				Partin, Judson W.; Cobb, Kim M.; Adkins, Jess F.; Clark, Brian; Fernandez, Diego P.			Millennial-scale trends in west Pacific warm pool hydrology since the Last Glacial Maximum	NATURE			English	Article							INTERTROPICAL CONVERGENCE ZONE; SEA-SURFACE TEMPERATURE; ISOTOPIC COMPOSITION; CLIMATE; ATLANTIC; HOLOCENE; DEGLACIATION; CIRCULATION; GREENLAND; CHINA	Models and palaeoclimate data suggest that the tropical Pacific climate system plays a key part in the mechanisms underlying orbital-scale and abrupt climate change(1-7). Atmospheric convection over the western tropical Pacific is a major source of heat and moisture to extratropical regions, and may therefore influence the global climate response to a variety of forcing factors. The response of tropical Pacific convection to changes in global climate boundary conditions, abrupt climate changes and radiative forcing remains uncertain, however. Here we present three absolutely dated oxygen isotope records from stalagmites in northern Borneo that reflect changes in west Pacific warm pool hydrology over the past 27,000 years. Our results suggest that convection over the western tropical Pacific weakened 18,000 20,000 years ago, as tropical Pacific(2,5,6,8) and Antarctic(9) temperatures began to rise during the early stages of deglaciation. Convective activity, as inferred from oxygen isotopes, reached a minimum during Heinrich event 1 (ref. 10), when the Atlantic meridional overturning circulation was weak(11), pointing to feed-backs between the strength of the overturning circulation and tropical Pacific hydrology. There is no evidence of the Younger Dryas event(12) in the stalagmite records, however, suggesting that different mechanisms operated during these two abrupt deglacial climate events. During the Holocene epoch, convective activity appears to track changes in spring and autumn insolation, highlighting the sensitivity of tropical Pacific convection to external radiative forcing. Together, these findings demonstrate that the tropical Pacific hydrological cycle is sensitive to high-latitude climate processes in both hemispheres, as well as to external radiative forcing, and that it may have a central role in abrupt climate change events.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Gunung Mulu Natl Pk, Sarawak, Malaysia	University System of Georgia; Georgia Institute of Technology; California Institute of Technology	Partin, JW (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	jpartin@eas.gatech.edu	Partin, Judson/A-3086-2012; Adkins, Jess/GYI-8778-2022	Cobb, Kim/0000-0002-2125-9164; Partin, Judson/0000-0003-0315-5545				Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Clement AC, 2001, J CLIMATE, V14, P2369, DOI 10.1175/1520-0442(2001)014<2369:AODTSF>2.0.CO;2; COBB KM, IN PRESS EARTH PLANE; DANSGAARD W, 1964, TELLUS, V16, P436; Dlugokencky EJ, 2001, GEOPHYS RES LETT, V28, P499, DOI 10.1029/2000GL012119; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; Kienast M, 2006, NATURE, V443, P846, DOI 10.1038/nature05222; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Robinson LF, 2002, EARTH PLANET SC LETT, V196, P175, DOI 10.1016/S0012-821X(01)00610-0; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Steinke S, 2006, QUATERNARY SCI REV, V25, P1475, DOI 10.1016/j.quascirev.2005.12.008; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Visser K, 2003, NATURE, V421, P152, DOI 10.1038/nature01297; Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	35	278	306	6	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					452	U3		10.1038/nature06164	http://dx.doi.org/10.1038/nature06164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898765				2022-12-28	WOS:000249724800038
J	Arboleda-Florez, J				Arboleda-Florez, Julio			Severe mental and neurological disorders in Mozambique	LANCET			English	Editorial Material												Jearflo@aol.com						Andrade L, 2000, B WORLD HEALTH ORGAN, V78, P413; Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122; Patel V, 2007, LANCET, V370, P1055, DOI 10.1016/S0140-6736(07)61479-2; World Health Organization (WHO), 2005, MENT HLTH ATL	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1012	1013		10.1016/S0140-6736(07)61456-1	http://dx.doi.org/10.1016/S0140-6736(07)61456-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889227				2022-12-28	WOS:000249727900006
J	Fegan, GW; Noor, AM; Akhwale, WS; Cousens, S; Snow, RW				Fegan, Greg W.; Noor, Abdisalan M.; Akhwale, Willis S.; Cousens, Simon; Snow, Robert W.			Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study	LANCET			English	Article							MALARIA MORBIDITY; NETS; MORTALITY; TANZANIA; PROGRAM; AFRICA	Background The potential of insecticide-treated bednets (ITNs) to contribute to child survival has been well documented in randomised controlled trials. ITN coverage has increased rapidly in Kenya from 7% in 2004 to 67% in 2006. We aimed to assess the extent to which this investment has led to improvements in child survival. Methods A dynamic cohort of about 3500 children aged 1-59 months were enumerated three times at yearly intervals in 72 rural clusters located in four districts of Kenya. The effect of ITN use on mortality was assessed with Poisson regression to take account of potential effect-modifying and confounding covariates. Findings 100 children died over 2 years. Overall mortality rates were much the same in the first and second years of the study (14.5 per 1000 person-years in the first year and 15.4 per 1000 person-years in the second). After adjustment for age, time period, and a number of other possible confounding variables, ITN use was associated with a 44% reduction in mortality (mortality rate ratio 0.56, 95% CI 0.33-0.96; p=0.04). This level of protection corresponds to about seven deaths averted for every 1000 ITNs distributed. Interpretation A combined approach of social marketing followed by mass free distribution of ITNs translated into child survival effects that are comparable with those seen in previous randomised controlled trials.	Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Minist Hlth, Div Malaria Control, Nairobi, Kenya	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Fegan, GW (corresponding author), KEMRI, Wellcome Res Programme, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	gfegan@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Snow, Robert William/AFR-1436-2022	Fegan, Greg W/0000-0002-2663-2765; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [081829, 058922, 079080] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lengeler C, 1998, TROP MED INT HEALTH, V3, P286, DOI 10.1046/j.1365-3156.1998.00236.x; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Omumbo J A, 2004, East Afr Med J, V81, P649; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6	15	161	162	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1035	1039		10.1016/S0140-6736(07)61477-9	http://dx.doi.org/10.1016/S0140-6736(07)61477-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214HJ	17889242	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000249727900027
J	Moayyedi, P				Moayyedi, Paul			Sequential regimens for Helicobacter pylori eradication	LANCET			English	Editorial Material							TRIPLE THERAPY		McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada	McMaster University	Moayyedi, P (corresponding author), McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada.	moayyep@mcmaster.ca	Moayyedi, Paul/M-6178-2014	Moayyedi, Paul/0000-0002-3616-9292				BAZZOLI F, 1994, EUR J GASTROEN HEPAT, V6, P773, DOI 10.1097/00042737-199409000-00004; De Francesco V, 2004, DIGEST LIVER DIS, V36, P322, DOI 10.1016/j.dld.2003.12.015; De Francesco V, 2004, ALIMENT PHARM THER, V19, P407, DOI 10.1046/j.1365-2036.2004.01818.x; Focareta R, 2003, DIG LIVER DIS S4, V35, pS33; Focareta R, 2002, DIGEST LIVER DIS, V34, pA17; Ford Alex, 2003, Can J Gastroenterol, V17 Suppl B, p36B; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Scaccianoce G, 2006, CAN J GASTROENTEROL, V20, P113, DOI 10.1155/2006/258768; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Zullo A, 2005, ALIMENT PHARM THERAP, V21, P1419, DOI 10.1111/j.1365-2036.2005.02519.x; Zullo A, 2003, ALIMENT PHARM THER, V17, P719, DOI 10.1046/j.1365-2036.2003.01461.x; Zullo A, 2000, ALIMENT PHARM THER, V14, P715	12	43	45	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2007	370	9592					1010	1012		10.1016/S0140-6736(07)61455-X	http://dx.doi.org/10.1016/S0140-6736(07)61455-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889226				2022-12-28	WOS:000249727900005
J	Geddis, AE; Kaushansky, K				Geddis, Amy E.; Kaushansky, Kenneth			The root of platelet production	SCIENCE			English	Editorial Material							C-MPL LIGAND; PROPLATELET FORMATION; BONE-MARROW; MEGAKARYOCYTES; THROMBOPOIESIS; STIMULATION; LINEAGES; INVITRO		Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Kaushansky, K (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	kkaushansky@ucsd.edu						BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; CHOI ES, 1995, BLOOD, V85, P402; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; LEVEN RM, 1992, EXP HEMATOL, V20, P1316; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; METCALF D, 1975, P NATL ACAD SCI USA, V72, P1744, DOI 10.1073/pnas.72.5.1744; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; TAVASSOLI M, 1989, BLOOD CELLS, V15, P3; VAINCHENKER W, 1979, BLOOD, V54, P940; ZUCKERFRANKLIN D, 1984, J CELL BIOL, V99, P390, DOI 10.1083/jcb.99.2.390	15	20	20	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1689	+		10.1126/science.1148946	http://dx.doi.org/10.1126/science.1148946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885117				2022-12-28	WOS:000249585900026
J	Turner, AH; Makovicky, PJ; Norell, MA				Turner, Alan H.; Makovicky, Peter J.; Norell, Mark A.			Feather quill knobs in the dinosaur Velociraptor	SCIENCE			English	Article									Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Turner, AH (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk W & 79th St, New York, NY 10024 USA.	turner@amnh.org						Clarke J, 2004, B AM MUS NAT HIST, P1; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Elzanowski Andrzej, 2002, P129; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Hopp TP, 2004, LIFE O PAST, P234; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855	8	48	50	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1721	1721		10.1126/science.1145076	http://dx.doi.org/10.1126/science.1145076			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885130	Green Submitted			2022-12-28	WOS:000249585900039
J	Eaton, L				Eaton, Lynn			Improving health through wealth	BRITISH MEDICAL JOURNAL			English	Article												lynn@lynneaton.co.uk						*COMM SOC DET HLTH, 2007, INT REP INT STAT COM; Mayor S, 1998, BRIT MED J, V317, P1471, DOI 10.1136/bmj.317.7171.1471	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					538	539		10.1136/bmj.39282.431100.AD	http://dx.doi.org/10.1136/bmj.39282.431100.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855319	Green Published			2022-12-28	WOS:000249790200029
J	Miao, F; Wijeratne, S; Zhang, Y; Coskun, UC; Bao, W; Lau, CN				Miao, F.; Wijeratne, S.; Zhang, Y.; Coskun, U. C.; Bao, W.; Lau, C. N.			Phase-coherent transport in graphene quantum billiards	SCIENCE			English	Article							MINIMAL CONDUCTIVITY; CARBON; SUPERCURRENT	As an emergent electronic material and model system for condensed-matter physics, graphene and its electrical transport properties have become a subject of intense focus. By performing low-temperature transport spectroscopy on single-layer and bilayer graphene, we observe ballistic propagation and quantum interference of multiply reflected waves of charges from normal electrodes and multiple Andreev reflections from superconducting electrodes, thereby realizing quantum billiards in which scattering only occurs at the boundaries. In contrast to the conductivity of conventional two-dimensional materials, graphene's conductivity at the Dirac point is geometry-dependent because of conduction via evanescent modes, approaching the theoretical value 4e(2)/pi h (where e is the electron charge and h is Planck's constant) only for short and wide devices. These distinctive transport properties have important implications for understanding chaotic quantum systems and implementing nanoelectronic devices, such as ballistic transistors.	Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA	University of California System; University of California Riverside	Lau, CN (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	lau@physics.ucr.edu	Bao, Wenzhong/B-2453-2012; Miao, Feng/D-4321-2009	Bao, Wenzhong/0000-0002-3871-467X; Miao, Feng/0000-0002-0962-5424; Lau, Chun Ning/0000-0003-2159-6723				Beenakker CWJ, 2005, LECT NOTES PHYS, V667, P131; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; BERRY MV, 1987, P ROY SOC LOND A MAT, V412, P53, DOI 10.1098/rspa.1987.0080; Buitelaar MR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057005; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Greenbaum D, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195437; Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555; Hwang EH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186806; Jarillo-Herrero P, 2006, NATURE, V439, P953, DOI 10.1038/nature04550; Jorgensen HI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207003; Katine JA, 1997, PHYS REV LETT, V79, P4806, DOI 10.1103/PhysRevLett.79.4806; Katsnelson MI, 2006, EUR PHYS J B, V51, P157, DOI [10.1140/epjb/e2006-00203-1, 10.1140/epjb/e200S-00203-1]; Katsnelson MI, 2006, EUR PHYS J B, V52, P151, DOI 10.1140/epjb/e2006-00294-6; Koshino M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245403; Liang WJ, 2001, NATURE, V411, P665, DOI 10.1038/35079517; Ludwig T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195322; Nilsson J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266801; Nomura K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076602; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; OCTAVIO M, 1983, PHYS REV B, V27, P6739, DOI 10.1103/PhysRevB.27.6739; Ostrovsky PM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235443; Peres NMR, 2006, ANN PHYS-NEW YORK, V321, P1559, DOI 10.1016/j.aop.2006.04.006; Titov M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045417; Titov M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041401; Tworzydlo J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246802; Uchoa B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146801; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	29	541	545	2	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1530	1533		10.1126/science.1144359	http://dx.doi.org/10.1126/science.1144359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872440	Green Submitted			2022-12-28	WOS:000249467900036
J	Rubin, AF; Green, P				Rubin, Alan F.; Green, Phil			Comment on "The consensus coding sequences of human breast and colorectal cancers"	SCIENCE			English	Editorial Material									Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Green, P (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	phg@u.washington.edu		Rubin, Alan/0000-0003-1474-605X				Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Li W. H, 1997, MOL EVOLUTION; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	7	32	34	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844								10.1126/science.1138956	http://dx.doi.org/10.1126/science.1138956			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872429				2022-12-28	WOS:000249467900021
J	Morel, CM				Morel, Carlos M.			The road to recovery	NATURE			English	Editorial Material							DEVELOPING-COUNTRIES; EXPERIENCE; BRAZIL		Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil; Fiocruz MS, Med & Drugs Technol Inst, BR-21045900 Rio De Janeiro, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Morel, CM (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil.		Morel, Carlos/AHD-9349-2022; Casas, Carmen Phang Romero/J-3465-2017; Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019	Casas, Carmen Phang Romero/0000-0002-2759-0544; Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009				Almeida Celia, 2002, Cad. Saúde Pública, V18, P905, DOI 10.1590/S0102-311X2002000400002; Basu P, 2005, NAT BIOTECHNOL, V23, P13, DOI 10.1038/nbt0105-13; Bernardes AT, 2003, RES POLICY, V32, P865, DOI 10.1016/S0048-7333(02)00089-6; Borgatti S. P., 1999, UCINET 6 0 VERSION 1; BUSS PM, 2005, VACINAS SOROS IMUNIZ; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; GADELHA C, 2003, SAUDE MANGUINHOS, V10, P697; Gama A. A. S., 2003, QUIM NOVA, V26, P618; Gadelha CAG, 2006, REV SAUDE PUBL, V40, P11, DOI 10.1590/S0034-89102006000400003; Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001; Mahoney RT, 2007, VACCINE, V25, P4003, DOI 10.1016/j.vaccine.2007.02.047; Morel C., 2005, INNOVATION STRATEGY, V1, P1; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Olive JM, 1997, J INFECT DIS, V175, pS189, DOI 10.1093/infdis/175.Supplement_1.S189; Temporão José Gomes, 2003, Hist. cienc. saude-Manguinhos, V10, P601, DOI 10.1590/S0104-59702003000500008; Viotti EB, 2002, TECHNOL FORECAST SOC, V69, P653, DOI 10.1016/S0040-1625(01)00167-6	16	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					180	182		10.1038/449180a	http://dx.doi.org/10.1038/449180a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851516	Bronze, Green Published			2022-12-28	WOS:000249394500040
J	LINDQUIST, EE				LINDQUIST, EE			AFRICANIZED HONEY BEES AND BEE MITES - NEEDHAM,GR, PAGE,RE, DELFINADOBAKER,M, BOWMAN,CE	SCIENCE			English	Book Review											LINDQUIST, EE (corresponding author), AGR CANADA,BIOSYSTEMAT RES CTR,OTTAWA K1A 0C6,ONTARIO,CANADA.							Needham G. R., 1988, AFRICANIZED HONEY BE	1	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1618	1618		10.1126/science.243.4898.1618	http://dx.doi.org/10.1126/science.243.4898.1618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847268				2022-12-28	WOS:A1989T795200046
J	Roper, MH; Vandelaer, JH; Gasse, FL				Roper, Martha H.; Vandelaer, Jos H.; Gasse, Francois L.			Maternal and neonatal tetanus	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURALLY ACQUIRED-IMMUNITY; WEST-AFRICAN POPULATION; RISK-FACTORS; UMBILICAL-CORD; INTENSIVE-CARE; NEUROTRANSMITTER RELEASE; TOPICAL ANTIMICROBIALS; BOTULINUM NEUROTOXINS; TOXOID IMMUNIZATION	Maternal and neonatal tetanus are important causes of maternal and neonatal mortality, claiming about 180 000 lives worldwide every year, almost exclusively in developing countries. Although easily prevented by maternal immunisation with tetanus toxoid vaccine, and aseptic obstetric and postnatal umbilical-cord care practices, maternal and neonatal tetanus persist as public-health problems in 48 countries, mainly in Asia and Africa. Survival of tetanus patients has improved substantially for those treated in hospitals with modern intensive-care facilities; however, such facilities are often unavailable where the tetanus burden is highest. The Maternal and Neonatal Tetanus Elimination Initiative assists countries in which maternal and neonatal tetanus has not been eliminated to provide immunisation with tetanus toxoid to women of childbearing age. The ultimate goal of this initiative is the worldwide elimination of maternal and neonatal tetanus. Since tetanus spores cannot be removed from the environment, sustaining elimination will require improvements to presently inadequate immunisation and health-service infrastructures, and universal access to those services. The renewed worldwide commitment to the reduction of maternal and child mortality, if translated into effective action, could help to provide the systemic changes needed for long-term elimination of maternal and neonatal tetanus.	WHO, Dept Immunizat Vaccines & Biol, Expanded Programme Immunizat, Geneva 27, Switzerland; UNICEF, Hlth Sect, Programme Div, New York, NY USA	World Health Organization; UNICEF	Vandelaer, JH (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Expanded Programme Immunizat, 20 Ave Appia, Geneva 27, Switzerland.	vandelaerj@who.int		Roper, Martha/0000-0002-0897-3793				Abrahamian FM, 2000, J EMERG MED, V18, P189, DOI 10.1016/S0736-4679(99)00192-4; Afridi Naseem Khan, 2005, J Coll Physicians Surg Pak, V15, P391; ANLAR B, 1989, DEV MED CHILD NEUROL, V31, P76; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P73; ANTIAOBONG OE, 1992, J TROP PEDIATRICS, V38, P173, DOI 10.1093/tropej/38.4.173; ARNOLD RB, 1986, B WORLD HEALTH ORGAN, V64, P259; Asekun-Olarinmoye EO, 2003, EUR J PEDIATR, V162, P526, DOI 10.1007/s00431-003-1225-8; Attygalle Deepthi, 2004, Expert Rev Anti Infect Ther, V2, P73, DOI 10.1586/14787210.2.1.73; Balmer P, 2007, IMMUNOLOGICAL BASIS; Barlow JL, 2001, TROP MED INT HEALTH, V6, P305, DOI 10.1046/j.1365-3156.2001.00705.x; Bassin Sarice L., 2004, Curr Treat Options Neurol, V6, P25, DOI 10.1007/s11940-004-0036-1; Bennett J, 1997, INT J EPIDEMIOL, V26, P897, DOI 10.1093/ije/26.4.897; Bennett J, 1999, INT J EPIDEMIOL, V28, P263, DOI 10.1093/ije/28.2.263; BENNETT J, 1995, INT J EPIDEMIOL, V24, P643, DOI 10.1093/ije/24.3.643; Bennett J, 1996, INT J EPIDEMIOL, V25, P879, DOI 10.1093/ije/25.4.879; Bennett J, 1999, INT J EPIDEMIOL, V28, P1172, DOI 10.1093/ije/28.6.1172; BERGGREN WL, 1974, AM J TROP MED HYG, V23, P936, DOI 10.4269/ajtmh.1974.23.936; Bleck TP, 2004, INFECT CENTRAL NERVO, P625; Bonetti TCS, 2004, VACCINE, V22, P3707, DOI 10.1016/j.vaccine.2004.03.023; BRABIN BJ, 1984, B WORLD HEALTH ORGAN, V62, P919; BRABIN L, 1995, BRIT MED J, V311, P73, DOI 10.1136/bmj.311.6997.73; BRABIN L, 1995, LANCET, V345, P300, DOI 10.1016/S0140-6736(95)90281-3; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; Brauner JS, 2002, INTENS CARE MED, V28, P930, DOI 10.1007/s00134-002-1332-4; Brenzel L, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P389; Bruce D, 1917, T R SOC TROP MED HYG, V11, P1; Bunch TJ, 2002, CHEST, V122, P1488, DOI 10.1378/chest.122.4.1488; BYTCHENK.B, 1966, B WORLD HEALTH ORGAN, V34, P71; *CDC, 1998, MMWR-MORBID MORTAL W, V47, P928; Chai F, 2004, INT J EPIDEMIOL, V33, P551, DOI 10.1093/ije/dyh073; CHEN ST, 1983, B WORLD HEALTH ORGAN, V61, P159; CRONE NE, 1992, NEUROLOGY, V42, P761, DOI 10.1212/WNL.42.4.761; da Silveira C M, 1991, World Health Forum, V12, P289; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DASTUR FD, 1981, LANCET, V2, P219; Davies-Adetugbo AA, 1998, TROP MED INT HEALTH, V3, P9, DOI 10.1046/j.1365-3156.1998.00162.x; de Melker HE, 1999, VACCINE, V18, P100, DOI 10.1016/S0264-410X(99)00186-3; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; Deming MS, 2002, B WORLD HEALTH ORGAN, V80, P696; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; DEMORAESPINTO MI, 1995, J INFECT DIS, V171, P1076, DOI 10.1093/infdis/171.4.1076; Dietz V, 1997, B WORLD HEALTH ORGAN, V75, P81; Dieye TN, 2001, VACCINE, V20, P905, DOI 10.1016/S0264-410X(01)00383-8; Dunn ER, 2002, MED J AUSTRALIA, V177, P687, DOI 10.5694/j.1326-5377.2002.tb05023.x; EREGIE CO, 1993, E AFR MED J, V70, P434; Ertem M, 2004, J TROP PEDIATRICS, V50, P297, DOI 10.1093/tropej/50.5.297; Farrar JJ, 2000, J NEUROL NEUROSUR PS, V69, P292, DOI 10.1136/jnnp.69.3.292; FAUVEAU V, 1993, INT J GYNECOL OBSTET, V40, P3, DOI 10.1016/0020-7292(93)90765-O; Feingold SM, 1998, TOPLEY WILSONS MICRO, P694; Galazka A, 1986, WHOEPIGEN868; Galazka A, 2004, GLOBAL EPIDEMIOLOGY, P151; GENDREL D, 1990, J TROP PEDIATRICS, V36, P279, DOI 10.1093/tropej/36.6.279; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Gitta Sheba N, 2006, MMWR Suppl, V55, P25; Griffiths UK, 2004, B WORLD HEALTH ORGAN, V82, P643; GULTEKIN A, 1988, TURKISH J PEDIATR, V30, P9; Gupta SD, 1998, PEDIATR INFECT DIS J, V17, P316, DOI 10.1097/00006454-199804000-00010; HEATH CW, 1964, AM J PUBLIC HEALTH N, V54, P769, DOI 10.2105/AJPH.54.5.769; Herreros J, 2002, INT J MED MICROBIOL, V291, P447; Hesse I F A, 2005, West Afr J Med, V24, P157; HLADY WG, 1992, AM J PUBLIC HEALTH, V82, P1365, DOI 10.2105/AJPH.82.10.1365; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; HUMBERT G, 1972, Scandinavian Journal of Infectious Diseases, V4, P129, DOI 10.3109/inf.1972.4.issue-2.12; Idema CD, 2002, TROP MED INT HEALTH, V7, P622, DOI 10.1046/j.1365-3156.2002.00903.x; JONES TS, 1983, RECENT ADV IMMUNIZAT, P52; Kanchanapongkul Jirasak, 2001, Journal of the Medical Association of Thailand, V84, P494; KERR JH, 1968, LANCET, V2, P236; KHANNA S S, 1985, Indian Pediatrics, V22, P125; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; LAIRD WJ, 1980, J INFECT DIS, V142, P623, DOI 10.1093/infdis/142.4.623; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Lalli G, 2003, TRENDS MICROBIOL, V11, P431, DOI 10.1016/S0966-842X(03)00210-5; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Lawn JE, 2004, LANCET, V364, P2020, DOI 10.1016/S0140-6736(04)17511-9; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Lederman HM, 2003, J INFECT DIS, V188, P1794, DOI 10.1086/379900; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MACLENNAN R, 1965, B WORLD HEALTH ORGAN, V32, P683; Mansour E, 1997, J INFECT DIS, V175, pS277, DOI 10.1093/infdis/175.Supplement_1.S277; Marshall F N, 1968, Adv Pediatr, V15, P65; Marvaud JC, 1998, INFECT IMMUN, V66, P5698, DOI 10.1128/IAI.66.12.5698-5702.1998; MASELLE SY, 1991, FEMS MICROBIOL IMMUN, V76, P171, DOI 10.1111/j.1574-6968.1991.tb04211.x; Matouskova I., 2005, Central European Journal of Public Health, V13, P99; MATZKIN H, 1985, INFECT IMMUN, V48, P267, DOI 10.1128/IAI.48.1.267-268.1985; Meegan ME, 2001, LANCET, V358, P640, DOI 10.1016/S0140-6736(01)05787-7; MOORE RM, 1939, SURG GYNECOL OBSTET, V69, P146; Moss WJ, 2003, B WORLD HEALTH ORGAN, V81, P61; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Mullany LC, 2003, PEDIATR INFECT DIS J, V22, P996, DOI 10.1097/01.inf.0000095429.97172.48; Neonatal Tetanus Elimination WHO, 1989, WHOEPIGAG89WP9; NEWELL KW, 1966, B WORLD HEALTH ORGAN, V35, P863; Ogunlesi TA, 2004, ANN TROP PAEDIATR, V24, P367, DOI 10.1179/146532804X10853; Okan M, 1997, J CHILD NEUROL, V12, P270, DOI 10.1177/088307389701200410; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x; OKUONGHAE HO, 1992, DEV MED CHILD NEUROL, V34, P448; Omoigberale A I, 2005, East Afr Med J, V82, P98; OUDESLUYSMURPHY AM, 1989, LANCET, V1, P843; Owa J A, 1998, Indian J Pediatr, V65, P441, DOI 10.1007/BF02761140; Oyelami O A, 1995, Cent Afr J Med, V41, P171; Panda NB, 2004, ANAESTH INTENS CARE, V32, P271, DOI 10.1177/0310057X0403200220; Parashar UD, 1998, INT J EPIDEMIOL, V27, P904, DOI 10.1093/ije/27.5.904; Pascual F Brian, 2003, MMWR Surveill Summ, V52, P1; Patel J C, 1999, Indian J Med Sci, V53, P393; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Pryor T, 1997, J FAM PRACTICE, V44, P299; Quddus A, 2002, INT J EPIDEMIOL, V31, P648, DOI 10.1093/ije/31.3.648; RAHMAN S, 1982, J TROP PEDIATRICS, V28, P163, DOI 10.1093/tropej/28.4.163; Raza S A, 2004, J Postgrad Med, V50, P247; RELYVELD E, 1991, VACCINE, V9, P369, DOI 10.1016/0264-410X(91)90066-F; Rochat R, 1999, LANCET, V354, P565, DOI 10.1016/S0140-6736(98)05193-9; Rosen JB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-53; Rosenblatt HM, 2005, J ALLERGY CLIN IMMUN, V116, P698, DOI 10.1016/j.jaci.2005.05.016; Rushdy AA, 2003, EPIDEMIOL INFECT, V130, P71, DOI 10.1017/S0950268802007884; SALIMPOUR R, 1978, J TROP PED ENV CH H, V24, P140, DOI 10.1093/tropej/24.3.140; Saltoglu N, 2004, CLIN MICROBIOL INFEC, V10, P229, DOI 10.1111/j.1198-743X.2004.00767.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHOFIELD FD, 1961, BMJ-BRIT MED J, V5255, P785; Seydi M, 2005, MED MALADIES INFECT, V35, P28, DOI 10.1016/j.medmal.2004.11.003; Seydi M, 2000, Dakar Med, V45, P5; Sharma A, 1976, Indian Pediatr, V13, P51; SIMENTAL PS, 1993, PEDIATR INFECT DIS J, V12, P722, DOI 10.1097/00006454-199309000-00004; SIMONSEN O, 1987, SCAND J INFECT DIS, V19, P437, DOI 10.3109/00365548709021676; SIMONSEN O, 1987, VACCINE, V5, P115, DOI 10.1016/0264-410X(87)90057-0; Singh J, 1997, Indian Pediatr, V34, P398; Soumare M, 2005, Bull Soc Pathol Exot, V98, P371; STANFIELD JP, 1973, LANCET, V1, P215; STANFIELD JP, 1984, B WORLD HEALTH ORGAN, V62, P647; Talesnik E, 1998, J ACQ IMMUN DEF SYND, V19, P471, DOI 10.1097/00042560-199812150-00005; TEKNETZI P, 1983, ARCH DIS CHILD, V58, P68, DOI 10.1136/adc.58.1.68; THAPA PJ, 1992, STUD FAMILY PLANN, V23, P311, DOI 10.2307/1966528; Thind A, 2005, TROP DOCT, V35, P75, DOI 10.1258/0049475054036977; Thwaites CL, 2006, TROP MED INT HEALTH, V11, P279, DOI 10.1111/j.1365-3156.2006.01562.x; Thwaites CL, 2004, T ROY SOC TROP MED H, V98, P671, DOI 10.1016/j.trstmh.2004.01.008; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; TRAVERSO HP, 1991, B WORLD HEALTH ORGAN, V69, P573; TRUJILLO MH, 1987, CHEST, V92, P63, DOI 10.1378/chest.92.1.63; Tutuncuoglu S., 1994, Indian Journal of Pediatrics, V61, P263, DOI 10.1007/BF02752221; UDWADIA FE, 1987, EPIDEMIOL INFECT, V99, P675, DOI 10.1017/S095026880006653X; *UK DEP HLTH, 2005, IMM INF DIS GREEN BO, pCH31; UNICEF, 2004, STAT WORLDS CHILDR 2; Vandelaer J, 2003, VACCINE, V21, P3442, DOI 10.1016/S0264-410X(03)00347-5; VERONESI R, 1975, J HYG EPID MICROB IM, V19, P126; Wasay M, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-2; WASSILAK SGF, 2004, VACCINES, P745; WEINSTEIN L, 1973, NEW ENGL J MED, V289, P1293, DOI 10.1056/NEJM197312132892408; WHO, 2002, WHOVB0228, P129; *WHO, 2005, IMM SURV ASS MON 200; *WHO, 2003, SHAP FUT, P193; *WHO, 1989, WHA 42 32 EXP PROGR; *WHO, 1985, WKLY EPIDEMIOL REC, V60, P5; *WHO, 1995, WKLY EPIDEMIOL REC, V70, P81; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P292; *WHO, 1982, WER, V57, P137; WHO, 2007, IMM SURV ASS MON MAT; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P5; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P198; *WHO, 1996, WKLY EPIDEMIOL REC, V71, P33; *WHO UNICEF UNFPA, 2000, WHOVB0209 UNICEF UNF; *WHO UNICEF WORLD, 2003, STAT WORLDS VACC IMM; World Health Organization, 1999, WHOVB9914; World Health Organization, 1994, WKLY EPIDEMIOL REC, V69, P29; World Health Organization. Expanded Programme on Immunization, 1993, WKLY EPIDEMIOL REC, V68, P277; World Health Organization/UNICEF, 2005, GIVS GLOB IMM VIS ST; YEN LM, 1994, LANCET, V344, P786, DOI 10.1016/S0140-6736(94)92342-6; YUSUF B, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P351; Zupan J, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/1465-1858.CD001057	171	151	163	2	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1947	1959		10.1016/S0140-6736(07)61261-6	http://dx.doi.org/10.1016/S0140-6736(07)61261-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	17854885				2022-12-28	WOS:000251517600033
J	Chan, HLY; Heathcote, EJ; Marcellin, P; Lai, CL; Cho, M; Moon, YM; Chao, YC; Myers, RP; Minuk, GY; Jeffers, L; Sievert, W; Bzowej, N; Harb, G; Kaiser, R; Qiao, XJ; Brown, NA				Chan, Henry L. Y.; Heathcote, E. Jenny; Marcellin, Patrick; Lai, Ching-Lung; Cho, Mong; Moon, Young M.; Chao, You-Chen; Myers, Robert P.; Minuk, Gerald Y.; Jeffers, Lennox; Sievert, William; Bzowej, Natalie; Harb, George; Kaiser, Ralf; Qiao, Xin-Jian; Brown, Nathaniel A.			Treatment of hepatitis B e antigen - Positive chronic hepatitis with telbivudine or adefovir	ANNALS OF INTERNAL MEDICINE			English	Article							EARLY HBV SUPPRESSION; LAMIVUDINE THERAPY; HEPATOCELLULAR-CARCINOMA; VIROLOGICAL RESPONSE; VIRUS INFECTION; LIVER-DISEASE; VIRAL LOAD; DNA LEVEL; DIPIVOXIL; ENTECAVIR	Background: The efficacy of nucleoside and nucleotide analogues for hepatitis B has been linked to the magnitude and durability of hepatitis B virus (HBV) suppression. Objective: To compare the antiviral efficacy of telbivudine and adefovir dipivoxil, and the effects of switching from adefovir to telbivudine, in hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B. Design: Randomized, controlled, open-label trial. Setting: 16 outpatient clinics. Patients: 135 treatment-naive, HBeAg-positive adults with chronic hepatitis B. Intervention: Patients were randomly assigned in a 1: 1: 1 ratio to 52 weeks of telbivudine (group A) or adefovir (group B), or 24 weeks of adefovir and then telbivudine for the remaining 28 weeks ( group C). One hundred thirty-one patients completed 52 weeks of treatment. Measurements: The primary efficacy comparison was serum HBV DNA reduction at week 24, with a secondary comparison at week 52. Results: At week 24, mean HBV DNA reduction was greater in group A than in pooled groups B and C (-6.30 vs. -4.97 log(10) copies/mL; difference, -1.33 log(10) copies/mL [95% Cl, 1.99 to 0.66 log(10) copies/mL]; P < 0.001), and more patients in group A were polymerase chain reaction - negative (39% vs. 12%; odds ratio, 4.46 [Cl, 1.86 to 10.72]; P = 0.001). At week 52, the mean residual HBV DNA level was lower in group A and group C than in group B (3.01 log(10) copies/mL [group A] and 3.02 log(10) copies/mL [group C] vs. 4.00 log(10) copies/mL [group B]; difference, 0 0.99 log(10) copies/mL [Cl, -1.67 to -0.32 log(10) copies/mL] and -0.98 log(10) copies/mL [Cl, -1.64 to -0.32 log(10) copies/mL]; P -0.004). Adverse events were similar across groups; the most common were upper respiratory symptoms, headache, back pain, and diarrhea. Limitations: The trial was open-label and was not of sufficient size or duration to compare clinical outcomes and long-term efficacy. Conclusion: Telbivudine demonstrated greater and more consistent HBV DNA suppression than adefovir after 24 weeks of treatment. After 52 weeks, HBV DNA suppression was greater in patients who had received continuous telbivudine or were switched to telbivudine after 24 weeks than in those who received continuous adefovir.	Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; Univ Toronto, Toronto, ON, Canada; Hop Beaujon, Clichy, France; Pusan Natl Univ Hosp, Pusan, South Korea; Severance Hosp, Seoul, South Korea; Tri Serv Gen Hosp, Taipei, Taiwan; Univ Calgary, Calgary, AB, Canada; Univ Manitoba, Winnipeg, MB, Canada; Univ Miami, Miami, FL 33152 USA; Monash Univ, Melbourne, Vic 3004, Australia; Calif Pacific Med Ctr, San Francisco, CA USA; Novartis Pharmaceut, Hanover, NH USA; Idenix Pharmaceut, Cambridge, MA USA	Chinese University of Hong Kong; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System; Tri-Service General Hospital; University of Calgary; University of Manitoba; University of Miami; Monash University; California Pacific Medical Center; Novartis	Chan, HLY (corresponding author), Chinese Univ Hong Kong, 9-F Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	hlychan@cuhk.edu.hk	Lai, Ching Lung/C-4298-2009; Chan, Henry Lik-Yuen/B-9636-2008	Chan, Henry Lik-Yuen/0000-0002-7790-1611; Poynard, Thierry/0000-0002-2050-640X; Lai, Ching-Lung/0000-0002-5927-2436				Chan HLY, 2007, ALIMENT PHARM THER, V25, P891, DOI 10.1111/j.1365-2036.2007.03272.x; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen G, 2006, AM J GASTROENTEROL, V101, P1797, DOI 10.1111/j.1572-0241.2006.00647.x; *CHMP, 2006, GUID CLIN EV MED PRO; Colledge D, 2000, ANTIMICROB AGENTS CH, V44, P551, DOI 10.1128/AAC.44.3.551-560.2000; Colonno RJ, 2006, HEPATOLOGY, V44, p229A; DiBisceglie A, 2006, HEPATOLOGY, V44, p230A; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Durantel S, 2004, HEPATOLOGY, V40, p654A; Eun JR, 2006, HEPATOLOGY, V44, p550A; Fung SK, 2006, J HEPATOL, V44, P283, DOI 10.1016/j.jhep.2005.10.018; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hezode C, 2007, J HEPATOL, V46, P791, DOI 10.1016/j.jhep.2007.01.018; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lai CL, 2005, HEPATOLOGY, V42, p748A; Lai CL, 2005, HEPATOLOGY, V42, p232A; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lampertico P, 2006, HEPATOLOGY, V44, p693A; Leung N, 2007, J HEPATOL, V46, pS24, DOI 10.1016/S0168-8278(07)61647-X; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Locarnini S, 2005, J HEPATOL, V42, P17; Locarnini S, 2004, ANTIVIR THER, V9, P679; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marzano A, 2006, HEPATOLOGY, V44, p231A; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; Perrillo R, 2000, HEPATOLOGY, V32, P129, DOI 10.1053/jhep.2000.8626; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Santos SA, 2006, EUR J GASTROEN HEPAT, V18, P1247, DOI 10.1097/01.meg.0000243877.17444.5e; Sasadeusz JJ, 2007, MED J AUSTRALIA, V186, P204, DOI 10.5694/j.1326-5377.2007.tb00863.x; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Standring DN, 2006, J HEPATOL, V44, pS191, DOI 10.1016/S0168-8278(06)80514-3; Standring David N., 2001, Antiviral Chemistry and Chemotherapy, V12, P119; van Bommel F, 2006, HEPATOLOGY, V44, P318, DOI 10.1002/hep.21253; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; Zollner B, 2001, J MED VIROL, V65, P659, DOI 10.1002/jmv.2087; 2006, HEPSERA	46	146	157	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					745	U14		10.7326/0003-4819-147-11-200712040-00183	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	17909201				2022-12-28	WOS:000251539100001
J	Lorimer, DR; Bailes, M; McLaughlin, MA; Narkevic, DJ; Crawford, F				Lorimer, D. R.; Bailes, M.; McLaughlin, M. A.; Narkevic, D. J.; Crawford, F.			A bright millisecond radio burst of extragalactic origin	SCIENCE			English	Article							GAMMA-RAY BURSTS; REIONIZATION HISTORY; DISCOVERY; PULSARS; RATES; GAS	Pulsar surveys offer a rare opportunity to monitor the radio sky for impulsive burst-like events with millisecond durations. We analyzed archival survey data and found a 30-jansky dispersed burst, less than 5 milliseconds in duration, located 3 degrees from the Small Magellanic Cloud. The burst properties argue against a physical association with our Galaxy or the Small Magellanic Cloud. Current models for the free electron content in the universe imply that the burst is less than 1 gigaparsec distant. No further bursts were seen in 90 hours of additional observations, which implies that it was a singular event such as a supernova or coalescence of relativistic objects. Hundreds of similar events could occur every day and, if detected, could serve as cosmological probes.	W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; Natl Radio Astron Observ, Green Bank, WV 24944 USA; Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; Franklin & Marshall Coll, Dept Phys & Astron, Lancaster, PA 17604 USA	West Virginia University; National Radio Astronomy Observatory (NRAO); Swinburne University of Technology; Franklin & Marshall College	Lorimer, DR (corresponding author), W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA.	duncan.lorimer@mail.wvu.edu	Lorimer, Duncan/ABH-7909-2020; Crawford, Fronefield/AAX-1677-2021	Crawford, Fronefield/0000-0002-2578-0360; McLaughlin, Maura/0000-0001-7697-7422; Bailes, Matthew/0000-0003-3294-3081				AMY SW, 1989, P ASTRON SOC AUST, V8, P172, DOI 10.1017/S1323358000023262; Burgay M, 2006, MON NOT R ASTRON SOC, V368, P283, DOI 10.1111/j.1365-2966.2006.10100.x; Cordes JM, 2004, NEW ASTRON REV, V48, P1459, DOI 10.1016/j.newar.2004.09.038; Cordes JM, 2004, ASTROPHYS J, V612, P375, DOI 10.1086/422495; Cordes JM, 2003, ASTROPHYS J, V596, P1142, DOI 10.1086/378231; Edwards RT, 2001, MON NOT R ASTRON SOC, V326, P358, DOI 10.1046/j.1365-8711.2001.04637.x; Gaustad JE, 2001, PUBL ASTRON SOC PAC, V113, P1326, DOI 10.1086/323969; GINZBURG VL, 1973, NATURE, V246, P415, DOI 10.1038/246415a0; Guetta D, 2007, ASTROPHYS J, V657, pL73, DOI 10.1086/511417; Hansen BMS, 2001, MON NOT R ASTRON SOC, V322, P695, DOI 10.1046/j.1365-8711.2001.04103.x; Hilditch RW, 2005, MON NOT R ASTRON SOC, V357, P304, DOI 10.1111/j.1365-2966.2005.08653.x; Hurley K, 2006, ASTROPHYS J SUPPL S, V164, P124, DOI 10.1086/501352; HURLEY K, COMMUNICATION; Inoue S, 2004, MON NOT R ASTRON SOC, V348, P999, DOI 10.1111/j.1365-2966.2004.07359.x; Ioka K, 2003, ASTROPHYS J, V598, pL79, DOI 10.1086/380598; Jacoby BA, 2007, ASTROPHYS J, V656, P408, DOI 10.1086/509312; JOHNSTON S, 2007, 13 ATNF SKA; Kalogera V, 2004, ASTROPHYS J, V601, pL179, DOI 10.1086/382155; LEE LC, 1976, ASTROPHYS J, V206, P735, DOI 10.1086/154434; Lorimer D. R., 2012, HDB PULSAR ASTRONOMY; Macquart JP, 2007, ASTROPHYS J, V658, pL1, DOI 10.1086/513424; Maloney PR, 1999, ASTROPHYS J, V522, pL81, DOI 10.1086/312223; Manchester RN, 2006, ASTROPHYS J, V649, P235, DOI 10.1086/505461; Manchester RN, 2001, MON NOT R ASTRON SOC, V328, P17, DOI 10.1046/j.1365-8711.2001.04751.x; McLaughlin MA, 2006, NATURE, V439, P817, DOI 10.1038/nature04440; Paturel G, 2003, ASTRON ASTROPHYS, V412, P45, DOI 10.1051/0004-6361:20031411; REES MJ, 1977, NATURE, V266, P333, DOI 10.1038/266333a0; Stanimirovic S, 1999, MON NOT R ASTRON SOC, V302, P417, DOI 10.1046/j.1365-8711.1999.02013.x; STAPPERS BW, 2006, P 363 HER SEM NEUTR, P101; StaveleySmith L, 1996, PUBL ASTRON SOC AUST, V13, P243, DOI 10.1017/S1323358000020919; Wilkinson PN, 2004, NEW ASTRON REV, V48, P1551, DOI 10.1016/j.newar.2004.09.036; [No title captured]	32	1030	1047	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					777	780		10.1126/science.1147532	http://dx.doi.org/10.1126/science.1147532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17901298	Green Submitted			2022-12-28	WOS:000250583900035
J	Toth, AL; Varala, K; Newman, TC; Miguez, FE; Hutchison, SK; Willoughby, DA; Simons, JF; Egholm, M; Hunt, JH; Hudson, ME; Robinson, GE				Toth, Amy L.; Varala, Kranthi; Newman, Thomas C.; Miguez, Fernando E.; Hutchison, Stephen K.; Willoughby, David A.; Simons, Jan Fredrik; Egholm, Michael; Hunt, James H.; Hudson, Matthew E.; Robinson, Gene E.			Wasp gene expression supports an evolutionary link between maternal behavior and eusociality	SCIENCE			English	Article							HONEY-BEE; SEQUENCE; ORIGIN; PERIOD; BRAIN; AGE	The presence of workers that forgo reproduction and care for their siblings is a defining feature of eusociality and a major challenge for evolutionary theory. It has been proposed that worker behavior evolved from maternal care behavior. We explored this idea by studying gene expression in the primitively eusocial wasp Polistes metricus. Because little genomic information existed for this species, we used 454 sequencing to generate 391,157 brain complementary DNA reads, resulting in robust hits to 3017 genes from the honey bee genome, from which we identified and assayed orthologs of 32 honey bee behaviorally related genes. Wasp brain gene expression in workers was more similar to that in foundresses, which show maternal care, than to that in queens and gynes, which do not. Insulin-related genes were among the differentially regulated genes, suggesting that the evolution of eusociality involved major nutritional and reproductive pathways.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; 454 Life Sci, Branford, CT 06405 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Saint Louis; University of Illinois System; University of Illinois Urbana-Champaign	Toth, AL (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	amytoth@uiuc.edu	Miguez, Fernando E/B-7988-2012; Toth, Amy L/A-9196-2011; Varala, Kranthi/A-2954-2013; Hunt, James/D-1740-2009; Hudson, Matthew E/A-4438-2008	Varala, Kranthi/0000-0003-1051-6636; Hudson, Matthew E/0000-0002-4737-0936				Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; AMENT SA, 2006, SOC NEUROSCIENCE ITI; [Anonymous], 1991, SOCIAL BIOL WASPS; [Anonymous], 1971, INSECT SOC; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Ben-Shahar Y, 2004, J EXP BIOL, V207, P3281, DOI 10.1242/jeb.01151; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch Guy, 2002, P195; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Danforth BN, 2004, SYST BIOL, V53, P309, DOI 10.1080/10635150490423737; Evans H.E., 1970, THE WASPS; HUDSON ME, 2007, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2007.020189.X; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nunes FMF, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-84; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Turillazzi S., 1996, NATURAL HIST EVOLUTI; Venables WN., 2002, MODERN APPL STAT S; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wheeler W. M., 1928, SOCIAL INSECTS THEIR; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	36	207	215	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					441	444		10.1126/science.1146647	http://dx.doi.org/10.1126/science.1146647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17901299				2022-12-28	WOS:000250230400044
J	Gostin, LO				Gostin, Lawrence O.			Abortion politics - Clinical freedom, trust in the judiciary, and the autonomy of women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*A COLL OBST GYN, 2004, ACOG STAT POL AB POL; Charo RA, 2007, NEW ENGL J MED, V356, P2125, DOI 10.1056/NEJMp078055; COHEN S, 2006, GUTTMACHER POLICY RE, V9, P8; Federal News Service, 2005, WASHINGTON POST 0913; JOHNSON K, 2007, NY TIMES        0420, pA18; Siegel RB, 2007, U ILLINOIS LAW REV, P991; STOTLAND NL, 1992, JAMA-J AM MED ASSOC, V268, P2078, DOI 10.1001/jama.268.15.2078; TONER R, 2007, NY TIMES        0302, pA1; 2007, NY TIMES        0426, pA25; 2007, KAISER NETWORK  0410	10	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1562	1564		10.1001/jama.298.13.1562	http://dx.doi.org/10.1001/jama.298.13.1562			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911502				2022-12-28	WOS:000249860500030
J	Amodeo, GA; Rudolph, MJ; Tong, L				Amodeo, Gabriele A.; Rudolph, Michael J.; Tong, Liang			Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA-SUBUNITS; YEAST SNF1; DOMAIN; GLYCOGEN; BINDING; DISEASE; COMPLEX; STRESS; MODELS	AMP-activated protein kinase ( AMPK) is a central regulator of energy homeostasis in mammals and is an attractive target for drug discovery against diabetes, obesity and other diseases(1-5). The AMPK homologue in Saccharomyces cerevisiae, known as SNF1, is essential for responses to glucose starvation as well as for other cellular processes, although SNF1 seems to be activated by a ligand other than AMP(1,6-8). Here we report the crystal structure at 2.6 angstrom resolution of the heterotrimer core of SNF1. The ligand-binding site in the gamma-subunit (Snf4) has clear structural differences from that of the Schizosaccharomyces pombe enzyme(9), although our crystallographic data indicate that AMP can also bind to Snf4. The glycogen-binding domain in the beta-subunit (Sip2) interacts with Snf4 in the heterotrimer but should still be able to bind carbohydrates(10-13). Our structure is supported by a large body of biochemical and genetic data on this complex(1,6-8,14-18). Most significantly, the structure reveals that part of the regulatory sequence in the alpha-subunit (Snf1)(15,16,18,19) is sequestered by Snf4, demonstrating a direct interaction between the alpha- and gamma-subunits and indicating that our structure may represent the heterotrimer core of SNF1 in its activated state.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tong, Liang/0000-0002-0563-6468				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; LEECH J, 1973, LANCET, V2, P265; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rudolph MJ, 2007, STRUCTURE, V15, P65, DOI 10.1016/j.str.2006.11.014; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004	37	130	135	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					492	U13		10.1038/nature06127	http://dx.doi.org/10.1038/nature06127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851534				2022-12-28	WOS:000249724800047
J	Nies, DH				Nies, Dietrich H.			How cells control zinc homeostasis	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; TRANSPORTER YIIP; MG2+ TRANSPORTER; METAL; PROTEINS; FIEF		Univ Halle Wittenberg, Inst Microbiol, D-06099 Halle, Germany	Martin Luther University Halle Wittenberg	Nies, DH (corresponding author), Univ Halle Wittenberg, Inst Microbiol, D-06099 Halle, Germany.	d.nies@mikrobiologie.uni-halle.de	Nies, Dietrich H/H-4143-2011					Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bloss T, 2002, PLANTA, V214, P783, DOI 10.1007/s00425-001-0677-1; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200	12	67	68	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1695	1696		10.1126/science.1149048	http://dx.doi.org/10.1126/science.1149048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885121				2022-12-28	WOS:000249585900030
J	Hofferberth, S; Lesanovsky, I; Fischer, B; Schumm, T; Schmiedmayer, J				Hofferberth, S.; Lesanovsky, I.; Fischer, B.; Schumm, T.; Schmiedmayer, J.			Non-equilibrium coherence dynamics in one-dimensional Bose gases	NATURE			English	Article							TONKS-GIRARDEAU GAS; ULTRACOLD ATOMS; QUANTUM; CROSSOVER; CHIP	Low-dimensional systems provide beautiful examples of many-body quantum physics(1). For one-dimensional (1D) systems(2), the Luttinger liquid approach(3) provides insight into universal properties. Much is known of the equilibrium state, both in the weakly(4-7) and strongly(8,9) interacting regimes. However, it remains a challenge to probe the dynamics by which this equilibrium state is reached(10). Here we present a direct experimental study of the coherence dynamics in both isolated and coupled degenerate 1D Bose gases. Dynamic splitting is used to create two 1D systems in a phase coherent state(11). The time evolution of the coherence is revealed through local phase shifts of the subsequently observed interference patterns. Completely isolated 1D Bose gases are observed to exhibit universal sub-exponential coherence decay, in excellent agreement with recent predictions(12). For two coupled 1D Bose gases, the coherence factor is observed to approach a non-zero equilibrium value, as predicted by a Bogoliubov approach(13). This coupled-system decay to finite coherence is the matter wave equivalent of phase-locking two lasers by injection. The non-equilibrium dynamics of superfluids has an important role in a wide range of physical systems, such as superconductors, quantum Hall systems, superfluid helium and spin systems(14-16). Our experiments studying coherence dynamics show that 1D Bose gases are ideally suited for investigating this class of phenomena.	Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Vienna Univ Technol, Atominst Osterreich, A-1020 Vienna, Austria; Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Ruprecht Karls University Heidelberg; Technische Universitat Wien; University of Innsbruck	Schmiedmayer, J (corresponding author), Heidelberg Univ, Inst Phys, Philosophenweg 12, D-69120 Heidelberg, Germany.	schmiedmayer@atomchip.org	Hofferberth, Sebastian/G-7076-2019; Schmiedmayer, Jörg/B-4717-2008; Lesanovsky, Igor/J-6012-2015; Schumm, Thorsten/B-8565-2008; Schmiedmayer, Jörg/M-9669-2019	Hofferberth, Sebastian/0000-0003-0309-9715; Schmiedmayer, Jörg/0000-0001-7799-5614; Lesanovsky, Igor/0000-0001-9660-9467; Schumm, Thorsten/0000-0002-1066-202X; Schmiedmayer, Jörg/0000-0001-7799-5614	Austrian Science Fund (FWF) [Z 118] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Ananikian D, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013604; ANDREEV AF, 1980, SOV PHYS JETP, V51, P1038; [Anonymous], 1983, FUNCTIONAL INTEGRALS; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Bouchoule I, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.031606; Bouchoule I, 2005, EUR PHYS J D, V35, P147, DOI 10.1140/epjd/e2005-00091-y; Cazalilla MA, 2004, J PHYS B-AT MOL OPT, V37, pS1, DOI 10.1088/0953-4075/37/7/051; Dettmer S, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.160406; Fisher NI, 1995, STAT ANAL CIRCULAR D; Folman R, 2002, ADV ATOM MOL OPT PHY, V48, P263; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; FORTE S, 1992, REV MOD PHYS, V64, P193, DOI 10.1103/RevModPhys.64.193; Gati R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130404; Gerbier F, 2004, EUROPHYS LETT, V66, P771, DOI 10.1209/epl/i2004-10035-7; Giamarchi T., 2003, QUANTUM PHYS ONE DIM, V121; GRITSEV V, ANAL QUENCH DYNAMICS; Gritsev V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174511; Groth S, 2004, APPL PHYS LETT, V85, P2980, DOI 10.1063/1.1804601; Hadzibabic Z, 2006, NATURE, V441, P1118, DOI 10.1038/nature04851; HALDANE FDM, 1981, PHYS REV LETT, V47, P1840, DOI 10.1103/PhysRevLett.47.1840; Hofferberth S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.013401; Hofferberth S, 2006, NAT PHYS, V2, P710, DOI 10.1038/nphys420; JO GB, 2007, MATTER WAVE INTERFER; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; KRUGER P, 2004, DISORDER POTENTIALS; Lesanovsky I, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033619; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; PRICOUPENKO L, 2004, J PHYSIQUE 4 P, V116; Richard S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.010405; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Rohrl A, 1997, PHYS REV LETT, V78, P4143, DOI 10.1103/PhysRevLett.78.4143; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; Shimshoni E, 1998, PHYS REV LETT, V80, P3352, DOI 10.1103/PhysRevLett.80.3352; Smerzi A, 1997, PHYS REV LETT, V79, P4950, DOI 10.1103/PhysRevLett.79.4950; Spietz L, 2003, SCIENCE, V300, P1929, DOI 10.1126/science.1084647; Whitlock NK, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.053609; Wildermuth S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216932; Wildermuth S, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.030901	42	577	578	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					324	+		10.1038/nature06149	http://dx.doi.org/10.1038/nature06149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882216	Green Submitted			2022-12-28	WOS:000249557300041
J	Shrestha, Y; Trottier, S				Shrestha, Yogesh; Trottier, Steven			Emphysematous cholecystitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Louis Univ, St Louis, MO 63117 USA	Saint Louis University	Shrestha, Y (corresponding author), St Louis Univ, St Louis, MO 63117 USA.	ygs17@hotmail.com							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1238	1238		10.1056/NEJMicm063675	http://dx.doi.org/10.1056/NEJMicm063675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881755				2022-12-28	WOS:000249541000009
J	Stettler, C; Wandel, S; Allemann, S; Kastrati, A; Morice, MC; Schomig, A; Pfisterer, ME; Stone, GW; Leon, MB; de Lezo, JS; Goy, JJ; Park, SJ; Sabate, M; Suttorp, MJ; Kelbaek, H; Spaulding, C; Menichelli, M; Vermeersch, P; Dirksen, MT; Cervinka, P; Petronio, AS; Nordmann, AJ; Diem, P; Meier, B; Zwahlen, M; Reichenbach, S; Trelle, S; Windecker, S; Juni, P				Stettler, Christoph; Wandel, Simon; Allemann, Sabin; Kastrati, Adnan; Morice, Marie Claude; Schoemig, Albert; Pfisterer, Matthias E.; Stone, Gregg W.; Leon, Martin B.; Suarez de Lezo, Jose; Goy, Jean Jacques; Park, Seung-Jung; Sabate, Manel; Suttorp, Maarten J.; Kelbaek, Henning; Spaulding, Christian; Menichelli, Maurizio; Vermeersch, Paul; Dirksen, Maurits T.; Cervinka, Pavel; Petronio, Anna Sonia; Nordmann, Alain J.; Diem, Peter; Meier, Bernhard; Zwahlen, Marcel; Reichenbach, Stephan; Trelle, Sven; Windecker, Stephan; Jueni, Peter			Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis	LANCET			English	Article							CORONARY-ARTERY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; MIXED TREATMENT COMPARISONS; ACUTE MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; INTRAVASCULAR ULTRASOUND; DIABETIC-PATIENTS; UNCOATED STENTS; DOUBLE-BLIND; POOLED ANALYSIS	Background Whether the two drug-eluting stents approved by the US Food and Drug Administration-a sirolimus-eluting stent and a paclitaxel-eluting stent-are associated with increased risks of death, myocardial infarction, or stent thrombosis compared with bare-metal stents is uncertain. Our aim was to compare the safety and effectiveness of these stents. Methods We searched relevant sources from inception to March, 2007, and contacted investigators and manufacturers to identify randomised controlled trials in patients with coronary artery disease that compared drug-eluting with bare-metal stents, or that compared sirolimus-eluting stents head-to-head with paclitaxel-eluting stents. Safety outcomes included mortality, myocardial infarction, and definite stent thrombosis; the effectiveness outcome was target lesion revascularisation. We included 38 trials (18 023 patients) with a follow-up of up to 4 years. Trialists and manufacturers provided additional data on clinical outcomes for 29 trials. We did a network meta-analysis with a mixed-treatment comparison method to combine direct within-trial comparisons between stents with indirect evidence from other trials while maintaining randomisation. Findings Mortality was similar in the three groups: hazard ratios (HR) were 1.00 (95% credibility interval 0.82-1.25) for sirolimus-eluting versus bare-metal stents, 1.03 (0.84-1.22) for paclitaxel-eluting versus bare-metal stents, and 0.96 (0.83-1.24) for sirolimus-eluting versus paclitaxel-eluting stents. Sirolimus-eluting stents were associated with the lowest risk of myocardial infarction (HR 0.81, 95% credibility interval 0.66-0.97, p=0.030 vs bare-metal stents; 0.83, 0.71-1.00, p=0.045 vs paclitaxel-eluting stents). There were no significant differences in the risk of definite stent thrombosis (0 days to 4 years). However, the risk of late definite stent thrombosis (>30 days) was increased with paclitaxel-eluting stents (HR 2.11, 95% credibility interval 1.19-4.23, p=0.017 vs bare-metal stents; 1.85, 1.02-3.85, p=0.041 vs sirolimus-eluting stents). The reduction in target lesion revascularisation. seen with drug-eluting stents compared with bare-metal stents was more pronounced with sirolimus-eluting stents than with paclitaxel-eluting stents (0.70, 0.56-0.84; p=0.0021). Interpretation The risks of mortality associated with drug-eluting and bare-metal stents are similar. Sirolimus-eluting stents seem to be clinically better than bare-metal and paclitaxel-eluting stents.	Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ Pisa, Dept Cardiothorac, Pisa, Italy; Masaryk Hosp, Div Cardiol, Usti Nad Labem, Czech Republic; Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; Antwerp Cardiovasc Inst, Antwerp, Belgium; San Camillo Hosp, Rome, Italy; Univ Paris 05, INSERM, U780, Paris, France; Hop Cochin, Assistance Publ Hop Paris, F-75674 Paris, France; Rigshosp, DK-2100 Copenhagen, Denmark; St Antonius Hosp Nieuwegein, Nieuwegein, Netherlands; San Carlos Univ Hosp, Madrid, Spain; ASAN Med Ctr, Dept Med, Seoul, South Korea; Clin Cecil, Serv Cardiol, Lausanne, Switzerland; Univ Cordoba, Reina sofia Hosp, Cordoba, Spain; Cardiovasc Res Fdn, New York, NY USA; Columbia Univ, Med Ctr, New York, NY USA; Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; Inst Hosp Jacques Cartier, Massy, France; Tech Univ Munich, Deutsch Herzzentrum, D-8000 Munich, Germany; Univ London Imperial Coll Sci Technol & Med, NHLI, Int Ctr circulatory Hlth, London, England; Univ Hosp Bern, Div Cardiol, CH-3010 Bern, Switzerland; Univ Hosp Bern, Div Endocrinol Diabet & Clin Nutr, CH-3010 Bern, Switzerland; Univ Bern, CTU Bern, Bern, Switzerland; Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University of Bristol; University of Pisa; Masaryk Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Rigshospitalet; University of Copenhagen; St. Antonius Hospital Utrecht; Hospital Clinico San Carlos; University of Ulsan; Asan Medical Center; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Cardiovascular Research Foundation (CRF); Columbia University; University of Basel; University of Basel; Jacques Cartier Private Hospital; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Imperial College London; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Diem, Peter/A-7650-2008; Menichelli, Maurizio/AAF-8525-2021; Zwahlen, Marcel/AFF-8559-2022; Trelle, Sven/D-3760-2009; Suárez de Lezo, José/AAX-9084-2021; Juni, Peter/Q-8700-2016; , Kastrati/Y-2389-2019; Sabate, Manel/AAX-7245-2021	Diem, Peter/0000-0002-1190-9880; Zwahlen, Marcel/0000-0002-6772-6346; Trelle, Sven/0000-0002-8162-8910; Suárez de Lezo, José/0000-0002-7621-3235; Juni, Peter/0000-0002-5985-0670; Reichenbach, Stephan/0000-0001-8098-6567; , Simon/0000-0002-1442-597X; Sabate Tenas, Manel/0000-0002-2316-3705; Stettler, Christoph/0000-0003-1691-6059				Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; BARRON BA, 1977, BIOMETRICS, V33, P414, DOI 10.2307/2529795; BAUMGART D, 2006, ANN SCI M TRANSC CAR; BURING JE, 1995, JAMA-J AM MED ASSOC, V274, P654, DOI 10.1001/jama.274.8.654; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Cervinka P, 2006, CATHETER CARDIO INTE, V67, P846, DOI 10.1002/ccd.20755; Chan C, 2005, AM J CARDIOL, V96, p31H; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; de Lezo JS, 2005, J AM COLL CARDIOL, V45, p75A; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; GALLOE AM, 2006, ANN SCI M TRANSC CAR; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Han Ya-ling, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P123; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hill RA, 2004, EUR HEART J, V25, P902, DOI 10.1016/j.ehj.2004.03.023; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Katritsis DG, 2005, AM J CARDIOL, V95, P640, DOI 10.1016/j.amjcard.2004.10.041; Kelbaek H, 2006, J AM COLL CARDIOL, V47, P449, DOI 10.1016/j.jacc.2005.10.045; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Kittleson MM, 2005, CAN J CARDIOL, V21, P581; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; LEE JH, 2006, ANN SCI M AM COLL CA; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2007, STAT MED, V26, P3681, DOI 10.1002/sim.2831; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehilli J, 2006, EUR HEART J, V27, P260, DOI 10.1093/eurheartj/ehi721; Menichelli M, 2007, J AM COLL CARDIOL, V49, P1924, DOI 10.1016/j.jacc.2007.01.081; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ortolani P, 2007, CATHETER CARDIO INTE, V69, P790, DOI 10.1002/ccd.21011; Pache J, 2005, EUR HEART J, V26, P1262, DOI 10.1093/eurheartj/ehi098; Petronio AS, 2007, J AM COLL CARDIOL, V49, P539, DOI 10.1016/j.jacc.2006.09.042; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Sidhu S, 2006, BRIT J CLIN PHARMACO, V61, P720, DOI 10.1111/j.1365-2125.2006.02614.x; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; TIERALA I, 2006, ANN SCI M TRANSC CAR; VANDERHOEVEN BL, 2006, ANN SCI M AM HEART A; Vermeersch P, 2006, J AM COLL CARDIOL, V48, P2423, DOI 10.1016/j.jacc.2006.09.021; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Zhang Q, 2006, CHINESE MED J-PEKING, V119, P165, DOI 10.1097/00029330-200601020-00013	72	1158	1224	5	193	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2007	370	9591					937	948		10.1016/S0140-6736(07)61444-5	http://dx.doi.org/10.1016/S0140-6736(07)61444-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17869634				2022-12-28	WOS:000249506500026
J	Buller, HR; Cohen, AT; Davidson, B; Decousus, H; Gallus, AS; Gent, M; Pillion, G; Piovella, F; Prins, MH; Raskob, GE				Buller, Harry R.; Cohen, Ander T.; Davidson, Bruce; Decousus, Herve; Gallus, Alex S.; Gent, Michael; Pillion, Gerard; Piovella, Franco; Prins, Martin H.; Raskob, Gary E.		van Gogh Investigators	Extended prophylaxis of venous thromboembolism with idraparinux	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; LONG-TERM; PREVENTION; EPISODE	Background: The extended use of vitamin K antagonists for prophylaxis against venous thromboembolism is often constrained by risk-benefit limitations and inconvenience. We evaluated the efficacy and safety of a 6-month extension of prophylaxis against recurrent venous thromboembolism with idraparinux in patients who had initially received 6 months of prophylaxis with an anticoagulant. Methods: We randomly assigned patients who had completed 6 months of prophylaxis with idraparinux or a vitamin K antagonist and in whom extended anticoagulation was warranted to receive once-weekly injections of 2.5 mg of idraparinux or placebo for 6 months without monitoring. The primary efficacy and safety outcomes were recurrent venous thromboembolism and major bleeding. Results: Of 1215 patients, 6 of 594 (1.0%) in the idraparinux group and 23 of 621 (3.7%) in the placebo group had recurrent venous thromboembolism (P=0.002). Major bleeding occurred in 11 patients (1.9%) in the idraparinux group and in none in the placebo group (P<0.001). Of these 11 episodes, 3 were fatal intracranial hemorrhages. As compared with patients whose initial treatment was a vitamin K antagonist, patients whose initial treatment was idraparinux who were assigned to 6 months in the placebo group had a lower incidence of recurrent thromboembolism (0.7% vs. 5.9%); patients who received 6 additional months of idraparinux therapy had a higher incidence of major bleeding (3.1% vs. 0.9%). Conclusions: During a 6-month extension of thromboprophylaxis, idraparinux was effective in preventing recurrent thromboembolism but was associated with increased risk of a major hemorrhage.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Kings Coll Hosp London, London, England; Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA USA; Univ St Etienne, INSERM CIE3, Ctr Hosp Univ St Etienne, Hop Bellevue,Serv Med Interne & Therapeut, St Etienne, France; Flinders Med Ctr, Bedford Pk, SA, Australia; McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; Sanofi Aventis, Antony, France; Policlin San Matteo, Fdn ist Ricovero & Cura Carattere Sci, UO Angiol 1, I-27100 Pavia, Italy; Univ Maastricht, Care & Publ Hlth Res Inst, Dept Epidemiol, Maastricht, Netherlands; Acad Hosp Maastricht, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Oklahoma City, OK USA	University of Amsterdam; Academic Medical Center Amsterdam; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Washington; University of Washington Seattle; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Flinders Medical Centre; McMaster University; Sanofi-Aventis; IRCCS Fondazione San Matteo; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Oklahoma System; University of Oklahoma Health Sciences Center	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4-211,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Piovella, Franco/AAM-8305-2020; Gallus, Alexander/AAH-6204-2020	Gallus, Alexander/0000-0001-7347-9989				Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2004, J THROMB HAEMOST, V2, P47; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2005, CHEST, V127, P416; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Herbert JM, 1998, BLOOD, V91, P4197, DOI 10.1182/blood.V91.11.4197.411k09_4197_4205; Hutten BA, 2006, COCHRANE DB SYST REV, V1; Minar E, 2004, J THROMB HAEMOST, V2, P540; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501	16	98	104	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1105	1112						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855671				2022-12-28	WOS:000249387200006
J	Jaccard, A; Moreau, P; Leblond, V; Leleu, X; Benboubker, L; Hermine, O; Recher, C; Asli, B; Lioure, B; Royer, B; Jardin, F; Bridoux, F; Grosbois, B; Jaubert, J; Piette, J; Ronco, P; Quet, F; Cogne, M; Fermand, J				Jaccard, Arnaud; Moreau, Philippe; Leblond, Veronique; Leleu, Xavier; Benboubker, Lotfi; Hermine, Olivier; Recher, Christian; Asli, Bouchra; Lioure, Bruno; Royer, Bruno; Jardin, Fabrice; Bridoux, Frank; Grosbois, Bernard; Jaubert, Jerome; Piette, Jean-Charles; Ronco, Pierre; Quet, Fabrice; Cogne, Michel; Fermand, Jean-Paul		Myelome Autogreffe MAG; Intergroupe Francophone	High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	39th Annual Meeting of the American-Society-of-Nephrology	NOV 14-19, 2006	San Diego, CA	Amer Soc Nephrol			STEM-CELL TRANSPLANTATION; PRIMARY SYSTEMIC AMYLOIDOSIS; IMMUNOGLOBULIN LIGHT-CHAINS; SURVIVAL; TRIAL; PREDNISONE; COLCHICINE; THERAPY; BLOOD	Background: High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation has been reported to provide higher response rates and better overall survival than standard chemotherapy in immunoglobulin-light-chain (AL) amyloidosis, but these two strategies have not been compared in a randomized study. Methods: We conducted a randomized trial comparing high-dose intravenous melphalan followed by autologous hematopoietic stem-cell rescue with standard-dose melphalan plus high-dose dexamethasone in patients with AL amyloidosis. Patients (age range, 18 to 70 years) with newly diagnosed AL amyloidosis were randomly assigned to receive intravenous high-dose melphalan plus autologous stem cells or oral melphalan plus oral high-dose dexamethasone. Results: Fifty patients were enrolled in each group. The results were analyzed on an intention-to-treat basis, with overall survival as the primary end point. After a median follow-up of 3 years, the estimated median overall survival was 22.2 months in the group assigned to receive high-dose melphalan and 56.9 months in the group assigned to receive melphalan plus high-dose dexamethasone (P=0.04). Among patients with high-risk disease, overall survival was similar in the two groups. Among patients with low-risk disease, there was a nonsignificant difference between the two groups in overall survival at 3 years (58% in the group assigned to receive high-dose melphalan vs. 80% in the group assigned to receive melphalan plus high-dose dexamethasone; P=0.13). Conclusions: The outcome of treatment of AL amyloidosis with high-dose melphalan plus autologous stem-cell rescue was not superior to the outcome with standard-dose melphalan plus dexamethsone.	Univ Limoges, Dept Hematol, Ctr Hosp Univ Limoges, F-87000 Limoges, France; CNRS, UMR 6101, Limoges, France; CHU Nantes, F-44035 Nantes 01, France; Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Paris, France; Univ Paris 06, Paris, France; CHU Lille, F-59037 Lille, France; CHU Lille, Tours, France; CHU Tours, Tours, France; Univ Paris 05, Hop Necker Enfants Malad, Assistance Publ Hop Paris, Paris, France; CNRS, UM 814, Paris, France; Ctr Hosp Univ Hop Purpan, Toulouse, France; Hop St Louis, Assistance Publ Hop Paris, Paris, France; CHU Strasbourg, F-67000 Strasbourg, France; Ctr Hosp Univ, Amiens, France; Ctr Henri Becquerel, F-76038 Rouen, France; Ctr Hosp Reg & Univ Poitiers, Poitiers, France; Ctr Hosp Univ, Rennes, France; Hop Tenon, Assistance Publ Hop Paris, F-75970 Paris, France; Univ Paris 06, INSERM, U702, Paris, France; Univ Paris 06, Inst Cancerol Loire St Priest Jarez, Paris, France	CHU Limoges; Universite de Limoges; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UNICANCER; Centre Henri Becquerel; CHU Poitiers; Universite de Poitiers; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Cancerologie de la Loire; UDICE-French Research Universities; Sorbonne Universite	Jaccard, A (corresponding author), Univ Limoges, Dept Hematol, Ctr Hosp Univ Limoges, F-87000 Limoges, France.	arnaud.jaccard@chu-limoges.fr	QUET, Fabrice/AAT-5871-2021; Ronco, Pierre/AAC-8390-2022; Hermine, Olivier/Q-7072-2018; cogne, michel/D-7370-2015; Jaccard, Arnaud/O-8819-2016	QUET, Fabrice/0000-0003-4777-5527; Bridoux, Frank/0000-0002-2005-8424; moreau, philippe/0000-0003-1780-8746; cogne, michel/0000-0002-8519-4427; Jaccard, Arnaud/0000-0001-7091-8253; Hermine, Olivier/0000-0003-2574-3874				Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V; Comenzo RL, 2002, BLOOD, V99, P4276, DOI 10.1182/blood.V99.12.4276; Dispenzieri A, 2001, J CLIN ONCOL, V19, P3350, DOI 10.1200/JCO.2001.19.14.3350; Dispenzieri A, 2004, BLOOD, V103, P3960, DOI 10.1182/blood-2003-12-4192; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Gertz MA, 2000, J HEMATOTH STEM CELL, V9, P635, DOI 10.1089/15258160050196678; Gertz MA, 2004, BONE MARROW TRANSPL, V34, P149, DOI 10.1038/sj.bmt.1704539; Gertz MA, 2002, AM J MED, V113, P549, DOI 10.1016/S0002-9343(02)01208-1; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Gertz MA, 1999, HEMATOLOGY, P339; Goodman HJB, 2006, BRIT J HAEMATOL, V134, P417, DOI 10.1111/j.1365-2141.2006.06204.x; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Moreau P, 1998, BRIT J HAEMATOL, V101, P766, DOI 10.1046/j.1365-2141.1998.00772.x; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Skinner M, 1996, AM J MED, V100, P290, DOI 10.1016/S0002-9343(97)89487-9; Skinner M, 2004, ANN INTERN MED, V140, P85, DOI 10.7326/0003-4819-140-2-200401200-00008; Vesole DH, 2003, BLOOD, V102, p118A	19	349	368	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1083	1093		10.1056/NEJMoa070484	http://dx.doi.org/10.1056/NEJMoa070484			11	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855669				2022-12-28	WOS:000249387200004
J	MARSHALL, E				MARSHALL, E			THE GEOPOLITICS OF NUCLEAR WASTE	SCIENCE			English	Editorial Material																		QUADE J, 1990, SCIENCE, V250, P1549, DOI 10.1126/science.250.4987.1549	1	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					864	867		10.1126/science.251.4996.864	http://dx.doi.org/10.1126/science.251.4996.864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847366				2022-12-28	WOS:A1991EY62900014
J	VARADHAN, SRS				VARADHAN, SRS			LARGE DEVIATIONS - DEUSCHEL,JD, STROOCK,DW	SCIENCE			English	Book Review											VARADHAN, SRS (corresponding author), NYU,COURANT INST MATH SCI,NEW YORK,NY 10012, USA.							DEUSCHEL JD, 1989, LARGE DEVIATIONS	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1351	1351		10.1126/science.247.4948.1351	http://dx.doi.org/10.1126/science.247.4948.1351			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843801				2022-12-28	WOS:A1990CU25300043
J	Sawa, M; Nusinow, DA; Kay, SA; Imaizumi, T				Sawa, Mariko; Nusinow, Dmitri A.; Kay, Steve A.; Imaizumi, Takato			FKF1 and GIGANTEA complex formation is required for day-length measurement in Arabidopsis	SCIENCE			English	Article							CIRCADIAN CLOCK; PROTEIN; LIGHT; CONSTANS; DOMAINS; FLORIGEN	Precise timing of CONSTANS (CO) gene expression is necessary for day-length discrimination for photoperiodic flowering. The FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1), and GIGANTEA (GI) proteins regulate CO transcription in Arabidopsis. We demonstrate that FKF1 and GI proteins form a complex in a blue-light-dependentmanner. The timing of this interaction regulates the timing of daytime CO expression. FKF1 function is dependent on GI, which interacts with a CO repressor, CYCLING DOF FACTOR 1 (CDF1), and controls CDF1 stability. GI, FKF1, and CDF1 proteins associate with CO chromatin. Thus, the FKF1-GI complex forms on the CO promoter in late afternoon to regulate CO expression, providing a mechanistic view of how the coincidence of light with circadian timing regulates photoperiodic flowering.	Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Imaizumi, T (corresponding author), Scripps Res Inst, Dept Biochem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	timaizumi@ucsd.edu	Sawa, Mariko/B-9944-2016; Nusinow, Dmitri/K-9129-2013	Sawa, Mariko/0000-0002-8056-3043; Nusinow, Dmitri/0000-0002-0497-1723	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056006, R01GM067837, R01GM079712] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM067837, R01 GM056006, R01 GM079712, R01 GM079712-03, GM079712, R01 GM067837, GM056006] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	16	591	669	8	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					261	265		10.1126/science.1146994	http://dx.doi.org/10.1126/science.1146994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17872410	Green Accepted			2022-12-28	WOS:000250086100044
J	Vermeulen, M; Mulder, KW; Denissov, S; Pijnappel, WWMP; van Schaik, FMA; Varier, RA; Baltissen, MPA; Stunnenberg, HG; Mann, M; Timmers, HTM				Vermeulen, Michiel; Mulder, Klaas W.; Denissov, Sergei; Pijnappel, W. W. M. Pim; van Schaik, Frederik M. A.; Varier, Radhika A.; Baltissen, Marijke P. A.; Stunnenberg, Henk G.; Mann, Matthias; Timmers, H. Th. Marc			Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4	CELL			English	Article							RNA-POLYMERASE-II; SPECTROMETRY-BASED PROTEOMICS; PHD FINGER; PROTEIN INTERACTIONS; MOLECULAR REGULATION; H3K4 TRIMETHYLATION; DIVERSE FUNCTIONS; NUCLEAR-PROTEIN; BINDING PROTEIN; GENE-EXPRESSION	Trimethylation of histone H3 at lysine 4 (H3K4me3) is regarded as a hallmark of active human promoters, but it remains unclear how this posttranslational modification links to transcriptional activation. Using a stable isotope labeling by amino acids in cell culture (SILAC)based proteomic screening we show that the basal transcription factor TFIID directly binds to the H3K4me3 mark via the plant homeodomain (PHD) finger of TAF3. Selective loss of H3K4me3 reduces transcription from and TFIID binding to a subset of promoters in vivo. Equilibrium binding assays and competition experiments show that the TAF3 PHD finger is highly selective for H3K4me3. In transient assays, TAF3 can act as a transcriptional coactivator in a PHD finger-dependent manner. Interestingly, asymmetric dimethylation of H3R2 selectively inhibits TFIID binding to H3K4me3, whereas acetylation of H3K9 and H3K14 potentiates TFIID interaction. Our experiments reveal crosstalk between histone modifications and the transcription factor TFIID. This has important implications for regulation of RNA polymerase II-mediated transcription in higher eukaryotes.	Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Univ Utrecht, Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biol Mol, NL-6500 HB Nijmegen, Netherlands	Max Planck Society; Utrecht University; Radboud University Nijmegen	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de; h.t.m.timmers@umcutrecht.nl	Mulder, Klaas/A-1882-2013; Mann, Matthias/A-3454-2013; Stunnenberg, Hendrik G./D-6875-2012; Vermeulen, Michiel/C-8883-2013	Mulder, Klaas/0000-0001-8516-4458; Mann, Matthias/0000-0003-1292-4799; Stunnenberg, Hendrik G./0000-0002-0066-1576; Vermeulen, Michiel/0000-0003-0836-6894; Varier, Radhika/0000-0003-1302-3159; Pijnappel, Pim/0000-0002-7042-2482				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nicolas RH, 1996, GENE, V175, P233, DOI 10.1016/0378-1119(96)82845-9; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pointud JC, 2001, DEV BIOL, V237, P368, DOI 10.1006/dbio.2001.0358; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RUTHENBURG AJ, 2007, NATURE, V25, P15; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	50	631	649	1	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					58	69		10.1016/j.cell.2007.08.016	http://dx.doi.org/10.1016/j.cell.2007.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17884155	Bronze			2022-12-28	WOS:000249934700011
J	Burns, T; Catty, J; Becker, T; Drake, RE; Fioritti, A; Knapp, M; Lauber, C; Rossler, W; Tomov, T; van Busschbach, J; White, S; Wiersma, D				Burns, Tom; Catty, Jocelyn; Becker, Thomas; Drake, Robert E.; Fioritti, Angelo; Knapp, Martin; Lauber, Christoph; Rossler, Wulf; Tomov, Toma; van Busschbach, Jooske; White, Sarah; Wiersma, Durk		EQOLISE Grp	The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial	LANCET			English	Article							INDIVIDUAL PLACEMENT; SCHIZOPHRENIA; OUTCOMES; DISORDERS; MODEL; WORK	Background The value of the individual placement and support (IPS) programme in helping people with severe mental illness gain open employment is unknown in Europe. Our aim was to assess the effectiveness of IPS, and to examine whether its effect is modified by local labour markets and welfare systems. Methods 312 patients with severe mental illness were randomly assigned in six European centres to receive IPS (n=156) or vocational services (n=156). Patients were followed up for 18 months. The primary outcome was the difference between the proportions of people entering competitive employment in the two groups. The heterogeneity of IPS effectiveness was explored with prospective meta-analyses to establish the effect of local welfare systems and labour markets. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, with the number NCT00461318. Findings IPS was more effective than vocational services for every vocational outcome, with 85 (55%) patients assigned to IPS working for at least 1 day compared with 43 (28%) patients assigned to vocational services (difference 26.9%, 95% CI 16.4-37.4). Patients assigned to vocational services were significantly more likely to drop out of the service and to be readmitted to hospital than were those assigned to IPS (drop-out 70 [45%] vs 20 [13%]; difference -32.1% [95% CI -41.5 to -22-7]; readmission 42 [31%] vs 28 [20%]; difference -11.2% [-21.5 to -0.90]). Local unemployment rates accounted for a substantial amount of the heterogeneity in IPS effectiveness. Interpretation Our demonstration of the effectiveness of IPS in widely differing labour market and welfare contexts confirms this service to be an effective approach for vocational rehabilitation in mental health that deserves investment and further investigation.	Warneford Hosp, Univ Dept Psychiat, Oxford OX3 7JX, England; St Georges Univ London, Div Mental Hlth, London, England; Univ Ulm, Dept Psychiat 2, BKH Guenzburg, Germany; New Hampshire Dartmouth Psychiat Res Ctr, Lebanon, NH USA; Azienda USL Rimini, Programma Salute Mentale, Rimini, Italy; Univ London London Sch Econ & Polit Sci, Dept Hlth & Social Care, London WC2A 2AE, England; Psychiat Univ Hosp, Zurich, Switzerland; Bulgarian Inst Human Relat, Sofia, Bulgaria; Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Oxford; St Georges University London; Ulm University; Dartmouth College; University of London; London School Economics & Political Science; Bulgarian Academy of Sciences; University of Groningen	Burns, T (corresponding author), Warneford Hosp, Univ Dept Psychiat, Oxford OX3 7JX, England.	Tom.Burns@psych.ox.ac.uk	Knapp, Martin RJ/G-3011-2011; Patel, Anita/F-9832-2010; Drake, Robert/AAS-3310-2020; Becker, Thomas/O-9769-2014	Becker, Thomas/0000-0001-8179-1219; White, Sarah/0000-0003-2468-6193; Rossler, Wulf/0000-0003-0049-4533; Knapp, Martin/0000-0003-1427-0215				Banks S, 2002, NEW DIRECTIONS EVALU, V2002, P45, DOI [DOI 10.1002/EV.50, 10.1002/ev.50]; Becker D., 2003, WORKING LIFE PEOPLE; Becker DR, 2006, COMMUNITY MENT HLT J, V42, P303, DOI 10.1007/s10597-006-9037-8; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cook JA, 2005, ARCH GEN PSYCHIAT, V62, P505, DOI 10.1001/archpsyc.62.5.505; Cook JA, 2005, AM J PSYCHIAT, V162, P1948, DOI 10.1176/appi.ajp.162.10.1948; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; *DEP WORK PENS UK, 2005, INC BEN SEV DIS ALL; Drake RE, 1999, ARCH GEN PSYCHIAT, V56, P627, DOI 10.1001/archpsyc.56.7.627; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Gold PB, 2006, SCHIZOPHRENIA BULL, V32, P378, DOI 10.1093/schbul/sbi056; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; IMMERVOLL H, 2004, 19 OECD DIR EMPL LAB; JARVISALO J, 2005, 66 EUR COMM SOC SEC; Latimer EA, 2006, BRIT J PSYCHIAT, V189, P65, DOI 10.1192/bjp.bp.105.012641; Lehman AF, 2004, SCHIZOPHRENIA BULL, V30, P193, DOI 10.1093/oxfordjournals.schbul.a007071; Lehman AF, 2002, ARCH GEN PSYCHIAT, V59, P165, DOI 10.1001/archpsyc.59.2.165; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Mueser KT, 2004, J CONSULT CLIN PSYCH, V72, P479, DOI 10.1037/0022-006X.72.3.479; Mueser KT, 2001, SCHIZOPHRENIA BULL, V27, P281, DOI 10.1093/oxfordjournals.schbul.a006874; THOMPSON SG, 2001, SYSTEMATIC REV HLTH; Twamley EW, 2003, J NERV MENT DIS, V191, P515, DOI 10.1097/01.nmd.0000082213.42509.69; Van Oorschot W., 2000, EUR J SOC SECUR, V2, P293, DOI [10.1023/A:1011564804757, DOI 10.1023/A:1011564804757]; Wewiorski Nancy J, 2004, Ment Health Serv Res, V6, P9	26	393	399	0	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1146	1152		10.1016/S0140-6736(07)61516-5	http://dx.doi.org/10.1016/S0140-6736(07)61516-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221YQ	17905167	Green Submitted			2022-12-28	WOS:000250263700029
J	Boyd, RW; Chan, KWC; O'Sullivan, MN				Boyd, Robert W.; Chan, Kam Wai Clifford; O'Sullivan, Malcolm N.			Quantum weirdness in the lab	SCIENCE			English	Editorial Material									Univ Rochester, Inst Opt, Rochester, NY 14627 USA	University of Rochester	Boyd, RW (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14627 USA.	boyd@optics.rochester.edu						Dirac P. A. M., 1958, PRINCIPLES QUANTUM M; Gerry C. C., 2005, INTRO QUANTUM OPTICS; Loudon R., 2000, QUANTUM THEORY LIGHT; Mandel L, 1995, OPTICAL COHERENCE QU; Parigi V, 2007, SCIENCE, V317, P1890, DOI 10.1126/science.1146204; Scully M.O., 1997, QUANTUM OPT; UEDA M, 1990, PHYS REV A, V41, P3891, DOI 10.1103/PhysRevA.41.3891	7	24	24	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1874	1875		10.1126/science.1148947	http://dx.doi.org/10.1126/science.1148947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901320				2022-12-28	WOS:000249764300024
J	Emerson, J; Silva, M; Moussa, O; Ryan, C; Laforest, M; Baugh, J; Cory, DG; Laflamme, R				Emerson, Joseph; Silva, Marcus; Moussa, Osama; Ryan, Colm; Laforest, Martin; Baugh, Jonathan; Cory, David G.; Laflamme, Raymond			Symmetrized characterization of noisy quantum processes	SCIENCE			English	Article								A major goal of developing high-precision control of many-body quantum systems is to realize their potential as quantum computers. A substantial obstacle to this is the extreme fragility of quantum systems to "decoherence" from environmental noise and other control limitations. Although quantum computation is possible if the noise affecting the quantum system satisfies certain conditions, existing methods for noise characterization are intractable for present multibody systems. We introduce a technique based on symmetrization that enables direct experimental measurement of some key properties of the decoherence affecting a quantum system. Our method reduces the number of experiments required from exponential to polynomial in the number of subsystems. The technique is demonstrated for the optimization of control over nuclear spins in the solid state.	Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada	University of Waterloo; University of Waterloo; University of Waterloo; Massachusetts Institute of Technology (MIT); Perimeter Institute for Theoretical Physics	Emerson, J (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.		da Silva, Marcus P./H-7266-2019; Baugh, Jonathan/S-9973-2019; Silva, Marcus P/B-2908-2010; Baugh, Jonathan/F-3879-2011	da Silva, Marcus P./0000-0002-6641-8712; Silva, Marcus P/0000-0002-6641-8712; Baugh, Jonathan/0000-0002-9300-7134				AHARONOV D, 1996, P 29 ANN ACM S THEOR, P176; Alicki R., 2007, LECT NOTES PHYS, V717; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Childs AM, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012314; CORY DG, 1990, J MAGN RESON, V90, P205, DOI 10.1016/0022-2364(90)90380-R; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; D'Ariano GM, 2001, PHYS REV LETT, V86, P4195, DOI 10.1103/PhysRevLett.86.4195; DANKERT C, 2006, QUANTPH0606161; Emerson J, 2003, SCIENCE, V302, P2098, DOI 10.1126/science.1090790; Fortunato EM, 2002, J CHEM PHYS, V116, P7599, DOI 10.1063/1.1465412; Haeberlen  U., 1976, ADV MAGNETIC RESONAN; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; KIATEV AY, 1997, USP MAT NAUK, V52, P53; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Levi B, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022314; Mohseni M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170501; Negrevergne C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.170501; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793	27	160	161	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1893	1896		10.1126/science.1145699	http://dx.doi.org/10.1126/science.1145699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901327	Green Submitted			2022-12-28	WOS:000249764300032
J	Fujisawa, K; Wrana, JL; Culotti, JG				Fujisawa, Kazuko; Wrana, Jeffrey L.; Culotti, Joseph G.			The slit receptor EVA-1 coactivates a SAX-3/robo-mediated guidance signal in C-elegans	SCIENCE			English	Article							AXON GUIDANCE; CAENORHABDITIS-ELEGANS; HEPARAN-SULFATE; DROSOPHILA; PROTEIN; MIDLINE; ROUNDABOUT; REPELLENT	The SAX-3/roundabout (Robo) receptor has Shiga-like toxin 1 (SLT-1)/Slit-dependent and -independent functions in guiding cell and axon migrations. We identified enhancer of ventral-axon guidance defects of unc-40 mutants (EVA-1) as a Caenorhabditis elegans transmembrane receptor for SLT-1. EVA-1 has two predicted galactose-binding ectodomains, acts cell-autonomously for SLT-1/Slit-dependent axon migration functions of SAX-3/Robo, binds to SLT-1 and SAX-3, colocalizes with SAX-3 on cells, and provides cell specificity to the activation of SAX-3 signaling by SLT-1. Double mutants of eva-1 or slt-1 with sax-3 mutations suggest that SAX-3 can (when slt-1 or eva-1 function is reduced) inhibit a parallel-acting guidance mechanism, which involves UNC-40/deleted in colorectal cancer.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Culotti, JG (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	culotti@mshri.on.ca	Culotti, Joseph/G-6467-2013; Wrana, Jeffrey/F-8857-2013	Culotti, Joseph/0000-0001-6325-4612	NINDS NIH HHS [NS41397] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041397] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	16	49	57	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1934	1938		10.1126/science.1144874	http://dx.doi.org/10.1126/science.1144874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901337				2022-12-28	WOS:000249764300043
J	Jurgens, G; Geldner, N				Juergens, Gerd; Geldner, Niko			The high road and the low road: Trafficking choices in plants	CELL			English	Editorial Material							ARABIDOPSIS; TRANSPORT; RETROMER	Polar transport of the signaling molecule auxin is critical for plant development and depends on both the polar distribution of auxin efflux carriers, which pump auxin out of the cell and the alignment of these polarized cells. Two papers in this issue of Cell ( Michniewicz et al., 2007; Jaillais et al., 2007) address how polar transport of these carriers occurs and describe the endosomal pathways involved.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; Univ Lausanne, DBMV, UNIL Sorge, CH-1015 Lausanne, Switzerland	Eberhard Karls University of Tubingen; University of Lausanne	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Auf Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de; niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019	Geldner, Niko/0000-0002-2300-9644				Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; JAILLAIS Y, 2007, CELL; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; MICHNIEWICZ M, 2007, CELL; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zhou HW, 2004, PLANT CELL, V16, P709, DOI 10.1105/tpc.018994	12	24	24	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					977	979		10.1016/j.cell.2007.09.003	http://dx.doi.org/10.1016/j.cell.2007.09.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889639	Bronze			2022-12-28	WOS:000250507500004
J	Braunstein, GD				Braunstein, Glenn D.			Gynecomastia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC GYNECOMASTIA; PUBERTAL GYNECOMASTIA; PROSTATE-CANCER; BREAST PAIN; INDUCE GYNECOMASTIA; CONTROLLED-TRIAL; DOUBLE-BLIND; TAMOXIFEN; MANAGEMENT; ESTROGEN		Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Braunstein, GD (corresponding author), Cedars Sinai Med Ctr, Dept Med, Rm 2119,Plaza Level,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	braunstein@cshs.org						ALAGARATNAM TT, 1987, CLIN THER, V9, P483; ANDERSEN JA, 1982, ACTA PATH MICRO IM A, V90, P185; BANNAYAN GA, 1972, AM J CLIN PATHOL, V57, P431; Boccardo F, 2005, J CLIN ONCOL, V23, P808, DOI 10.1200/JCO.2005.12.013; Bowers SP, 1998, AM J SURG, V176, P638, DOI 10.1016/S0002-9610(98)00281-5; Braunstein GD, 1999, ENDOCR-RELAT CANCER, V6, P315, DOI 10.1677/erc.0.0060315; BRAUNSTEIN GD, 1993, NEW ENGL J MED, V328, P490; Brody Steven A, 2003, Endocr Pract, V9, P370; CARLSON HE, 1980, NEW ENGL J MED, V303, P795, DOI 10.1056/NEJM198010023031405; Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893; Di Lorenzo G, 2005, LANCET ONCOL, V6, P972, DOI 10.1016/S1470-2045(05)70464-2; Ersoz HO, 2002, INT J ANDROL, V25, P312, DOI 10.1046/j.1365-2605.2002.00374.x; Evans GFF, 2001, AM J SURG, V181, P579; EVERSMANN T, 1984, DEUT MED WOCHENSCHR, V109, P1678, DOI 10.1055/s-2008-1069434; FINKELSTEIN JS, 1988, NEW ENGL J MED, V318, P961, DOI 10.1056/NEJM198804143181505; GEORGIADIS E, 1994, ANN HUM BIOL, V21, P579, DOI 10.1080/03014469400003582; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Gruntmanis U, 2001, Curr Opin Investig Drugs, V2, P643; Hanavadi S, 2006, BREAST, V15, P276, DOI 10.1016/j.breast.2005.04.007; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Henley DV, 2007, NEW ENGL J MED, V356, P479, DOI 10.1056/NEJMoa064725; Irving LM, 2002, J ADOLESCENT HEALTH, V30, P243, DOI 10.1016/S1054-139X(01)00414-1; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Khan HN, 2004, BREAST, V13, P61, DOI 10.1016/j.breast.2003.10.005; KONIG R, 1987, KLIN PADIATR, V199, P389, DOI 10.1055/s-2008-1026828; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Lawrence SE, 2004, J PEDIATR-US, V145, P71, DOI 10.1016/j.jpeds.2004.03.057; Ley S Jill, 2002, Reflect Nurs Leadersh, V28, P35; Mathur R, 1997, HORM RES, V48, P95, DOI 10.1159/000185497; MCDERMOTT MT, 1990, SOUTHERN MED J, V83, P1283, DOI 10.1097/00007611-199011000-00013; NICOLIS GL, 1971, J CLIN ENDOCR METAB, V32, P173, DOI 10.1210/jcem-32-2-173; NIEWOEHNER CB, 1984, AM J MED, V77, P633, DOI 10.1016/0002-9343(84)90353-X; NUTTALL FQ, 1979, J CLIN ENDOCR METAB, V48, P338, DOI 10.1210/jcem-48-2-338; PARKER LN, 1986, METABOLISM, V35, P705, DOI 10.1016/0026-0495(86)90237-4; Perdona S, 2005, LANCET ONCOL, V6, P295, DOI 10.1016/S1470-2045(05)70103-0; Plourde PV, 2004, J CLIN ENDOCR METAB, V89, P4428, DOI 10.1210/jc.2004-0082; Rahim S, 2004, AIDS READ, V14, P35; Rahim S, 2004, AIDS READ, V14, P29; Rahim Sibtain, 2004, AIDS Read, V14, P23; RODRIGUEZ LAG, 1994, BRIT MED J, V308, P819; RODRIGUEZ LAG, 1994, BRIT MED J, V308, P503, DOI 10.1136/bmj.308.6927.503; Rohrich RJ, 2003, PLAST RECONSTR SURG, V111, P909, DOI 10.1097/01.PRS.0000042146.40379.25; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Saltzstein D, 2005, PROSTATE CANCER P D, V8, P75, DOI 10.1038/sj.pcan.4500782; Satoh T, 2000, ANAL BIOCHEM, V286, P179, DOI 10.1006/abio.1999.4775; Satoh T, 2004, BIOL PHARM BULL, V27, P1844, DOI 10.1248/bpb.27.1844; Satoh T, 2003, BIOL PHARM BULL, V26, P695; SAUER MA, 1983, J PHARMACOL EXP THER, V224, P404; Shozu M, 2003, NEW ENGL J MED, V348, P1855, DOI 10.1056/NEJMoa021559; Staiman VR, 1997, UROLOGY, V50, P929, DOI 10.1016/S0090-4295(97)00457-3; Tashkandi M, 2004, ANN PLAS SURG, V53, P17, DOI 10.1097/01.sap.0000112347.30612.f4; THOMPSON DF, 1993, PHARMACOTHERAPY, V13, P37; Ting ACW, 2000, AM SURGEON, V66, P38; TREVES N, 1958, CANCER, V11, P1083, DOI 10.1002/1097-0142(195811/12)11:6<1083::AID-CNCR2820110602>3.0.CO;2-9; WILLIAMS MJ, 1963, AM J MED, V34, P103, DOI 10.1016/0002-9343(63)90044-5	55	211	226	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1229	1237		10.1056/NEJMcp070677	http://dx.doi.org/10.1056/NEJMcp070677			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881754				2022-12-28	WOS:000249541000008
J	Jasti, J; Furukawa, H; Gonzales, EB; Gouaux, E				Jasti, Jayasankar; Furukawa, Hiroyasu; Gonzales, Eric B.; Gouaux, Eric			Structure of acid-sensing ion channel 1 at 1.9A resolution and low pH	NATURE			English	Article							GATED NA+ CHANNEL; ION CHANNELS; SODIUM-CHANNEL; ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR DOMAIN; ACTIVATED CURRENTS; SUBUNIT; H+; DESENSITIZATION; ASIC1	Acid-sensing ion channels (ASICs) are voltage-independent, proton-activated receptors that belong to the epithelial sodium channel/degenerin family of ion channels and are implicated in perception of pain, ischaemic stroke, mechanosensation, learning and memory. Here we report the low-pH crystal structure of a chicken ASIC1 deletion mutant at 1.9 angstrom resolution. Each subunit of the chalice-shaped homotrimer is composed of short amino and carboxy termini, two transmembrane helices, a bound chloride ion and a disulphide-rich, multidomain extracellular region enriched in acidic residues and carboxyl-carboxylate pairs within 3 angstrom, suggesting that at least one carboxyl group bears a proton. Electrophysiological studies on aspartate-to-asparagine mutants confirm that these carboxyl-carboxylate pairs participate in proton sensing. Between the acidic residues and the transmembrane pore lies a disulphide-rich 'thumb' domain poised to couple the binding of protons to the opening of the ion channel, thus demonstrating that proton activation involves long-range conformational changes.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Gonzales, Eric B./0000-0001-8596-9053				Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Grunder S, 2000, NEUROREPORT, V11, P1607; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; KORKUSHKO AO, 1983, NEUROPHYSIOLOGY+, V15, P469; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REYNOLDS JA, 1978, BIOCHEMISTRY-US, V17, P2035, DOI 10.1021/bi00604a001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Todorovic NA, 2005, ANN NY ACAD SCI, V1048, P331, DOI 10.1196/annals.1342.030; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	53	798	823	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					316	+		10.1038/nature06163	http://dx.doi.org/10.1038/nature06163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882215				2022-12-28	WOS:000249557300040
J	Eriksson, BI; Dahl, OE; Rosencher, N; Kurth, AA; van Dijk, CN; Frostick, SP; Prins, MH; Hettiarachchi, R; Hantel, S; Schnee, J; Buller, HR				Eriksson, Bengt I.; Dahl, Ola E.; Rosencher, Nadia; Kurth, Andreas A.; van Dijk, C. Niek; Frostick, Simon P.; Prins, Martin H.; Hettiarachchi, Rohan; Hantel, Stefan; Schnee, Janet; Bueller, Harry R.		RE-NOVATE Study Grp	Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; DIRECT THROMBIN INHIBITOR; DEEP-VEIN THROMBOSIS; KNEE REPLACEMENT; ORAL ANTICOAGULANTS; PROPHYLAXIS; ARTHROPLASTY; THROMBOPROPHYLAXIS; XIMELAGATRAN; COMPRESSION	Background After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of venous thromboembolism. Our aim was to assess the oral, direct thrombin inhibitor dabigatran etexilate for such prophylaxis. Methods In this double-blind study, we randomised 3494 patients undergoing total hip replacement to treatment for 28-35 days with dabigatran etexilate 220 mg (n=1157) or 150 mg (1174) once daily, starting with a half-dose 1-4 h after surgery, or subcutaneous enoxaparin 40 mg once daily (1162), starting the evening before surgery. The primary efficacy outcome was the composite of total venous thromboembolism (venographic or symptomatic) and death from all causes during treatment. On the basis of the absolute difference in rates of venous thromboembolism with enoxaparin versus placebo, the non-inferiority margin for the difference in rates of thromboembolism was defined as 7.7%. Efficacy analyses were done by modified intention to treat. This trial is registered with ChnicalTrials.gov, number NCT00168818. Findings Median treatment duration was 33 days. 880 patients in the dabigatran etexilate 220 mg group, 874 in the dabigatran etexilate 150 mg group, and 897 in the enoxaparin group were available for the primary efficacy outcome analysis; the main reasons for exclusion in all three groups were the lack of adequate venographic data. The primary efficacy outcome occurred in 60 (6.7%) of 897 individuals in the enoxaparin group versus 53 (6.0%) of 880 patients in the dabigatran etexilate 220 mg group (absolute difference -0.7%, 95% CI -2.9 to 1.6%) and 75 (8.6%) of 874 people in the 150 mg group (1.9%, -0.6 to 4.4%). Both doses were thus non-inferior to enoxaparin. There was no significant difference in major bleeding rates with either dose of dabigatran etexilate compared with enoxaparin (p=0.4.4 for 220 mg, p=0.60 for 150 mg). The frequency of increases in liver enzyme concentrations and of acute coronary events during the study did not differ significantly between the groups. Interpretation Oral dabigatran etexilate was as effective as enoxaparin in reducing the risk of venous thromboembolism after total hip replacement surgery, with a similar safety profile.	Sahlgrens Univ Hosp, Dept Orthopaed Surg, SE-41685 Gothenburg, Sweden; Thrombosis Res Inst, Int Surg Thrombosis Forum, London SW3 6LR, England; Univ Paris 05, Dept Anaesthesia, Cochin Hosp, AP HP, Paris, France; Orthopaed Univ Hosp Stiftung Friedrichsheim, Dept Orthopaed Surg, Frankfurt, Germany; Univ Amsterdam, Acad Med Ctr, Dept Orthopaed Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Boehringer Ingelheim KG, Dept Med, Ridgefield, CT USA; Royal Liverpool Univ Hosp, Dept Musculoskeletal Sci, Liverpool, Merseyside, England; Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; Boehringer Ingelheim KG, Dept Med, Alkmaar, Netherlands; Boehringer Ingelheim KG, Med Data Serv & Biostat, Biberach, Germany	Sahlgrenska University Hospital; Thrombosis Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Boehringer Ingelheim; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Maastricht University; Boehringer Ingelheim; Boehringer Ingelheim	Eriksson, BI (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, SE-41685 Gothenburg, Sweden.	b.eriksson@orthop.gu.se	Rosencher, Nadia/AAS-3888-2020					Anderson FA, 2003, CHEST, V124, p349S, DOI 10.1378/chest.124.6_suppl.349S; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Boudes PF, 2006, CONTEMP CLIN TRIALS, V27, P432, DOI 10.1016/j.cct.2006.04.005; Committee for Proprietary Medicinal Products, POINTS CONS CLIN INV; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2006, DRUGS, V66, P1411, DOI 10.2165/00003495-200666110-00001; Eriksson BI, 2005, J THROMB HAEMOST, V3, P103, DOI 10.1111/j.1538-7836.2004.01100.x; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson BI, 2003, ARCH INTERN MED, V163, P1337, DOI 10.1001/archinte.163.11.1337; Eriksson BI, 2003, THROMB HAEMOSTASIS, V89, P288; ERIKSSON BI, 2006, BLOOD, V108, pA572; FRIEDMAN RJ, 2007, J THROMB HAEMOST S2, V5, pOC51; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Hauel NH, 2002, J MED CHEM, V45, P1757, DOI 10.1021/jm0109513; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Kalebo P, 1997, ACTA RADIOL, V38, P320, DOI 10.3109/02841859709172072; Kalebo P, 1996, THROMB HAEMOSTASIS, V76, P893; Kalodiki EP, 1996, INT ANGIOL, V15, P162; Lotke PA, 2005, J ARTHROPLASTY, V20, P15, DOI 10.1016/j.arth.2005.03.002; O'Donnell M, 2003, ARCH INTERN MED, V163, P1362, DOI 10.1001/archinte.163.11.1362; O'Donnell M, 2007, LANCET, V369, P1413, DOI 10.1016/S0140-6736(07)60647-3; Prandoni P, 2002, ARCH INTERN MED, V162, P1966, DOI 10.1001/archinte.162.17.1966; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Samama CM, 1997, BRIT J ANAESTH, V78, P660, DOI 10.1093/bja/78.6.660; STASSEN JM, 2001, 28 C INT SOC THROMB; Tapson VF, 2005, ARCH INTERN MED, V165, P1458, DOI 10.1001/archinte.165.13.1458; Thabut G, 2006, EUR HEART J, V27, P227, DOI 10.1093/eurheartj/ehi587; TURPIE AGG, 1986, NEW ENGL J MED, V315, P925, DOI 10.1056/NEJM198610093151503; Weitz JI, 2006, THROMB HAEMOSTASIS, V96, P274, DOI 10.1160/TH06-05-0234	29	857	924	3	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					949	956		10.1016/S0140-6736(07)61445-7	http://dx.doi.org/10.1016/S0140-6736(07)61445-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17869635				2022-12-28	WOS:000249506500027
J	KAYE, DH				KAYE, DH			PUNITIVE DAMAGES AND INNOVATION	SCIENCE			English	Letter											KAYE, DH (corresponding author), ARIZONA STATE UNIV,CTR STUDY LAW SCI & TECHNOL,TEMPE,AZ 85287, USA.							MAHONEY RJ, 1989, SCIENCE, V246, P1395, DOI 10.1126/science.246.4936.1395	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1280	1280		10.1126/science.247.4948.1280-b	http://dx.doi.org/10.1126/science.247.4948.1280-b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843771				2022-12-28	WOS:A1990CU25300004
J	NORMAN, C				NORMAN, C			THE UPS AND DOWNS OF STRATEGIC DEFENSE WEAPONS	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1285	1285		10.1126/science.247.4948.1285	http://dx.doi.org/10.1126/science.247.4948.1285			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU253	17843781				2022-12-28	WOS:A1990CU25300014
J	MARSHALL, E				MARSHALL, E			EPAS PLAN FOR COOLING THE GLOBAL GREENHOUSE	SCIENCE			English	Editorial Material																		1989, POLICY OPTIONS STABI; 1988, SCIENCE, V242, P510	2	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1544	1545		10.1126/science.243.4898.1544	http://dx.doi.org/10.1126/science.243.4898.1544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847254				2022-12-28	WOS:A1989T795200010
J	Kirmizis, A; Santos-Rosa, H; Penkett, CJ; Singer, MA; Vermeulen, M; Mann, M; Bahler, J; Green, RD; Kouzarides, T				Kirmizis, Antonis; Santos-Rosa, Helena; Penkett, Christopher J.; Singer, Michael A.; Vermeulen, Michiel; Mann, Matthias; Baehler, Juerg; Green, Roland D.; Kouzarides, Tony			Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR REGULATION; LYSINE METHYLATION; GENE-EXPRESSION; PHD FINGER; YEAST; CHROMATIN; GENOME; TRANSCRIPTION; GENERATION	Modifications on histones control important biological processes through their effects on chromatin structure(1-3). Methylation at lysine 4 on histone H3 (H3K4) is found at the 5' end of active genes and contributes to transcriptional activation by recruiting chromatin-remodelling enzymes(4,5). An adjacent arginine residue (H3R2) is also known to be asymmetrically dimethylated (H3R2me2a) in mammalian cells(6), but its location within genes and its function in transcription are unknown. Here we show that H3R2 is also methylated in budding yeast (Saccharomyces cerevisiae), and by using an antibody specific for H3R2me2a in a chromatin immunoprecipitation-on-chip analysis we determine the distribution of this modification on the entire yeast genome. We find that H3R2me2a is enriched throughout all heterochromatic loci and inactive euchromatic genes and is present at the 3' end of moderately transcribed genes. In all cases the pattern of H3R2 methylation is mutually exclusive with the trimethyl form of H3K4 (H3K4me3). We show that methylation at H3R2 abrogates the trimethylation of H3K4 by the Set1 methyltransferase. The specific effect on H3K4me3 results from the occlusion of Spp1, a Set1 methyltransferase subunit necessary for trimethylation. Thus, the inability of Spp1 to recognize H3 methylated at R2 prevents Set1 from trimethylating H3K4. These results provide the first mechanistic insight into the function of arginine methylation on chromatin.	Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England; Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; NimbleGen Syst Inc, Madison, WI 53711 USA; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	University of Cambridge; Wellcome Trust Sanger Institute; Roche Holding; Roche NimbleGen; Max Planck Society	Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Vermeulen, Michiel/C-8883-2013; Bahler, Jurg/B-4572-2009; Mann, Matthias/A-3454-2013	Vermeulen, Michiel/0000-0003-0836-6894; Bahler, Jurg/0000-0003-4036-1532; Mann, Matthias/0000-0003-1292-4799; Kouzarides, Tony/0000-0002-8918-4162	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118, 092096] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; GUCCIONE E, NATURE; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	29	263	264	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					928	U17		10.1038/nature06160	http://dx.doi.org/10.1038/nature06160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17898715	Green Accepted			2022-12-28	WOS:000250230600052
J	Lan, F; Bayliss, PE; Rinn, JL; Whetstine, JR; Wang, JK; Chen, SZ; Iwase, S; Alpatov, R; Issaeva, I; Canaani, E; Roberts, TM; Chang, HY; Shi, Y				Lan, Fei; Bayliss, Peter E.; Rinn, John L.; Whetstine, Johnathan R.; Wang, Jordon K.; Chen, Shuzhen; Iwase, Shigeki; Alpatov, Roman; Issaeva, Irina; Canaani, Eli; Roberts, Thomas M.; Chang, Howard Y.; Shi, Yang			A histone H3 lysine 27 demethylase regulates animal posterior development	NATURE			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE ACTIVITY; X-INACTIVATION; BREAST-CANCER; TARGET GENES; Y-CHROMOSOME; POLYCOMB; METHYLATION; PROTEIN; REPRESSION	The recent discovery of a large number of histone demethylases suggests a central role for these enzymes in regulating histone methylation dynamics. Histone H3K27 trimethylation (H3K27me3) has been linked to polycomb-group-protein-mediated suppression of Hox genes and animal body patterning, X-chromosome inactivation and possibly maintenance of embryonic stem cell (ESC) identity. An imbalance of H3K27 methylation owing to overexpression of the methylase EZH2 has been implicated in metastatic prostate and aggressive breast cancers. Here we show that the JmjC-domain-containing related proteins UTX and JMJD3 catalyse demethylation of H3K27me3/2. UTX is enriched around the transcription start sites of many HOX genes in primary human fibroblasts, in which HOX genes are differentially expressed, but is selectively excluded from the HOX loci in ESCs, in which HOX genes are largely silent. Consistently, RNA interference inhibition of UTX led to increased H3K27me3 levels at some HOX gene promoters. Importantly, morpholino oligonucleotide inhibition of a zebrafish UTX homologue resulted in mis-regulation of hox genes and a striking posterior developmental defect, which was partially rescued by wild-type, but not by catalytically inactive, human UTX. Taken together, these findings identify a small family of H3K27 demethylases with important, evolutionarily conserved roles in H3K27 methylation regulation and in animal anterior-posterior development.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Dermatol, Program Epithelial Biol, Stanford, CA 94305 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Stanford University; Weizmann Institute of Science	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yshi@hms.harvard.edu	Iwase, Shigeki/J-8294-2019	Iwase, Shigeki/0000-0003-2280-7422; Wang, Jordon/0000-0003-1108-2534; Bayliss, Peter/0000-0003-4807-6365; Rinn, John/0000-0002-7231-7539				Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Ginalski K, 2004, P NATL ACAD SCI USA, V101, P2305, DOI 10.1073/pnas.0306306101; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	40	587	618	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					689	U3		10.1038/nature06192	http://dx.doi.org/10.1038/nature06192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17851529				2022-12-28	WOS:000250045000036
J	Marmot, M				Marmot, Michael		Commission Social Determinants Hlt	Achieving health equity: from root causes to fair outcomes	LANCET			English	Article							SOCIOECONOMIC INEQUALITIES; MORTALITY; INCOME; COUNTRIES	Health is a universal human aspiration and a basic human need. The development of society, rich or poor, can be judged by the quality of its population's health, how fairly health is distributed across the social spectrum, and the degree of protection provided from disadvantage due to ill-health. Health equity is central to this premise and to the work of the Commission on Social Determinants of Health. Strengthening health equity-globally and within countries-means going beyond contemporary concentration on the immediate causes of disease. More than any other global health endeavour, the Commission focuses on the "causes of the causes"-the fundamental structures of social hierarchy and the socially determined conditions these create in which people grow, live, work, and age. The time for action is now, not just because better health makes economic sense, but because it is right and just. The outcry against inequity has been intensifying for many years from country to country around the world. These cries are forming a global movement. The Commission on Social Determinants of Health places action to ensure fair health at the head and the heart of that movement.	UCL, Int Inst Soc & Hlth, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Int Inst Soc & Hlth, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 1999, DEV FREEDOM; Bartley M, 2006, SOCIAL DETERMINANTS; Baum, 2002, NEW PUBLIC HLTH; Benach J, 2007, J EPIDEMIOL COMMUN H, V61, P276, DOI 10.1136/jech.2005.045237; Birdsall Nancy, 2007, BOSTON REV       MAR; Birdsall Nancy, 2006, WIDER ANN LECT 2005; [C. o. S. D. o. Health CSDH], 2007, SOC DET IND HLTH INT; Catford J, 2006, HEALTH PROMOT INT, V21, P1, DOI 10.1093/heapro/dak004; Cline W.R., 2004, TRADE POLICY GLOBAL; Erikson R, 2001, CRADLE GRAVE LIFE CO; FRIEL S, UNPUB BMJ; Gottlieb S, 2000, BRIT MED J, V320, P1295, DOI 10.1136/bmj.320.7245.1295; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hanlon P, 2006, LET GLASGOW FLOURISH; HAWKES C, 2007, GLOBALISATION FOOD N; Huisman M, 2005, PREV MED, V40, P756, DOI 10.1016/j.ypmed.2004.09.022; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; LUNDBERG O, 2007, NORDIC EXPERIENCE WE; MACKENBACH JP, UNPUB EC IMPLICATION; Magalhaes R, 2007, CONDITIONAL INCOME T; Marmot M., 2006, SOCIAL DETERMINANTS, P97; Marmot M, 2004, STATUS SYNDROME; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; MCMICHAEL AJ, UNPUB BMJ; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Najman JM, 2007, DRUG ALCOHOL REV, V26, P273, DOI 10.1080/09595230701247699; *NAT BOARD HLTH WE, 2005, PUBL HLTH SWED STAT; Navarro V, 2006, LANCET, V368, P1033, DOI 10.1016/S0140-6736(06)69341-0; Nettleton C., 2007, OVERVIEW CURRENT KNO; *OECD, 2002, AS SUST DEV ROL SOC; *PAHO, 2007, REN PRIM HLTH CAR AM; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; People's Health Movement, 2000, PEOPL CHART HLTH; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Soares S, 2007, CONDITIONAL CASH TRA; Solar O, 2007, CONCEPTUAL FRAMEWORK; STERN N, 2004, GROWTH EMPOWERMENT M; Stern Nicholas, 2006, STERN REV EC CLIMATE; Tajer D, 2003, AM J PUBLIC HEALTH, V93, P2023, DOI 10.2105/AJPH.93.12.2023; UN, 2000, GEN COMM 14 RIGHT HI; *UN HABITAT, 2005, MILL DECL URB PERSP; UNDESA, 2006, WORLD POP PROSP 2006; *UNDESA, 2006, WORLD EC SIT PROSP; *UNDP, 2005, HUM DEV REP 2005 INT; United Nations, 2000, MILL DEV GOALS; Vagero D, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(97)26033-2; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Weinehall L, 1999, J EPIDEMIOL COMMUN H, V53, P243, DOI 10.1136/jech.53.4.243; Weinehall L, 2001, SCAND J PUBLIC HEALT, P59; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO REG OFF EUR, SOC DET HLTH FRISK S; WILLETS RC, 2004, LONGEVITY 21 CENTUR6; World Bank, 2006, WORLD DEV REP 2006 E; World Health Organization, 1986, OTT CHART GES; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; INTERPARLIAMENT UNIO	66	483	492	1	113	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1153	1163		10.1016/S0140-6736(07)61385-3	http://dx.doi.org/10.1016/S0140-6736(07)61385-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221YQ	17905168				2022-12-28	WOS:000250263700030
J	Wang, PS; Simon, GE; Avorn, J; Azocar, F; Ludman, EJ; McCulloch, J; Petukhova, MZ; Kessler, RC				Wang, Philip S.; Simon, Gregory E.; Avorn, Jerry; Azocar, Francisca; Ludman, Evette J.; McCulloch, Joyce; Petukhova, Maria Z.; Kessler, Ronald C.			Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-ORGANIZATION HEALTH; SERIOUS MENTAL-ILLNESS; COLLABORATIVE CARE; COST-EFFECTIVENESS; MAJOR DEPRESSION; SYMPTOMATOLOGY IDS; ANXIETY DISORDERS; IMPROVE TREATMENT; ECONOMIC BURDEN; HIGH UTILIZERS	Context Although guideline-concordant depression treatment is clearly effective, treatment often falls short of evidence-based recommendations. Organized depression care programs significantly improve treatment quality, but employer purchasers have been slow to adopt these programs based on lack of evidence for cost-effectiveness from their perspective. Objective To evaluate the effects of a depression outreach-treatment program on workplace outcomes, a concern to employers. Design, Setting, and Participants A randomized controlled trial involving 604 employees covered by a managed behavioral health plan were identified in a 2-stage screening process as having significant depression. Patient treatment allocation was concealed and assessment of depression severity and work performance at months 6 and 12 was blinded. Employees with lifetime bipolar disorder, substance disorder, recent mental health specialty care, or suicidality were excluded. Intervention A telephonic outreach and care management program encouraged workers to enter outpatient treatment (psychotherapy and/or antidepressant medication), monitored treatment quality continuity, and attempted to improve treatment by giving recommendations to providers. Participants reluctant to enter treatment were offered a structured telephone cognitive behavioral psychotherapy. Main Outcome Measures Depression severity (Quick Inventory of Depressive Symptomatology, QIDS) and work performance (World Health Organization Health and Productivity Questionnaire [HPQ], a validated self-report instrument assessing job retention, time missed from work, work performance, and critical workplace incidents). Results Combining data across 6- and 12-month assessments, the intervention group had significantly lower QIDS self-report scores (relative odds of recovery, 1.4; 95% confidence interval, 1.1-2.0; P = .009), significantly higher job retention (relative odds, 1.7; 95% confidence interval, 1.1-3.3; P = .02), and significantly more hours worked among the intervention (beta = 2.0; P = .02; equivalent to an annualized effect of 2 weeks of work) than the usual care groups that were employed. Conclusions A systematic program to identify depression and promote effective treatment significantly improves not only clinical outcomes but also workplace outcomes. The financial value of the latter to employers in terms of recovered hiring, training, and salary costs suggests that many employers would experience a positive return on investment from outreach and enhanced treatment of depressed workers.	NIMH, Div Serv & Intervent Res, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; United Behav Hlth, San Francisco, CA USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Grp Hlth Cooperat, Seattle, WA 98101 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Group Health Cooperative	Wang, PS (corresponding author), NIMH, Div Serv & Intervent Res, 6001 Execut Blvd,Room 7141,MSC 9629, Bethesda, MD 20892 USA.	wangphi@mail.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061941] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGOSTI V, 1991, J AFFECT DISORDERS, V23, P35, DOI 10.1016/0165-0327(91)90033-O; [Anonymous], 1994, Vital Health Stat 2, P1; [Anonymous], SELECTIVE SEROTONIN; Azocar Francisca, 2007, J Healthc Qual, V29, P4; BARGESCHAAPVELD DQCM, 1995, J AFFECT DISORDERS, V34, P139, DOI 10.1016/0165-0327(95)00012-C; Beck AT, 1987, COGNITIVE THERAPY DE; Berndt ER, 1998, J HEALTH ECON, V17, P511, DOI 10.1016/S0167-6296(97)00043-X; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; Brodey BB, 2005, AM J MANAG CARE, V11, P774; Burton WN, 1999, J OCCUP ENVIRON MED, V41, P863, DOI 10.1097/00043764-199910000-00007; Bush T, 2004, INT J PSYCHIAT MED, V34, P247, DOI 10.2190/LF18-KX2G-KT79-05U8; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Frank RG, 2003, PSYCHIAT SERV, V54, P682, DOI 10.1176/appi.ps.54.5.682; Gensichen J, 2006, PSYCHOL MED, V36, P7, DOI 10.1017/S0033291705005568; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Goetzel RZ, 2002, J OCCUP ENVIRON MED, V44, P320, DOI 10.1097/00043764-200204000-00012; Gold MR, 1996, COST EFFECTIVENESS H; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; HAYS S, 1999, ACCEPTANCE COMMITMEN; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; KESSLER RC, 2001, CARING DOING OTHER O; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KOCSIS JH, 1988, AM J PSYCHIAT, V145, P997; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Lewinsohn P., 1986, CONTROL YOUR DEPRESS; Ludman E, 2000, INT J PSYCHIAT MED, V30, P229, DOI 10.2190/44LK-28E9-RRJ5-KQVW; Ludman EJ, 2007, J CONSULT CLIN PSYCH, V75, P257, DOI 10.1037/0022-006X.75.2.257; Mauskopf JA, 1996, J CLIN PSYCHIAT, V57, P588, DOI 10.4088/JCP.v57n1207; MINTZ J, 1992, ARCH GEN PSYCHIAT, V49, P761; MORGADO A, 1989, ACTA PSYCHIAT SCAND, V80, P541, DOI 10.1111/j.1600-0447.1989.tb03023.x; Murray C.J, 1996, GLOBAL BURDEN DIS CO; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; Nicholson S, 2006, HEALTH ECON, V15, P111, DOI 10.1002/hec.1052; ORMEL J, 1993, AM J PUBLIC HEALTH, V83, P385, DOI 10.2105/AJPH.83.3.385; Pincus HA, 2003, INT J METH PSYCH RES, V12, P54, DOI 10.1002/mpr.142; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rost K, 2004, MED CARE, V42, P1202, DOI 10.1097/00005650-200412000-00007; Rush A.J., 2000, INT J METH PSYCH RES, V9, P45, DOI [DOI 10.1002/MPR.79, 10.1002/mpr.79]; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Ryder R., 1999, SPM HDB HLTH ASSESSM, P179; Schoenbaum M, 2004, PSYCHIAT SERV, V55, P392, DOI 10.1176/appi.ps.55.4.392; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; Simon G, 2006, CREATING BALANCE STE; Simon GE, 1998, PSYCHOL MED, V28, P693, DOI 10.1017/S0033291798006588; Simon GE, 2001, AM J PSYCHIAT, V158, P1638, DOI 10.1176/appi.ajp.158.10.1638; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Sturm R, 2001, PSYCHIATR SERV, V52, P738, DOI 10.1176/appi.ps.52.6.738; Tutty S, 2000, Eff Clin Pract, V3, P170; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Von Korff M, 1998, PSYCHOSOM MED, V60, P143, DOI 10.1097/00006842-199803000-00005; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; Wang PS, 2006, ARCH GEN PSYCHIAT, V63, P1345, DOI 10.1001/archpsyc.63.12.1345; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Wang PS, 2003, J OCCUP ENVIRON MED, V45, P1303, DOI 10.1097/01.jom.0000100200.90573.df; Wang PS, 2003, INT J METH PSYCH RES, V12, P22, DOI 10.1002/mpr.139; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wang PS, 2002, MED CARE, V40, P752, DOI 10.1097/00005650-200209000-00005; Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	83	268	271	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1401	1411		10.1001/jama.298.12.1401	http://dx.doi.org/10.1001/jama.298.12.1401			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	213WV	17895456	Bronze, Green Accepted			2022-12-28	WOS:000249698900019
J	Patel, V; Simbine, APF; Soares, IC; Weiss, HA; Wheeler, E				Patel, Vikram; Simbine, Ana Paula Ferrao; Soares, Isabel Cristina; Weiss, Helen A.; Wheeler, Erica			Prevalence of severe mental and neurological disorders in Mozambique: a population-based survey	LANCET			English	Article							DEVELOPING-COUNTRIES; SCHIZOPHRENIA; ETHIOPIA; EPILEPSY	Background The scarcity of information about the mental and neurological health of people in Mozambique has hindered policymaking and investment. We aimed to assess the prevalence of seizure disorders, psychoses, and mental retardation in urban and rural Mozambique. Methods 2739 households were randomly selected, 1796 of which were in Maputo city and 943 in the rural town of Culamba. A key informant from each household was asked to identify household members with disorders that matched the descriptions given in case vignettes. Key informants were also asked about causes of disorders, and their treatment, and current state. Findings Lifetime prevalence rates for all three disorders were higher in rural than in urban settings. Prevalence of psychoses (in adults) was 4.4% in the rural town versus 1.6% in the city (standardised prevalence ratio 2.79); mental retardation 1.9% versus 1.3% (1.48); and seizure disorders 4.0% versus 1.6% (2.00). Of the three disorders, key informants most frequently attributed psychoses to supernatural causes, followed by seizure disorder. In about three-quarters of all cases, households had consulted a traditional medical practitioner. Nearly half the people with these disorders in rural areas were rated as being in poor health. Interpretation Advocacy to improve understanding of mental disorders; investment in mental-health resources in rural areas; and collaboration with traditional medical practitioners are urgently needed, especially in the poor rural areas of Mozambique.	Univ London London Sch Hyg & Trop Med, NPHIRU, London WC1E 7HT, England; Minist Hlth, Govt Mozambique, Maputo, Mozambique; WHO, Dept Mental Hlth & Subst Dependence, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, NPHIRU, Keppel St, London WC1E 7HT, England.	vikram.patel@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Patel, Vikram/0000-0003-1066-8584	Medical Research Council [G0700837] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BENTOVIM DI, 1986, BRIT J PSYCHIAT, V148, P576, DOI 10.1192/bjp.148.5.576; Birbeck GL, 2004, TROP MED INT HEALTH, V9, P92, DOI 10.1046/j.1365-3156.2003.01149.x; *INE, 1999, PROJ AN POP PROV AR; ISAAC MK, 1980, BRIT J PSYCHIAT, V137, P540, DOI 10.1192/bjp.137.6.540; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P11, DOI 10.1111/j.1600-0447.1999.tb10688.x; Kleinman A., 1980, PATIENTS HEALERS CON; OSUNTOKUN BO, 1987, EPILEPSIA, V28, P272, DOI 10.1111/j.1528-1157.1987.tb04218.x; PATEL V, 1995, SOC SCI MED, V40, P1291, DOI 10.1016/0277-9536(94)00231-H; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; RWIZA HT, 1992, EPILEPSIA, V33, P1051, DOI 10.1111/j.1528-1157.1992.tb01758.x; Shaji KS, 2002, INT J GERIATR PSYCH, V17, P222, DOI 10.1002/gps.553; Shibre T, 2002, INT J SOC PSYCHIATR, V48, P200, DOI 10.1177/002076402128783244; STEVENS J, 1987, BRIT J PSYCHIAT, V151, P393, DOI 10.1192/bjp.151.3.393; *WHO, 1999, REG STRAT MENT HLTH; WIG NN, 1980, ACTA PSYCHIAT SCAND, V61, P111, DOI 10.1111/j.1600-0447.1980.tb00571.x; World Health Organization (WHO), 2005, MENT HLTH ATL	16	37	38	2	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2007	370	9592					1055	1060		10.1016/S0140-6736(07)61479-2	http://dx.doi.org/10.1016/S0140-6736(07)61479-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889244				2022-12-28	WOS:000249727900029
J	Miltat, J; Thiaville, A				Miltat, J; Thiaville, A			Magnetism - Magnets fast and small	SCIENCE			English	Editorial Material									Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Miltat, J (corresponding author), Univ Paris 11, Phys Solides Lab, Batiment 510, F-91405 Orsay, France.							Acremann Y, 2000, SCIENCE, V290, P492, DOI 10.1126/science.290.5491.492; *ADV LIGHT SOURC, 1999, LBNL45613 ADV LIGHT; Back CH, 1999, SCIENCE, V285, P864, DOI 10.1126/science.285.5429.864; Ballentine GE, 2000, J APPL PHYS, V87, P6830, DOI 10.1063/1.372856; Hubert A, 1998, MAGNETIC DOMAINS; KIKUCHI R, 1956, J APPL PHYS, V27, P1352, DOI 10.1063/1.1722262; KITTEL C, 1976, INTRO SOLID STATE PH, P502; MILTAT J, INPRESS SPIN DYNAMIC, pCH1	8	18	18	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					466	467		10.1126/science.290.5491.466	http://dx.doi.org/10.1126/science.290.5491.466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	17844284				2022-12-28	WOS:000089946000035
J	TODD, EN				TODD, EN			THE KAISERS CHEMISTS - SCIENCE AND MODERNIZATION IN IMPERIAL GERMANY - JOHNSON,JA	SCIENCE			English	Book Review											TODD, EN (corresponding author), UNIV NEW HAVEN,DEPT HIST,W HAVEN,CT 06516, USA.							Johnson Jeffrey Alan, 1990, KAISERS CHEM SCI MOD	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					957	958		10.1126/science.251.4996.957-a	http://dx.doi.org/10.1126/science.251.4996.957-a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847392				2022-12-28	WOS:A1991EY62900051
J	WEISENHORN, AL; MACDOUGALL, JE; GOULD, SAC; COX, SD; WISE, WS; MASSIE, J; MAIVALD, P; ELINGS, VB; STUCKY, GD; HANSMA, PK				WEISENHORN, AL; MACDOUGALL, JE; GOULD, SAC; COX, SD; WISE, WS; MASSIE, J; MAIVALD, P; ELINGS, VB; STUCKY, GD; HANSMA, PK			IMAGING AND MANIPULATING MOLECULES ON A ZEOLITE SURFACE WITH AN ATOMIC FORCE MICROSCOPE	SCIENCE			English	Article									UNIV CALIF SANTA BARBARA,DEPT CHEM,SANTA BARBARA,CA 93106; UNIV CALIF SANTA BARBARA,DEPT GEOL SCI,SANTA BARBARA,CA 93106; DIGITAL INSTRUMENTS INC,GOLETA,CA 93117	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	WEISENHORN, AL (corresponding author), UNIV CALIF SANTA BARBARA,DEPT PHYS,SANTA BARBARA,CA 93106, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108538] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRECHT TR, 1987, J APPL PHYS, V62, P2599, DOI 10.1063/1.339435; ALBRECHT TR, 1988, J APPL PHYS, V64, P1178, DOI 10.1063/1.341881; ALEXANDER S, 1989, J APPL PHYS, V65, P164, DOI 10.1063/1.342563; AMER NM, 1988, B AM PHYS SOC, V33, P319; ANDRADE JD, COMMUNICATION; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1987, EUROPHYS LETT, V3, P1281, DOI 10.1209/0295-5075/3/12/006; Breck D. W., 1974, ZEOLITE MOL SIEVES; BUNTON CA, COMMUNICATION; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; ERLANDSSON R, 1988, J VAC SCI TECHNOL A, V6, P266, DOI 10.1116/1.575440; FISCHER RX, 1985, J APPL CRYSTALLOGR, V18, P258, DOI 10.1107/S002188988501024X; FLANK WH, 1988, ACS S SERIES, V368; GOULD S, 1988, NATURE, V332, P332, DOI 10.1038/332332a0; GOULD SAC, 1990, J VAC SCI TECHNOL A, V8, P369, DOI 10.1116/1.576398; Groenenboom C. J., 1989, ZEOLITES CATALYSTS S, P99; HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380; HARANDI MN, 1989, ENERG FUEL, V3, P620; KIRK MD, 1988, REV SCI INSTRUM, V59, P833, DOI 10.1063/1.1139788; MACDOUGALL JK, UNPUB; MAMIN HJ, 1988, APPL PHYS LETT, V53, P1563, DOI 10.1063/1.99952; MARTI O, 1988, J VAC SCI TECHNOL A, V6, P287, DOI 10.1116/1.575427; MARTI O, 1987, APPL PHYS LETT, V51, P484, DOI 10.1063/1.98374; MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942; MERKLE AB, 1967, AM MINERAL, V42, P273; MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061; OLAH J, 1989, ZEOLITES CATALYSTS S, P711; RUGAR D, 1988, REV SCI INSTRUM, V59, P2337, DOI 10.1063/1.1139958; STERN JE, 1988, APPL PHYS LETT, V53, P2717, DOI 10.1063/1.100162; SUGIYAMA K, 1986, NEW DEV ZEOLITE SCI, P449; WEISENHORN AL, 1989, APPL PHYS LETT, V54, P2651, DOI 10.1063/1.101024; WISE RM, 1984, Patent No. 50894; Wise W. D., UNPUB	33	121	123	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1330	1333		10.1126/science.247.4948.1330	http://dx.doi.org/10.1126/science.247.4948.1330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843797				2022-12-28	WOS:A1990CU25300035
J	John, M; Constien, R; Akinc, A; Goldberg, M; Moon, YA; Spranger, M; Hadwiger, P; Soutschek, J; Vornlocher, HP; Manoharan, M; Stoffel, M; Langer, R; Anderson, DG; Horton, JD; Koteliansky, V; Bumcrot, D				John, Matthias; Constien, Rainer; Akinc, Akin; Goldberg, Michael; Moon, Young-Ah; Spranger, Martina; Hadwiger, Philipp; Soutschek, Juergen; Vornlocher, Hans-Peter; Manoharan, Muthiah; Stoffel, Markus; Langer, Robert; Anderson, Daniel G.; Horton, Jay D.; Koteliansky, Victor; Bumcrot, David			Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway	NATURE			English	Article							IN-VIVO; MICE; INTERFERENCE	Systemic administration of synthetic small interfering RNAs (siRNAs) effectively silences hepatocyte gene expression in rodents and primates(1-3). Whether or not in vivo gene silencing by synthetic siRNA can disrupt the endogenous microRNA (miRNA) pathway remains to be addressed. Here we show that effective target-gene silencing in the mouse and hamster liver can be achieved by systemic administration of synthetic siRNA without any demonstrable effect on miRNA levels or activity. Indeed, siRNA targeting two hepatocyte-specific genes (apolipoprotein B and factor VII) that achieved efficient (80%) silencing of messenger RNA transcripts and a third irrelevant siRNA control were administered to mice without significant changes in the levels of three hepatocyte-expressed miRNAs (miR-122, miR-16 and let-7a) or an effect on miRNA activity. Moreover, multiple administrations of an siRNA targeting the hepatocyte-expressed gene Scap in hamsters achieved long-term mRNA silencing without significant changes in miR-122 levels. This study advances the use of siRNAs as safe and effective tools to silence gene transcripts in animal studies, and supports the continued advancement of RNA interference therapeutics using synthetic siRNA.	Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; Alnylam Europe AG, D-95326 Kulmbach, Germany; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bumcrot, D (corresponding author), Alnylam Pharmaceut Inc, 300 3rd St, Cambridge, MA 02142 USA.	dbumcrot@alnylam.com		Stoffel, Markus/0000-0003-1304-5817	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB000244, R01 EB000244-27, R37 EB000244] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AKINC A, UNPUB NATURE BIOTECH; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Narvaiza I, 2006, J VIROL, V80, P12236, DOI 10.1128/JVI.01205-06; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	12	116	145	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					745	U12		10.1038/nature06179	http://dx.doi.org/10.1038/nature06179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17898712	Green Accepted			2022-12-28	WOS:000250045000049
J	Chaikof, EL				Chaikof, Elliot L.			The development of prosthetic heart valves - Lessons in form and function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AORTIC VALVE; BALL-VALVE; REPLACEMENT		Emory Univ, Dept Surg, Div Vasc Surg, Atlanta, GA 30322 USA; Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Chaikof, EL (corresponding author), Emory Univ, Dept Surg, Div Vasc Surg, Atlanta, GA 30322 USA.							Carpentier A, 1971, Thoraxchir Vask Chir, V19, P379; HARKEN DE, 1962, AM J CARDIOL, V9, P292, DOI 10.1016/0002-9149(62)90047-4; HUFNAGEL CA, 1954, SURGERY, V35, P673; ROSS DN, 1962, LANCET, V2, P487; STARR A, 1961, ANN SURG, V154, P726, DOI 10.1097/00000658-196110000-00017	5	32	36	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1368	1371		10.1056/NEJMp078175	http://dx.doi.org/10.1056/NEJMp078175			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914037				2022-12-28	WOS:000249892900002
J	Cleland, JGF; Atkin, SL				Cleland, John G. F.; Atkin, Stephen L.			Thiazolidinediones, deadly sins, surrogates, and elephants	LANCET			English	Editorial Material							HEART-FAILURE; CONTROLLED-TRIAL; ROSIGLITAZONE; RISK		Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England; Hull York Med Sch, Dept Diabet, Kingston Upon Hull, N Humberside, England	University of Hull; University of Hull; University of York - UK	Cleland, JGF (corresponding author), Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England.	j.g.cleland@hull.ac.uk	Cleland, John G./AAZ-4185-2020; atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	Cleland, John G./0000-0002-1471-7016; atkin, stephen/0000-0002-5887-7257; 				Anand IS, 2002, J AM COLL CARDIOL, V39, P1414, DOI 10.1016/S0735-1097(02)01773-4; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Cleland JGF, 2007, NEW ENGL J MED, V357, P829, DOI 10.1056/NEJMc076179; Cleland JGR, 2006, EUR J HEART FAIL, V8, P326, DOI 10.1016/j.ejheart.2006.04.005; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622	11	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1103	1104		10.1016/S0140-6736(07)61488-3	http://dx.doi.org/10.1016/S0140-6736(07)61488-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905146				2022-12-28	WOS:000250263700004
J	Gilbert, MTP; Tomsho, LP; Rendulic, S; Packard, M; Drautz, DI; Sher, A; Tikhonov, A; Dalen, L; Kuznetsova, T; Kosintsev, P; Campos, PF; Higham, T; Collins, MJ; Wilson, AS; Shidlovskiy, F; Buigues, B; Ericson, PGP; Germonpre, M; Gotherstrom, A; Iacumin, P; Nikolaev, V; Nowak-Kemp, M; Willerslev, E; Knight, JR; Irzyk, GP; Perbost, CS; Fredrikson, KM; Harkins, TT; Sheridan, S; Miller, W; Schuster, SC				Gilbert, M. Thomas P.; Tomsho, Lynn P.; Rendulic, Snjezana; Packard, Michael; Drautz, Daniela I.; Sher, Andrei; Tikhonov, Alexei; Dalen, Love; Kuznetsova, Tatyana; Kosintsev, Pavel; Campos, Paula F.; Higham, Thomas; Collins, Matthew J.; Wilson, Andrew S.; Shidlovskiy, Fyodor; Buigues, Bernard; Ericson, Per G. P.; Germonpre, Mietje; Goetherstroem, Anders; Iacumin, Paola; Nikolaev, Vladimir; Nowak-Kemp, Malgosia; Willerslev, Eske; Knight, James R.; Irzyk, Gerard P.; Perbost, Clotilde S.; Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon; Miller, Webb; Schuster, Stephan C.			Whole-genome shotgun sequencing of mitochondria from ancient hair shafts	SCIENCE			English	Article							MAMMUTHUS-PRIMIGENIUS; DNA; MAMMOTH; AMPLIFICATION; EVOLUTION	Although the application of sequencing-by-synthesis techniques to DNA extracted from bones has revolutionized the study of ancient DNA, it has been plagued by large fractions of contaminating environmental DNA. The genetic analyses of hair shafts could be a solution: We present 10 previously unexamined Siberian mammoth (Mammuthus primigenius) mitochondrial genomes, sequenced with up to 48-fold coverage. The observed levels of damage-derived sequencing errors were lower than those observed in previously published frozen bone samples, even though one of the specimens was >50,000 C-14 years old and another had been stored for 200 years at room temperature. The method therefore sets the stage for molecular-genetic analysis of museum collections.	Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Copenhagen, Ctr Ancient Genet, DK-2100 Copenhagen, Denmark; Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; ISCII Evoluc & Comportamiento Humanos, Ctr UCM, Madrid 28029, Spain; Moscow MV Lomonosov State Univ, Fac Geol, Dept Paleontol, Moscow 119992, Russia; Russian Acad Sci, Urals Branch, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; Univ Oxford Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; Ice Age Museum, All Russia Exhibit Ctr, York YO10 5YW, N Yorkshire, England; Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden; Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1000 Brussels, Belgium; Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Univ Parma, Dept Earth Sci, I-43100 Parma, Italy; Russian Acad Sci, Inst Geog, Dept Glaciol, Moscow 109017, Russia; Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England; Roche Diagnost Corp, Indianapolis, IN 46250 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Complutense University of Madrid; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Oxford; Swedish Museum of Natural History; Uppsala University; University of Parma; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; University of Oxford; Roche Holding	Miller, W (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, 310 Wartik Bldg, University Pk, PA 16802 USA.	webb@bx.psu.edu; scs@bx.psu.edu	Dalén, Love/A-6686-2008; Collins, Matthew J/A-7534-2008; Willerslev, Eske/A-9619-2011; Higham, Tom/Y-2707-2019; Nikolaev, Vladimir/AAV-2153-2020; Campos, Paula F/B-1634-2010; Germonpré, Mietje/O-5952-2014; Collins, Matthew James/O-1095-2019; Campos, Paula/ABF-9898-2021; Tikhonov, Alexei/G-7478-2016; Iacumin, Paola/AAV-8855-2021; Willerslev, Eske/AAA-5686-2019; Gilbert, Marcus TP/A-8936-2013; Kuznetsova, Tatyana/J-4806-2013	Dalén, Love/0000-0001-8270-7613; Collins, Matthew J/0000-0003-4226-5501; Willerslev, Eske/0000-0002-7081-6748; Higham, Tom/0000-0002-5949-598X; Campos, Paula F/0000-0003-1285-4671; Germonpré, Mietje/0000-0001-8865-0937; Collins, Matthew James/0000-0003-4226-5501; Gilbert, Marcus TP/0000-0002-5805-7195; Iacumin, Paola/0000-0001-6944-1814; Gotherstrom, Anders/0000-0001-8579-1304; wilson, andrew/0000-0003-1346-937X; Tikhonov, Alexei/0000-0002-7227-5797; Fredrikson, Karin/0000-0001-7360-4276; Kuznetsova, Tatyana/0000-0003-4302-9607	NERC [NE/C511148/1] Funding Source: UKRI; NHGRI NIH HHS [HG002238] Funding Source: Medline; Natural Environment Research Council [NE/C511148/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Linch CA, 2001, J FORENSIC SCI, V46, P844; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; PILKINGTON S, 1987, LANCET, V329, P1112; PINEAU P, 2004, POUR SCI DOSSIER HOR, V43, P35; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rogaev EI, 2006, PLOS BIOL, V4, P403, DOI 10.1371/journal.pbio.0040073; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; TOLMACHOFF IP, 1929, SIBERIA T AM PHILOS, V23, P1; VANSCOTT EJ, 1963, J INVEST DERMATOL, V41, P269, DOI 10.1038/jid.1963.110	25	184	192	4	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1927	1930		10.1126/science.1146971	http://dx.doi.org/10.1126/science.1146971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901335				2022-12-28	WOS:000249764300041
J	Diamond, J				Diamond, Jared			Easter Island revisited	SCIENCE			English	Editorial Material							RAPA NUI		Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						BORK HR, 2006, LANDSCHAFTEN ERDE; FLENLEY J, 2007, RAPA NUI J, V21, P12; Flenley J., 2003, ENIGMAS EASTER ISLAN; FUKUSAWA H, 2005, MONSOON, V6, P32; Hunt TL, 2006, AM SCI, V94, P412, DOI 10.1511/2006.61.412; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; Ladefoged TN, 2005, RAPA NUI J, V19, P100; Mieth A, 2006, SOILS AND SOCIETIES: PERSPECTIVES FROM ENVIRONMENTAL HISTORY, P273; Mieth Andreas, 2004, RAPA NUI J, V18, P10; ORLIAC C, 2006, NOUV ARCHEOL, V102, P29; Orliac Catherine, 2005, Archaeology in Oceania, V40, P115; Peiser Benny, 2005, ENERGY ENV, V16, P513, DOI DOI 10.1260/0958305054672385; Rainbird P, 2002, WORLD ARCHAEOL, V33, P436, DOI 10.1080/00438240120107468; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Steadman David W., 1994, Asian Perspectives, V33, P79; Stevenson CM, 2006, ANTIQUITY, V80, P919, DOI 10.1017/S0003598X00094515; VANTILBURG J, 2007, 7 INT C EAST ISL PAC, P14; VANTILBURG JA, 2005, ONWARD UPWARD PAPERS, P279; VARGAS P, 2006, 1000 ANOS RAPA NUI A; WALLIN P, 2005, SWEET POTATO OCEANIA; WHITE C, 1998, MEX J SCI, V38, P251; Wozniak Joan A., 1999, RAPA NUI J, V13, P95	22	22	24	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1692	1694		10.1126/science.1138442	http://dx.doi.org/10.1126/science.1138442			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885119				2022-12-28	WOS:000249585900028
J	DiNardo, S; Braun, RE				DiNardo, Steve; Braun, Robert E.			Home for the precious few	SCIENCE			English	Editorial Material							CELL SELF-RENEWAL; SPERMATOGONIAL STEM-CELLS; MOUSE TESTIS; SPERMATOGENESIS; NEUROGENESIS; MAINTENANCE; DIVISION; PLZF		Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Pennsylvania; University of Washington; University of Washington Seattle	DiNardo, S (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	sdinardo@mail.med.upenn.edu; braun@washington.edu		DiNardo, Stephen/0000-0003-4131-5511				BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	16	0	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1696	1697		10.1126/science.1149533	http://dx.doi.org/10.1126/science.1149533			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885122				2022-12-28	WOS:000249585900031
J	Dong, JX; Feldmann, G; Huang, JB; Wu, S; Zhang, NL; Comerford, SA; Gayyed, MF; Anders, RA; Maitra, A; Pan, DJ				Dong, Jixin; Feldmann, Georg; Huang, Jianbin; Wu, Shian; Zhang, Nailing; Comerford, Sarah A.; Gayyed, Mariana F.; Anders, Robert A.; Maitra, Anirban; Pan, Duojia			Elucidation of a universal size-control mechanism in Drosophila and mammals	CELL			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CELL; YAP; APOPTOSIS; CANCER; DOMAIN; MICE; TRANSCRIPTION; WW	Coordination of cell proliferation and cell death is essential to attain proper organ size during development and for maintaining tissue homeostasis throughout postnatal life. In Drosophila, these two processes are orchestrated by the Hippo kinase cascade, a growth- suppressive pathway that ultimately antagonizes the transcriptional coactivator Yorkie ( Yki). Here we demonstrate that a single phosphorylation site in Yki mediates the growth suppressive output of the Hippo pathway. Hippo- mediated phosphorylation inactivates Yki by excluding it from the nucleus, whereas loss of Hippo signaling leads to nuclear accumulation and therefore increased Yki activity. We further delineate a mammalian Hippo signaling pathway that culminates in the phosphorylation of YAP, the mammalian homolog of Yki. Using a conditional YAP transgenic mouse model, we demonstrate that the mammalian Hippo pathway is a potent regulator of organ size, and that its dysregulation leads to tumorigenesis. These results uncover a universal size- control mechanism in metazoan.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu		Comerford, Sarah Ann/0000-0002-7452-7759; Gayyed, Mariana/0000-0002-9455-2257; Wu, Shian/0000-0003-4990-6594	NATIONAL CANCER INSTITUTE [R01CA113669] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072532, K08DK067187, R01DK081417] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA113669, R01 CA113669-02, R01 CA113669, R01 CA113669-04, R01 CA113669-01, R01 CA113669-05, R01 CA113669-03] Funding Source: Medline; NEI NIH HHS [R01 EY015708, EY015708] Funding Source: Medline; NIDDK NIH HHS [R21 DK072532, R01 DK081417, K08 DK067187, R21DK072532, DK067187] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; Ferrigno O, 2002, ONCOGENE, V21, P4879, DOI 10.1038/sj.onc.1205623; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Howell M, 2004, J BIOL CHEM, V279, P26300, DOI 10.1074/jbc.M401070200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; SUDOL M, 1994, ONCOGENE, V9, P2145; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	40	1705	1749	6	188	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1120	1133		10.1016/j.cell.2007.07.019	http://dx.doi.org/10.1016/j.cell.2007.07.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889654	Green Accepted, Bronze			2022-12-28	WOS:000250507500020
J	Paul, WE				Paul, William E.			Dendritic cells bask in the limelight	CELL			English	Article							PERIPHERAL LYMPHOID ORGANS; MICE; IDENTIFICATION	Ralph Steinman is to receive the 2007 Albert Lasker Award for Basic Medical Research for his discovery of dendritic cells and his path- breaking work demonstrating their central role as the principal antigen- presenting cells of the immune system and key activators of T cell responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wpaul@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000926, Z01AI000926] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Sousa CRE, 2001, IMMUNITY, V14, P495; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; STEINMAN RM, 1975, J EXP MED, V141, P804; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172	14	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					967	970		10.1016/j.cell.2007.09.001	http://dx.doi.org/10.1016/j.cell.2007.09.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889637	Bronze			2022-12-28	WOS:000250507500002
J	Mochida, S; Hunt, T				Mochida, Satoru; Hunt, Tim			Calcineurin is required to release Xenopus egg extracts from meiotic M phase	NATURE			English	Article							CYTOSTATIC FACTOR; PROTEIN PHOSPHATASE; CELL-CYCLE; METAPHASE ARREST; MAP KINASE; LAEVIS EGGS; PHOSPHORYLATION; FERTILIZATION; DEGRADATION; INHIBITOR	Fertilization induces a transient increase in cytoplasmic Ca2+ concentration in animal eggs that releases them from cell cycle arrest in the second meiotic metaphase(1). In frog eggs, Ca2+ activates Ca2+/calmodulin-activated kinase, which inactivates cytostatic factor(2-5), allowing the anaphase-promoting factor to turn on and ubiquitinate cyclins and securin, which returns the cell cycle to interphase(6). Here we show that the calcium-activated protein phosphatase calcineurin(7) is also important in this process. Calcineurin is transiently activated after adding Ca2+ to egg extracts, and inhibitors of calcineurin such as cyclosporin A (ref. 8) delay the destruction of cyclins, the global dephosphorylation of M-phase-specific phosphoproteins and the re-formation of a fully functional nuclear envelope. We found that a second wave of phosphatase activity directed at mitotic phosphoproteins appears after the spike of calcineurin activity. This activity disappeared the next time the extract entered M phase and reappeared at the end of mitosis. We surmise that inhibition of this second phosphatase activity is important in allowing cells to enter mitosis, and, conversely, that its activation is required for a timely return to interphase. Calcineurin is required to break the deep cell cycle arrest imposed by the Mos-MAP (mitogen-activated protein) kinase pathway(4,5,9), and we show that Fizzy/Cdc20, a key regulator of the anaphase-promoting factor(6), is an excellent substrate for this phosphatase.	Imperial Canc Res Fund, Clare Hall Labs, London Res Ctr, Canc Res UK, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Hunt, T (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, London Res Ctr, Canc Res UK, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk	Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038				BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; Chatterjee S, 1997, EXP CELL RES, V236, P346, DOI 10.1006/excr.1997.3746; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LORCA T, 1991, MOL CELL BIOL, V11, P1171, DOI 10.1128/MCB.11.2.1171; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Maller JL, 2001, BIOL CELL, V93, P27, DOI 10.1016/S0248-4900(01)01127-3; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622	32	115	117	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					336	+		10.1038/nature06121	http://dx.doi.org/10.1038/nature06121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882219				2022-12-28	WOS:000249557300044
J	Leitch, A; McGinness, P; Wallbridge, D				Leitch, Andrew; McGinness, Peter; Wallbridge, David			Drug points - Calculate the QT interval in patients taking drugs for dementia	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, Dept Anaesthet, Southampton SO16 6YD, Hants, England	University of Southampton	Leitch, A (corresponding author), Southampton Gen Hosp, Dept Anaesthet, Tremona Rd, Southampton SO16 6YD, Hants, England.	AndrewLeitch@doctors.org.uk	Leitch, Andrew R/J-6385-2014	Leitch, Andrew R/0000-0001-8574-302X				De Ponti F, 2000, LANCET, V356, P75, DOI 10.1016/S0140-6736(05)73412-7; *MED HEALTHC PROD, ADV DRUG REACT ONL I; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363	3	20	20	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					557	557		10.1136/bmj.39020.710602.47	http://dx.doi.org/10.1136/bmj.39020.710602.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855324	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000249790200037
J	MILNER, ST				MILNER, ST			POLYMER BRUSHES	SCIENCE			English	Article							TERMINALLY ATTACHED CHAINS; ADSORBED BLOCK COPOLYMERS; CONSISTENT FIELD-THEORY; DIBLOCK COPOLYMERS; MOLECULAR-DYNAMICS; GRAFTED POLYMERS; SURFACES; LAYERS; FORCES; ADSORPTION	Polymers attached by one end to an interface at relatively high coverage stretch away from the interface to avoid overlapping, forming a polymer "brush." This simple picture may serve as the basis for models in diverse interfacial systems in polymer science, such as polymeric surfactants, stabilized suspensions of colloidal particles, and structures formed by block copolymers. The structure and dynamics of polymer brushes have been the subject of considerable theoretical and experimental activity in recent years. Ann account is given of recent advances in theoretical understanding of stretched polymers at interfaces, and the diverse experimental probes of systems modeled by brushes are briefly reviewed.			MILNER, ST (corresponding author), EXXON RES & ENGN CO,CORP RES SCI LABS,ANNANDALE,NJ 08801, USA.							ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700; ALLAIN C, 1982, PHYS REV LETT, V49, P1694, DOI 10.1103/PhysRevLett.49.1694; ANASTASIADIS SH, 1990, J CHEM PHYS, V92, P5677, DOI 10.1063/1.458499; AUROY P, PREPRINT; AUSSERRE D, 1985, PHYS REV LETT, V54, P1948, DOI 10.1103/PhysRevLett.54.1948; BALL RC, IN PRESS MACROMOLECU; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; BIRSHTEIN TM, 1989, POLYMER, V30, P170, DOI 10.1016/0032-3861(89)90399-6; BIRSHTEIN TM, 1990, POLYMER, V31, P1312, DOI 10.1016/0032-3861(90)90223-L; BLOCH JM, 1985, PHYS REV LETT, V54, P1039, DOI 10.1103/PhysRevLett.54.1039; BLUM FD, 1990, MACROMOLECULES, V23, P3592, DOI 10.1021/ma00217a600; BLUM FD, 1990, COLLOID SURFACE, V45, P361, DOI 10.1016/0166-6622(90)80037-5; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; CANTOR R, 1981, MACROMOLECULES, V14, P1186, DOI 10.1021/ma50006a010; CHAKRABARTI A, 1990, MACROMOLECULES, V23, P2016, DOI 10.1021/ma00209a023; COHENSTUART M, 1986, ADV COLLOID INTERFAC, V24, P143; COSGROVE T, 1987, MACROMOLECULES, V20, P1692, DOI 10.1021/ma00173a041; COSGROVE T, 1987, MACROMOLECULES, V20, P2879, DOI 10.1021/ma00177a040; COSGROVE T, 1990, LANGMUIR, V6, P136, DOI 10.1021/la00091a021; CROUCHER MD, 1988, COLLOID SURFACE, V31, P311, DOI 10.1016/0166-6622(88)80202-6; DAOUD M, 1982, J PHYS-PARIS, V43, P531, DOI 10.1051/jphys:01982004303053100; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DEGENNES PG, 1985, CR ACAD SCI II, V300, P839; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; DEGENNES PG, 1976, MACROMOLECULES, V9, P594, DOI 10.1021/ma60052a012; DEGENNES PG, 1976, J PHYS LES ULIS, V37, P1443; DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH1; DIMARZIO EA, 1971, J CHEM PHYS, V55, P4318, DOI 10.1063/1.1676755; DOLAN AK, 1974, P ROY SOC LOND A MAT, V337, P509, DOI 10.1098/rspa.1974.0063; DOLAN AK, 1975, P ROY SOC LOND A MAT, V343, P427, DOI 10.1098/rspa.1975.0077; EDWARDS SF, 1965, P PHYS SOC LOND, V93, P605; EVERS OA, 1990, J CHEM SOC FARADAY T, V86, P1333, DOI 10.1039/ft9908601333; FLEER GJ, 1989, COLLOID SURFACE, V35, P151, DOI 10.1016/0166-6622(89)80293-8; FLORY PJ, 1981, PRINCIPLES POLYM CHE, pCH14; FREDERICKSON GH, IN PRESS MACROMOLECU; FREED KF, 1974, J CHEM PHYS, V61, P3626, DOI 10.1063/1.1682545; GRANICK S, 1985, MACROMOLECULES, V18, P460, DOI 10.1021/ma00145a027; HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014; HALPERIN A, 1988, EUROPHYS LETT, V6, P329, DOI 10.1209/0295-5075/6/4/009; HALPERIN A, 1989, MACROMOLECULES, V22, P2403, DOI 10.1021/ma00195a069; HELFAND E, 1978, MACROMOLECULES, V11, P960, DOI 10.1021/ma60065a023; HELFAND E, 1976, MACROMOLECULES, V9, P879, DOI 10.1021/ma60054a001; HIRZ SJ, 1986, THESIS U MINNESOTA M; HU HW, 1990, MACROMOLECULES, V23, P613, DOI 10.1021/ma00204a039; HU HW, 1989, LANGMUIR, V5, P270, DOI 10.1021/la00085a052; Israelachvili J., COMMUNICATION; KAWAGUCHI M, 1988, MACROMOLECULES, V21, P1059, DOI 10.1021/ma00182a036; LEIBLER L, 1983, J CHEM PHYS, V79, P3550, DOI 10.1063/1.446209; LEIBLER L, 1988, MAKROMOL CHEM-M SYMP, V15, P1; LEIBLER L, PREPRINT; LIGOURE C, 1990, J PHYS-PARIS, V51, P1313, DOI 10.1051/jphys:0199000510120131300; MARKO JF, PREPRINT; MARQUES C, 1988, MACROMOLECULES, V21, P1051, DOI 10.1021/ma00182a035; Marra J, 1988, COLLOID SURFACE, V34, P215; MAYES AM, 1988, MACROMOLECULES, V21, P2543, DOI 10.1021/ma00186a038; MILNER ST, 1988, EUROPHYS LETT, V5, P413, DOI 10.1209/0295-5075/5/5/006; MILNER ST, 1988, J PHYS-PARIS, V49, P1951, DOI 10.1051/jphys:0198800490110195100; MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005; MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051; MILNER ST, 1990, J CHEM SOC FARADAY T, V86, P1349, DOI 10.1039/ft9908601349; MILNER ST, 1989, MACROMOLECULES, V22, P853, DOI 10.1021/ma00192a057; MUNCH MR, 1990, MACROMOLECULES, V23, P2313, DOI 10.1021/ma00210a030; MUNCH MR, 1990, J CHEM SOC FARADAY T, V86, P1341, DOI 10.1039/ft9908601341; MURAT M, 1989, MACROMOLECULES, V22, P4054, DOI 10.1021/ma00200a041; MURAT M, 1989, PHYS REV LETT, V63, P1074, DOI 10.1103/PhysRevLett.63.1074; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P965, DOI 10.1021/ma00192a072; PARSONAGE E, IN PRESS MACROMOLECU; PATEL S, 1988, COLLOID SURFACE, V31, P157, DOI 10.1016/0166-6622(88)80191-4; PATEL SS, 1989, ANNU REV PHYS CHEM, V40, P597; SAFRAN SA, 1984, J PHYS LETT-PARIS, V45, pL69, DOI 10.1051/jphyslet:0198400450206900; SATIJA SK, 1990, MACROMOLECULES, V23, P3860, DOI 10.1021/ma00218a023; SAUER BB, 1987, MACROMOLECULES, V20, P393, DOI 10.1021/ma00168a027; SAUER BB, 1989, LANGMUIR, V5, P278, DOI 10.1021/la00085a055; SCHEUTJENS JMHM, 1979, J PHYS CHEM-US, V83, P1619, DOI 10.1021/j100475a012; SEMENOV AN, 1985, ZH EKSP TEOR FIZ, V0061, P00733; SHIM DFK, 1989, J PHYS-PARIS, V50, P3535, DOI 10.1051/jphys:0198900500240353500; SKVORTSOV AM, 1988, VYSOKOMOL SOEDIN A+, V30, P1615; SZLEIFER I, 1988, PHYS REV LETT, V60, P1966, DOI 10.1103/PhysRevLett.60.1966; SZLEIFER I, 1990, J PHYS CHEM-US, V94, P5081, DOI 10.1021/j100375a060; TASSIN JF, 1989, J PHYS CHEM-US, V93, P2106, DOI 10.1021/j100342a078; TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033; TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0; TAUNTON HJ, 1988, MACROMOLECULES, V21, P3333, DOI 10.1021/ma00189a035; TIRRELL M, 1987, P NATL ACAD SCI USA, V84, P4725, DOI 10.1073/pnas.84.14.4725; WANG ZG, 1990, J PHYS-PARIS, V51, P185, DOI 10.1051/jphys:01990005102018500; WEBBER RM, 1990, MACROMOLECULES, V23, P1026, DOI 10.1021/ma00206a020; WHITMORE MD, 1988, MACROMOLECULES, V21, P1482, DOI 10.1021/ma00183a044; WHITMORE MD, 1990, MACROMOLECULES, V23, P3321, DOI 10.1021/ma00215a020; WITTEN TA, 1990, MACROMOLECULES, V23, P824, DOI 10.1021/ma00205a022; ZHULINA EB, 1990, J COLLOID INTERF SCI, V137, P495, DOI 10.1016/0021-9797(90)90423-L; ZHULINA YB, 1989, VYSOKOMOL SOEDIN A+, V31, P185	91	1697	1740	10	791	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					905	914		10.1126/science.251.4996.905	http://dx.doi.org/10.1126/science.251.4996.905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847384				2022-12-28	WOS:A1991EY62900036
J	SUOMI, VE; LIMAYE, SS; JOHNSON, DR				SUOMI, VE; LIMAYE, SS; JOHNSON, DR			HIGH WINDS OF NEPTUNE - A POSSIBLE MECHANISM	SCIENCE			English	Article							VOYAGER	Neptune receives only 1/900th of the earth's solar energy, but has wind speeds of nearly 600 meters per second. How the near-supersonic winds can be maintained has been a puzzle. A plausible mechanism, based on principles of angular momentum and energy conservation in conjunction with deep convection, leads to a regime of uniform angular momentum at low latitudes. In this model, the rapid retrograde winds observed are a manifestation of deep convection, and the high efficiency of the planet's heat engine is intrinsic from the room allowed at low latitudes for reversible processes, the high temperatures at which heat is added to the atmosphere, and the low temperatures at which heat is extracted.			SUOMI, VE (corresponding author), UNIV WISCONSIN,CTR SPACE SCI & ENGN,1225 W DAYTON ST,MADISON,WI 53706, USA.							Eliassen A., 1951, ASTROPHYS NORV, V5, P19; HAMMEL HB, 1989, SCIENCE, V245, P1367, DOI 10.1126/science.245.4924.1367; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; JOHNSON DR, 1989, ADV GEOPHYS, V31, P43, DOI 10.1016/S0065-2687(08)60053-9; LIMAYE SS, IN PRESS ADV SPACE R; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; TASSOUL J, 1978, THEORY ROTATING STAR, P506; TOLMAN RC, 1948, REV MOD PHYS, V20, P51, DOI 10.1103/RevModPhys.20.51; WARWICK JW, 1989, SCIENCE, V246, P1498, DOI 10.1126/science.246.4936.1498	9	17	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					929	932		10.1126/science.251.4996.929	http://dx.doi.org/10.1126/science.251.4996.929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847386				2022-12-28	WOS:A1991EY62900041
J	DELANEY, PT; FISKE, RS; MIKLIUS, A; OKAMURA, AT; SAKO, MK				DELANEY, PT; FISKE, RS; MIKLIUS, A; OKAMURA, AT; SAKO, MK			DEEP MAGMA BODY BENEATH THE SUMMIT AND RIFT ZONES OF KILAUEA VOLCANO, HAWAII	SCIENCE			English	Article									US GEOL SURVEY,HAWAIIAN VOLCANO OBSERV,HAWAII NATL PK,HI 96718; NATL MUSEUM NAT HIST,WASHINGTON,DC 20560	United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Smithsonian National Museum of Natural History								ANDO M, 1979, J GEOPHYS RES, V84, P7616, DOI 10.1029/JB084iB13p07616; CROSSON RS, 1981, B SEISMOL SOC AM, V71, P713; DECKER RW, 1987, US GEOL SURV PROF PA, V1350, P997; DIETERICH JH, 1988, J GEOPHYS RES-SOLID, V93, P4258, DOI 10.1029/JB093iB05p04258; DIETERICH JH, 1975, J GEOPHYS RES, V80, P4094, DOI 10.1029/JB080i029p04094; DVORAK J, 1983, J GEOPHYS RES, V88, P9295, DOI 10.1029/JB088iB11p09295; DVORAK JJ, 1986, TECTONOPHYSICS, V124, P193, DOI 10.1016/0040-1951(86)90200-3; DZURISIN D, 1984, J VOLCANOL GEOTH RES, V21, P177, DOI 10.1016/0377-0273(84)90022-2; EATON JP, 1960, SCIENCE, V132, P925, DOI 10.1126/science.132.3432.925; EATON JP, COMMUNICATION; FISKE RS, 1969, SCIENCE, V165, P341, DOI 10.1126/science.165.3891.341; FISKE RS, 1968, 607 US GEOL SURV PRO; FURUMOTO AS, 1979, PHYS EARTH PLANET IN, V18, P197, DOI 10.1016/0031-9201(79)90114-6; Johnson D., 1987, US GEOL SURV PROF PA, V1350, P1297; Klein F.W., 1987, VOLCANISM HAWAII, P1019; LAURILA SH, 1983, ELECTRONIC SURVEYING, pCH5; LIPMAN JP, 1985, 1276 US GEOL SURV PR; MACDONALD GA, 1964, US GEOL SURV B, V1171; Maruyama T., 1964, B EARTHQ RES I TOKYO, V42, P289; MOORE JG, 1988, J VOLCANOL GEOTH RES, V35, P165, DOI 10.1016/0377-0273(88)90013-3; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; POLLARD DD, 1983, TECTONOPHYSICS, V94, P541, DOI 10.1016/0040-1951(83)90034-3; RICHTER DH, 1970, 537E US GEOL SURV PR; RUBIN AM, 1988, GEOLOGY, V16, P413, DOI 10.1130/0091-7613(1988)016<0413:DIFIRZ>2.3.CO;2; RYAN MP, 1988, J GEOPHYS RES-SOLID, V93, P4213, DOI 10.1029/JB093iB05p04213; RYAN MP, 1983, J GEOPHYS RES, V88, P4147, DOI 10.1029/JB088iB05p04147; SWANSON DA, 1972, SCIENCE, V175, P169, DOI 10.1126/science.175.4018.169; SWANSON DA, 1975, 963 US GEOL SURV PRO, V963; TILLING RI, 1976, 740 US GEOL SURV CIR; VANICEK P, 1986, GEODESY CONCEPTS, pCH19; WILSON RM, 1935, U HAWAII RES PUBL, V12; WOLFE EW, 1988, 1463 US GEOL SURV PR; 1984, STANDARDS SPECIFICAT	34	121	121	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1311	1316		10.1126/science.247.4948.1311	http://dx.doi.org/10.1126/science.247.4948.1311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843792				2022-12-28	WOS:A1990CU25300029
J	SHUKLA, J; NOBRE, C; SELLERS, P				SHUKLA, J; NOBRE, C; SELLERS, P			AMAZON DEFORESTATION AND CLIMATE CHANGE	SCIENCE			English	Article											SHUKLA, J (corresponding author), UNIV MARYLAND, DEPT METEOROL, CTR OCEAN LAND ATMOSPHERE INTERACT, COLLEGE PK, MD 20742 USA.		Noojipady, Praveen/B-2511-2010					CHARNEY J, 1977, J ATMOS SCI, V34, P1366, DOI 10.1175/1520-0469(1977)034<1366:ACSOTE>2.0.CO;2; DIAS ACCP, 1985, TROP AGRIC, V62, P207; DICKINSON RE, 1988, Q J ROY METEOR SOC, V114, P439, DOI 10.1002/qj.49711448009; Dickinson RE, 1986, BIOSPHERE ATMOSPHERE; DORMAN JL, 1989, J APPL METEOROL, V28, P833, DOI 10.1175/1520-0450(1989)028<0833:AGCOAR>2.0.CO;2; Fearnside P.M., 1987, GEOPHYS AMAZONIA VEG, P37; Ghuman B.S., 1987, GEOPHYSIOLOGY AMAZON, P225; HAMILTON A, 1989, ECOSYSTEMS WORLD B, V14, P155; HOUGHTON RA, 1985, NATURE, V316, P617, DOI 10.1038/316617a0; KINTER JL, 1988, J ATMOS SCI, V45, P2486, DOI 10.1175/1520-0469(1988)045<2486:ASOTWA>2.0.CO;2; LAUER W, 1989, ECOSYSTEMS WORLD B, V14, P7; Lawson T. L., 1981, Tropical agricultural hydrology, P141; LEHOUEROU HN, 1978, ECOCLIMATE CLASSIFIC; LUDLOW MM, 1985, AUST J PLANT PHYSIOL, V12, P131, DOI 10.1071/PP9850131; MAHAR DJ, 1989, GOVT POLICIES DEFORE; MEYERS N, 1982, ACTA AMAZONICA, V12, P745; Mintz Y., 1984, Global climate, P79; Mori S. A., 1987, GEOPHYSIOLOGY AMAZON, P69; PRANCE GT, 1984, AMAZONIA; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; SANFORD RL, 1985, SCIENCE, V227, P53, DOI 10.1126/science.227.4682.53; SATO N, 1989, J ATMOS SCI, V46, P2757, DOI 10.1175/1520-0469(1989)046<2757:EOITSB>2.0.CO;2; SELLERS PJ, 1989, J APPL METEOROL, V28, P727, DOI 10.1175/1520-0450(1989)028&lt;0727:CTSBMF&gt;2.0.CO;2; SELLERS PJ, 1986, J ATMOS SCI, V43, P505, DOI 10.1175/1520-0469(1986)043<0505:ASBMFU>2.0.CO;2; SHUBART H, 1976, CIENCIA CULT SAO PAU, V28, P507; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; SHUTTLEWORTH WJ, 1984, Q J ROY METEOR SOC, V110, P1143, DOI 10.1002/qj.49711046622; STERNBERG HO, 1987, GEOGR ANN A, V69, P201, DOI 10.2307/521378; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; 1989, AVALIACAO COBERTURA	30	654	706	8	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	1990	247	4948					1322	1325		10.1126/science.247.4948.1322	http://dx.doi.org/10.1126/science.247.4948.1322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843795	Green Submitted			2022-12-28	WOS:A1990CU25300032
J	van Sluijs, EMF; McMinn, AM; Griffin, S				van Sluijs, Esther M. F.; McMinn, Alison M.; Griffin, Simon			Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; SCHOOL-BASED INTERVENTION; DISEASE RISK-FACTORS; HEALTH-EDUCATION INTERVENTION; NUTRITION EDUCATION; OBESITY PREVENTION; CARDIOVASCULAR HEALTH; ACTIVITY BEHAVIORS; ACTIVITY PATTERNS; 10TH GRADERS	Objective To review the published literature on the effectiveness of interventions to promote physical activity in children and adolescents. Design Systematic review. Data sources Literature search using PubMed, SCOPUS, Psychlit, Ovid Medline, Sportdiscus, and Embase up to December 2006. Review methods Two independent reviewers assessed studies against the following inclusion criteria: controlled trial, comparison of intervention to promote physical activity with no intervention control condition, participants younger than 18 years, and reported statistical analyses of a physical activity outcome measure. Levels of evidence, accounting for methodological quality, were assessed for three types of intervention, five settings, and three target populations. Results The literature search identified 57 studies: 33 aimed at children and 24 at adolescents. Twenty four studies were of high methodological quality, including 13 studies in children. Interventions that were found to be effective achieved increases ranging from an additional 2.6 minutes of physical education related physical activity to 283 minutes per week of overall physical activity. Among children, limited evidence for an effect was found for interventions targeting children from low socioeconomic populations, and environmental interventions. Strong evidence was found that school based interventions with involvement of the family or community and multicomponent interventions can increase physical activity in adolescents. Conclusion Some evidence was found for potentially effective strategies to increase children's levels of physical activity. For adolescents, multicomponent interventions and interventions that included both school and family or community involvement have the potential to make important differences to levels of physical activity and should be promoted. A lack of high quality evaluations hampers conclusions concerning effectiveness, especially among children.	Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	van Sluijs, EMF (corresponding author), Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England.	esther.vansluijs@mrc-epid.cam.ac.uk	Griffin, Simon J/K-3106-2013	Griffin, Simon J/0000-0002-2157-4797; van Sluijs, Esther/0000-0001-9141-9082	Medical Research Council [MC_U106179474] Funding Source: Medline; Department of Health [RP-PG-0606-1259] Funding Source: Medline; MRC [MC_U106179474] Funding Source: UKRI; National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; BARANOWSKI T, 1990, HEALTH EDUC QUART, V17, P179, DOI 10.1177/109019819001700205; Baranowski T, 2003, ETHN DIS S1, V13; Bautista-Castano I, 2004, EUR J EPIDEMIOL, V19, P617, DOI 10.1023/B:EJEP.0000036890.72029.7c; Bayne-Smith M, 2004, AM J PUBLIC HEALTH, V94, P1538, DOI 10.2105/AJPH.94.9.1538; BEECH BM, 2003, ETHN DIS S1, V13; Bradley CB, 2000, MED SCI SPORT EXER, V32, P2071, DOI 10.1097/00005768-200012000-00017; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Caballero B, 2003, AM J CLIN NUTR, V78, P308; Christodoulos AD, 2006, BRIT J SPORT MED, V40, P367, DOI 10.1136/bjsm.2005.024521; Coleman KJ, 2005, ARCH PEDIAT ADOL MED, V159, P217, DOI 10.1001/archpedi.159.3.217; DAVIS CE, 1999, AM J CLIN NUTR S, V69; Department of Health, 2005, CHOOS ACT PHYS ACT A; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Dishman RK, 2005, MED SCI SPORT EXER, V37, P478, DOI 10.1249/01.MSS.0000155391.62733.A7; Dishman RK, 2004, PREV MED, V38, P628, DOI 10.1016/j.ypmed.2003.12.007; Doak CM, 2006, OBES REV, V7, P111, DOI 10.1111/j.1467-789X.2006.00234.x; Dollman J, 2005, BRIT J SPORT MED, V39, P892, DOI 10.1136/bjsm.2004.016675; Dowda M, 2007, PREV MED, V44, P153, DOI 10.1016/j.ypmed.2006.10.001; Engbers LH, 2005, AM J PREV MED, V29, P61, DOI 10.1016/j.amepre.2005.03.001; Fahlman MM, 2006, J SCHOOL HEALTH, V76, P12, DOI 10.1111/j.1746-1561.2006.00061.x; Fairclough S, 2005, HEALTH EDUC RES, V20, P448, DOI 10.1093/her/cyg137; FAIRCLOUGH SJ, 2006, PHYS ED SPORT PEDAGO, V11; Fitzgibbon ML, 2006, OBESITY, V14, P1616, DOI 10.1038/oby.2006.186; Fitzgibbon ML, 2005, J PEDIATR-US, V146, P618, DOI 10.1016/j.jpeds.2004.12.019; Flodmark CE, 2006, INT J OBESITY, V30, P579, DOI 10.1038/sj.ijo.0803290; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; Fox KR, 2000, P NUTR SOC, V59, P497, DOI 10.1017/S0029665100000720; FRENCH SA, 2005, INT J BEHAV NUTR PHY, P2; Frenn M, 2005, APPL NURS RES, V18, P13, DOI 10.1016/j.apnr.2004.04.003; Frenn Marilyn, 2003, J Community Health Nurs, V20, P1; Froberg K, 2005, INT J OBESITY, V29, pS34, DOI 10.1038/sj.ijo.0803096; GOING S, 2003, PREV MED S1, V37; Gordon-Larsen P, 1999, J PEDIATR-US, V135, P301, DOI 10.1016/S0022-3476(99)70124-1; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Haerens L, 2006, HEALTH EDUC RES, V21, P911, DOI 10.1093/her/cyl115; Haerens L, 2006, OBESITY, V14, P847, DOI 10.1038/oby.2006.98; Hardeman W, 2005, HEALTH EDUC RES, V20, P676, DOI 10.1093/her/cyh022; Harrell JS, 1996, J PEDIATR-US, V128, P797, DOI 10.1016/S0022-3476(96)70332-3; Harrison M, 2006, J SCI MED SPORT, V9, P388, DOI 10.1016/j.jsams.2006.06.012; Harvey-Berino J, 2003, OBES RES, V11, P606, DOI 10.1038/oby.2003.87; Howard J K, 1996, J Sch Nurs, V12, P4, DOI 10.1177/105984059601200402; Hsu Li-Fang, 2004, Hu Li Za Zhi, V51, P27; Jago R, 2006, PREV MED, V42, P181, DOI 10.1016/j.ypmed.2005.12.010; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Jamner MS, 2004, J ADOLESCENT HEALTH, V34, P279, DOI 10.1016/j.jadohealth.2003.06.003; Jurg ME, 2006, HEALTH PROMOT INT, V21, P320, DOI 10.1093/heapro/dal032; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kelder S, 2005, PUBLIC HEALTH NUTR, V8, P133, DOI 10.1079/PHN2004678; KILLEN JD, 1988, JAMA-J AM MED ASSOC, V260, P1728, DOI 10.1001/jama.260.12.1728; KILLEN JD, 1989, HEALTH EDUC QUART, V16, P263, DOI 10.1177/109019818901600210; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Kumar BN, 2004, PUBLIC HEALTH NUTR, V7, P999, DOI 10.1079/PHN2004644; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Lewis BA, 2002, AM J PREV MED, V23, P26, DOI 10.1016/S0749-3797(02)00471-3; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Macaulay AC, 1997, PREV MED, V26, P779, DOI 10.1006/pmed.1997.0241; Manios Y, 1998, HEALTH EDUC RES, V13, P593, DOI 10.1093/her/13.4.593; Manios Y, 2002, BRIT J NUTR, V88, P315, DOI 10.1079/BJN2002672; Manios Y, 1999, PREV MED, V28, P149, DOI 10.1006/pmed.1998.0388; Manios Y, 2006, PREV MED, V43, P442, DOI 10.1016/j.ypmed.2006.06.001; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; McKenzie TL, 1996, PREV MED, V25, P423, DOI 10.1006/pmed.1996.0074; McKenzie TL, 2001, AM J PREV MED, V21, P101, DOI 10.1016/S0749-3797(01)00335-X; McKenzie TL, 1997, RES Q EXERCISE SPORT, V68, P280, DOI 10.1080/02701367.1997.10608009; MCKENZIE TL, 1993, RES Q EXERCISE SPORT, V64, P178, DOI 10.1080/02701367.1993.10608795; McVeigh JA, 2004, ACTA PAEDIATR, V93, P982, DOI [10.1080/08035250410024961, 10.1111/j.1651-2227.2004.tb02699.x]; Muller MJ, 2005, P NUTR SOC, V64, P249, DOI 10.1079/PNS2005424; Nader PR, 1999, ARCH PEDIAT ADOL MED, V153, P695, DOI 10.1001/archpedi.153.7.695; NADER PR, 1992, FAM COMMUNITY HLTH; Neumark-Sztainer D, 2003, PREV MED, V37, P41, DOI 10.1016/S0091-7435(03)00057-4; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Ortega-Sanchez R, 2004, PREV MED, V38, P219, DOI 10.1016/j.ypmed.2003.09.042; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Palmer S, 2005, AM J HEALTH EDUC, V36, P86, DOI 10.1080/19325037.2005.10608164; Pangrazi RP, 2003, J SCHOOL HEALTH, V73, P317, DOI 10.1111/j.1746-1561.2003.tb06589.x; Paradis G, 2005, PEDIATRICS, V115, P333, DOI 10.1542/peds.2004-0745; Pate RR, 2003, AM J HEALTH PROMOT, V17, P171, DOI 10.4278/0890-1171-17.3.171; Pate RR, 2005, AM J PUBLIC HEALTH, V95, P1582, DOI 10.2105/AJPH.2004.045807; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Patrick K, 2006, ARCH PEDIAT ADOL MED, V160, P128, DOI 10.1001/archpedi.160.2.128; Perry C, 1987, HLTH ED Q, V2, P93, DOI [10.1093/her/2.2.93, DOI 10.1093/HER/2.2.93]; PERRY CL, 1985, PREV MED, V14, P379, DOI 10.1016/0091-7435(85)90064-7; Perry CL, 1994, EUR J PUBLIC HEALTH, V4, P188; Prochaska JJ, 2004, HEALTH PSYCHOL, V23, P314, DOI 10.1037/0278-6133.23.3.314; Reilly JJ, 2003, P NUTR SOC, V62, P611, DOI 10.1079/PNS2003276; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Resnicow K, 1997, ANN EPIDEMIOL, V7, pS14, DOI 10.1016/S1047-2797(97)80005-1; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ridgers ND, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-19; Robbins LB, 2006, NURS RES, V55, P206, DOI 10.1097/00006199-200605000-00007; Saakslahti A, 2004, PEDIATR EXERC SCI, V16, P167, DOI 10.1123/pes.16.2.167; Sahota P, 2001, BRIT MED J, V323, P1027, DOI 10.1136/bmj.323.7320.1027; Sahota P, 2001, BMJ-BRIT MED J, V323, P1029, DOI 10.1136/bmj.323.7320.1029; SALIS JF, 2004, HLTH BEHAV HLTH ED T, P403; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1997, AM J PUBLIC HEALTH, V87, P1328, DOI 10.2105/AJPH.87.8.1328; SALLIS JF, 1992, MED SCI SPORT EXER, V24, pS248; Sallis JF, 2003, AM J PREV MED, V24, P209, DOI 10.1016/S0749-3797(02)00646-3; Sallis JF, 2004, HLTH BEHAV HLTH ED T, P403; SALMON J, 2005, OBESITY PREVENTION 2, P129; Schofield L, 2005, MED SCI SPORT EXER, V37, P1414, DOI 10.1249/01.mss.0000174889.89600.e3; Simon C, 2004, INT J OBESITY, V28, pS96, DOI 10.1038/sj.ijo.0802812; Sleap M, 1996, INT J SPORTS MED, V17, P248, DOI 10.1055/s-2007-972841; Smith B J, 2004, J Sci Med Sport, V7, P67, DOI 10.1016/S1440-2440(04)80280-9; Stone EJ, 1998, AM J PREV MED, V15, P298, DOI 10.1016/S0749-3797(98)00082-8; Story Mary, 2003, Ethn Dis, V13, pS54; Stratton G, 2002, PEDIATR EXERC SCI, V14, P170, DOI 10.1123/pes.14.2.170; Stratton G, 2000, ERGONOMICS, V43, P1538, DOI 10.1080/001401300750003961; STRATTON G, 2005, PREV MED; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Timperio A, 2004, J Sci Med Sport, V7, P20, DOI 10.1016/S1440-2440(04)80274-3; Tsorbatzoudis H, 2005, PERCEPT MOTOR SKILL, V101, P787, DOI 10.2466/pms.101.3.787-802; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; *US SECR HLTH HUM, 2006, PROM BETT HLTH YOUNG; van Beurden E, 2003, PREV MED, V36, P493, DOI 10.1016/S0091-7435(02)00044-0; van Sluijs EMF, 2004, AM J PREV MED, V26, P330, DOI 10.1016/j.amepre.2003.12.010; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Verstraete SJM, 2006, EUR J PUBLIC HEALTH, V16, P415, DOI 10.1093/eurpub/ckl008; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; Warren JM, 2003, HEALTH PROMOT INT, V18, P287, DOI 10.1093/heapro/dag402; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; Wilson DK, 2005, ANN BEHAV MED, V30, P119, DOI 10.1207/s15324796abm3002_4; World Health Organization, 2004, GLOB STRAT DIET PHYS; Young DR, 2006, ARCH PEDIAT ADOL MED, V160, P1255, DOI 10.1001/archpedi.160.12.1255; Zaninotto P., 2006, FORECASTING OBESITY	132	679	686	8	224	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					703	707		10.1136/bmj.39320.843947.BE	http://dx.doi.org/10.1136/bmj.39320.843947.BE			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220KY	17884863	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000250156800031
J	Goodacre, S; Cross, E; Lewis, C; Nicholl, J; Capewell, S				Goodacre, Steve; Cross, Elizabeth; Lewis, Cath; Nicholl, Jon; Capewell, Simon			Effectiveness and safety of chest pain assessment to prevent emergency admissions: ESCAPE cluster randomised tria	BRITISH MEDICAL JOURNAL			English	Article							OBSERVATION UNIT; CARE; PROTOCOL; IMPACT	Objective To determine whether introducing chest pain unit care reduces emergency admissions without increasing reattendances and admissions over the next 30 days. Design Cluster randomised before and after intervention trial. Setting 14 diverse acute hospitals in the United Kingdom. Participants Patients attending the emergency department with acute chest pain during the year before and the year after the intervention started. Intervention Establishment of chest pain unit care compared with continuation of routine care. Main outcome measures Proportion of chest pain attendances resulting in admission; reattendances and admissions over the next 30 days; daily emergency medical admissions (all causes); and proportion of emergency department attendances with chest pain. Results The introduction of chest pain unit care was associated with weak evidence of an increase in emergency department attendances with chest pain (16% v 3.5%; P=0.08); no change in the proportion of chest pain attendances resulting in admission (odds ratio 0.998, 95% confidence interval 0.940 to 1.059; P=0.945); small increases in the proportion reattending (odds ratio 1.10, 1.00 to 1.21; P=0.036) or being admitted (1.30, 0.97 to 1.74; P=0.083) over the next 30 days; and evidence of increased daily medical admissions (1.7 per day, 95% confidence interval 0.8 to 2.5; P<0.001). However, this last finding was highly sensitive to changes in the method used to handle missing data. Conclusion The introduction of chest pain unit care did not reduce the proportion of patients with chest pain admitted and may have been associated with increased emergency department attendances with chest pain.	Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Sheffield; University of Liverpool	Goodacre, S (corresponding author), Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England.	s.goodacre@sheffield.ac.uk	Nicholl, Jon/B-8257-2008	Goodacre, Steve/0000-0003-0803-8444				Abbott BG, 2001, AM J CARDIOL, V87, P1351, DOI 10.1016/S0002-9149(01)01551-X; Arnold J, 2007, EMERG MED J, V24, P462, DOI 10.1136/emj.2007.046862; Capewell S, 1996, BRIT MED J, V312, P991; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Gomez MA, 1996, J AM COLL CARDIOL, V28, P25, DOI 10.1016/0735-1097(96)00093-9; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Goodacre S, 2004, BRIT MED J, V328, P254, DOI 10.1136/bmj.37956.664236.EE; Graff LG, 1997, AM J CARDIOL, V80, P563, DOI 10.1016/S0002-9149(97)00422-0; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Hensher M, 1999, BRIT MED J, V319, P1127, DOI 10.1136/bmj.319.7217.1127; NHS Institute for Innovation and Improvement, 2007, DIR EM AMB CAR AD; Roberts RR, 1997, JAMA-J AM MED ASSOC, V278, P1670, DOI 10.1001/jama.278.20.1670; SHAH SS, 2001, BR J CLIN GOVERNANCE, V6, P40	13	35	35	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					659	662A		10.1136/bmj.39325.624109.AE	http://dx.doi.org/10.1136/bmj.39325.624109.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17878265	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000249989600042
J	Li, JZ; Huen, W				Li, Jonathan Z.; Huen, William			Calciphylaxis with arterial calcification	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Li, JZ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94121 USA.	jonathan.li@ucsf.edu							0	8	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1326	1326		10.1056/NEJMicm060859	http://dx.doi.org/10.1056/NEJMicm060859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898102				2022-12-28	WOS:000249711500009
J	Havas, S; Dickinson, BD; Wilson, M				Havas, Stephen; Dickinson, Barry D.; Wilson, Modena			The urgent need to reduce sodium consumption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIETARY-SODIUM; PUBLIC-HEALTH; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HYPERTENSION; BURDEN; PROGRAM; RISK		Amer Med Assoc, Sci Qual & Publ Hlth, Chicago, IL 60610 USA; Amer Med Assoc, Sci Policy, Chicago, IL 60610 USA; Amer Med Assoc, Profess Stand, Chicago, IL 60610 USA	American Medical Association; American Medical Association; American Medical Association	Havas, S (corresponding author), Amer Med Assoc, Sci Qual & Publ Hlth, 515 N State St, Chicago, IL 60610 USA.	stephen.havas@ama-assn.org						Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; *CTR SCI PUBL INT, PET REV GRAS STAT SA; Cutler JA, 2006, HYPERTENSION, V48, P818, DOI 10.1161/01.HYP.0000245673.93844.6d; Dickinson BD, 2007, ARCH INTERN MED, V167, P1460, DOI 10.1001/archinte.167.14.1460; Food Safety Authority of Ireland, SALT HLTH REV SCI EV; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Institute of Medicine Food and Nutrition Board, 2004, DIET REF INT WAT POT; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mackay J, 2004, ATLAS HEART DIS STRO; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; *US DHHS, HLTH PEOPL 2010, V2, pCH19; *USDA AGR RES SERV, 1997, 1994 CONT SURV FOOD, P7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; *WHO FOR, RED SALT INT POP REP; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	24	67	69	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1439	1441		10.1001/jama.298.12.1439	http://dx.doi.org/10.1001/jama.298.12.1439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895460				2022-12-28	WOS:000249698900023
J	Ghedin, E; Wang, SL; Spiro, D; Caler, E; Zhao, Q; Crabtree, J; Allen, JE; Delcher, AL; Guiliano, DB; Miranda-Saavedra, D; Angiuoli, SV; Creasy, T; Amedeo, P; Haas, B; El-Sayed, NM; Wortman, JR; Feldblyum, T; Tallon, L; Schatz, M; Shumway, M; Koo, H; Salzberg, SL; Schobel, S; Pertea, M; Pop, M; White, O; Barton, GJ; Carlow, CKS; Crawford, MJ; Daub, J; Dimmic, MW; Estes, CF; Foster, JM; Ganatra, M; Gregory, WF; Johnson, NM; Jin, JM; Komuniecki, R; Korf, I; Kumar, S; Laney, S; Li, BW; Li, W; Lindblom, TH; Lustigman, S; Ma, D; Maina, CV; Martin, DMA; McCarter, JP; McReynolds, L; Mitreva, M; Nutman, TB; Parkinson, J; Peregrin-Alvarez, JM; Poole, C; Ren, QH; Saunders, L; Sluder, AE; Smith, K; Stanke, M; Unnasch, TR; Ware, J; Wei, AD; Weil, G; Williams, DJ; Zhang, YH; Fraser-Liggett, C; Slatko, B; Blaxter, ML; Scott, AL				Ghedin, Elodie; Wang, Shiliang; Spiro, David; Caler, Elisabet; Zhao, Qi; Crabtree, Jonathan; Allen, Jonathan E.; Delcher, Arthur L.; Guiliano, David B.; Miranda-Saavedra, Diego; Angiuoli, Samuel V.; Creasy, Todd; Amedeo, Paolo; Haas, Brian; El-Sayed, Najib M.; Wortman, Jennifer R.; Feldblyum, Tamara; Tallon, Luke; Schatz, Michael; Shumway, Martin; Koo, Hean; Salzberg, Steven L.; Schobel, Seth; Pertea, Mihaela; Pop, Mihai; White, Owen; Barton, Geoffrey J.; Carlow, Clotilde K. S.; Crawford, Michael J.; Daub, Jennifer; Dimmic, Matthew W.; Estes, Chris F.; Foster, Jeremy M.; Ganatra, Mehul; Gregory, William F.; Johnson, Nicholas M.; Jin, Jinming; Komuniecki, Richard; Korf, Ian; Kumar, Sanjay; Laney, Sandra; Li, Ben-Wen; Li, Wen; Lindblom, Tim H.; Lustigman, Sara; Ma, Dong; Maina, Claude V.; Martin, David M. A.; McCarter, James P.; McReynolds, Larry; Mitreva, Makedonka; Nutman, Thomas B.; Parkinson, John; Peregrin-Alvarez, Jose M.; Poole, Catherine; Ren, Qinghu; Saunders, Lori; Sluder, Ann E.; Smith, Katherine; Stanke, Mario; Unnasch, Thomas R.; Ware, Jenna; Wei, Aguan D.; Weil, Gary; Williams, Deryck J.; Zhang, Yinhua; Fraser-Liggett, Claire; Slatko, Barton; Blaxter, Mark L.; Scott, Alan L.			Draft genome of the filarial nematode parasite Brugia malayi	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; PAHANGI; EXPRESSION; MICROFILARIAE; IVERMECTIN; SEQUENCES; HOMOLOG; CLONING	Parasitic nematodes that cause elephantiasis and river blindness threaten hundreds of millions of people in the developing world. We have sequenced the similar to 90 megabase (Mb) genome of the human filarial parasite Brugia malayi and predict similar to 11,500 protein coding genes in 71 Mb of robustly assembled sequence. Comparative analysis with the free-living, model nematode Caenorhabditis elegans revealed that, despite these genes having maintained little conservation of local synteny during similar to 350 million years of evolution, they largely remain in linkage on chromosomal units. More than 100 conserved operons were identified. Analysis of the predicted proteome provides evidence for adaptations of B. malayi to niches in its human and vector hosts and insights into the molecular basis of a mutualistic relationship with its Wolbachia endosymbiont. These findings offer a foundation for rational drug design.	Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15261 USA; J Craig Venter Inst, Rockville, MD 20850 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; Univ Dundee, Sch Life Sci Res, Dundee DD1 5EH, Scotland; New England Biolabs Inc, Div Parasitol, Ipswich, MA 01938 USA; Divergence Inc, St Louis, MO 63141 USA; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Lyon Coll, Div Sci, Batesville, AR 72501 USA; Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; New England Biolabs Inc, Div RNA Biol, Ipswich, MA 01938 USA; Univ Toledo, Dept Sci Biol, Toledo, OH 43606 USA; Univ Calif Davis, Div Biol Sci, Mol Biol Sect, Genome Ctr, Davis, CA 95616 USA; Smith Coll, Clark Sci Ctr, Northampton, MA 01063 USA; Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol Lab, New York, NY 10021 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1L7, Canada; Cambria Biosci, Woburn, MA 01801 USA; Univ Gottingen, Dept Bioinformat, D-37077 Gottingen, Germany; Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; J. Craig Venter Institute; J. Craig Venter Institute; Imperial College London; University of Dundee; New England Biolabs; University of Edinburgh; University of Edinburgh; Australian National University; New England Biolabs; University System of Ohio; University of Toledo; University of California System; University of California Davis; Smith College; Washington University (WUSTL); New York Blood Center; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Gottingen; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ghedin, E (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15261 USA.	GhedinE@dom.pitt.edu	El-Sayed, Najib M.A./K-7266-2015; Miranda-Saavedra, Diego/C-2707-2012; Blaxter, Mark/O-2535-2019; Ghedin, Elodie/Y-5654-2019; Blaxter, Mark L/B-4113-2010; Martin, David/C-2984-2009; Sluder, Ann/AAS-3102-2020; Stanke, Mario/P-7876-2019; Barton, Geoffrey/N-1037-2019; Schatz, Michael/L-2690-2019; Pertea, Mihaela/AAT-2705-2021; Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Kumar, Sanjay/AAO-2593-2021; Parkinson, John/A-4424-2008; Barton, Geoffrey J/C-6267-2011; Pop, Mihai/A-7987-2013; Angiuoli, Samuel V/H-7340-2014	El-Sayed, Najib M.A./0000-0001-7970-3312; Ghedin, Elodie/0000-0002-1515-725X; Blaxter, Mark L/0000-0003-2861-949X; Stanke, Mario/0000-0001-8696-0384; Barton, Geoffrey/0000-0002-9014-5355; Schatz, Michael/0000-0002-4118-4446; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Parkinson, John/0000-0001-9815-1189; Pop, Mihai/0000-0001-9617-5304; Angiuoli, Samuel/0000-0001-9525-4350; Zhang, Yinhua/0000-0003-0592-9153; Mitreva, Makedonka/0000-0001-9572-3436; Alvarez, Jose/0000-0002-7184-832X; Fraser, Claire/0000-0003-1462-2428; Daub, Jennifer/0000-0001-6022-563X; McCarter, James/0000-0001-7646-810X; Wortman, Jennifer/0000-0002-8713-1227; Williams, Steven/0000-0002-4881-7496; Allen, Jonathan/0000-0002-4359-8263; Martin, David/0000-0002-8732-204X; Schobel, Seth/0000-0002-8967-257X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000512, U01AI050903, R01AI048562, U01AI048828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES013128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845, R01LM007938] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI50903, R01 AI048562, U01 AI048828, R01 AI048562-09] Funding Source: Medline; NIEHS NIH HHS [R15 ES013128, R15 ES013128-01] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM007938, R01 LM006845, R01 LM007938-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aboobaker AA, 2003, MOL BIOCHEM PARASIT, V129, P41, DOI 10.1016/S0166-6851(03)00092-6; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Blaxter ML, 2003, ADV PARASIT, V54, P101, DOI 10.1016/S0065-308X(03)54003-9; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; CHEN SN, 1981, EXP PARASITOL, V51, P296, DOI 10.1016/0014-4894(81)90117-X; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Ghedin E, 2004, TRENDS PARASITOL, V20, P151, DOI 10.1016/j.pt.2004.01.011; Gomez-Escobar N, 1998, EXP PARASITOL, V88, P200, DOI 10.1006/expr.1998.4248; Gomez-Escobar N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-8; Guiliano DB, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0057; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Kato Y, 1996, J BIOL CHEM, V271, P30493, DOI 10.1074/jbc.271.48.30493; Lee KZ, 2003, NUCLEIC ACIDS RES, V31, P2553, DOI 10.1093/nar/gkg359; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/pnas.83.3.797; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; OU XU, 1995, EXP PARASITOL, V80, P515, DOI 10.1006/expr.1995.1064; Pastrana DV, 1998, INFECT IMMUN, V66, P5955, DOI 10.1128/IAI.66.12.5955-5963.1998; SAKAGUCHI Y, 1983, J PARASITOL, V69, P1090, DOI 10.2307/3280871; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; SIM BKL, 1987, CIBA F SYMP, V127, P107; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; VANFLETEREN JR, 1994, MOL PHYLOGENET EVOL, V3, P92, DOI 10.1006/mpev.1994.1012; Whitton C, 2004, METH MOL B, V270, P75; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836	28	488	552	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1756	1760		10.1126/science.1145406	http://dx.doi.org/10.1126/science.1145406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885136	Green Accepted, Green Submitted			2022-12-28	WOS:000249585900050
J	Junt, T; Schulze, H; Chen, Z; Massberg, S; Goerge, T; Krueger, A; Wagner, DD; Graf, T; Italiano, JE; Shivdasani, RA; von Andrian, UH				Junt, Tobias; Schulze, Harald; Chen, Zhao; Massberg, Steffen; Goerge, Tobias; Krueger, Andreas; Wagner, Denisa D.; Graf, Thomas; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.; von Andrian, Ulrich H.			Dynamic visualization of thrombopoiesis within bone marrow	SCIENCE			English	Article							TRANSCRIPTION FACTOR NF-E2; IN-VIVO; PLATELET-RELEASE; PROPLATELET FORMATION; HUMAN MEGAKARYOCYTES; MICE; THROMBOCYTOPOIESIS; HEMATOPOIESIS; BIOGENESIS; CELLS	Platelets are generated from megakaryocytes (MKs) in mammalian bone marrow (BM) by mechanisms that remain poorly understood. Here we describe the use of multiphoton intravital microscopy in intact BM to visualize platelet generation in mice. MKs were observed as sessile cells that extended dynamic proplatelet-like protrusions into microvessels. These intravascular extensions appeared to be sheared from their transendothelial stems by flowing blood, resulting in the appearance of proplatelets in peripheral blood. In vitro, proplatelet production from differentiating MKs was enhanced by fluid shear. These results confirm the concept of proplatelet formation in vivo and are consistent with the possibility that blood flow-induced hydrodynamic shear stress is a biophysical determinant of thrombopoiesis.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Ctr Regulacio Genom, Barcelona 08003, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	von Andrian, UH (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; uva@hms.harvard.edu	Junt, Tobias/AAE-4389-2021; Massberg, Steffen/AAN-6054-2021; von Andrian, Ulrich H/A-5775-2008; Graf, Thomas/B-4252-2015; Krueger, Andreas/M-9769-2019; Krueger, Andreas/B-9427-2009	Graf, Thomas/0000-0003-2774-4117; Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL063143, R01HL063143, R01HL068130, P01HL056949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL068130, HL63143, HL56949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; Behnke O, 1998, EUR J HAEMATOL, V60, P3; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; CHOI ES, 1995, BLOOD, V85, P402; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; ELDOR A, 1991, BLOOD CELLS, V17, P447; HANDAGAMA PJ, 1987, AM J VET RES, V48, P962; Howell WH, 1937, J EXP MED, V65, DOI 10.1084/jem.65.2.177; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Kabaya K, 1996, STEM CELLS, V14, P651, DOI 10.1002/stem.140651; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; Kosaki G, 2005, INT J HEMATOL, V81, P208, DOI 10.1532/IJH97.04177; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lecine P, 2000, BLOOD, V96, P1366, DOI 10.1182/blood.V96.4.1366.h8001366_1366_1373; Lecine P, 1998, BLOOD, V92, P1608, DOI 10.1182/blood.V92.5.1608.417k27_1608_1616; LICHTMAN MA, 1978, AM J HEMATOL, V4, P303, DOI 10.1002/ajh.2830040402; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Poujol C, 1998, BLOOD, V92, P2012, DOI 10.1182/blood.V92.6.2012.418k28_2012_2023; RADLEY JM, 1980, BLOOD, V56, P996; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; TAVASSOLI M, 1980, BLOOD, V55, P537; YAMADA E., 1957, ACTA ANAT, V29, P267; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; ZUCKERFRANKLIN D, 1984, J CELL BIOL, V99, P390, DOI 10.1083/jcb.99.2.390	27	449	467	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1767	1770		10.1126/science.1146304	http://dx.doi.org/10.1126/science.1146304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885137				2022-12-28	WOS:000249585900053
J	Lifton, RP				Lifton, Richard P.			Lasker award to heart valve pioneers	CELL			English	Article							HETEROGRAFTS; PROSTHESIS	This year, the Lasker Foundation recognizes Albert Starr and Alain Carpentier for their development of effective treatments for valvular heart disease. Their innovative work is a model of interdisciplinary basic and clinical research and has benefited millions of people.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06536 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 333 Cedar St, New Haven, CT 06536 USA.	richard.lifton@yale.edu						BINET JP, 1965, CR HEBD ACAD SCI, V261, P5733; BONOW RO, 2005, BRAUNWALDS HEART DIS, pCH56; CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467, DOI 10.1016/S0022-5223(19)42561-0; CARPENTIER A, 1971, J THORAC CARDIOV SUR, V61, P1; CARPENTIER A, 1974, J THORAC CARDIOV SUR, V68, P771; Carpentier SM, 1998, ANN THORAC SURG, V66, pS264, DOI 10.1016/S0003-4975(98)01101-1; Gao GQ, 2004, J HEART VALVE DIS, V13, P91; Gott VL, 2003, ANN THORAC SURG, V76, pS2230, DOI 10.1016/j.athoracsur.2003.09.002; HERR R, 1965, Ann Thorac Surg, V1, P403; HUFNAGEL CA, 1951, B GEORGETOWN U MED C, V5, P128; Murday AJ, 2003, ANN THORAC SURG, V76, P66, DOI 10.1016/S0003-4975(03)00118-8; PERIER P, 1991, J CARDIAC SURG, V6, P589; STARR A, 1961, ANN SURG, V154, P726, DOI 10.1097/00000658-196110000-00017; World Health Organization, 2004, WHO EXP CONS	14	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					971	974		10.1016/j.cell.2007.08.042	http://dx.doi.org/10.1016/j.cell.2007.08.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889638	Bronze			2022-12-28	WOS:000250507500003
J	Chan, CC; Chiu, HC				Chan, Chih-Chieh; Chiu, Hsien-Ching			Herpetic glossitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Taiwan Univ Hosp, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital	Chan, CC (corresponding author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.	hcchiu1003@ntu.edu.tw		CHIU, HSIEN-CHING/0000-0002-1409-8470					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					E13	E13		10.1056/NEJMicm063551	http://dx.doi.org/10.1056/NEJMicm063551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881747				2022-12-28	WOS:000249541000010
J	Bennet, AM; Di Angelantonio, E; Ye, Z; Wensley, F; Dahlin, A; Ahlbom, A; Keavney, B; Collins, R; Wiman, B; de Faire, U; Danesh, J				Bennet, Anna M.; Di Angelantonio, Emanuele; Ye, Zheng; Wensley, Frances; Dahlin, Anette; Ahlbom, Anders; Keavney, Bernard; Collins, Rory; Wiman, Bjoern; de Faire, Ulf; Danesh, John			Association of apolipoprotein E genotypes with lipid levels and coronary risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ISCHEMIC-HEART-DISEASE; ESTER TRANSFER PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; PREMATURE MYOCARDIAL-INFARCTION; ANGIOTENSIN-CONVERTING ENZYME; CYSTEINE-ARGININE INTERCHANGE; E GENE POLYMORPHISM; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; ARTERY-DISEASE	Context Previous reviews of associations of apolipoprotein E (apoE) genotype and coronary disease have been dominated by smaller studies that are liable to biases. Objective To reassess associations of apoE genotypes with circulating lipid levels and with coronary risk. Data Sources We conducted an updated meta-analysis including both published and previously unreported studies, using MEDLINE, EMBASE, BIOSIS, Science Citation Index, and the Chinese National Knowledge Infrastructure Database published between January 1970 and January 2007, reference lists of articles retrieved, and a registry of relevant studies. Study Selection Eighty-two studies of lipid levels (86 067 healthy participants) and 121 studies of coronary outcomes (37 850 cases and 82 727 controls) were identified, with prespecified principal focus on studies with at least 1000 healthy participants for lipids and those with at least 500 coronary outcomes. Data Extraction Information on genotype frequencies, lipid levels, coronary outcomes, and laboratory and population characteristics were recorded independently by 2 investigators and/or supplied by study investigators. Results In the most extreme comparison, people with the epsilon 2/epsilon 2 genotype had 1.14 mmol/L (95% confidence interval [CI], 0.87-1.40 mmol/L [44.0 mg/dL; 95% CI; 33.6-51.1 mg/dL]) or about 31% (95% CI, 23%-38%) lower mean low-density lipoprotein cholesterol (LDL-C) values than those with the epsilon 4/epsilon 4 genotype. There were approximately linear relationships of apoE genotypes (when ordered epsilon 2/epsilon 2, epsilon 2/epsilon 3, epsilon 2/epsilon 4, epsilon 3/epsilon 3, epsilon 3/epsilon 4, epsilon 4/epsilon 4) with LDL-C and with coronary risk. The relationship with high-density lipoprotein cholesterol was inverse and shallow and that with triglycerides was nonlinear and largely confined to the epsilon 2/epsilon 2 genotype. Compared with epsilon 3/epsilon 3, the odds ratio for coronary disease was 0.80 (95% CI, 0.700.90) in epsilon 2 carriers and was 1.06 (95% CI, 0.99-1.13) in epsilon 4 carriers. Conclusions There are approximately linear relationships of apoE genotypes with both LDL-C levels and coronary risk. Compared with individuals with the epsilon 3/epsilon 3 genotype, epsilon 2 carriers have a 20% lower risk of coronary heart disease and epsilon 4 carriers have a slightly higher risk.	Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; Karolinska Univ Hosp, Div Clin Chem, Dept Mol Med & Surg, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Univ Oxford, Clin Trial Serv Unit, Oxford OX1 2JD, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX1 2JD, England	University of Cambridge; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Newcastle University - UK; University of Oxford; University of Oxford	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Worts Causeway, Cambridge CB1 8RN, England.	john.danesh@phpc.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020	Wensley, Frances/0000-0003-4371-5340; Keavney, Bernard/0000-0001-9573-0812; Di Angelantonio, Emanuele/0000-0001-8776-6719; Bennet-Bark, Anna/0000-0003-2704-2625				Attila G, 2001, CLIN CHIM ACTA, V312, P191, DOI 10.1016/S0009-8981(01)00624-6; Bai X, 2001, Zhonghua Yi Xue Za Zhi, V81, P340; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baitasova N B, 2001, Klin Med (Mosk), V79, P19; Banares VG, 2005, HUM BIOL, V77, P247, DOI 10.1353/hub.2005.0036; Baroni Marco G, 2003, BMC Med Genet, V4, P8, DOI 10.1186/1471-2350-4-8; Batalla A, 2000, CLIN CHEM, V46, P1910; Benes P, 2000, MOL GENET METAB, V69, P137, DOI 10.1006/mgme.1999.2957; Bennet AM, 2006, ATHEROSCLEROSIS, V187, P408, DOI 10.1016/j.atherosclerosis.2005.09.022; Biggart S, 1998, CLIN CARDIOL, V21, P831, DOI 10.1002/clc.4960211109; Bioletto S, 1998, ATHEROSCLEROSIS, V138, P207, DOI 10.1016/S0021-9150(98)00002-1; Boer JMA, 1997, ARTERIOSCL THROM VAS, V17, P1675, DOI 10.1161/01.ATV.17.9.1675; Brouwer DAJ, 1997, W INDIAN MED J, V46, P47; Brown CM, 2002, FREE RADICAL BIO MED, V32, P1071, DOI 10.1016/S0891-5849(02)00803-1; Cao W, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P249; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; [陈忠 Cheng Zhong], 2002, [临床心血管病杂志, Journal of Clinical Cardiology], V18, P150; Choi YH, 2003, J GERONTOL A-BIOL, V58, P227; Colton CA, 2005, NEUROBIOL AGING, V26, P363, DOI 10.1016/j.neurobiolaging.2004.08.001; Corbo RM, 1999, CLIN BIOCHEM, V32, P217, DOI 10.1016/S0009-9120(99)00011-9; CUI JB, 2000, J HENAN MED U, V35, P519; CUMMING AM, 1984, CLIN GENET, V25, P310; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DAMARAJU S, 1995, AM J CARDIOL, V75, P1181, DOI 10.1016/S0002-9149(99)80756-5; Dart A, 1997, ATHEROSCLEROSIS, V130, P161, DOI 10.1016/S0021-9150(96)06062-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djousse L, 2002, STROKE, V33, P1357, DOI 10.1161/01.STR.0000014325.54063.1A; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dzimiri N, 1999, ARCH PATHOL LAB MED, V123, P1241; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EHNHOLM C, 1986, J LIPID RES, V27, P227; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; ETO M, 1989, CLIN GENET, V36, P183; Fan P, 1999, Hua Xi Yi Ke Da Xue Xue Bao, V30, P373; Feng SZ, 2005, GERIATR HLTH CARE, V11, P174; Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Garces C, 2005, DIS MARKERS, V21, P153, DOI 10.1155/2005/381657; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; GONG W, 2000, APPL GERIATR, V14, P131; GONG W, 2000, CHIN J GERONTOL, V5, P149; [管思明 Guan Siming], 2002, [临床心血管病杂志, Journal of Clinical Cardiology], V18, P166; Guo Y, 1997, CHINESE J NEUROL, V30, P236; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Heijmans BT, 2002, AM J MED GENET, V107, P201, DOI 10.1002/ajmg.10142; Hergenc Gulay, 1995, Journal of Biomedical Science, V2, P46, DOI 10.1007/BF02257924; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Inbal A, 1999, BLOOD, V93, P2186, DOI 10.1182/blood.V93.7.2186.407k28_2186_2190; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Isbir T, 2003, CLIN GENET, V64, P228, DOI 10.1034/j.1399-0004.2003.00137.x; JIN W, 1998, SHANGHAI MED J, V21, P697; Joven J, 1998, ATHEROSCLEROSIS, V140, P155, DOI 10.1016/S0021-9150(98)00076-8; Kardaun JWPF, 2000, CLIN CHEM, V46, P1548; Kataoka S, 1996, ARTERIOSCL THROM VAS, V16, P918, DOI 10.1161/01.ATV.16.8.918; Katsuya T, 2002, J HYPERTENS, V20, P2017, DOI 10.1097/00004872-200210000-00021; Keavney B, 2004, INT J EPIDEMIOL, V33, P1002, DOI 10.1093/ije/dyh275; Keavney B, 2003, LANCET, V361, P396, DOI 10.1016/S0140-6736(03)12386-0; Kharrazi H, 2006, CLIN BIOCHEM, V39, P613, DOI 10.1016/j.clinbiochem.2006.02.002; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Kim IJ, 1999, YONSEI MED J, V40, P377, DOI 10.3349/ymj.1999.40.4.377; Kolovou G, 2002, CURR MED RES OPIN, V18, P118, DOI 10.1185/030079902125000444; Kolovou GD, 2003, ANGIOLOGY, V54, P51, DOI 10.1177/000331970305400107; Kumar P, 2003, ANN CLIN BIOCHEM, V40, P382, DOI 10.1258/000456303766477020; KUUSI T, 1989, ARTERIOSCLEROSIS, V9, P237, DOI 10.1161/01.ATV.9.2.237; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Larson IA, 2000, ATHEROSCLEROSIS, V148, P327, DOI 10.1016/S0021-9150(99)00280-4; LEHTINEN S, 1995, ATHEROSCLEROSIS, V114, P83, DOI 10.1016/0021-9150(94)05469-Y; LENZEN HJ, 1986, CLIN CHEM, V32, P778; Letonja M, 2004, ANN GENET-PARIS, V47, P147, DOI 10.1016/j.anngen.2004.01.002; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Li HM, 2003, CHIN J MOD MED, V13, P35; Li WH, 2000, CHIN J ARTERIOSCI, V8, P54; Li X., 2002, J CARDIOVASC PULM DI, V21, P193; Liao MZ, 2004, PRACT PREV MED, V11, P691; Licastro F, 2004, MECH AGEING DEV, V125, P575, DOI 10.1016/j.mad.2004.06.008; LIOU FE, 2001, CHIN J CONT PEDIAT, V3, P667; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; LIU HX, 1999, CHINA J MOD MED, V9, P78; Liu SM, 2003, ATHEROSCLEROSIS, V166, P323, DOI 10.1016/S0021-9150(02)00335-0; [刘晓春 Liu Xiaochun], 2003, [上海医学检验杂志, Shanghai Journal of Medical Laboratory Sciences], V18, P36; Long Shi-yin, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P615; LUC G, 1994, ARTERIOSCLER THROMB, V14, P1412, DOI 10.1161/01.ATV.14.9.1412; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Maitland-van der Zee AH, 2006, ACTA CARDIOL, V61, P327, DOI 10.2143/AC.61.3.2014836; Mamotte Cyril D.S., 2002, Eur J Intern Med, V13, P250, DOI 10.1016/S0953-6205(02)00030-4; Mansur AP, 2000, CLIN CARDIOL, V23, P335, DOI 10.1002/clc.4960230506; Marques-Vidal P, 2003, AM J CARDIOL, V92, P1102, DOI 10.1016/j.amjcard.2003.06.008; MARSHALL HW, 1994, CIRCULATION, V89, P567, DOI 10.1161/01.CIR.89.2.567; Marz W, 2004, EUR HEART J, V25, P2109, DOI 10.1016/j.ehj.2004.08.024; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; Mustafina O. E., 2002, Molekulyarnaya Biologiya (Moscow), V36, P978; Nakai K, 1998, CORONARY ARTERY DIS, V9, P329, DOI 10.1097/00019501-199809060-00002; Ng MCY, 2004, GENOMICS, V83, P559, DOI 10.1016/j.ygeno.2003.09.008; NIAO Q, 2004, J SICHUAN U, V35, P285; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Ordovas JM, 1999, CURR OPIN LIPIDOL, V10, P15, DOI 10.1097/00041433-199902000-00004; Orth M, 1999, ARTERIOSCL THROM VAS, V19, P1306, DOI 10.1161/01.ATV.19.5.1306; Orth M, 2003, CLIN CHEM LAB MED, V41, P652, DOI 10.1515/CCLM.2003.099; Ou T, 1998, ATHEROSCLEROSIS, V137, P23, DOI 10.1016/S0021-9150(97)00244-X; Pablos-Mendez A, 1997, ARTERIOSCL THROM VAS, V17, P3534, DOI 10.1161/01.ATV.17.12.3534; Pan YY, 2001, J CLIN INTERN MED, V18, P267; Peng DQ, 2003, INT J CARDIOL, V92, P257, DOI 10.1016/S0167-5273(03)00101-3; PENG J, 1999, CHIN J ARTERIOSCL, V7, P307; Peng S, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P375; Ranjith N, 2004, Cardiovasc J S Afr, V15, P111; Raslova K, 2001, METABOLISM, V50, P24, DOI 10.1053/meta.2001.19499; RegisBailly A, 1996, CLIN GENET, V50, P339; Ritter MM, 1997, ATHEROSCLEROSIS, V131, P243, DOI 10.1016/S0021-9150(97)06105-4; Rodrigues MO, 2005, CLIN CHEM LAB MED, V43, P907, DOI 10.1515/CCLM.2005.155; Rump P, 2002, NUTR METAB CARDIOVAS, V12, P317; Salah D, 1997, J LIPID RES, V38, P904; Salazar LA, 2000, CLIN CHIM ACTA, V300, P139, DOI 10.1016/S0009-8981(00)00308-9; Scaglione L, 1999, NUTR METAB CARDIOVAS, V9, P118; Scuteri A, 2005, AM J PHYSIOL-ENDOC M, V289, pE322, DOI 10.1152/ajpendo.00408.2004; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sorli JV, 2006, CLIN CHIM ACTA, V366, P196, DOI 10.1016/j.cca.2005.10.001; Stengard JH, 1996, HUM GENET, V97, P677; Sturgeon JD, 2005, STROKE, V36, P2484, DOI 10.1161/01.STR.0000185687.28520.3f; Talmud PJ, 2005, ANN HUM GENET, V69, P613, DOI 10.1111/j.1529-8817.2005.00205.x; Talmud PJ, 2004, ATHEROSCLEROSIS, V177, P105, DOI 10.1016/j.atherosclerosis.2004.06.008; Tan CE, 2003, ATHEROSCLEROSIS, V170, P253, DOI 10.1016/S0021-9150(03)00232-6; Terry JG, 1996, STROKE, V27, P1755, DOI 10.1161/01.STR.27.10.1755; Tremblay AJ, 2005, METABOLISM, V54, P1014, DOI 10.1016/j.metabol.2005.03.003; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; UTERMANN G, 1980, AM J HUM GENET, V32, P339; von Muhlen D, 2002, ATHEROSCLEROSIS, V161, P209, DOI 10.1016/S0021-9150(01)00632-3; Wang Chun-Hong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P982; Wang CH, 2006, INT J HYG ENVIR HEAL, V209, P265, DOI 10.1016/j.ijheh.2005.12.005; WANG GQ, 2001, CHIN J GERONTOL, V5, P325; WANG XH, 2000, J CLIN CARDIOL, V16, P440; WANG XL, 1995, ARTERIOSCL THROM VAS, V15, P1030, DOI 10.1161/01.ATV.15.8.1030; Wang XL, 2001, CHINESE MED J-PEKING, V114, P817; Weber M, 1997, CAN J CARDIOL, V13, P253; Weggemans RM, 2001, ATHEROSCLEROSIS, V154, P547, DOI 10.1016/S0021-9150(00)00720-6; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wu JH, 2002, HUM BIOL, V74, P25, DOI 10.1353/hub.2002.0012; Wu QP, 2005, CHIN J CLIN REHABILI, V9, P82; WU QP, 2002, CHIN J CLIN REHABILI, V6, P74; Wu XL, 2000, J NAVY MED, V21, P32; Xiang Wei, 1999, Hunan Yike Daxue Xuebao, V24, P232; Xie Y H, 1989, Zhonghua Yi Xue Za Zhi, V69, P585; YAMAMURA T, 1990, JPN CIRC J, V54, P448, DOI 10.1253/jcj.54.448; Yan SK, 1999, CHINESE MED J-PEKING, V112, P224; [Yang Shengli 杨胜利], 2003, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V11, P429; [杨胜利 Yang Shengli], 2003, [临床心血管病杂志, Journal of Clinical Cardiology], V19, P134; Yang ZJ, 2001, CHINESE MED J-PEKING, V114, P983; YANG ZJ, 2000, JIANGSU MED J, V26, P269; Ye S, 2003, EUR J HUM GENET, V11, P437, DOI 10.1038/sj.ejhg.5200983; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; YUAN RY, 1998, CHIN J CARDIOL, V3, P320; Zak I, 2005, CLIN CHIM ACTA, V362, P110, DOI 10.1016/j.cccn.2005.06.011; ZENG HS, 1998, CHIN J CHILD HLTH CA, V6, P83; Zhang G., 2002, APPL MATH E-NOTES, V2, P22; Zhang GB, 2001, CHIN J ARTERIOSCL, V9, P310; [张少敏 Zhang Shaomin], 2003, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V23, P475; ZHANG ST, 1998, XIN SHENG ER KE ZA Z, V13, P241; Zhang YL, 1998, CHIN J CARDIOL, V26, P443; ZHAO M, 2002, J CHIN JMED U, V31, P6; Zhou X, 1998, BASIC MED SCI CLIN, V18, P48; [祝成亮 Zhu Chengliang], 2005, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V13, P203; Zhu DM, 1997, CHIN CIRC J, V12, P347; [朱健华 Zhu Jianhua], 2002, [临床心血管病杂志, Journal of Clinical Cardiology], V18, P63; Zhu JY, 2002, CLIN MED J CHIN, V9, P224; ZHU TB, 2000, CHIN CIRC J, V15, P221; [邹阳春 Zou Yangchun], 2005, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V13, P355; 李伟, 2003, [中华老年医学杂志, Chinese Journal of Geriatrics], V22, P214; 陆元善, 1999, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V7, P110	182	589	611	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1300	1311		10.1001/jama.298.11.1300	http://dx.doi.org/10.1001/jama.298.11.1300			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878422				2022-12-28	WOS:000249524100020
J	Leshner, AI				Leshner, Alan I.			Beyond the teachable moment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Am Assoc Adv Sci, Washington, DC 20005 USA		Leshner, AI (corresponding author), Am Assoc Adv Sci, 1200 New York Ave NW, Washington, DC 20005 USA.	aleshner@aaas.org						*AM AC PED, 2007, PREV HUM PAP INF PRO; Barnes Patricia M, 2004, Adv Data, P1; *EUR RES ADV BOARD, 2007, EURAB REP REC RES SO; Leshner AI., 2006, CHRONICLE REV, V53, pB20; *NAT SCI BOARD, 2006, SCI ENG IND 2006, V1; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Turney J., 2006, ENGAGING SCI THOUGHT; Yankelovich D, 2003, ISSUES SCI TECHNOL, V19, P7	8	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1326	1328		10.1001/jama.298.11.1326	http://dx.doi.org/10.1001/jama.298.11.1326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878425				2022-12-28	WOS:000249524100023
J	Lechene, CP; Luyten, Y; McMahon, G; Distel, DL				Lechene, Claude P.; Luyten, Yvette; McMahon, Gregory; Distel, Daniel L.			Quantitative imaging of nitrogen fixation by individual bacteria within animal cells	SCIENCE			English	Article							SYMBIOTIC MICROBIAL COMMUNITY; LYRODUS-PEDICELLATUS BIVALVIA; TEREDINIDAE; SHIPWORMS; MICROORGANISMS; PERSPECTIVES; ECOSYSTEMS; TERMITES; GILLS; GUT	Biological nitrogen fixation, the conversion of atmospheric nitrogen to ammonia for biosynthesis, is exclusively performed by a few bacteria and archaea. Despite the essential importance of biological nitrogen fixation, it has been impossible to quantify the incorporation of nitrogen by individual bacteria or to map the fate of fixed nitrogen in host cells. In this study, with multi-isotope imaging mass spectrometry we directly imaged and measured nitrogen fixation by individual bacteria within eukaryotic host cells and demonstrated that fixed nitrogen is used for host metabolism. This approach introduces a powerful way to study microbes and global nutrient cycles.	Harvard Univ, Sch Med, Natl Resource Imaging Mass Spectrometry, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Cambridge, MA 02139 USA; Ctr Marine Genom Res, Ocean Genome Legacy, Ipswich, MA 01938 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Natl Resource Imaging Mass Spectrometry, 65 Landsdowne St, Cambridge, MA 02139 USA.	cpl@harvard.edu; distel@oglf.org	McMahon, Greg/C-3991-2013; Distel, Daniel/A-8047-2017; McMahon, Greg/C-1693-2018	Distel, Daniel/0000-0002-3860-194X; McMahon, Greg/0000-0003-3175-1512	NIBIB NIH HHS [P41 EB001974] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; CARPENTER EJ, 1975, SCIENCE, V187, P551, DOI 10.1126/science.187.4176.551; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Daniel G, 2003, ACS SYM SER, V845, P34; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Distel DL, 2003, ACS SYM SER, V845, P253; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; FISHER CR, 1990, REV AQUAT SCI, V2, P399; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; McMahon G, 2006, APPL SURF SCI, V252, P6895, DOI 10.1016/j.apsusc.2006.02.170; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Noda S, 1999, APPL ENVIRON MICROB, V65, P4935; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; POPHAM JD, 1973, MAR BIOL, V19, P338, DOI 10.1007/BF00348904; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Rynk R., 1992, ON FARM COMPOSTING H; VILLAREAL TA, 1992, NATO ADV SCI I C-MAT, V362, P163; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4; 2004, GENETICS REGULATION	26	201	207	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1563	1566		10.1126/science.1145557	http://dx.doi.org/10.1126/science.1145557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872448				2022-12-28	WOS:000249467900046
J	Lim, M; Metzler, R; Bar-Yam, Y				Lim, May; Metzler, Richard; Bar-Yam, Yaneer			Global pattern formation and ethnic/cultural violence	SCIENCE			English	Article							CIVIL-WAR; ETHNICITY; AFRICA; SEGREGATION; BEHAVIOR; KINETICS; MODEL	We identify a process of global pattern formation that causes regions to differentiate by culture. Violence arises at boundaries between regions that are not sufficiently well defined. We model cultural differentiation as a separation of groups whose members prefer similar neighbors, with a characteristic group size at which violence occurs. Application of this model to the area of the former Yugoslavia and to India accurately predicts the locations of reported conflict. This model also points to imposed mixing or boundary clarification as mechanisms for promoting peace.	New England Complex syst Inst, Cambridge, MA 02138 USA; Brandeis Univ, Waltham, MA 02454 USA; MIT, Cambridge, MA 02139 USA	Brandeis University; Massachusetts Institute of Technology (MIT)	Bar-Yam, Y (corresponding author), New England Complex syst Inst, 24 Mt auburn St, Cambridge, MA 02138 USA.	yaneer@necsi.edu	Lim, May/A-4709-2010	Lim, May/0000-0002-6529-7998				[Anonymous], 2000, ETHNIC GROUPS CONFLI; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; BARYAM Y, 1997, DYNAMICS COMPLEX SYS, pCH7; Bates RH, 2000, AM ECON REV, V90, P131, DOI 10.1257/aer.90.2.131; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Buhaug H, 2002, J PEACE RES, V39, P417, DOI 10.1177/0022343302039004003; CHAUDHURI K, FRONTLINE, V18; Chirot D., 2001, ETHNOPOLITICAL WARFA; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Daubechies I, 1992, 10 LECT WAVELETS; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Fox Jonathan, 2005, RELIG CIVILIZATION C; Gulden Timothy R, 2002, Politics Life Sci, V21, P26; Harff Barbara, 2004, ETHNIC CONFLICT WORL, V2, P83; Huntington Samuel P., 1997, CLASH CIVILIZATIONS; HUSE DA, 1986, PHYS REV B, V34, P7845, DOI 10.1103/PhysRevB.34.7845; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Kaufmann CD, 1998, INT SECURITY, V23, P120, DOI 10.2307/2539381; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Lustick IS, 2004, AM POLIT SCI REV, V98, P209, DOI 10.1017/S0003055404001108; Mann Michael, 2004, DARK SIDE DEMOCRACY; MIMKES J, 1995, J THERM ANAL CALORIM, V43, P521, DOI 10.1007/BF02546843; MURPHY D, 2002, CHRISTIAN SCI M 0205; Petrovic R, 1992, Yugosl Surv, V33, P3; Posner DN, 2004, AM J POLIT SCI, V48, P849, DOI 10.1111/j.0092-5853.2004.00105.x; Reynal-Querol M, 2002, J CONFLICT RESOLUT, V46, P29, DOI 10.1177/0022002702046001003; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Toft MD, 2003, GEOGRAPHY OF ETHNIC VIOLENCE: IDENTITY, INTERESTS, AND THE INDIVISIBILITY OF TERRITORY, P1; Tullberg J, 1997, POLIT LIFE SCI, V16, P237, DOI 10.1017/S0730938400024710; van Kempen R, 1998, URBAN STUD, V35, P1631, DOI 10.1080/0042098984088; Varshney A., 2003, ETHNIC CONFLICT CIVI; White M., 2005, DEATHS MASS UNPLEASA; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	34	125	129	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1540	1544		10.1126/science.1142734	http://dx.doi.org/10.1126/science.1142734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210PK	17872443				2022-12-28	WOS:000249467900039
J	Herrmann, WA				Herrmann, Wolfgang A.			Obituary - Ernst Otto Fischer (1918-2007)	NATURE			English	Biographical-Item									Dept Inorgan Chem, D-80333 Munich, Germany; Tech Univ Munich, D-80333 Munich, Germany	Technical University of Munich	Herrmann, WA (corresponding author), Dept Inorgan Chem, Arcisstr 21, D-80333 Munich, Germany.	praesident@tum.de	Herrmann, Wolfgang A/A-3588-2010						0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					156	156		10.1038/449156a	http://dx.doi.org/10.1038/449156a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851507				2022-12-28	WOS:000249394500031
J	Singer, PA				Singer, Peter A.			A tough transition	NATURE			English	Editorial Material							HEALTH; INNOVATION		McLaughlin Rotman Ctr Global Hlth, Program Life Sci Eth & Policy, Toronto, ON, Canada; St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Singer, PA (corresponding author), McLaughlin Rotman Ctr Global Hlth, Program Life Sci Eth & Policy, Toronto, ON, Canada.							Commission on Intellectual Property Rights Innovation and Public Health (CIPIH), 2006, PUBL HLTH INN INT PR; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; Frew SE, 2007, NAT BIOTECHNOL, V25, P403, DOI 10.1038/nbt0407-403; Geroski PA, 2000, RES POLICY, V29, P603, DOI 10.1016/S0048-7333(99)00092-X; Keller W, 2004, J ECON LIT, V42, P752, DOI 10.1257/0022051042177685; Maitland C., 1999, AI & Society, V13, P341, DOI 10.1007/BF01205982; Mitchell P, 2003, NAT BIOTECHNOL, V21, P6, DOI 10.1038/nbt0103-6a; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; STONEMAN P, 1994, ECON J, V104, P918, DOI 10.2307/2234987; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC48, DOI 10.1038/nbt1204supp-DC48; Widdus R., 2004, COMBATING DIS ASS PO	12	18	18	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					160	163		10.1038/449160a	http://dx.doi.org/10.1038/449160a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851510	Bronze			2022-12-28	WOS:000249394500034
J	Hrdy, SB; Rodman, P; Charnow, EL; Seger, EL; Hawkes, K; Emlen, ST; Foster, SA; Gowaty, PA; Haig, D; Hauser, M; Jacobs, LF; Smuts, BB				Hrdy, SB; Rodman, P; Charnow, EL; Seger, EL; Hawkes, K; Emlen, ST; Foster, SA; Gowaty, PA; Haig, D; Hauser, M; Jacobs, LF; Smuts, BB			Sociobiology's successes	SCIENCE			English	Letter							GENETIC CONFLICTS; EVOLUTION; ALTRUISM		UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, DEPT ANTHROPOL, SALT LAKE CITY, UT 84112 USA; CORNELL UNIV, NEUROBIOL & BEHAV SECT, ITHACA, NY 14853 USA; CLARK UNIV, DEPT BIOL, WORCESTER, MA 01610 USA; UNIV GEORGIA, INST ECOL & WOMENS STUDIES, ATHENS, GA 30602 USA; HARVARD UNIV, DEPT ORGANISM & EVOLUTIONARY BIOL, CAMBRIDGE, MA 02138 USA; HARVARD UNIV, DEPT ANTHROPOL, CAMBRIDGE, MA 02138 USA; HARVARD UNIV, DEPT PSYCHOL, CAMBRIDGE, MA 02138 USA; UNIV CALIF BERKELEY, DEPT PSYCHOL, BERKELEY, CA 94720 USA; UNIV MICHIGAN, DEPT ANTHROPOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT PSYCHOL, ANN ARBOR, MI 48109 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Cornell University; Clark University; University System of Georgia; University of Georgia; Harvard University; Harvard University; Harvard University; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hrdy, SB (corresponding author), UNIV CALIF DAVIS, DEPT ANTHROPOL, DAVIS, CA 95616 USA.		Rodman, Peter S/M-2950-2016					ALCOCK J, 1993, ANIMAL BEHAVIOR EVOL; Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; BASS A, 1992, TRENDS NEUROSCI, V15, P139, DOI 10.1016/0166-2236(92)90356-D; Becker G., 1991, TREATISE FAMILY ENLA; BETZIG L, 1996, HUMAN NATURE CRITICA; Binmore K., 1992, FUN GAMES TEXT GAME; Corning PA, 1995, J SOC EVOL SYST, V18, P421, DOI 10.1016/1061-7361(95)90027-6; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Dissanayake, 1992, HOMO AESTHETICUS ART; DOMINGUEZ CA, 1995, TRENDS ECOL EVOL, V10, P412, DOI 10.1016/S0169-5347(00)89158-2; DOUST JL, 1988, PLANT REPRODUCTIVE E; EBERHARD MJW, 1989, ANNU REV ECOL SYST, V20, P249; FRIEDMAN WE, 1995, P NATL ACAD SCI USA, V92, P3913, DOI 10.1073/pnas.92.9.3913; GOWATY PA, IN PRESS FEMINISM EV; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HAIG D, 1991, CELL, V64, P1045; Hauser, 1996, EVOL COMMUN; HIRSHLEIFER J, 1977, J LAW ECON, V20, P1, DOI 10.1086/466891; Hodgson G., 1996, EC EVOLUTION BRINGIN, DOI DOI 10.3998/MPUB.14010; HURST LD, 1994, NATURE, V368, P811, DOI 10.1038/368811a0; Jacobs Lucia F., 1996, Trends in Ecology & Evolution, V11, P82, DOI 10.1016/0169-5347(96)81048-2; Lamb ME., 1985, PARENTING LIFESPAN B; LIESEN LT, 1995, POLIT LIFE SCI, V14, P145, DOI 10.1017/S0730938400018955; MACDONALD K, 1988, SOCIOBIOLOGICAL PERS; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Posner Richard A., 1992, SEX REASON; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; SHUB DA, 1994, CURR BIOL, V4, P555, DOI 10.1016/S0960-9822(00)00124-X; Smith E.A., 1992, EVOL ECOL; WADE N, 1976, SCIENCE, V191, P1151, DOI 10.1126/science.11643305; WERREN JH, 1988, TRENDS ECOL EVOL, V3, P297, DOI 10.1016/0169-5347(88)90105-X; Wilson E.O., 1975, P1; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528	35	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	1996	274	5285					162	163		10.1126/science.274.5285.162	http://dx.doi.org/10.1126/science.274.5285.162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VM671	17847218				2022-12-28	WOS:A1996VM67100004
J	FLAM, F				FLAM, F			PLASTICS GET ORIENTED - AND GET NEW PROPERTIES	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					874	876		10.1126/science.251.4996.874	http://dx.doi.org/10.1126/science.251.4996.874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847380				2022-12-28	WOS:A1991EY62900030
J	GILINSKY, NL; GOULD, SJ; GERMAN, RZ				GILINSKY, NL; GOULD, SJ; GERMAN, RZ			ASYMMETRIES OF CLADE SHAPE AND THE DIRECTION OF EVOLUTIONARY TIME	SCIENCE			English	Article									HARVARD UNIV,MUSEUM COMPARAT ZOOL,CAMBRIDGE,MA 02138; WASHINGTON UNIV,SCH DENT MED,ST LOUIS,MO 63110	Harvard University; Washington University (WUSTL)	GILINSKY, NL (corresponding author), VIRGINIA POLYTECH INST & STATE UNIV,BLACKSBURG,VA 24061, USA.							GOULD SJ, 1987, SCIENCE, V236, P1437, DOI 10.1126/science.236.4807.1437; KITCHELL JA, 1988, SCIENCE, V240, P1190, DOI 10.1126/science.240.4856.1190; SEPKOSKI JJ, 1982, MILWAUKEE PUB MUS CO, V51	3	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1613	1614		10.1126/science.243.4898.1613	http://dx.doi.org/10.1126/science.243.4898.1613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847263				2022-12-28	WOS:A1989T795200041
J	Reuben, DB				Reuben, David B.			Update in geriatric medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE FUNCTION; ELDERLY-MEN; METAANALYSIS	In 2006, the evidence base in geriatric medicine added new therapies and approaches to improve the health and health care of older persons. The field was also advanced by findings from carefully conducted studies indicating that some commonly used treatments are ineffective and should be discarded. A summary of changes that clinicians can implement on the basis of this research is provided in the Table.	Univ Calif Los Angeles, Sch Med, Div Geriatr, Hlth Sci Ctr, Los Angeles, CA 90095 USA; David Geffen Sch Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, Sch Med, Div Geriatr, Hlth Sci Ctr, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucla.edu						Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hall WJ, 2006, ANN INTERN MED, V145, P538, DOI 10.7326/0003-4819-145-7-200610030-00012; Hochberg MC, 2006, NEW ENGL J MED, V354, P858, DOI 10.1056/NEJMe058324; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836	9	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					470	477		10.7326/0003-4819-147-7-200710020-00005	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909208				2022-12-28	WOS:000250214700004
J	Colbourn, TE; Asseburg, C; Bojke, L; Philips, Z; Welton, NJ; Claxton, K; Ades, AE; Gilbert, RE				Colbourn, Tim E.; Asseburg, Christian; Bojke, Laura; Philips, Zoe; Welton, Nicky J.; Claxton, Karl; Ades, A. E.; Gilbert, Ruth E.			Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL DECISION-MAKING; VACCINATION	Objective To determine the cost effectiveness of strategies for preventing neonatal infection with group B streptococci and other bacteria in the UK and the value of further information from research. Design Use of a decision model to compare the cost effectiveness of prenatal testing for group B streptococcal infection (by polymerase chain reaction or culture), prepartum antibiotic treatment (intravenous penicillin or oral erythromycin), and vaccination during pregnancy (not yet available) for serious bacterial infection in early infancy across 12 maternal risk groups. Model parameters were estimated using multi-parameter evidence synthesis to incorporate all relevant data inputs. Data sources 32 systematic reviews were conducted: 14 integrated results from published studies, 24 involved analyses of primary datasets, and five included expert opinion. Main outcomes measures Healthcare costs per quality adjusted life year (QALY) gained. Results Current best practice (to treat only high risk women without prior testing for infection) and universal testing by culture or polymerase chain reaction were not cost effective options. Immediate extension of current best practice to treat all women with preterm and high risk term deliveries without testing (11% treated) would result in substantial net benefits. Currently, addition of culture testing for low risk term women, while treating all preterm and high risk term women, would be the most cost effective option (21% treated). If available in the future, vaccination combined with treating all preterm and high risk term women and no testing for low risk women would probably be marginally more cost effective and would limit antibiotic exposure to 11% of women. The value of information is highest (67m) pound if vaccination is included as an option. Conclusions Extension of current best practice to treat all women with preterm and high risk term deliveries is readily achievable and would be beneficial. The choice between adding culture testing for tow risk women or vaccination for all should be informed by further research. Trials to evaluate vaccine efficacy should be prioritised.	UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; Univ Nottingham, Sch Econ, Nottingham NG7 2UH, England; Univ Bristol, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England	University of London; University College London; University of York - UK; University of Nottingham; University of Bristol	Gilbert, RE (corresponding author), UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England.	r.gilbert@ich.ucl.ac.uk	Asseburg, Christian/AAK-2903-2020; Colbourn, Tim/AAE-6645-2019	Asseburg, Christian/0000-0001-7196-3363; Colbourn, Tim/0000-0002-6917-6552; Ades, Tony/0000-0001-7822-3552; Gilbert, Ruth/0000-0001-9347-2709; Welton, Nicky/0000-0003-2198-3205	MRC [MC_U145079307, MC_U145079308] Funding Source: UKRI; Medical Research Council [G0802413, MC_U145079307, MC_U145079308] Funding Source: Medline; Department of Health [04/51/01] Funding Source: Medline; National Institute for Health Research [04/51/01] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; CLAXTON K, 2005, RP4 NICE CTR HLTH EC; Colbourn TE, 2007, HLTH TECHNOL ASSESS, V11; COLOUM TE, 2007, HLTH TECHNOL ASSESS, V11; CROMWELL D, 2007, PREVENTION EARLY ONS; Gilbert R, 2004, INT J EPIDEMIOL, V33, P2, DOI 10.1093/ije/dyh062; GILBERT RE, 2004, BRIT J OBSTET GYNAEC, V111, P1; HASSELBLAD VIC, 1995, MED DECIS MAKING, V15, P81, DOI 10.1177/0272989X9501500112; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Heath PT, 2005, EXPERT REV VACCINES, V4, P207, DOI 10.1586/14760584.4.2.207; JOHANNESSON M, 1993, J HEALTH ECON, V12, P459, DOI 10.1016/0167-6296(93)90005-Y; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Sinha A, 2005, VACCINE, V23, P3187, DOI 10.1016/j.vaccine.2004.12.021; Spaetgens R, 2002, OBSTET GYNECOL, V100, P525, DOI 10.1016/S0029-7844(02)02068-9; UK NSC, 2015, CRIT APPR VIAB EFF A	18	42	43	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2007	335	7621					655	658A		10.1136/bmj.39325.681806.AD	http://dx.doi.org/10.1136/bmj.39325.681806.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17848402	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000249989600041
J	Coombes, R				Coombes, Rebecca			Who are the doctor bloggers and what do they want?	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					644	645		10.1136/bmj.39349.478148.59	http://dx.doi.org/10.1136/bmj.39349.478148.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901512	Green Published			2022-12-28	WOS:000249989600035
J	Kwiek, NC; Halpin, MJ; Reiter, JP; Hoeffler, LA; Schwartz-Bloom, RD				Kwiek, Nicole C.; Halpin, Myra J.; Reiter, Jerome P.; Hoeffler, Leanne A.; Schwartz-Bloom, Rochelle D.			Relevance - Pharmacology in the high-school classroom	SCIENCE			English	Editorial Material							SCIENCE; EDUCATION		Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; N Carolina Sch Sci & Math, Durham, NC 27705 USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA	Duke University; University of North Carolina; Duke University	Schwartz-Bloom, RD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	schwa001@duke.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R25DA010904] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10904] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1996, NAT SCI ED STAND, p[55, 62]; Bardeen MG, 1998, SCIENCE, V281, P178, DOI 10.1126/science.281.5374.178; Brooks J., 1999, SEARCH UNDERSTANDING; Gelman A., 2004, BAYESIAN DATA ANAL; James R. K., 1988, SCH SCI MATH, V88, P149; Jenkins E. W., 2005, RES SCI TECHNOL EDUC, V23, P41, DOI [10.1080/02635140500068435, DOI 10.1080/02635140500068435]; Lou YP, 1996, REV EDUC RES, V66, P423, DOI 10.3102/00346543066004423; MAYER RE, 1983, J EDUC PSYCHOL, V75, P40, DOI 10.1037/0022-0663.75.1.40; MOSENTHAL JH, 1992, J TEACH EDUC, V43, P347, DOI 10.1177/0022487192043005004; Raudenbush SW, 2002, HIERARCHICAL LINEAR; SANDOVAL J, 1995, ANNU REV PSYCHOL, V46, P355, DOI 10.1146/annurev.ps.46.020195.002035; Schwartz-Bloom RD, 2003, J RES SCI TEACH, V40, P922, DOI 10.1002/tea.10116; WILLETT JB, 1983, J RES SCI TEACH, V20, P405, DOI 10.1002/tea.3660200505	13	24	24	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1871	1872		10.1126/science.1146811	http://dx.doi.org/10.1126/science.1146811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901318				2022-12-28	WOS:000249764300022
J	Marzi, S; Myasnikov, AG; Serganov, A; Ehresmann, C; Romby, P; Yusupov, M; Klaholz, BP				Marzi, Stefano; Myasnikov, Alexander G.; Serganov, Alexander; Ehresmann, Chantal; Romby, Pascale; Yusupov, Marat; Klaholz, Bruno P.			Structured mRNAs regulate translation initiation by binding to the platform of the ribosome	CELL			English	Article							PROTEIN S15; OWN TRANSLATION; 80S RIBOSOME; COMPLEX; SITE; VISUALIZATION; MECHANISMS; TERMINATION; EXPRESSION; OPERATOR	Gene expression can be regulated at the level of initiation of protein biosynthesis via structural elements present at the 50 untranslated region of mRNAs. These folded mRNA segments may bind to the ribosome, thus blocking translation until the mRNA unfolds. Here, we report a series of cryo- electron microscopy snapshots of ribosomal complexes directly visualizing either the mRNA structure blocked by repressor protein S15 or the unfolded, active mRNA. In the stalled state, the folded mRNA prevents the start codon from reaching the peptidyl- tRNA ( P) site inside the ribosome. Upon repressor release, the mRNA unfolds and moves into the mRNA channel allowing translation initiation. A comparative structure and sequence analysis suggests the existence of a universal stand- by site on the ribosome ( the 30S platform) dedicated for binding regulatory 50 mRNA elements. Different types of mRNA structures may be accommodated during translation preinitiation and regulate gene expression by transiently stalling the ribosome.	IGBMC, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, F-67000 Strasbourg, France; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Memorial Sloan Kettering Cancer Center	Klaholz, BP (corresponding author), IGBMC, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France.	klaholz@igbmc.u-strasbg.fr	Yusupov, Marat/I-6126-2013; Marzi, Stefano/A-1810-2012; Myasnikov, Alexander/T-4654-2018; ROMBY, Pascale/AGP-3328-2022	Yusupov, Marat/0000-0001-5544-0597; Marzi, Stefano/0000-0003-0399-4613; Serganov, Alexander/0000-0001-8328-9310				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; DECKMAN IC, 1987, J MOL BIOL, V196, P323, DOI 10.1016/0022-2836(87)90693-0; Ehresmann Chantal, 2004, RNA Biol, V1, P66; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; KOLB A, 1977, P NATL ACAD SCI USA, V74, P2379, DOI 10.1073/pnas.74.6.2379; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mathy N, 2004, MOL MICROBIOL, V52, P661, DOI 10.1111/j.1365-2958.2004.04005.x; Merianos HJ, 2004, RNA, V10, P954, DOI 10.1261/rna.7030704; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Orlov IM, 2006, J STRUCT BIOL, V154, P287, DOI 10.1016/j.jsb.2006.03.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILIPPE C, 1993, P NATL ACAD SCI USA, V90, P4394, DOI 10.1073/pnas.90.10.4394; PHILIPPE C, 1994, NUCLEIC ACIDS RES, V22, P2538, DOI 10.1093/nar/22.13.2538; PHILIPPE C, 1995, NUCLEIC ACIDS RES, V23, P18, DOI 10.1093/nar/23.1.18; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; RINGQUIST S, 1995, BIOCHEMISTRY-US, V34, P3640, DOI 10.1021/bi00011a019; RODNINA MV, 1994, ANAL BIOCHEM, V219, P380, DOI 10.1006/abio.1994.1282; Romby P, 2003, TRENDS GENET, V19, P155, DOI 10.1016/S0168-9525(03)00020-9; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schlax PJ, 2003, MOL MICROBIOL, V48, P1157, DOI 10.1046/j.1365-2958.2003.03517.x; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Scott LG, 2005, J MOL BIOL, V351, P280, DOI 10.1016/j.jmb.2005.06.030; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Serganov A, 2002, J MOL BIOL, V320, P963, DOI 10.1016/S0022-2836(02)00553-3; Serganov A, 2001, J MOL BIOL, V305, P785, DOI 10.1006/jmbi.2000.4354; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SPEDDING G, 1993, J MOL BIOL, V229, P609, DOI 10.1006/jmbi.1993.1067; Springer M, 2003, NAT STRUCT BIOL, V10, P420, DOI 10.1038/nsb0603-420; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; TANG CK, 1989, CELL, V57, P531, DOI 10.1016/0092-8674(89)90123-2; Tedin K, 1997, MOL MICROBIOL, V25, P189, DOI 10.1046/j.1365-2958.1997.4421810.x; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1	65	106	107	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1019	1031		10.1016/j.cell.2007.07.008	http://dx.doi.org/10.1016/j.cell.2007.07.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889647	Bronze			2022-12-28	WOS:000250507500012
J	Vassallo, P; Trohman, RG				Vassallo, Patricia; Trohman, Richard G.			Prescribing amiodarone - An evidence-based review of clinical indications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LOW-DOSE AMIODARONE; ONSET ATRIAL-FIBRILLATION; CONGESTIVE-HEART-FAILURE; NONSUSTAINED VENTRICULAR-TACHYCARDIA; GUIDELINES WRITING COMMITTEE; PARKINSON-WHITE-SYNDROME; ASSOCIATION TASK-FORCE; SUDDEN CARDIAC DEATH; LONG-TERM EFFICACY	Context Although amiodarone is approved by the US Food and Drug Administration only for refractory ventricular arrhythmias, it is one of the most frequently prescribed antiarrhythmic medications in the United States. Objective To evaluate and synthesize evidence regarding optimal use of amiodarone for various arrhythmias. Evidence Acquisition Systematic search of MEDLINE to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and other studies with clinical pertinence. The search was limited to human-participant, English-language reports published between 1970 and 2007. Amiodarone was searched using the terms adverse effects, atrial fibrillation, atrial flutter, congestive heart failure, electrical storm, hypertrophic cardiomyopathy, implantable cardioverter-defibrillator, surgery, ventricular arrhythmia, ventricular fibrillation, and Wolff-Parkinson-White. Bibliographies of identified articles and guidelines from official societies were reviewed for additional references. Ninety-two identified studies met inclusion criteria and were included in the review. Evidence Synthesis Amiodarone may have clinical value in patients with left ventricular dysfunction and heart failure as first-line treatment for atrial fibrillation, though other agents are available. Amiodarone is useful in acute management of sustained ventricular tachyarrythmias, regardless of hemodynamic stability. The only role for prophylactic amiodarone is in the perioperative period of cardiac surgery. Amiodarone may be effective as an adjunct to implantable cardioverter-defibrillator therapy to reduce number of shocks. However, amiodarone has a number of serious adverse effects, including corneal microdeposits (>90%), optic neuropathy/neuritis (<= 1%-2%), blue-gray skin discoloration (4%-9%), photosensitivity (25%-75%), hypothyroidism (6%), hyperthyroidism (0.9%-2%), pulmonary toxicity (1%-17%), peripheral neuropathy (0.3% annually), and hepatotoxicity (elevated enzyme levels, 15%-30%; hepatitis and cirrhosis, <3% [0.6% annually]). Conclusion Amiodarone should be used with close follow-up in patients who are likely to derive the most benefit, namely those with atrial fibrillation and left ventricular dysfunction, those with acute sustained ventricular arrhythmias, those about to undergo cardiac surgery, and those with implantable cardioverter-defibrillators and symptomatic shocks.	Rush Univ, Med Ctr, Dept Med, Sect Cardiol electrophysiol Arrhythmia & Pacemake, Chicago, IL 60612 USA	Rush University	Trohman, RG (corresponding author), Rush Univ, Med Ctr, Dept Med, Sect Cardiol electrophysiol Arrhythmia & Pacemake, 1653 W Congress Pkwy, Chicago, IL 60612 USA.	rtrohman@rush.edu						Aasbo JD, 2005, ANN INTERN MED, V143, P327, DOI 10.7326/0003-4819-143-5-200509060-00008; *ACLS, 2001, ACLS PROV MAN; Al-Khatib SM, 2003, AM J CARDIOL, V91, P91, DOI 10.1016/S0002-9149(02)03008-4; ANDREASEN F, 1981, EUR J CLIN PHARMACOL, V19, P293, DOI 10.1007/BF00562807; Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barron HV, 1997, AM J CARDIOL, V79, P1180, DOI 10.1016/S0002-9149(97)00078-7; Barry JJ, 1999, AM J PSYCHIAT, V156, P1119; Bianconi L, 2000, EUR HEART J, V21, P1265, DOI 10.1053/euhj.1999.2039; Blanc JJ, 1999, AM J CARDIOL, V84, P1029, DOI 10.1016/S0002-9149(99)00493-2; Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; Bocker D, 1998, CIRCULATION, V98, P1636, DOI 10.1161/01.CIR.98.16.1636; Boriani G, 1996, AM HEART J, V131, P1214, DOI 10.1016/S0002-8703(96)90098-8; BURKART F, 1990, J AM COLL CARDIOL, V16, P1711, DOI 10.1016/0735-1097(90)90324-I; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Calkins H, 1999, CIRCULATION, V99, P262, DOI 10.1161/01.CIR.99.2.262; Cecchi F, 1998, HEART, V79, P331, DOI 10.1136/hrt.79.4.331; Chevalier P, 2003, J AM COLL CARDIOL, V41, P255, DOI 10.1016/S0735-1097(02)02705-5; CHUN SH, 1995, AM J CARDIOL, V76, P47, DOI 10.1016/S0002-9149(99)80799-1; Clemo HF, 1998, AM J CARDIOL, V81, P594, DOI 10.1016/S0002-9149(97)00962-4; Connolly SJ, 1997, LANCET, V350, P1417; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Credner SC, 1998, J AM COLL CARDIOL, V32, P1909, DOI 10.1016/S0735-1097(98)00495-1; Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E; Cybulski J, 1996, CLIN CARDIOL, V19, P563, DOI 10.1002/clc.4960190708; Da Costa A, 2006, CIRCULATION, V114, P1676, DOI 10.1161/CIRCULATIONAHA.106.638395; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; Delle Karth G, 2001, CRIT CARE MED, V29, P1149, DOI 10.1097/00003246-200106000-00011; DONOVAN KD, 1995, AM J CARDIOL, V75, P693, DOI 10.1016/S0002-9149(99)80655-9; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Fogel RI, 2000, AM HEART J, V139, P690, DOI 10.1016/S0002-8703(00)90049-8; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Galve E, 1996, J AM COLL CARDIOL, V27, P1079, DOI 10.1016/0735-1097(95)00595-1; Goldschlager N, 2000, ARCH INTERN MED, V160, P1741, DOI 10.1001/archinte.160.12.1741; Goodman LS, 2005, GOODMAN GILMANS PHAR; GOSSELINK ATM, 1992, JAMA-J AM MED ASSOC, V267, P3289, DOI 10.1001/jama.267.24.3289; GOTTLIEB SS, 1994, J AM COLL CARDIOL, V23, P560, DOI 10.1016/0735-1097(94)90736-6; GREENE HL, 1993, AM J CARDIOL, V72, P280; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; Gupta A, 2007, AM HEART J, V153, P891, DOI 10.1016/j.ahj.2007.01.040; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Harjai KJ, 1996, PACE, V19, P1548, DOI 10.1111/j.1540-8159.1996.tb03179.x; Harjai KJ, 1997, ANN INTERN MED, V126, P63, DOI 10.7326/0003-4819-126-1-199701010-00009; HELMY I, 1988, J AM COLL CARDIOL, V12, P1015, DOI 10.1016/0735-1097(88)90470-6; Hilleman DE, 2002, PHARMACOTHERAPY, V22, P66, DOI 10.1592/phco.22.1.66.33492; Hiraoka M, 1994, ELECTROPHARMACOLOGIC; Hohnloser SH, 2006, CIRCULATION, V114, P104, DOI 10.1161/CIRCULATIONAHA.106.618421; Joseph AP, 2000, ANN EMERG MED, V36, P1, DOI 10.1067/mem.2000.107655; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; JUNG W, 1992, AM J CARDIOL, V70, P1023, DOI 10.1016/0002-9149(92)90354-2; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kaushik S, 2001, ANN THORAC SURG, V72, P1760, DOI 10.1016/S0003-4975(01)02585-1; Khan IA, 2003, INT J CARDIOL, V89, P239, DOI 10.1016/S0167-5273(02)00477-1; Kochiadakis GE, 2000, HEART, V84, P251, DOI 10.1136/heart.84.3.251; Kochiadakis GE, 1998, PACE, V21, P2475, DOI 10.1111/j.1540-8159.1998.tb01204.x; KOUVARAS G, 1989, JPN HEART J, V30, P301; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Lafuente-Lafuente C, 2006, ARCH INTERN MED, V166, P719, DOI 10.1001/archinte.166.7.719; Letelier LM, 2003, ARCH INTERN MED, V163, P777, DOI 10.1001/archinte.163.7.777; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Martinez-Marcos FJ, 2000, AM J CARDIOL, V86, P950, DOI 10.1016/S0002-9149(00)01128-0; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MCKENNA WJ, 1985, BRIT HEART J, V53, P412; MCKENNA WJ, 1984, AM J CARDIOL, V54, P802, DOI 10.1016/S0002-9149(84)80212-X; MIDDLEKAUFF HR, 1993, AM J CARDIOL, V72, pF75, DOI 10.1016/0002-9149(93)90967-H; Miller MR, 2000, J FAM PRACTICE, V49, P1033; Mitchell LB, 2005, JAMA-J AM MED ASSOC, V294, P3093, DOI 10.1001/jama.294.24.3093; MORADY F, 1983, AM J CARDIOL, V52, P975, DOI 10.1016/0002-9149(83)90515-5; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 1998, CIRCULATION, V97, P1514; NADEMANEE K, 1989, PROG CARDIOVASC DIS, V31, P427, DOI 10.1016/0033-0620(89)90017-0; Nademanee K, 2000, CIRCULATION, V102, P742, DOI 10.1161/01.CIR.102.7.742; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; NATTEL S, 1988, CIRCULATION, V77, P200, DOI 10.1161/01.CIR.77.1.200; NOC M, 1990, AM J CARDIOL, V65, P679, DOI 10.1016/0002-9149(90)91053-9; Nuttall SL, 2000, BRIT MED J, V320, P581, DOI 10.1136/bmj.320.7234.581; Oikawa H, 2005, WORLD J GASTROENTERO, V11, P5394, DOI 10.3748/wjg.v11.i34.5394; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Ott MC, 2003, CHEST, V123, P646, DOI 10.1378/chest.123.2.646; Paul T, 2000, Paediatr Drugs, V2, P171, DOI 10.2165/00128072-200002030-00002; Pelosi F, 2000, J CARDIOVASC ELECTR, V11, P736, DOI 10.1111/j.1540-8167.2000.tb00043.x; PERTICONE F, 1987, CLIN CARDIOL, V10, P477, DOI 10.1002/clc.4960100813; PINSKI SL, 1991, AM J CARDIOL, V68, P800, DOI 10.1016/0002-9149(91)90660-D; Pollak PT, 1999, AM J CARDIOL, V84, p37R; Pritchett ELC, 1998, PACE, V21, P1457, DOI 10.1111/j.1540-8159.1998.tb00218.x; RAEDER EA, 1985, AM HEART J, V109, P975, DOI 10.1016/0002-8703(85)90238-8; Raitt MH, 2001, CIRCULATION, V103, P244; Redfearn DP, 2005, EXPERT OPIN PHARMACO, V6, P955, DOI 10.1517/14656566.6.6.955; ROBINSON K, 1990, J AM COLL CARDIOL, V15, P1279, DOI 10.1016/S0735-1097(10)80014-2; ROSENBAUM MB, 1976, AM J CARDIOL, V38, P934, DOI 10.1016/0002-9149(76)90807-9; ROSENBAUM MB, 1983, AM HEART J, V106, P957, DOI 10.1016/0002-8703(83)90022-4; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; SCHUTZENBERGER W, 1987, INT J CARDIOL, V16, P93, DOI 10.1016/0167-5273(87)90273-7; Siddoway LA, 2003, AM FAM PHYSICIAN, V68, P2189; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; STAFFORD WJ, 1986, J AM COLL CARDIOL, V7, P701, DOI 10.1016/S0735-1097(86)80484-3; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; TROHMAN RG, 1988, ANN INTERN MED, V108, P68, DOI 10.7326/0003-4819-108-1-68; Vardas PE, 2000, CHEST, V117, P1538, DOI 10.1378/chest.117.6.1538; VILLAIN E, 1990, CIRCULATION, V81, P1544, DOI 10.1161/01.CIR.81.5.1544; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zareba W, 2006, HEART RHYTHM, V3, P631, DOI 10.1016/j.hrthm.2006.02.012; Zarembski DG, 1999, PHARMACOTHERAPY, V19, P249, DOI 10.1592/phco.19.3.249.30929; Zimetbaum P, 2007, NEW ENGL J MED, V356, P935, DOI 10.1056/NEJMct065916; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]; Zipes DP, 2004, CARDIAC ELECTROPHYSI; ZIPES DP, 2005, BRAUNWALDS HEART DIS	116	268	286	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1312	1322		10.1001/jama.298.11.1312	http://dx.doi.org/10.1001/jama.298.11.1312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878423				2022-12-28	WOS:000249524100021
J	Osborne, M				Osborne, Molly			Intensive insulin therapy in the medical	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97239 USA	Oregon Health & Science University	Osborne, M (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Mail COde L102,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.							Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					412	413		10.7326/0003-4819-147-6-200709180-00011	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876023				2022-12-28	WOS:000249726200006
J	Liu, JG; Dietz, T; Carpenter, SR; Alberti, M; Folke, C; Moran, E; Pell, AN; Deadman, P; Kratz, T; Lubchenco, J; Ostrom, E; Ouyang, Z; Provencher, W; Redman, CL; Schneider, SH; Taylor, WW				Liu, Jianguo; Dietz, Thomas; Carpenter, Stephen R.; Alberti, Marina; Folke, Carl; Moran, Emilio; Pell, Alice N.; Deadman, Peter; Kratz, Timothy; Lubchenco, Jane; Ostrom, Elinor; Ouyang, Zhiyun; Provencher, William; Redman, Charles L.; Schneider, Stephen H.; Taylor, William W.			Complexity of coupled human and natural systems	SCIENCE			English	Review							SOCIAL-ECOLOGICAL SYSTEMS; ECOSYSTEM MANAGEMENT; URBAN PATTERNS; GIANT PANDAS; HABITAT; TRANSFORMATION; GLOBALIZATION; ENVIRONMENT; DYNAMICS; SWEDEN	Integrated studies of coupled human and natural systems reveal new and complex patterns and processes not evident when studied by social or natural scientists separately. Synthesis of six case studies from around the world shows that couplings between human and natural systems vary across space, time, and organizational units. They also exhibit nonlinear dynamics with thresholds, reciprocal feedback loops, time lags, resilience, heterogeneity, and surprises. Furthermore, past couplings have legacy effects on present conditions and future possibilities.	Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Washington, Dept Urban Design & Planning, Seattle, WA 98195 USA; Royal Swedish Acad Sci, Beijer Int Inst Ecol Econ, SE-10405 Stockholm, Sweden; Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; Cornell Univ, Cornell Int Inst Food Agr & Dev, Ithaca, NY 14853 USA; Univ Waterloo, Dept Geog, Waterloo, ON N2L 3G1, Canada; Univ Wisconsin, Trout Lake Stn, Boulder Jct, WI 54512 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Indiana Univ, Workshop Polit Theory & Policy Anal, Bloomington, IN 47408 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing 100085, Peoples R China; Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; Arizona State Univ, Global Inst Sustainabil, Tempe, AZ 85287 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Stockholm University; Indiana University System; Indiana University Bloomington; Cornell University; University of Waterloo; University of Wisconsin System; Oregon State University; Indiana University System; Indiana University Bloomington; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Wisconsin System; University of Wisconsin Madison; Arizona State University; Arizona State University-Tempe; Stanford University	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	Pell, Alice/N-6607-2019; Liu, Jianguo/G-5211-2015; Carpenter, Stephen/AAQ-6404-2020; Moran, Emilio/T-7456-2019; Folke, Carl/Z-1545-2019	Liu, Jianguo/0000-0001-6344-0087; Dietz, Thomas/0000-0001-9399-0784; alberti, marina/0000-0002-1920-309X; Folke, Carl/0000-0002-4050-3281				Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; ALBERTI M, 2005, 2005 LANDSCAPE BENCH; Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; An L, 2005, ANN ASSOC AM GEOGR, V95, P54, DOI 10.1111/j.1467-8306.2005.00450.x; An L, 2006, BIODIVERS CONSERV, V15, P2343, DOI 10.1007/s10531-004-1064-6; [Anonymous], 2001, PANARCHY UNDERSTANDI; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Brock W. A., 2006, PUNCTUATED EQUILIBRI, P47; Carpenter SR, 2007, BIOSCIENCE, V57, P323, DOI 10.1641/B570407; Carpenter SR, 2006, TRENDS ECOL EVOL, V21, P309, DOI 10.1016/j.tree.2006.02.007; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Levin S., 1999, FRAGILE DOMINION; Liu J., 2003, PEOPLE ENV APPROACHE, P241, DOI [10.1007/0-306-48130-8_9, DOI 10.1007/0-306-48130-8_9]; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Magnuson J.J., 2006, LONG TERM DYNAMICS L; Marsh G. P., 1864, MAN NATURE; Marzluff John M., 2005, Urban Ecosystems, V8, P157, DOI 10.1007/s11252-005-4378-6; McCracken SD, 1999, PHOTOGRAMM ENG REM S, V65, P1311; Moran EF, 2005, SEEING THE FOREST AND THE TREES, P1; National Research Council, 1999, OUR COMM JOURN; Olsson P, 2004, ECOL SOC, V9; Olsson P, 2006, ECOL SOC, V11, DOI 10.5751/ES-01595-110118; Rosa EA, 1998, INT SOCIOL, V13, P421, DOI 10.1177/026858098013004002; Sass GG, 2006, FISHERIES, V31, P321, DOI 10.1577/1548-8446(2006)31[321:FCAFWR]2.0.CO;2; Schneider Stephen, 1984, COEVOLUTION CLIMATE; Schultz L, 2007, ENVIRON CONSERV, V34, P140, DOI 10.1017/S0376892907003876; Turner B., 1990, EARTH TRANSFORMED HU; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B, 2004, ECOL SOC, V9; Wittfogel K., 1956, MANS ROLE CHANGING F; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004	35	2010	2167	83	1230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1513	1516		10.1126/science.1144004	http://dx.doi.org/10.1126/science.1144004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872436	Green Published			2022-12-28	WOS:000249467900031
J	Butler, D				Butler, Declan			Lost in translation	NATURE			English	Editorial Material																			0	33	34	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					158	159		10.1038/449158a	http://dx.doi.org/10.1038/449158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851509	Bronze			2022-12-28	WOS:000249394500033
J	DeRoeck, D; Jodar, L; Clemens, J				DeRoeck, Denise; Jodar, Luis; Clemens, John			Perspective: Putting typhoid vaccination on the global health agenda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FEVER		Int Vaccine Inst, Seoul, South Korea	International Vaccine Institute	DeRoeck, D (corresponding author), Int Vaccine Inst, Seoul, South Korea.							Acosta CJ, 2004, EXPERT OPIN BIOL TH, V4, P1939, DOI 10.1517/14712598.4.12.1939; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; *IN VACC RES, TYPH FEV; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168	4	46	46	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1069	1071		10.1056/NEJMp078144	http://dx.doi.org/10.1056/NEJMp078144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855666				2022-12-28	WOS:000249387200001
J	Hopkins, AL; Witty, MJ; Nwaka, S				Hopkins, Andrew L.; Witty, Michael J.; Nwaka, Solomon			Mission possible	NATURE			English	Editorial Material							DRUG DISCOVERY; CHALLENGES; DISEASES		Pfizer Global Res & Dev, Sandwich, Kent, England; Pfizer Anim Hlth, Sandwich, Kent, England; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Pfizer; Pfizer; World Health Organization	Hopkins, AL (corresponding author), Pfizer Global Res & Dev, Sandwich, Kent, England.		Hopkins, Andrew/H-5138-2011	Hopkins, Andrew/0000-0003-1977-018X				Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Chesbrough H., 2006, OPEN BUSINESS MODELS; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Ropars AL, 2005, NEW LANDSCAPE NEGLEC	10	42	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					166	169		10.1038/449166a	http://dx.doi.org/10.1038/449166a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851512				2022-12-28	WOS:000249394500036
J	Scanlon, TM; Caylor, KK; Levin, SA; Rodriguez-Iturbe, I				Scanlon, Todd M.; Caylor, Kelly K.; Levin, Simon A.; Rodriguez-Iturbe, Ignacio			Positive feedbacks promote power-law clustering of Kalahari vegetation	NATURE			English	Article							LOCAL INTERACTIONS; SPATIAL-PATTERNS; DYNAMICS; DISTURBANCE; SIGNATURES; SAVANNAS; ECOLOGY; FORESTS; AFRICA; MODEL	The concept of local-scale interactions driving large-scale pattern formation has been supported by numerical simulations, which have demonstrated that simple rules of interaction are capable of reproducing patterns observed in nature(1,2). These models of self-organization suggest that characteristic patterns should exist across a broad range of environmental conditions provided that local interactions do indeed dominate the development of community structure. Readily available observations that could be used to support these theoretical expectations, however, have lacked sufficient spatial extent or the necessary diversity of environmental conditions to confirm the model predictions. We use high-resolution satellite imagery to document the prevalence of self-organized vegetation patterns across a regional rainfall gradient in southern Africa, where percent tree cover ranges from 65% to 4%. Through the application of a cellular automata model, we find that the observed power-law distributions of tree canopy cluster sizes can arise from the interacting effects of global-scale resource constraints (that is, water availability) and local-scale facilitation. Positive local feedbacks result in power-law distributions without entailing threshold behaviour commonly associated with criticality. Our observations provide a framework for integrating a diverse suite of previous studies that have addressed either mean wet season rainfall or landscape-scale soil moisture variability as controls on the structural dynamics of arid and semi-arid ecosystems.	Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; Indiana Univ, Dept Geog, Bloomington, IN 47401 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	University of Virginia; Indiana University System; Indiana University Bloomington; Princeton University; Princeton University	Scanlon, TM (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	tms2v@virginia.edu	Scanlon, Todd M/B-8743-2008; Levin, Simon A/J-1218-2014; Caylor, Kelly/B-7734-2008; Caylor, Kelly/ABF-2818-2020	Levin, Simon A/0000-0002-8216-5639; Caylor, Kelly/0000-0002-6466-6448; Caylor, Kelly/0000-0002-6466-6448; Scanlon, Todd/0000-0001-8869-1675				AGUIAR MR, 1994, OIKOS, V70, P26, DOI 10.2307/3545695; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; CALE WG, 1989, BIOSCIENCE, V39, P600, DOI 10.2307/1311089; Caylor KK, 2003, J ARID ENVIRON, V54, P281, DOI 10.1006/jare.2002.1090; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; GRASSBERGER P, 1993, J PHYS A-MATH GEN, V26, P2081, DOI 10.1088/0305-4470/26/9/007; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Holdo RM, 2005, PLANT ECOL, V180, P77, DOI 10.1007/s11258-005-2796-4; Katori M, 1998, FRACTALS, V6, P81, DOI 10.1142/S0218348X98000092; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; KOCH GW, 1995, 36 INT GEOSPH BIOSPH; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Manrubia SC, 1997, J THEOR BIOL, V187, P159, DOI 10.1006/jtbi.1997.0409; Molofsky J, 2001, P ROY SOC B-BIOL SCI, V268, P273, DOI 10.1098/rspb.2000.1355; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Scanlon TM, 2002, REMOTE SENS ENVIRON, V82, P376, DOI 10.1016/S0034-4257(02)00054-8; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; Stauffer D., 1994, INTRO PERCOLATION TH; Wang GL, 2000, Q J ROY METEOR SOC, V126, P1261, DOI 10.1256/smsqj.56503; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Yeomans J.M., 1992, STAT MECH PHASE TRAN, VVolume 19	30	277	286	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					209	U4		10.1038/nature06060	http://dx.doi.org/10.1038/nature06060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851523				2022-12-28	WOS:000249394500048
J	Lyles, KW; Colon-Emeric, CS; Magaziner, JS; Adachi, JD; Pieper, CF; Mautalen, C; Hyldstrup, L; Recknor, C; Nordsletten, L; Moore, KA; Lavecchia, C; Zhang, J; Mesenbrink, P; Hodgson, PK; Abrams, K; Orloff, JJ; Horowitz, Z; Eriksen, EF; Boonen, S				Lyles, Kenneth W.; Colon-Emeric, Cathleen S.; Magaziner, Jay S.; Adachi, Jonathan D.; Pieper, Carl F.; Mautalen, Carlos; Hyldstrup, Lars; Recknor, Chris; Nordsletten, Lars; Moore, Kathy A.; Lavecchia, Catherine; Zhang, Jie; Mesenbrink, Peter; Hodgson, Patricia K.; Abrams, Ken; Orloff, John J.; Horowitz, Zebulun; Eriksen, Erik Fink; Boonen, Steven		HORIZON Recurrent Fracture	Zoledronic acid and clinical fractures and mortality after hip fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; QUALITY-OF-LIFE; OSTEOPOROTIC FRACTURES; SUBSEQUENT FRACTURES; ELDERLY-PATIENTS; WOMEN; RISK; INTERVENTIONS; POPULATION; COMMUNITY	Background: Mortality is increased after a hip fracture, and strategies that improve outcomes are needed. Methods: In this randomized, double-blind, placebo-controlled trial, 1065 patients were assigned to receive yearly intravenous zoledronic acid (at a dose of 5 mg), and 1062 patients were assigned to receive placebo. The infusions were first administered within 90 days after surgical repair of a hip fracture. All patients (mean age, 74.5 years) received supplemental vitamin D and calcium. The median follow-up was 1.9 years. The primary end point was a new clinical fracture. Results: The rates of any new clinical fracture were 8.6% in the zoledronic acid group and 13.9% in the placebo group, a 35% risk reduction with zoledronic acid (P=0.001); the respective rates of a new clinical vertebral fracture were 1.7% and 3.8% (P=0.02), and the respective rates of new nonvertebral fractures were 7.6% and 10.7% (P=0.03). In the safety analysis, 101 of 1054 patients in the zoledronic acid group (9.6%) and 141 of 1057 patients in the placebo group (13.3%) died, a reduction of 28% in deaths from any cause in the zoledronic acid group (P=0.01). The most frequent adverse events in patients receiving zoledronic acid were pyrexia, myalgia, and bone and musculoskeletal pain. No cases of osteonecrosis of the jaw were reported, and no adverse effects on the healing of fractures were noted. The rates of renal and cardiovascular adverse events, including atrial fibrillation and stroke, were similar in the two groups. Conclusions: An annual infusion of zoledronic acid within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate of new clinical fractures and with improved survival. (ClinicalTrials.gov number, NCT00046254.).	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA; Univ Maryland, Baltimore, MD 21201 USA; McMaster Univ, Hamilton, ON, Canada; Ctr Osteopatias Med, Buenos Aires, DF, Argentina; Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; United Osteoporosis Ctr, Gainesville, GA USA; Ullevaal Univ Hosp, Oslo, Norway; Novartis Pharmaceut, E Hanover, NJ USA; Savient Pharmaceut, E Brunswick, NJ USA; Novartis Pharmaceut, Basel, Switzerland; Katholieke Univ Leuven, Louvain, Belgium	Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore; McMaster University; University of Copenhagen; University of Oslo; Novartis; Novartis; KU Leuven	Lyles, KW (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3881, Durham, NC 27710 USA.	kenneth.lyles@duke.edu	Brown, Matthew A/E-5749-2010; Eriksen, Erik Fink/AAF-5056-2020	Brown, Matthew A/0000-0003-0538-8211; Rodriguez, Susana/0000-0002-6170-5253	Medical Research Council [U1475000001, G0400491, MC_UP_A620_1014] Funding Source: Medline; NIA NIH HHS [K23 AG024787-04, K23 AG024787] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG024787] Funding Source: NIH RePORTER; MRC [G0400491] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; [Anonymous], 2003, WHO TECH REP SER, V921, P1; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Colon-Emeric C, 2003, OSTEOPOROSIS INT, V14, P879, DOI 10.1007/s00198-003-1460-x; Colon-Emeric CS, 2004, CURR MED RES OPIN, V20, P903, DOI 10.1185/030079904125003683; COLONEMERIC C, IN PRESS AM J MED; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COX DR, 1972, J R STAT SOC B, V34, P187; Davison CW, 2001, NEW ZEAL MED J, V114, P329; Gardner MJ, 2005, J BONE JOINT SURG AM, V87A, P3, DOI 10.2106/JBJS.D.02289; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; JACOBSEN SJ, 1990, AM J PUBLIC HEALTH, V80, P871, DOI 10.2105/AJPH.80.7.871; Kamel HK, 2000, AM J MED, V109, P326, DOI 10.1016/S0002-9343(00)00457-5; Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lu Y, 2001, OSTEOPOROSIS INT, V12, P438, DOI 10.1007/s001980170087; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Solomon DH, 2003, AM J MED, V115, P398, DOI 10.1016/S0002-9343(03)00357-7; van Eijken M, 2003, DRUG AGING, V20, P229, DOI 10.2165/00002512-200320030-00006; 2003, MED DICT REGULATORY	30	1255	1355	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1799	1809		10.1056/NEJMoa074941	http://dx.doi.org/10.1056/NEJMoa074941			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17878149	Green Accepted			2022-12-28	WOS:000250526900003
J	Joo, HY; Zhai, L; Yang, CY; Nie, SY; Erdjument-Bromage, H; Tempst, P; Chang, CB; Wang, HB				Joo, Heui-Yun; Zhai, Ling; Yang, Chunying; Nie, Shuyi; Erdjument-Bromage, Hediye; Tempst, Paul; Chang, Chenbei; Wang, Hengbin			Regulation of cell cycle progression and gene expression by H2A deubiquitination	NATURE			English	Article							HISTONE H2A; RECOMBINANT HISTONES; X-INACTIVATION; UBIQUITYLATION; UBIQUITINATION; TRANSCRIPTION; PHOSPHORYLATION; PURIFICATION; CHROMOSOMES; METHYLATION	Post-translational histone modifications have important regulatory roles in chromatin structure and function(1-3). One example of such modifications is histone ubiquitination, which occurs predominately on histone H2A and H2B. Although the recent identification of the ubiquitin ligase for histone H2A has revealed important roles for H2A ubiquitination in Hox gene silencing(4-6) as well as in X-chromosome inactivation(7,8), the enzyme(s) involved in H2A deubiquitination and the function of H2A deubiquitination are not known. Here we report the identification and functional characterization of the major deubiquitinase for histone H2A, Ubp-M (also called USP16). Ubp-M prefers nucleosomal substrates in vitro, and specifically deubiquitinates histone H2A but not H2B in vitro and in vivo. Notably, knockdown of Ubp-M in HeLa cells results in slow cell growth rates owing to defects in the mitotic phase of the cell cycle. Further studies reveal that H2A deubiquitination by Ubp-M is a prerequisite for subsequent phosphorylation of Ser 10 of H3 and chromosome segregation when cells enter mitosis. Furthermore, we demonstrate that Ubp-M regulates Hox gene expression through H2A deubiquitination and that blocking the function of Ubp-M results in defective posterior development in Xenopus laevis. This study identifies the major deubiquitinase for histone H2A and demonstrates that H2A deubiquitination is critically involved in cell cycle progression and gene expression.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Memorial Sloan Kettering Cancer Center	Wang, HB (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Kaul Human Genet Bldg 402A,720 S 20th St, Birmingham, AL 35294 USA.	hbwang@uab.edu	Yang, Chunying/C-2888-2011	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Wang, Hengbin/0000-0003-2414-0609; Tempst, Paul/0000-0002-6680-3987				Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; ERDJUMENTBROMAG.H, 1988, J CHROMATOGR A, V826, P167; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Fang J, 2004, METHOD ENZYMOL, V377, P213; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Luger K, 1999, METHOD ENZYMOL, V304, P3; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0	26	240	256	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1068	U9		10.1038/nature06256	http://dx.doi.org/10.1038/nature06256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17914355				2022-12-28	WOS:000250395000056
J	Bergquist, BA; Blum, JD				Bergquist, Bridget A.; Blum, Joel D.			Mass-dependent and -independent fractionation of Hg isotopes by photoreduction in aquatic systems	SCIENCE			English	Article							MERCURY ISOTOPES; METHYLMERCURY; DELTA-N-15; REDUCTION; WATER	Mercury (Hg) isotopes can be used as tracers of Hg biogeochemical pathways in the environment. The photochemical reduction of aqueous Hg species by natural sunlight leads to both mass-dependent fractionation (MDF) of Hg isotopes and mass-independent fractionation (MIF) of the odd-mass isotopes, with the relation between the MIF for the two odd isotopes being distinct for different photoreduction pathways. Large variations in MDF and MIF are observed in fish and provide new insights into the sources and bioaccumulation of Hg in food webs. MIF in fish can also be used to estimate the loss of methylmercury via photoreduction in aquatic ecosytems.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bergquist, BA (corresponding author), Univ Michigan, Dept Geol Sci, 1100 N Univ Ave, Ann Arbor, MI 48109 USA.							ALLARD B, 1991, WATER AIR SOIL POLL, V56, P457, DOI 10.1007/BF00342291; AMYOT M, 1994, ENVIRON SCI TECHNOL, V28, P2366, DOI 10.1021/es00062a022; BACHE CA, 1971, SCIENCE, V172, P951, DOI 10.1126/science.172.3986.951; Barkay T, 2005, GEOCHIM COSMOCHIM AC, V69, pA702; Berdinskii VL, 2004, RUSS J PHYS CHEM+, V78, P261; BERGQUIST BA, 2006, EOS, V52; Bigeleisen J, 1996, J AM CHEM SOC, V118, P3676, DOI 10.1021/ja954076k; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; Blum JD, 2007, ANAL BIOANAL CHEM, V388, P353, DOI 10.1007/s00216-007-1236-9; Buchachenko AL, 2007, DOKL PHYS CHEM, V413, P39, DOI 10.1134/S0012501607030013; Buchachenko AL, 2001, J PHYS CHEM A, V105, P9995, DOI 10.1021/jp011261d; CLARKSON TW, 1993, ENVIRON HEALTH PERSP, V100, P31, DOI 10.2307/3431518; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Foucher D, 2006, ANAL BIOANAL CHEM, V384, P1470, DOI 10.1007/s00216-006-0373-x; Hammerschmidt CR, 2006, ENVIRON SCI TECHNOL, V40, P1212, DOI 10.1021/es0513234; Hintelmann H, 2003, ANALYST, V128, P635, DOI 10.1039/b300451a; Hintelmann H, 2003, ACS SYM SER, V835, P321; Jackson TA, 2006, GEOCHIM COSMOCHIM AC, V70, pA284, DOI 10.1016/j.gca.2006.06.577; Jackson TA, 2004, ENVIRON SCI TECHNOL, V38, P2813, DOI 10.1021/es0306009; Kannan K, 1998, ARCH ENVIRON CON TOX, V34, P109, DOI 10.1007/s002449900294; KIDD KA, 1995, WATER AIR SOIL POLL, V80, P1011, DOI 10.1007/BF01189756; KIM JP, 1986, SCIENCE, V231, P1131, DOI 10.1126/science.231.4742.1131; Kritee K, 2007, ENVIRON SCI TECHNOL, V41, P1889, DOI 10.1021/es062019t; Lamborg CH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001847; Lauretta DS, 2001, GEOCHIM COSMOCHIM AC, V65, P2807, DOI 10.1016/S0016-7037(01)00630-5; MASON RP, 1995, WATER AIR SOIL POLL, V80, P775, DOI 10.1007/BF01189729; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Schauble EA, 2007, GEOCHIM COSMOCHIM AC, V71, P2170, DOI 10.1016/j.gca.2007.02.004; Sellers P, 1996, NATURE, V380, P694, DOI 10.1038/380694a0; Smith CN, 2005, GEOLOGY, V33, P825, DOI 10.1130/G21863.1; Thiemens MH, 2006, ANNU REV EARTH PL SC, V34, P217, DOI 10.1146/annurev.earth.34.031405.125026; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; VANDAL GM, 1991, WATER AIR SOIL POLL, V56, P791, DOI 10.1007/BF00342317; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P1095, DOI 10.1016/S0016-7037(01)00832-8; Zhang H, 2006, STRUCT BOND, V120, P37, DOI 10.1007/430_015	40	583	613	29	500	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					417	420		10.1126/science.1148050	http://dx.doi.org/10.1126/science.1148050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17872409				2022-12-28	WOS:000250230400037
J	Holland, SM; DeLeo, FR; Elloumi, HZ; Hsu, AP; Uzel, G; Brodsky, N; Freeman, AF; Demidowich, A; Davis, J; Turner, ML; Anderson, VL; Darnell, DN; Welch, PA; Kuhns, DB; Frucht, DM; Malech, HL; Gallin, JI; Kobayashi, SD; Whitney, AR; Voyich, JM; Musser, JM; Woellner, C; Schaffer, AA; Puck, JM; Grimbacher, B				Holland, Steven M.; Deleo, Frank R.; Elloumi, Houda Z.; Hsu, Amy P.; Uzel, Gulbu; Brodsky, Nina; Freeman, Alexandra F.; Demidowich, Andrew; Davis, Joie; Turner, Maria L.; Anderson, Victoria L.; Darnell, Dirk N.; Welch, Pamela A.; Kuhns, Douglas B.; Frucht, David M.; Malech, Harry L.; Gallin, John I.; Kobayashi, Scott D.; Whitney, Adeline R.; Voyich, Jovanka M.; Musser, James M.; Woellner, Cristina; Schaeffer, Alejandro A.; Puck, Jennifer M.; Grimbacher, Bodo			STAT3 mutations in the hyper-IgE syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERIMMUNOGLOBULIN-E SYNDROME; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; CYTOKINE SIGNALS; INNATE IMMUNITY; T-CELLS; DISEASE; INTERFERON; DEFICIENCY; ACTIVATION	Background The hyper-IgE syndrome (or Job's syndrome) is a rare disorder of immunity and connective tissue characterized by dermatitis, boils, cyst-forming pneumonias, elevated serum IgE levels, retained primary dentition, and bone abnormalities. Inheritance is autosomal dominant; sporadic cases are also found. Methods We collected longitudinal clinical data on patients with the hyper-IgE syndrome and their families and assayed the levels of cytokines secreted by stimulated leukocytes and the gene expression in resting and stimulated cells. These data implicated the signal transducer and activator of transcription 3 gene (STAT3) as a candidate gene, which we then sequenced. Results We found increased levels of proinflammatory gene transcripts in unstimulated peripheral-blood neutrophils and mononuclear cells from patients with the hyper-IgE syndrome, as compared with levels in control cells. In vitro cultures of mononuclear cells from patients that were stimulated with lipopolysaccharide, with or without interferon-(gamma), had higher tumor necrosis factor (alpha) levels than did identically treated cells from unaffected persons (P=0.003). In contrast, the cells from patients with the hyper-IgE syndrome generated lower levels of monocyte chemoattractant protein 1 in response to the presence of interleukin-6 (P=0.03), suggesting a defect in interleukin-6 signaling through its downstream mediators, one of which is STAT3. We identified missense mutations and single-codon in-frame deletions in STAT3 in 50 familial and sporadic cases of the hyper-IgE syndrome. Eighteen discrete mutations, five of which were hot spots, were predicted to directly affect the DNA-binding and SRC homology 2 (SH2) domains. Conclusions Mutations in STAT3 underlie sporadic and dominant forms of the hyper-IgE syndrome, an immunodeficiency syndrome involving increased innate immune response, recurrent infections, and complex somatic features.	NIAID, NIH, Bethesda, MD 20892 USA; NIAID, Hamilton, MT USA; NHGRI, Bethesda, MD 20892 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Sci Applicat Int Corp, NCI, Frederick, MD USA; US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Royal Free Hosp & UCL, London, England; Univ Calif San Francisco, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); US Food & Drug Administration (FDA); University of London; University College London; University of California System; University of California San Francisco	Holland, SM (corresponding author), NIAID, NIH, CRC B3-4141 MSC 1684, Bethesda, MD 20892 USA.	smh@nih.gov	Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Hsu, Amy/0000-0001-6841-2122; Malech, Harry/0000-0001-5874-5775; DeLeo, Frank/0000-0003-3150-2516; Brodsky, Nina/0000-0003-2472-7397; Kobayashi, Scott/0000-0002-5705-1381	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000900, Z01AI000645, Z01AI000646, Z01AI000155] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000097] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Buckley RH, 2001, CLIN REV ALLERG IMMU, V20, P139, DOI 10.1385/CRIAI:20:1:139; Chehimi J, 2001, CLIN IMMUNOL, V100, P49, DOI 10.1006/clim.2001.5039; COLOTTA F, 1992, BLOOD, V80, P2012; DAVIS SD, 1966, LANCET, V1, P1013; DELPRETE G, 1989, J CLIN INVEST, V84, P1830, DOI 10.1172/JCI114368; Fleisher TA, 1999, CLIN IMMUNOL, V90, P425, DOI 10.1006/clim.1998.4654; FREEMAN AF, 2007, PED AC SOC ANN M TOR; Freeman AF, 2007, J ALLERGY CLIN IMMUN, V119, P1234, DOI 10.1016/j.jaci.2006.12.666; Freeman AF, 2007, PEDIATRICS, V119, pE1121, DOI 10.1542/peds.2006-2649; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Ling JC, 2007, CLIN IMMUNOL, V122, P255, DOI 10.1016/j.clim.2006.10.005; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka T, 2005, CLIN EXP IMMUNOL, V140, P524, DOI 10.1111/j.1365-2249.2005.02805.x; Wang L, 2005, EXP HEMATOL, V33, P308, DOI 10.1016/j.exphem.2004.11.014; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019	39	827	871	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1608	1619		10.1056/NEJMoa073687	http://dx.doi.org/10.1056/NEJMoa073687			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17881745				2022-12-28	WOS:000250200500006
J	Biertumpfel, C; Yang, W; Suck, D				Biertuempfel, Christian; Yang, Wei; Suck, Dietrich			Crystal structure of T4 endonuclease VII resolving a Holliday junction	NATURE			English	Article							FAST SEDIMENTING DNA; NUCLEIC-ACIDS; ESCHERICHIA-COLI; DIFFRACTION DATA; ACTIVE-SITE; CLEAVAGE; BINDING; RESOLUTION; BACTERIOPHAGE-T4; CRYSTALLOGRAPHY	Holliday proposed a four-way DNA junction as an intermediate in homologous recombination(1), and such Holliday junctions have since been identified as a central component in DNA recombination and repair(2). Phage T4 endonuclease VII (endo VII) was the first enzyme shown to resolve Holliday junctions into duplex DNAs by introducing symmetrical nicks in equivalent strands(3). Several Holliday junction resolvases have since been characterized(4), but an atomic structure of a resolvase complex with a Holliday junction remained elusive. Here we report the crystal structure of an inactive T4 endo VII(N62D) complexed with an immobile four-way junction with alternating arm lengths of 10 and 14 base pairs. The junction is a hybrid of the conventional square-planar and stacked-X conformation. Endo VII protrudes into the junction point from the minor groove side, opening it to a 14 angstrom x 32 angstrom parallelogram. This interaction interrupts the coaxial stacking, yet every base pair surrounding the junction remains intact. Additional interactions involve the positively charged protein and DNA phosphate backbones. Each scissile phosphate that is two base pairs from the crossover interacts with a Mg2+ ion in the active site. The similar overall shape and surface charge potential of the Holliday junction resolvases endo VII, RuvC, Ydc2, Hjc and RecU, despite having different folds, active site composition and DNA sequence preference, suggest a conserved binding mode for Holliday junctions.	NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; European Mol Biol Lab, Struct & Computat Biol Programme, D-69117 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); European Molecular Biology Laboratory (EMBL)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wei.yang@nih.gov; suck@embl.de	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Biertumpfel, Christian/0000-0002-7528-6547	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036145] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Declais AC, 2001, J MOL BIOL, V307, P1145, DOI 10.1006/jmbi.2001.4541; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; GiraudPanis MJE, 1996, J BIOL CHEM, V271, P33148, DOI 10.1074/jbc.271.51.33148; Golz S, 1997, EUR J BIOCHEM, V245, P573, DOI 10.1111/j.1432-1033.1997.00573.x; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEMPER B, 1976, J VIROL, V18, P1000, DOI 10.1128/JVI.18.3.1000-1015.1976; KEMPER B, 1976, J VIROL, V18, P992, DOI 10.1128/JVI.18.3.992-999.1976; Khuu PA, 2006, J MOL RECOGNIT, V19, P234, DOI 10.1002/jmr.765; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pohler JRG, 1996, J MOL BIOL, V260, P678; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Scholz SR, 2003, BIOCHEMISTRY-US, V42, P9288, DOI 10.1021/bi0348765; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	39	92	94	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					616	U14		10.1038/nature06152	http://dx.doi.org/10.1038/nature06152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873859				2022-12-28	WOS:000249893500049
J	Nichol, KL; Nordin, JD; Nelson, DB; Mullooly, JP; Hak, E				Nichol, Kristin L.; Nordin, James D.; Nelson, David B.; Mullooly, John P.; Hak, Eelko			Effectiveness of influenza vaccine in the community-dwelling elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; FUNCTIONAL STATUS; PROGNOSTIC INDEX; MORTALITY; VALIDATION; OLDER; HOSPITALIZATIONS; BENEFITS; US; EFFICACY	Background Reliable estimates of the effectiveness of influenza vaccine among persons 65 years of age and older are important for informed vaccination policies and programs. Short-term studies may provide misleading pictures of long-term benefits, and residual confounding may have biased past results. This study examined the effectiveness of influenza vaccine in seniors over the long term while addressing potential bias and residual confounding in the results. Methods Data were pooled from 18 cohorts of community-dwelling elderly members of one U.S. health maintenance organization (HMO) for 1990-1991 through 1999-2000 and of two other HMOs for 1996-1997 through 1999-2000. Logistic regression was used to estimate the effectiveness of the vaccine for the prevention of hospitalization for pneumonia or influenza and death after adjustment for important covariates. Additional analyses explored for evidence of bias and the potential effect of residual confounding. Results There were 713,872 person-seasons of observation. Most high-risk medical conditions that were measured were more prevalent among vaccinated than among unvaccinated persons. Vaccination was associated with a 27% reduction in the risk of hospitalization for pneumonia or influenza (adjusted odds ratio, 0.73; 95% confidence interval [CI], 0.68 to 0.77) and a 48% reduction in the risk of death (adjusted odds ratio, 0.52; 95% CI, 0.50 to 0.55). Estimates were generally stable across age and risk subgroups. In the sensitivity analyses, we modeled the effect of a hypothetical unmeasured confounder that would have caused overestimation of vaccine effectiveness in the main analysis; vaccination was still associated with statistically significant - though lower - reductions in the risks of both hospitalization and death. Conclusions During 10 seasons, influenza vaccination was associated with significant reductions in the risk of hospitalization for pneumonia or influenza and in the risk of death among community-dwelling elderly persons. Vaccine delivery to this high-priority group should be improved.	Minneapolis Vet Affairs Med Ctr, Med Serv, Minneapolis, MN USA; Minneapolis Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; HealthPartners Res Fdn, Minneapolis, MN USA; Kaiser Permanente NW, Portland, OR USA; Univ Med Ctr, Julius Ctr Hlth Serv & Primary Care, Utrecht, Netherlands	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research; Kaiser Permanente; Utrecht University; Utrecht University Medical Center	Nichol, KL (corresponding author), VA Med Ctr, Med Serv, 111,1 Vet Dr, Minneapolis, MN 55417 USA.	nicho014@umn.edu	Nelson, David/G-7142-2011	Nelson, David/0000-0003-1163-1222; Nordin, James/0000-0002-3359-5843				*ADV COMM IMM PRAC, 2006, MMWR-MORBID MORTAL W, V55, P800; Advisory Committee on Immunization Practices, 2006, MMWR Recomm Rep, V55, P1; BANTHIN JS, 1996, 15 AG HEALTHC RES PO; Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P958; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Fukuda K, 2006, NEW ENGL J MED, V355, P2586, DOI 10.1056/NEJMe068257; Fulop T, 1999, J GERONTOL A-BIOL, V54, pM59, DOI 10.1093/gerona/54.2.M59; Glezen WP, 2006, INT J EPIDEMIOL, V35, P352, DOI 10.1093/ije/dyi293; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; GROSS PA, 1989, VACCINE, V7, P303, DOI 10.1016/0264-410X(89)90190-4; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hak E, 2006, INT J EPIDEMIOL, V35, P800, DOI 10.1093/ije/dyl068; Hak E, 2004, J INFECT DIS, V189, P450, DOI 10.1086/381165; Hak E, 2002, J EPIDEMIOL COMMUN H, V56, P951, DOI 10.1136/jech.56.12.951; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jacobson RA, 2007, VACCINE, V25, P3153, DOI 10.1016/j.vaccine.2007.01.047; Jefferson T, 2006, LANCET, V367, P986; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jefferson T, 2006, BMJ-BRIT MED J, V333, P912, DOI 10.1136/bmj.38995.531701.80; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; LETHRIDGECEJKU M, 2006, VITAL HLTH STAT 10, V228; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mayo NE, 2005, MED CARE, V43, P1194, DOI 10.1097/01.mlr.0000185749.04875.cb; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 2005, DRUG AGING, V22, P495, DOI 10.2165/00002512-200522060-00004; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schwartz B, 2006, J INFECT DIS, V194, pS147, DOI 10.1086/507556; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987	47	485	505	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1373	1381		10.1056/NEJMoa070844	http://dx.doi.org/10.1056/NEJMoa070844			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914038				2022-12-28	WOS:000249892900003
J	Lago, RM; Singh, PP; Nesto, RW				Lago, Rodrigo M.; Singh, Premranjan P.; Nesto, Richard W.			Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials	LANCET			English	Article							VENTRICULAR SYSTOLIC FUNCTION; ACUTE MYOCARDIAL-INFARCTION; NORMAL EJECTION FRACTION; INSULIN-RESISTANCE; CARDIAC STRUCTURE; ROSIGLITAZONE; PREVALENCE; COMMUNITY; EVENTS; IMPACT	Background The overall clinical benefit of thiazolidinediones (TZDs) as a treatment for hyperglycaemia can be difficult to assess because of the risk of congestive heart failure due to TZD-related fluid retention. Since prediabetic and diabetic patients are at high cardiovascular risk, the outcome and natural history of such risks need to be better understood. We aimed to examine the risk of congestive heart failure and of cardiac death in patients given TZDs. Methods We used a search strategy to identify 3048 studies. 3041 were excluded, and we did a systematic review and meta-analysis of the seven remaining randomised double-blind clinical trials of drug-related congestive heart failure in patients given TZDs (either rosiglitazone or pioglitazone). We calculated pooled random-effects estimates of the risk ratios for development of congestive heart failure in patients given TZDs compared with controls. The main outcome measures were development of congestive heart failure and the risk of cardiovascular death. Findings 360 of 20191 patients who had either prediabetes or type 2 diabetes had congestive heart failure events (214 with TZDs and 146 with comparators). Results showed no heterogeneity of effects across studies (I-2=22.8%; p for interaction=0.26), which indicated a class effect for TZDs. Compared with controls, patients given TZDs had increased risk for development of congestive heart failure across a wide background of cardiac risk (relative risk [RR] 1.72, 95% CI 1.21-2.42, p=0.002). By contrast, the risk of cardiovascular death was not increased with either of the two TZDs (0.93, 0.67-1.29, p=0.68). Interpretation Congestive heart failure in patients given TZDs might not carry the risk that is usually associated with congestive heart failure which is caused by progressive systolic or diastolic dysfunction of the left ventricle. Longer follow-up and better characterisation of such patients is needed to determine the effect of TZDs on overall cardiovascular outcome.	Lahey Clin Fdn, Med Ctr, Burlington, MA 01805 USA	Lahey Hospital & Medical Center	Nesto, RW (corresponding author), Lahey Clin Fdn, Med Ctr, 41 Mall Rd, Burlington, MA 01805 USA.	Richard.W.Nesto@lahey.org						Aguilar D, 2007, J AM COLL CARDIOL, V50, P32, DOI 10.1016/j.jacc.2007.01.096; Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bhatt DL, 2007, AM HEART J, V154, P137, DOI 10.1016/j.ahj.2007.03.029; Blaschke F, 2006, VASC PHARMACOL, V45, P3, DOI 10.1016/j.vph.2005.11.009; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Dauterman KW, 1998, AM HEART J, V135, pS310, DOI 10.1016/S0002-8703(98)70258-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Egger M, 2001, SYSTEMATIC REV HLTH; ERDMANN E, 2007, DIABETES CARE   0731, DOI DOI 10.2357/DC07-0717; Fang ZY, 2003, J AM COLL CARDIOL, V41, P611, DOI 10.1016/S0735-1097(02)02869-3; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Inzucchi SE, 2005, DIABETES CARE, V28, P1680, DOI 10.2337/diacare.28.7.1680; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Karalliedde J, 2006, J AM SOC NEPHROL, V17, P3482, DOI 10.1681/ASN.2006060606; Kupari M, 1997, J INTERN MED, V241, P387, DOI 10.1046/j.1365-2796.1997.129150000.x; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maurer MS, 2007, J AM COLL CARDIOL, V49, P972, DOI 10.1016/j.jacc.2006.10.061; Maurer MS, 2006, PROG CARDIOVASC DIS, V49, P182, DOI 10.1016/j.pcad.2006.08.007; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nesto RW, 1998, CIRCULATION, V97, P12, DOI 10.1161/01.CIR.97.1.12; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; O'Connor CM, 2000, AM J CARDIOL, V86, P863, DOI 10.1016/S0002-9149(00)01107-3; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Riche DM, 2007, DIABETES CARE, V30, P384, DOI 10.2337/dc06-1854; Rothstein H, 2005, COMPREHENSIVE META A, P104; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Ryden L, 2007, LANCET, V369, P189, DOI 10.1016/S0140-6736(07)60106-8; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SETARO JF, 1992, AM J CARDIOL, V69, P1212, DOI 10.1016/0002-9149(92)90938-U; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Sutton MS, 2002, DIABETES CARE, V25, P2058, DOI 10.2337/diacare.25.11.2058; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	48	537	554	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1129	1136		10.1016/S0140-6736(07)61514-1	http://dx.doi.org/10.1016/S0140-6736(07)61514-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905165				2022-12-28	WOS:000250263700027
J	Treadway, K				Treadway, Katharine			The code	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Treadway, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.								0	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1273	1275		10.1056/NEJMp078115	http://dx.doi.org/10.1056/NEJMp078115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898094				2022-12-28	WOS:000249711500001
J	Hawkes, N				Hawkes, Nigel			Have charities been silenced by government gold?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					592	592		10.1136/bmj.39338.667558.59	http://dx.doi.org/10.1136/bmj.39338.667558.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215TR	17884903	Green Published			2022-12-28	WOS:000249832400031
J	Bass, JK; Bolton, PA; Murray, LK				Bass, Judith K.; Bolton, Paul A.; Murray, Laura K.			Do not forget culture when studying mental health	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DEPRESSION PREVALENCE; RURAL UGANDA; INSTRUMENT; VALIDITY; ISSUES		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA; Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University	Bass, JK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.	jbass@jhsph.edu		Bass, Judith/0000-0002-5192-628X				Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; DESJARLAIS R, 2005, WORLD MENTAL HLTH PR; Draguns JG, 2003, BEHAV RES THER, V41, P755, DOI 10.1016/S0005-7967(02)00190-0; Gureje O, 2007, LANCET, V370, P957, DOI 10.1016/S0140-6736(07)61446-9; Kleinman A., 1988, RETHINKING PSYCHIAT; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Phan Tuong, 2004, Transcult Psychiatry, V41, P200, DOI 10.1177/1363461504043565; Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457; Van Ommeren M, 2003, BRIT J PSYCHIAT, V182, P376, DOI 10.1192/bjp.182.5.376; WHO, 2001, WORLD HLTH REPORT 20	14	86	86	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2007	370	9591					918	919		10.1016/S0140-6736(07)61426-3	http://dx.doi.org/10.1016/S0140-6736(07)61426-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211EG	17869621				2022-12-28	WOS:000249506500007
J	Schorghofer, N				Schorghofer, Norbert			Dynamics of ice ages on Mars	NATURE			English	Article							GROUND ICE; ASTRONOMICAL THEORY; HIGH OBLIQUITY; NEAR-SURFACE; DEPOSITS; PRECIPITATION; INSOLATION; LATITUDES; STABILITY; HYDROGEN	Unlike Earth, where astronomical climate forcing is comparatively small, Mars experiences dramatic changes in incident sunlight that are capable of redistributing ice on a global scale(1-6). The geographic extent of the subsurface ice found poleward of approximately +/-60 degrees latitude on both hemispheres of Mars(7-9) coincides with the areas where ice is stable(7,10,11). However, the tilt of Mars' rotation axis (obliquity) changed considerably in the past several million years. Earlier work(3,12) has shown that regions of ice stability, which are defined by temperature and atmospheric humidity, differed in the recent past from today's, and subsurface ice is expected to retreat quickly when unstable(11-13). Here I explain how the subsurface ice sheets could have evolved to the state in which we see them today. Simulations of the retreat and growth of ground ice as a result of sublimation loss and recharge reveal forty major ice ages over the past five million years. Today, this gives rise to pore ice at mid-latitudes and a three-layered depth distribution in the high latitudes of, from top to bottom, a dry layer, pore ice, and a massive ice sheet. Combined, these layers provide enough ice to be compatible with existing neutron and gamma-ray measurements(7-9).	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Univ Hawaii, NASA, Astrobiol Inst, Honolulu, HI 96822 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); University of Hawaii System	Schorghofer, N (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	norbert@hawaii.edu	Schorghofer, Norbert/A-1194-2007	Schorghofer, Norbert/0000-0002-5821-4066				Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Feldman WC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028936; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Forget F, 2006, SCIENCE, V311, P368, DOI 10.1126/science.1120335; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hudson TL, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002815; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Litvak ML, 2006, ICARUS, V180, P23, DOI 10.1016/j.icarus.2005.08.009; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Prettyman TH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002139; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Schorghofer N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041201; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375	25	78	80	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					192	U2		10.1038/nature06082	http://dx.doi.org/10.1038/nature06082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851518				2022-12-28	WOS:000249394500043
J	Gupta, V; Nivarthi, SS; Keffer, D; McCormick, AV; Davis, HT				Gupta, V; Nivarthi, SS; Keffer, D; McCormick, AV; Davis, HT			Evidence of single-file diffusion in zeolites	SCIENCE			English	Letter											Gupta, V (corresponding author), UNIV MINNESOTA,DEPT CHEM ENGN & MAT SCI,421 WASHINGTON AVE SE,MINNEAPOLIS,MN 55455, USA.		Keffer, David/Q-6408-2019; Keffer, David/GSN-5096-2022; Keffer, David/C-5133-2014	Keffer, David/0000-0002-6246-0286; Keffer, David/0000-0002-6246-0286; Keffer, David/0000-0002-6246-0286				Gupta V, 1995, CHEM PHYS LETT, V247, P596, DOI 10.1016/S0009-2614(95)01246-X; NIVARTHI SS, 1994, CHEM PHYS LETT, V229, P297, DOI 10.1016/0009-2614(94)01059-5	2	24	24	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 11	1996	274	5285					164	164		10.1126/science.274.5285.164	http://dx.doi.org/10.1126/science.274.5285.164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VM671	17847219				2022-12-28	WOS:A1996VM67100006
J	ABELSON, PH				ABELSON, PH			SUPPORT FOR MATERIALS SCIENCE AND ENGINEERING	SCIENCE			English	Editorial Material																		1989, MATERIALS SCI ENG 19	1	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1273	1273		10.1126/science.247.4948.1273	http://dx.doi.org/10.1126/science.247.4948.1273			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843770				2022-12-28	WOS:A1990CU25300001
J	NORMAN, C				NORMAN, C			DOD LISTS CRITICAL TECHNOLOGIES	SCIENCE			English	Editorial Material																		1989, PENTAGONS REPORT	1	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1543	1543		10.1126/science.243.4898.1543	http://dx.doi.org/10.1126/science.243.4898.1543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847253				2022-12-28	WOS:A1989T795200009
J	Curtis, LH; Al-Khatib, SM; Shea, AM; Hammill, BG; Hernandez, AF; Schulman, KA				Curtis, Lesley H.; Al-Khatib, Sana M.; Shea, Alisa M.; Hammill, Bradley G.; Hernandez, Adrian F.; Schulman, Kevin A.			Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR ARRHYTHMIAS; UNITED-STATES; HIGH-RISK; SURVIVAL; MANAGEMENT; ICD-9-CM	Context Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years. Objective To examine sex differences in ICD use for primary and secondary prevention of sudden cardiac death. Design, Setting, and Participants Analysis of a 5% national sample of research-identifiable files obtained from the US Centers for Medicare & Medicaid Services for the period 1991 through 2005. Patients were those aged 65 years or older with Medicare fee-for-service coverage and diagnosed with acute myocardial infarction and either heart failure or cardiomyopathy but no prior cardiac arrest or ventricular tachycardia (ie, the primary prevention cohort [n = 65 917 men and 70 504 women]), or with cardiac arrest or ventricular tachycardia (ie, the secondary prevention cohort [n = 52 252 men and 47 411 women]), from 1999 through 2005. Main Outcome Measures Receipt of ICD therapy and all-cause mortality at 1 year. Results In the 2005 primary prevention cohort, 32.3 per 1000 men and 8.6 per 1000 women received ICD therapy within 1 year of cohort entry. In multivariate analyses, men were more likely than women to receive ICD therapy (hazard ratio [HR], 3.15; 95% confidence interval [CI], 2.86-3.47). Among men and women alive at 180 days after cohort entry, the hazard of mortality in the subsequent year was not significantly lower among those who received ICD therapy (HR, 1.01; 95% CI, 0.82-1.23). In the 2005 secondary prevention cohort, 102.2 per 1000 men and 38.4 per 1000 women received ICD therapy. Controlling for demographic variables and comorbid conditions, men were more likely than women to receive ICD therapy (HR, 2.44; 95% CI, 2.30-2.59). Among men and women alive at 30 days after cohort entry, the hazard of mortality in the subsequent year was significantly lower among those who received ICD therapy (HR, 0.65; 95% CI, 0.60-0.71). Conclusion In the Medicare population, women are significantly less likely than men to receive ICD therapy for primary or secondary prevention of sudden cardiac death.	Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Duke University; Duke University	Curtis, LH (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, POB 17969, Durham, NC 27715 USA.	lesley.curtis@duke.edu	Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616	NHLBI NIH HHS [5U01HL66461-05] Funding Source: Medline; NIA NIH HHS [1R01AG026038-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026038] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander M, 2002, AM HEART J, V144, P431, DOI 10.1067/mhj.2002.125500; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Ezekowitz JA, 2003, ANN INTERN MED, V138, P445, DOI 10.7326/0003-4819-138-6-200303180-00007; Gauri AJ., 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.08.021, 10.1016/j.amjmed.2005.08.021]; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Groeneveld PW, 2005, J AM COLL CARDIOL, V45, P72, DOI 10.1016/j.jacc.2004.07.061; Hlatky MA, 2002, AM HEART J, V144, P397, DOI 10.1067/mhj.2002.125496; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Phurrough S., 2003, DECISION MEMORANDUM; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Russo AM, 2004, J CARDIOVASC ELECTR, V15, P993, DOI 10.1046/j.1540-8167.2004.04050.x; Sheifer SE, 2000, AM HEART J, V139, P848, DOI 10.1016/S0002-8703(00)90017-6; Voigt A, 2004, J AM COLL CARDIOL, V44, P855, DOI 10.1016/j.jacc.2004.05.053; Wyse DG, 2001, J AM COLL CARDIOL, V38, P1718, DOI 10.1016/S0735-1097(01)01597-2; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	193	194	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1517	1524		10.1001/jama.298.13.1517	http://dx.doi.org/10.1001/jama.298.13.1517			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911496				2022-12-28	WOS:000249860500023
J	Guthrie, B; Inkster, M; Fahey, T				Guthrie, Bruce; Inkster, Melanie; Fahey, Tom			Tackling therapeutic inertia: role of treatment data in quality indicators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTENSION-SOCIETY GUIDELINES; PATIENT; PERFORMANCE; DECISION; CARE		Univ Dundee, Dundee DD2 4BF, Scotland; Royal Coll Surgeons Ireland, Dept Family Med & Gen Practice, Dublin 2, Ireland	University of Dundee; Royal College of Surgeons - Ireland	Guthrie, B (corresponding author), Univ Dundee, Dundee DD2 4BF, Scotland.	b.guthrie@chs.dundee.ac.uk	Fahey, Tom/C-9367-2012; Guthrie, Bruce/HHM-9696-2022	Fahey, Tom/0000-0002-5896-5783; Guthrie, Bruce/0000-0003-4191-4880	Chief Scientist Office [CZF/2/16] Funding Source: Medline	Chief Scientist Office		Borzecki AM, 2003, ARCH INTERN MED, V163, P2705, DOI 10.1001/archinte.163.22.2705; *BRIT MED ASS, 2003, INV GEN PRACT GMS CO; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Davis BR, 2001, CLINICAL TRIALS IN HYPERTENSION, P27; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Hayward RA, 2004, DIABETES CARE, V27, pB54, DOI 10.2337/diacare.27.suppl_2.B54; *INF STAT DIV NHS, 2007, QUAL OUTC FRAM DAT S; Inkster M, 2005, BRIT J GEN PRACT, V55, P931; Inkster ME, 2006, J HUM HYPERTENS, V20, P295, DOI 10.1038/sj.jhh.1001981; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Montgomery AA, 2003, J HYPERTENS, V21, P1753, DOI 10.1097/00004872-200309000-00026; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Psaty BM, 2002, ARCH INTERN MED, V162, P2325, DOI 10.1001/archinte.162.20.2325; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	20	53	53	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2007	335	7619					542	+		10.1136/bmj.39259.400069.AD	http://dx.doi.org/10.1136/bmj.39259.400069.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855323	Green Published			2022-12-28	WOS:000249790200033
J	Gao, L; Theuns, T				Gao, Liang; Theuns, Tom			Lighting the universe with filaments	SCIENCE			English	Article							WARM DARK-MATTER; INITIAL MASS FUNCTION; STAR-FORMATION; LAMBDA-CDM; 1ST STARS; COSMOLOGY; CLOUD; CONSTRAINTS; PHYSICS; CORES	The first stars in the universe form when chemically pristine gas heats as it falls into dark-matter potential wells, cools radiatively because of the formation of molecular hydrogen, and becomes self-gravitating. Using supercomputer simulations, we demonstrated that the stars' properties depend critically on the currently unknown nature of the dark matter. If the dark-matter particles have intrinsic velocities that wipe out small-scale structure, then the first stars form in filaments with lengths on the order of the free-streaming scale, which can be similar to 10(20) meters (similar to 3 kiloparsecs, corresponding to a baryonic mass of similar to 10(7) solar masses) for realistic "warm dark matter" candidates. Fragmentation of the filaments forms stars with a range of masses, which may explain the observed peculiar element abundance pattern of extremely metal-poor stars, whereas coalescence of fragments and stars during the filament's ultimate collapse may seed the supermassive black holes that lurk in the centers of most massive galaxies.	Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium	Durham University; University of Antwerp	Gao, L (corresponding author), Univ Durham, Inst Computat Cosmol, South Rd, Durham DH1 3LE, England.	liang.gao@durham.ac.uk	Theuns, Tom/GXV-6618-2022; Gao, Liang/O-6598-2014; Gao, Liang/A-8924-2008	Theuns, Tom/0000-0002-3790-9520; Gao, Liang/0000-0002-9276-917X				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Bode P, 2001, ASTROPHYS J, V556, P93, DOI 10.1086/321541; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Dalcanton JJ, 2001, ASTROPHYS J, V561, P35, DOI 10.1086/323207; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Galli D, 1998, ASTRON ASTROPHYS, V335, P403; Gao L, 2007, MON NOT R ASTRON SOC, V378, P449, DOI 10.1111/j.1365-2966.2007.11814.x; Gao L, 2005, MON NOT R ASTRON SOC, V363, P379, DOI 10.1111/j.1365-2966.2005.09509.x; Gotz M, 2002, ASTROPHYS SPACE SCI, V281, P415, DOI 10.1023/A:1019543230202; Inutsuka S, 1997, ASTROPHYS J, V480, P681, DOI 10.1086/303982; Johnson JL, 2006, MON NOT R ASTRON SOC, V366, P247, DOI 10.1111/j.1365-2966.2005.09846.x; LARSON RB, 1985, MON NOT R ASTRON SOC, V214, P379, DOI 10.1093/mnras/214.3.379; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Nakamura F, 2002, ASTROPHYS J, V569, P549, DOI 10.1086/339392; O'Shea BW, 2006, ASTROPHYS J, V648, P31, DOI 10.1086/505684; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; Seljak U, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.191303; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Viel M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.071301; Yoshida N, 2003, ASTROPHYS J, V591, pL1, DOI 10.1086/376963; Yoshida N, 2007, ASTROPHYS J, V663, P687, DOI 10.1086/518227; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978	28	90	90	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1527	1530		10.1126/science.1146676	http://dx.doi.org/10.1126/science.1146676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872439	Green Submitted			2022-12-28	WOS:000249467900035
J	Hadders, MA; Beringer, DX; Gros, P				Hadders, Michael A.; Beringer, Dennis X.; Gros, Piet			Structure of C8 alpha-MACPF reveals mechanism of membrane attack in complement immune defense	SCIENCE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; PORE-FORMING TOXINS; MACPF DOMAIN; KILLER CELLS; 2 PARTS; BINDING; PERFORIN; POLYMERIZATION; INTERMEDILYSIN; IMMUNOLOGY	Membrane attack is important for mammalian immune defense against invading microorganisms and infected host cells. Proteins of the complement membrane attack complex (MAC) and the protein perforin share a common MACPF domain that is responsible for membrane insertion and pore formation. We determined the crystal structure of the MACPF domain of complement component C8 alpha at 2.5 angstrom resolution and show that it is structurally homologous to the bacterial, pore-forming, cholesterol-dependent cytolysins. The structure displays two regions that (in the bacterial cytolysins) refold into transmembrane beta hairpins, forming the lining of a barrel pore. Local hydrophobicity explains why C8 alpha is the first complement protein to insert into the membrane. The size of the MACPF domain is consistent with known C9 pore sizes. These data imply that these mammalian and bacterial cytolytic proteins share a common mechanism of membrane insertion.	Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Beringer, Dennis/0000-0002-5986-1134				Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; DeLano W.L, PYMOL MOL GRAPHICS S; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DISCIPIO RG, 1985, J BIOL CHEM, V260, P4802; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; GEE AP, 1980, J IMMUNOL, V124, P1905; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2006, BIOCHEMISTRY-US, V45, P5290, DOI 10.1021/bi0601860; SODETZ JM, 1989, CURR TOP MICROBIOL, V140, P19; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1984, J BIOL CHEM, V259, P7857; TSCHOPP J, 1982, NATURE, V298, P534, DOI 10.1038/298534a0; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wurzner R, 1992, Immunodefic Rev, V3, P123	30	187	194	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1552	1554		10.1126/science.1147103	http://dx.doi.org/10.1126/science.1147103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872444	Green Submitted			2022-12-28	WOS:000249467900042
J	Buller, HR; Cohen, AT; Davidson, B; Decousus, H; Gallus, AS; Gent, M; Pillion, G; Piovella, F; Prins, MH; Raskob, GE				Buller, Harry R.; Cohen, Ander T.; Davidson, Bruce; Decousus, Herve; Gallus, Alex S.; Gent, Michael; Pillion, Gerard; Piovella, Franco; Prins, Martin H.; Raskob, Gary E.		van Gogh Investigators	Idraparinux versus standard therapy for venous thromboembolic disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPARIN; THROMBOSIS	Background: Venous thromboembolism is treated with unfractionated heparin or low-molecular-weight heparin, followed by a vitamin K antagonist. We investigated the potential use of idraparinux, a long-acting inhibitor of activated factor X, as a substitute for standard therapy. Methods: We conducted two randomized, open-label noninferiority trials involving 2904 patients with deep-vein thrombosis and 2215 patients with pulmonary embolism to compare the efficacy and safety of idraparinux versus standard therapy. Patients received either subcutaneous idraparinux (2.5 mg once weekly) or a heparin followed by an adjusted-dose vitamin K antagonist for either 3 or 6 months. The primary efficacy outcome was the 3-month incidence of symptomatic recurrent venous thromboembolism (nonfatal or fatal). Results: In the study of patients with deep venous thrombosis, the incidence of recurrence at day 92 was 2.9% in the idraparinux group as compared with 3.0% in the standard-therapy group (odds ratio, 0.98; 95% confidence interval [CI], 0.63 to 1.50), a result that satisfied the prespecified noninferiority requirement. At 6 months, the hazard ratio for idraparinux was 1.01. The rates of clinically relevant bleeding at day 92 were 4.5% in the idraparinux group and 7.0% in the standard-therapy group (P=0.004). At 6 months, bleeding rates were similar. In the study of patients with pulmonary embolism, the incidence of recurrence at day 92 was 3.4% in the idraparinux group and 1.6% in the standard-therapy group (odds ratio, 2.14; 95% CI, 1.21 to 3.78), a finding that did not meet the noninferiority requirement. Conclusions: In patients with deep venous thrombosis, once-weekly subcutaneous idraparinux for 3 or 6 months had an efficacy similar to that of heparin plus a vitamin K antagonist. However, in patients with pulmonary embolism, idraparinux was less efficacious than standard therapy.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; Acad Hosp Maastricht, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; Univ Maastricht, Res Inst, Dept Epidemiol Care & Publ Hlth, Maastricht, Netherlands; Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, UO Angiol 1, I-27100 Pavia, Italy; Sanofi Aventis, Antony, France; McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; Flinders Med Ctr, Bedford Pk, SA, Australia; Univ St Etienne, CHU St Etienne, Hop Bellevue,INSERM,CIE3, Serv Med Interne & Therapeut, St Etienne, France; Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA USA; Kings Coll Hosp London, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Oklahoma System; University of Oklahoma Health Sciences Center; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; IRCCS Fondazione San Matteo; Sanofi-Aventis; McMaster University; Flinders Medical Centre; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of Washington; University of Washington Seattle; King's College Hospital NHS Foundation Trust; King's College Hospital	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,F4-211, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Gallus, Alexander/AAH-6204-2020; Kovacs, Michael/G-3315-2011; Piovella, Franco/AAM-8305-2020	Gallus, Alexander/0000-0001-7347-9989				[Anonymous], 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001100.pub2, DOI 10.1002/14651858.CD001100.PUB2]; BRANDJES DPM, 1995, NEW ENGL J MED, V327, P1485; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2004, J THROMB HAEMOST, V2, P47; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2005, CHEST, V127, P416; Herbert JM, 1998, BLOOD, V91, P4197, DOI 10.1182/blood.V91.11.4197.411k09_4197_4205; HIRSH J, 1976, CIRCULATION, V53, P691, DOI 10.1161/01.CIR.53.4.691; Minar E, 2004, J THROMB HAEMOST, V2, P540; Palla A, 2004, NEW ENGL J MED, V350, P423; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; SIMON TL, 1978, BRIT J HAEMATOL, V39, P111, DOI 10.1111/j.1365-2141.1978.tb07133.x; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Tu D, 1998, J Biopharm Stat, V8, P263, DOI 10.1080/10543409808835238	15	271	284	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1094	1104						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855670				2022-12-28	WOS:000249387200005
J	Singh, S; Loke, YK; Furberg, CD				Singh, Sonal; Loke, Yoon K.; Furberg, Curt D.			Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEART-FAILURE; THIAZOLIDINEDIONES; PIOGLITAZONE; TRIAL	Context Recent reports of serious adverse events with rosiglitazone use have raised questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes. Objective To systematically review the long-term cardiovascular risks of rosiglitazone, including myocardial infarction, heart failure, and cardiovascular mortality. Data Sources We searched MEDLINE, the GlaxoSmithKline clinical trials register, the US Food and Drug Administration Web site, and product information sheets for randomized controlled trials, systematic reviews, and meta-analyses published in English through May 2007. Study Selection Studies were selected for inclusion if they were randomized controlled trials of rosiglitazone for prevention or treatment of type 2 diabetes, had at least 12 months of follow-up, and monitored cardiovascular adverse events and provided numerical data on all adverse events. Four studies were included after detailed screening of 140 trials for cardiovascular events. Data Extraction Relative risks (RRs) of myocardial infarction, heart failure, and cardiovascular mortality were estimated using a fixed-effects meta-analysis of 4 randomized controlled trials (n = 14 291, including 6421 receiving rosiglitazone and 7870 receiving control therapy, with a duration of follow-up of 1-4 years). Results Rosiglitazone significantly increased the risk of myocardial infarction (n = 94/6421 vs 83/7870; RR, 1.42; 95% confidence interval [CI], 1.06-1.91; P = .02) and heart failure (n = 102/6421 vs 62/7870; RR, 2.09; 95% CI, 1.52-2.88; P < .001) without a significant increase in risk of cardiovascular mortality (n = 59/6421 vs 72/7870; RR, 0.90; 95% CI, 0.63-1.26; P = .53). There was no evidence of substantial heterogeneity among the trials for these end points (I-2 = 0% for myocardial infarction, 18% for heart failure, and 0% for cardiovascular mortality). Conclusion Among patients with impaired glucose tolerance or type 2 diabetes, rosiglitazone use for at least 12 months is associated with a significantly increased risk of myocardial infarction and heart failure, without a significantly increased risk of cardiovascular mortality.	Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	Wake Forest University; Wake Forest University; University of East Anglia	Singh, S (corresponding author), Wake Forest Univ, Sch Med, Dept Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.	sosingh@wfubmc.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X				BOLEN S, 2007, ANN INTERN MED  0716; Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; *DIV MET END PROD, 2007, FDA BRIEF DOC JOINT; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; *GLAXOSMITHKLINE, 2006, HUM RAC ANN REP, P31; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kendall C, 2006, CAN MED ASSOC J, V174, P623, DOI 10.1503/cmaj.060074; Krall RL, 2007, LANCET, V369, P1995, DOI 10.1016/S0140-6736(07)60824-1; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; LOKE YK, 2006, COCHRANE HDB SYSTEMA; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; *NAT CTR CHRON DIS, DAT TRENDS NAT DIAB; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Qayyum R, 2006, AM J CARDIOL, V97, P655, DOI 10.1016/j.amjcard.2005.09.105; Qayyum Rehan, 2006, J Clin Hypertens (Greenwich), V8, P19, DOI 10.1111/j.1524-6175.2005.04784.x; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141	26	633	660	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1189	1195		10.1001/jama.298.10.1189	http://dx.doi.org/10.1001/jama.298.10.1189			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848653				2022-12-28	WOS:000249374200024
J	CHARLES, D				CHARLES, D			SPY SATELLITES - ENTERING A NEW ERA	SCIENCE			English	Editorial Material																		WOODWARD B, VEIL	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1541	1543		10.1126/science.243.4898.1541	http://dx.doi.org/10.1126/science.243.4898.1541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847251				2022-12-28	WOS:A1989T795200007
J	Kniemeyer, O; Musat, F; Sievert, SM; Knittel, K; Wilkes, H; Blumenberg, M; Michaelis, W; Classen, A; Bolm, C; Joye, SB; Widdel, F				Kniemeyer, Olaf; Musat, Florin; Sievert, Stefan M.; Knittel, Katrin; Wilkes, Heinz; Blumenberg, Martin; Michaelis, Walter; Classen, Arno; Bolm, Carsten; Joye, Samantha B.; Widdel, Friedrich			Anaerobic oxidation of short-chain hydrocarbons by marine sulphate-reducing bacteria	NATURE			English	Article							GULF-OF-MEXICO; GUAYMAS BASIN; HYDROTHERMAL SEDIMENTS; GAS HYDRATE; METHANE; CARBON; CALIFORNIA; REDUCTION; PROPANE; COMMUNITIES	The short-chain hydrocarbons ethane, propane and butane are constituents of natural gas. They are usually assumed to be of thermochemical origin(1), but biological formation of ethane and propane has been also observed(2). Microbial utilization of short-chain hydrocarbons has been shown in some aerobic species(3,4) but not in anaerobic species of bacteria. On the other hand, anaerobic utilization of short-chain hydrocarbons would in principle be expected because various anaerobic bacteria grow with higher homologues (>= C-6)(5). Indeed, chemical analyses of hydrocarbon-rich habitats with limited or no access of oxygen indicated in situ biodegradation of short-chain hydrocarbons(6-10). Here we report the enrichment of sulphate-reducing bacteria (SRB) with such capacity from marine hydrocarbon seep areas. Propane or n-butane as the sole growth substrate led to sediment-free sulphate-reducing enrichment cultures growing at 12, 28 or 60 degrees C. With ethane, a slower enrichment with residual sediment was obtained at 12 degrees C. Isolation experiments resulted in a mesophilic pure culture (strain BuS5) that used only propane and n-butane (methane, isobutane, alcohols or carboxylic acids did not support growth). Complete hydrocarbon oxidation to CO2 and the preferential oxidation of C-12-enriched alkanes were observed with strain BuS5 and other cultures. Metabolites of propane included iso- and n-propylsuccinate, indicating a subterminal as well as an unprecedented terminal alkane activation with involvement of fumarate. According to 16S ribosomal RNA analyses, strain BuS5 affiliates with Desulfosarcina/Desulfococcus, a cluster of widespread marine SRB. An enrichment culture with propane growing at 60 degrees C was dominated by Desulfotomaculum-like SRB. Our results suggest that diverse SRB are able to thrive in seep areas and gas reservoirs on propane and butane, thus altering the gas composition and contributing to sulphide production.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02536 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Rhein Westfal TH Aachen Univ, Inst Organ Chem, D-52056 Aachen, Germany; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	Max Planck Society; Woods Hole Oceanographic Institution; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Hamburg; RWTH Aachen University; University System of Georgia; University of Georgia	Widdel, F (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	fwiddel@mpi-bremen.de	Musat, Florin/AAI-9615-2020; Musat, Florin/CAF-4018-2022; Kniemeyer, Olaf/K-1253-2013; Bolm, Carsten/G-2247-2014	Musat, Florin/0000-0002-4240-3495; Kniemeyer, Olaf/0000-0002-9493-6402; Bolm, Carsten/0000-0001-9415-9917; Sievert, Stefan/0000-0002-9541-2707; Blumenberg, Martin/0000-0002-9791-8568; Joye, Samantha/0000-0003-1610-451X				AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Arp DJ, 1999, MICROBIOL-SGM, V145, P1173, DOI 10.1099/13500872-145-5-1173; ASHRAF W, 1994, FEMS MICROBIOL LETT, V122, P1, DOI 10.1111/j.1574-6968.1994.tb07134.x; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; CLAYPOOL GE, 1983, ANNU REV EARTH PL SC, V11, P299, DOI 10.1146/annurev.ea.11.050183.001503; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Formolo MJ, 2004, CHEM GEOL, V205, P253, DOI 10.1016/j.chemgeo.2003.12.021; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; GIESE B, 1977, CHEM BER-RECL, V110, P2588, DOI 10.1002/cber.19771100717; GIESE B, 1984, CHEM BER-RECL, V117, P3175, DOI 10.1002/cber.19841171103; GIESE B, 1982, CHEM BER-RECL, V115, P2012, DOI 10.1002/cber.19821150533; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hinrichs KU, 2006, P NATL ACAD SCI USA, V103, P14684, DOI 10.1073/pnas.0606535103; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, APPL ENVIRON MICROB, V70, P1231, DOI 10.1128/AEM.70.2.1231-1233.2004; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kinnaman FS, 2007, GEOCHIM COSMOCHIM AC, V71, P271, DOI 10.1016/j.gca.2006.09.007; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Martini AM, 2003, AAPG BULL, V87, P1355, DOI 10.1306/031903200184; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Orcutt BN, 2004, CHEM GEOL, V205, P239, DOI 10.1016/j.chemgeo.2003.12.020; PLASSDULMER C, 1995, GLOBAL BIOGEOCHEM CY, V9, P79, DOI 10.1029/94GB02416; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rabus R, 2001, J BACTERIOL, V183, P1707, DOI 10.1128/JB.183.5.1707-1715.2001; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; Seifert R, 2006, ORG GEOCHEM, V37, P1411, DOI 10.1016/j.orggeochem.2006.03.007; SIMONEIT BRT, 1988, CHEM GEOL, V71, P169, DOI 10.1016/0009-2541(88)90113-1; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Weber A, 2002, DEEP-SEA RES PT I, V49, P827, DOI 10.1016/S0967-0637(01)00079-6; Wenger LM, 2002, SPE RESERV EVAL ENG, V5, P375, DOI 10.2118/80168-PA; WHELAN JK, 1988, ORG GEOCHEM, V12, P171, DOI 10.1016/0146-6380(88)90253-7; WIDDEL F, 2006, PROKARYOTES, V2, P1028, DOI DOI 10.1007/1020-1387-30742-30747_	37	247	256	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					898	U10		10.1038/nature06200	http://dx.doi.org/10.1038/nature06200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17882164				2022-12-28	WOS:000250230600045
J	Lane, NE				Lane, Nancy E.			Osteoarthritis of the hip	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CHONDROITIN SULFATE; UNITED-STATES; DOUBLE-BLIND; KNEE; MANAGEMENT; ARTHRITIS; RISK; REPLACEMENT; TRIAL		Univ Calif Davis, Davis Med Sch, Dept Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Lane, NE (corresponding author), Univ Calif Davis, Davis Med Sch, Dept Med, 4800 2nd Ave,Suite 2600, Sacramento, CA 95817 USA.	nelane@ucdavis.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052000, R01AR043052, K24AR048841] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, P454, DOI 10.1016/j.joca.2006.10.008; ANDERSON BC, 2007, EVALUATION ADULT HIP; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cepeda MS, 2007, J RHEUMATOL, V34, P543; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Cutts S, 2006, POSTGRAD MED J, V82, P802, DOI 10.1136/pgmj.2005.044594; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; DiCesare PE, 2005, KELLEYS TXB RHEUMATO, P1493; Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P2539, DOI 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T; DOUGADOS M, 2005, KELLEYS TXB RHEUMATO, V2, P1514; Felson DT, 2006, NEW ENGL J MED, V354, P2520; FELSON DT, 2003, OSTEOARTHRITIS, P9; Lopez JCF, 2006, OSTEOARTHR CARTILAGE, V14, P1306, DOI 10.1016/j.joca.2006.08.003; Fidelix TSA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005117.pub2; Fortin PR, 2002, ARTHRITIS RHEUM, V46, P3327, DOI 10.1002/art.10631; Fransen M, 2002, J RHEUMATOL, V29, P1737; Haddox JD, 1997, CLIN J PAIN, V13, P6; Hinman RS, 2007, PHYS THER, V87, P32, DOI 10.2522/ptj.20060006; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1535, DOI 10.1002/art.1780381103; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Jones DL, 2005, ARTHRIT RHEUM-ARTHR, V53, P772, DOI 10.1002/art.21465; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; KIRWAN JR, 1994, BRIT J RHEUMATOL, V33, P357; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Lane NE, 2006, ARTHRITIS RHEUM-US, V54, P1246, DOI 10.1002/art.21673; LANE NE, 1993, J RHEUMATOL, V20, P1911; Lane NE, 2000, ARTHRITIS RHEUM-US, V43, P400, DOI 10.1002/1529-0131(200002)43:2<400::AID-ANR21>3.0.CO;2-D; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leeb BF, 2000, J RHEUMATOL, V27, P205; Lian K, 2005, ARTHRITIS RHEUM-US, V52, P1431, DOI 10.1002/art.21011; LIAN K, IN PRESS OSTEOARTHRI; Lievense A, 2001, J RHEUMATOL, V28, P2520; Lievense AM, 2004, ANN RHEUM DIS, V63, P621, DOI 10.1136/ard.2003.009860; Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155; Lievense AM, 2003, ARTHRIT RHEUM-ARTHR, V49, P228, DOI 10.1002/art.11012; Loughlin John, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009257; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; *MED MAN OST HIP K, 2000, ARTHRITIS RHEUM, V43, P1905; Murphy S, 2002, CLIN ORTHOP RELAT R, P168, DOI 10.1097/01.blo.0000038466.05771.d9; MURRAY DG, 1995, JAMA-J AM MED ASSOC, V273, P1950, DOI 10.1001/jama.1995.03520480070043; Nevitt MC, 2002, ARTHRITIS RHEUM-US, V46, P1773, DOI 10.1002/art.10332; NEVITT MC, 2006, OSTEOARTHRITIS HDB, P23; NGUYEN M, 1994, ARTHRITIS RHEUM-US, V37, P529, DOI 10.1002/art.1780370413; Osborne RH, 2007, J RHEUMATOL, V34, P1112; Peloso PM, 2000, J RHEUMATOL, V27, P764; Plant MJ, 1997, ANN RHEUM DIS, V56, P476, DOI 10.1136/ard.56.8.476; Qvistgaard E, 2006, OSTEOARTHR CARTILAGE, V14, P163, DOI 10.1016/j.joca.2005.09.007; STEINBERG GG, 1999, ORTHOPAEDICS PRIMARY; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Warsi A, 2003, ARTHRITIS RHEUM-US, V48, P2207, DOI 10.1002/art.11210; Waseem M, 2002, Hip Int, V12, P378, DOI 10.5301/HIP.2008.2404; Witt CM, 2006, ARTHRITIS RHEUM-US, V54, P3485, DOI 10.1002/art.22154; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; 2003, ARCH INTERN MED, V163, P169	57	88	89	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1413	1421		10.1056/NEJMcp071112	http://dx.doi.org/10.1056/NEJMcp071112			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914042				2022-12-28	WOS:000249892900007
J	Markel, H				Markel, Howard			"Gotta' sing! Gotta' diagnose!" - A postmortem examination of Rodgers and Hammerstein's medical musical allegro	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, 102 Observ 0725,100 SMI, Ann Arbor, MI 48109 USA.	howard@umich.edu						ATKINSON B, 1947, NY TIMES        1011, P10; BLOCK G, 2002, R RODGERS READER, P309; BROWN JM, 1947, SATURDAY REV    1108, P30; FORDIN H, 1995, GETTING KNOW HIM BIO, P239; GIBBS W, 1947, NEW YORKER      1018, P55; GREEN A, 1951, SHOW BIZ VAUDE VIDEO, P181; HAMMERSTEIN O, 1948, ALLEGRO MUSICAL PLAY; KRUTCH JW, 1947, ALLEGRO NATION  1122, P567; MORDDEN E, 1992, RODGERS HAMMERSTEIN, P86; *NY PUBL LIB PERF, R RODG PAP 1914 1989, V8; *OR HIST COLL COL, 1959, REM OSC HAMM, V2, P1063; PHELAN K, 1947, ALLEGRO COMMONW 1031, P70; RODGERS R, 1995, THEATRE GUILD PRESEN; RODGERS R, 2002, MUSICAL STAGES AUTOB, P246; RODGERS R, 1993, ALLEGRO ORIGINAL CAS; SECREST M, 2001, SOMEWHERE ME BIOGRAP, P260; SECREST M, 1998, S SONDHEIM LIFE, P53; 1947, LIFE            1012, P70; 1947, TIME            1022, P66	19	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1575	1577		10.1001/jama.298.13.1575	http://dx.doi.org/10.1001/jama.298.13.1575			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	216EE	17911505				2022-12-28	WOS:000249860500033
J	Carrim, ZI; MacPhillimy, J; Jampana, R				Carrim, Zia I.; MacPhillimy, Jane; Jampana, Ravi			4-week headache after 60 pints of beer	LANCET			English	Editorial Material							SINUS THROMBOSIS		So Gen Hosp, Dept Ophthalmol, Glasgow G51 4TF, Lanark, Scotland; So Gen Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow	Carrim, ZI (corresponding author), So Gen Hosp, Dept Ophthalmol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	zia.carrim@doctors.org.uk						GILL GV, 1982, BRIT MED J, V285, P1770, DOI 10.1136/bmj.285.6357.1770; Masuhr E, 2004, J NEUROL, V251, P11, DOI 10.1007/s00415-004-0321-7; Renowden S, 2004, EUR RADIOL, V14, P215, DOI 10.1007/s00330-003-2021-6; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1188	1188		10.1016/S0140-6736(07)61517-7	http://dx.doi.org/10.1016/S0140-6736(07)61517-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905169				2022-12-28	WOS:000250263700033
J	Wilkinson, P; Smith, KR; Beevers, S; Tonne, C; Oreszczyn, T				Wilkinson, Paul; Smith, Kirk R.; Beevers, Sean; Tonne, Cathryn; Oreszczyn, Tadj			Energy and Health 4 - Energy, energy efficiency, and the built environment	LANCET			English	Article							LONG-TERM EXPOSURE; HEAT-RELATED MORTALITY; LOW-INCOME HOUSEHOLDS; INDOOR AIR-POLLUTION; PUBLIC-HEALTH; CARDIOPULMONARY MORTALITY; STOVE INTERVENTION; EMPIRICAL-APPROACH; PHYSICAL-ACTIVITY; WINTER MORTALITY	Since the last decades of the 19th century, technological advances have brought substantial improvements in the efficiency with which energy can be exploited to service human needs. That trend has been accompanied by an equally notable increase in energy consumption, which strongly correlates with socioeconomic development. Nonetheless, feasible gains in the efficiency and technology of energy use in towns and cities and in homes have the potential to contribute to the mitigation of greenhouse-gas emissions, and to improve health, for example, through protection against temperature-related morbidity and mortality, and the alleviation of fuel poverty. A shift towards renewable energy production would also put increasing focus on cleaner energy carriers, especially electricity, but possibly also hydrogen, which would have benefits to urban air quality. In low-income countries, a vital priority remains the dissemination of affordable technology to alleviate the burdens of indoor air pollution and other health effects in individuals obliged to rely on biomass fuels for cooking and heating, as well as the improvement in access to electricity, which would have many benefits to health and wellbeing.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Calif Berkeley, Berkeley, CA 94720 USA; Kings Coll London, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; University of London; King's College London	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk	Tonne, Cathryn/F-5020-2017	Tonne, Cathryn/0000-0003-3919-8264; Oreszczyn, Tadeusz/0000-0002-9667-7336; Wilkinson, Paul/0000-0001-7456-259X	Engineering and Physical Sciences Research Council [EP/D506859/1] Funding Source: researchfish; EPSRC [EP/D506859/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Akbari H, 2002, ENVIRON POLLUT, V116, pS119, DOI 10.1016/S0269-7491(01)00264-0; Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816; Berkowicz R, 2000, ENVIRON MONIT ASSESS, V65, P323, DOI 10.1023/A:1006448321977; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Brunekreef B, 2004, THORAX, V59, P729, DOI 10.1136/thx.2004.024091; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Carslaw DC, 2001, ATMOS ENVIRON, V35, P1505, DOI 10.1016/S1352-2310(00)00287-9; *CERC, 2004, ADMS 3 US GUID VERS; *CERC, 2003, ADMS ROADS US GUID V; Cifuentes L, 2001, ENVIRON HEALTH PERSP, V109, P419, DOI 10.2307/3434790; Cifuentes L, 2001, SCIENCE, V293, P1257, DOI 10.1126/science.1063357; Crowther D, 2006, EXP APPL ACAROL, V39, P127, DOI 10.1007/s10493-006-9003-8; Dannenberg AL, 2003, AM J PUBLIC HEALTH, V93, P1500, DOI 10.2105/AJPH.93.9.1500; Davies M., 2016, INT J VENT, V3, P155; Davis DL, 1997, LANCET, V350, P1341, DOI 10.1016/S0140-6736(97)10209-4; Diaz E, 2007, J EPIDEMIOL COMMUN H, V61, P74, DOI 10.1136/jech.2006.043133; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Edwards RD, 2007, INDOOR AIR, V17, P189, DOI 10.1111/j.1600-0668.2007.00465.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FELDMAN R, 2002, CARBON MONOXIDE OCCU, P378; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Filleul L, 2006, ENVIRON HEALTH PERSP, V114, P1344, DOI 10.1289/ehp.8328; FLOOD M, 1991, ENERGY END; Foster C, 2004, J SPORT SCI, V22, P755, DOI 10.1080/02640410410001712458; Fuller GW, 2002, ATMOS ENVIRON, V36, P1431, DOI 10.1016/S1352-2310(01)00580-5; Gehring U, 2006, EPIDEMIOLOGY, V17, P545, DOI 10.1097/01.ede.0000224541.38258.87; Gilbertson J, 2006, SOC SCI MED, V63, P946, DOI 10.1016/j.socscimed.2006.02.021; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; *GROUP AQE, 2007, AIR QUAL CLIM CHANG; Hacker JN, 2005, BEATING HEAT KEEPING; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Hong SH, 2006, ENERG BUILDINGS, V38, P1171, DOI 10.1016/j.enbuild.2006.01.007; HORELACY I, 2006, NUCL ENERGY 21 CENTU; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jacobson MZ, 2005, SCIENCE, V308, P1901, DOI 10.1126/science.1109157; JENKIN N, 2004, MAT HLTH AMSS BALANC; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1989, INT J BIOMETEOROL, V33, P71, DOI 10.1007/BF01686280; Krewski D, 2005, INHAL TOXICOL, V17, P335, DOI 10.1080/08958370590929402; Kunitomi K, 2007, NUCL ENG TECHNOL, V39, P9, DOI 10.5516/NET.2007.39.1.009; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Lowe R, 2007, BUILD RES INF, V35, P412, DOI 10.1080/09613210701238268; Manuel J, 1999, ENVIRON HEALTH PERSP, V107, pA352, DOI 10.2307/3434388; McCracken John, 2004, NORSK EPIDEMIOLOGI, V14, P137; McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Miller BG, 2003, J EPIDEMIOL COMMUN H, V57, P200, DOI 10.1136/jech.57.3.200; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Naess O, 2007, AM J EPIDEMIOL, V165, P435, DOI 10.1093/aje/kwk016; *NAT HEART FOR COM, BUILD HLTH CREAT ENH; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Norman J, 2006, J URBAN PLAN DEV, V132, P10, DOI 10.1061/(ASCE)0733-9488(2006)132:1(10); O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oreszczyn T, 2006, ENERG BUILDINGS, V38, P245, DOI 10.1016/j.enbuild.2005.06.006; Oreszczyn T, 2006, INDOOR BUILT ENVIRON, V15, P125, DOI 10.1177/1420326X06063051; ORESZCZYN T, 2000, CUTTING COST COLD AF, P122; ORMANDY D, 2003, STAT EVIDENCE SUPPOR, V2; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6; Rollin HB, 2004, INDOOR AIR, V14, P208, DOI 10.1111/j.1600-0668.2004.00238.x; Schwartz J, 2005, AM J RESP CRIT CARE, V171, P627, DOI 10.1164/rccm.200407-933OC; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Simoni JM, 2004, AIDS BEHAV, V8, P33, DOI 10.1023/B:AIBE.0000017524.40093.6b; SMIL V, 2005, ENERGY CROSSROADS GL, P317; SMITH K, 2005, ANN REV ENERGY RES, V30, P29; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith KR, 2006, EPIDEMIOLOGY, V17, pS44, DOI 10.1097/00001648-200611001-00077; SMITH KR, IN PRESS ANN REV PUB; Smith KR., 1987, BIOFUELS AIR POLLUTI; SMITH KR, 2007, ENERGY SUSTAIN DEV, V15, P3; Sorensen B, 2004, RENEWABLE ENERGY; Stedman JR, 2004, ATMOS ENVIRON, V38, P1087, DOI 10.1016/j.atmosenv.2003.11.011; Stern Nicholas, 2007, EC CLIMATE CHANGE; *UN, 2002, WORLD URB PROSP 2001; *WHO, 2003, EUR035042688 WHO WOR; *WHO, 1999, WHO ENV HLTH CRIT, V213; *WHO, 2002, ADD LINKS IND AIR PO; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Wilkinson P, 2001, COLD COMFORT SOCIAL; World Health Organization, 2006, WHO HOUS EN DAT	88	112	112	3	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1175	1187		10.1016/S0140-6736(07)61255-0	http://dx.doi.org/10.1016/S0140-6736(07)61255-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17868820				2022-12-28	WOS:000250263700032
J	Anbar, AD; Duan, Y; Lyons, TW; Arnold, GL; Kendall, B; Creaser, RA; Kaufman, AJ; Gordon, GW; Scott, C; Garvin, J; Buick, R				Anbar, Ariel D.; Duan, Yun; Lyons, Timothy W.; Arnold, Gail L.; Kendall, Brian; Creaser, Robert A.; Kaufman, Alan J.; Gordon, Gwyneth W.; Scott, Clinton; Garvin, Jessica; Buick, Roger			A whiff of oxygen before the Great Oxidation Event?	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; SULFUR ISOTOPES; BLACK SHALES; RISE; MOLYBDENUM; EVOLUTION; GEOCHEMISTRY; SEDIMENTS; PGE; OS	High-resolution chemostratigraphy reveals an episode of enrichment of the redox-sensitive transition metals molybdenum and rhenium in the late Archean Mount McRae Shale in Western Australia. Correlations with organic carbon indicate that these metals were derived from contemporaneous seawater. Rhenium/osmium geochronology demonstrates that the enrichment is a primary sedimentary feature dating to 2501 +/- 8 million years ago (Ma). Molybdenum and rhenium were probably supplied to Archean oceans by oxidative weathering of crustal sulfide minerals. These findings point to the presence of small amounts of O-2 in the environment more than 50 million years before the start of the Great Oxidation Event.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of California System; University of California Riverside; University of Alberta; University System of Maryland; University of Maryland College Park; University of Washington; University of Washington Seattle	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu	Kendall, Brian S/I-6820-2012; Arnold, Gail L/A-5572-2010	Arnold, Gail L/0000-0001-9631-9830; Creaser, Robert/0000-0002-7672-035X; Buick, Roger/0000-0003-0139-1659; Kendall, Brian/0000-0002-8914-2309				Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BERTINE KK, 1973, GEOCHIM COSMOCHIM AC, V37, P1415, DOI 10.1016/0016-7037(73)90080-X; Blum AE, 1995, REV MINERAL, V31, P291; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Claire M., 2006, GEOBIOLOGY, V4, P239, DOI [10.1111/j.1472-4669.2006.00084.x, DOI 10.1111/J.1472-4669.2006.00084.X]; COLLIER RW, 1985, LIMNOL OCEANOGR, V30, P1351, DOI 10.4319/lo.1985.30.6.1351; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Hannah JL, 2004, EARTH PLANET SC LETT, V225, P43, DOI 10.1016/j.epsl.2004.06.013; Helz GR, 1996, GEOCHIM COSMOCHIM AC, V60, P3631, DOI 10.1016/0016-7037(96)00195-0; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Holland HD., 1984, CHEM EVOLUTION ATMOS; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; McManus J, 2006, GEOCHIM COSMOCHIM AC, V70, P4643, DOI 10.1016/j.gca.2006.06.1564; MORACHEVSKII DE, 1960, GEOCHEMISTRY, V6, P649; Morford JL, 1999, GEOCHIM COSMOCHIM AC, V63, P1735, DOI 10.1016/S0016-7037(99)00126-X; Nelson DR, 1999, PRECAMBRIAN RES, V97, P165, DOI 10.1016/S0301-9268(99)00031-5; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Scott CT, 2004, GEOCHIM COSMOCHIM AC, V68, pA787; Siebert C, 2005, GEOCHIM COSMOCHIM AC, V69, P1787, DOI 10.1016/j.gca.2004.10.006; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Trendall AF, 1998, AUST J EARTH SCI, V45, P137, DOI 10.1080/08120099808728374; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	29	659	678	12	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1903	1906		10.1126/science.1140325	http://dx.doi.org/10.1126/science.1140325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901330				2022-12-28	WOS:000249764300035
J	Huang, CC; Lam, SN; Acharya, P; Tang, M; Xiang, SH; Hussan, SSU; Stanfield, RL; Robinson, J; Sodroski, J; Wilson, IA; Wyatt, R; Bewley, CA; Kwong, PD				Huang, Chih-chin; Lam, Son N.; Acharya, Priyamvada; Tang, Min; Xiang, Shi-Hua; Hussan, Syed Shahzad-ul; Stanfield, Robyn L.; Robinson, James; Sodroski, Joseph; Wilson, Ian A.; Wyatt, Richard; Bewley, Carole A.; Kwong, Peter D.			Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; CORECEPTOR; BINDING; RECEPTORS; ENTRY; V3; DETERMINANTS; DOMAINS; REGION	The CCR5 co-receptor binds to the HIV-1 gp120 envelope glycoprotein and facilitates HIV-1 entry into cells. Its N terminus is tyrosine-sulfated, as are many antibodies that react with the co-receptor binding site on gp120. We applied nuclear magnetic resonance and crystallographic techniques to analyze the structure of the CCR5 N terminus and that of the tyrosine-sulfated antibody 412d in complex with gp120 and CD4. The conformations of tyrosine-sulfated regions of CCR5 (alpha-helix) and 412d (extended-loop) are surprisingly different. Nonetheless, a critical sulfotyrosine on CCR5 and on 412d induces similar structural rearrangements in gp120. These results now provide a framework for understanding HIV-1 interactions with the CCR5 N terminus during viral entry and define a conserved site on gp120, whose recognition of sulfotyrosine engenders posttranslational mimicry by the immune system.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Tulane University	Bewley, CA (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov; pdkwong@nih.gov	Stanfield, Robyn/AAH-3190-2019	Acharya, Priyamvada/0000-0002-0089-277X; Bewley, Carole/0000-0003-2203-0852	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005025, Z01AI005022, P30AI060354, U19AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK032103] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NIAID NIH HHS [U19 AI067854, P30 AI060354, U19 AI067854-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brelot A, 1997, J VIROL, V71, P4744, DOI 10.1128/JVI.71.6.4744-4751.1997; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; FEENEY J, 1983, BIOCHEMISTRY-US, V22, P628, DOI 10.1021/bi00272a016; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kabat EA, 1991, SEQUENCES PROTEINS I; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Quiocho FA, 1996, KIDNEY INT, V49, P943, DOI 10.1038/ki.1996.132; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2005, J VIROL, V79, P6068, DOI 10.1128/JVI.79.10.6068-6077.2005	28	331	348	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1930	1934		10.1126/science.1145373	http://dx.doi.org/10.1126/science.1145373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901336	Green Submitted, Green Accepted			2022-12-28	WOS:000249764300042
J	Lee, J				Lee, Jooyun			Purple urine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York Med Coll, Valhalla, NY 10595 USA	New York Medical College	Lee, J (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.		Bermejo, José Antonio Álvarez/M-1691-2014	Bermejo, José Antonio Álvarez/0000-0002-5815-7858					0	15	15	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					E14	E14		10.1056/NEJMicm061573	http://dx.doi.org/10.1056/NEJMicm061573			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898093				2022-12-28	WOS:000249711500010
J	Yang, HY; Yang, T; Baur, JA; Perez, E; Matsui, T; Carmona, JJ; Lamming, DW; Souza-Pinto, NC; Bohr, VA; Rosenzweig, A; de Cabo, R; Sauve, AA; Sinclair, DA				Yang, Hongying; Yang, Tianle; Baur, Joseph A.; Perez, Evelyn; Matsui, Takashi; Carmona, Juan J.; Lamming, Dudley W.; Souza-Pinto, Nadja C.; Bohr, Vilhelm A.; Rosenzweig, Anthony; de Cabo, Rafael; Sauve, Anthony A.; Sinclair, David A.			Nutrient-sensitive mitochondrial NAD(+) levels dictate cell survival	CELL			English	Article							COLONY-ENHANCING FACTOR; LIFE-SPAN EXTENSION; NICOTINAMIDE ADENINE-DINUCLEOTIDE; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; SIR2 PROTEIN; ACETYL-COA; APOPTOSIS	A major cause of cell death caused by genotoxic stress is thought to be due to the depletion of NAD+ from the nucleus and the cytoplasm. Here we show that NAD+ levels in mitochondria remain at physiological levels following genotoxic stress and can maintain cell viability even when nuclear and cytoplasmic pools of NAD+ are depleted. Rodents fasted for 48 hr show increased levels of the NAD+ biosynthetic enzyme Nampt and a concomitant increase in mitochondrial NAD+. Increased Nampt provides protection against cell death and requires an intact mitochondrial NAD+ salvage pathway as well as the mitochondrial NAD(+)- dependent deacetylases SIRT3 and SIRT4. We discuss the relevance of these findings to understanding how nutrition modulates physiology and to the evolution of apoptosis.	Cornell Univ, Weill Med Col, Dept Pharmacol, New York, NY 10021 USA; NIA, Lab Expt Gerontol, Inst Hlth, Baltimore, MD 21224 USA; NIA, Lab Mol Gerontol, Inst Hlth, Baltimore, MD 21224 USA; Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Beth Israel Deaconess Medical Center	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Paul F Glenn Labs, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Baur, Joseph A/D-8163-2011; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; Souza-Pinto, Nadja C./C-3462-2013; Bohr, Vilhelm/AAP-5931-2020; Souza-Pinto, Nadja/T-3050-2019; Rosenzweig, Anthony/AAD-7893-2019; Lamming, Dudley/O-7191-2015; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; Souza-Pinto, Nadja C./0000-0003-4206-964X; Souza-Pinto, Nadja/0000-0003-4206-964X; Lamming, Dudley/0000-0002-0079-4467; Sinclair, David/0000-0002-9936-436X; Baur, Joseph/0000-0001-8262-6549; de Cabo, Rafael/0000-0002-3354-2442; Carmona, Juan/0000-0002-3029-4658	Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [R01 AG019719-07, R01 AG028730-02, P01 AG027916, P01 AG027916-030003, P01 AG027916-020003, P01 AG027916-010003, P01 AG027916-04S20003, R01 AG028730-01A1, P01 AG027916-040003, P01 AG027916-04S10003, R01 AG019719, R01 AG019719-06A1, R01AG028730, R01 AG028730] Funding Source: Medline; NIDDK NIH HHS [R01 DK 073466, R01 DK073466] Funding Source: Medline; NIGMS NIH HHS [R01GM068072, R01 GM068072] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028730, R01AG019719, P01AG027916, Z01AG000362] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Barile M, 1996, CONTACT DERMATITIS, V35, P113, DOI 10.1111/j.1600-0536.1996.tb02309.x; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Brenner C, 2005, STRUCTURE, V13, P1239, DOI 10.1016/j.str.2005.08.004; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; FOSTER JW, 1990, J BACTERIOL, V172, P4187, DOI 10.1128/jb.172.8.4187-4196.1990; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Horton JK, 2005, DNA REPAIR, V4, P1111, DOI 10.1016/j.dnarep.2005.05.011; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; James SJ, 1998, ENVIRON HEALTH PERSP, V106, P307, DOI 10.2307/3433932; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; KUN E, 1975, P NATL ACAD SCI USA, V72, P1436, DOI 10.1073/pnas.72.4.1436; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; NOACK H, 1992, ANAL BIOCHEM, V202, P162, DOI 10.1016/0003-2697(92)90222-S; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; TOBIN A, 1980, PLANT PHYSIOL, V66, P225, DOI 10.1104/pp.66.2.225; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9	63	730	766	6	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1095	1107		10.1016/j.cell.2007.07.035	http://dx.doi.org/10.1016/j.cell.2007.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889652	Bronze, Green Accepted			2022-12-28	WOS:000250507500018
J	Crowther, CA; Doyle, LW; Haslam, RR; Hiller, JE; Harding, JE; Robinson, JS				Crowther, Caroline A.; Doyle, Lex W.; Haslam, Ross R.; Hiller, Janet E.; Harding, Jane E.; Robinson, Jeffrey S.		ACTORDS Study Grp	Outcomes at 2 years of age after repeat doses of antenatal corticosteroids	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; CEREBRAL-PALSY; LATE-GESTATION; SINGLE COURSE; FOLLOW-UP; EXPOSURE; BIRTH; COURSES; GROWTH; GLUCOCORTICOIDS	Background We previously reported the results of a randomized, controlled trial showing that repeat doses of antenatal corticosteroids reduced the risk of respiratory distress syndrome and serious neonatal morbidity. However, data have not been available regarding longer-term effects of this treatment. Methods Women who had received an initial course of corticosteroid treatment 7 or more days previously were randomly assigned to receive an intramuscular injection of corticosteroid (11.4 mg of betamethasone) or saline placebo; the dose was repeated weekly if the mother was still considered to be at risk for preterm delivery and the duration of gestation was less than 32 weeks. We assessed survival free of major neurosensory disability and body size of the children at 2 years of corrected age. Results Of the 1085 children who were alive at 2 years of age, 1047 (96.5%) were seen for assessment (521 exposed to repeat-corticosteroid treatment and 526 exposed to placebo). The rate of survival free of major disability was similar in the repeat-corticosteroid and placebo groups (84.4% and 81.0%, respectively; adjusted relative risk, 1.04, 95% confidence interval, 0.98 to 1.10; adjusted P=0.20). There were no significant differences between the groups in body size, blood pressure, use of health services, respiratory morbidity, or child behavior scores, although children exposed to repeat doses of corticosteroids were more likely than those exposed to placebo to warrant assessment for attention problems (P=0.04). Conclusions Administration of repeat doses of antenatal corticosteroids reduces neonatal morbidity without changing either survival free of major neurosensory disability or body size at 2 years of age.	Univ Adelaide, Womens & Childrens Hosp, Dept Neonatal Med, Adelaide, SA 5006, Australia; Univ Adelaide, Disciplines Obstet & Gynaecol, Adelaide, SA, Australia; Univ Adelaide, Disciplines Publ Hlth, Adelaide, SA, Australia; Univ Melbourne, Dept Obstet & Gynaecol & Paediat, Melbourne, Vic, Australia; Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Melbourne; University of Auckland	Crowther, CA (corresponding author), Univ Adelaide, Womens & Childrens Hosp, Discipline Obstet & Gynaecol, 72 King William Rd, Adelaide, SA 5006, Australia.	caroline.crowther@adelaide.edu.au	Dodd, Jodie/Y-6849-2019; Harding, Jane E/J-5853-2015; Lawrence, Annemarie/I-4180-2013; Pritchard, Margo A/G-5188-2010; Hiller, Janet E./A-5633-2008; Doyle, Lex/AAJ-5205-2021	Dodd, Jodie/0000-0002-6363-4874; Harding, Jane E/0000-0003-2697-1422; Lawrence, Annemarie/0000-0002-8736-4741; Pritchard, Margo A/0000-0002-1058-9117; Hiller, Janet E./0000-0002-8532-4033; Doyle, Lex/0000-0002-7667-7312				Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; [Anonymous], 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003935.pub2, DOI 10.1002/14651858.CD003935.PUB2]; Bayley N, 1993, BAYLEY SCALES INFANT; Brocklehurst P, 1999, BRIT J OBSTET GYNAEC, V106, P977, DOI 10.1111/j.1471-0528.1999.tb08440.x; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Dalziel SR, 2004, PEDIATRICS, V114, pE373, DOI 10.1542/peds.2004-0196; DALZIEL SR, IN PRESS INT J EPIDE; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; DOBBING J, 1974, SCI F PAEDIATRICS, P565; Dodic M, 2001, CLIN EXP PHARMACOL P, V28, P952, DOI 10.1046/j.1440-1681.2001.03556.x; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gilstrap LC, 2001, OBSTET GYNECOL, V98, P144; Hasbargen U, 2001, EUR J PEDIATR, V160, P552, DOI 10.1007/s004310100804; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Jensen EC, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740027; KITCHEN WH, 1987, AM J PERINAT, V4, P29, DOI 10.1055/s-2007-999733; Leon DA, 2000, AM J EPIDEMIOL, V152, P597, DOI 10.1093/aje/152.7.597; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McLaughlin KJ, 2003, AUST NZ J OBSTET GYN, V43, P101, DOI 10.1046/j.0004-8666.2003.00052.x; McLaughlin KJ, 2002, AUST NZ J OBSTET GYN, V42, P353, DOI 10.1111/j.0004-8666.2002.00353.x; Mildenhall LFJ, 2006, ARCH DIS CHILD-FETAL, V91, pF56, DOI 10.1136/adc.2004.065300; *MIRU, 2006, MULT COURS ANT CORT; Moss TJM, 2002, EARLY HUM DEV, V66, P11, DOI 10.1016/S0378-3782(01)00227-4; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Owen D, 2007, J PHYSIOL-LONDON, V578, P249, DOI 10.1113/jphysiol.2006.122887; Peltoniemi OM, 2007, PEDIATRICS, V119, P290, DOI 10.1542/peds.2006-1549; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Spinillo A, 2004, AM J OBSTET GYNECOL, V191, P217, DOI 10.1016/j.ajog.2003.12.023; TREACY MMJ, 2002, PHYS REV B, V66, P11; *VIC INF COLL STUD, 1997, J PAEDIATR CHILD H, V33, P202; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453; Wapner RJ, 2006, AM J OBSTET GYNECOL, V195, P633, DOI 10.1016/j.ajog.2006.03.087; Woods LL, 2006, AM J PHYSIOL-REG I, V291, pR1069, DOI 10.1152/ajpregu.00753.2005	41	194	196	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1179	1189		10.1056/NEJMoa071152	http://dx.doi.org/10.1056/NEJMoa071152			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881750	Bronze			2022-12-28	WOS:000249541000003
J	Qaseern, A; Vijan, S; Snow, V; Cross, JT; Weiss, KB; Owens, DK				Qaseern, Amir; Vijan, Sandeep; Snow, Vincenza; Cross, J. Thomas; Weiss, Kevin B.; Owens, Douglas K.		Clinical Efficacy American PHYS	Glycemic control and type 2 diabetes mellitus: The optimal hemoglobin A(1c) targets. A guidance statement from the American college of physicians	ANNALS OF INTERNAL MEDICINE			English	Article								This guidance statement is derived from other organizations' guidelines and is based on an evaluation of the strengths and weaknesses of the available guidelines. We used the Appraisal of Guidelines, Research and Evaluation in Europe (AGREE) appraisal instrument to evaluate the guidelines from various organizations. On the basis of the review of the available guidelines, we recommend: Statement 1: To prevent microvascular complications of diabetes, the goal for glycemic control should be as low as is feasible without undue risk for adverse events or an unacceptable burden on patients. Treatment goals should be based on a discussion of the benefits and harms of specific levels of glycemic control with the patient. A hemoglobin Ale level less than 7% based on individualized assessment is a reasonable goal for many but not all patients. Statement 2: The goal for hemoglobin A(1c) level should be based on individualized assessment of risk for complications from diabetes, comorbidity, life expectancy, and patient preferences. Statement 3: We recommend further research to assess the optimal level of glycemic control, particularly in the presence of comerbid conditions.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Michigan, Vet Affairs Hlth Serv Res, Ann Arbor, MI 48109 USA; Vet Affairs Edward Hines Jr Hosp, Hines, IL USA; Northwestern Univ, Chicago, IL 60611 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Stanford, CA 94305 USA	American College of Physicians; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Qaseern, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS1; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; *COMM ID PRIOR AR, 2003, PRIOR AR NAT ACT TRA; *I CLIN SYST IMPR, 2004, MAN TYP 2 DIAB MELL; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; *MAN DIAB MELL, 1999, CLIN PRACT GUID WORK; McIntosh AHA, 2002, CLIN GUIDELINES EVID; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WOOLF SH, 1999, BENEFITS RISKS CONTR	14	105	107	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					417	422		10.7326/0003-4819-147-6-200709180-00012	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876024				2022-12-28	WOS:000249726200013
J	Callan, B; Gillespie, I				Callan, Benedicte; Gillespie, Iain			The path to new medicines	NATURE			English	Editorial Material									OECD, Div Biotechnol, Paris, France	Organisation for Economic Co-operation & Development (OECD)	Callan, B (corresponding author), OECD, Div Biotechnol, Paris, France.								0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					164	165		10.1038/449164a	http://dx.doi.org/10.1038/449164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851511				2022-12-28	WOS:000249394500035
J	Shaddy, RE; Boucek, MM; Hsu, DT; Boucek, RJ; Canter, CE; Mahony, L; Ross, RD; Pahl, E; Blume, ED; Dodd, DA; Rosenthal, DN; Burr, J; LaSalle, B; Holubkov, R; Lukas, MA; Tani, LY				Shaddy, Robert E.; Boucek, Mark M.; Hsu, Daphne T.; Boucek, Robert J.; Canter, Charles E.; Mahony, Lynn; Ross, Robert D.; Pahl, Elfriede; Blume, Elizabeth D.; Dodd, Debra A.; Rosenthal, David N.; Burr, Jeri; LaSalle, Bernie; Holubkov, Richard; Lukas, Mary Ann; Tani, Lloyd Y.		Pediat Carvedilos Study Grp	Carvedilol for children and adolescents with heart failure - A Randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURROGATE END-POINTS; DILATED CARDIOMYOPATHY; VENTRICULAR-FUNCTION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION; PEDIATRIC-PATIENTS; EXERCISE CAPACITY; GREAT-ARTERIES; ATRIAL REPAIR; METOPROLOL	Context Although beta-blockers improve symptoms and survival in adults with heart failure, little is known about these medications in children and adolescents. Objective To prospectively evaluate the effects of carvedilol in children and adolescents with symptomatic systemic ventricular systolic dysfunction. Design, Setting, and Participants A multicenter, randomized, double-blind, placebo-controlled study of 161 children and adolescents with symptomatic systolic heart failure from 26 US centers. In addition to treatment with conventional heart failure medications, patients were assigned to receive placebo or carvedilol. Enrollment began in June 2000 and the last dose was given in May 2005 (each patient received medication for 8 months). Interventions Patients were randomized in a 1:1:1 ratio to twice-daily dosing with placebo, low-dose carvedilol (0.2 mg/kg per dose if weight <62.5 kg or 12.5 mg per dose if weight >= 62.5 kg), or high-dose carvedilol (0.4 mg/kg per dose if weight <62.5 kg or 25 mg per dose if weight >= 62.5 kg) and were stratified according to whether each patient's systemic ventricle was a left ventricle or not. Main Outcome Measures The primary outcome was a composite measure of heart failure outcomes in patients receiving carvedilol (low- and high-dose combined) vs placebo. Secondary efficacy variables included individual components of this composite, echocardiographic measures, and plasma b-type natriuretic peptide levels. Results There was no statistically significant difference between groups for the composite end point based on the percentage of patients who improved, worsened, or were unchanged. Among 54 patients assigned to placebo, 30 improved (56%), 16 worsened (30%), and 8 were unchanged (15%); among 103 patients assigned to carvedilol, 58 improved ( 56%), 25 worsened (24%), and 20 were unchanged (19%). The rates of worsening were lower than expected. The odds ratio for worsened outcome for patients in the combined carvedilol group vs the placebo group was 0.79 (95% CI, 0.36-1.59; P = .47). A prespecified subgroup analysis noted significant interaction between treatment and ventricular morphology (P = .02), indicating a possible differential effect of treatment between patients with a systemic left ventricle (beneficial trend) and those whose systemic ventricle was not a left ventricle (nonbeneficial trend). Conclusions These preliminary results suggest that carvedilol does not significantly improve clinical heart failure outcomes in children and adolescents with symptomatic systolic heart failure. However, given the lower than expected event rates, the trial may have been underpowered. There may be a differential effect of carvedilol in children and adolescents based on ventricular morphology.	Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Univ S Florida, Dept Pediat, St Petersburg, FL 33701 USA; Washington Univ, Dept Pediat, St Louis, MO 63130 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA; Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; GlaxoSmithKline Inc, Philadelphia, PA USA	Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Columbia University; State University System of Florida; University of South Florida; Washington University (WUSTL); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wayne State University; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Vanderbilt University; Stanford University; GlaxoSmithKline	Shaddy, RE (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	shad-dyr@email.chop.edu	Hsu, Daphne/C-8913-2017	Hsu, Daphne/0000-0002-2654-0430; Rosenthal, David/0000-0002-6342-2759; Burr, Jeri/0000-0002-5443-6534				Anand IS, 2002, J AM COLL CARDIOL, V39, P1414, DOI 10.1016/S0735-1097(02)01773-4; Azeka E, 2002, J AM COLL CARDIOL, V40, P2034, DOI 10.1016/S0735-1097(02)02570-6; Blume ED, 2006, PEDIATR CARDIOL, V27, P336, DOI 10.1007/s00246-005-1159-1; Boucek MM, 2005, J HEART LUNG TRANSPL, V24, P968, DOI 10.1016/j.healun.2005.05.020; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Bristow MR, 1997, AM J CARDIOL, V80, pL26, DOI 10.1016/S0002-9149(97)00846-1; Bruns LA, 2001, J PEDIATR-US, V138, P505, DOI 10.1067/mpd.2001.113045; BURCH M, 1994, BRIT HEART J, V72, P246; CHEN SC, 1990, J AM COLL CARDIOL, V15, P189, DOI 10.1016/0735-1097(90)90199-Y; Derrick G, 2004, EUR HEART J, V25, P1863, DOI 10.1016/j.ehj.2004.07.023; Derrick GP, 2001, HEART, V86, P203, DOI 10.1136/heart.86.2.203; Derrick GP, 2000, CIRCULATION, V102, P154; Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470; Gheorghiade M, 2003, AM HEART J, V145, pS67, DOI 10.1067/mhj.2003.159; Hechter SJ, 2001, AM J CARDIOL, V87, P660, DOI 10.1016/S0002-9149(00)01452-1; Hjalmarson A, 1999, LANCET, V353, P2001; Kouatli AA, 1997, CIRCULATION, V96, P1507, DOI 10.1161/01.CIR.96.5.1507; Laer S, 2002, AM HEART J, V143, P916, DOI 10.1067/mhj.2002.121265; Lechat P, 1999, LANCET, V353, P9; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Packer M, 2006, AM J CARDIOL, V98, p39L, DOI 10.1016/j.amjcard.2006.07.018; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rosenthal D, 2004, J HEART LUNG TRANSPL, V23, P1313, DOI 10.1016/j.healun.2004.03.018; Rusconi P, 2004, J HEART LUNG TRANSPL, V23, P832, DOI 10.1016/j.healun.2003.07.025; Shaddy RE, 1999, J HEART LUNG TRANSPL, V18, P269, DOI 10.1016/S1053-2498(98)00030-8; Shaddy RE, 2002, AM HEART J, V144, P383, DOI 10.1067/mhj.2002.124402; SHADDY RE, 1995, AM HEART J, V129, P197, DOI 10.1016/0002-8703(95)90061-6; Tsirka AE, 2004, J AM COLL CARDIOL, V44, P391, DOI 10.1016/j.jacc.2004.04.035; Vogel M, 2004, J AM COLL CARDIOL, V43, P100, DOI 10.1016/j.jacc.2003.06.018; WU YT, 1993, AM J CARDIOL, V71, P727, DOI 10.1016/0002-9149(93)91018-D	33	342	353	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1171	1179		10.1001/jama.298.10.1171	http://dx.doi.org/10.1001/jama.298.10.1171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848651	Bronze			2022-12-28	WOS:000249374200022
J	LAWTON, SL; ROHRBAUGH, WJ				LAWTON, SL; ROHRBAUGH, WJ			THE FRAMEWORK TOPOLOGY OF ZSM-18, A NOVEL ZEOLITE CONTAINING RINGS OF 3 (SI,AL)-O SPECIES	SCIENCE			English	Article											LAWTON, SL (corresponding author), MOBIL RES & DEV CORP,RES DEPT,PAULSBORO,NJ 08066, USA.							BAERLOCHER C, 1981, DLS76 EIDG TH PROGR; BENNETT JM, 1988, INNOVATION ZEOLITE M, V37, P269; BRECK DW, 1974, ZEOLITE MOL SIEVES, P636; BRUNNER GO, 1989, NATURE, V337, P146, DOI 10.1038/337146a0; CHESTER AW, 1987, MAY N AM CAT SOC M S; CIRIC J, 1978, J AM CHEM SOC, V100, P2173, DOI 10.1021/ja00475a030; CIRIC J, 1976, Patent No. 3950496; LAWTON SL, 1985, ACTA CRYSTALLOGR C, V41, P1683, DOI 10.1107/S0108270185009027; MEIER WM, 1987, ATLAS ZEOLITE STRUCT; SMITH DK, 1983, POWD10 PENNS STAT U	10	161	163	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1319	1322		10.1126/science.247.4948.1319	http://dx.doi.org/10.1126/science.247.4948.1319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843794				2022-12-28	WOS:A1990CU25300031
J	WALDROP, MM				WALDROP, MM			SCIENCE IN THE 90S .6. PARTICLE PHYSICISTS LOOK TO THE HEAVENS	SCIENCE			English	Editorial Material														Waldrop, M Mitchell/0000-0002-8063-1472					0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1291	1293		10.1126/science.247.4948.1291	http://dx.doi.org/10.1126/science.247.4948.1291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843785				2022-12-28	WOS:A1990CU25300018
J	BLOOM, AL				BLOOM, AL			GEOMORPHOLOGY AND HYDROLOGY OF KARST TERRAINS - WHITE,WB	SCIENCE			English	Book Review											BLOOM, AL (corresponding author), CORNELL UNIV,DEPT GEOL SCI,ITHACA,NY 14853, USA.							White W.B., 1988, GEOMORPHOLOGY HYDROL	1	8	9	8	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1618	1619		10.1126/science.243.4898.1618-a	http://dx.doi.org/10.1126/science.243.4898.1618-a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847267				2022-12-28	WOS:A1989T795200047
J	McMichael, AJ; Powles, JW; Butler, CD; Uauy, R				McMichael, Anthony J.; Powles, John W.; Butler, Colin D.; Uauy, Ricardo			Energy and health 5 - Food, livestock production, energy, climate change, and health	LANCET			English	Article							COLORECTAL-CANCER RISK; MEAT CONSUMPTION; BREAST-CANCER; IMPACTS; TRANSITION; PROTEIN; FAT; CO2	Food provides energy and nutrients, but its acquisition requires energy expenditure. In post-hunter-gatherer societies, extra-somatic energy has greatly expanded and intensified the catching, gathering, and production of food. Modern relations between energy, food, and health are very complex, raising serious, high-level policy challenges. Together with persistent widespread under-nutrition, over-nutrition (and sedentarism) is causing obesity and associated serious health consequences. Worldwide, agricultural activity, especially livestock production, accounts for about a fifth of total greenhouse-gas emissions, thus contributing to climate change an its adverse health consequences, including the threat to food yields in many regions. Particular policy attention should be paid to the health risks posed by the rapid worldwide growth in meat consumption, both by exacerbating climate change and by directly contributing to certain diseases. To prevent increased greenhouse-gas emissions from this production sector, both the average worldwide consumption level of animal products and the intensity of emissions from livestock production must be reduced. An international contraction and convergence strategy offers a feasible route to such a goal. The current global average meat consumption is 100 g per person per day, with about a ten-fold variation between high-consuming and low-consuming populations. 90 g per day is proposed as a working global target, shared more evenly, with not more than 50 g per day coming from red meat from ruminants (ie, cattle, sheep, goats, and other digastric grazers).	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Cambridge, Inst Publ Hlth, Cambridge, England; London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1, England; Univ Chile, Inst Nutr, INTA, Santiago, Chile	Australian National University; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Universidad de Chile	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294; Powles, John/0000-0002-0766-7989				Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; BAGGOTT L, 2006, UK GREENH GAS INV 19; Barnes E., 2005, DIS HUMAN EVOLUTION; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Black R, 2003, B WORLD HEALTH ORGAN, V81, P79; Bruinsma J., 2017, WORLD AGR 20152030 F, DOI [10.4324/9781315083858, DOI 10.4324/9781315083858]; Burke EJ, 2006, J HYDROMETEOROL, V7, P1113, DOI 10.1175/JHM544.1; Butler CD, 2006, ECOL SOC, V11; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; CHARLTON J, 1997, HLTH ADULT BRITAIN 1, P93; Chen J., 2006, MORTALITY BIOCH DIET; Cho EY, 2006, ARCH INTERN MED, V166, P2253, DOI 10.1001/archinte.166.20.2253; DeAngelo BJ, 2006, ENERG J, P89; *DEFRA, GREENH GAS EM LIV SE; Delgado C., 1999, Food, Agriculture and the Environment Discussion Paper - International Food Policy Research Institute; Diamond J., 2011, COLLAPSE SOC CHOOSE, V4th ed; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; *FAO, 2005, STAT FOOD INS WORLD, P36; *FAO, 2006, LIV LONG SHAD ENV IS, P414; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fischer G, 2002, GLOBAL AGROECOLOGICA; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; HAINES A, 2000, LANCET          0913, DOI DOI 10.1016/S0140-6736(07)61254-9; HORTON S, 1999, INVESTING CHILD NUTR; Hu F.B., 1998, RELATIONSHIP CONSUMP; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; IPCC, 2007, PHYS BAS CLIM CHANG; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kinjo Y, 1999, J Epidemiol, V9, P268; LAKDAWALLA D, 2002, 8946 NAT BUR EC RES; LAPPE FM, 1991, DIET SMALL PLANET; Leitzmann C, 2005, PUBLIC HEALTH NUTR, V8, P787, DOI 10.1079/PHN2005821; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; McMichael A J, 1993, PLANETARY OVERLOAD G; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2001, HUMAN FRONTIERS ENV, DOI [10.1017/CBO9781139106924, DOI 10.1017/CBO9781139106924]; Meyer A., 2000, CONTRACTION CONVERGE; Naylor R, 2005, SCIENCE, V310, P1621, DOI 10.1126/science.1117856; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Sahlins MarshallD., 1972, STONE AGE EC; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sauvaget C, 2004, STROKE, V35, P1531, DOI 10.1161/01.STR.0000130426.52064.09; Schmidhuber J., 2004, eJADE - Electronic Journal of Agricultural and Development Economics, V1, P272; Shine KP, 2007, SCIENCE, V315, P1804, DOI 10.1126/science.1141677; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Steckel R.H., 2002, BACKBONE HIST HLTH N, DOI DOI 10.1017/CBO9780511549953.004; Stern Nicholas, 2006, STERN REV EC CLIMATE; Tainter J., 1988, COLLAPSE COMPLEX SOC; Taylor EF, 2007, BRIT J CANCER, V96, P1139, DOI 10.1038/sj.bjc.6603689; UAUY R, 2006, ROLE INT COMMUNITY F, P24; United States Environmental Protection Agency (EPA), 2006, GLOB ANTHR NONCO2 GR; Vaz M., 2005, SAJCN - South African Journal of Clinical Nutrition, V18, P198; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WHO, 2003, WHO TECH REP SER, V916, P1; World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) Food, FOOD NUTR PHYS ACT P; World Wide Fund for Nature (WWF), 2006, LIVING PLANET REPORT	68	718	724	10	384	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1253	1263		10.1016/S0140-6736(07)61256-2	http://dx.doi.org/10.1016/S0140-6736(07)61256-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17868818	Green Submitted			2022-12-28	WOS:000250091900026
J	Gladman, MA; Shami, SS				Gladman, Marc A.; Shami, Shukri S.			Medical mystery - An unusual complication of colonoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Queens Hosp, Romford RM7 0AG, Essex, England		Gladman, MA (corresponding author), Queens Hosp, Romford RM7 0AG, Essex, England.	m.a.gladman@qmul.ac.uk							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1431	1431		10.1056/NEJMicm066934	http://dx.doi.org/10.1056/NEJMicm066934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914044				2022-12-28	WOS:000249892900009
J	Hernandez, AF; Fonarow, GC; Liang, L; Al-Khatib, SM; Curtis, LH; LaBresh, KA; Yancy, CW; Albert, NM; Peterson, ED				Hernandez, Adrian F.; Fonarow, Gregg C.; Liang, Li; Al-Khatib, Sana M.; Curtis, Lesley H.; LaBresh, Kenneth A.; Yancy, Clyde W.; Albert, Nancy M.; Peterson, Eric D.			Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; PREVENTION; SURVIVAL; DISEASE; AMIODARONE; GUIDELINES; ARRHYTHMIA; MORTALITY; COMMUNITY	Context Practice guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for patients with heart failure and left ventricular ejection fraction of 30% or less. The influence of sex and race on ICD use among eligible patients is unknown. Objective To examine sex and racial differences in the use of ICD therapy. Design, Setting, and Patients Observational analysis of 13 034 patients admitted with heart failure and left ventricular ejection fraction of 30% or less and discharged alive from hospitals in the American Heart Association's Get With the Guidelines Heart Failure quality-improvement program. Patients were treated between January 2005 and June 2007 at 217 participating hospitals. Main Outcome Measures Use of ICD therapy or planned ICD therapy at discharge. Results Among patients eligible for ICD therapy, 4615 (35.4%) had ICD therapy at discharge (1614 with new ICDs, 527 with planned ICDs, and 2474 with prior ICDs). ICDs were used in 375 of 1329 eligible black women (28.2%), 754 of 2531 white women (29.8%), 660 of 1977 black men (33.4%), and 2356 of 5403 white men (43.6%) (P < .001). After adjustment for patient characteristics and hospital factors, the adjusted odds of ICD use were 0.73 (95% confidence interval, 0.60-0.88) for black men, 0.62 (95% confidence interval, 0.56-0.68) for white women, and 0.56 (95% confidence interval, 0.44-0.71) for black women, compared with white men. The differences were not attributable to the proportions of women and black patients at participating hospitals or to differences in the reporting of left ventricular ejection fraction. Conclusions Less than 40% of potentially eligible patients hospitalized for heart failure received ICD therapy, and rates of use were lower among eligible women and black patients than among white men.	Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; Masspro, Waltham, MA USA; Baylor Heart & Vasc Inst, Dallas, TX USA; Cleveland Clin, Cleveland, OH 44106 USA	Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cleveland Clinic Foundation	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Peterson, Eric David/ABF-5033-2021; LaBresh, Kenneth A/A-6995-2017; Fonarow, Gregg C/D-5988-2014; Hernandez, Adrian F/A-7818-2016	LaBresh, Kenneth A/0000-0001-9040-1956; Fonarow, Gregg C/0000-0002-3192-8093; Hernandez, Adrian F/0000-0003-3387-9616				*AM HEART ASS, 2006, 2006 HEART STROK STA; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bonow RO, 2005, CIRCULATION, V112, P1853, DOI 10.1161/CIRCULATIONAHA.105.170072; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Groeneveld PW, 2006, J GEN INTERN MED, V21, P559, DOI 10.1111/j.1525-1497.2006.00453.x; GUARI AJ, 2006, AM J MED, V119, DOI UNSP 167.E17-167.E21; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Russo AM, 2004, J CARDIOVASC ELECTR, V15, P993, DOI 10.1046/j.1540-8167.2004.04050.x; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015; Stevenson LW, 2006, CIRCULATION, V114, P101, DOI 10.1161/CIRCULATIONAHA.106.637405; *US DEP HHS, HOSP QUAL IN; Yancy CW, 2005, CIRCULATION, V111, P1339, DOI 10.1161/01.CIR.0000157740.93598.51; Zareba W, 2005, J CARDIOVASC ELECTR, V16, P1265, DOI 10.1111/j.1540-8167.2005.00224.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 2001, CIRCULATION, V103, P1372, DOI 10.1161/01.CIR.103.10.1372	31	296	296	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1525	1532		10.1001/jama.298.13.1525	http://dx.doi.org/10.1001/jama.298.13.1525			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911497				2022-12-28	WOS:000249860500024
J	Bacon, D				Bacon, Dave			Does our universe allow for robust quantum computation?	SCIENCE			English	Editorial Material									Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bacon, D (corresponding author), Univ Washington, Dept Comp Sci & Engn, Box 352350, Seattle, WA 98195 USA.	dabacon@cs.washington.edu	Bacon, Dave/A-3112-2008					Aspuru-Guzik A, 2005, SCIENCE, V309, P1704, DOI 10.1126/science.1113479; Emerson J, 2007, SCIENCE, V317, P1893, DOI 10.1126/science.1145699; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Kitaev AY, 1997, QUANTUM COMMUNICATION, COMPUTING, AND MEASUREMENT, P181; Knill E, 1998, P ROY SOC A-MATH PHY, V454, P365, DOI 10.1098/rspa.1998.0166; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700	10	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1876	1877		10.1126/science.1148848	http://dx.doi.org/10.1126/science.1148848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901322				2022-12-28	WOS:000249764300026
J	Chan, AOO; Jim, MH; Lam, KF; Morris, JS; Siu, DCW; Tong, T; Ng, FH; Wong, SY; Hui, WM; Chan, CK; Lai, KC; Cheung, TK; Chan, P; Wong, G; Yuen, MF; Lau, YK; Lee, S; Szeto, ML; Wong, BCY; Lam, SK				Chan, Annie On On; Jim, Man Hong; Lam, Kwok Fai; Morris, Jeffrey S.; Siu, David Chun Wah; Tong, Teresa; Ng, Fook Hong; Wong, Siu Yin; Hui, Wai Mo; Chan, Chi Kuen; Lai, Kam Chuen; Cheung, Ting Kin; Chan, Pierre; Wong, Grace; Yuen, Man Fung; Lau, Yuk Kong; Lee, Stephen; Szeto, Ming Leung; Wong, Benjamin C. Y.; Lam, Shiu Kum			Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; HEART-DISEASE; CANCER; RISK; ASSOCIATION; INFLAMMATION; REGRESSION; CHINESE; POLYPS	Context Colorectal neoplasm and coronary artery disease (CAD) share similar risk factors, and their co-occurrence may be associated. Objectives To investigate the prevalence of colorectal neoplasm in patients with CAD in a cross-sectional study and to identify the predisposing factors for the association of the 2 diseases. Design, Setting, and Participants Patients in Hong Kong, China, were recruited for screening colonoscopy after undergoing coronary angiography for suspected CAD during November 2004 to June 2006. Presence of CAD (n = 206) was defined as at least 50% diameter stenosis in any 1 of the major coronary arteries; otherwise, patients were considered CAD-negative (n = 208). An age- and sex-matched control group was recruited from the general population (n = 207). Patients were excluded for use of aspirin or statins, personal history of colonic disease, or colonoscopy in the past 10 years. Main Outcome Measures The prevalence of colorectal neoplasm in CAD-positive, CAD-negative, and general population participants was determined. Bivariate logistic regression was performed to study the association between colorectal neoplasm and CAD and to identify risk factors for the association of the 2 diseases after adjusting for age and sex. Results The prevalence of colorectal neoplasm in the CAD-positive, CAD-negative, and general population groups was 34.0%, 18.8%, and 20.8% (P < .001 by chi(2) test), prevalence of advanced lesions was 18.4%, 8.7%, and 5.8% (P < .001), and prevalence of cancer was 4.4%, 0.5%, and 1.4% (P = .02), respectively. Fifty percent of the cancers in CAD-positive participants were early stage. After adjusting for age and sex, an association still existed between colorectal neoplasm and presence of CAD (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.25-2.70; P = .002) and between advanced lesions and presence of CAD (OR, 2.51; 95% CI, 1.43-4.35; P = .001). The metabolic syndrome (OR, 5.99; 95% CI, 1.43-27.94; P = .02) and history of smoking (OR, 4.74; 95% CI, 1.38-18.92; P = .02) were independent factors for the association of advanced colonic lesions and CAD. Conclusions In this study population undergoing coronary angiography, the prevalence of colorectal neoplasm was greater in patients with CAD. The association between the presence of advanced colonic lesions and CAD was stronger in persons with the metabolic syndrome and a history of smoking.	Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Ruttonjee Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Hong Kong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Tuen Mun Hospital; University of Hong Kong; University of Hong Kong	Chan, AOO (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	aoochan@hku.hk	Yuen, Man-Fung/C-4466-2009; Siu, Chung Wah/C-6947-2011; Wong, Benjamin Chun Yu/ABB-1962-2020; Wong, Benjamin Chun Yu/C-4436-2009; Siu, David/C-4394-2009	Yuen, Man-Fung/0000-0001-7985-7725; Lam, Kwok/0000-0001-5453-994X				Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; American Cancer Society, 2000, CANC FACTS FIG 2000; Ananth CV, 1999, STAT MED, V18, P2011; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; Chan AOO, 2006, ALIMENT PHARM THER, V24, P535, DOI 10.1111/j.1365-2036.2006.02958.x; Chan JSK, 1997, BIOMETRICAL J, V39, P409, DOI 10.1002/bimj.4710390403; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; CORREA P, 1982, J CHRON DIS, V35, P313, DOI 10.1016/0021-9681(82)90002-9; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; HOLM S, 1979, SCAND J STAT, V6, P65; Hospital Authority Hong Kong SAR Government, HONG KONG CANC REG; Kwon Hyuk Sang, 2005, Korean Journal of Internal Medicine, V20, P310; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LAKLER JB, 1992, AM J MED, V93, pS8; Lieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959; Lin RT, 2004, J FORMOS MED ASSOC, V103, P317; McEwen JE, 2005, CURR OPIN CARDIOL, V20, P399, DOI 10.1097/01.hco.0000175517.50181.89; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Morita Takako, 2005, Asian Pac J Cancer Prev, V6, P485; *MULT RISK FACT IN, 1975, DHEW PUBL NIH; NEUGUT AI, 1995, DIS COLON RECTUM, V38, P873, DOI 10.1007/BF02049845; Neugut AI, 1998, CANCER EPIDEM BIOMAR, V7, P869; Parker S, 2005, HIST TODAY, V55, P2; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Reicher-Reiss H, 2001, AM J CARDIOL, V87, P459, DOI 10.1016/S0002-9149(00)01405-3; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sepulveda JL, 2005, CURR OPIN CARDIOL, V20, P407; Simmons DT, 2006, ALIMENT PHARM THERAP, V24, P965, DOI 10.1111/j.1365-2036.2006.03080.x; Sung JJY, 2003, GASTROENTEROLOGY, V124, P608, DOI 10.1053/gast.2003.50090; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Wang YY, 2005, J GASTROEN HEPATOL, V20, P1410, DOI 10.1111/j.1440-1746.2005.03971.x; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104; Winawer Sidney J., 1999, American Journal of Medicine, V106, p3S, DOI 10.1016/S0002-9343(98)00338-6	36	116	129	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1412	1419		10.1001/jama.298.12.1412	http://dx.doi.org/10.1001/jama.298.12.1412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895457	Bronze			2022-12-28	WOS:000249698900020
J	Schneider, HJ; Kreitschmann-Andermahr, I; Ghigo, E; Stalla, GK; Agha, A				Schneider, Harald Joern; Kreitschmann-Andermahr, Ilonka; Ghigo, Ezio; Stalla, Guenter Karl; Agha, Amar			Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ANTERIOR-PITUITARY DYSFUNCTION; QUALITY-OF-LIFE; GROWTH-HORMONE; NEUROENDOCRINE DYSFUNCTION; LONG-TERM; PREMATURE MORTALITY; GH DEFICIENCY; HEAD-INJURY; HIGH-RISK; HYPOPITUITARISM	Context Neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage may occur with a much higher prevalence than previously suspected. This sequela is a potentially serious but treatable complication of brain injury. Objective To review research on hypothalamopituitary dysfunction as an underdiagnosed consequence of traumatic brain injury and subarachnoid hemorrhage, the natural history of this complication, and the potential clinical and public health implications of posttraumatic hypopituitarism. Evidence Acquisition The MEDLINE database was searched for articles published between 2000 and 2007 using any combination of the terms traumatic brain injury or subarachnoid hemorrhage with pituitary, hypopituitarism, growth hormone deficiency, hypogonadism, hypocortisolism, hypothyroidism, or diabetes insipidus. The reference lists of articles identified by this search strategy were also searched. All articles reporting original data on endocrine outcomes after traumatic brain injury or aneurysmal subarachnoid hemorrhage in peer-reviewed journals with regard to prevalence, pathogenesis, risk factors, outcomes, and clinical course were selected. We pooled data and calculated prevalence rates and 95% confidence intervals (CIs). Results We identified 19 studies including 1137 patients. The pooled prevalences of hypopituitarism in the chronic phase after traumatic brain injury and aneurysmal subarachnoid hemorrhage were 27.5% ( 95% confidence interval [CI], 22.8%-28.9%) and 47% (95% CI, 37.4%-56.8%), respectively. The pooled prevalence of hypopituitarism was greater in patients with severe compared with those with mild or moderate traumatic brain injury. Early neuroendocrine abnormalities were transient in some patients while, less commonly, hypopituitarism evolved over time in others. Patients with posttraumatic hypopituitarism showed an impaired quality of life and an adverse metabolic profile. Conclusion Hypopituitarism is a common complication of both traumatic brain injury and aneurysmal subarachnoid hemorrhage and might contribute to morbidity and poor recovery after brain injury.	Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany; Univ Aachen, Rhein Westfal TH Aachen, Dept Neurosurg, D-5100 Aachen, Germany; Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy; Beaumont Hosp, Div Endocrinol, Dublin 9, Ireland; RCSI Med Sch, Dublin, Ireland	Max Planck Society; RWTH Aachen University; University of Turin; Royal College of Surgeons - Ireland	Schneider, HJ (corresponding author), Max Planck Inst Psychiat, Neuroendocrinol Grp, Kraepelinstr 10, D-80804 Munich, Germany.	schneider@mpipsykl.mpg.de						Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Ceballos R, 1966, Ala J Med Sci, V3, P185; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E, DEUT MED WOCHENSCHR, V44, P1261; Darzy K H, 2005, J Endocrinol Invest, V28, P78; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Erfurth EM, 2005, TRENDS ENDOCRIN MET, V16, P334, DOI 10.1016/j.tem.2005.07.004; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gola M, 2005, J CLIN ENDOCR METAB, V90, P1864, DOI 10.1210/jc.2004-0545; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutter BO, 1999, ACT NEUR S, V72, P157; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KERKHOVE.P, 1967, SCHWEIZ MED WSCHR, V97, P263; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Monson JP, 2003, EUR J ENDOCRINOL, V148, pS9, DOI 10.1530/eje.0.148S009; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Rap Z, 1971, Pol Med J, V10, P188; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P553, DOI 10.1530/eje.1.02258; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TEASDALE G, 1974, LANCET, V2, P81; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Vernet M, 2001, CRIT CARE MED, V29, P2220, DOI 10.1097/00003246-200111000-00028	62	333	352	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1429	1438		10.1001/jama.298.12.1429	http://dx.doi.org/10.1001/jama.298.12.1429			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895459	Bronze			2022-12-28	WOS:000249698900022
J	Luke, CJ; Pak, SC; Askew, YS; Naviglia, TL; Askew, DJ; Nobar, SM; Vetica, AC; Long, OS; Watkins, SC; Stolz, DB; Barstead, RJ; Moulder, GL; Bromme, D; Silverman, GA				Luke, Cliff J.; Pak, Stephen C.; Askew, Yuko S.; Naviglia, Terra L.; Askew, David J.; Nobar, Shila M.; Vetica, Anne C.; Long, Olivia S.; Watkins, Simon C.; Stolz, Donna B.; Barstead, Robert J.; Moulder, Gary L.; Bromme, Dieter; Silverman, Gary A.			An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-DEATH; LIFE-SPAN; SIGNALING PATHWAY; CALPAIN; STRESS; NEURODEGENERATION; DISRUPTION; MECHANISMS	Extracellular serpins such as antithrombin and a1- antitrypsin are the quintessential regulators of proteolytic pathways. In contrast, the biological functions of the intracellular serpins remain obscure. We now report that the C. elegans intracellular serpin, SRP- 6, exhibits a prosurvival function by blocking necrosis. Minutes after hypotonic shock, srp- 6 null animals underwent a catastrophic series of events culminating in lysosomal disruption, cytoplasmic proteolysis, and death. This newly defined hypo- osmotic stress lethal ( Osl) phenotype was dependent upon calpains and lysosomal cysteine peptidases, two in vitro targets of SRP- 6. By protecting against both the induction of and the lethal effects from lysosomal injury, SRP- 6 also blocked death induced by heat shock, oxidative stress, hypoxia, and cation channel hyperactivity. These findings suggest that multiple noxious stimuli converge upon a peptidase- driven, core stress response pathway that, in the absence of serpin regulation, triggers a lysosomal- dependent necrotic cell death routine.	Childrens Hosp Pittsburgh, Dept Pediat, UPMC Newborn Med Program, Pittsburgh, PA 15213 USA; Magee Womens Res Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; Oklahoma Med Res Fdn, Dept Mol & Cell Biol, Oklahoma City, OK 73104 USA; Univ British Columbia, Fac Dent, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oklahoma Medical Research Foundation; University of British Columbia	Silverman, GA (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, UPMC Newborn Med Program, Pittsburgh, PA 15213 USA.	gsilverman@mail.magee.edu	Silverman, Gary/AAJ-1269-2020; Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Pak, Stephen/0000-0002-8089-3237	NATIONAL CANCER INSTITUTE [R01CA086002, R01CA087007, R01CA087006, R01CA086007] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001843] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA087006-05, CA87007, R01 CA087006, R01 CA086002-04, R01 CA087006-01, R01 CA086002-05, R01 CA087006-02, R01 CA087006-06, R01 CA087006-03, R01 CA086002-03, R01 CA086002-02, CA86007, R01 CA087007, R01 CA087006-04, R01 CA086002] Funding Source: Medline; NCRR NIH HHS [RR02241] Funding Source: Medline; NHGRI NIH HHS [R01 HG001843] Funding Source: Medline; CGH CDC HHS [GH001843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CGH CDC HHS		Barger AJ, 1998, J NEUROSCI, V18, P2871; Bolger BS, 1997, GYNECOL ONCOL, V65, P309, DOI 10.1006/gyno.1997.4619; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirsch C, 2006, TRENDS CELL BIOL, V16, P657, DOI 10.1016/j.tcb.2006.10.006; Hiruma H, 2007, J PHOTOCH PHOTOBIO B, V86, P1, DOI 10.1016/j.jphotobiol.2006.08.003; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LLOYD JB, 1986, TRENDS BIOCHEM SCI, V11, P365, DOI 10.1016/0968-0004(86)90205-7; Luke CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P581, DOI 10.2741/1820; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Scarff KL, 2004, MOL CELL BIOL, V24, P4075, DOI 10.1128/MCB.24.9.4075-4082.2004; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	44	119	146	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1108	1119		10.1016/j.cell.2007.07.013	http://dx.doi.org/10.1016/j.cell.2007.07.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889653	Green Accepted, Bronze			2022-12-28	WOS:000250507500019
J	Heath, I				Heath, Iona			The blind leading the blind	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dst.pipex.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					540	540		10.1136/bmj.39331.651250.59	http://dx.doi.org/10.1136/bmj.39331.651250.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855320	Green Published			2022-12-28	WOS:000249790200030
J	Januzzi, JL; Garasic, JM; Neilan, TG; Gonzalez, RG; Stone, JR				Januzzi, James L., Jr.; Garasic, Joseph M.; Neilan, Tomas G.; Gonzalez, R. Gilberto; Stone, James R.			Case 28-2007: A 68-year-old man with syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC MYXOMA; THROMBUS		Massachusetts Gen Hosp, Coronary Care Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Vasc Med Sect, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Januzzi, JL (corresponding author), Massachusetts Gen Hosp, Coronary Care Unit, Boston, MA 02114 USA.		Januzzi, James/Y-2436-2019					Basson CT, 2002, NEW ENGL J MED, V346, P1152, DOI 10.1056/NEJMcpc010057; BURKE AP, 1993, AM J CLIN PATHOL, V100, P671, DOI 10.1093/ajcp/100.6.671; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; Butany J, 2004, J CARDIAC SURG, V19, P349, DOI 10.1111/j.0886-0440.2004.4073_11.x; Dhawan S, 2004, ECHOCARDIOGR-J CARD, V21, P621, DOI 10.1111/j.0742-2822.2004.03135.x; Erentug Vedat, 2003, Anadolu Kardiyol Derg, V3, P288; Konishi H, 2001, ANN THORAC SURG, V71, P2022, DOI 10.1016/S0003-4975(00)02576-5; Kurdi M, 2004, CAN J CARDIOL, V20, P549; Letsas K, 2005, Minerva Cardioangiol, V53, P337; Markides V, 2000, Eur J Echocardiogr, V1, P291, DOI 10.1053/euje.2000.0027; Mendoza CE, 2001, TEX HEART I J, V28, P3; Porter A, 2005, CORONARY ARTERY DIS, V16, P275, DOI 10.1097/00019501-200508000-00003; Ribot S, 2005, AM J MED SCI, V330, P204, DOI 10.1097/00000441-200510000-00011; Tenedios F, 2006, RHEUM DIS CLIN N AM, V32, P491, DOI 10.1016/j.rdc.2006.05.008; Terracciano LM, 2000, AM J CLIN PATHOL, V114, P754, DOI 10.1309/NR6G-T872-F090-LBRW; Thomas CE, 2005, SEMIN NEUROL, V25, P371, DOI 10.1055/s-2005-923531; Toth C, 2002, ACTA CARDIOL, V57, P205, DOI 10.2143/AC.57.3.2005390	17	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1137	1145		10.1056/NEJMcpc079022	http://dx.doi.org/10.1056/NEJMcpc079022			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855675				2022-12-28	WOS:000249387200011
J	Seife, C				Seife, C			Economics Nobel - Dealing with biases and discrete choices	SCIENCE			English	News Item														Seife, Charles/0000-0001-5309-8716					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					427	427		10.1126/science.290.5491.427	http://dx.doi.org/10.1126/science.290.5491.427			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	17844279				2022-12-28	WOS:000089946000010
J	WEINER, AM; LEAIRD, DE; WIEDERRECHT, GP; NELSON, KA				WEINER, AM; LEAIRD, DE; WIEDERRECHT, GP; NELSON, KA			FEMTOSECOND PULSE SEQUENCES USED FOR OPTICAL MANIPULATION OF MOLECULAR-MOTION	SCIENCE			English	Article									MIT,DEPT CHEM,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	WEINER, AM (corresponding author), BELL COMMUN RES INC,331 NEWMAN SPRINGS RD,RED BANK,NJ 07701, USA.							CHESNOY J, 1988, PHYS REV A, V38, P3566, DOI 10.1103/PhysRevA.38.3566; DANTUS M, 1988, J CHEM PHYS, V89, P6128, DOI 10.1063/1.455428; DESILVESTRI S, 1985, CHEM PHYS LETT, V116, P146, DOI 10.1016/0009-2614(85)80143-3; FORK RL, 1981, APPL PHYS LETT, V38, P671, DOI 10.1063/1.92500; HANER M, 1988, APPL PHYS LETT, V52, P1458, DOI 10.1063/1.99097; HARTKE B, 1989, CHEM PHYS LETT, V158, P238, DOI 10.1016/0009-2614(89)87328-2; JOLY AG, 1988, SPRINGER SERIES CHEM, V48, P506; KNOX WH, 1984, OPT LETT, V9, P552, DOI 10.1364/OL.9.000552; KOBAYASHI T, 1978, J CHEM PHYS, V69, P3570, DOI 10.1063/1.437062; KOSIC TJ, 1983, CHEM PHYS LETT, V96, P57, DOI 10.1016/0009-2614(83)80117-1; LIN CP, 1987, J CHEM PHYS, V86, P3750, DOI 10.1063/1.451976; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; RUHMAN S, 1987, REV PHYS APPL, V22, P1717, DOI 10.1051/rphysap:0198700220120171700; SHI SH, 1988, J CHEM PHYS, V88, P6870, DOI 10.1063/1.454384; TANAKA J, 1974, B CHEM SOC JPN, V47, P2376, DOI 10.1246/bcsj.47.2376; TANNOR DJ, 1986, J CHEM PHYS, V85, P5805, DOI 10.1063/1.451542; VALDMANIS JA, 1985, OPT LETT, V10, P131, DOI 10.1364/OL.10.000131; WARREN WS, 1988, SCIENCE, V242, P878, DOI 10.1126/science.3055299; WEINER AM, 1988, J OPT SOC AM B, V5, P1563, DOI 10.1364/JOSAB.5.001563; WEINER AM, 1988, OPT LETT, V13, P300, DOI 10.1364/OL.13.000300; WEINER AM, 1990, OPT LETT, V15, P51, DOI 10.1364/OL.15.000051; WEINER AM, 1988, PHYS REV LETT, V61, P2445, DOI 10.1103/PhysRevLett.61.2445; WEINER AM, 1989, OCT OPT SOC AM ANN M; WISE FW, 1987, J CHEM PHYS, V86, P2827, DOI 10.1063/1.452032; YAN YX, 1985, J CHEM PHYS, V83, P5391, DOI 10.1063/1.449708; YAN YX, 1988, ADV SPECTROSCOPY SER, V16, P299	26	386	399	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1317	1319		10.1126/science.247.4948.1317	http://dx.doi.org/10.1126/science.247.4948.1317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843793				2022-12-28	WOS:A1990CU25300030
J	SANDERS, LC; LORD, EM				SANDERS, LC; LORD, EM			DIRECTED MOVEMENT OF LATEX-PARTICLES IN THE GYNOECIA OF 3 SPECIES OF FLOWERING PLANTS	SCIENCE			English	Article											SANDERS, LC (corresponding author), UNIV CALIF RIVERSIDE,DEPT BOT & PLANT SCI,RIVERSIDE,CA 92521, USA.							BRONNERFRASER M, 1985, DEV BIOL, V108, P131, DOI 10.1016/0012-1606(85)90015-6; CLARKE A, 1979, P NATL ACAD SCI USA, V76, P3358, DOI 10.1073/pnas.76.7.3358; CLARKE AE, 1981, EXTRACELLULAR CARBOH, P517; DUFOUR S, 1988, TRENDS GENET, V4, P198, DOI 10.1016/0168-9525(88)90076-5; Heslop-Harrison J, 1986, BIOL REPRODUCTION CE, P169; HESLOPHARRISON J, 1983, PROC R SOC SER B-BIO, V218, P371, DOI 10.1098/rspb.1983.0046; HILL JP, 1987, AM J BOT, V74, P988, DOI 10.2307/2443938; Knox R. B., 1984, Cellular interactions, P508; LORD EM, 1986, AM J BOT, V73, P70, DOI 10.2307/2444279; Mascarenhas J.P., 1978, RECEPTORS RECOGNITIO, P171; NEWMAN SA, 1985, SCIENCE, V228, P885, DOI 10.1126/science.4001925; PICTON JM, 1982, J THEOR BIOL, V98, P158; SHIVANNA KR, 1979, DEV PHYSL ANGIOSPERM, P59; [No title captured]	14	96	99	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1606	1608		10.1126/science.243.4898.1606	http://dx.doi.org/10.1126/science.243.4898.1606			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847262				2022-12-28	WOS:A1989T795200038
J	Whisson, SC; Boevink, PC; Moleleki, L; Avrova, AO; Morales, JG; Gilroy, EM; Armstrong, MR; Grouffaud, S; van West, P; Chapman, S; Hein, I; Toth, IK; Pritchard, L; Birch, PRJ				Whisson, Stephen C.; Boevink, Petra C.; Moleleki, Lucy; Avrova, Anna O.; Morales, Juan G.; Gilroy, Eleanor M.; Armstrong, Miles R.; Grouffaud, Severine; van West, Pieter; Chapman, Sean; Hein, Ingo; Toth, Ian K.; Pritchard, Leighton; Birch, Paul R. J.			A translocation signal for delivery of oomycete effector proteins into host plant cells	NATURE			English	Article							PHYTOPHTHORA-INFESTANS; PSEUDOMONAS-SYRINGAE; POTATO INFECTION; DOWNY MILDEW; AVIRULENCE; GENE; RESISTANCE; SECRETION; PATHOGEN; TRANSCRIPTION	Bacterial(1), oomycete(2) and fungal(3) plant pathogens establish disease by translocation of effector proteins into host cells, where they may directly manipulate host innate immunity. In bacteria, translocation is through the type III secretion system(1), but analogous processes for effector delivery are uncharacterized in fungi and oomycetes. Here we report functional analyses of two motifs, RXLR and EER, present in translocated oomycete effectors(2). We use the Phytophthora infestans RXLR-EER-containing protein Avr3a as a reporter for translocation because it triggers RXLR-EER-independent hypersensitive cell death following recognition within plant cells that contain the R3a resistance protein(4,5). We show that Avr3a, with or without RXLR-EER motifs, is secreted from P. infestans biotrophic structures called haustoria, demonstrating that these motifs are not required for targeting to haustoria or for secretion. However, following replacement of Avr3a RXLR-EER motifs with alanine residues, singly or in combination, or with residues KMIK-DDK-representing a change that conserves physicochemical properties of the protein-P. infestans fails to deliver Avr3a or an Avr3a-GUS fusion protein into plant cells, demonstrating that these motifs are required for translocation. We show that RXLR-EER-encoding genes are transcriptionally upregulated during infection. Bioinformatic analysis identifies 425 potential genes encoding secreted RXLR-EER class proteins in the P. infestans genome. Identification of this class of proteins provides unparalleled opportunities to determine how oomycetes manipulate hosts to establish infection.	Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland; Univ Aberdeen, Inst Med Sci, Aberdeen Oomycete Grp, Aberdeen AB25 2ZD, Scotland	James Hutton Institute; University of Aberdeen	Birch, PRJ (corresponding author), Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland.	Paul.Birch@scri.ac.uk	Boevink, Petra/AAO-6498-2021; Pritchard, Leighton/A-7331-2008; Chapman, Sean N/H-5193-2013; Birch, Paul/F-7681-2012; Moleleki, Lucy/E-8951-2010	Boevink, Petra/0000-0002-7021-9097; Pritchard, Leighton/0000-0002-8392-2822; Moleleki, Lucy/0000-0002-1003-4621; Gilroy, Eleanor/0000-0002-5301-4268; Hein, Ingo/0000-0002-0128-2084; van West, Pieter/0000-0002-0767-6017; Birch, Paul/0000-0002-6559-3746	BBSRC [BB/E007120/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E007120/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Blanco FA, 2005, MOL MICROBIOL, V56, P638, DOI 10.1111/j.1365-2958.2005.04575.x; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; DENECKE J, 1990, PLANT CELL, V2, P51, DOI 10.1105/tpc.2.1.51; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Haldar K, 2006, NAT REV MICROBIOL, V4, P922, DOI 10.1038/nrmicro1549; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 1999, FEMS MICROBIOL LETT, V178, P71, DOI 10.1111/j.1574-6968.1999.tb13761.x	27	524	567	9	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					115	+		10.1038/nature06203	http://dx.doi.org/10.1038/nature06203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17914356				2022-12-28	WOS:000250585800048
J	Watanabe, K; Toh, Y; Suto, K; Shimizu, Y; Oka, N; Wada, T; Tomita, K				Watanabe, Kazunori; Toh, Yukimatsu; Suto, Kyoko; Shimizu, Yoshihiro; Oka, Natsuhisa; Wada, Takeshi; Tomita, Kozo			Protein-based peptide-bond formation by aminoacyl-tRNA protein transferase	NATURE			English	Article							N-END RULE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURES; PATHWAY; SYSTEM; FAMILY; NUCLEOTIDES; MECHANISM; INSIGHTS; SUBUNIT	Eubacterial leucyl/phenylalanyl-tRNA protein transferase (LF-transferase) catalyses peptide-bond formation by using Leu-tRNA(Leu) (or Phe-tRNA(Phe)) and an amino-terminal Arg (or Lys) of a protein, as donor and acceptor substrates, respectively. However, the catalytic mechanism of peptide-bond formation by LF-transferase remained obscure. Here we determine the structures of complexes of LF-transferase and phenylalanyl adenosine, with and without a short peptide bearing an N-terminal Arg. Combining the two separate structures into one structure as well as mutation studies reveal the mechanism for peptide-bond formation by LF-transferase. The electron relay from Asp 186 to Gln 188 helps Gln 188 to attract a proton from the alpha-amino group of the N-terminal Arg of the acceptor peptide. This generates the attacking nucleophile for the carbonyl carbon of the aminoacyl bond of the aminoacyl-tRNA, thus facilitating peptide-bond formation. The protein-based mechanism for peptide-bond formation by LF-transferase is similar to the reverse reaction of the acylation step observed in the peptide hydrolysis reaction by serine proteases.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Tomita, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	kozo-tomita@aist.go.jp	Tomita, Kozo/J-5746-2013; Oka, Natsuhisa/ABC-1654-2021; Toh, Yukimatsu/B-6549-2013; Shimizu, Yoshihiro/A-6472-2016; Tomita, Kozo/E-9390-2017; Watanabe, Kazunori/G-6671-2012	Oka, Natsuhisa/0000-0002-3114-9233; Shimizu, Yoshihiro/0000-0003-3499-1394; Tomita, Kozo/0000-0002-7374-3898; Watanabe, Kazunori/0000-0003-3678-636X				Abramochkin G, 1996, J BIOL CHEM, V271, P22901, DOI 10.1074/jbc.271.37.22901; Benson TE, 2002, STRUCTURE, V10, P1107, DOI 10.1016/S0969-2126(02)00807-9; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Biarrotte-Sorin S, 2004, STRUCTURE, V12, P257, DOI 10.1016/j.str.2004.01.006; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHLADEK S, 1973, BIOCHEMISTRY-US, V12, P5135, DOI 10.1021/bi00749a017; COWTAN K, 1994, NEWSLETTER PROTEIN C, V31, P34; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; GOTTIKH BP, 1970, TETRAHEDRON, V26, P4419, DOI 10.1016/S0040-4020(01)93090-X; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAJI H, 1963, Biochim Biophys Acta, V76, P474; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rodnina MV, 2007, TRENDS BIOCHEM SCI, V32, P20, DOI 10.1016/j.tibs.2006.11.007; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; SOFFER RL, 1973, J BIOL CHEM, V248, P8424; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Suto K, 2006, EMBO J, V25, P5942, DOI 10.1038/sj.emboj.7601433; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003	35	66	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					867	U5		10.1038/nature06167	http://dx.doi.org/10.1038/nature06167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17891155				2022-12-28	WOS:000250230600038
J	Westaby, S; Archer, N; Manning, N; Adwani, S; Grebenik, C; Ormerod, O; Pillai, R; Wilson, N				Westaby, Stephen; Archer, Nicholas; Manning, Nicola; Adwani, Satish; Grebenik, Catherine; Ormerod, Oliver; Pillai, Ravi; Wilson, Neil			Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality	BRITISH MEDICAL JOURNAL			English	Article							SURGICAL MORTALITY	Objective To verify or refute the value of hospital episode statistics (HES) in determining 30 day mortality after open congenital cardiac surgery in infants nationally in comparison with central cardiac audit database (CCAD) information. Design External review of paediatric cardiac surgical outcomes in England (HES) and all UK units (CCAD), as derived from each database. Setting Congenital heart surgery centres in the United Kingdom. Data sources HES for congenital heart surgery and corresponding information from CCAD for the period 1 April 2000 to 31 March 2002. HES was restricted to the 11 English centres; CCAD covered all 13 UK centres. Main outcome measure Mortality within 30 days of open heart surgery in infants aged under 12 months. Results In a direct comparison for the years when data from the 11 English centres were available from both databases, HES omitted between 5% and 38% of infants operated on in each centre. A median 40% (range 0-73%) shortfall occurred in identification of deaths by HES. As a result, mean 30 day mortality was underestimated at 4% by HES as compared with 8% for CCAD. In CCAD, between 1% and 23% of outcomes were missing in nine of 11 English centres used in the comparison (predominantly those for overseas patients). Accordingly, CCAD mortality could also be underestimated. Oxford provided the most complete dataset to HES, including all deaths recorded by CCAD. From three years of CCAD, Oxford's infant mortality from open cardiac surgery (10%) was not statistically different from the mean for all 13 UK centres (8%), in marked contrast to the conclusions drawn from HES for two of those years. Conclusions Hospital episode statistics are unsatisfactory for the assessment of activity and outcomes in congenital heart surgery. The central cardiac audit database is more accurate and complete, but furtherwork is needed to achieve fully comprehensive risk stratified mortality data. Given unresolved limitations in data quality, commercial organisations should reconsider placing centre specific or surgeon specific mortality data in the public domain.	Oxford Radcliffe Hosp NHS Trust, Dept Cardiac Surg, Oxford OX3 9DU, England; Oxford Radcliffe Hosp NHS Trust, Dept Paediat Cardiol, Oxford OX3 9DU, England; Oxford Radcliffe Hosp NHS Trust, Dept Anaesthet, Oxford OX3 9DU, England; Oxford Radcliffe Hosp NHS Trust, Dept Cardiol, Oxford OX3 9DU, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Westaby, S (corresponding author), Oxford Radcliffe Hosp NHS Trust, Dept Cardiac Surg, Oxford OX3 9DU, England.	swestaby@AHF.org.uk						Aylin P, 2004, BRIT MED J, V329, P825, DOI 10.1136/bmj.329.7470.825; Bristol Royal Infirmary Inquiry, 2001, CM5207; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Gibbs JL, 2004, BRIT MED J, V328, P611, DOI 10.1136/bmj.38027.613403.F6; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Mack MJ, 2005, J THORAC CARDIOV SUR, V129, P1309, DOI 10.1016/j.jtcvs.2004.10.036; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Ryan TJ, 2007, CIRCULATION, V115, P1508, DOI 10.1161/CIRCULATIONAHA.106.686725; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; SPIEGELHALTER DJ, 2000, OVERVIEW STAT EVIDEN; *THAM VALL STRAT H, 2005, REP PAED CARD SURG S; WESTABY S, 2002, BR J CARDIOL ACUTE I, V9, P5	14	59	61	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2007	335	7623					759	A762		10.1136/bmj.39318.644549.AE	http://dx.doi.org/10.1136/bmj.39318.644549.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17884862	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000250418600034
J	Ahimastos, AA; Aggarwal, A; D'Orsa, KM; Formosa, MF; White, AJ; Savarirayan, R; Dart, AM; Kingwell, BA				Ahimastos, Anna A.; Aggarwal, Anuradha; D'Orsa, Kellie M.; Formosa, Melissa F.; White, Anthony J.; Savarirayan, Ravi; Dart, Anthony M.; Kingwell, Bronwyn A.			Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING ENZYME-INHIBITORS; BETA-ADRENERGIC-BLOCKADE; SMOOTH-MUSCLE-CELLS; PROPRANOLOL; DILATATION; ANEURYSMS; HYPERTENSION; IMPROVEMENT; INCREASES; PRESSURE	Context Aortic stiffness is increased in Marfan syndrome contributing to aortic dilatation and rupture, the major cause of premature death in this population. Angiotensin-converting enzyme inhibitors have been shown to reduce arterial stiffness. Objective To determine whether perindopril therapy reduces aortic stiffness and attenuates aortic dilatation in patients with Marfan syndrome. Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial of 17 patients with Marfan syndrome (mean [SD], 33 [6] years) taking standard beta-blocker therapy, initiated in January 2004 and completed in September 2006, at Alfred Hospital Marfan Syndrome Clinic, Melbourne, Australia. Intervention Patients were administered 8 mg/d of perindopril (n = 10) or placebo (n = 7) for 24 weeks. Main Outcome Measures Indices of arterial stiffness were assessed via systemic arterial compliance, and central and peripheral pulse wave velocities. Aortic root diameters were assessed at 4 sites via transthoracic echocardiography. Results Perindopril reduced arterial stiffness as indicated by increased systemic arterial compliance (mean [SEM], 0.33 [0.01] mL/mm Hg at baseline to 0.54 [0.04] mL/mm Hg at 24 weeks in perindopril group vs 0.30 [0.01] mL/mm Hg to 0.29 [0.01] mL/mm Hg in placebo group, P = .004), and reduced central (7.6 [0.4] m/s to 5.9 [0.3] m/s in perindopril group, P < .001 vs placebo) and peripheral (10.9 [0.4] m/s to 8.7 [0.4] m/s in perindopril group, P < .001 vs placebo) pulse wave velocities. In addition, perindopril significantly reduced aortic root diameters relative to placebo in both end-systole and end-diastole (P < .01 to P < .001 for all comparisons between groups). Although perindopril marginally reduced mean arterial pressure (from 81 [2] mm Hg to 80 [1] mmHg in perindopril group vs 83 [2] mmHg to 84 [3] mmHg in placebo group, P = .004), the observed changes in both stiffness and left ventricular outflow tract diameter remained significant when mean arterial pressure was included as a covariate. Transforming growth factor beta (TGF-beta), which contributes to aortic degeneration in Marfan syndrome, was reduced by perindopril compared with placebo in both latent (59 [6] ng/mL to 45 [3] ng/mL in perindopril group, P = .01 vs placebo) and active (46 [2] ng/mL to 42 [1] ng/mL in perindopril group, P = .02 vs placebo) forms. Conclusions Perindopril reduced both aortic stiffness and aortic root diameter in patients with Marfan syndrome taking standard beta-blocker therapy, possibly through attenuation of TGF-beta signaling. Large clinical trials are needed to assess the clinical benefit of angiotensin II blockade in Marfan syndrome.	Baker Heart Res Inst, Alfred & Baker Med Unit, Central Melbourne, Vic 8008, Australia; Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Murdoch, WA, Australia; Univ Melbourne, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Royal Melbourne Hospital; Murdoch Children's Research Institute; University of Melbourne	Kingwell, BA (corresponding author), Baker Heart Res Inst, Alfred & Baker Med Unit, POB 6492,St Kilda Rd, Central Melbourne, Vic 8008, Australia.	bronwyn.kingwell@baker.edu.au	Dart, Anthony/E-7461-2010	Dart, Anthony/0000-0003-1360-3778				Ahimastos AA, 2005, HYPERTENSION, V45, P1194, DOI 10.1161/01.HYP.0000168945.44069.aa; Asmar RG, 2001, HYPERTENSION, V38, P922, DOI 10.1161/hy1001.095774; CAMERON JD, 1994, AM J PHYSIOL, V266, pH693, DOI 10.1152/ajpheart.1994.266.2.H693; CUSHMAN DW, 1989, BRIT J CLIN PHARMACO, V28, pS115, DOI 10.1111/j.1365-2125.1989.tb03587.x; Dean JCS, 2007, EUR J HUM GENET, V15, P724, DOI 10.1038/sj.ejhg.5201851; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Girerd X, 1998, J AM COLL CARDIOL, V31, P1064, DOI 10.1016/S0735-1097(98)00043-6; Gott VL, 1999, NEW ENGL J MED, V340, P1307, DOI 10.1056/NEJM199904293401702; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Kingwell BA, 1997, AM J PHYSIOL-HEART C, V273, pH2186, DOI 10.1152/ajpheart.1997.273.5.H2186; Kornbluth M, 1999, AM J CARDIOL, V84, P753, DOI 10.1016/S0002-9149(99)00430-0; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; Lindholt JS, 1999, INT ANGIOL, V18, P52; LIU ZR, 1986, AM J PHYSIOL, V251, pH588, DOI 10.1152/ajpheart.1986.251.3.H588; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; MOURSI MM, 1995, J VASC SURG, V21, P792, DOI 10.1016/S0741-5214(05)80010-2; Nagashima H, 2002, J VASC SURG, V36, P818, DOI 10.1067/mva.2002.126091; Nagashima H, 2001, CIRCULATION, V104, pI282; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pannier BM, 2001, CLIN EXP PHARMACOL P, V28, P1074, DOI 10.1046/j.1440-1681.2001.03570.x; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032	31	143	151	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1539	1547		10.1001/jama.298.13.1539	http://dx.doi.org/10.1001/jama.298.13.1539			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911499	Bronze			2022-12-28	WOS:000249860500026
J	Patel, AA; Chen, MH; Renshaw, AA; D'Amico, AV				Patel, Abhijit A.; Chen, Ming-Hui; Renshaw, Andrew A.; D'Amico, Anthony V.			PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; CONFORMAL RADIATION-THERAPY; PROGNOSTIC-SIGNIFICANCE; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; ANDROGEN SUPPRESSION; CONSENSUS CONFERENCE; RADIOTHERAPY; ADENOCARCINOMA; CARCINOMA	Context In 2005, the International Society of Urologic Pathology consensus conference recommended that men with biopsy Gleason score 3 + 4 or 4 + 3 prostate cancer and tertiary pattern 5 should have their cancer classified as Gleason score 8 or 9, respectively. Yet, the management of men with Gleason score 7 vs 8 or 9 prostate cancer differs. Objective To compare the prognostic significance of Gleason score 7 with tertiary grade 5 vs other Gleason scores with respect to time to prostate-specific antigen (PSA) failure in men with prostate cancer. Design, Setting, and Patients From 1989 to 2005, 2370 men with clinical tumor category 1c to 3b, node-negative, and nonmetastatic prostate cancer underwent definitive therapy with surgery or radiation therapy with or without hormonal therapy. A pathologist with expertise in genitourinary cancers assigned Gleason scores to the prostate needle biopsy specimens. Cox regression was used to assess whether a significant association existed between the presence of tertiary grade 5 in men with Gleason score 7 disease and time to recurrence compared with men with Gleason score 7 without tertiary grade 5, Gleason score 5 to 6, or 8 to 10 disease, adjusting for known prognostic factors and treatment. Main Outcome Measure Time to PSA failure. Results Men with Gleason score 7 and tertiary grade 5 disease had a significantly shorter time to PSA failure than men with 7 without tertiary grade 5 (median time, 5.0 vs 6.7 years, respectively; adjusted hazard ratio (HR), 0.56; 95% confidence interval [CI], 0.32-0.97; P = .04) or score of 6 or less (median time, 15.4 years; adjusted HR, 0.24; 95% CI, 0.13-0.43; P < .001). However, a significant difference was not observed when these men were compared with men with Gleason score 8 to 10 disease (median time, 5.1 years; adjusted HR, 0.96; 95% CI, 0.54-1.71; P = .90). Conclusion In this study population, men with prostate cancer having biopsy Gleason score 7 and tertiary grade 5 had a higher risk of PSA-failure when compared with men with Gleason score 7 without tertiary grade 5 and had a comparable risk with men with Gleason score 8 to 10.	Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Baptist Hosp Miami, Dept Pathol, Miami, FL USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Baptist Hospital Miami; University of Connecticut	Patel, AA (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St,L-2 Level, Boston, MA 02115 USA.	aapatel@partners.org			NATIONAL CANCER INSTITUTE [R01CA074015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070335] Funding Source: NIH RePORTER; NCI NIH HHS [CA 74015] Funding Source: Medline; NIGMS NIH HHS [GM 70335] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALHARA M, 1994, UROLOGY, V43, P60; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Egevad L, 2005, HUM PATHOL, V36, P5, DOI 10.1016/j.humpath.2004.10.001; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7; Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023; Hattab EM, 2006, J UROLOGY, V175, P1695, DOI 10.1016/S0022-5347(05)00998-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kattan MW, 2003, J CLIN ONCOL, V21, P4568, DOI 10.1200/JCO.2003.05.046; Klein JP, 1997, SURVIVAL ANAL TECHNI, P96; MELLINGER GT, 1967, J UROLOGY, V97, P331, DOI 10.1016/S0022-5347(17)63039-8; Mosse CA, 2004, AM J SURG PATHOL, V28, P394, DOI 10.1097/00000478-200403000-00014; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Pan CC, 2000, AM J SURG PATHOL, V24, P563, DOI 10.1097/00000478-200004000-00011; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Pollack A, 2000, J CLIN ONCOL, V18, P3904, DOI 10.1200/JCO.2000.18.23.3904; Rasiah KK, 2003, CANCER, V98, P2560, DOI 10.1002/cncr.11850; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Sim HG, 2007, J UROLOGY, V177, P157, DOI 10.1016/S0022-5347(18)30723-7; Trpkov K, 2007, MODERN PATHOL, V20, p180A; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	28	56	57	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1533	1538		10.1001/jama.298.13.1533	http://dx.doi.org/10.1001/jama.298.13.1533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911498	Bronze			2022-12-28	WOS:000249860500025
J	Dixon, J; Chantler, C; Billings, J				Dixon, Jennifer; Chantler, Cyril; Billings, John			Competition on outcomes and physician leadership are not enough to reform health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Kings Fund Inst, London W1G 0AN, England; NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA	New York University	Dixon, J (corresponding author), Kings Fund Inst, 11-13 Cavendish Sq, London W1G 0AN, England.	jdixon@kingsfund.org.uk						Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; *BRIST ROYAL INF I, LEARN BRIST REP PUBL; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Chantler C, 2006, JAMA-J AM MED ASSOC, V296, P2255, DOI 10.1001/jama.296.18.2255; Davies Huw, 2007, J Health Serv Res Policy, V12, P129, DOI 10.1258/135581907781543139; HARVEY SL, 2007, WINDMILL 2007 SIMULA; *KINGS FUND WEB SI, 2007, HLTH 10 YEARS LAB GO; Kmietowicz Z, 2002, BRIT MED J, V324, P994, DOI 10.1136/bmj.324.7344.994; Lewis R, 2007, PRACTICE BASED COMMI; LIGHT DW, 1998, EFFECTIVE COMMISSION; *NAT HLTH SERV WEB, 2007, FRAM ACT; PALMER K, 2006, NHS REFORM GETTING B; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; *UK DEP HLTH WEB, DEP HLTH BUS PLAN 20; *UK DEP HLTH WEB S, EXP PAT PROGR; *UK DEP HLTH WEB S, NAT SERV FRAM NSFS; *UK DEP HLTH WEB S, TREATM CTR; *UK DEP HLTH WEB S, PRACT BAS COMM ENG P; *UK DEP HLTH WEB S, NHS FDN TRUSTS; *UK DEP HLTH WEB S, OUR HLTH OUR CAR OUR; *UK DEP HLTH WEB S, PAYM RES 2007 08 NAT; *UK DEP HLTH WEB S, CAS MAN; *UK DEP HLTH WEB S, QUAL OUTC FRAM GUID; *UK DEP HLTH WEB S, 2001, CANC SERV COLL 12 MO	24	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1445	1447		10.1001/jama.298.12.1445	http://dx.doi.org/10.1001/jama.298.12.1445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895462				2022-12-28	WOS:000249698900025
J	Woodcock, J; Banister, D; Edwards, P; Prentice, AM; Roberts, I				Woodcock, James; Banister, David; Edwards, Phil; Prentice, Andrew M.; Roberts, Ian			Energy and health 3 - Energy and transport	LANCET			English	Article							PHYSICAL-ACTIVITY; CLIMATE-CHANGE; AIR-POLLUTION; WALKING; ENVIRONMENT; DISEASE; IMPACT	We examine the links between fossil-fuel-based transportation, greenhouse-gas emissions, and health. Transport-related carbon emissions are rising and there is increasing consensus that the growth in motorised land vehicles and aviation is incompatible with averting serious climate change. The energy intensity of land transport correlates with its adverse health effects. Adverse health effects occur through climate change, road-traffic injuries, physical inactivity, urban air pollution, energy-related conflict, and environmental degradation. For the world's poor people, walking is the main mode of transport, but such populations often experience the most from the harms of energy-intensive transport. New energy sources and improvements in vehicle design and in information technology are necessary but not sufficient to reduce transport-related carbon emissions without accompanying behavioural change. By contrast, active transport has the potential to improve health and equity, and reduce emissions. Cities require safe and pleasant environments for active transport with destinations in easy reach and, for longer journeys, public transport that is powered by renewable energy, thus providing high levels of accessibility without car use. Much investment in major road projects does not meet the transport needs of poor people, especially women whose trips are primarily local and off road. Sustainable development is better promoted through improving walking and cycling infrastructures, increasing access to cycles, and investment in transport services for essential needs. Our model of London shows how increased active transport could help achieve substantial reductions in emissions by 2030 while improving population health. There exists the potential for a global contraction and convergence in use of fossil-fuel energy for transport to benefit health and achieve sustainability.	London Sch Hyg & Trop Med, London WC1E 5HT, England; Univ Oxford St Annes Coll, Oxford OX2 6HS, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Woodcock, J (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 5HT, England.	james.woodcock@lshtm.ac.uk	Woodcock, James/AAH-6753-2021; Prentice, Andrew/AAG-1961-2019	Edwards, Phil/0000-0003-4431-8822; Woodcock, James/0000-0003-4769-5375				Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; Asian Development Bank, 2006, EN EFF CLIM CHANG CO; Badami MG, 2005, INT DEV PLANN REV, V27, P169, DOI 10.3828/idpr.27.2.2; Banister D, 2004, TRANSPORT REV, V24, P611, DOI 10.1080/0144164042000206060; BANISTER D, 2006, PLANN RES C LOND APR; BANISTER D, VISIONING BACKCASTIN; Banister D., 2005, UNSUSTAINABLE TRANSP; BANISTER D, 2005, ROLE TRANSPORT SUPPO; Brand C, 2006, INTEGRATED TRAVEL EM; Bull FC, 2004, COMP QUANTIFICATION, DOI DOI 10.1016/j.diabres.2013.11.002; Cairns S, 2002, P I CIVIL ENG-MUNIC, V151, P13; Cairns S., 2006, PREDICT DECIDE AVIAT; CARSON I, 2004, ECONOMIST       0902; Chen CH, 2006, ENERG POLICY, V34, P754, DOI 10.1016/j.enpol.2004.07.007; *CHRISTIANAID, 2003, FUELL POV OIL WAR CO; *CIV AV AUTH, CAA PUBL AIR PASS SU; *DEP TRANSP, GREENH GAS EM TRANSP; Dora C, 2003, B WORLD HEALTH ORGAN, V81, P399; *EARTHTRENDS, SUST TRANSP DEV WORL; *EUR COMM, KEEP EUR MOV SUST MO; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Freund P, 2001, DISABIL SOC, V16, P689, DOI 10.1080/09687590120070079; Frumkin H., 2004, URBAN SPRAWL PUBLIC; FULTON L, REDUCING OIL CONSUMP; HAINES A, 2007, LANCET, DOI DOI 10.1016/S0140-6736(07)61254-9; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Heinrich J., 2005, HLTH EFFECTS TRANSPO; HILLMAN M, 2005, WE CAN SAVE PLANET; Hillman M., 1990, ONE FALSE MOVE STUDY; Howe J., 2001, WORLD TRANSPORT POLI, V7, P8; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Jackson-Leach R, 2004, COMP QUANTIFICATION; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; KEUKEN M, 2005, HLTH EFFECTS TRANSPO; Killoran A, 2006, TRANSPORT INTERVENTI; Krzyanowski M., 2005, HLTH EFFECTS TRANSPO; Lipfert FW, 2004, J EPIDEMIOL COMMUN H, V58, P2, DOI 10.1136/jech.58.1.2; LITMAN T, 2006, MOBILITY POSITIONAL; LOPEZCASANOVAS G, 2005, HLTH EC GROWTH; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; MASHIRI M, TRANSPORT SECTOR JOI; McMichael AJ, 2002, LANCET, V359, P1145, DOI 10.1016/S0140-6736(02)08164-3; Mitchell G, 2003, ENVIRON PLANN A, V35, P909, DOI 10.1068/a35240; MOHAN D, 2002, INDIAN J TRANSPORT M, V26, P225; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Patz JA, 2002, BMJ-BRIT MED J, V325, P1094, DOI 10.1136/bmj.325.7372.1094; Peden M., 2004, WORLD REPORT ROAD TR; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Pruss-Ustun A., 2004, COMP QUANTIFICATION; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Roberts I, 2007, BRIT MED J, V334, P324, DOI 10.1136/bmj.39125.468171.80; *ROYAL COMM ENV PO, 2002, ENV EFF CIV AIRCR FL; Sachs JD, 2001, EUR ECON REV, V45, P827, DOI 10.1016/S0014-2921(01)00125-8; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sausen R, 2005, METEOROL Z, V14, P555, DOI 10.1127/0941-2948/2005/0049; Schade B, 2005, TRANSPORT REV, V25, P647, DOI 10.1080/01441640500361033; Sharma DC, 2006, ENVIRON HEALTH PERSP, V114, pA222, DOI 10.1289/ehp.114-a222; *STAND ADV COMM TR, TRANSP EC FULL REP; Stern N., STERN REV EC CLIMATE; Sturm R, 2004, PUBLIC HEALTH, V118, P488, DOI 10.1016/j.puhe.2004.02.007; Tiwari G, 2002, BRIT MED J, V324, P1164, DOI 10.1136/bmj.324.7346.1164; *UN EN, SUST BIOEN FRAM DEC; VALLETTE J, ENERGY TUG WAR WINNE; van Wee B., 2004, EUR J TRANSP INFRAST, V4, P47; Watkiss P., 2000, INFORMING TRANSPORT; WHITELEGG J, 2003, EARTHSCAN READER WOR, P3; *WHO, 2003, NEGL GLOB EP 3 GROW, pCH6; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; WILSON ME, 2003, J APPL MICROBIOL, V94, P1; Wright L, 2005, TRANSPORT REV, V25, P691, DOI 10.1080/01441640500360951; YULIN J, 2006, WORLD TRANSPORT POLI, V12, P17; Zhou W., 2006, WORLD TRANSPORT POLI, V12, P10; ZIMMERMANN N, INJURIES EUROPEAN UN; 2006, GREENH GAS EM US TRA	79	216	218	4	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1078	1088		10.1016/S0140-6736(07)61254-9	http://dx.doi.org/10.1016/S0140-6736(07)61254-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17868817				2022-12-28	WOS:000249727900031
J	Jaillais, Y; Santambrogio, M; Rozier, F; Fobis-Loisy, I; Miege, C; Gaude, T				Jaillais, Yvon; Santambrogio, Martina; Rozier, Frederique; Fobis-Loisy, Isabelle; Miege, Christine; Gaude, Thierry			The retromer protein VPS29 links cell polarity and organ initiation in plants	CELL			English	Article							DEPENDENT AUXIN GRADIENTS; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; REQUIRES RETROMER; EFFLUX; TRANSPORT; TRAFFICKING; RECEPTOR; WNT; PHOSPHOESTERASE	A key feature of plants ( as opposed to animals) is their ability to establish new organs not only during embryogenesis, but also throughout their development. A master regulator of organ initiation in plants is the phytohormone auxin. Auxin acts locally as a morphogen and is directionally transported from cell to cell by polarized auxin efflux carriers, termed PIN- FORMED ( PIN) proteins. Here we report that the Arabidopsis ortholog of the yeast and mammalian vacuolar protein sorting 29 ( VPS29), a member of the retromer complex, mediates the formation of new axes of development. Furthermore, we show that VPS29 is required for endosome homeostasis, PIN protein cycling, and dynamic PIN1 repolarization during development. We propose a model that links VPS29 function, PIN1 polarity, and organ initiation in plants.	Univ Lyon 1, Ecole Normale Super Lyon, CNRS,Inst Natl Rech Agronom, Inst Federatif Rech 128,Reprod & Dev Plantes, 48 Allee Italie, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS,Inst Natl Rech Agronom, Inst Federatif Rech 128,Reprod & Dev Plantes, 48 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; GAUDE, Thierry/0000-0002-0804-9445				Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Lavy M, 2007, CURR BIOL, V17, P947, DOI 10.1016/j.cub.2007.04.038; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, CURR OPIN PLANT BIOL, V8, P613, DOI 10.1016/j.pbi.2005.09.003; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	40	179	186	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1057	1070		10.1016/j.cell.2007.08.040	http://dx.doi.org/10.1016/j.cell.2007.08.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889650	Bronze			2022-12-28	WOS:000250507500015
J	Zuber, MT; Phillips, RJ; Andrews-Hanna, JC; Asmar, SW; Konopliv, AS; Lemoine, FG; Plaut, JJ; Smith, DE; Smrekar, SE				Zuber, Maria T.; Phillips, Roger J.; Andrews-Hanna, Jeffrey C.; Asmar, Sami W.; Konopliv, Alexander S.; Lemoine, Frank G.; Plaut, Jeffrey J.; Smith, David E.; Smrekar, Suzanne E.			Density of Mars' south polar layered deposits	SCIENCE			English	Article							CAP	Both poles of Mars are hidden beneath caps of layered ice. We calculated the density of the south polar layered deposits by combining the gravity field obtained from initial results of radio tracking of the Mars Reconnaissance Orbiter with existing surface topography from the Mars Orbiter Laser Altimeter on the Mars Global Surveyor spacecraft and basal topography from the Mars Advanced Radar for Subsurface and Ionospheric Sounding on the Mars Express spacecraft. The results indicate a best-fit density of 1220 kilograms per cubic meter, which is consistent with water ice that has similar to 15% admixed dust. The results demonstrate that the deposits are probably composed of relatively clean water ice and also refine the martian surface-water inventory.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91009 USA; NASA, Goddard Space Flight Ctr, Solar syst Explorat div, Greenbelt, MD 20771 USA	Massachusetts Institute of Technology (MIT); Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zuber@mit.edu	Lemoine, Frank/D-1215-2013; Smrekar, Suzanne/AAH-8074-2020	Smrekar, Suzanne/0000-0001-8775-075X; Lemoine, Frank G./0000-0002-3051-1456				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Durham WB, 1999, GEOPHYS RES LETT, V26, P3493, DOI 10.1029/1999GL008373; Johnson CL, 2000, ICARUS, V144, P313, DOI 10.1006/icar.1999.6310; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Neumann GA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002262; PARKER RL, 1973, GEOPHYS J ROY ASTR S, V31, P447, DOI 10.1111/j.1365-246X.1973.tb06513.x; PHILLIPS RJ, 2007, 7 INT C MARS 9 13 JU; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; Zuber MT, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002833; Zurek RW, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002701	15	63	65	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1718	1719		10.1126/science.1146995	http://dx.doi.org/10.1126/science.1146995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885129				2022-12-28	WOS:000249585900038
J	Houck, AA; Schuster, DI; Gambetta, JM; Schreier, JA; Johnson, BR; Chow, JM; Frunzio, L; Majer, J; Devoret, MH; Girvin, SM; Schoelkopf, RJ				Houck, A. A.; Schuster, D. I.; Gambetta, J. M.; Schreier, J. A.; Johnson, B. R.; Chow, J. M.; Frunzio, L.; Majer, J.; Devoret, M. H.; Girvin, S. M.; Schoelkopf, R. J.			Generating single microwave photons in a circuit	NATURE			English	Article							QUANTUM ELECTRODYNAMICS; ROOM-TEMPERATURE; NUMBER STATES; CAVITY; FLUORESCENCE; MOLECULE; DEMAND; ATOM; ION	Microwaves have widespread use in classical communication technologies, from long-distance broadcasts to short-distance signals within a computer chip. Like all forms of light, microwaves, even those guided by the wires of an integrated circuit, consist of discrete photons(1). To enable quantum communication between distant parts of a quantum computer, the signals must also be quantum, consisting of single photons, for example. However, conventional sources can generate only classical light, not single photons. One way to realize a single-photon source(2) is to collect the fluorescence of a single atom. Early experiments measured the quantum nature of continuous radiation(3,4), and further advances allowed triggered sources of photons on demand(5-11). To allow efficient photon collection, emitters are typically placed inside optical or microwave cavities(12-19), but these sources are difficult to employ for quantum communication on wires within an integrated circuit. Here we demonstrate an on-chip, on-demand single-photon source, where the microwave photons are injected into a wire with high efficiency and spectral purity. This is accomplished in a circuit quantum electrodynamics architecture(20), with a microwave transmission line cavity that enhances the spontaneous emission of a single superconducting qubit. When the qubit spontaneously emits, the generated photon acts as a flying qubit, transmitting the quantum information across a chip. We perform tomography of both the qubit and the emitted photons, clearly showing that both the quantum phase and amplitude are transferred during the emission. Both the average power and voltage of the photon source are characterized to verify performance of the system. This single-photon source is an important addition to a rapidly growing toolbox for quantum optics on a chip.	Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Dept Phys, New Haven, CT 06520 USA	Yale University; Yale University	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	robert.schoelkopf@yale.edu	Frunzio, Luigi/O-1573-2019; Schoelkopf, Robert J/J-8178-2012; Majer, Johannes B/C-1864-2008	Frunzio, Luigi/0000-0002-0272-5481; Majer, Johannes B/0000-0002-5192-1809; schuster, david/0000-0002-0012-3874				BASCHE T, 1992, PHYS REV LETT, V69, P1516, DOI 10.1103/PhysRevLett.69.1516; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Brattke S, 2001, PHYS REV LETT, V86, P3534, DOI 10.1103/PhysRevLett.86.3534; Brunel C, 1999, PHYS REV LETT, V83, P2722, DOI 10.1103/PhysRevLett.83.2722; CLAUSER JF, 1974, PHYS REV D, V9, P853, DOI 10.1103/PhysRevD.9.853; Darquie B, 2005, SCIENCE, V309, P454, DOI 10.1126/science.1113394; DIEDRICH F, 1987, PHYS REV LETT, V58, P203, DOI 10.1103/PhysRevLett.58.203; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; KOCH J, 2007, IN PRESS PHYS REV A; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; Leonhardt U., 1997, MEASURING QUANTUM ST; Lounis B, 2000, NATURE, V407, P491, DOI 10.1038/35035032; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Michler P, 2000, NATURE, V406, P968, DOI 10.1038/35023100; Moreau E, 2001, APPL PHYS LETT, V79, P2865, DOI 10.1063/1.1415346; Oxborrow M, 2005, CONTEMP PHYS, V46, P173, DOI 10.1080/00107510512331337936; Pelton M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.233602; PURCELL EM, 1946, PHYS REV, V69, P681; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	29	330	337	3	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					328	331		10.1038/nature06126	http://dx.doi.org/10.1038/nature06126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882217	Green Submitted			2022-12-28	WOS:000249557300042
J	Kleiner, K				Kleiner, Kurt			The shipping forecast	NATURE			English	News Item																			0	3	3	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					272	273		10.1038/449272a	http://dx.doi.org/10.1038/449272a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882191				2022-12-28	WOS:000249557300016
J	Markandya, A; Wilkinson, P				Markandya, Anil; Wilkinson, Paul			Energy and Health 2 - Electricity generation and health	LANCET			English	Article							PARTICULATE AIR-POLLUTION; LONG-TERM EXPOSURE; CARDIOPULMONARY MORTALITY; OZONE; ASSOCIATION; MORBIDITY; CHILDREN; MALARIA; DAMS	The provision of electricity has been a great benefit to society, particularly in health terms, but it also carries health costs. Comparison of different forms of commercial power generation by use of the fuel cycle methods developed in European studies shows the health burdens to be greatest for power stations that most pollute outdoor air (those based on lignite, coal, and oil). The health burdens are appreciably smaller for generation from natural gas, and lower still for nuclear power. This same ranking also applies in terms of greenhouse-gas emissions and thus, potentially, to long-term health, social, and economic effects arising from climate change. Nuclear power remains controversial, however, because of public concern about storage of nuclear waste, the potential for catastrophic accident or terrorist attack, and the diversion of fissionable material for weapons production. Health risks are smaller for nuclear fusion, but commercial exploitation will not be achieved in time to help the crucial near-term reduction in greenhouse-gas emissions. The negative effects on health of electricity generation from renewable sources have not been assessed as fully as those from conventional sources, but for solar, wind, and wave power, such effects seem to be small; those of biofuels depend on the type of fuel and the mode of combustion. Carbon dioxide (CO2) capture and storage is increasingly being considered for reduction of CO2 emissions from fossil fuel plants, but the health effects associated with this technology are largely unquantified and probably mixed: efficiency losses mean greater consumption of the primary fuel and accompanying increases in some waste products. This paper reviews the state of knowledge regarding the health effects of different methods of generating electricity.	Univ Bath, Dept Econ & Int Dev, Bath BA2 7AY, Avon, England; London Sch Hyg & Trop Med, London WC1, England	University of Bath; University of London; London School of Hygiene & Tropical Medicine	Markandya, A (corresponding author), Univ Bath, Dept Econ & Int Dev, Bath BA2 7AY, Avon, England.	A.Markandya@bath.ac.uk	Azkarate, Ainhoa/K-9087-2013; Markandya, Anil/K-9381-2013	Azkarate, Ainhoa/0000-0003-0471-3094; Wilkinson, Paul/0000-0001-7456-259X				Anderson H.R., 2004, METAANALYSIS TIME SE; [Anonymous], 2004, ENV BURDEN DIS SERIE; *APHEIS 3, 2005, AIR POLL HLTH EUR IN; Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816; BERRY JE, POWER GENERATION ENV, V1; Bosello F, 2006, ECOL ECON, V58, P579, DOI 10.1016/j.ecolecon.2005.07.032; Burney P, 1996, EUR RESPIR J, V9, P687; Deaton A, 2004, HLTH AGE GLOBALIZATI, V1050; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DREICER M, 1995, 16524 EUR, V5; Durand B., 2005, CARB DIOX CAPT STOR; ELIASON B, 2003, INTEGRATED ASSESSMEN; *EURATOM UKAEA FUS, 2007, FUS POW EN FUT; *EXTERNE, EXTERNE NAT IMPL; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Gehring U, 2006, EPIDEMIOLOGY, V17, P545, DOI 10.1097/01.ede.0000224541.38258.87; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Glinianaia SV, 2004, ENVIRON HEALTH PERSP, V112, P1365, DOI 10.1289/ehp.6857; GOLDEMBERG J, 2005, WORLD ENERGY ASSESSM; Greenpeace, 2006, CHERNOBYL CATASTROPH; Grubler A, 1996, TECHNOL FORECAST SOC, V51, P237, DOI 10.1016/0040-1625(95)00251-0; HERBST AM, 2006, NUCL ENERGY TIME COM; Hiltermann TJN, 1998, EUR RESPIR J, V11, P686; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; HORELACY I, 2006, NUCL ENERGY 21 CENTU; Hurley F, 2005, METHODOLOGY COST BEN, V2; *INT AT EN AG, 2006, NUCL TECHN REV; *INT AT EN AG, 2001, SUST DEV NUCL POW; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; JOBIN W, 1999, DAMS DIS; Just J, 2002, EUR RESPIR J, V20, P899, DOI 10.1183/09031936.02.00236902; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Krewski D, 2005, INHAL TOXICOL, V17, P335, DOI 10.1080/08958370590929402; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; MADDISON A, 2003, WORLD EC HIST PERSPE; MARKANDYA A, 2007, POWER SYSTEM PLANNIN; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Miyamoto K., 1997, FAO AGR SERVICES B, P128; MURTY M, 2003, HLTH BENEFITS URBAN; Naess O, 2007, AM J EPIDEMIOL, V165, P435, DOI 10.1093/aje/kwk016; OSTRO BD, 1989, ENVIRON RES, V50, P238, DOI 10.1016/S0013-9351(89)80004-0; OSTRO BD, 1987, J ENVIRON ECON MANAG, V14, P87, DOI 10.1016/0095-0696(87)90008-8; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; PORTINGA W, 2006, 0602 U E ANGL ENV RI; Rabl A, 2003, J AIR WASTE MANAGE, V53, P41, DOI 10.1080/10473289.2003.10466118; RUBIN ES, 2005, P 7 INT C GREENH GAS, V1, P285; SMIL V, 2005, ENERGY CROSSROADS GL, P317; Sorensen B, 2004, RENEWABLE ENERGY; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Stephens C., 2001, WORKER COMMUNITY HLT; *TERI, 2006, TERI EN DAT DIR YB; *UK DEP HLTH, 1999, EC APPR HLTH EFF AIR; WANG L, 2001, 2831 WPS WORLD BANK; Ward DJ, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.007088; Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608, DOI 10.1289/ehp.97105608; Woods R., 2000, DEMOGRAPHY VICTORIAN; *WORLD COMM DAMS, 2000, DAMS DEV NEW FRAM RE; *WORLD WILD FUND N, 2005, DAM NOT DAM 5 YEARS; [No title captured]	60	160	161	7	118	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					979	990		10.1016/S0140-6736(07)61253-7	http://dx.doi.org/10.1016/S0140-6736(07)61253-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17876910				2022-12-28	WOS:000249506500030
J	Thamdrup, B				Thamdrup, Bo			New players in an ancient cycle	SCIENCE			English	Editorial Material							EARLY ARCHEAN ERA; WESTERN-AUSTRALIA; ELEMENTAL SULFUR; DISPROPORTIONATION; REDUCTION; OCEAN; ROCKS; LIFE		Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark	University of Southern Denmark	Thamdrup, B (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark.	bot@biology.sdu.dk	Thamdrup, Bo/F-3889-2016	Thamdrup, Bo/0000-0002-1221-7077				BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Obraztsova AY, 2002, GEOMICROBIOL J, V19, P121, DOI 10.1080/014904502317246219; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005	13	4	5	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1508	1509		10.1126/science.1148137	http://dx.doi.org/10.1126/science.1148137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872432				2022-12-28	WOS:000249467900027
J	RETALLACK, GJ; DUGAS, DP; BESTLAND, EA				RETALLACK, GJ; DUGAS, DP; BESTLAND, EA			FOSSIL SOILS AND GRASSES OF A MIDDLE MIOCENE EAST-AFRICAN GRASSLAND	SCIENCE			English	Article									UNIV OREGON,DEPT GEOG,EUGENE,OR 97403	University of Oregon	RETALLACK, GJ (corresponding author), UNIV OREGON,DEPT GEOL SCI,EUGENE,OR 97403, USA.		Dugas, Daniel/AAC-7204-2021; Bestland, Erick/F-1311-2015	Bestland, Erick/0000-0001-8424-9150				ANDERSON GD, 1965, J ECOL, V53, P33, DOI 10.2307/2257564; ANDERSON GD, 1963, SOLS AFRICAINS, V8, P339; ARKLEY RODNEY J., 1963, SOIL SCI, V96, P239, DOI 10.1097/00010694-196310000-00003; Axelrod D. I., 1978, Monographiae Biologicae, V31, P79; BALDWIN B, 1985, AAPG BULL, V69, P622; Bonnefille R., 1984, EVOLUTION E ASIAN EN, VII, P579; DALRYMPLE GB, 1979, GEOLOGY, V7, P558, DOI 10.1130/0091-7613(1979)7<558:CTFCOK>2.0.CO;2; DEWIT HA, 1978, SOILS GRASSLAND TYP; DUGAS DP, 1989, THESIS U OREGON EUGE; Ellis RP., 1987, GRASS SYSTEMATICS EV, P3; Hamilton A., 1968, UGANDA J, V32, P157; HAY RL, 1978, SEDIMENTOLOGY, V25, P649, DOI 10.1111/j.1365-3091.1978.tb00324.x; HAY RL, 1989, J VOLCANOL GEOTH RES, V37, P77, DOI 10.1016/0377-0273(89)90114-5; HERRERA CM, 1985, OIKOS, V45, P446, DOI 10.2307/3565581; HILL A, 1987, J HUM EVOL, V16, P583, DOI 10.1016/0047-2484(87)90014-5; Hooijer DA, 1968, ZOOLOGISCHE MEDEDELI, V43, P77; JACOBS BF, 1987, J HUM EVOL, V16, P147, DOI 10.1016/0047-2484(87)90073-X; Jager T., 1982, SOILS SERENGETI WOOD; Jenny H., 1941, FACTORS SOIL FORMATI; KAPPELMAN J, 1988, AM J PHYS ANTHROPOL, V75, P229; Le Bas M.J., 1977, CARBONATITE NEPHELIN; MACHETTE MN, 1985, SPEC PAP GEOL SOC AM, V302, P1; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO, V1; MIZOTA C, 1988, GEODERMA, V43, P131, DOI 10.1016/0016-7061(88)90039-0; OLSON SL, 1986, SCIENCE, V233, P1202, DOI 10.1126/science.233.4769.1202; Palmer P.G., 1986, SMITHSONIAN CONTRIBU, V62, P120, DOI [10.5962/bhl.title.122494, DOI 10.5962/BHL.TITLE.122494]; PALMER PG, 1987, SMITHSON CONTRIB BOT, V67, P1; PALMER PG, 1983, SMITHSON CONTRIB BOT, V59, P1; PALMER PG, 1985, SMITHSONIAN CONTRIBU, V55, P1; Palmer PG, 1981, SMITHSONIAN CONTRIB, V49, P1, DOI [DOI 10.5479/SI.0081024X.49, DOI 10.5479/si.0081024X.49]; PICKFORD M, 1987, J HUM EVOL, V16, P305, DOI 10.1016/0047-2484(87)90006-6; PICKFORD M, 1985, J HUM EVOL, V14, P113, DOI 10.1016/S0047-2484(85)80002-6; PICKFORD M, 1986, MUENCH GEOWISS ABH, V8; Retallack G.J., 1990, SOILPAST, P20; Sehgal J. L., 1968, Pedologie, Gand, V18, P351; SENUT B, 1988, ANN PALEONTOL, V74, P128; SHIPMAN P, 1981, J HUM EVOL, V10, P49, DOI 10.1016/S0047-2484(81)80025-5; Shipman P., 1977, THESIS NEW YORK U; STEVENSON FJ, 1969, SOIL SCI, V107, P470, DOI 10.1097/00010694-196906000-00012; Tassy P., 1979, Bulletin de la Societe Geologique de France, V21, P265; THACKRAY GD, 1989, THESIS U OREGON EUGE; THOMAS H, 1984, PALAEOGEOGR PALAEOCL, V40, P251; WHITE F, 1983, VEGETATION AFRICA; 1975, HDB USDA, V436	44	82	85	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1325	1328		10.1126/science.247.4948.1325	http://dx.doi.org/10.1126/science.247.4948.1325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843796				2022-12-28	WOS:A1990CU25300033
J	HUNTER, DA; GALLAGHER, JS				HUNTER, DA; GALLAGHER, JS			STAR FORMATION IN IRREGULAR GALAXIES	SCIENCE			English	Article											HUNTER, DA (corresponding author), LOWELL OBSERV,FLAGSTAFF,AZ 86001, USA.							ALLSOPP NJ, 1978, MON NOT R ASTRON SOC, V184, P397, DOI 10.1093/mnras/184.3.397; ALLSOPP NJ, 1979, MON NOT R ASTRON SOC, V188, P371, DOI 10.1093/mnras/188.2.371; BALICK B, 1980, ASTROPHYS J, V242, P584, DOI 10.1086/158493; BENVENUTI P, 1982, MON NOT R ASTRON SOC, V198, P825, DOI 10.1093/mnras/198.3.825; Black D. C., 1985, PROTOSTARS PLANETS; BOK B, 1977, STRUCTURE EVOLUTION, P22; BOLARD W, 1985, BIRTH EVOLUTION MASS; BOSMA A, 1981, ASTRON J, V86, P1825, DOI 10.1086/113063; BOSMA A, 1981, ASTRON J, V86, P1791, DOI 10.1086/113062; BRINKS E, 1981, ASTRON ASTROPHYS, V95, pL1; BUAT V, 1987, ASTRON ASTROPHYS, V185, P33; BUTCHER H, 1977, ASTROPHYS J, V216, P372, DOI 10.1086/155477; CASSE M, 1979, ASTRON ASTROPHYS, V76, P346; COHEN RS, 1988, ASTROPHYS J, V331, pL95, DOI 10.1086/185243; COMINS N, 1983, ASTROPHYS J, V284, P90; COMINS NF, 1983, ASTROPHYS J, V266, P543, DOI 10.1086/160801; COTTRELL GA, 1976, MON NOT R ASTRON SOC, V177, P463, DOI 10.1093/mnras/177.2.463; COX DP, 1983, ASTROPHYS J, V265, pL61, DOI 10.1086/183958; DONAS J, 1984, ASTRON ASTROPHYS, V140, P325; DONAS J, 1987, ASTRON ASTROPHYS, V180, P12; DOPITA M, 1987, STAR FORMING REGIONS, P501; DOPITA MA, 1985, ASTROPHYS J, V297, P599, DOI 10.1086/163556; EINASTO J, 1972, ASTROPHYS LETT COMM, V11, P195; ELMEGREEN BG, 1980, ASTROPHYS J, V240, P455, DOI 10.1086/158251; ELMEGREEN BG, 1986, ASTROPHYS J, V311, P554, DOI 10.1086/164795; FABER S, 1986, NEARLY NORMAL GALAXI; FEITZINGER JV, 1981, ASTRON ASTROPHYS, V98, P371; FLECK RC, 1980, ASTROPHYS J, V242, P1019, DOI 10.1086/158533; FRANCO J, 1984, ASTROPHYS J, V285, P813, DOI 10.1086/162560; FREEDMAN WL, 1985, ASTROPHYS J, V299, P74, DOI 10.1086/163683; FREEDMAN WL, 1984, ASTROPHYS J, V280, P592, DOI 10.1086/162030; GALLAGHER JS, 1984, ANNU REV ASTRON ASTR, V22, P37; GALLAGHER JS, 1984, ASTROPHYS J, V284, P544, DOI 10.1086/162437; GALLAGHER JS, 1987, ASTRON J, V94, P43, DOI 10.1086/114445; GALLAGHER JS, 1987, STAR FORMATION GALAX, P167; GEROLA H, 1978, ASTROPHYS J, V223, P129, DOI 10.1086/156243; GEROLA H, 1980, ASTROPHYS J, V242, P517, DOI 10.1086/158485; GUIDERDONI B, 1987, ASTRON ASTROPHYS, V172, P27; Gusten R., 1983, VISTAS ASTRON, V26, P159; HODGE P, 1986, PUBL ASTRON SOC PAC, V98, P1095, DOI 10.1086/131879; HODGE PW, 1977, ASTROPHYS J SUPPL S, V33, P69, DOI 10.1086/190419; HODGE PW, 1983, ASTRON J, V88, P1323, DOI 10.1086/113422; HODGE PW, 1978, ASTROPHYS J SUPPL S, V37, P145, DOI 10.1086/190522; HODGE PW, 1974, PUBL ASTRON SOC PAC, V86, P263, DOI 10.1086/129595; HODGE PW, 1972, PUBL ASTRON SOC PAC, V84, P365, DOI 10.1086/129295; HODGE PW, 1980, ASTROPHYS J, V241, P125, DOI 10.1086/158323; HOESSEL J, 1987, ASTROPHYS J SUPPL, V60, P507; HOYLE F, 1953, ASTROPHYS J, V118, P513, DOI 10.1086/145780; HUCHRA JP, 1983, ASTROPHYS J, V274, P125, DOI 10.1086/161430; HUCHRA JP, 1977, ASTROPHYS J, V217, P928, DOI 10.1086/155638; HUCHTMEIER WK, 1979, ASTRON ASTROPHYS, V75, P170; HUNTER DA, 1986, ASTROPHYS J, V303, P171, DOI 10.1086/164064; HUNTER DA, 1985, ASTRON J, V90, P80, DOI 10.1086/113711; HUNTER DA, 1989, ASTROPHYS J, V336, P152, DOI 10.1086/167002; HUNTER DA, 1982, ASTROPHYS J, V260, P81, DOI 10.1086/160236; HUNTER DA, 1986, PUBL ASTRON SOC PAC, V98, P5, DOI 10.1086/131711; HUNTER DA, 1985, ASTROPHYS J SUPPL S, V58, P533, DOI 10.1086/191051; HUNTER DA, IN PRESS ASTROPHYS J; HUNTER DA, 1982, ASTROPHYS J, V260, P80; ISRAEL FP, 1980, ASTRON ASTROPHYS, V90, P246; ISRAEL FP, 1982, ASTROPHYS J, V262, P100, DOI 10.1086/160400; ISRAEL FP, 1986, ASTRON ASTROPHYS, V168, P369; ISSERSTEDT J, 1984, ASTRON ASTROPHYS, V139, P115; KENNICUTT RC, 1979, ASTROPHYS J, V228, P394, DOI 10.1086/156858; KENNICUTT RC, 1983, ASTROPHYS J, V272, P54, DOI 10.1086/161261; KUNTH D, 1986, STAR FORMING DWARF G; LAMB S, UNPUB; LAMB SA, 1985, ASTROPHYS J, V291, P63, DOI 10.1086/163041; LARSON RB, 1982, MON NOT R ASTRON SOC, V200, P159, DOI 10.1093/mnras/200.2.159; LARSON RB, 1985, MON NOT R ASTRON SOC, V214, P379, DOI 10.1093/mnras/214.3.379; LARSON RB, 1983, HIGHLIGHTS ASTRONOMY, V6, P191; LARSON RB, 1988, GALACTIC EXTRAGALACT, P459; LEQUEUX J, 1981, ASTRON ASTROPHYS, V103, P305; MALONEY P, 1987, THESIS U ARIZONA; MASSEY P, 1985, PUBL ASTRON SOC PAC, V97, P5, DOI 10.1086/131486; MCCALL ML, 1986, ASTROPHYS J, V311, P548, DOI 10.1086/164794; MCCRAY R, 1987, ASTROPHYS J, V317, P190, DOI 10.1086/165267; MEABURN J, 1981, MON NOT R ASTRON SOC, V196, pP19, DOI 10.1093/mnras/196.1.19P; Mouschovias T. Ch., 1981, Fundamental Problems in the Theory of Stellar Evolution. International Astronomical Union Symposium. No.93, P27; MUELLER MW, 1976, ASTROPHYS J, V210, P670, DOI 10.1086/154873; MYERS PC, 1986, ASTROPHYS J, V301, P398, DOI 10.1086/163909; NOGUCHI M, IN PRESS ASTRON ASTR; PAYNEGAPOSCHKIN C, 1974, SMITHSONIAN CONTRIB, V16; PEIMBERT M, 1987, STAR FORMING REGIONS; PUDRITZ RE, 1988, GALACTIC EXTRAGALACT; REAKES M, 1980, MON NOT R ASTRON SOC, V192, P297, DOI 10.1093/mnras/192.2.297; REDDISH VC, 1975, MON NOT R ASTRON SOC, V170, P261, DOI 10.1093/mnras/170.2.261; ROGSTAD DH, 1972, ASTROPHYS J, V176, P315, DOI 10.1086/151636; ROSA M, 1984, ASTRON ASTROPHYS, V130, P29; Rosa M., 1984, Astronomy & Astrophysics Supplement Series, V57, P361; SALPETER EE, 1959, APJ, V121, P161; SANDAGE A, 1974, ASTROPHYS J, V194, P559, DOI 10.1086/153275; SANDAGE A, 1979, ASTRON J, V84, P472, DOI 10.1086/112440; Scalo J. M., 1986, Fundamentals of Cosmic Physics, V11, P1; SEARLE L, 1973, ASTROPHYS J, V179, P427, DOI 10.1086/151882; SHORE SN, 1981, ASTROPHYS J, V249, P93, DOI 10.1086/159263; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; SKILLMAN E, IN PRESS ASTRON ASTR; Skillman E. D., 1987, STAR FORMATION GALAX, P263; SMITH MG, 1970, ASTROPHYS J, V161, P33, DOI 10.1086/150510; TACCONI LJ, 1985, ASTROPHYS J, V290, P602, DOI 10.1086/163017; TACCONI LJ, 1987, ASTROPHYS J, V322, P681, DOI 10.1086/165763; TALBOT RJ, 1974, ASTROPHYS J, V189, P209, DOI 10.1086/152790; THRONSON H, 1988, ASTROPHYS J, V319, pL63; THRONSON HA, 1986, ASTROPHYS J, V311, P98, DOI 10.1086/164756; THRONSON HA, 1987, ASTROPHYS J, V317, P180, DOI 10.1086/165266; THRONSON HA, IN PRESS ASTROPHYS J; THUAN TX, 1987, STARBURSTS GALAXY EV; TULLY RB, 1978, ASTRON ASTROPHYS, V63, P37; van Woerden H, 1975, DYNAMIQUE GALAXIES S, P483; VANDENBE.S, 1974, ASTROPHYS J, V193, P63, DOI 10.1086/153127; VANDENBERGH S, 1981, ASTRON J, V86, P1464, DOI 10.1086/113029; VANGORKOM J, UNPUB; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; YOUNG JS, 1984, ASTROPHYS J, V276, P476, DOI 10.1086/161635	115	8	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1557	1563		10.1126/science.243.4898.1557	http://dx.doi.org/10.1126/science.243.4898.1557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847260				2022-12-28	WOS:A1989T795200026
J	Rashid, H; Boyle, EA				Rashid, Harunur; Boyle, Edward A.			Mixed-layer deepening during Heinrich events: A multi-planktonic foraminiferal delta O-18 approach	SCIENCE			English	Article							NORTH-ATLANTIC; ISOTOPIC COMPOSITION; OCEAN MODEL; CIRCULATION; SEA; SEDIMENTS; RECORDS	Proxies from Greenland ice cores and North Atlantic marine sediment cores document repeated extreme climate swings of a few decades to millennia during the last glacial cycle, including periods of intense ice rafting called Heinrich events (HEs). We have found similar oxygen isotope variations recorded in mixed-layer-and thermocline-dwelling planktonic foraminifera during HEs 0, 1, and 4, suggesting that three foraminiferal taxa calcified their shells at similar temperatures in a homogenized upperwater column. This implies that the surface mixed layer was deeper during HEs. Similar deepening occurred on the northern margin of the ice-rafted-debris belt, implying that these deep mixed layers during HEs were widespread in the region. We suggest that an increase in storminess during HEs intensified the vertical mixing of meltwater from ice rafting in the upper ocean.	Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; MIT, Dept Earth & Planetary Sci, Cambridge, MA 02139 USA	State University System of Florida; University of South Florida; Massachusetts Institute of Technology (MIT)	Rashid, H (corresponding author), Univ S Florida, Coll Marine Sci, 140 7th Ave S, St Petersburg, FL 33701 USA.	hrashid@marine.usf.edu		Rashid, Harunur/0000-0002-7612-3790				ALLEY RB, 1994, PALEOCEANOGRAPHY, V9, P503, DOI 10.1029/94PA01008; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; DEUSER WG, 1987, J FORAMIN RES, V17, P14, DOI 10.2113/gsjfr.17.1.14; Emery WJ., 1990, DESCRIPTIVE PHYS OCE; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; FAIRBANKS RG, 1980, SCIENCE, V207, P61, DOI 10.1126/science.207.4426.61; Fluckiger J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001204; Ganssen GM, 2000, J GEOL SOC LONDON, V157, P693, DOI 10.1144/jgs.157.3.693; Gildor H, 2003, PHILOS T R SOC A, V361, P1935, DOI 10.1098/rsta.2003.1244; Gulev SK, 2003, J CLIMATE, V16, P3085, DOI 10.1175/1520-0442(2003)016<3085:WMTITN>2.0.CO;2; HANAWA K, 2003, OCEAN ATMOSPHERE INT, P63; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; KEIGWIN LD, 1994, PALEOCEANOGRAPHY, V9, P185, DOI 10.1029/94PA00032; LABEYRIE L, 1999, AGU MONOGR, V112, P77; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; MAYEWSKI PA, 1994, SCIENCE, V263, P1747, DOI 10.1126/science.263.5154.1747; Mulitza S, 1997, GEOLOGY, V25, P335, DOI 10.1130/0091-7613(1997)025<0335:PFAROP>2.3.CO;2; OTTENS JJ, 1991, OCEANOL ACTA, V14, P123; Peck VL, 2006, EARTH PLANET SC LETT, V243, P476, DOI 10.1016/j.epsl.2005.12.023; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Rashid H, 2003, EARTH PLANET SC LETT, V208, P319, DOI 10.1016/S0012-821X(03)00030-X; Rashid H, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001240; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27335, DOI 10.1029/2000JD000070; ROBINSON MK, 1978, US NAVAL OCEANOGR OF, V18; RUDDIMAN WF, 1977, GEOL SOC AM BULL, V88, P1813, DOI 10.1130/0016-7606(1977)88<1813:LQDOIS>2.0.CO;2; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000771; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904	30	32	34	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					439	441		10.1126/science.1146138	http://dx.doi.org/10.1126/science.1146138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17885097				2022-12-28	WOS:000250230400043
J	Jeffersom, T; Di Pietrantonj, C				Jeffersom, Tom; Di Pietrantonj, Carlo			Inactivated influenza vaccines in the elderly - are you sure?	LANCET			English	Editorial Material							VACCINATION; EFFICACY; POLICY; PEOPLE		Cochrane Vaccines Field, I-15100 Alessandria, Italy		Jeffersom, T (corresponding author), Cochrane Vaccines Field, I-15100 Alessandria, Italy.	Jefferson.tom@gmail.com	Di Pietrantonj, Carlo/AAK-1340-2020	Di Pietrantonj, Carlo/0000-0002-7302-5714				Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Fedson DS, 2006, BMJ-BRIT MED J, V333, P1020, DOI 10.1136/bmj.39024.451389.FA; GRIFFITHS PD, 2006, BMJ RAPID RESPONSE; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jefferson T, 2006, BMJ-BRIT MED J, V333, P912, DOI 10.1136/bmj.38995.531701.80; Mandl CW, 2006, BRIT MED J, V333, P1020, DOI 10.1136/bmj.39024.354120.1F; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; *U MICH, ADV GLOB PUBL HLTH	11	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1199	1200		10.1016/S0140-6736(07)61389-0	http://dx.doi.org/10.1016/S0140-6736(07)61389-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17897708				2022-12-28	WOS:000250091900009
J	Parmigiani, G; Chen, S; Iversen, ES; Friebel, TM; Finkelstein, DM; Anton-Culver, H; Ziogas, A; Weber, BL; Eisen, A; Malone, KE; Daling, JR; Hsu, L; Ostrander, EA; Peterson, LE; Schildkraut, JM; Isaacs, C; Corio, C; Leondaridis, L; Tomlinson, G; Amos, CI; Strong, LC; Berry, DA; Weitzel, JN; Sand, S; Dutson, D; Kerber, R; Peshkin, BN; Euhus, DM				Parmigiani, Giovanni; Chen, Sining; Iversen, Edwin S., Jr.; Friebel, Tara M.; Finkelstein, Dianne M.; Anton-Culver, Hoda; Ziogas, Argyrios; Weber, Barbara L.; Eisen, Andrea; Malone, Kathleen E.; Daling, Janet R.; Hsu, Li; Ostrander, Elaine A.; Peterson, Leif E.; Schildkraut, Joellen M.; Isaacs, Claudine; Corio, Camille; Leondaridis, Leoni; Tomlinson, Gail; Amos, Christopher I.; Strong, Louise C.; Berry, Donald A.; Weitzel, Jeffrey N.; Sand, Sharon; Dutson, Debra; Kerber, Rich; Peshkin, Beth N.; Euhus, David M.			Validity of models for predicting BRCA1 and BRCA2 mutations	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER; OVARIAN-CANCER; FAMILY-HISTORY; HIGH-RISK; GENETIC SUSCEPTIBILITY; PRETEST PREDICTION; GERMLINE MUTATIONS; CASE SERIES; WOMEN; VALIDATION	Background: Deleterious mutations of the BRCA1 and BRCA2 genes confer susceptibility to breast and ovarian cancer. At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood. Objective: To systematically quantify the accuracy of the following publicly available models to predict mutation carrier status: BRCAPRO, family history assessment tool, Finnish, Myriad, National Cancer Institute, University of Pennsylvania, and Yale University. Design: Cross-sectional validation study, using model predictions and BRCA1 or BRCA2 mutation status of patients different from those used to develop the models. Setting: Multicenter study across Cancer Genetics Network participating centers. Patients: 3 population-based samples of participants in research studies and 8 samples from genetic counseling clinics. Measurements: Discrimination between individuals testing positive for a mutation in BRCA1 or BRCA2 from those testing negative, as measured by the c-statistic, and sensitivity and specificity of model predictions. Results: The 7 models differ in their predictions. The better-performing models have a c-statistic around 80%. BRCAPRO has the largest c-statistic overall and in all but 2 patient subgroups, although the margin over other models is narrow in many strata. Outside of high-risk populations, all models have high false-negative and false-positive rates across a range of probability thresholds used to refer for mutation testing. Limitation: Three recently published models were not included. Conclusions: All models identify women who probably carry a deleterious mutation of BRCA1 or BRCA2 with adequate discrimination to support individualized genetic counseling, although discrimination varies across models and populations.	Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Parmigiani, G (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, 550 N Broadway,Suite 1103, Baltimore, MD 21205 USA.	gp@jhu.edu	Tomlinson, Gail/AAR-9776-2020; Friebel-Klingner, Tara/ABF-4212-2021; Kerber, Richard/B-8038-2009	Weber, Barbara/0000-0002-6004-4860; Peterson, Leif/0000-0002-1187-0883; Ostrander, Elaine/0000-0001-6075-9738; Friebel, Tara/0000-0002-3726-9527; Sand, Sharon/0000-0002-9390-5583	NATIONAL CANCER INSTITUTE [P30CA051008, P50CA088843, R01CA105090, R01CA063705, RC4CA153828, K05CA090754, P50CA062924, P30CA006973, U01CA078284] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099024] Funding Source: NIH RePORTER; NCI NIH HHS [RC4 CA153828, R01 CA105090-04, P50 CA088843, K05 CA-90754, R01 CA105090-03, R01 CA105090-01A1, CA78284, P50CA62924-05, R01 CA 36397, R01 CA105090, U01 CA078284, R01 CA 63705, 5P30 CA06973-39, P30-CA-51008, K05 CA090754, P50CA88843, R01CA105090-01A1, P50 CA062924, R01 CA105090-02, P30 CA051008, P30 CA006973] Funding Source: Medline; NCRR NIH HHS [M01 RR000043, M01 RR00043] Funding Source: Medline; NHLBI NIH HHS [HL 99-024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Anton-Culver H, 2000, EUR J CANCER, V36, P1200, DOI 10.1016/S0959-8049(00)00110-6; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1365; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Apicella C, 2003, BREAST CANCER RES, V5, pR206, DOI 10.1186/bcr644; BARCENS CH, J CLIN ONCOL, V24, P35406; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Bluman LG, 1999, J CLIN ONCOL, V17, P1040, DOI 10.1200/JCO.1999.17.3.1040; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Capalbo C, 2006, EUR J HUM GENET, V14, P49, DOI 10.1038/sj.ejhg.5201511; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de la Hoya M, 2003, J MED GENET, V40, P503, DOI 10.1136/jmg.40.7.503; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Euhus DM, 2002, J NATL CANCER I, V94, P844, DOI 10.1093/jnci/94.11.844; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Friebel TM, 2004, J CLIN EPIDEMIOL, V57, P1172, DOI 10.1016/j.jclinepi.2004.04.007; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; Hartman AR, 2004, CANCER-AM CANCER SOC, V100, P479, DOI 10.1002/cncr.11926; Iversen ES, 2000, J AM STAT ASSOC, V95, P28; James PA, 2006, J CLIN ONCOL, V24, P707, DOI 10.1200/JCO.2005.01.9737; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kristensen VN, 2001, BIOTECHNIQUES, V30, P318, DOI 10.2144/01302tt01; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Marroni F, 2004, J MED GENET, V41, P278, DOI 10.1136/jmg.2003.013623; Martin AM, 2001, J CLIN ONCOL, V19, P2247, DOI 10.1200/JCO.2001.19.8.2247; Miron A, 2000, ANN SURG, V231, P624, DOI 10.1097/00000658-200005000-00002; MURPHY EA, 1969, HUM HERED, V19, P126, DOI 10.1159/000152210; *MYR GEN LAB, 2006, BRACA AN TECHN SPEC; *MYR GEN LAB, 2006, MYR GEN 2006 ANN REP; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Newman B, 1997, EPIDEMIOL REV, V19, P69, DOI 10.1093/oxfordjournals.epirev.a017948; OFFIT K, 1994, J CLIN ONCOL, V12, P1724, DOI 10.1200/JCO.1994.12.8.1724; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Richards CS, 1997, AM J HUM GENET, V60, P1085; Schwartz MD, 2002, J CLIN ONCOL, V20, P514, DOI 10.1200/JCO.20.2.514; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Skinner CS, 2002, GENET TEST, V6, P93, DOI 10.1089/10906570260199348; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Szolovits P., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P679; Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Vahteristo P, 2001, BRIT J CANCER, V84, P704, DOI 10.1054/bjoc.2000.1626; VOGEL KJ, IN PRESS J CLIN ONCO; WEBER BL, 1996, SCI MED, V3, P12; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323; Yen H, 2000, SCIENCE, V289, P1890	60	83	83	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					441	450		10.7326/0003-4819-147-7-200710020-00002	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909205	Green Accepted			2022-12-28	WOS:000250214700001
J	Roberts, WT; Timmis, AD				Roberts, Will T.; Timmis, Adam D.			Change page - Patients with cardiac chest pain should call emergency services	BRITISH MEDICAL JOURNAL			English	Editorial Material									London Chest Hosp, Dept Cardiol, London E2 9JX, England	University of London; Queen Mary University London	Timmis, AD (corresponding author), London Chest Hosp, Dept Cardiol, London E2 9JX, England.	adamtimmis@mac.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					669	669		10.1136/bmj.39342.693252.47	http://dx.doi.org/10.1136/bmj.39342.693252.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901519	Green Published			2022-12-28	WOS:000249989600045
J	Kaufman, AJ; Johnston, DT; Farquhar, J; Masterson, AL; Lyons, TW; Bates, S; Anbar, AD; Arnold, GL; Garvin, J; Buick, R				Kaufman, Alan J.; Johnston, David T.; Farquhar, James; Masterson, Andrew L.; Lyons, Timothy W.; Bates, Steve; Anbar, Ariel D.; Arnold, Gail L.; Garvin, Jessica; Buick, Roger			Late Archean biospheric oxygenation and atmospheric evolution	SCIENCE			English	Article							IRON-FORMATION DEPOSITION; TRANSVAAL SUPERGROUP; SULFUR ISOTOPES; MOLECULAR FOSSILS; FRACTIONATION; TRANSITION; SEDIMENTS; LIMESTONE; SEQUENCE; BASIN	High-resolution geochemical analyses of organic-rich shale and carbonate through the 2500 million-year-old Mount McRae Shale in the Hamersley Basin of northwestern Australia record changes in both the oxidation state of the surface ocean and the atmospheric composition. The Mount McRae record of sulfur isotopes captures the widespread and possibly permanent activation of the oxidative sulfur cycle for perhaps the first time in Earth's history. The correlation of the time-series sulfur isotope signals in northwestern Australia with equivalent strata from South Africa suggests that changes in the exogenic sulfur cycle recorded in marine sediments were global in scope and were linked to atmospheric evolution. The data suggest that oxygenation of the surface ocean preceded pervasive and persistent atmospheric oxygenation by 50 million years or more.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Washington, Astrobiol Program, Seattle, WA 98195 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Riverside; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaufman, AJ (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	kaufman@geol.umd.edu	Arnold, Gail L/A-5572-2010; Johnston, David/A-9796-2010	Arnold, Gail L/0000-0001-9631-9830; Buick, Roger/0000-0003-0139-1659; Masterson, Andrew/0000-0002-3422-2985; Johnston, David/0000-0002-2487-1084				Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Baublys KA, 2004, RAPID COMMUN MASS SP, V18, P2765, DOI 10.1002/rcm.1681; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BEUKES NJ, 1987, SEDIMENT GEOL, V54, P1, DOI 10.1016/0037-0738(87)90002-9; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Cheney ES, 1996, PRECAMBRIAN RES, V79, P3, DOI 10.1016/0301-9268(95)00085-2; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, GEOCHIM COSMOCHIM AC, V71, pA269; FRY B, 1986, J BACTERIOL, V165, P328, DOI 10.1128/jb.165.1.328-330.1986; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Johnston DT, 2006, GEOCHIM COSMOCHIM AC, V70, P5723, DOI 10.1016/j.gca.2006.08.001; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 1996, PRECAMBRIAN RES, V79, P171, DOI 10.1016/0301-9268(95)00093-3; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Krapez B, 2003, SEDIMENTOLOGY, V50, P979, DOI 10.1046/j.1365-3091.2003.00594.x; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837	30	276	285	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1900	1903		10.1126/science.1138700	http://dx.doi.org/10.1126/science.1138700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901329				2022-12-28	WOS:000249764300034
J	Keeling, PJ				Keeling, Patrick J.			Deep questions in the tree of life	SCIENCE			English	Editorial Material							PROTEIN IMPORT; EVOLUTION; ORGANELLES; PROTISTS		Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia	Keeling, PJ (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	pkeeling@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745				Andersson JO, 2005, MOL BIOL EVOL, V22, P85, DOI 10.1093/molbev/msh254; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Cavalier-Smith T, 1983, ENDOCYTOBIOLOGY, pl027; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MULLER M, 1992, BIOSYSTEMS, V28, P33, DOI 10.1016/0303-2647(92)90005-J; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Williams BAP, 2003, ADV PARASIT, V54, P9, DOI 10.1016/S0065-308X(03)54001-5	15	27	27	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1875	1876		10.1126/science.1149593	http://dx.doi.org/10.1126/science.1149593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901321				2022-12-28	WOS:000249764300025
J	Unanue, ER				Unanue, Emil R.			Viral infections and nonspecific protection - Good or bad?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.							Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BLANDEN RV, 1973, AUST J EXP BIOL MED, V51, P393, DOI 10.1038/icb.1973.35; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; Vercelli D, 2006, CURR OPIN IMMUNOL, V18, P733, DOI 10.1016/j.coi.2006.09.002	5	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1345	1346		10.1056/NEJMcibr074519	http://dx.doi.org/10.1056/NEJMcibr074519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898106				2022-12-28	WOS:000249711500014
J	Murray, CJL; Frenk, J; Evans, T				Murray, Christopher J. L.; Frenk, Julio; Evans, Timothy			The Global Campaign for the Health MDGs: challenges, opportunities, and the imperative of shared learning	LANCET			English	Editorial Material									Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA; Bill & Melinda Gates Fdn, Seattle, WA USA; Carso Hlth Inst, Mexico City, DF, Mexico; WHO, CH-1211 Geneva, Switzerland	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; World Health Organization	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA.	cjlm@u.washington.edu						*DFID, 2007, INT HLTH PARTN LAUNC; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GLOB HLTH COUNC N, 2007, WOM CHILDR 1 SNEAK P; International Health Partnership, 2007, GLOB COMP ACH HLTH M; Jeppsson A, 2002, SOC SCI MED, V55, P2053, DOI 10.1016/S0277-9536(01)00345-8; Murray C, 2007, LANCET, V369, P1768, DOI 10.1016/S0140-6736(07)60792-2; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Peters D, 1998, INT J HEALTH PLAN M, V13, P177, DOI 10.1002/(SICI)1099-1751(199804/06)13:2<177::AID-HPM504>3.0.CO;2-T; Schieber G, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P225; Sundewall J, 2006, HEALTH POLICY, V76, P277, DOI 10.1016/j.healthpol.2005.06.009; *UNFPA NEWS, 2007, 2 REG SESS UNDP UNFP; Weil DEC, 2000, INT J TUBERC LUNG D, V4, P597; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	13	36	36	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1018	1020		10.1016/S0140-6736(07)61458-5	http://dx.doi.org/10.1016/S0140-6736(07)61458-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889229				2022-12-28	WOS:000249727900010
J	Watts, G				Watts, Geoff			Scent trials	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Hawkes CH, 1998, EXP NEUROL, V150, P248, DOI 10.1006/exnr.1997.6773; *UCL I OPHTH, 1 TRIAL GEN THER CHI	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					588	589		10.1136/bmj.39315.453056.AD	http://dx.doi.org/10.1136/bmj.39315.453056.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884900	Green Published			2022-12-28	WOS:000249832400028
J	Yamanouchi, M; Ieda, J; Matsukura, F; Barnes, SE; Maekawa, S; Ohno, H				Yamanouchi, M.; Ieda, J.; Matsukura, F.; Barnes, S. E.; Maekawa, S.; Ohno, H.			Universality classes for domain wall motion in the ferromagnetic semiconductor (Ga, Mn)As	SCIENCE			English	Article							CREEP; NANOWIRES; DYNAMICS	Magnetic domain wall motion induced by magnetic fields and spin-polarized electrical currents is experimentally well established. A full understanding of the underlying mechanisms, however, remains elusive. For the ferromagnetic semiconductor (Ga, Mn)As, we have measured and compared such motions in the thermally activated subthreshold, or "creep," regime, where the velocity obeys an Arrhenius scaling law. Within this law, the clearly different exponents of the current and field reflect different universality classes, showing that the drive mechanisms are fundamentally different.	Japan Sci & Technol Agcy, Semicond Spintron Project, Exploratory Res Adv Technol, Aoba Ku, Sendai, Miyagi 9800023, Japan; Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Elect Commun Res Inst, Lab Nanoelect & Spintron, Aoba Ku, Sendai, Miyagi 9808577, Japan	Japan Science & Technology Agency (JST); University of Miami; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University	Ohno, H (corresponding author), Japan Sci & Technol Agcy, Semicond Spintron Project, Exploratory Res Adv Technol, Aoba Ku, 1-18 Kitamemachi, Sendai, Miyagi 9800023, Japan.	ohno@riec.tohoku.ac.jp	Ieda, Jun'ichi/A-3345-2009; Maekawa, Sadamichi/J-6194-2018; Ohno, Hideo/E-6453-2010; Yamanouchi, Michihiko/G-9635-2014	Ieda, Jun'ichi/0000-0001-6069-8533; Maekawa, Sadamichi/0000-0002-4237-7741; Ohno, Hideo/0000-0001-9688-8259; 				Barnes SE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107204; BERGER L, 1984, J APPL PHYS, V55, P1954, DOI 10.1063/1.333530; Cayssol F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107202; Chauve P, 2000, PHYS REV B, V62, P6241, DOI 10.1103/PhysRevB.62.6241; Dietl T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241201; Dietl T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195205; Duine RA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.056605; Giamarchi T, 2006, LECT NOTES PHYS, V688, P91; Hayashi M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207205; Klaui M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.106601; Krusin-Elbaum L, 2001, NATURE, V410, P444, DOI 10.1038/35068515; Lemerle S, 1998, PHYS REV LETT, V80, P849, DOI 10.1103/PhysRevLett.80.849; Malozemoff A.P., 1979, MAGNETIC DOMAIN WALL; Nguyen AK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146602; Parkin SSP, 2004, ( 2004- 2007) U. S. Patents, Patent No. [Patents 6,834,005, 6834005, 6,834,005]; Repain V, 2004, EUROPHYS LETT, V68, P460, DOI 10.1209/epl/i2004-10213-7; Saitoh E, 2004, NATURE, V432, P203, DOI 10.1038/nature03009; Tang HX, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041310; Tatara G, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951058; Tatara G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086601; Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Tserkovnyak Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144405; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; Xiao J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054428; Yamanouchi M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096601; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204	28	128	128	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1726	1729		10.1126/science.1145516	http://dx.doi.org/10.1126/science.1145516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885131				2022-12-28	WOS:000249585900041
J	Yellon, DM; Hausenloy, DJ				Yellon, Derek M.; Hausenloy, Derek J.			Mechanisms of disease: Myocardial reperfusion injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; MITOCHONDRIAL PERMEABILITY TRANSITION; ANTI-C5 COMPLEMENT ANTIBODY; GLUCAGON-LIKE PEPTIDE-1; REDUCES INFARCT SIZE; ISCHEMIA-REPERFUSION; INTRAVENOUS-MAGNESIUM; FREE-RADICALS; ADJUNCTIVE THERAPY; DOUBLE-BLIND		UCL Hosp & Med Sch, Hatter Cardiovasc Inst, London WC1E 6HX, England	University of London; University College London	Yellon, DM (corresponding author), UCL Hosp & Med Sch, Hatter Cardiovasc Inst, 67 Chenies Mews, London WC1E 6HX, England.	hatter-institute@ucl.ac.uk	Yellon, Derek M/ABD-5110-2021	Yellon, Derek/0000-0001-7791-9320; Hausenloy, Derek/0000-0003-0729-4956				Abdallah Y, 2006, CARDIOVASC RES, V70, P346, DOI 10.1016/j.cardiores.2006.02.020; Aldor, 2000, EUR HEART J, V21, P1537; Antman E, 2002, LANCET, V360, P1189, DOI 10.1016/S0140-6736(02)11278-5; Apstein CS, 2005, EUR HEART J, V26, P956, DOI 10.1093/eurheartj/ehi200; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bar FW, 2006, EUR HEART J, V27, P2516, DOI 10.1093/eurheartj/ehl304; Baran KW, 2001, CIRCULATION, V104, P2778, DOI 10.1161/hc4801.100236; Baxter GF, 2000, CARDIOVASC DRUG THER, V14, P607, DOI 10.1023/A:1007850527878; Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4; BESHANSKY J, IMMEDIATE METABOLIC; Boden WE, 2000, LANCET, V355, P1751, DOI 10.1016/S0140-6736(00)02262-5; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BOND JM, 1991, BIOCHEM BIOPH RES CO, V179, P798, DOI 10.1016/0006-291X(91)91887-I; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; Bullard AJ, 2005, BASIC RES CARDIOL, V100, P397, DOI 10.1007/s00395-005-0537-4; Carry M M, 1989, Am J Cardiovasc Pathol, V2, P335; CHIEN GL, 1994, CARDIOVASC RES, V28, P1014, DOI 10.1093/cvr/28.7.1014; CHRISTENSEN CW, 1995, CIRCULATION, V92, P2617, DOI 10.1161/01.CIR.92.9.2617; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; COLLINS R, 1995, LANCET, V345, P669; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; Davidson SM, 2006, INT J BIOCHEM CELL B, V38, P414, DOI 10.1016/j.biocel.2005.09.017; Dirksen MT, 2007, CARDIOVASC RES, V74, P343, DOI 10.1016/j.cardiores.2007.01.014; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doukas J, 2006, P NATL ACAD SCI USA, V103, P19866, DOI 10.1073/pnas.0606956103; DOWNEY JM, 1990, ANNU REV PHYSIOL, V52, P487, DOI 10.1146/annurev.ph.52.030190.002415; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; FLAHERTY JT, 1994, CIRCULATION, V89, P1982, DOI 10.1161/01.CIR.89.5.1982; GOTO M, 1991, CARDIOVASC RES, V25, P943, DOI 10.1093/cvr/25.11.943; Granger CB, 2003, CIRCULATION, V108, P1184, DOI 10.1161/01.CIR.0000087447.12918.85; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Guan WP, 2003, J CARDIOVASC PHARM, V41, P699, DOI 10.1097/00005344-200305000-00005; Gumina RJ, 1999, CIRCULATION, V100, P2519, DOI 10.1161/01.CIR.100.25.2519; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; Hayward R, 1999, CARDIOVASC RES, V41, P65, DOI 10.1016/S0008-6363(98)00266-1; HEARSE DJ, 1973, J MOL CELL CARDIOL, V5, P395, DOI 10.1016/0022-2828(73)90030-8; Heusch G, 2004, J AM COLL CARDIOL, V44, P1111, DOI 10.1016/j.jacc.2004.06.013; Holzer M, 2002, NEW ENGL J MED, V346, P549; Inagaki K, 2006, CARDIOVASC RES, V70, P222, DOI 10.1016/j.cardiores.2006.02.015; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; Jang IK, 2005, J THROMB THROMBOLYS, V20, P147, DOI 10.1007/s11239-005-3267-4; JENNINGS RB, 1960, ARCH PATHOL, V70, P68; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; KITAKAZE M, 2006, AN HEART ASS SCI SES; KLEIN HH, 1989, J AM COLL CARDIOL, V13, P1395, DOI 10.1016/0735-1097(89)90317-3; KLONER RA, 1993, J AM COLL CARDIOL, V21, P537, DOI 10.1016/0735-1097(93)90700-B; Kloner RA, 2006, EUR HEART J, V27, P2400, DOI 10.1093/eurheartj/ehl094; KRUG A, 1966, CIRC RES, V19, P57, DOI 10.1161/01.RES.19.1.57; Laskey WK, 2005, CATHETER CARDIO INTE, V65, P361, DOI 10.1002/ccd.20397; Lemasters J J, 1996, EXS, V76, P99; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Ma Xiaojing, 2006, J Interv Cardiol, V19, P367, DOI 10.1111/j.1540-8183.2006.00191.x; MA XL, 1991, J CLIN INVEST, V88, P1237, DOI 10.1172/JCI115427; Mahaffey KW, 2003, CIRCULATION, V108, P1176, DOI 10.1161/01.CIR.0000087404.53661.F8; MANNING AS, 1984, J MOL CELL CARDIOL, V16, P497, DOI 10.1016/S0022-2828(84)80638-0; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Mertens P, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.020; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; O'Neill W., 2003, TRANSC CARD THER C W; OLAFSSON B, 1987, CIRCULATION, V76, P1135, DOI 10.1161/01.CIR.76.5.1135; Ono H, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.05.014; OPIE L H, 1970, Journal of Molecular and Cellular Cardiology, V1, P107, DOI 10.1016/0022-2828(70)90045-3; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Roe MT, 2007, J AM COLL CARDIOL, V49, p215A; Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061; Santoro GM, 2000, AM HEART J, V140, P891, DOI 10.1067/mhj.2000.110767; Shanmuganathan S, 2005, AM J PHYSIOL-HEART C, V289, pH237, DOI 10.1152/ajpheart.01192.2004; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Tanguay JF, 2003, J AM COLL CARDIOL, V41, p404A; Theroux P, 2000, CIRCULATION, V102, P3032; Tsujita K, 2006, CIRC J, V70, P832, DOI 10.1253/circj.70.832; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Vinten-Johansen J, 2005, CIRCULATION, V112, P2085, DOI 10.1161/CIRCULATIONAHA.105.569798; WEYRICH AS, 1992, CIRCULATION, V86, P279, DOI 10.1161/01.CIR.86.1.279; WOODS KL, 1992, LANCET, V339, P1553, DOI 10.1016/0140-6736(92)91828-V; Yang XM, 2006, BASIC RES CARDIOL, V101, P311, DOI 10.1007/s00395-006-0587-2; Yellon DM, 2006, LANCET, V367, P456, DOI 10.1016/S0140-6736(06)68157-9; Yellon DM, 2005, NAT CLIN PRACT CARD, V2, P568, DOI 10.1038/ncpcardio0346; Yellon DM, 1999, TRENDS CARDIOVAS MED, V9, P245, DOI 10.1016/S1050-1738(00)00029-3; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644; Zhao ZQ, 2006, CARDIOVASC RES, V70, P200, DOI 10.1016/j.cardiores.2006.01.024; Zhao ZQ, 2004, AM J PHYSIOL-HEART C, V286, pH477; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhao ZQ, 2003, CARDIOVASC RES, V59, P132, DOI 10.1016/S0008-6363(03)00344-4; Zhao ZQ, 1997, J LEUKOCYTE BIOL, V62, P292, DOI 10.1002/jlb.62.3.292; Zhao ZQ, 2000, J SURG RES, V94, P133, DOI 10.1006/jsre.2000.6029; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353	105	2312	2501	11	333	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1121	1135		10.1056/NEJMra071667	http://dx.doi.org/10.1056/NEJMra071667			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855673				2022-12-28	WOS:000249387200008
J	Vogel, G				Vogel, G			Meeting briefs - Hubble spectrograph takes a hard look in the ultraviolet	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 27	1996	273	5283					1799	1800		10.1126/science.273.5283.1799	http://dx.doi.org/10.1126/science.273.5283.1799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VJ713	17843721				2022-12-28	WOS:A1996VJ71300023
J	NORMAN, C				NORMAN, C			ARMY, AIR-FORCE EYE SDI SPINOFFS	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1284	1284		10.1126/science.247.4948.1284	http://dx.doi.org/10.1126/science.247.4948.1284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843780				2022-12-28	WOS:A1990CU25300013
J	Powrie, RO				Powrie, Raymond O.			A 30-year-old woman with chronic hypertension trying to conceive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BLOOD-PRESSURE-MEASUREMENT; CARDIOVASCULAR-DISEASE; PREGNANCY HYPERTENSION; PREVENT PREECLAMPSIA; RISK-FACTORS; VITAMIN-C; URIC-ACID; WOMEN; NIFEDIPINE; DISORDERS	Mrs F is a 30-year-old woman with a history of chronic hypertension and possible preeclampsia during her first pregnancy. She is currently trying to conceive and wants to know how her hypertension will affect a future pregnancy and how it should best be managed, both now and during a pregnancy. The management of chronic hypertension before, during, and after a pregnancy is discussed with an emphasis on the goals of treatment and safety of medications during pregnancy and with breastfeeding. Preeclampsia is the most common complication of chronic hypertension in pregnancy and is a particular worry for Mrs F because she may have had it with her prior pregnancy. The current understanding of the pathogenesis of this enigmatic illness is therefore also reviewed, along with its implications for long-term maternal health.	Brown Univ, Women & Infants Hosp, Sch Med, Providence, RI 02905 USA; Harvard Univ, Sch Med, Boston, MA USA	Brown University; Women & Infants Hospital Rhode Island; Harvard University; Harvard Medical School	Powrie, RO (corresponding author), Brown Univ, Women & Infants Hosp, Sch Med, 101 Dudley St,Ste 1200, Providence, RI 02905 USA.	raymond_powrie@brown.edu						Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; *AM COLL OBST GYN, 2001, ACOG PRACT B, V29; American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002863; ARMARIO P, 1994, DRUG SAFETY, V11, P80, DOI 10.2165/00002018-199411020-00002; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; August P, 2004, AM J OBSTET GYNECOL, V191, P1666, DOI 10.1016/j.ajog.2004.03.029; Ayala DE, 2001, HYPERTENSION, V38, P753, DOI 10.1161/01.HYP.38.3.753; Beilin LJ, 2006, HYPERTENSION, V47, P1035, DOI 10.1161/01.HYP.0000218586.21932.3c; BEROYZ G, 1994, LANCET, V343, P619; Borghi C, 2002, J HYPERTENS, V20, pS52; Bortolus R, 2000, BRIT J OBSTET GYNAEC, V107, P792, DOI 10.1111/j.1471-0528.2000.tb13342.x; Briggs G., 2005, DRUGS PREGNANCY LACT; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Burkman R, 2004, AM J OBSTET GYNECOL, V190, pS5, DOI 10.1016/j.ajog.2004.01.061; CAMPESE VM, 1989, AM J HYPERTENS, V2, pS34, DOI 10.1093/ajh/2.2.34S; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; CHILDRESS CH, 1994, OBSTET GYNECOL, V83, P616, DOI 10.1097/00006250-199404000-00024; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Churchill D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004451.pub2; Coccagna G, 2006, CLIN EXP HYPERTENS, V28, P217, DOI 10.1080/10641960600549090; COCKBURN J, 1982, LANCET, V1, P647; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P882; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Danzi S, 2003, CURR HYPERTENS REP, V5, P513, DOI 10.1007/s11906-003-0060-7; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duggan PM, 1998, AUST NZ J OBSTET GYN, V38, P197, DOI 10.1111/j.1479-828X.1998.tb03001.x; Duley L, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001449.pub2, 10.1002/14651858.CD001449.pub3]; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; DULEY L, 2004, COCHRANE DATABASE SC; FARMAKIDES G, 1992, CLIN OBSTET GYNECOL, V35, P387; FERRAZZANI S, 1994, AM J OBSTET GYNECOL, V171, P506, DOI 10.1016/0002-9378(94)90290-9; Funai EF, 2005, EPIDEMIOLOGY, V16, P206, DOI 10.1097/01.ede.0000152912.02042.cd; Gupta M, 1997, BRIT J OBSTET GYNAEC, V104, P350, DOI 10.1111/j.1471-0528.1997.tb11467.x; HALE TW, 2006, MED MOTHERS MILK; HARTIKAINENSORRI AL, 1987, OBSTET GYNECOL, V69, P598; Haukkamaa L, 2004, AM J CARDIOL, V93, P805, DOI 10.1016/j.amjcard.2003.11.065; Hayes SN, 2002, J HYPERTENS, V20, pS47; Hershkovitz R, 2005, HYPERTENS PREGNANCY, V24, P273, DOI 10.1080/10641950500280995; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; JOUPPILA P, 1986, BRIT J OBSTET GYNAEC, V93, P543, DOI 10.1111/j.1471-0528.1986.tb07951.x; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lim KH, 1998, AM J OBSTET GYNECOL, V178, P1067, DOI 10.1016/S0002-9378(98)70549-6; Lippi G, 2007, CLIN LAB, V53, P173; Magee L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub2; Magee L A, 2004, Expert Opin Drug Saf, V3, P25, DOI 10.1517/14740338.3.1.25; Magee LA, 2001, BEST PRACT RES CL OB, V15, P827, DOI 10.1053/beog.2001.0232; Magee LA, 2003, BMJ-BRIT MED J, V327, P955, DOI 10.1136/bmj.327.7421.955; Magee LA, 2000, EUR J OBSTET GYN R B, V88, P15, DOI 10.1016/S0301-2115(99)00113-X; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; MATTSSON C, NAT CLIN PRACT NEPHR; McBride SM, 2005, ENDOCRINE, V28, P199, DOI 10.1385/ENDO:28:2:199; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; MULROW C, 2000, AHRQ PUBLICATION; Natarajan P, 1999, AM J OBSTET GYNECOL, V181, P1203, DOI 10.1016/S0002-9378(99)70109-2; Neilson JP, 2000, COCHRANE DB SYST REV, V2; North American Association for the Study of Obesity NHL Blood Institute NIoHNOEI, 2000, PRACTICAL GUIDE IDEN; Os I, 2004, BLOOD PRESSURE, V13, P272, DOI 10.1080/08037050410024330; Ostchega Y, 2005, J HUM HYPERTENS, V19, P885, DOI 10.1038/sj.jhh.1001905; Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pomini F, 2001, J Matern Fetal Med, V10, P398, DOI 10.1080/714052781; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; QUAN A, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002146; Rao P Syamasundar, 2005, Curr Cardiol Rep, V7, P425, DOI 10.1007/s11886-005-0060-0; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1977, BRIT J OBSTET GYNAEC, V84, P419, DOI 10.1111/j.1471-0528.1977.tb12616.x; Rey E, 1997, CAN MED ASSOC J, V157, P1245; REYNODLS B, 1984, ARCH DIS CHILD, V59, P10611; Richardson AD, 2000, INT J CLIN PHARM TH, V38, P75; Richardson DK, 2001, JAMA-J AM MED ASSOC, V286, P1498, DOI 10.1001/jama.286.12.1498; Roberts JM, 2005, HYPERTENSION, V46, P1263, DOI 10.1161/01.HYP.0000188703.27002.14; Roberts JM, 2005, LANCET, V366, P961, DOI 10.1016/S0140-6736(05)67349-7; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; SACERDOTE A, 2005, CURR HYPERTENS REP; Safar ME, 2004, AM J HYPERTENS, V17, P82, DOI 10.1016/S0895-7061(03)01008-2; Salem MM, 2002, SEMIN NEPHROL, V22, P17, DOI 10.1053/snep.2002.28640; Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1984, AM J OBSTET GYNECOL, V150, P831, DOI 10.1016/0002-9378(84)90458-7; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Stergiou George S, 2004, Expert Rev Cardiovasc Ther, V2, P359, DOI 10.1586/14779072.2.3.359; Sullivan MHF, 1999, AM J OBSTET GYNECOL, V181, P508, DOI 10.1016/S0002-9378(99)70587-9; TURNBULL JM, 1995, JAMA-J AM MED ASSOC, V274, P1299, DOI 10.1001/jama.274.16.1299; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; von Dadelszen P, 2006, OBSTET GYNECOL, V107, P209; von Dadelszen P, 2005, OBSTET GYNECOL, V106, P335, DOI 10.1097/01.AOG.0000171121.31564.14; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; WALTERS BNJ, 1986, CLIN SCI, V71, P589, DOI 10.1042/cs0710589; Webster J, 1996, J CARDIOVASC PHARM, V27, pS49, DOI 10.1097/00005344-199627003-00007; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	101	11	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1548	1558		10.1001/jama.298.13.1548	http://dx.doi.org/10.1001/jama.298.13.1548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911500				2022-12-28	WOS:000249860500027
J	Chou, R; Qaseem, A; Snow, V; Casey, D; Cross, JT; Shekelle, P; Owens, DK				Chou, Roger; Qaseem, Amir; Snow, Vincenza; Casey, Donald; Cross, J. Thomas, Jr.; Shekelle, Paul; Owens, Douglas K.			Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American college of physicians and the American pain society	ANNALS OF INTERNAL MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LUMBAR SPINAL STENOSIS; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NONCANCER PAIN; PRIMARY-CARE; DOUBLE-BLIND; ANKYLOSING-SPONDYLITIS; NONOPERATIVE TREATMENT; CONSERVATIVE TREATMENT; NONSURGICAL TREATMENT	Recommendation 1: Clinicians should conduct a focused history and physical examination to help place patients with low back pain into 1 of 3 broad categories: nonspecific low back pain, back pain potentially associated with radiculopathy or spinal stenosis, or back pain potentially associated with another specific spinal cause. The history should include assessment of psychosocial risk factors, which predict risk for chronic disabling back pain (strong recommendation, moderate-quality evidence). Recommendation 2: Clinicians should not routinely obtain imaging or other diagnostic tests in patients with nonspecific low back pain (strong recommendation, moderate-quality evidence). Recommendation 3: Clinicians should perform diagnostic imaging and testing for patients with low back pain when severe or progressive neurologic deficits are present or when serious underlying conditions are suspected on the basis of history and physical examination (strong recommendation, moderate-quality evidence). Recommendation 4: Clinicians should evaluate patients with persistent low back pain and signs or symptoms of radiculopathy or spinal stenosis with magnetic resonance imaging (preferred) or computed tomography only if they are potential candidates for surgery or epidural steroid injection (for suspected radiculopathy) (strong recommendation, moderate-quality evidence). Recommendation 5: Clinicians should provide patients with evidence-based information on low back pain with regard to their expected course, advise patients to remain active, and provide information about effective self-care options (strong recommendation, moderate-quality evidence). Recommendation 6: For patients with low back pain, clinicians should consider the use of medications with proven benefits in conjunction with back care information and self-care. Clinicians should assess severity of baseline pain and functional deficits, potential benefits, risks, and relative lack of long-term efficacy and safety data before initiating therapy (strong recommendation, moderate-quality evidence). For most patients, first-line medication options are acetaminophen or nonsteroidal anti-inflammatory drugs. Recommendation 7: For patients who do not improve with self-care options, clinicians should consider the addition of nonpharmacologic therapy with proven benefits-for acute low back pain, spinal manipulation; for chronic or subacute low back pain, intensive interdisciplinary rehabilitation, exercise therapy, acupuncture, massage therapy, spinal manipulation, yoga, cognitive-behavioral therapy, or progressive relaxation (weak recommendation, moderate-quality evidence).	Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Casey, Donald/AFM-6658-2022	Casey, Donald/0000-0002-3820-598X; Chou, Roger/0000-0001-9889-8610				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bigos S., 1994, ACUTE LOW BACK PROBL; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Brox JI, 2003, SPINE, V28, P1913; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; Carey TS, 1996, SPINE, V21, P339, DOI 10.1097/00007632-199602010-00018; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; CHERKIN DC, 1995, SPINE, V20, P1, DOI 10.1097/00007632-199501000-00001; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Chou R, 2004, J PAIN SYMPTOM MANAG, V28, P140, DOI 10.1016/j.jpainsymman.2004.05.002; Chou R, 2003, J PAIN SYMPTOM MANAG, V26, P1026, DOI 10.1016/j.jpainsymman.2003.03.003; CHOU R, 2007, IN PRESS AM PAIN SOC; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Clarke J, 2006, SPINE, V31, P1591, DOI 10.1097/01.brs.0000222043.09835.72; COLLINS A, 2005, RECOMMENDATIONS APPO; de Graaf I, 2006, SPINE, V31, P1168, DOI 10.1097/01.brs.0000216463.32136.7b; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Deville WLJM, 2000, SPINE, V25, P1140, DOI 10.1097/00007632-200005010-00016; DEYO RA, 1993, SPINE, V18, P2153, DOI 10.1097/00007632-199311000-00002; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Fayad F., 2004, Annales de Readaptation et de Medecine Physique, V47, P179, DOI 10.1016/j.annrmp.2004.01.005; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; French SD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004750.pub2; Friedman BW, 2006, J EMERG MED, V31, P365, DOI 10.1016/j.jemermed.2005.09.023; Fritz JM, 2003, SPINE, V28, P1363; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2002, SPINE, V27, P1896, DOI 10.1097/00007632-200209010-00017; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; GANIER JJ, 2006, COCHRANE DB SYST REV; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; GIBSON JN, 2000, COCHRANE DB SYST REV; GIBSON NJ, 2005, COCHRANE DB SYST REV; Gilbert FJ, 2004, RADIOLOGY, V231, P343, DOI 10.1148/radiol.2312030886; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Hagen EM, 2000, SPINE, V25, P1973, DOI 10.1097/00007632-200008010-00017; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; HAIMOVIC IC, 1986, NEUROLOGY, V36, P1593, DOI 10.1212/WNL.36.12.1593; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Harte AA, 2003, ARCH PHYS MED REHAB, V84, P1542, DOI 10.1016/S0003-9993(03)00294-6; Hay EM, 2005, LANCET, V365, P2024, DOI 10.1016/S0140-6736(05)66696-2; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Heymans MW, 2005, SPINE, V30, P2153, DOI 10.1097/01.brs.0000182227.33627.15; Hilde GG, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003632; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, NEUROIMAG CLIN N AM, V13, P293, DOI 10.1016/S1052-5149(03)00022-4; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jellema P, 2001, SPINE, V26, P377, DOI 10.1097/00007632-200102150-00014; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Jovey Roman D, 2003, Pain Res Manag, V8 Suppl A, p3A; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kalso E, 2003, EUR J PAIN, V7, P381, DOI 10.1016/S1090-3801(02)00143-X; Karjalainen K, 2001, SPINE, V26, P262, DOI 10.1097/00007632-200102010-00011; Karjalainen K, 2003, SPINE, V28, P533, DOI 10.1097/00007632-200303150-00004; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Kerry S, 2002, BRIT J GEN PRACT, V52, P469; Kovacs FM, 2003, LANCET, V362, P1599, DOI 10.1016/S0140-6736(03)14792-7; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lee C, 2004, ARTHRIT RHEUM-ARTHR, V51, P746, DOI 10.1002/art.20698; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McCleane GJ, 2001, PAIN CLINIC, V13, P103, DOI 10.1163/156856901753420945; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Nelemans PJ, 2001, SPINE, V26, P501, DOI 10.1097/00007632-200103010-00014; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; Pengel HM, 2002, CLIN REHABIL, V16, P811, DOI 10.1191/0269215502cr562oa; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; PORSMAN O, 1979, SCAND J RHEUMATOL, V8, P142, DOI 10.3109/03009747909114446; Rahme E, 2002, ARTHRITIS RHEUM-US, V46, P3046, DOI 10.1002/art.10604; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; Scheel IB, 2002, SPINE, V27, P2734, DOI 10.1097/00007632-200212010-00014; Schonstein E, 2003, SPINE, V28, pE391, DOI 10.1097/01.BRS.0000092482.76386.97; SHEKELLE PG, 1995, SPINE, V20, P221, DOI 10.1097/00007632-199501150-00018; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Staiger TO, 2003, SPINE, V28, P2540, DOI 10.1097/01.BRS.0000092372.73527.BA; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; SuarezAlmazor ME, 1997, JAMA-J AM MED ASSOC, V277, P1782, DOI 10.1001/jama.277.22.1782; Todd NV, 2005, BRIT J NEUROSURG, V19, P301, DOI 10.1080/02688690500305324; TOWHEED TE, 2003, COCHRANE DB SYST REV; Tsiodras S, 2006, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000203454.82264.cd; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013; van Tulder MW, 2003, SPINE, V28, P1978, DOI 10.1097/01.BRS.0000090503.38830.AD; VANDENHOOGEN HMM, 1995, SPINE, V20, P318, DOI 10.1097/00007632-199502000-00010; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; VOLINN E, 1992, SPINE, V17, P575, DOI 10.1097/00007632-199205000-00017; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Vroomen PCAJ, 1999, J NEUROL, V246, P899, DOI 10.1007/s004150050480; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Waddell G, 1996, CLIN GUIDELINES MANA; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Wegman A, 2004, J RHEUMATOL, V31, P344; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Yildirim K, 2003, PAIN CLINIC, V15, P213, DOI 10.1163/156856903767650718; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	131	1939	2066	16	424	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					478	491		10.7326/0003-4819-147-7-200710020-00006	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909209				2022-12-28	WOS:000250214700005
J	Hutton, DW; Tan, D; So, SK; Brandeau, ML				Hutton, David W.; Tan, Daniel; So, Samuel K.; Brandeau, Margaret L.			Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B	ANNALS OF INTERNAL MEDICINE			English	Article							FRANCISCO BAY AREA; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; ADEFOVIR DIPIVOXIL; LIVER-TRANSPLANTATION; IMMUNE GLOBULIN; VIRUS-INFECTION; ECONOMIC-EVALUATION; INTERFERON-ALPHA; VIRAL-HEPATITIS	Background: As many as 10% of Asian and Pacific Islander adults in the United States are chronically infected with hepatitis B virus (HBV), and up to two thirds are unaware that they are infected. Without proper medical management and antiviral therapy, up to 25% of Asian and Pacific Islander persons with chronic HBV infection will die of liver disease. Objective: To assess the cost-effectiveness of 4 HBV screening and vaccination programs for Asian and Pacific Islander adults in the United States. Design: Markov model with costs and benefits discounted at 3%. Data Sources: Published literature and expert opinion. Target Population: Asian and Pacific Islander adults (base-case age, 40 years; sensitivity analysis conducted on ages 20 to 60 years). Time Horizon: Lifetime. Perspective: U.S. societal. Interventions: A universal vaccination strategy in which all individuals are given a 3-dose vaccination series; a screen-and-treat strategy, in which individuals are given blood tests to determine whether they are chronically infected, and infected persons are monitored and treated; a screen, treat, and ring vaccinate strategy, in which all individuals are tested for chronic HBV infection and close contacts of infected persons are screened and vaccinated if needed; and a screen, treat, and vaccinate strategy, in which all individuals are tested and then vaccinated with a 3-dose series if needed. in all cases, persons found to be chronically infected are monitored and treated if indicated. Outcome Measures: Costs (2006 U.S. dollars), quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Compared with the status quo, the screen-and-treat strategy has an incremental cost-effectiveness ratio of $36088 per QALY gained. The screen, treat, and ring vaccinate strategy gains more QALYs than the screen and treat strategy and incurs modest incremental costs, leading to incremental cost-effectiveness of $39 903 per QALY gained compared with the screen and treat strategy. The universal vaccination and screen, treat, and vaccinate strategies were weakly dominated by the other 2 strategies. Results of Sensitivity Analysis: Over a wide range of variables, the incremental cost-effectiveness ratios of the screen and treat and screen, treat, and ring vaccinate strategies were less than $50 000 per QALY gained. Limitations: Results depend on the accuracy of the underlying data and assumptions. The long-term effectiveness of new and future HBV treatments is uncertain. Conclusions: Screening programs for HBV among Asian and Pacific Islander adults are likely to be cost effective. Clinically significant benefits accrue from identifying chronically infected persons for medical management and vaccinating their close contacts. Such efforts can greatly reduce the burden of HBV-associated liver cancer and chronic liver disease in the Asian and Pacific Islander population.	Stanford Univ, Dept Management Sci & Engn, Asian Liver Ctr, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Brandeau, ML (corresponding author), Stanford Univ, Dept Management Sci & Engn, Asian Liver Ctr, Terman Bldg, Stanford, CA 94305 USA.	brandeau@stanford.edu						*ACIP, 2005, MMWR-MORBID MORTAL W, V54, P1; Alderman EM, 1998, CLIN INFECT DIS, V26, P1459, DOI 10.1086/516346; Alimonos K, 1998, CLIN INFECT DIS, V26, P566, DOI 10.1086/514575; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; *AM CANC SOC, 2007, CAL CANC FACTS FIG; ANDRE FE, 1987, POSTGRAD MED J, V63, P169; ANDRE FE, 1994, J MED VIROL, V44, P144, DOI 10.1002/jmv.1890440206; ANDRE FE, 1989, AM J MED, V87, pS14, DOI 10.1016/0002-9343(89)90525-1; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; *AS LIV CTR STANF, JAD RIBB CAM; *AS LIV CTR STANF, ADV; ATKINSON W, 2007, CDCP EPIDEMIOLOGY PR; BEASLEY RP, 1983, HEPATOLOGY, V3, P135; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; BLOOM BS, 1993, ANN INTERN MED, V118, P298, DOI 10.7326/0003-4819-118-4-199302150-00009; Blostein J, 2001, PUBLIC HEALTH REP, V116, P165, DOI 10.1016/S0033-3549(04)50008-0; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks EA, 2001, AM J MANAG CARE, V7, P677; *CDC, 2000, MMWR-MORBID MORTAL W, V49, P616; *CDC, 1995, MMWR-MORBID MORTAL W, V44, P574; *CDC, 2005, 60 US DEP HHS; *CDC, 1999, MMWR-MORBID MORTAL W, V48, P33; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P317; *CDCP, DIS BURD HEP A B C U; *CDCP, 2004, EST VACC COV HEP B V; *CDCP, HEP B FACT SHEET; Centers for Disease Control and prevention, CDC VACC PRIC LIST; Chan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006; Chang ET, 2007, CANCER-AM CANCER SOC, V109, P2100, DOI 10.1002/cncr.22642; Chao S, 2004, HEPATOLOGY, V40, p717A; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Choe JH, 2005, CANCER-AM CANCER SOC, V104, P2955, DOI 10.1002/cncr.21518; Cooksley WG, 2004, SEMIN LIVER DIS, V24, P45, DOI 10.1055/s-2004-828678; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Gold MR, 1996, COST EFFECTIVENESS H; Guane R, 2004, HEPATOLOGY, V40, p716A; Gust ID, 1996, GUT, V38, pS18, DOI 10.1136/gut.38.Suppl_2.S18; Han SHB, 2000, LIVER TRANSPLANT, V6, P741, DOI 10.1053/jlts.2000.18702; HERNANDEZ S, 2003, ANTIVIR THER, V8, P1; Hu RH, 2005, CLIN TRANSPLANT, V19, P175, DOI 10.1111/j.1399-0012.2005.00277.x; Hwang SJ, 1996, J GASTROEN HEPATOL, V11, P949, DOI 10.1111/j.1440-1746.1996.tb00279.x; Jacobs RJ, 2003, J AM COLL HEALTH, V51, P227, DOI 10.1080/07448480309596355; Jacobs RJ, 2003, PUBLIC HEALTH REP, V118, P550, DOI 10.1016/S0033-3549(04)50291-1; Kanwal F, 2005, ANN INTERN MED, V142, P821, DOI 10.7326/0003-4819-142-10-200505170-00007; Kaur S, 1996, HEPATOLOGY, V24, P979; Kim SY, 2006, AM J PREV MED, V30, P498, DOI 10.1016/j.amepre.2006.01.017; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; KRAHN M, 1993, MED DECIS MAKING, V13, P4, DOI 10.1177/0272989X9301300103; Krahn M, 1998, AM J PUBLIC HEALTH, V88, P1638, DOI 10.2105/AJPH.88.11.1638; Krogsgaard K, 1998, J VIRAL HEPATITIS, V5, P389, DOI 10.1046/j.1365-2893.1998.00118.x; Lee H, 2005, APPL NURS RES, V18, P2, DOI 10.1016/j.apnr.2004.04.002; LIN SY, 2007, HEPATOLOGY; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; LOK ASF, 1987, AM J EPIDEMIOL, V126, P492, DOI 10.1093/oxfordjournals.aje.a114681; Maluf DG, 2007, TRANSPLANT P, V39, P153, DOI 10.1016/j.transproceed.2006.10.029; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Nath DS, 2006, CLIN TRANSPLANT, V20, P206, DOI 10.1111/j.1399-0012.2005.00467.x; Nguyen MH, 2002, J CLIN GASTROENTEROL, V35, pS86, DOI 10.1097/00004836-200211002-00004; *ORG PROC TRANSP N, DAT VIEW DAT RP; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Owens DK, 2005, ANN INTERN MED, V142, P863, DOI 10.7326/0003-4819-142-10-200505170-00013; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Pierie JPEN, 2005, ANN SURG ONCOL, V12, P552, DOI 10.1245/ASO.2004.03.029; Pisu M, 2002, VACCINE, V21, P312, DOI 10.1016/S0264-410X(02)00457-7; Pollack H., 2006, Morbidity and Mortality Weekly Report, V55, P505; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Shepard C., 2004, Morbidity and Mortality Weekly Report, V53, P1015; Shepherd J, 2006, HEALTH TECHNOL ASSES, V10, P1; Shivanada, 2006, CLIN VACCINE IMMUNOL, V13, P661, DOI 10.1128/CVI.00087-06; Takeda A, 2007, J VIRAL HEPATITIS, V14, P75, DOI 10.1111/j.1365-2893.2006.00808.x; Taylor VM, 2005, J COMMUN HEALTH, V30, P477, DOI 10.1007/s10900-005-7282-3; Terrault NA, 2006, LIVER TRANSPLANT, V12, P801, DOI 10.1002/lt.20776; U.S. Bureau of the Census, 1997, STAT ABSTR US; *US CEN BUR, 2005, AM COMM SURV; *US CEN BUR, STAT COUNT QUICKF RA; *US CENS BUR, 2000, US CENS FACTF; van Steenbergen JE, 2004, J HEPATOL, V40, P979, DOI 10.1016/j.jhep.2004.02.025; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; *WHO, 2000, HEP B FACT SHEET; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Wu CA, 2007, ASIAN PAC J CANCER P, V8, P127; Yao FY, 1999, LIVER TRANSPLANT SUR, V5, P491, DOI 10.1002/lt.500050605; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zhou FJ, 2003, PEDIATRICS, V111, P1289, DOI 10.1542/peds.111.6.1289	93	130	132	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					460	469		10.7326/0003-4819-147-7-200710020-00004	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909207				2022-12-28	WOS:000250214700003
J	Thompson, WW; Price, C; Goodson, B; Shay, DK; Benson, P; Hinrichsen, VL; Lewis, E; Eriksen, E; Ray, P; Marcy, SM; Dunn, J; Jackson, LA; Lieu, TA; Black, S; Stewart, G; Weintraub, ES; Davis, RL; DeStefano, F				Thompson, William W.; Price, Cristofer; Goodson, Barbara; Shay, David K.; Benson, Patti; Hinrichsen, Virginia L.; Lewis, Edwin; Eriksen, Eileen; Ray, Paula; Marcy, S. Michael; Dunn, John; Jackson, Lisa A.; Lieu, Tracy A.; Black, Steve; Stewart, Gerrie; Weintraub, Eric S.; Davis, Robert L.; DeStefano, Frank		Vaccine Safety Datalink Team	Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE SAFETY DATALINK; DEVELOPMENTAL DISORDERS; METHYLMERCURY EXPOSURE; CONFOUNDER-SELECTION; UNITED-KINGDOM; CELL-DEATH; INFANTS; NEURODEVELOPMENT; NEUROTOXICITY; ACTIVATION	Background It has been hypothesized that early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children. Methods We enrolled 1047 children between the ages of 7 and 10 years and administered standardized tests assessing 42 neuropsychological outcomes. (We did not assess autism-spectrum disorders.) Exposure to mercury from thimerosal was determined from computerized immunization records, medical records, personal immunization records, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We assessed the association between current neuropsychological performance and exposure to mercury during the prenatal period, the neonatal period (birth to 28 days), and the first 7 months of life. Results Among the 42 neuropsychological outcomes, we detected only a few significant associations with exposure to mercury from thimerosal. The detected associations were small and almost equally divided between positive and negative effects. Higher prenatal mercury exposure was associated with better performance on one measure of language and poorer performance on one measure of attention and executive functioning. Increasing levels of mercury exposure from birth to 7 months were associated with better performance on one measure of fine motor coordination and on one measure of attention and executive functioning. Increasing mercury exposure from birth to 28 days was associated with poorer performance on one measure of speech articulation and better performance on one measure of fine motor coordination. Conclusions Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.	Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA; ABT Associates Inc, Cambridge, MA 02138 USA; Grp Hlth Ctr Hlth Studies, Seattle, WA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Kaiser Permanente, Div Res, Oakland, CA USA; Vaccine Study Ctr, Oakland, CA USA; Univ Calif Los Angeles, Ctr Vaccine Res, Torrance, CA USA; So Calif Kaiser Permanente, Los Angeles, CA USA; RTI Int, Atlanta, GA USA; Stanford Univ, Palo Alto, CA 94304 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; ABT Associates; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Kaiser Permanente; University of California System; University of California Los Angeles; Kaiser Permanente; Research Triangle Institute; Stanford University	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, MS A32,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	wct2@cdc.gov		Shay, David/0000-0001-9619-4820				Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; Andrews N, 2004, PEDIATRICS, V114, P584, DOI 10.1542/peds.2003-1177-L; [Anonymous], 1999, PEDIATRICS, V104, P568; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; Budtz-Jorgensen E, 2007, ANN EPIDEMIOL, V17, P27, DOI 10.1016/j.annepidem.2006.05.007; Burbacher TM, 2005, ENVIRON HEALTH PERSP, V113, P1015, DOI 10.1289/ehp.7712; Chen RT, 2000, B WORLD HEALTH ORGAN, V78, P186; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Davidson PU, 2001, JAMA-J AM MED ASSOC, V285, P1291, DOI 10.1001/jama.285.10.1291-a; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Goldfrank LR, 2002, GOLDFRANKS TOXICOLOG; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Havarinasab S, 2006, TOXICOL APPL PHARM, V214, P43, DOI 10.1016/j.taap.2005.12.004; Havarinasab S, 2005, TOXICOL APPL PHARM, V204, P109, DOI 10.1016/j.taap.2004.08.019; Heron J, 2004, PEDIATRICS, V114, P577, DOI 10.1542/peds.2003-1176-L; Hornig M, 2004, MOL PSYCHIATR, V9, P833, DOI 10.1038/sj.mp.4001529; Hunter JE, 2002, HUM COMMUN RES, V28, P552, DOI 10.1093/hcr/28.4.552; Jacobson JL, 2001, NEUROTOXICOLOGY, V22, P667, DOI 10.1016/S0161-813X(01)00040-7; James SJ, 2005, NEUROTOXICOLOGY, V26, P1, DOI 10.1016/j.neuro.2004.07.012; KIM JO, 1981, SOCIOL METHOD RES, V10, P187, DOI 10.1177/004912418101000203; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; *MED EC, 1995, PHYS DESK REF; Medical Economics, 1999, PHYS DESK REF, V53rd; Mutkus L, 2005, BIOL TRACE ELEM RES, V105, P71, DOI 10.1385/BTER:105:1-3:071; Parran DK, 2005, TOXICOL SCI, V86, P132, DOI 10.1093/toxsci/kfi175; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; PRICE C, 2007, INFANT ENV EXPOSURE, V1; Stern Alan H, 2004, Environ Health, V3, P2, DOI 10.1186/1476-069X-3-2; Stewart G, 2007, INFANT ENV EXPOSURE, VII; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476	36	174	182	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1281	1292		10.1056/NEJMoa071434	http://dx.doi.org/10.1056/NEJMoa071434			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898097				2022-12-28	WOS:000249711500004
J	Dyer, CB; Pickens, S; Burnett, J				Dyer, Carmel Bitondo; Pickens, Sabrina; Burnett, Jason			Vulnerable elders - When it is no longer safe to live alone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIOGENES SYNDROME; NEGLECT; BREAKDOWN; ABUSE		Univ Texas, Hlth Sci Ctr, Dept Med, Div Geriatr & Palliat Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dyer, CB (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Geriatr & Palliat Med, 6431 Fannin,MSB 4-200, Houston, TX 77030 USA.	Carmel.B.Dyer@uth.tmc.edu			NCRR NIH HHS [P20RR20626] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020626] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bitondo C, 2007, AM J PUBLIC HEALTH, V97, P1671, DOI 10.2105/AJPH.2006.097113; Brandl B., 2007, ELDER ABUSE DETECTIO; BURSTON GR, 1975, BRIT MED J, V3, P592, DOI 10.1136/bmj.3.5983.592-a; CLARK ANG, 1975, LANCET, V1, P366; Drummond LM, 1997, IRISH J PSYCHOL MED, V14, P99, DOI 10.1017/S0790966700003190; GORDON AJ, 2007, NEW YORK SUN    0723; Heath JM, 2005, J AM GERIATR SOC, V53, P1538, DOI 10.1111/j.1532-5415.2005.53469.x; KARP N, 2003, HUMAN RIGHTS MAGAZIN; Lachs MS, 1997, GERONTOLOGIST, V37, P469, DOI 10.1093/geront/37.4.469; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; MACMILLAN D, 1957, ROY SOC HEALTH J, V77, P830; MACMILLAN D, 1966, BMJ-BRIT MED J, V2, P1032, DOI 10.1136/bmj.2.5521.1032; Mosqueda L, 2004, GERONTOLOGIST, V44, P703, DOI 10.1093/geront/44.5.703; *NAT CTR ELD AB PU, 1998, NAT ELD AB INC STUD; National Center on Elder Abuse, 2006, 2004 SURV STAT AD PR; Pavlik VN, 2001, J AM GERIATR SOC, V49, P45, DOI 10.1046/j.1532-5415.2001.49008.x; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; *US C SEL COMM AG, 1981, REP EL AB EX HIDD PR	18	49	52	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1448	1450		10.1001/jama.298.12.1448	http://dx.doi.org/10.1001/jama.298.12.1448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895463				2022-12-28	WOS:000249698900026
J	Tirosh, A; Rudich, A; Shochat, T; Tekes-Manova, D; Israeli, E; Henkin, Y; Kochba, I; Shai, I				Tirosh, Amir; Rudich, Assaf; Shochat, Tzippora; Tekes-Manova, Dorit; Israeli, Eran; Henkin, Yaakov; Kochba, Ilan; Shai, Iris			Changes in triglyceride levels and risk for coronary heart disease in young men	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; PLASMA TRIGLYCERIDE; FOLLOW-UP; ATHEROSCLEROSIS; ADULTS; PREDICTION; MORTALITY; TRENDS; LIPIDS	Background: Current triglyceride levels might be only a weak predictor of risk for coronary heart disease (CHID). Objective: To assess the association between changes over time in fasting triglyceride levels and CHID risk in young adults. Design: Follow-up study over 5.5 years after 2 measurements of fasting triglycerides 5 years apart. Setting: The Staff Periodic Examination Center of the Israel Defense Forces, Zrifin, Israel. Patierts: 13 953 apparently healthy, untreated, young men (age 26 to 45 years) with triglycericle levels less than 3.39 mmol/L (< 300 mg/dL). Measurements: Two triglycericle measurements (at enrollment [time 1] and 5 years later [time 2]), lifestyle variables, and incident cases of angiography-proven CHID. Results: Within 5.5 years, 158 new cases of CHID were identified. The multivariate model was adjusted for age; family history; fasting glucose; high-density lipoprotein cholesterol; blood pressure; body mass index; and changes between time 1 and time 2 in body mass index, physical activity, smoking status, and habit of eating breakfast. Investigators categorized triglyceride levels according to low, intermediate, and high tertiles (as measured at time 1 and time 2 [expressed as tertile at time 1/tertile at time 2]). The risk for CHID in men with high-tertile triglyceride levels at time 1 changed depending on the tertile at time 2 (hazard ratios, 8.23 [95% Cl, 2.50 to 27.13] for high/high, 6.84 [Cl, 1.95 to 23.98] for high/intermediate, and 4.90 [Cl, 1.01 to 24.55] for high/low, compared with the stable low/low group). The risk for CHD in men with low-tertile levels at time 1 also changed depending on the tertile at time 2 (hazard ratios, 3.81 [Cl, 0.96 to 15.31] for low/intermediate and 6.76 [Cl, 1.34 to 33.92] for low/high, compared with the stable low/low group). Limitations: Participants were healthy and had a low incidence rate of CHD. The study was observational. Conclusions: Two triglyceride measurements obtained 5 years apart may assist in assessing CHD risk in young men. A decrease in initially elevated triglyceride levels is associated with a decrease in CHD risk compared with stable high triglyceride levels. However, this risk remains higher than in those with persistently low triglyceride levels.	Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth Nutr, Soroka Med Ctr, Dept Epidemiol & Hlth Syst Evaluat, IL-84105 Beer Sheva, Israel; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Israel Def Forces Med Corps, Zerifin, Israel	Ben Gurion University; Soroka Medical Center; Chaim Sheba Medical Center	Shai, I (corresponding author), Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth Nutr, Soroka Med Ctr, Dept Epidemiol & Hlth Syst Evaluat, PO Box 653, IL-84105 Beer Sheva, Israel.	irish@bgu.ac.il		Tirosh, Amir/0000-0003-2210-5906; Rudich, Assaf/0000-0002-1366-1444; Shai, Iris/0000-0001-9050-4605				AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; BRENNER H, 1990, EUR HEART J, V11, P1054, DOI 10.1093/oxfordjournals.eurheartj.a059642; Breuer HWM, 2001, CURR MED RES OPIN, V17, P60, DOI 10.1185/03007990152005379; BRUCE RA, 1983, J AM COLL CARDIOL, V2, P565, DOI 10.1016/S0735-1097(83)80286-1; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; CASTELLI WP, 1992, AM J CARDIOL, V70, pH3, DOI 10.1016/0002-9149(92)91083-G; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; GEURIAN K, 1992, ANN PHARMACOTHER, V26, P1109, DOI 10.1177/106002809202600913; Ginsberg HN, 2000, AM J CARDIOL, V86, p41L; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JACOBS DR, 1982, AM J EPIDEMIOL, V116, P878, DOI 10.1093/oxfordjournals.aje.a113490; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Szapary Philippe O, 2003, Curr Cardiol Rep, V5, P488, DOI 10.1007/s11886-003-0112-2; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023	30	122	174	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					377	385		10.7326/0003-4819-147-6-200709180-00007	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876021				2022-12-28	WOS:000249726200003
J	Wilson, JF				Wilson, Jennifer Fisher			To stop osteoarthritis, fixing cartilage may not be enough	ANNALS OF INTERNAL MEDICINE			English	News Item							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED TRIAL; KNEE OSTEOARTHRITIS; EDUCATIONAL-PROGRAM; REDUCE USE; HIP; RISEDRONATE; CHONDROITIN; PROGRESSION; PHYSICIANS					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122; Brandt KD, 1997, ANN INTERN MED, V127, P154, DOI 10.7326/0003-4819-127-2-199707150-00011; Bukulmez H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1878; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Dieppe P, 2003, RHEUM DIS CLIN N AM, V29, P687, DOI 10.1016/S0889-857X(03)00054-1; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P1378, DOI 10.1002/art.22526; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; LOUGHLIN J, 2004, ARTHRITIS RES THE S3, V6, P2; Ray WA, 2001, MED CARE, V39, P425, DOI 10.1097/00005650-200105000-00003; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Spector TD, 2005, ARTHRITIS RES THER, V7, pR625, DOI 10.1186/ar1716; Stein CM, 2001, MED CARE, V39, P436	13	15	16	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					437	439		10.7326/0003-4819-147-6-200709180-00024	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876032				2022-12-28	WOS:000249726200024
J	Webster, MWI; Ormiston, JA				Webster, Markw W. I.; Ormiston, John A.			Drug-eluting stents and late stent thrombosis	LANCET			English	Editorial Material							NEOINTIMAL COVERAGE; IMPLANTATION; RESTENOSIS		Auckland City Hosp, Auckland 1031, New Zealand	Auckland City Hospital	Webster, MWI (corresponding author), Auckland City Hosp, Auckland 1031, New Zealand.	mwebster@adhb.govt.nz						Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Koo BK, 2007, LANCET, V370, P567, DOI 10.1016/S0140-6736(07)61295-1; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Rodriguez AE, 2006, J AM COLL CARDIOL, V47, P1522, DOI 10.1016/j.jacc.2005.12.052; Rosmarakis ES, 2007, AM HEART J, V154, P144, DOI 10.1016/j.ahj.2007.04.005; SCHOMIG A, 2007, IN PRESS J AM COLL C; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Takano M, 2007, AM J CARDIOL, V99, P1033, DOI 10.1016/j.amjcard.2006.11.068	14	25	26	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					914	915		10.1016/S0140-6736(07)61424-X	http://dx.doi.org/10.1016/S0140-6736(07)61424-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17869619				2022-12-28	WOS:000249506500005
J	Cassidy, DB; Mills, AP				Cassidy, D. B.; Mills, A. P., Jr.			The production of molecular positronium	NATURE			English	Article							ANNIHILATION; SURFACES; PULSES	It has been known for many years that an electron and its antiparticle, the positron, may together form a metastable hydrogen-like atom, known as positronium or Ps (ref. 1). In 1946, Wheeler speculated(2) that two Ps atoms may combine to form the dipositronium molecule (Ps(2)), with a binding energy(3) of 0.4 eV. More recently, this molecule has been studied theoretically(4); however, because Ps has a short lifetime and it is difficult to obtain low-energy positrons in large numbers, Ps(2) has not previously been observed unambiguously(5). Here we show that when intense positron bursts are implanted into a thin film of porous silica, Ps(2) is created on the internal pore surfaces. We found that molecule formation occurs much more efficiently than the competing process of spin exchange quenching, which appears to be suppressed in the confined pore geometry. This result experimentally confirms the existence of the Ps(2) molecule and paves the way for further multi-positronium work. Using similar techniques, but with a more intense positron source, we expect to increase the Ps density to the point where many thousands of atoms interact and can undergo a phase transition to form a Bose-Einstein condensate(6). As a purely leptonic, macroscopic quantum matter-antimatter system this would be of interest in its own right, but it would also represent a milestone on the path to produce an annihilation gamma-ray laser(7).	Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA	University of California System; University of California Riverside	Cassidy, DB (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	cassidy@physics.ucr.edu		Cassidy, David/0000-0001-8332-5553				BRANDT W, 1960, PHYS REV, V120, P1289, DOI 10.1103/PhysRev.120.1289; Cassidy DB, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2221509; Cassidy DB, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2203336; Cassidy DB, 2007, NUCL INSTRUM METH B, V262, P59, DOI 10.1016/j.nimb.2007.04.220; Cassidy DB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.195006; Charlton M., 2001, POSITRON PHYS; CHU S, 1981, PHYS REV B, V23, P2060, DOI 10.1103/PhysRevB.23.2060; DEUTSCH M, 1951, PHYS REV, V82, P455, DOI 10.1103/PhysRev.82.455; Gidley DW, 1999, PHYS REV B, V60, pR5157, DOI 10.1103/PhysRevB.60.R5157; He CQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195404; HYLLERAAS EA, 1947, PHYS REV, V71, P493, DOI 10.1103/PhysRev.71.493; KIM SM, 1978, J PHYS C SOLID STATE, V11, P101, DOI 10.1088/0022-3719/11/1/020; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; MARTIN T, 1991, PHYS REV B, V43, P6466, DOI 10.1103/PhysRevB.43.6466; Mills AP, 2007, RADIAT PHYS CHEM, V76, P76, DOI 10.1016/j.radphyschem.2006.03.009; Mills AP, 2004, MATER SCI FORUM, V445-6, P424, DOI 10.4028/www.scientific.net/MSF.445-446.424; MILLS AP, 1979, SOLID STATE COMMUN, V31, P623, DOI 10.1016/0038-1098(79)90310-7; Mills AP, 1995, P INT SCH PHYS, V125, P209; MORGENSEN OE, 1974, J CHEM PHYS, V60, P998, DOI 10.1063/1.1681180; PAULIN R, 1968, J PHYS-PARIS, V29, P263, DOI 10.1051/jphys:01968002904026300; PLATZMAN PM, 1994, PHYS REV B, V49, P454, DOI 10.1103/PhysRevB.49.454; Saito H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.193401; SANIZ R, 2007, HTTPARXIVORGABS07050; Schrader DM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.043401; SFERLAZZO P, 1985, PHYS REV B, V32, P6067, DOI 10.1103/PhysRevB.32.6067; Surko CM, 2004, PHYS PLASMAS, V11, P2333, DOI 10.1063/1.1651487; Tanaka HKM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193408; Varga K, 1998, PHYS REV LETT, V80, P1876, DOI 10.1103/PhysRevLett.80.1876; WHEELER JA, 1946, ANN NY ACAD SCI, V48, P219, DOI 10.1111/j.1749-6632.1946.tb31764.x	29	216	218	6	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					195	197		10.1038/nature06094	http://dx.doi.org/10.1038/nature06094			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851519				2022-12-28	WOS:000249394500044
J	Enquist, BJ; Kerkhoff, AJ; Stark, SC; Swenson, NG; McCarthy, MC; Price, CA				Enquist, Brian J.; Kerkhoff, Andrew J.; Stark, Scott C.; Swenson, Nathan G.; McCarthy, Megan C.; Price, Charles A.			A general integrative model for scaling plant growth, carbon flux, and functional trait spectra	NATURE			English	Article							ECOSYSTEM; RESPIRATION; ALLOMETRY; RANGE; FORM	Linking functional traits to plant growth is critical for scaling attributes of organisms to the dynamics of ecosystems(1,2) and for understanding how selection shapes integrated botanical phenotypes(3). However, a general mechanistic theory showing how traits specifically influence carbon and biomass flux within and across plants is needed. Building on foundational work on relative growth rate(4-6), recent work on functional trait spectra(7-9), and metabolic scaling theory(10,11), here we derive a generalized trait-based model of plant growth. In agreement with a wide variety of empirical data, our model uniquely predicts how key functional traits interact to regulate variation in relative growth rate, the allometric growth normalizations for both angiosperms and gymnosperms, and the quantitative form of several functional trait spectra relationships. The model also provides a general quantitative framework to incorporate additional leaf-level trait scaling relationships(7,8) and hence to unite functional trait spectra with theories of relative growth rate, and metabolic scaling. We apply the model to calculate carbon use efficiency. This often ignored trait, which may influence variation in relative growth rate, appears to vary directionally across geographic gradients. Together, our results show how both quantitative plant traits and the geometry of vascular transport networks can be merged into a common scaling theory. Our model provides a framework for predicting not only how traits covary within an integrated allometric phenotype but also how trait variation mechanistically influences plant growth and carbon flux within and across diverse ecosystems.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Sci Conservat Int, Ctr Appl Biodivers, Arlington, VA 22202 USA; Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; Kenyon Coll, Dept Math, Gambier, OH 43022 USA	University of Arizona; The Santa Fe Institute; Kenyon College; Kenyon College	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	benquist@email.arizona.edu	Swenson, Nathan/A-3514-2012; Price, Charles A/B-1171-2011; Price, Chuck A/HIK-1431-2022; Enquist, Brian J/B-6436-2008	Swenson, Nathan/0000-0003-3819-9767; Enquist, Brian J/0000-0002-6124-7096; Kerkhoff, Andrew/0000-0001-9617-8687; Stark, Scott C/0000-0002-1579-1648				Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Bonser SP, 2006, OIKOS, V114, P187, DOI 10.1111/j.2006.0030-1299.14425.x; Chambers JQ, 2004, ECOL APPL, V14, pS72; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; ENQUIST BJ, 2007, NATURE, V13, P591; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Enquist BJ, 2007, NATURE, V445, pE9, DOI 10.1038/nature05548; Field C. H., 1986, EC FORM FUNCTION, P25; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Hunt R., 1978, PLANT GROWTH ANAL, Vfirst; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; KONINGS H, 1989, VARIATION GROWTH RAT, P101; Lambers H., 1989, CAUSES CONSEQUENCES, P1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; POORTER H, 1989, VARIATION GROWTH RAT, P45; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; TILMAN D, 1988; Waring RH, 1998, TREE PHYSIOL, V18, P129; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WRIGHT IJ, ANN BOT-LONDON, DOI DOI 10.1093/AOB.MCL066	31	162	180	9	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					218	222		10.1038/nature06061	http://dx.doi.org/10.1038/nature06061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851525				2022-12-28	WOS:000249394500050
J	Korbel, JO; Urban, AE; Affourtit, JP; Godwin, B; Grubert, F; Simons, JF; Kim, PM; Palejev, D; Carriero, NJ; Du, L; Taillon, BE; Chen, ZT; Tanzer, A; Saunders, ACE; Chi, JX; Yang, FT; Carter, NP; Hurles, ME; Weissman, SM; Harkins, TT; Gerstein, MB; Egholm, M; Snyder, M				Korbel, Jan O.; Urban, Alexander Eckehart; Affourtit, Jason P.; Godwin, Brian; Grubert, Fabian; Simons, Jan Fredrik; Kim, Philip M.; Palejev, Dean; Carriero, Nicholas J.; Du, Lei; Taillon, Bruce E.; Chen, Zhoutao; Tanzer, Andrea; Saunders, A. C. Eugenia; Chi, Jianxiang; Yang, Fengtang; Carter, Nigel P.; Hurles, Matthew E.; Weissman, Sherman M.; Harkins, Timothy T.; Gerstein, Mark B.; Egholm, Michael; Snyder, Michael			Paired-end mapping reveals extensive structural variation in the human genome	SCIENCE			English	Article							COPY NUMBER VARIATION; SEGMENTAL DUPLICATIONS; ARRAY CGH; RESOLUTION; SUSCEPTIBILITY; POLYMORPHISM; BREAKPOINTS; VARIANTS	Structural variation of the genome involves kilobase- to megabase-sized deletions, duplications, insertions, inversions, and complex combinations of rearrangements. We introduce high-throughput and massive paired- end mapping (PEM), a large-scale genome-sequencing method to identify structural variants (SVs) similar to 3 kilobases (kb) or larger that combines the rescue and capture of paired ends of 3-kb fragments, massive 454 sequencing, and a computational approach to map DNA reads onto a reference genome. PEM was used to map SVs in an African and in a putatively European individual and identified shared and divergent SVs relative to the reference genome. Overall, we fine-mapped more than 1000 SVs and documented that the number of SVs among humans is much larger than initially hypothesized; many of the SVs potentially affect gene function. The breakpoint junction sequences of more than 200 SVs were determined with a novel pooling strategy and computational analysis. Our analysis provided insights into the mechanisms of SV formation in humans.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; 454 Life Sci, Branford, CT 06405 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Roche Appl Sci, Indianapolis, IN 46250 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Yale University; European Molecular Biology Laboratory (EMBL); Yale University; Yale University; Yale University; Yale University; Leipzig University; University of Vienna; Wellcome Trust Sanger Institute; Roche Holding; Yale University	Egholm, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	megholm@454.com; michael.snyder@yale.edu	Korbel, Jan O/G-6470-2012; Tanzer, Andrea/L-3147-2015; Tanzer, Andrea/AAY-5431-2021	Korbel, Jan O/0000-0002-2798-3794; Tanzer, Andrea/0000-0003-2873-4236; Tanzer, Andrea/0000-0003-2873-4236; Snyder, Michael/0000-0003-0784-7987; Palejev, Dean/0000-0002-0563-6636	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019895, RR19895] Funding Source: Medline; Wellcome Trust [077008, 077014] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kim Philip, UNPUB; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103	23	825	922	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					420	426		10.1126/science.1149504	http://dx.doi.org/10.1126/science.1149504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17901297	Green Accepted			2022-12-28	WOS:000250230400038
J	Krause, J; Orlando, L; Serre, D; Viola, B; Prufer, K; Richards, MP; Hublin, JJ; Hanni, C; Derevianko, AP; Paabo, S				Krause, Johannes; Orlando, Ludovic; Serre, David; Viola, Bence; Pruefer, Kay; Richards, Michael P.; Hublin, Jean-Jacques; Haenni, Catherine; Derevianko, Anatoly P.; Paeaebo, Svante			Neanderthals in central Asia and Siberia	NATURE			English	Article							MITOCHONDRIAL-DNA; SEQUENCE	Morphological traits typical of Neanderthals began to appear in European hominids at least 400,000 years ago(1) and about 150,000 years ago(2) in western Asia. After their initial appearance, such traits increased in frequency and the extent to which they are expressed until they disappeared shortly after 30,000 years ago. However, because most fossil hominid remains are fragmentary, it can be difficult or impossible to determine unambiguously whether a fossil is of Neanderthal origin. This limits the ability to determine when and where Neanderthals lived. To determine how far to the east Neanderthals ranged, we determined mitochondrial DNA (mtDNA) sequences from hominid remains found in Uzbekistan and in the Altai region of southern Siberia. Here we show that the DNA sequences from these fossils fall within the European Neanderthal mtDNA variation. Thus, the geographic range of Neanderthals is likely to have extended at least 2,000 km further to the east than commonly assumed.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Lyon, Inst Genom Fonct Lyon,CNRS,INRA, Inst Federat Biosci Gerland Lyon Sud, Ecole Normale Super Lyon, F-69364 Lyon 07, France; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Univ Vienna, Fac Life Sci, Dept Anthropol, A-1090 Vienna, Austria; Russian Acad Sci, Inst Archaeol & Ethnog, Paleolith Dept, Siberian Branch, Novosibirsk 630090, Russia	Max Planck Society; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); McGill University; University of Vienna; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	paabo@eva.mpg.de	Krause, Johannes/E-6640-2015; Richards, Michael/A-9374-2008; Richards, Michael/O-3717-2016; Derevianko, Anatoly P./Q-5975-2016; Krause, Johannes/AFP-2642-2022; Viola, Bence/B-7390-2011; Orlando, Ludovic/A-8932-2013	Krause, Johannes/0000-0001-5475-4690; Richards, Michael/0000-0001-5274-8887; Richards, Michael/0000-0001-5274-8887; Derevianko, Anatoly P./0000-0003-1156-8331; Krause, Johannes/0000-0001-9144-3920; Orlando, Ludovic/0000-0003-3936-1850; Viola, Bence/0000-0001-8052-707X				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2002, DESOLATE LANDSCAPES; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Debetz G., 1940, T UZBEKIST FIL AKAD, V1, P46; DEREVIANKO AP, 2007, PROBLEM NEANDERTAL H; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FOHLAND N, 2007, BIOTECHNIQUES, V42, P343; Glantz MM, 2004, AM J PHYS ANTHROPOL, P100; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Grun R, 2000, J HUM EVOL, V39, P601, DOI 10.1006/jhev.2000.0443; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Shpakova ElenaG., 2000, ARCHAEOLOGY ETHNOLOG, V1, P125; STRINGER C, 2005, COMPLETE WORLD HUMAN, P156; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Turner C. G., 1990, CHRONOSTRATIGRAPHY P, P239; VIOLA TB, 2006, TERRA NOSTRA 2006 2, P139; Weidenreich F, 1945, AM J PHYS ANTHROP-NE, V3, P151, DOI 10.1002/ajpa.1330030211	30	227	241	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					902	904		10.1038/nature06193	http://dx.doi.org/10.1038/nature06193			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17914357	Green Published			2022-12-28	WOS:000250230600046
J	Shuchman, M				Shuchman, Miriam			Commercializing clinical trials - Risks and benefits of the CRO boom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		AZOULAY P, 2003, I0142 NBER; Expert Scientific Group on Phase 1 Clinical Trials, 2006, FIN REP; STROM BL, IN PRESS PHARMACOEPI; *THOM CTR WATCH, 2007, STAT CLIN TRIALS IND; *TRAS BAYER CORP B, 2007, REP TRAS BAYER CORP	5	62	73	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1365	1368		10.1056/NEJMp078176	http://dx.doi.org/10.1056/NEJMp078176			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914036				2022-12-28	WOS:000249892900001
J	Farag, N; Delbanco, T; Carrozza, JP				Farag, Nadine; Delbanco, Tom; Carrozza, Joseph P., Jr.			Update: A 69-year-old woman with left main coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES; STENOSIS; STENTS											Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Carrozza JP, 2004, JAMA-J AM MED ASSOC, V292, P2506, DOI 10.1001/jama.292.20.2506; Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONAHA.105.595694; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; KHATTAB AA, IN PRESS HEART; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Park SJ, 2003, AM J CARDIOL, V91, P12, DOI 10.1016/S0002-9149(02)02990-9; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193	8	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1558	1559		10.1001/jama.298.13.1558	http://dx.doi.org/10.1001/jama.298.13.1558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911501				2022-12-28	WOS:000249860500028
J	Lilford, RJ; Brown, CA; Nicholl, J				Lilford, Richard J.; Brown, Celia A.; Nicholl, Jon			Use of process measures to monitor the quality of clinical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE INDICATORS; HEALTH-CARE; OF-CARE; MORTALITY		Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Birmingham; University of Sheffield	Lilford, RJ (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Nicholl, Jon/B-8257-2008	Brown, Celia/0000-0002-7526-0793				Bird SM, 2005, J ROY STAT SOC A STA, V168, P1, DOI 10.1111/j.1467-985X.2004.00333.x; Brown C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-81; Crow R, 2002, Health Technol Assess, V6, P1; Deeks J J, 2003, Health Technol Assess, V7, piii; Esmail A, 2005, BRIT MED J, V330, P1144, DOI 10.1136/bmj.330.7500.1144; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Hayward RA, 2007, NEW ENGL J MED, V356, P951, DOI 10.1056/NEJMe068285; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Kamerow D, 2007, BRIT MED J, V334, P1086, DOI 10.1136/bmj.39223.635451.59; Kirk SA, 2003, QUAL SAF HEALTH CARE, V12, P421, DOI 10.1136/qhc.12.6.421; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford RJ, 2003, QUAL SAF HLTH CAR S2, V12, P118, DOI DOI 10.1136/QHC.12.SUPPL_2.II8; LILFORD RJ, 2007, J HEALTH SERV RES PO, V12, P172; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Locker TE, 2006, EMERG MED J, V23, P558, DOI 10.1136/emj.2005.032748; Locker TE, 2005, BRIT MED J, V330, P1188, DOI 10.1136/bmj.38440.588449.AE; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; NICHOLL J, IN PRESS J EPIDEMIOL; Parry GJ, 1998, BRIT MED J, V316, P1931, DOI 10.1136/bmj.316.7149.1931; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; *ROYAL COLL OBST G, 1993, EFF PROC OBST SUIT A; Shortell SM, 2000, MED CARE, V38, P207, DOI 10.1097/00005650-200002000-00010; Wilson B, 2002, INT J QUAL HEALTH C, V14, P175, DOI 10.1093/oxfordjournals.intqhc.a002609	25	134	136	4	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2007	335	7621					648	650		10.1136/bmj.39317.641296.AD	http://dx.doi.org/10.1136/bmj.39317.641296.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901516	Green Published			2022-12-28	WOS:000249989600039
J	Asser-Kaiser, S; Fritsch, E; Undorf-Spahn, K; Kienzle, J; Eberle, KE; Gund, NA; Reineke, A; Zebitz, CPW; Heckel, DG; Huber, J; Jehle, JA				Asser-Kaiser, S.; Fritsch, E.; Undorf-Spahn, K.; Kienzle, J.; Eberle, K. E.; Gund, N. A.; Reineke, A.; Zebitz, C. P. W.; Heckel, D. G.; Huber, J.; Jehle, J. A.			Rapid emergence of baculovirus resistance in codling moth due to dominant, sex-linked inheritance	SCIENCE			English	Article								Insect-specific baculoviruses are increasingly used as biological control agents of lepidopteran pests in agriculture and forestry, and they have been previously regarded as robust to resistance development by the insects. However, in more than a dozen cases of field resistance of the codling moth Cydia pomonella to commercially applied C. pomonella granulovirus (CpGV) in German orchards, resistance ratios exceed 1000. The rapid emergence of resistance is facilitated by sex-linkage and concentration-dependent dominance of the major resistance gene and genetic uniformity of the virus. When the gene is fixed, resistance levels approach 100,000-fold. Our findings highlight the need for development of resistance management strategies for baculoviruses.	Agr Serv Ctr Palatinate, DLR Rheinpfalz, Dept Phytopathol, Lab Biotechnol Crop Protect, D-67435 Neustadt, Germany; Fed Biol Res Ctr, Inst Biol Control, D-64287 Darmstadt, Germany; Univ Hohenheim, Inst Phytomed, D-70593 Stuttgart, Germany; Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Helmholtz Association; German Aerospace Centre (DLR); University Hohenheim; Max Planck Society	Jehle, JA (corresponding author), Agr Serv Ctr Palatinate, DLR Rheinpfalz, Dept Phytopathol, Lab Biotechnol Crop Protect, Breitenweg 71, D-67435 Neustadt, Germany.	heckel@ice.mpg.de; johannes.jehle@dlr.rlp.de	Zebitz, Claus/ABW-3991-2022; Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150; Jehle, Johannes A./0000-0002-8143-7743				Briese D., 1986, BIOL BACULOVIRUSES, P89; Crook NE, 1997, J GEN VIROL, V78, P965, DOI 10.1099/0022-1317-78-4-965; Eberle KE, 2006, J INVERTEBR PATHOL, V93, P201, DOI 10.1016/j.jip.2006.07.001; Fritsch E., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P29; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; FUXA JR, 1993, PARASITES PATHOGENS, V2, P197; Huber J., 1981, Mitteilungen der Deutschen Gesellschaft fur Allgemeine und Angewandte Entomologie, V2, P141; Hunter-Fujita FR, 1998, INSECT VIRUSES PEST; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Mota-Sanchez D, 2002, BOOK SOIL P, P241; Sauphanor B., 2006, PHYTOMA DEFENSE VEGE, V590, P24; TANADA Y, 1964, J INSECT PATHOL, V6, P378; THEILMANN DA, 2005, VIRUS TAXONOMY, P177	14	111	128	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1916	1918		10.1126/science.1146542	http://dx.doi.org/10.1126/science.1146542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901332				2022-12-28	WOS:000249764300038
J	Purnell, MA; Bell, MA; Baines, DC; Hart, PJB; Travis, MP				Purnell, Mark A.; Bell, Michael A.; Baines, David C.; Hart, Paul J. B.; Travis, Matthew P.			Correlated evolution and dietary change in fossil stickleback	SCIENCE			English	Article							THREESPINE STICKLEBACK		Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Leicester	Purnell, MA (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mark.purnell@leicester.ac.uk	Self, Casey J/B-6871-2011; Hart, Paul JB/A-1814-2008; Purnell, Mark/A-2336-2010	Hart, Paul JB/0000-0002-9188-2437; Purnell, Mark/0000-0002-1777-9220	Natural Environment Research Council [NE/B000125/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bell MA, 2006, PALEOBIOLOGY, V32, P562, DOI 10.1666/05026.1; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD	4	33	35	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1887	1887		10.1126/science.1147337	http://dx.doi.org/10.1126/science.1147337			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901325				2022-12-28	WOS:000249764300029
J	Neumann, HPH; Vortmeyer, A; Schmidt, D; Werner, M; Erlic, Z; Cascon, A; Bausch, B; Januszewicz, A; Eng, C				Neumann, Hartmut P. H.; Vortmeyer, Alexander; Schmidt, Dieter; Werner, Martin; Erlic, Zoran; Cascon, Alberto; Bausch, Birke; Januszewicz, Andrzej; Eng, Charis			Evidence of MEN-2 in the original description of classic pheochromocytoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUTATIONS; GENE	The first description of pheochromocytoma in 1886 has been attributed to Felix Frankel, who described an 18-year-old woman with bilateral adrenal "sarcoma and angio-sarcoma." We reviewed the publication and then approached and assessed relatives of the patient to update the findings with the use of current technology. In-depth review revealed that the histopathological findings were consistent with pheochromocytoma. Because the proband was young and had bilateral disease at diagnosis, we hypothesized that she had an inherited condition. The presence of germ-line RET mutations in four living relatives demonstrates that the original patient and her family had multiple endocrine neoplasia type 2 and provides molecular evidence that she had pheochromocytoma.	Univ Freiburg, Med Klin, Med Ctr, Dept Nephrol, D-79106 Freiburg, Germany; Univ Freiburg, Med Ctr, Dept Ophthalmol, D-79106 Freiburg, Germany; Univ Freiburg, Med Ctr, Dept Pathol, D-79106 Freiburg, Germany; NINDS, Bethesda, MD 20892 USA; NCI, Pathol Lab, Bethesda, MD 20892 USA; Univ Padua, Sch Med, Dept Endocrinol, Padua, Italy; Ctr Nacl Invest Oncol, Hereditary Endocrine Canc Grp, Madrid, Spain; Inst Cardiol, Warsaw, Poland; Lerner Res Inst, Genom Med Inst, Cleveland, OH USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA	University of Freiburg; University of Freiburg; University of Freiburg; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua; Institute of Cardiology - Poland; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Neumann, HPH (corresponding author), Univ Freiburg, Med Klin, Med Ctr, Dept Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany.	hartmut.neumann@uniklinik-freiburg.de	Cascon, Alberto/G-3160-2014; Erlic, Zoran/AAA-5680-2020	Cascon, Alberto/0000-0003-2119-891X; Erlic, Zoran/0000-0001-6953-9133; Eng, Charis/0000-0002-3693-5145	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD39058-01S1, R01HD39058-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bausch B, 2006, ANN NY ACAD SCI, V1073, P122, DOI 10.1196/annals.1353.013; Bausch B, 2006, NEW ENGL J MED, V354, P2729, DOI 10.1056/NEJMc066006; FRANKEL F, 1984, CA-CANCER J CLIN, V34, P93, DOI 10.3322/canjclin.34.2.93; FRANKEL F, 1886, ARCH PATHOL ANAT PHY, V103, P244; Keith NM, 1939, AM J MED SCI, V197, P332, DOI 10.1097/00000441-193903000-00006; LANDSBERG L, 2005, HARRISONS PRINCIPLES, P2148; Manger WM, 2006, ANN NY ACAD SCI, V1073, P1, DOI 10.1196/annals.1353.001; MANGER WM, 1996, CLIN EXPT PHEOCHROMO, P5; McNicol AM, 2004, PATHOLOGY GENETICS T, P151; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P1686, DOI 10.1001/jama.292.8.943; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; Pick L, 1912, BERL KLIN WCHNSCHR, V49, P16; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Schiavi F, 2006, JAMA-J AM MED ASSOC, V295, P628	15	57	60	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1311	1315		10.1056/NEJMoa071407	http://dx.doi.org/10.1056/NEJMoa071407			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898100				2022-12-28	WOS:000249711500007
J	Jin, MS; Kim, SE; Heo, JY; Lee, ME; Kim, HM; Paik, SG; Lee, HY; Lee, JO				Jin, Mi Sun; Kim, Sung Eun; Heo, Jin Young; Lee, Mi Eun; Kim, Ho Min; Paik, Sang-Gi; Lee, Hayyoung; Lee, Jie-Oh			Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide	CELL			English	Article							TOLL-LIKE RECEPTORS; LEUCINE-RICH REPEAT; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; BORRELIA-BURGDORFERI LIPOPROTEINS; ESCHERICHIA-COLI; CUTTING EDGE; BACTERIAL LIPOPEPTIDES; LEPROMATOUS LEPROSY; TREPONEMA-PALLIDUM; OUTER MEMBRANE	TLR2 in association with TLR1 or TLR6 plays an important role in the innate immune response by recognizing microbial lipoproteins and lipopeptides. Here we present the crystal structures of the human TLR1- TLR2- lipopeptide complex and of the mouse TLR2- lipopeptide complex. Binding of the tri- acylated lipopeptide, Pam(3)CSK(4), induced the formation of an `` m'' shaped heterodimer of the TLR1 and TLR2 ectodomains whereas binding of the diacylated lipopeptide, Pam(2)CSK(4), did not. The three lipid chains of Pam3CSK4 mediate the heterodimerization of the receptor; the two esterbound lipid chains are inserted into a pocket in TLR2, while the amide- bound lipid chain is inserted into a hydrophobic channel in TLR1. An extensive hydrogen- bonding network, as well as hydrophobic interactions, between TLR1 and TLR2 further stabilize the heterodimer. We propose that formation of the TLR1- TLR2 heterodimer brings the intracellular TIR domains close to each other to promote dimerization and initiate signaling.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Inst Biocentury, Taejon 305701, South Korea; Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Kim, Ho Min/G-2712-2011; Lee, Jie-Oh/AAG-4302-2020; KIM, SUNG EUN/E-4918-2011; Lee, Jie-Oh/C-1581-2011; Kang, Jin Young/E-4384-2019	Lee, Jie-Oh/0000-0001-6519-6049				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BERG M, 1994, AM J PHYSIOL, V266, pC1684, DOI 10.1152/ajpcell.1994.266.6.C1684; BESSLER WG, 1985, J IMMUNOL, V135, P1900; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Iwaki D, 2005, BIOCHEM BIOPH RES CO, V328, P173, DOI 10.1016/j.bbrc.2004.12.162; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SEIFERT R, 1990, BIOCHEM J, V267, P795, DOI 10.1042/bj2670795; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; WIESMULLER KH, 1992, INT J PEPT PROT RES, V40, P255; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; ZLOTNICK GW, 1988, J BIOL CHEM, V263, P9790	65	955	997	3	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1071	1082		10.1016/j.cell.2007.09.008	http://dx.doi.org/10.1016/j.cell.2007.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889651	Bronze			2022-12-28	WOS:000250507500016
J	Tocheri, MW; Orr, CM; Larson, SG; Sutikna, T; Jatmiko; Saptomo, EW; Due, RA; Djubiantono, T; Morwood, MJ; Jungers, WL				Tocheri, Matthew W.; Orr, Caley M.; Larson, Susan G.; Sutikna, Thomas; Jatmiko; Saptomo, E. Wahyu; Due, Rokus Awe; Djubiantono, Tony; Morwood, Michael J.; Jungers, William L.			The primitive wrist of Homo floresiensis and its implications for hominin evolution	SCIENCE			English	Article							AUSTRALOPITHECUS-AFARENSIS; EASTERN INDONESIA; LATE PLEISTOCENE; OLDUVAI GORGE; GRAN DOLINA; HAND; AFFINITIES; ATAPUERCA; CAPITATE; REMAINS	Whether the Late Pleistocene hominin fossils from Flores, Indonesia, represent a new species, Homo floresiensis, or pathological modern humans has been debated. Analysis of three wrist bones from the holotype specimen (LB1) shows that it retains wrist morphology that is primitive for the African ape-human clade. In contrast, Neandertals and modern humans share derived wrist morphology that forms during embryogenesis, which diminishes the probability that pathology could result in the normal primitive state. This evidence indicates that LB1 is not a modern human with an undiagnosed pathology or growth defect; rather, it represents a species descended from a hominin ancestor that branched off before the origin of the clade that includes modern humans, Neandertals, and their last common ancestor.	Natl Museum Nat Hist, Dept Anthropol, Human Origins Program, Smithsonian Inst, Washington, DC 20013 USA; Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Natl Res & Dev Ctr Archaeol, Jakarta, Indonesia; SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Wollongong; National Research & Development Centre for Archaeology - Indonesia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Tocheri, MW (corresponding author), Natl Museum Nat Hist, Dept Anthropol, Human Origins Program, Smithsonian Inst, Washington, DC 20013 USA.	tocherim@si.edu	Larson, Susan/AAL-1935-2021; Tocheri, Matthew/C-5288-2013; Tocheri, Matthew/H-8851-2019; Sutikna, Thomas/C-4709-2018	Tocheri, Matthew/0000-0001-7600-8998; Sutikna, Thomas/0000-0002-9742-4226				Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CIHAK R, 1972, ERG ANAT ENTWICKLU, V46, P1; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kivell TL, 2007, J HUM EVOL, V52, P321, DOI 10.1016/j.jhevol.2006.10.002; Lewis O.J., 1989, FUNCTIONAL MORPHOLOG; Lorenzo C, 1999, J HUM EVOL, V37, P501, DOI 10.1006/jhev.1999.0341; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; MARZKE MW, 1983, J HUM EVOL, V12, P197, DOI 10.1016/S0047-2484(83)80025-6; MCHENRY HM, 1983, AM J PHYS ANTHROPOL, V62, P187, DOI 10.1002/ajpa.1330620208; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; SARMIENTO EE, 2002, NEW ANATOMIST, V269, P50; Sarmiento Esteban E., 1994, American Museum Novitates, V3091, P1; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Spranger J, 2002, BONE DYSPLASIAS ATLA, V2nd; Stafford BJ, 1998, J MORPHOL, V235, P135, DOI 10.1002/(SICI)1097-4687(199802)235:2<135::AID-JMOR4>3.0.CO;2-8; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; Thorington RW, 2000, J MORPHOL, V246, P85, DOI 10.1002/1097-4687(200011)246:2<85::AID-JMOR4>3.0.CO;2-5; Tocheri M.W., 2007, THESIS ARIZONA STATE; Tocheri MW, 2005, J HUM EVOL, V49, P570, DOI 10.1016/j.jhevol.2005.06.005; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Weidenreich F., 1941, Palaeontologia Sinica New Ser D, Vno. 5, P1; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659	31	137	141	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1743	1745		10.1126/science.1147143	http://dx.doi.org/10.1126/science.1147143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885135	Green Published			2022-12-28	WOS:000249585900046
J	Wojtowicz, WM; Wu, W; Andre, I; Qian, B; Baker, D; Zipursky, SL				Wojtowicz, Woj M.; Wu, Wei; Andre, Ingemar; Qian, Bin; Baker, David; Zipursky, S. Lawrence			A vast repertoire of Dscam binding Specificities arises from modular interactions of variable ig domains	CELL			English	Article							LEECH HAEMENTERIA-GHILIANII; SENSORY NEURONS; DROSOPHILA DSCAM; CELL-ADHESION; AXON GUIDANCE; DEVELOPMENTAL ARBORIZATION; BRANCHING PATTERN; SELF-AVOIDANCE; DIVERSITY; MORPHOGENESIS	Dscam encodes a family of cell surface proteins required for establishing neural circuits in Drosophila. Alternative splicing of Drosophila Dscam can generate 19,008 distinct extracellular domains containing different combinations of three variable immunoglobulin domains. To test the binding properties of many Dscam isoforms, we developed a high- throughput ELISA- based binding assay. We provide evidence that 95% (> 18,000) of Dscam isoforms exhibit striking isoform- specific homophilic binding. We demonstrate that each of the three variable domains binds to the same variable domain in an opposing isoform and identify the structural elements that mediate this self- binding of each domain. These studies demonstrate that self- binding domains can assemble in different combinations to generate an enormous family of homophilic binding proteins. We propose that this vast repertoire of Dscam recognition molecules is sufficient to provide each neuron with a unique identity and homotypic binding specificity, thereby allowing neuronal processes to distinguish between self and nonself.	Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Baker, David/K-8941-2012; André, Ingemar/O-4777-2014	Baker, David/0000-0001-7896-6217; André, Ingemar/0000-0002-4753-8233; Zipursky, Stephen/0000-0001-5630-7181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC006485, R01 DC006485-05] Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayer MW, 2007, J COMP NEUROL, V500, P850, DOI 10.1002/cne.21228; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kidd T, 2007, NEURON, V54, P350, DOI 10.1016/j.neuron.2007.04.018; KRAMER AP, 1985, J NEUROSCI, V5, P759; KRAMER AP, 1985, J NEUROSCI, V5, P768; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zinn K, 2007, CELL, V129, P455, DOI 10.1016/j.cell.2007.04.024; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	30	160	163	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1134	1145		10.1016/j.cell.2007.08.026	http://dx.doi.org/10.1016/j.cell.2007.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889655	Green Accepted, Bronze			2022-12-28	WOS:000250507500021
J	Bromm, V				Bromm, Volker			From darkness to light	SCIENCE			English	Editorial Material							STARS		Univ Texas, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bromm, V (corresponding author), Univ Texas, Dept Astron, RLM 15308, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu						Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Gao L, 2007, SCIENCE, V317, P1527, DOI 10.1126/science.1146676; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Ripamonti E, 2007, MON NOT R ASTRON SOC, V375, P1399, DOI 10.1111/j.1365-2966.2006.11402.x; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Yoshida N, 2003, ASTROPHYS J, V591, pL1, DOI 10.1086/376963	9	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1511	1512		10.1126/science.1147794	http://dx.doi.org/10.1126/science.1147794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872435				2022-12-28	WOS:000249467900030
J	Kuypers, MMM				Kuypers, Marcel M. M.			Sizing up the uncultivated majority	SCIENCE			English	Editorial Material							SHIPWORMS		Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Max Planck Society	Kuypers, MMM (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de						AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; CARPENTER EJ, 1975, SCIENCE, V187, P551, DOI 10.1126/science.187.4176.551; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Kuypers MMM, 2007, ENVIRON MICROBIOL, V9, P6, DOI 10.1111/j.1462-2920.2006.01222_5.x; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Moreau JW, 2007, SCIENCE, V316, P1600, DOI 10.1126/science.1141064; Neufeld JD, 2007, ISME J, V1, P103, DOI 10.1038/ismej.2007.30; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401	10	13	14	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1510	1511		10.1126/science.1148538	http://dx.doi.org/10.1126/science.1148538			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872434	Green Published			2022-12-28	WOS:000249467900029
J	Zhang, SY; Jouanguy, E; Ugolini, S; Smahi, A; Elain, G; Romero, P; Segal, D; Sancho-Shimizu, V; Lorenzo, L; Puel, A; Picard, C; Chapgier, A; Plancoulaine, S; Titeux, M; Cognet, C; von Bernuth, H; Ku, CL; Casrouge, A; Zhang, XX; Barreiro, L; Leonard, J; Hamilton, C; Lebon, P; Heron, B; Vallee, L; Quintana-Murci, L; Hovnanian, A; Rozenberg, F; Vivier, E; Geissmann, F; Tardieu, M; Abel, L; Casanova, JL				Zhang, Shen-Ying; Jouanguy, Emmanuelle; Ugolini, Sophie; Smahi, Asma; Elain, Gaelle; Romero, Pedro; Segal, David; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Picard, Capucine; Chapgier, Ariane; Plancoulaine, Sabine; Titeux, Matthias; Cognet, Celine; von Bernuth, Horst; Ku, Cheng-Lung; Casrouge, Armanda; Zhang, Xin-Xin; Barreiro, Luis; Leonard, Joshua; Hamilton, Claire; Lebon, Pierre; Heron, Benedicte; Vallee, Louis; Quintana-Murci, Lluis; Hovnanian, Alain; Rozenberg, Flore; Vivier, Eric; Geissmann, Frederic; Tardieu, Marc; Abel, Laurent; Casanova, Jean-Laurent			TLR3 deficiency in patients with herpes simplex encephalitis	SCIENCE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; T-LYMPHOCYTES; NK CELLS; VIRUS; RECOGNITION; EXPRESSION; GENE; ALPHA/BETA; ACTIVATION	Some Toll and Toll-like receptors (TLRs) provide immunity to experimental infections in animal models, but their contribution to host defense in natural ecosystems is unknown. We report a dominant-negative TLR3 allele in otherwise healthy children with herpes simplex virus 1 (HSV-1) encephalitis. TLR3 is expressed in the central nervous system (CNS), where it is required to control HSV-1, which spreads from the epithelium to the CNS via cranial nerves. TLR3 is also expressed in epithelial and dendritic cells, which apparently use TLR3-independent pathways to prevent further dissemination of HSV-1 and to provide resistance to other pathogens in TLR3-deficient patients. Human TLR3 appears to be redundant in host defense to most microbes but is vital for natural immunity to HSV-1 in the CNS, which suggests that neurotropic viruses have contributed to the evolutionary maintenance of TLR3.	Fac Med Necker Enfants Malad, INSERM, U550, F-75015 Paris, France; Univ Paris 05, F-75015 Paris, France; Shanghai Jiao Tong Univ, Rui Jin Hosp, French Chinese Lab Genet & Life Sci, Shanghai 200025, Peoples R China; Marseille Luminy Immunol Inst, F-13288 Marseille, France; Hop Necker Enfants Malad, INSERM, U781, Dept Genet, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U838, Lab Mononucl Cell Biol, F-75015 Paris, France; Univ Lausanne Hosp, Lausanne Branch, Ludwig Inst Canc Res, CH-1005 Lausanne, Switzerland; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Hop Necker Enfants Malad, Ctr Study Immunodeficiencies, F-75015 Paris, France; Univ Toulouse 3, INSERM, U563, F-31000 Toulouse, France; Inst Pasteur, CNRS, URA3012, F-75015 Paris, France; Univ Paris 05, Cochin St Vincent de Paul Hosp, F-75014 Paris, France; Trousseau Hosp, F-75012 Paris, France; Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; Univ Paris Sud, Hop Bicetre, F-94720 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Casanova, JL (corresponding author), Fac Med Necker Enfants Malad, INSERM, U550, F-75015 Paris, France.	casanova@necker.fr	Vivier, Eric/F-8939-2010; Rozenberg, Flore/O-8854-2017; Hovnanian, Alain/I-4711-2017; PLANCOULAINE, Sabine/E-2824-2017; Barreiro, Luis/I-7772-2015; Li, Chia Cheng/D-9906-2015; Jouanguy, Emmanuelle/H-7901-2017; Lorenzo, Lazaro/H-7902-2017; Abel, Laurent/H-8888-2017; Puel, Anne/H-7305-2017; Titeux, Matthias/K-8411-2017; Smahi, Asma/J-4184-2017; von Bernuth, Horst/AAQ-9797-2021; Zhang, Shen-Ying/I-2685-2017; KU, Cheng-Lung/AAT-1033-2020; Quintana-Murci, Lluis/AAB-7468-2022; Casanova, Jean-Laurent/I-3418-2017; Picard, Capucine/H-3914-2017; Leonard, Joshua/B-7649-2009; KU, Cheng-Lung/L-6073-2015	Vivier, Eric/0000-0001-7022-8287; Hovnanian, Alain/0000-0003-3412-7512; PLANCOULAINE, Sabine/0000-0003-0725-8306; Jouanguy, Emmanuelle/0000-0002-7358-9157; Lorenzo, Lazaro/0000-0001-6648-8684; Abel, Laurent/0000-0001-7016-6493; Puel, Anne/0000-0003-2603-0323; Titeux, Matthias/0000-0001-7386-2769; Smahi, Asma/0000-0002-6002-0981; von Bernuth, Horst/0000-0002-5812-7675; Zhang, Shen-Ying/0000-0002-9449-3672; KU, Cheng-Lung/0000-0002-0643-2256; Picard, Capucine/0000-0001-8788-5056; KU, Cheng-Lung/0000-0002-0643-2256; Ugolini, Sophie/0000-0003-4041-0103; geissmann, frederic/0000-0001-5029-2468; Barreiro, Luis/0000-0001-9456-367X; Casanova, Jean-Laurent/0000-0002-7782-4169; Leonard, Joshua/0000-0003-4359-6126; Quintana-Murci, Lluis/0000-0003-2429-6320; Chapgier, Ariane/0000-0002-1734-0744; CASROUGE, Armanda/0000-0002-7356-0901	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Eidenschenk C, 2006, J IMMUNOL, V177, P8835, DOI 10.4049/jimmunol.177.12.8835; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; JACQUEMONT B, 1975, J VIROL, V15, P707, DOI 10.1128/JVI.15.4.707-713.1975; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee H, 2007, GLIA, V55, P712, DOI 10.1002/glia.20493; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tabiasco J, 2006, J IMMUNOL, V177, P8708, DOI 10.4049/jimmunol.177.12.8708; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	39	800	828	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1522	1527		10.1126/science.1139522	http://dx.doi.org/10.1126/science.1139522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872438				2022-12-28	WOS:000249467900034
J	Chen, CW; Jao, SW				Chen, Chuang-Wei; Jao, Shu-Wen			Ehlers-Danlos syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Triserv Gen Hosp, Taipei 114, Taiwan	Tri-Service General Hospital	Chen, CW (corresponding author), Triserv Gen Hosp, Taipei 114, Taiwan.	1211cathy@yahoo.com.tw							0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					E12	E12		10.1056/NEJMicm066971	http://dx.doi.org/10.1056/NEJMicm066971			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855665				2022-12-28	WOS:000249387200010
J	Dolin, R				Dolin, Raphael			Perspective: Noroviruses - Challenges to control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIOUS NONBACTERIAL GASTROENTERITIS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dolin, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; Fields B.N., 2007, FIELDS VIROLOGY, V1; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224	5	36	45	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1072	1073		10.1056/NEJMp078050	http://dx.doi.org/10.1056/NEJMp078050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855667				2022-12-28	WOS:000249387200002
J	THIEMENS, MH; TROGLER, WC				THIEMENS, MH; TROGLER, WC			NYLON PRODUCTION - AN UNKNOWN SOURCE OF ATMOSPHERIC NITROUS-OXIDE	SCIENCE			English	Article							OXYGEN ISOTOPE RATIOS; N2O; NITRIFICATION; PACIFIC	Nitrous oxide in the earth's atmosphere contributes to catalytic stratospheric ozone destruction and is also a greenhouse gas component. A precise budgetary accounting of N2O sources has remained elusive, and there is an apparent lack of source identification. One source of N2O is as a by-product in the manufacture of nylon, specifically in the preparation of adipic acid. Characterization of the reaction N2O stoichiometry and its isotopic composition with a simulated industrial adipic acid synthesis indicates that because of high rates of global adipic acid production, this N2O may account for approximately 10 percent of the increase observed for atmospheric N2O.			THIEMENS, MH (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093, USA.		Trogler, William C/F-9515-2011	Trogler, William C/0000-0001-6098-7685				BEARD RR, 1982, PATTYS IND HYGIENE T, P4096; BEREZIN IV, 1966, OXIIDATION CYCLOHEXA, P251; BHATTACHARYA SK, 1989, Z NATURFORSCH A, V44, P435; CICERONE RJ, 1989, J GEOPHYS RES-ATMOS, V94, P18265, DOI 10.1029/JD094iD15p18265; CLAYTON RN, 1963, GEOCHIM COSMOCHIM AC, V27, P43, DOI 10.1016/0016-7037(63)90071-1; CLINE JD, 1987, DEEP-SEA RES, V34, P857, DOI 10.1016/0198-0149(87)90041-0; CRUTZEN PJ, 1983, PLANET SPACE SCI, V31, P1009, DOI 10.1016/0032-0633(83)90092-2; Davis D. D., 1985, ULLMANNS ENCY IND A, V1, P269; DICKINSON RE, 1986, NATURE, V319, P109, DOI 10.1038/319109a0; ELKINS JW, 1978, NATURE, V275, P602, DOI 10.1038/275602a0; KHALIL MAK, 1983, TELLUS B, V35, P161, DOI 10.1111/j.1600-0889.1983.tb00020.x; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Luedeke V., 1977, ENCY CHEM PROCESSING, V2, P128; PARSHALL GW, 1980, HOMOGENEOUS CATALYSI, P193; SHRIVER DF, 1990, INORG CHEM, P382; STILLE JK, 1972, CONDENSATION MONOMER, P36; ULRICH H, 1988, RAW MATERIALS IND PO, P138; WAHLEN M, 1985, NATURE, V313, P780, DOI 10.1038/313780a0; WEISS RF, 1981, J GEOPHYS RES-OCEANS, V86, P7185, DOI 10.1029/JC086iC08p07185; WEISS RF, 1981, EOS, V62, P894; YOSHIDA N, 1988, NATURE, V335, P528, DOI 10.1038/335528a0; YOSHIDA N, 1984, NATURE, V307, P442, DOI 10.1038/307442a0; YOSHIDA N, 1983, GEOCHEM J, V17, P231, DOI 10.2343/geochemj.17.231; YOSHINARI T, 1985, NATURE, V317, P349, DOI 10.1038/317349a0; [No title captured]; 1985, GLOBAL OZONE RES MON, V1, P78; 1990, CHEM ENG NEWS, V68, P4; 1989, PROTECTION ENV, V40, P265; 1989, TOXIC RELEASE INVENT	29	242	258	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					932	934		10.1126/science.251.4996.932	http://dx.doi.org/10.1126/science.251.4996.932			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847387				2022-12-28	WOS:A1991EY62900042
J	Kim, DH; Pickhardt, PJ; Taylor, AJ; Leung, WK; Winter, TC; Hinshaw, JL; Gopal, DV; Reichelderfer, M; Hsu, RH; Pfau, PR				Kim, David H.; Pickhardt, Perry J.; Taylor, Andrew J.; Leung, Winifred K.; Winter, Thomas C.; Hinshaw, J. Louis; Gopal, Deepak V.; Reichelderfer, Mark; Hsu, Richard H.; Pfau, Patrick R.			CT colonography versus colonoscopy for the detection of advanced neoplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER; ASYMPTOMATIC ADULTS; UNRESECTED POLYPS; GROWTH; RISK; PREVALENCE; PREVENTION; SCREEN; COLON	Background Advanced neoplasia represents the primary target for colorectal-cancer screening and prevention. We compared the diagnostic yield from parallel computed tomographic colonography (CTC) and optical colonoscopy (OC) screening programs. Methods We compared primary CTC screening in 3120 consecutive adults (mean [+/-SD] age, 57.0+/-7.2 years) with primary OC screening in 3163 consecutive adults (mean age, 58.1+/-7.8 years). The main outcome measures included the detection of advanced neoplasia (advanced adenomas and carcinomas) and the total number of harvested polyps. Referral for polypectomy during OC was offered for all CTC-detected polyps of at least 6 mm in size. Patients with one or two small polyps (6 to 9 mm) also were offered the option of CTC surveillance. During primary OC, nearly all detected polyps were removed, regardless of size, according to established practice guidelines. Results During CTC and OC screening, 123 and 121 advanced neoplasms were found, including 14 and 4 invasive cancers, respectively. The referral rate for OC in the primary CTC screening group was 7.9% (246 of 3120 patients). Advanced neoplasia was confirmed in 100 of the 3120 patients in the CTC group (3.2%) and in 107 of the 3163 patients in the OC group (3.4%), not including 158 patients with 193 unresected CTC-detected polyps of 6 to 9 mm who were undergoing surveillance. The total numbers of polyps removed in the CTC and OC groups were 561 and 2434, respectively. There were seven colonic perforations in the OC group and none in the CTC group. Conclusions Primary CTC and OC screening strategies resulted in similar detection rates for advanced neoplasia, although the numbers of polypectomies and complications were considerably smaller in the CTC group. These findings support the use of CTC as a primary screening test before therapeutic OC.	Univ Wisconsin, Sch Med, Dept Radiol, Clin Sci Ctr E3 311, Madison, WI 53792 USA; Univ Wisconsin, Sch Med, Sect Gastroenterol & Hepatol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kim, DH (corresponding author), Univ Wisconsin, Sch Med, Dept Radiol, Clin Sci Ctr E3 311, 600 Highland Ave, Madison, WI 53792 USA.	dkim@uwhealth.org		Gopal, Deepak/0000-0002-2679-9856; Taylor, Andrew/0000-0002-9806-8729				[Anonymous], 2004, RAD RISK PERSP POS S; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bond J H, 2000, Semin Gastrointest Dis, V11, P176; Bond JH, 2001, ENDOSCOPY, V33, P454, DOI 10.1055/s-2001-14266; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Church JM, 2004, DIS COLON RECTUM, V47, P481, DOI 10.1007/s10350-003-0078-6; HOFSTAD B, 1994, SCAND J GASTROENTERO, V29, P640, DOI 10.3109/00365529409092485; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kim DH, 2007, AM J ROENTGENOL, V188, P940, DOI 10.2214/AJR.06.0764; Kim DH, 2007, J COMPUT ASSIST TOMO, V31, P53, DOI 10.1097/01.rct.0000230003.61392.2b; KNOERNSCHILD H E, 1963, Surg Forum, V14, P137; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lin OS, 2006, GASTROENTEROLOGY, V131, P1011, DOI 10.1053/j.gastro.2006.08.015; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Odom SR, 2005, AM SURGEON, V71, P1024; Pickhardt PJ, 2006, RADIOLOGY, V241, P417, DOI 10.1148/radiol.2412052007; Pickhardt PJ, 2007, CANCER, V109, P2213, DOI 10.1002/cncr.22668; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2005, RADIOLOGY, V236, P872, DOI 10.1148/radiol.2363041534; Pickhardt PJ, 2004, RADIOLOGY, V232, P784, DOI 10.1148/radiol.2323031614; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2006, AM J GASTROENTEROL, V101, P1410, DOI 10.1111/j.1572-0241.2006.00585.x; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; WELIN S, 1963, AMER J ROENTGENOL RA, V90, P673; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926	35	496	513	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1403	1412		10.1056/NEJMoa070543	http://dx.doi.org/10.1056/NEJMoa070543			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914041				2022-12-28	WOS:000249892900006
J	Kamerow, D				Kamerow, Douglas			Wham, bam, thank you CAM	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALTERNATIVE MEDICINE; COMPLEMENTARY					dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957				Franck L, 2007, BRIT MED J, V334, P506, DOI 10.1136/bmj.39122.512211.BE; Franck L, 2007, BRIT MED J, V334, P507; Shekelle PG, 2005, ANN INTERN MED, V142, P1042, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00003	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					647	647		10.1136/bmj.39349.437442.43	http://dx.doi.org/10.1136/bmj.39349.437442.43			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901515	Green Published			2022-12-28	WOS:000249989600038
J	Allen, EA; Pasley, BN; Duong, T; Freeman, RD				Allen, Elena A.; Pasley, Brian N.; Duong, Thang; Freeman, Ralph D.			Transcranial magnetic stimulation elicits coupled neural and hemodynamic consequences	SCIENCE			English	Article							HUMAN MOTOR CORTEX; BLOOD-FLOW; REGIONAL EXCITABILITY; CORTICAL EXCITABILITY; VISUAL-CORTEX; BRAIN; MODULATION; RAT; OSCILLATIONS; OXYGENATION	Transcranial magnetic stimulation (TMS) is an increasingly common technique used to selectively modify neural processing. However, application of TMS is limited by uncertainty concerning its physiological effects. We applied TMS to the cat visual cortex and evaluated the neural and hemodynamic consequences. Short TMS pulse trains elicited initial activation (similar to 1 minute) and prolonged suppression (5 to 10 minutes) of neural responses. Furthermore, TMS disrupted the temporal structure of activity by altering phase relationships between neural signals. Despite the complexity of this response, neural changes were faithfully reflected in hemodynamic signals; quantitative coupling was present over a range of stimulation parameters. These results demonstrate long-lasting neural responses to TMS and support the use of hemodynamic-based neuroimaging to effectively monitor these changes over time.	Univ Calif Berkeley, Sch Optometry, Helen Wills Neurosci Inst, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Sch Optometry, Helen Wills Neurosci Inst, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NEI NIH HHS [EY01175, EY03176] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003176, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER AT, 1985, LANCET, V1, P1106; Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; GEORE MS, 2007, TRANSCRANIAL MAGNETI; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Holscher C, 1997, J NEUROSCI, V17, P6470; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Sack AT, 2003, BRAIN RES REV, V43, P41, DOI 10.1016/S0165-0173(03)00191-7; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siebner HR, 2001, NEUROIMAGE, V14, P883, DOI 10.1006/nimg.2001.0889; Singh N, 2007, PROG NEUROBIOL, V81, P29, DOI 10.1016/j.pneurobio.2006.11.009; Suh M, 2005, J NEUROSCI, V25, P68, DOI 10.1523/JNEUROSCI.2823-04.2005; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang H, 1996, NEUROREPORT, V7, P521, DOI 10.1097/00001756-199601310-00035; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	30	226	239	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1918	1921		10.1126/science.1146426	http://dx.doi.org/10.1126/science.1146426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901333				2022-12-28	WOS:000249764300039
J	Greilich, A; Shabaev, A; Yakovlev, DR; Efros, AL; Yugova, IA; Reuter, D; Wieck, AD; Bayer, M				Greilich, A.; Shabaev, A.; Yakovlev, D. R.; Efros, Al. L.; Yugova, I. A.; Reuter, D.; Wieck, A. D.; Bayer, M.			Nuclei-induced frequency focusing of electron spin coherence	SCIENCE			English	Article							QUANTUM DOTS; RELAXATION	The hyperfine interaction of an electron with the nuclei is considered as the primary obstacle to coherent control of the electron spin in semiconductor quantum dots. We show, however, that the nuclei in singly charged quantum dots act constructively by focusing the electron spin precession about a magnetic field into well-defined modes synchronized with a laser pulse protocol. In a dot with a synchronized electron, the light-stimulated fluctuations of the hyperfine nuclear field acting on the electron are suppressed. The information about electron spin precession is imprinted in the nuclei and thereby can be stored for tens of minutes in darkness. The frequency focusing drives an electron spin ensemble into dephasing-free subspaces with the potential to realize single frequency precession of the entire ensemble.	Univ Dortmund, D-44221 Dortmund, Germany; USN, Res Lab, Washington, DC 20375 USA; George Mason Univ, Sch Computat Sci, Fairfax, VA 22030 USA; AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; St Petersburg State Univ, Inst Phys, St Petersburg 1908504, Russia; Ruhr Univ Bochum, D-44780 Bochum, Germany	Dortmund University of Technology; United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Saint Petersburg State University; Ruhr University Bochum	Efros, AL (corresponding author), Univ Dortmund, D-44221 Dortmund, Germany.	efros@dave.nrl.navy.mil; manfred.bayer@physik.uni-dortmund.de	Greilich, Alex/A-8927-2009; Yakovlev, Dmitri R./AAO-7408-2020; Bayer, Manfred/I-7947-2013; Wieck, Andreas Dirk D/C-5129-2009; Yugova, Irina/F-6823-2011	Greilich, Alex/0000-0001-7813-682X; Yakovlev, Dmitri R./0000-0001-7349-2745; Wieck, Andreas Dirk D/0000-0001-9776-2922; Yugova, Irina/0000-0003-0020-3679; Bayer, Manfred/0000-0002-0893-5949				ABRAGAM A, 1961, PRINCIPLES NUCLEAR M, P273; Berkovits V. L., 1974, SOV PHYS JETP, V38, P169; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; Coish WA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125337; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; Dyakonov M. I., 1984, OPTICAL ORIENTATION; DYAKONOV MI, 1973, ZH EKSP TEOR FIZ+, V65, P362; Gammon D, 1997, SCIENCE, V277, P85, DOI 10.1126/science.277.5322.85; Greilich A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.233301; Greilich A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227401; Greilich A, 2006, SCIENCE, V313, P341, DOI 10.1126/science.1128215; Imamoglu A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017402; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Khaetskii AV, 2000, PHYS REV B, V61, P12639, DOI 10.1103/PhysRevB.61.12639; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; Kofman AG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130406; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Leuenberger MN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.207601; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; PAGET D, 1982, PHYS REV B, V25, P4444, DOI 10.1103/PhysRevB.25.4444; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; RYABCHENKO SM, 1983, SOV PHYS JETP, V84, P1412; Taylor JM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206803; Witzel WM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077601; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	30	202	202	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1896	1899		10.1126/science.1146850	http://dx.doi.org/10.1126/science.1146850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901328				2022-12-28	WOS:000249764300033
J	Parigi, V; Zavatta, A; Kim, M; Bellini, M				Parigi, Valentina; Zavatta, Alessandro; Kim, Myungshik; Bellini, Marco			Probing quantum commutation rules by addition and subtraction of single photons to/from a light field	SCIENCE			English	Article							STATES	The possibility of arbitrarily "adding" and "subtracting" single photons to and from a light field may give access to a complete engineering of quantum states and to fundamental quantum phenomena. We experimentally implemented simple alternated sequences of photon creation and annihilation on a thermal field and used quantum tomography to verify the peculiar character of the resulting light states. In particular, as the final states depend on the order in which the two actions are performed, we directly observed the noncommutativity of the creation and annihilation operators, one of the cardinal concepts of quantum mechanics, at the basis of the quantum behavior of light. These results represent a step toward the full quantum control of a field and may provide new resources for quantum information protocols.	European Lab Nonlinear Spect, I-50019 Florence, Italy; Univ Florence, Dept Phys, I-50019 Florence, Italy; Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; CNR, Ist Nazl Ott Applicata, I-50125 Florence, Italy	University of Florence; Queens University Belfast; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Bellini, M (corresponding author), European Lab Nonlinear Spect, Via Nella Carrara 1, I-50019 Florence, Italy.	bellini@inoa.it	Parigi, Valentina/AAC-6557-2019; Zavatta, Alessandro/C-1130-2009; Zavatta, Alessandro/O-1592-2019; Bellini, Marco/J-4990-2013; Kim, Myungshik/G-6046-2010; Parigi, Valentina/A-3733-2015	Zavatta, Alessandro/0000-0002-1359-7956; Zavatta, Alessandro/0000-0002-1359-7956; Bellini, Marco/0000-0001-7352-1366; Parigi, Valentina/0000-0002-0779-1971	Engineering and Physical Sciences Research Council [EP/E003931/1] Funding Source: researchfish; EPSRC [EP/E003931/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Dell'Anno F, 2006, PHYS REP, V428, P53, DOI 10.1016/j.physrep.2006.01.004; DIRAC PAM, 1954, PRINCIPLES QUANTUM M; Eisert J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137903; Hradil Z, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230401; Kim MS, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.043805; LEE CT, 1995, PHYS REV A, V52, P3374, DOI 10.1103/PhysRevA.52.3374; Leonhardt U., 1997, MEASURING QUANTUM ST; Lvovsky AI, 2004, J OPT B-QUANTUM S O, V6, pS556, DOI 10.1088/1464-4266/6/6/014; Wenger J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153601; Zavatta A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.023820; Zavatta A, 2004, SCIENCE, V306, P660, DOI 10.1126/science.1103190; Zavatta A, 2002, J OPT SOC AM B, V19, P1189, DOI 10.1364/JOSAB.19.001189; Zavatta A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052106	14	340	344	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1890	1893		10.1126/science.1146204	http://dx.doi.org/10.1126/science.1146204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901326				2022-12-28	WOS:000249764300031
J	Meyer, TW; Hostetter, TH				Meyer, Timothy W.; Hostetter, Thomas H.			Uremia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; P-CRESOL; COGNITIVE IMPAIRMENT; INSULIN-RESISTANCE; HEMODIALYSIS; DIALYSIS; FAILURE		Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA; Stanford Univ, Sch Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Yeshiva University; Albert Einstein College of Medicine; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hostetter, TH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Rm 615,Ullmann Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA.	thostett@aecom.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK071251, R21DK077326] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK077326, R33 DK71251] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Avesani CM, 2006, KIDNEY INT, V70, pS8, DOI 10.1038/sj.ki.5001969; Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; BABB AL, 1981, AM J KIDNEY DIS, V1, P46, DOI 10.1016/S0272-6386(81)80011-X; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Blake C, 2004, NEPHROL DIAL TRANSPL, V19, P3124, DOI 10.1093/ndt/gfh538; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Canaud Bernard, 2006, Hemodial Int, V10 Suppl 1, pS5, DOI 10.1111/j.1542-4758.2006.01183.x; Capeillere-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008; Chang JM, 2000, AM J KIDNEY DIS, V35, P189, DOI 10.1016/S0272-6386(00)70325-8; Chertow GM, 2006, KIDNEY INT, V70, P24, DOI 10.1038/sj.ki.5001544; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; De Deyn PP, 2001, KIDNEY INT, V59, pS77, DOI 10.1046/j.1523-1755.2001.59780077.x; De Smet R, 2003, CLIN CHEM, V49, P470, DOI 10.1373/49.3.470; Dember LM, 2006, SEMIN DIALYSIS, V19, P105, DOI 10.1111/j.1525-139X.2006.00134.x; Depner TA, 2001, SEMIN DIALYSIS, V14, P246, DOI 10.1046/j.1525-139X.2001.00072.x; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eloot S, 2005, KIDNEY INT, V67, P1566, DOI 10.1111/j.1523-1755.2005.00238.x; Fine RN, 2002, PEDIATR TRANSPLANT, V6, P47, DOI 10.1034/j.1399-3046.2002.1p067.x; GIOVANNETTI S, 1964, LANCET, V1, P1000; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Griva K, 2006, NEPHROL DIAL TRANSPL, V21, P3275, DOI 10.1093/ndt/gfl385; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; Himmelfarb J, 2000, KIDNEY INT, V58, P2571, DOI 10.1046/j.1523-1755.2000.00443.x; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Himmelfarb J, 2002, KIDNEY INT, V61, P705, DOI 10.1046/j.1523-1755.2002.00151.x; Johansen KL, 1999, ADV RENAL REPLACE TH, V6, P141, DOI 10.1016/S1073-4449(99)70032-4; JOHNSON WJ, 1972, MAYO CLIN PROC, V47, P21; KAHN T, 1987, AM J PHYSIOL, V252, pF785; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; Komiyama Y, 2005, CLIN BIOCHEM, V38, P36, DOI 10.1016/j.clinbiochem.2004.08.005; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Krishnan AV, 2005, BRAIN, V128, P2164, DOI 10.1093/brain/awh558; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Martinez AW, 2005, J AM SOC NEPHROL, V16, P3430, DOI 10.1681/ASN.2005030310; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Meyer TW, 2004, J AM SOC NEPHROL, V15, P1927, DOI 10.1097/01.asn.0000131521.62256.f0; Miyata T, 2001, KIDNEY INT, V59, pS25; Mucsi F, 2005, NEPHROL DIAL TRANSPL, V20, P571, DOI 10.1093/ndt/gfh654; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; NIWA T, 1991, NEPHROL DIAL TRANSPL, V6, P105, DOI 10.1093/ndt/6.2.105; Norden AGW, 2004, KIDNEY INT, V66, P1994, DOI 10.1111/j.1523-1755.2004.00970.x; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; Palevsky PM, 2005, CLIN TRIALS, V2, P423, DOI 10.1191/1740774505cn116oa; Perl J, 2006, KIDNEY INT, V70, P1687, DOI 10.1038/sj.ki.5001791; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Pierratos A, 2004, KIDNEY INT, V65, P1975, DOI 10.1111/j.1523-1755.2004.00603.x; Pirisino R, 2005, MED SCI MONITOR, V11, pRA257; Raj DSC, 2000, NEPHROL DIAL TRANSPL, V15, P58, DOI 10.1093/ndt/15.1.58; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Rigalleau V, 2005, CURR OPIN CLIN NUTR, V8, P463, DOI 10.1097/01.mco.0000172590.32564.b9; Rocco MV, 1997, AM J KIDNEY DIS, V29, P888, DOI 10.1016/S0272-6386(97)90463-7; Schneditz D, 2001, SEMIN DIALYSIS, V14, P271, DOI 10.1046/j.1525-139X.2001.00066.x; Schreiner G, 1960, UREMIA, P55; Shinohara K, 2002, J AM SOC NEPHROL, V13, P1894, DOI 10.1097/01.ASN.0000019900.87535.43; SIMENHOFF ML, 1978, KIDNEY INT, pS16; SIMENHOFF ML, 1977, NEW ENGL J MED, V297, P132, DOI 10.1056/NEJM197707212970303; SMITH JL, 1994, TOXICOL APPL PHARM, V125, P296, DOI 10.1006/taap.1994.1076; Suri RS, 2007, KIDNEY INT, V71, P349, DOI 10.1038/sj.ki.5002032; US Renal Data System, 2006, USRDS 2006 ANN DAT R; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Weissinger EM, 2004, NEPHROL DIAL TRANSPL, V19, P3068, DOI 10.1093/ndt/gfh509; WELT LG, 1964, T ASSOC AM PHYSICIAN, V77, P169; Zoccali C, 2006, KIDNEY INT, V70, P26, DOI 10.1038/sj.ki.5000417	71	321	356	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1316	1325		10.1056/NEJMra071313	http://dx.doi.org/10.1056/NEJMra071313			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898101				2022-12-28	WOS:000249711500008
J	Flum, DR; Khan, TV; Dellinger, EP				Flum, David R.; Khan, Tipu V.; Dellinger, E. Patchen			Toward the rational and equitable use of bariatric surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS; UNITED-STATES; OBESITY; MORTALITY; OVERWEIGHT; WEIGHT; PREVALENCE; ADULTS; TRENDS; MEN		Univ Washington, Dept Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Flum, DR (corresponding author), Univ Washington, Dept Surg, 1959 NE Pacific St, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022	Khan, Tipu/0000-0003-1560-6155				Allison D B, 1993, Obes Res, V1, P425; *AM SOC BAR SURG, FACT SHEET; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Blokstra A, 1999, INT J OBESITY, V23, P7, DOI 10.1038/sj.ijo.0800803; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Livingston EH, 2004, SURGERY, V135, P288, DOI 10.1016/j.surg.2003.07.008; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; MROSOVSKY N, 1977, BEHAV BIOL, V20, P205, DOI 10.1016/S0091-6773(77)90773-8; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Poulose BK, 2005, J AM COLL SURGEONS, V201, P77, DOI 10.1016/j.jamcollsurg.2005.03.022; ROBERTSON K, 2003, SACRAMENTO BUSI 0418; Santry HP, 2007, ANN SURG, V245, P59, DOI 10.1097/01.sla.0000232551.55712.b3; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Shinogle JA, 2005, OBES RES, V13, P2202, DOI 10.1038/oby.2005.273; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547	25	57	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1442	1444		10.1001/jama.298.12.1442	http://dx.doi.org/10.1001/jama.298.12.1442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895461				2022-12-28	WOS:000249698900024
J	Lee, TH				Lee, Thomas H.			Eulogy for a quality measure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; IMPROVEMENT; MORTALITY		Partners Healthcare Syst, Boston, MA USA	Partners Healthcare System	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA USA.							Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; LAMAS GA, 1992, NEW ENGL J MED, V327, P241, DOI 10.1056/NEJM199207233270405; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964	5	103	105	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1175	1177		10.1056/NEJMp078102	http://dx.doi.org/10.1056/NEJMp078102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881749				2022-12-28	WOS:000249541000002
J	Watson, EB; Thomas, JB; Cherniak, DJ				Watson, E. Bruce; Thomas, Jay B.; Cherniak, Daniele J.			Ar-40 retention in the terrestrial planets	NATURE			English	Article							NOBLE-GAS SOLUBILITIES; SILICATE LIQUIDS; EXCESS AR-40; BASALT MELT; MANTLE; DIFFUSION; OLIVINE; ARGON; AR; DISEQUILIBRIUM	The solid Earth is widely believed to have lost its original gases through a combination of early catastrophic release and regulated output over geologic time. In principle, the abundance of Ar-40 in the atmosphere represents the time-integrated loss of gases from the interior, thought to occur through partial melting in the mantle followed by melt ascent to the surface and gas exsolution. Here we present data that reveal two major difficulties with this simple magmatic degassing scenario-argon seems to be compatible in the major phases of the terrestrial planets, and argon diffusion in these phases is slow at upper-mantle conditions. These results challenge the common belief that the upper mantle is nearly degassed of Ar-40, and they call into question the suitability of Ar-40 as a monitor of planetary degassing. An alternative to magmatism is needed to release argon to the atmosphere, with one possibility being hydration of oceanic lithosphere consisting of relatively argon-rich olivine and orthopyroxene.	Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Watson, EB (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA.	watsoe@rpi.edu						ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Anderson DL, 2000, INT GEOL REV, V42, P289, DOI 10.1080/00206810009465084; ARMSTRONG RL, 1991, AUST J EARTH SCI, V38, P613, DOI 10.1080/08120099108727995; BATIZA R, 1979, CONTRIB MINERAL PETR, V69, P301, DOI 10.1007/BF00372332; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; BROADHURST CL, 1990, GEOCHIM COSMOCHIM AC, V54, P299, DOI 10.1016/0016-7037(90)90319-G; Brooker RA, 2003, NATURE, V423, P738, DOI 10.1038/nature01708; Burnard P, 2004, EARTH PLANET SC LETT, V220, P287, DOI 10.1016/S0012-821X(04)00060-3; CARROLL MR, 1993, GEOCHIM COSMOCHIM AC, V57, P5039, DOI 10.1016/0016-7037(93)90606-W; Cherniak DJ, 2007, GEOCHIM COSMOCHIM AC, V71, P1324, DOI 10.1016/j.gca.2006.12.001; Davies GF, 1999, EARTH PLANET SC LETT, V166, P149, DOI 10.1016/S0012-821X(99)00007-2; HARRISON TM, 1981, EARTH PLANET SC LETT, V55, P123, DOI 10.1016/0012-821X(81)90092-3; HART SR, 1993, P NATL ACAD SCI USA, V90, P11914, DOI 10.1073/pnas.90.24.11914; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; HIYAGON H, 1982, EARTH PLANET SC LETT, V58, P255, DOI 10.1016/0012-821X(82)90198-4; HIYAGON H, 1986, GEOCHIM COSMOCHIM AC, V50, P2045, DOI 10.1016/0016-7037(86)90258-9; IWAMORI H, 1993, NATURE, V366, P734, DOI 10.1038/366734a0; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; JAMBON A, 1986, GEOCHIM COSMOCHIM AC, V50, P401, DOI 10.1016/0016-7037(86)90193-6; JOCHUM KP, 1983, NATURE, V306, P431, DOI 10.1038/306431a0; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; Korenaga J, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004502; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; LANPHERE MA, 1976, EARTH PLANET SC LETT, V32, P141, DOI 10.1016/0012-821X(76)90052-2; LASSITER JC, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI DOI 10.1029/2004GC00711; Li XP, 2004, J METAMORPH GEOL, V22, P159, DOI 10.1111/j.1525-1314.2004.00503.x; LUX G, 1987, GEOCHIM COSMOCHIM AC, V51, P1549, DOI 10.1016/0016-7037(87)90336-X; MARTY B, 1993, CHEM GEOL, V106, P1, DOI 10.1016/0009-2541(93)90162-C; McDougall I., 1999, GEOCHRONOLOGY THERMO, P1; MCDOUGALL I, 1964, NORSK GEOL TIDSSKR, V44, P183; Murthy VM, 2003, NATURE, V423, P163, DOI 10.1038/nature01560; Parman SW, 2005, NATURE, V437, P1140, DOI 10.1038/nature04215; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P411, DOI 10.2138/rmg.2002.47.11; PORCELLI D, 2006, TREATISE GEOCHEM, V4, P281; POREDA RJ, 1992, EARTH PLANET SC LETT, V113, P129, DOI 10.1016/0012-821X(92)90215-H; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Schmidt BC, 2002, EARTH PLANET SC LETT, V195, P277, DOI 10.1016/S0012-821X(01)00584-2; Shibata T, 1998, GEOCHIM COSMOCHIM AC, V62, P1241, DOI 10.1016/S0016-7037(98)00046-5; SPIEGELMAN M, 1992, EARTH PLANET SC LETT, V109, P611, DOI 10.1016/0012-821X(92)90119-G; STAUDACHER T, 1982, EARTH PLANET SC LETT, V60, P389, DOI 10.1016/0012-821X(82)90075-9; THOMAS JB, UNPUB CHEM GEOL; Tsuchiyama A., 1994, NOBLE GAS GEOCHEMIST, P315; Turekian K. K., 1990, MANTLE METEORITES, P147; VALBRACHT PJ, 1994, NOBLE GAS GEOCHEMIST, P373; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Watson EB, 2003, GEOCHIM COSMOCHIM AC, V67, P2043, DOI 10.1016/S0016-7037(02)01340-6; WHITE BS, 1989, AM MINERAL, V74, P513	48	42	42	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					299	304		10.1038/nature06144	http://dx.doi.org/10.1038/nature06144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882213				2022-12-28	WOS:000249557300037
J	Culleton, BF; Walsh, M; Klarenbach, SW; Mortis, G; Scott-Douglas, N; Quinn, RR; Tonelli, M; Donnelly, S; Friedrich, MG; Kumar, A; Mahallati, H; Hemmelgarn, BR; Manns, BJ				Culleton, Bruce F.; Walsh, Michael; Klarenbach, Scott W.; Mortis, Garth; Scott-Douglas, Narine; Quinn, Robert R.; Tonelli, Marcello; Donnelly, Sarah; Friedrich, Matthias G.; Kumar, Andreas; Mahallati, Houman; Hemmelgarn, Brenda R.; Manns, Braden J.			Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; RECEIVING HEMODIALYSIS; PERITONEAL-DIALYSIS; HOME HEMODIALYSIS; BLOOD-PRESSURE; COST-UTILITY; FOLLOW-UP; HYPERTROPHY; SURVIVAL; IMPROVEMENT	Context Morbidity and mortality rates in hemodialysis patients remain excessive. Alterations in the delivery of dialysis may lead to improved patient outcomes. Objective To compare the effects of frequent nocturnal hemodialysis vs conventional hemodialysis on change in left ventricular mass and health-related quality of life over 6 months. Design, Setting, and Participants A 2-group, parallel, randomized controlled trial conducted at 2 Canadian university centers between August 2004 and December 2006. A total of 52 patients undergoing hemodialysis were recruited. Intervention Participants were randomly assigned in a 1:1 ratio to receive nocturnal hemodialysis 6 times weekly or conventional hemodialysis 3 times weekly. Main Outcome Measures The primary outcome was change in left ventricular mass, as measured by cardiovascular magnetic resonance imaging. The secondary outcomes were patient-reported quality of life, blood pressure, mineral metabolism, and use of medications. Results Frequent nocturnal hemodialysis significantly improved the primary outcome (mean left ventricular mass difference between groups, 15.3 g, 95% confidence interval [CI], 1.0 to 29.6 g; P = .04). Frequent nocturnal hemodialysis did not significantly improve quality of life (difference of change in EuroQol 5-D index from baseline, 0.05; 95% CI, -0.07 to 0.17; P = .43). However, frequent nocturnal hemodialysis was associated with clinically and statistically significant improvements in selected kidney-specific domains of quality of life (P = .01 for effects of kidney disease and P = .02 for burden of kidney disease). Frequent nocturnal hemodialysis was also associated with improvements in systolic blood pressure (P = .01 after adjustment) and mineral metabolism, including a reduction in or discontinuation of antihypertensive medications (16/26 patients in the nocturnal hemodialysis group vs 3/25 patients in the conventional hemodialysis group; P < .001) and oral phosphate binders (19/26 patients in the nocturnal hemodialysis group vs 3/25 patients in the conventional dialysis group; P < .001). No benefit in anemia management was seen with nocturnal hemodialysis. Conclusion This preliminary study revealed that, compared with conventional hemodialysis (3 times weekly), frequent nocturnal hemodialysis improved left ventricular mass, reduced the need for blood pressure medications, improved some measures of mineral metabolism, and improved selected measures of quality of life.	Univ Calgary, Dept Med, Calgary, AB, Canada; Alberta Kidney Dis Network, Edmonton, AB, Canada; Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; Univ Alberta, Dept Med, Edmonton, AB T6G 2M7, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Cardiovasc Magnet Resonance Ctr, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Radiol, Calgary, AB T2N 1N4, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Culleton, BF (corresponding author), Foothills Prov Gen Hosp, Room C210,1403 29th St NW, Calgary, AB T2N 2T9, Canada.	bruce_culleton@baxter.com	Walsh, Michael/ABE-1278-2021; Manns, Braden J/I-8942-2012; Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009; Hemmelgarn, Brenda R./I-6894-2012; Friedrich, Matthias/H-8474-2015	Walsh, Michael/0000-0001-8292-2014; Tonelli, Marcello/0000-0002-0846-3187; Friedrich, Matthias/0000-0003-1204-5647				Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Chan CT, 2003, HYPERTENSION, V42, P925, DOI 10.1161/01.HYP.0000097605.35343.64; Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x; Collins AJ, 2007, AM J KIDNEY DIS, V49, P135, DOI 10.1053/j.ajkd.2006.09.020; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; CULLETON BF, 2003, J AM SOC NEPHROL, V14, pS220; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Foley RN, 1998, KIDNEY INT, V54, P1720, DOI 10.1046/j.1523-1755.1998.00154.x; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; Heidenheim AP, 2003, AM J KIDNEY DIS, V42, pS36, DOI 10.1016/S0272-6386(03)00536-5; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kliger AS, 2007, CLIN J AM SOC NEPHRO, V2, P390, DOI 10.2215/CJN.03110906; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Kroeker A, 2003, AM J KIDNEY DIS, V42, pS49, DOI 10.1016/S0272-6386(03)00538-9; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lo WK, 2003, KIDNEY INT, V64, P649, DOI 10.1046/j.1523-1755.2003.00098.x; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; McFarlane PA, 2003, KIDNEY INT, V64, P1004, DOI 10.1046/j.1523-1755.2003.00157.x; McPhatter LL, 1999, ADV RENAL REPLACE TH, V6, P358, DOI 10.1016/S1073-4449(99)70048-8; Mucsi I, 1998, KIDNEY INT, V53, P1399, DOI 10.1046/j.1523-1755.1998.00875.x; Myerson SG, 2002, HYPERTENSION, V39, P750, DOI 10.1161/hy0302.104674; Nesrallah G, 2003, AM J KIDNEY DIS, V42, pS13, DOI 10.1016/S0272-6386(03)00532-8; Nesrallah GE, 2004, SEMIN DIALYSIS, V17, P131, DOI 10.1111/j.0894-0959.2004.17210.x; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Piccoli GB, 2005, KIDNEY INT, V68, P2913, DOI 10.1111/j.1523-1755.2005.00583_11.x; SAMAK MJ, 2003, CIRCULATION, V108, P2154; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Suri RS, 2007, KIDNEY INT, V71, P349, DOI 10.1038/sj.ki.5002032; Walsh M, 2005, KIDNEY INT, V67, P1500, DOI 10.1111/j.1523-1755.2005.00228.x; Walsh Michael, 2006, BMC Nephrol, V7, P2, DOI 10.1186/1471-2369-7-2; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	38	504	552	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1291	1299		10.1001/jama.298.11.1291	http://dx.doi.org/10.1001/jama.298.11.1291			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878421	Bronze			2022-12-28	WOS:000249524100019
J	Hopper, AD; Hadjivassiliou, M; Butt, S; Sanders, DS				Hopper, Andrew D.; Hadjivassiliou, Marios; Butt, Sohail; Sanders, David S.			Adult coeliac disease	BRITISH MEDICAL JOURNAL			English	Review							GLUTEN-FREE DIET; SECONDARY CARE; FOLLOW-UP; DIAGNOSIS; ASSOCIATION; ANTIBODIES; ENDOSCOPY; SPECTRUM; PEOPLE		Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England; Studholme Med Ctr, Ashford TW15 2TU, Kent, England	University of Sheffield; University of Sheffield	Hopper, AD (corresponding author), Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Dept Gastroenterol, Room P39,P Floor, Sheffield S10 2JF, S Yorkshire, England.	andydhopper@aol.com						*AM GASTR ASS, 2001, GASTROENTEROLOGY, V120, P1522; BARDELLA MT, 1994, ARCH DIS CHILD, V70, P211, DOI 10.1136/adc.70.3.211; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; Dickey W, 1996, J CLIN GASTROENTEROL, V23, P21, DOI 10.1097/00004836-199607000-00007; Elli L, 2006, GUT, V55, P1672; Esteve M, 2006, GUT, V55, P1739, DOI 10.1136/gut.2006.095299; Fasano A, 2003, NEW ENGL J MED, V348, P2568, DOI 10.1056/NEJMe030050; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Lewis BS, 2002, GASTROINTEST ENDOSC, V56, P349, DOI 10.1067/mge.2002.126906; Lo WS, 2003, DIGEST DIS SCI, V48, P395, DOI 10.1023/A:1021956200382; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Sanders DS, 2005, ANN SURG, V242, P201, DOI 10.1097/01.sla.0000171301.35513.cf; Sanders DS, 2005, BMJ-BRIT MED J, V330, P775, DOI 10.1136/bmj.330.7494.775; Sanders DS, 2003, GUT, V52, P1070, DOI 10.1136/gut.52.7.1070-b; Sanders DS, 2002, POSTGRAD MED J, V78, P31, DOI 10.1136/pmj.78.915.31; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Scoglio R, 2003, AM J GASTROENTEROL, V98, P1325, DOI 10.1016/S0002-9270(03)00229-6; Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Walters JRF, 2007, GUT, V56, P310, DOI 10.1136/gut.2006.107847; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6	25	67	70	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					558	+		10.1136/bmj.39316.442338.AD	http://dx.doi.org/10.1136/bmj.39316.442338.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855325	Green Published			2022-12-28	WOS:000249790200038
J	O'Connor, PJ				O'Connor, Philip J.			Rational imaging - A painful hip	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-SCINTIGRAPHY; DIAGNOSIS; FRACTURES; MRI		Leeds Teaching Hosp Trust, Leeds LS1 3EX, W Yorkshire, England	University of Leeds	O'Connor, PJ (corresponding author), Leeds Teaching Hosp Trust, Leeds LS1 3EX, W Yorkshire, England.	Philip.o'connor@leedsth.nhs.uk						BOGOST GA, 1995, RADIOLOGY, V197, P263, DOI 10.1148/radiology.197.1.7568834; Bohndorf K, 2002, EUR RADIOL, V12, P1605, DOI 10.1007/s00330-002-1461-8; Bradley M, 2006, BRIT J RADIOL, V79, P216, DOI 10.1259/bjr/31965396; HOLDER LE, 1990, RADIOLOGY, V174, P509, DOI 10.1148/radiology.174.2.2404320; Laurin Sven, 2004, Lakartidningen, V101, P2423; LEWIS SL, 1991, BRIT J RADIOL, V64, P403, DOI 10.1259/0007-1285-64-761-403; MATIN P, 1979, J NUCL MED, V20, P1227; Pandey R, 1998, INJURY, V29, P61, DOI 10.1016/S0020-1383(97)00165-4; Pathak G, 1997, INJURY, V28, P299, DOI 10.1016/S0020-1383(96)00198-2; PRATHER JL, 1977, J BONE JOINT SURG AM, V59, P869, DOI 10.2106/00004623-197759070-00006; RIZZO PF, 1993, J BONE JOINT SURG AM, V75A, P395, DOI 10.2106/00004623-199303000-00011; Roberts CS, 2002, CLIN ORTHOP RELAT R, P248; Rubin SJ, 1998, SKELETAL RADIOL, V27, P199, DOI 10.1007/s002560050365; Verbeeten KM, 2005, EUR RADIOL, V15, P165, DOI 10.1007/s00330-004-2421-2	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2007	335	7619					563	564		10.1136/bmj.39239.420220.80	http://dx.doi.org/10.1136/bmj.39239.420220.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855326	Green Published			2022-12-28	WOS:000249790200039
J	Philippot, P; Van Zuilen, M; Lepot, K; Thomazo, C; Farquhar, J; Van Kranendonk, MJ				Philippot, Pascal; Van Zuilen, Mark; Lepot, Kevin; Thomazo, Christophe; Farquhar, James; Van Kranendonk, Martin J.			Early Archaean microorganisms preferred elemental sulfur, not sulfate	SCIENCE			English	Article							ISOTOPE FRACTIONATION; BACTERIAL REDUCTION; WESTERN-AUSTRALIA; CYCLE; OCEAN; DISPROPORTIONATION; ATMOSPHERE; MECHANISM; EVOLUTION; SULPHATE	Microscopic sulfides with low S-34/S-32 ratios in marine sulfate deposits from the 3490-million-year-old Dresser Formation, Australia, have been interpreted as evidence for the presence of early sulfate-reducing organisms on Earth. We show that these microscopic sulfides have a massin-dependently fractionated sulfur isotopic anomaly (Delta S-33) that differs from that of their host sulfate (barite). These microscopic sulfides could not have been produced by sulfate-reducing microbes, nor by abiologic processes that involve reduction of sulfate. Instead, we interpret the combined negative delta S-34 and positive Delta S-33 signature of these microscopic sulfides as evidence for the early existence of organisms that disproportionate elemental sulfur.	CNRS, Inst Phys Globe, Equipe Geobiosphere Actuelle & Primit, F-75005 Paris, France; Univ Maryland, Dept Geol, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Geol Survey Western Australia, Perth, WA 6004, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University System of Maryland; University of Maryland College Park; Geological Survey of Western Australia	Philippot, P (corresponding author), CNRS, Inst Phys Globe, Equipe Geobiosphere Actuelle & Primit, 4 Pl Jussieu, F-75005 Paris, France.	philippot@ipgp.jussieu.fr	Van Kranendonk, Martin J/J-8755-2012; Philippot, Pascal/AAD-4313-2020; Lepot, Kevin/C-7072-2014	Van Kranendonk, Martin J/0000-0002-0611-2703; Thomazo, Christophe/0000-0002-2475-0514; van Zuilen, Mark/0000-0001-6723-6366; Lepot, Kevin/0000-0003-0556-0405				AHMEND JP, 2004, SULFUR BIOGEOCHEMIST, V379, P17; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Canfield DE, 1998, LIMNOL OCEANOGR, V43, P253, DOI 10.4319/lo.1998.43.2.0253; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; FRY B, 1984, FEMS MICROBIOL LETT, V22, P283; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 1998, GEOCHIM COSMOCHIM AC, V62, P2585, DOI 10.1016/S0016-7037(98)00167-7; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; LAMBERT IB, 1978, NATURE, V276, P808, DOI 10.1038/276808a0; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; RUNNEGAR B, 2001, GEOL SOC AM, pA4104; Rye RO, 2005, CHEM GEOL, V215, P5, DOI 10.1016/j.chemgeo.2004.06.034; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Shen YN, 2004, EARTH-SCI REV, V64, P243, DOI 10.1016/S0012-8252(03)00054-0; Smith JW, 2000, GEOCHEM J, V34, P95, DOI 10.2343/geochemj.34.95; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1111/j.1574-6968.1990.tb04089.x; STETTER KO, 1983, NATURE, V305, P309, DOI 10.1038/305309a0; THORPE RI, 1992, ARCHAEAN TERRAINS PR, V22, P395; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; VANKRANENDONK MJ, 2006, 200614 W AUST GEOL S, P25	33	230	236	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1534	1537		10.1126/science.1145861	http://dx.doi.org/10.1126/science.1145861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872441				2022-12-28	WOS:000249467900037
J	Wood, GJ; Shega, JW; Lynch, B; Von Roenn, JH				Wood, Gordon J.; Shega, Joseph W.; Lynch, Beth; Von Roenn, Jamie H.			Management of intractable nausea and vomiting in patients at the end of life - " I was feeling nauseous all of the time ... nothing was working"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HIGH-DOSE METOCLOPRAMIDE; OPIOID-INDUCED NAUSEA; DOUBLE-BLIND; TERMINAL CANCER; ANTIEMETIC EFFICACY; RELEASE METOCLOPRAMIDE; INTESTINAL-OBSTRUCTION; POSTOPERATIVE NAUSEA; CONTROLLED ANALGESIA; ANTICIPATORY NAUSEA	Nausea and vomiting, symptoms that occur commonly near the end of life, represent a substantial source of physical and psychological distress for patients and families. In the context of the case of MrQ, a 50-year-old man with metastatic esophageal cancer admitted to the hospital with intractable nausea and vomiting, we review the evaluation and treatment of this symptom complex. A thorough history and physical examination are essential first steps in the management of these patients because they define the severity of the symptoms and clues to their underlying etiology. Once the most likely cause is determined, the clinician discerns the mechanism, specific transmitters, and receptors by which this etiology is triggering nausea and vomiting. Subsequent pharmacological management focuses on prescribing the appropriate antagonist to the implicated receptors. If symptoms are refractory despite adequate dosage and around-the-clock prophylactic administration, an empirical trial combining several therapies to block multiple emetic pathways should be attempted. Less traditional agents are also discussed, although evidence for their use is limited. Often, oral administration of medication is not feasible and alternate routes such as rectal suppositories, subcutaneous infusions, and orally dissolvable tablets should be considered. Using this step-wise approach, nausea and vomiting can be successfully managed in most patients at the end of life.	Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Wood, GJ (corresponding author), Univ Pittsburgh, Inst Enhance Palliat Care, Sect Palliat Care & Med Eth, Sch Med,Dept Med,Div Gen Internal Med, 200 Lothrop St,Suite 933 W, Pittsburgh, PA 15213 USA.	woodgj@upmc.edu						ALDRETE JA, 1995, J PAIN SYMPTOM MANAG, V10, P544, DOI 10.1016/0885-3924(95)00104-7; ANDRYKOWSKI MA, 1990, PSYCHOSOM MED, V52, P458, DOI 10.1097/00006842-199007000-00008; Ashby MA, 1999, MED J AUSTRALIA, V170, P68, DOI 10.5694/j.1326-5377.1999.tb126885.x; BAINES M, 1985, LANCET, V2, P990; BARDFELD PA, 1966, J AMER MED ASSOC, V196, P796; Barnes S, 2006, J PAIN SYMPTOM MANAG, V32, P208, DOI 10.1016/j.jpainsymman.2006.04.005; BARTON MD, 1975, ANESTHESIOLOGY, V42, P508, DOI 10.1097/00000542-197504000-00028; BEAL JE, 1995, J PAIN SYMPTOM MANAG, V10, P89, DOI 10.1016/0885-3924(94)00117-4; Bentley A, 2001, PALLIATIVE MED, V15, P247, DOI 10.1191/026921601678576239; Berger A, 2007, PRINCIPLES PRACTICE, P139; Bernard SA, 2000, J CLIN ONCOL, V18, P1780, DOI 10.1200/JCO.2000.18.8.1780; Bittinger M, 1999, CLIN AUTON RES, V9, P75, DOI 10.1007/BF02311763; Blair SL, 2001, ANN SURG ONCOL, V8, P632, DOI 10.1007/s10434-001-0632-1; BORISON HL, 1953, PHARMACOL REV, V5, P193; Braude D, 2006, AM J EMERG MED, V24, P177, DOI 10.1016/j.ajem.2005.08.017; Brooksbank MA, 2002, PALLIATIVE MED, V16, P520, DOI 10.1191/0269216302pm590oa; Bruera E, 2004, J PAIN SYMPTOM MANAG, V28, P381, DOI 10.1016/j.jpainsymman.2004.01.009; Bruera E, 1987, J Pain Symptom Manage, V2, P19, DOI 10.1016/S0885-3924(87)80041-6; BRUERA E, 1994, J PAIN SYMPTOM MANAG, V9, P515, DOI 10.1016/0885-3924(94)90113-9; Bruera E, 1996, J PAIN SYMPTOM MANAG, V11, P147, DOI 10.1016/0885-3924(95)00161-1; Bruera E, 2000, J PAIN SYMPTOM MANAG, V19, P427, DOI 10.1016/S0885-3924(00)00138-X; BRUERA ED, 1994, CANCER, V74, P3204, DOI 10.1002/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO;2-G; BRUERA ED, 1995, CANCER, V75, P1733; BURISH TG, 1992, J PAIN SYMPTOM MANAG, V7, P287, DOI 10.1016/0885-3924(92)90062-M; Burmeister MA, 2003, BRIT J ANAESTH, V90, P194, DOI 10.1093/bja/aeg047; CAMPORA E, 1991, J PAIN SYMPTOM MANAG, V6, P428, DOI 10.1016/0885-3924(91)90041-2; CARPENTER DO, 1990, CAN J PHYSIOL PHARM, V68, P230, DOI 10.1139/y90-036; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; COLE RM, 1994, J PAIN SYMPTOM MANAG, V9, P48, DOI 10.1016/0885-3924(94)90147-3; Cowan JD, 2001, SUPPORT CARE CANCER, V9, P403, DOI 10.1007/s005200100235; Critchley P, 2001, J PAIN SYMPTOM MANAG, V22, P631, DOI 10.1016/S0885-3924(01)00323-2; Currow DC, 1997, J PAIN SYMPTOM MANAG, V13, P302, DOI 10.1016/S0885-3924(97)00079-1; DALAL S, 2007, PRINCIPLES PRACTICE, P151; Davis MP, 2000, SUPPORT CARE CANCER, V8, P444, DOI 10.1007/s005200000151; DESTOUTZ ND, 1995, J PAIN SYMPTOM MANAG, V10, P378, DOI 10.1016/0885-3924(95)90924-C; Ernst AA, 2000, ANN EMERG MED, V36, P89, DOI 10.1067/mem.2000.108652; Fainsinger R, 1991, J Palliat Care, V7, P5; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fallon MT, 1998, BRIT MED J, V317, P81, DOI 10.1136/bmj.317.7150.81; Familoni BO, 2006, IEEE T BIO-MED ENG, V53, P1038, DOI 10.1109/TBME.2006.873395; Feuer DJ., 2000, COCHRANE DB SYST REV, V2000; Flynn J, 1992, J Palliat Care, V8, P46; Gagnon P, 2000, J PAIN SYMPTOM MANAG, V19, P412, DOI 10.1016/S0885-3924(00)00143-3; Gan TJ, 2003, ANESTH ANALG, V97, P62, DOI 10.1213/01.ANE.0000068580.00245.95; Glare P, 2004, SUPPORT CARE CANCER, V12, P432, DOI 10.1007/s00520-004-0629-y; GonzalezRosales F, 1997, J PAIN SYMPTOM MANAG, V14, P311, DOI 10.1016/S0885-3924(97)00229-7; GRALLA RJ, 1981, NEW ENGL J MED, V305, P905, DOI 10.1056/NEJM198110153051601; GROND S, 1994, J PAIN SYMPTOM MANAG, V9, P372, DOI 10.1016/0885-3924(94)90174-0; Grunberg SM, 2004, CANCER-AM CANCER SOC, V100, P2261, DOI 10.1002/cncr.20230; GUTNER LB, 1952, J CLIN INVEST, V31, P259, DOI 10.1172/JCI102601; HAGEN NA, 1991, J PAIN SYMPTOM MANAG, V6, P125, DOI 10.1016/0885-3924(91)90961-3; Hall W, 2005, LANCET ONCOL, V6, P35, DOI 10.1016/S1470-2045(05)70024-3; Hardy J, 2002, SUPPORT CARE CANCER, V10, P231, DOI 10.1007/s00520-001-0332-1; Haug TT, 2002, GEN HOSP PSYCHIAT, V24, P81, DOI 10.1016/S0163-8343(01)00184-0; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson W Clay, 2003, J Palliat Med, V6, P251, DOI 10.1089/109662103764978506; KAUFMANN MA, 1994, ANESTH ANALG, V78, P988; KENNY GNC, 1994, ANAESTHESIA, V49, P6, DOI 10.1111/j.1365-2044.1994.tb03576.x; Klepstad P, 2003, PALLIATIVE MED, V17, P679, DOI 10.1191/0269216303pm835oa; Kris MG, 2006, J CLIN ONCOL, V24, P2932, DOI 10.1200/JCO.2006.06.9591; Lang IM, 1999, DIGEST DIS SCI, V44, p58S; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Liaw CC, 2003, AM J CLIN ONCOL-CANC, V26, P12, DOI 10.1097/00000421-200302000-00003; Lichter I, 1993, J Palliat Care, V9, P19; Ljutic D, 2002, KIDNEY BLOOD PRESS R, V25, P61, DOI 10.1159/000049437; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; LOPRINZI CL, 1990, JNCI-J NATL CANCER I, V82, P1127, DOI 10.1093/jnci/82.13.1127; LUND B, 1989, SURG GYNECOL OBSTET, V169, P213; Lundstrom S, 2005, J PAIN SYMPTOM MANAG, V30, P570, DOI 10.1016/j.jpainsymman.2005.05.017; MALIK IA, 1995, AM J CLIN ONCOL-CANC, V18, P170, DOI 10.1097/00000421-199504000-00017; Mannix K, 2006, CLIN MED, V6, P144, DOI 10.7861/clinmedicine.6-2-144; MARTY M, 1990, NEW ENGL J MED, V322, P816, DOI 10.1056/NEJM199003223221205; MCGEE JL, 1979, AM J HOSP PHARM, V36, P633, DOI 10.1093/ajhp/36.5.633; Mercadante S, 2004, J PAIN SYMPTOM MANAG, V28, P412, DOI 10.1016/j.jpainsymman.2004.01.007; Meuser T, 2001, PAIN, V93, P247, DOI 10.1016/S0304-3959(01)00324-4; Mok TSK, 2007, ANN ONCOL, V18, P768, DOI 10.1093/annonc/mdl465; Morrow GR, 2002, PSYCHOPHYSIOLOGY, V39, P491, DOI 10.1017/S0048577202991195; Morrow GR, 1996, ONCOLOGY, V53, P4, DOI 10.1159/000227633; MORROW GR, 1984, J CLIN ONCOL, V2, P1170, DOI 10.1200/JCO.1984.2.10.1170; Mystakidou K, 1998, J PAIN SYMPTOM MANAG, V15, P176, DOI 10.1016/S0885-3924(97)00349-7; Mystakidou K, 1998, CANCER-AM CANCER SOC, V83, P1214, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1214::AID-CNCR22>3.3.CO;2-3; Norval DA, 2004, SAMJ S AFR MED J, V94, P450; ORDOG GJ, 1984, ANN EMERG MED, V13, P253, DOI 10.1016/S0196-0644(84)80473-4; Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1; Passik SD, 2002, J PAIN SYMPTOM MANAG, V23, P526, DOI 10.1016/S0885-3924(02)00391-3; Pereira J, 1996, J PALLIAT CARE, V12, P47, DOI 10.1177/082585979601200210; Pick N, 1996, J AM GERIATR SOC, V44, P763, DOI 10.1111/j.1532-5415.1996.tb03731.x; Porcel JM, 1998, J PAIN SYMPTOM MANAG, V15, P265; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Priestman T J, 1990, Clin Oncol (R Coll Radiol), V2, P71, DOI 10.1016/S0936-6555(05)80790-3; PYYKKO I, 1985, ACTA OTO-LARYNGOL, V99, P588, DOI 10.3109/00016488509182265; REUBEN DB, 1986, ARCH INTERN MED, V146, P2021, DOI 10.1001/archinte.146.10.2021; Rhodes VA, 2001, CA-CANCER J CLIN, V51, P232, DOI 10.3322/canjclin.51.4.232; RHODES VA, 1994, CANCER NURS, V17, P45; Ripamonti C, 2001, SUPPORT CARE CANCER, V9, P223, DOI 10.1007/s005200000198; Ripamonti C., 2004, OXFORD TXB PALLIATIV, V3, P496; ROBBINS EL, 1975, J AM GERIATR SOC, V23, P38, DOI 10.1111/j.1532-5415.1975.tb00378.x; SALLER R, 1986, J CLIN PHARMACOL, V26, P115, DOI 10.1002/j.1552-4604.1986.tb02918.x; SIMMS SG, 1993, NURS RES, V42, P234; SONG HY, 1994, RADIOLOGY, V193, P689, DOI 10.1148/radiology.193.3.7526414; Srivastava M, 2003, J PAIN SYMPTOM MANAG, V25, P578, DOI 10.1016/S0885-3924(03)00143-X; Starke PR, 2005, NEW ENGL J MED, V352, P2653, DOI 10.1056/NEJM200506233522522; Stephenson J, 2006, SUPPORT CARE CANCER, V14, P348, DOI 10.1007/s00520-005-0897-1; Storey P, 1990, J Pain Symptom Manage, V5, P33, DOI 10.1016/S0885-3924(05)80007-7; Sussman G, 1999, CLIN THER, V21, P1216, DOI 10.1016/S0149-2918(00)80024-7; Taixiang W, 2005, Cochrane Database Syst Rev, pCD004540; Theobald DE, 2002, J PAIN SYMPTOM MANAG, V23, P442, DOI 10.1016/S0885-3924(02)00381-0; Thompson DS, 2000, PSYCHOSOMATICS, V41, P356, DOI 10.1176/appi.psy.41.4.356; Traldi A, 1965, Cancro, V18, P336; Veehof LJG, 1999, EUR J CLIN PHARMACOL, V55, P533, DOI 10.1007/s002280050669; Vickers AJ, 1996, J ROY SOC MED, V89, P303, DOI 10.1177/014107689608900602; Vutyavanich T, 2001, OBSTET GYNECOL, V97, P577, DOI 10.1016/S0029-7844(00)01228-X; WALDER AD, 1994, ANAESTHESIA, V49, P804; Weschules Douglas J, 2006, Am J Hosp Palliat Care, V23, P135, DOI 10.1177/104990910602300211; Weschules DJ, 2005, J PALLIAT MED, V8, P1135, DOI 10.1089/jpm.2005.8.1135; Wickham Rita, 2004, Clin J Oncol Nurs, V8, P91; Winkelbauer FW, 1996, AM J ROENTGENOL, V166, P79, DOI 10.2214/ajr.166.1.8571911	118	57	58	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1196	1207		10.1001/jama.298.10.1196	http://dx.doi.org/10.1001/jama.298.10.1196			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848654				2022-12-28	WOS:000249374200025
J	HAWKINS, DB				HAWKINS, DB			UNITED-STATES OIL AND GAS CONSUMPTION - IS ANOTHER CRISIS AHEAD	SCIENCE			English	Letter											HAWKINS, DB (corresponding author), UNIV ALASKA,DEPT GEOL & GEOPHYS,FAIRBANKS,AK 99775, USA.							HUBBERT MK, 1969, RESOURCES MAN, P163; KERR RA, 1989, SCIENCE, V245, P1330, DOI 10.1126/science.245.4924.1330	2	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1280	1280		10.1126/science.247.4948.1280	http://dx.doi.org/10.1126/science.247.4948.1280			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843773				2022-12-28	WOS:A1990CU25300002
J	Hannaford, PC; Selvaraj, S; Elliott, AM; Angus, V; Iversen, L; Lee, AJ				Hannaford, Philip C.; Selvaraj, Sivasubramaniam; Elliott, Alison M.; Angus, Valerie; Iversen, Lisa; Lee, Amanda J.			Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners' oral contraception study	BRITISH MEDICAL JOURNAL			English	Article							HORMONAL CONTRACEPTIVES; FOLLOW-UP; MORTALITY; WOMEN	Objective To examine the absolute risks or benefits on cancer associated with oral contraception, using incident data. Design Inception cohort study. Setting Royal College of General Practitioners' oral contraception study. Participants Directly standardised data from the Royal College of General Practitioners' oral contraception study. Main outcome measures Adjusted relative risks between never and ever users of oral contraceptives for different types of cancer, main gynaecological cancers combined, and any cancer. Standardisation variables were age, smoking, parity, social class, and (for the general practitioner observation dataset) hormone replacement therapy. Subgroup analyses examined whether the relative risks changed with user characteristics, duration of oral contraception usage, and time since last use of oral contraception. Results The main dataset contained about 339 000 woman years of observation for never users and 744 000 woman years for ever users. Compared with never users ever users had statistically significant lower rates of cancers of the large bowel or rectum, uterine body, and ovaries, tumours of unknown site, and other malignancies; main gynaecological cancers combined; and any cancer. The relative risk for any cancer in the smaller general practitioner observation dataset was not significantly reduced. Statistically significant trends of increasing risk of cervical and central nervous system or pituitary cancer, and decreasing risk of uterine body and ovarian malignancies, were seen with increasing duration of oral contraceptive use. Reduced relative risk estimates were observed for ovarian and uterine body cancer many years after stopping oral contraception, although some were not statistically significant. The estimated absolute rate reduction of any cancer among ever users was 45 or 10 per 100 000 woman years, depending on whether the main or general practitioner observation dataset was used. Conclusion In this UK cohort, oral contraception was not associated with an overall increased risk of cancer; indeed it may even produce a net public health gain. The balance of cancer risks and benefits, however, may vary internationally, depending on patterns of oral contraception usage and the incidence of different cancers.	Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland; Ctr Rural Hlth, Inverness, Scotland; Univ Aberdeen, Coll Life Sci & Med, Aberdeen AB25 2AY, Scotland	University of Aberdeen; University of Aberdeen	Hannaford, PC (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland.	p.hannaford@abdn.ac.uk	Hannaford, Philip C/B-7867-2012; Angus, Valerie/A-5324-2008	Iversen, Lisa/0000-0002-2524-5229				BERAL V, 1988, LANCET, V2, P1331; Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; Beral V, 1996, EVIDENCE GUIDED PRES, P327; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; COLDITZ GA, 1994, ANN INTERN MED, V120, P821, DOI 10.7326/0003-4819-120-10-199405150-00002; Dickinson HO, 2001, J EPIDEMIOL COMMUN H, V55, P414, DOI 10.1136/jech.55.6.414; Fernandez E, 2001, BRIT J CANCER, V84, P722, DOI 10.1054/bjoc.2000.1622; Iversen L, 2005, BMJ-BRIT MED J, V330, P1482, DOI 10.1136/bmj.38483.669178.8F; Kumle Merethe, 2003, Tidsskr Nor Laegeforen, V123, P1653; La Vecchia C, 2001, DRUG SAFETY, V24, P741; Owen-Smith V, 1998, J EPIDEMIOL COMMUN H, V52, P420, DOI 10.1136/jech.52.7.420; Rosner B., 2000, FUNDAMENTALS BIOSTAT; *ROYAL COLL GEN PR, 1974, OR CONTR HLTH; Royar J, 2001, INT J CANCER, V95, P370, DOI 10.1002/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Vessey M, 2006, BRIT J CANCER, V95, P385, DOI 10.1038/sj.bjc.6603260; Weiderpass E, 1999, CANCER CAUSE CONTROL, V10, P277, DOI 10.1023/A:1008945721786	18	170	189	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					651	654A		10.1136/bmj.39289.649410.55	http://dx.doi.org/10.1136/bmj.39289.649410.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17855280	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-28	WOS:000249989600040
J	Norris, JM; Yin, X; Lamb, MM; Barriga, K; Seifert, J; Hoffman, M; Orton, HD; Baron, AE; Clare-Salzler, M; Chase, HP; Szabo, NJ; Erlich, H; Eisenbarth, GS; Rewers, M				Norris, Jill M.; Yin, Xiang; Lamb, Molly M.; Barriga, Katherine; Seifert, Jennifer; Hoffman, Michelle; Orton, Heather D.; Baron, Anna E.; Clare-Salzler, Michael; Chase, H. Peter; Szabo, Nancy J.; Erlich, Henry; Eisenbarth, George S.; Rewers, Marian			Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; TUMOR-NECROSIS-FACTOR; PRESCHOOL-CHILDREN; LIPID EXTRACTION; DENDRITIC CELLS; YOUNG DAISY; VITAMIN-D; NOD MICE; INSULIN; AUTOANTIBODIES	Context Cod liver oil supplements in infancy have been associated with a decreased risk of type 1 diabetes mellitus in a retrospective study. Objective To examine whether intakes of omega-3 and omega-6 fatty acids are associated with the development of islet autoimmunity (IA) in children. Design, Setting, and Participants A longitudinal, observational study, the Diabetes Autoimmunity Study in the Young (DAISY), conducted in Denver, Colorado, between January 1994 and November 2006, of 1770 children at increased risk for type 1 diabetes, defined as either possession of a high diabetes risk HLA genotype or having a sibling or parent with type 1 diabetes. The mean age at follow-up was 6.2 years. Islet autoimmunity was assessed in association with reported dietary intake of polyunsaturated fatty acids starting at age 1 year. A case-cohort study (N = 244) was also conducted in which risk of IA by polyunsaturated fatty acid content of erythrocyte membranes (as a percentage of total lipids) was examined. Main Outcome Measure Risk of IA, defined as being positive for insulin, glutamic acid decarboxylase, or insulinoma-associated antigen-2 autoantibodies on 2 consecutive visits and still autoantibody positive or having diabetes at last follow-up visit. Results Fifty-eight children developed IA. Adjusting for HLA genotype, family history of type 1 diabetes, caloric intake, and omega-6 fatty acid intake, omega-3 fatty acid intake was inversely associated with risk of IA (hazard ratio [HR], 0.45; 95% confidence interval [CI], 0.21-0.96; P = .04). The association was strengthened when the definition of the outcome was limited to those positive for 2 or more autoantibodies (HR, 0.23; 95% CI, 0.09-0.58; P = .002). In the case-cohort study, omega-3 fatty acid content of erythrocyte membranes was also inversely associated with IA risk (HR, 0.63; 95% CI, 0.41-0.96; P = .03). Conclusion Dietary intake of omega-3 fatty acids is associated with reduced risk of IA in children at increased genetic risk for type 1 diabetes.	Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; Univ Florida, Analyt Toxicol Core Lab, Gainesville, FL USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; Hlth Sci Ctr, Aurora, CO USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roche Holding; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver	Norris, JM (corresponding author), Univ Colorado, Dept Prevent Med & Biostat, 4200 E 9th Ave,Box B-119, Denver, CO 80262 USA.	jill.norris@uchsc.edu		Lamb, Molly/0000-0002-2331-2555	NIDDK NIH HHS [R01 DK049654, R01-DK49654, P30 DK 57516, DK32493] Funding Source: Medline; PHS HHS [P01-142288] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032493, P30DK057516, R01DK049654, R01DK032493] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison PaulD., 1982, SOCIOL METHODOL, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Baur LA, 2000, LIPIDS, V35, P77, DOI 10.1007/s11745-000-0497-y; BENHAMOU PY, 1995, PANCREAS, V11, P26, DOI 10.1097/00006676-199507000-00003; Bingham SA, 1997, AM J CLIN NUTR, V65, P1130; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calder PC, 1998, NUTR REV, V56, pS70; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Chase HP, 2004, DIABETES, V53, P2569, DOI 10.2337/diabetes.53.10.2569; Dahlen E, 1998, J IMMUNOL, V160, P3585; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; De Caterina Raffaele, 2004, Curr Atheroscler Rep, V6, P485, DOI 10.1007/s11883-004-0090-x; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; GLATZ JFC, 1989, AM J CLIN NUTR, V49, P269, DOI 10.1093/ajcn/49.2.269; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; HAYTOWITZ DB, 1995, J NUTR, V125, P1952, DOI 10.1093/jn/125.7.1952; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hughes DA, 2000, AM J CLIN NUTR, V71, p357S, DOI 10.1093/ajcn/71.1.357s; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Kleemann R, 1998, J AUTOIMMUN, V11, P97, DOI 10.1006/jaut.1997.0179; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; LEFKOWITH J, 1990, J EXP MED, V171, P729, DOI 10.1084/jem.171.3.729; LETY MA, 1992, CLIN IMMUNOL IMMUNOP, V64, P188, DOI 10.1016/0090-1229(92)90199-X; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; MAXWELL RJ, 1983, LIPIDS, V18, P453, DOI 10.1007/BF02535785; Mohan IK, 2001, NUTRITION, V17, P126, DOI 10.1016/S0899-9007(00)00468-8; Mori TA, 1999, METABOLISM, V48, P1402, DOI 10.1016/S0026-0495(99)90150-6; Norris JM, 2007, DIABETES, V56, pA262; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; ORTON HD, EUR J CLIN NUTR; Parrish LA, 2003, EPIDEMIOLOGY, V14, P213, DOI 10.1097/00001648-200303000-00016; Poppitt Sally D, 2005, Lipids Health Dis, V4, P30, DOI 10.1186/1476-511X-4-30; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; ROMON M, 1995, METABOLISM, V44, P1139, DOI 10.1016/0026-0495(95)90006-3; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SINGER JD, 1991, PSYCHOL BULL, V110, P268, DOI 10.1037/0033-2909.110.2.268; STEIN AD, 1992, AM J EPIDEMIOL, V135, P667, DOI 10.1093/oxfordjournals.aje.a116346; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; WANDER RC, 1991, AM J CLIN NUTR, V54, P326, DOI 10.1093/ajcn/54.2.326; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264	50	194	197	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1420	1428		10.1001/jama.298.12.1420	http://dx.doi.org/10.1001/jama.298.12.1420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895458	Bronze			2022-12-28	WOS:000249698900021
J	Byrne, E				Byrne, Edward			Should postgraduate training places be reserved for UK graduates? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London, England	University of London; University College London	Byrne, E (corresponding author), UCL, London, England.	ebyrne@medsch.ucl.ac.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					590	590		10.1136/bmj.39302.639792.94	http://dx.doi.org/10.1136/bmj.39302.639792.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884901	Green Published			2022-12-28	WOS:000249832400029
J	Wald, DS; Bestwick, JP; Wald, NJ				Wald, David S.; Bestwick, Jonathan P.; Wald, Nicholas J.			Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEONATAL DIAGNOSIS; FOLLOW-UP; SERUM; LIPOPROTEINS	Objective To develop a population screening strategy for familial hypercholesterolaemia. Design Meta-analysis of published data on total and low density lipoprotein (LDL) cholesterol in people with and without familial hypercholesterolaemia according to age. Thirteen studies reporting on 1907 cases and 16 221 controls were used in the analysis. Included studies had at least 10 cases and controls with data on the distribution of cholesterol in affected and unaffected individuals. Main outcome measures Detection rates (sensitivity) for specified false positive rates (0.1%, 0.5%, and 1%) in newborns and in age groups 1-9, 10-19, 20-39, 40-59, and >= 60 years. Results Serum cholesterol concentration discriminated best between people with and without familial hypercholesterolaemia at ages 1-9, when the detection rates with total cholesterol were 88%, 94%, and 96% for false positive rates of 0.1%, 0.5%, and 1%. The results were similar with LDL cholesterol. Screening newborns was much less effective. Once an affected child is identified, measurement of cholesterol would detect about 96% of parents with the disorder, using the simple rule that the parent with the higher serum cholesterol concentration is the affected parent. Conclusions The proposed strategy of screening children and parents for familial hypercholesterolaermia could have considerable impact in preventing the medical consequences of this disorder in two generations simultaneously.	Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	d.s.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021		Medical Research Council [G1002158] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AITCHESON J, 1969, LOGNORMAL DISTRIBUTI; [Anonymous], 1991, BMJ, V303, P893; [Anonymous], 1977, LANCET, V1, P1323; ASSOULINE L, 1995, PEDIATRICS, V96, P239; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; BOULTON TJC, 1979, ACTA PAEDIATR SCAND, V68, P363, DOI 10.1111/j.1651-2227.1979.tb05021.x; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P148, DOI 10.1056/NEJM196701192760305; Goldstein JL, 1995, METABOLIC BASIS INHE, P1215; HUMPHRIES SE, 2004, FAMILIAL HYPERCHOLES; Ketomaki A, 2003, PEDIATR RES, V53, P648, DOI 10.1203/01.PDR.0000055771.28409.40; KWITEROVICH PO, 1973, LANCET, V1, P118; KWITEROVICH PO, 1974, J CLIN INVEST, V53, P1237, DOI 10.1172/JCI107670; LEONARD JV, 1977, BRIT MED J, V1, P1566, DOI 10.1136/bmj.1.6076.1566; Marks D, 2002, BMJ-BRIT MED J, V324, P1303, DOI 10.1136/bmj.324.7349.1303; Morris JK, 2004, AM J MED GENET A, V128A, P271, DOI 10.1002/ajmg.a.30024; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; OHTA T, 1993, EUR J PEDIATR, V152, P939, DOI 10.1007/BF01957537; OSE L, 1975, POSTGRAD MED J, V51, P88; RIFKIND BM, 1979, CIRCULATION, V60, P427; Tonstad S, 1997, J PEDIATR-US, V130, P274, DOI 10.1016/S0022-3476(97)70354-8; Vuorio AF, 1997, ARTERIOSCL THROM VAS, V17, P3127, DOI 10.1161/01.ATV.17.11.3127; Vuorio AF, 1997, ARTERIOSCL THROM VAS, V17, P3332, DOI 10.1161/01.ATV.17.11.3332; Wald N., 1976, PRENATAL DIAG, P227; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ., 2004, EPIDEMIOLOGICAL APPR; WEST RJ, 1980, LANCET, V2, P873; Wiegman A, 2003, CIRCULATION, V107, P1473, DOI 10.1161/01.CIR.0000058166.99182.54; 1986, DIET NUTR SURVEY	28	129	131	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2007	335	7620					599	603		10.1136/bmj.39300.616076.55	http://dx.doi.org/10.1136/bmj.39300.616076.55			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17855284	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000249832400034
J	Chazelle, B				Chazelle, Bernard			Coding and computing join forces	SCIENCE			English	Editorial Material							REED-SOLOMON		Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA	Princeton University	Chazelle, B (corresponding author), Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA.	chazelle@cs.princeton.edu						Chor B, 1998, J ACM, V45, P965, DOI 10.1145/293347.293350; Elias P., 1957, 335 MIT RES LAB EL; Guruswami V, 1999, IEEE T INFORM THEORY, V45, P1757, DOI 10.1109/18.782097; Guruswami V., 2006, P 38 ANN ACM S THEOR, P1; Parvaresh F, 2005, ANN IEEE SYMP FOUND, P285, DOI 10.1109/SFCS.2005.29; Sudan M, 1997, J COMPLEXITY, V13, P180, DOI 10.1006/jcom.1997.0439; Yekhanin S, 2007, ACM S THEORY COMPUT, P266, DOI 10.1145/1250790.1250830	7	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1691	1692		10.1126/science.1148064	http://dx.doi.org/10.1126/science.1148064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885118	Green Submitted			2022-12-28	WOS:000249585900027
J	Solimini, NL; Luo, J; Elledge, SJ				Solimini, Nicole L.; Luo, Ji; Elledge, Stephen J.			Non-oncogene addiction and the stress phenotype of cancer cells	CELL			English	Editorial Material							INHIBITORS; CHK1	Heat- shock factor 1 ( HSF1) is a transcription factor that is activated upon proteotoxic stress and coordinates induction of the heat- shock response. In this issue, Dai et al. ( 2007) show that HSF1 is a potent modifier of tumorigenesis and is required for tumor initiation and maintenance in a variety of cancer models. These findings add HSF1 to a growing list of non- oncogenes that could be exploited as cancer drug targets.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Genet & Genom,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Genet & Genom,Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Genet & Genom,Howard Hughes Med Inst, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu						Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; DAI C, 2007, CELL; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	8	256	271	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					986	988		10.1016/j.cell.2007.09.007	http://dx.doi.org/10.1016/j.cell.2007.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889643	Bronze			2022-12-28	WOS:000250507500008
J	Burton, DR; Wilson, IA				Burton, Dennis R.; Wilson, Ian A.			Square-dancing antibodies	SCIENCE			English	Editorial Material							IGG4 ANTIBODIES		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu						Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; [Anonymous], 1995, J ALLERGY CLIN IMMUN, V95, P652; Bloom JW, 1997, PROTEIN SCI, V6, P407; CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022; FRENCH M, 1986, MONOGR ALLERGY, V19, P100; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566	13	17	19	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1507	1508		10.1126/science.1148905	http://dx.doi.org/10.1126/science.1148905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872431				2022-12-28	WOS:000249467900026
J	Lincoff, AM; Wolski, K; Nicholls, SJ; Nissen, SE				Lincoff, A. Michael; Wolski, Kathy; Nicholls, Stephen J.; Nissen, Steven E.			Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PROLIFERATOR-ACTIVATED RECEPTORS; MYOCARDIAL-INFARCTION; DENSITY-LIPOPROTEIN; INTERVENTION TRIAL; CLINICAL-TRIAL; BLOOD-PRESSURE; HEART-FAILURE; ROSIGLITAZONE; THERAPY; DEATH	Context Pioglitazone is widely used for glycemic control in patients with type 2 diabetes mellitus, but evidence is mixed regarding the influence of medications of this class on cardiovascular outcomes. Objective To systematically evaluate the effect of pioglitazone on ischemic cardiovascular events. Data Sources and Study Selection A database containing individual patient-level time-to-event data collected during pioglitazone clinical trials was transferred from the drug's manufacturer for independent analysis. Trials were included if they were randomized, double-blinded, and controlled with placebo or active comparator. Data Extraction The primary outcome was a composite of death, myocardial infarction, or stroke. Secondary outcome measures included the incidence of serious heart failure. A fixed-effects approach was used to combine the estimates across the duration strata and statistical heterogeneity across all the trials was tested with the I-2 statistic. Data Synthesis A total of 19 trials enrolling 16 390 patients were analyzed. Study drug treatment duration ranged from 4 months to 3.5 years. Death, myocardial infarction, or stroke occurred in 375 of 8554 patients (4.4%) receiving pioglitazone and 450 of 7836 patients (5.7%) receiving control therapy (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.72-0.94; P = .005). Progressive separation of time-to-event curves became apparent after approximately 1 year of therapy. Individual components of the primary end point were all reduced by a similar magnitude with pioglitazone treatment, with HRs ranging from 0.80 to 0.92. Serious heart failure was reported in 200 (2.3%) of the pioglitazone-treated patients and 139 (1.8%) of the control patients (HR, 1.41; 95% CI, 1.14-1.76; P = .002). The magnitude and direction of the favorable effect of pioglitazone on ischemic events and unfavorable effect on heart failure was homogeneous across trials of different durations, for different comparators, and for patients with or without established vascular disease. There was no evidence of heterogeneity across the trials for either end point (I-2 = 0%; P = .87 for the composite end point and I-2 = 0%; P = .97 for heart failure). Conclusions Pioglitazone is associated with a significantly lower risk of death, myocardial infarction, or stroke among a diverse population of patients with diabetes. Serious heart failure is increased by pioglitazone, although without an associated increase in mortality.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Lincoff, AM (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lincofa@ccf.org		Nicholls, Stephen/0000-0002-9668-4368				Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Derosa G, 2006, CLIN THER, V28, P679, DOI 10.1016/j.clinthera.2006.05.012; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerber P, 2003, CURR MED RES OPIN, V19, P532, DOI 10.1185/030079903125002180; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Sarafidis PA, 2004, J HYPERTENS, V22, P1769, DOI 10.1097/00004872-200409000-00022; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Wang CH, 2003, CIRCULATION, V107, P1350, DOI 10.1161/01.CIR.0000054675.30348.9A; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	25	956	978	0	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1180	1188		10.1001/jama.298.10.1180	http://dx.doi.org/10.1001/jama.298.10.1180			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848652				2022-12-28	WOS:000249374200023
J	BATES, FS				BATES, FS			POLYMER-POLYMER PHASE-BEHAVIOR	SCIENCE			English	Article							STAGE SPINODAL DECOMPOSITION; BLOCK COPOLYMERS; MICROPHASE SEPARATION; THERMODYNAMICS; MIXTURES; NUCLEATION; MORPHOLOGY; BLENDS	Different polymers can be combined into a single material in many ways, which can lead to a wide range of phase behaviors that directly influence the associated physical properties and ultimate applications. Four factors control polymer-polymer phase behavior: choice of monomers, molecular architecture, composition, and molecular size. Current theories and experiments that deal with the equilibrium thermodynamics and non-equilibrium dynamics of polymer mixtures are described in terms of these experimentally accessible parameters. Two representative molecular architectures, binary linear homopolymer mixtures and diblock copolymers, exhibiting macrophase separation and microphase segregation, respectively, are examined in some detail. Although these model systems are fairly well understood, a myriad of mixing scenarios, with both existing and unrealized materials applications, remain unexplored at a fundamental level.			BATES, FS (corresponding author), UNIV MINNESOTA, DEPT CHEM ENGN & MAT SCI, MINNEAPOLIS, MN 55455 USA.		Iglesias, María-José/B-2052-2018; otal, isabel/K-1556-2014	Iglesias, María-José/0000-0003-2266-8602; otal, isabel/0000-0003-1027-7583; Bates, Frank/0000-0003-3977-1278				Abraham F. F., 1974, HOMOGENEOUS NUCLEATI; ALMDAL K, 1990, PHYS REV LETT, V65, P1112, DOI 10.1103/PhysRevLett.65.1112; ALMDAL K, UNPUB; Anderson D. M., 1990, ADV CHEM PHYS, P337; ANDERSON DM, 1988, MACROMOLECULES, V21, P3221, DOI 10.1021/ma00189a016; BATES FS, 1988, PHYS REV LETT, V61, P2229, DOI 10.1103/PhysRevLett.61.2229; BATES FS, 1990, PHYS REV LETT, V65, P1893, DOI 10.1103/PhysRevLett.65.1893; BATES FS, 1990, J CHEM PHYS, V92, P6255, DOI 10.1063/1.458350; BATES FS, 1988, MACROMOLECULES, V21, P1086, DOI 10.1021/ma00182a040; BATES FS, 1988, J CHEM PHYS, V89, P535, DOI 10.1063/1.455442; BATES FS, 1985, PHYS REV LETT, V55, P2425, DOI 10.1103/PhysRevLett.55.2425; BATES FS, 1989, J CHEM PHYS, V91, P3258, DOI 10.1063/1.456901; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; BINDER K, 1983, J CHEM PHYS, V79, P6387, DOI 10.1063/1.445747; BINDER K, 1984, PHYS REV A, V29, P341, DOI 10.1103/PhysRevA.29.341; CAHN JW, 1965, J CHEM PHYS, V42, P93, DOI 10.1063/1.1695731; CUMMING A, 1990, PHYS REV LETT, V65, P863, DOI 10.1103/PhysRevLett.65.863; CURRO JG, 1990, MACROMOLECULES, V23, P1402, DOI 10.1021/ma00207a027; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DUDOWICZ J, 1990, MACROMOLECULES, V23, P4803, DOI 10.1021/ma00224a009; Flory PJ, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; FLORY PJ, 1965, J AM CHEM SOC, V87, P1833, DOI 10.1021/ja01087a002; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; FREDRICKSON GH, 1987, J CHEM PHYS, V87, P697, DOI 10.1063/1.453566; FREED KF, 1989, J PHYS CHEM-US, V93, P2194, DOI 10.1021/j100343a006; GAULIN BD, 1987, PHYS REV LETT, V59, P668, DOI 10.1103/PhysRevLett.59.668; GUENOUN P, 1987, PHYS REV A, V36, P4876, DOI 10.1103/PhysRevA.36.4876; HADZIIOANNOU G, 1982, MACROMOLECULES, V15, P258, DOI 10.1021/ma00230a011; HADZIIOANNOU G, 1979, COLLOID POLYM SCI, V257, P136, DOI 10.1007/BF01638138; HASEGAWA H, 1987, MACROMOLECULES, V20, P1651, DOI 10.1021/ma00173a036; HASHIMOTO T, 1990, MACROMOLECULES, V23, P4378, DOI 10.1021/ma00222a009; HASHIMOTO T, 1986, J CHEM PHYS, V85, P6118, DOI 10.1063/1.451477; HASHIMOTO T, 1986, J CHEM PHYS, V85, P6773, DOI 10.1063/1.451409; Helfand E., 1982, DEV BLOCK COPOLYMERS, V1, P99; HERMAN DS, 1987, MACROMOLECULES, V20, P2940, DOI 10.1021/ma00177a050; Huggins ML, 1942, J AM CHEM SOC, V64, P1712, DOI 10.1021/ja01259a068; Huggins ML, 1942, J PHYS CHEM-US, V46, P151, DOI 10.1021/j150415a018; JONES RAL, 1989, PHYS REV LETT, V62, P280, DOI 10.1103/PhysRevLett.62.280; Kesting RE, 1985, SYNTHETIC POLYM MEMB; LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047; MacKnight W. J., 1978, POLYM BLENDS, V1, P185; McCrum N.G., 1988, PRINCIPLES POLYM ENG; MCGARTH JE, 1981, ACS S SERIES, V166; MCMASTER LP, 1973, MACROMOLECULES, V6, P760, DOI 10.1021/ma60035a024; Odian G., 1981, PRINCIPLES POLYM; Olabisi O., 1969, POLYM POLYM MISCIBIL; ROSEDALE JH, 1990, MACROMOLECULES, V23, P2329, DOI 10.1021/ma00210a032; Sanchez I.C., 1978, POLYMERS BLENDS, V3, P115; SCHWAHN D, 1987, PHYS REV LETT, V58, P1544, DOI 10.1103/PhysRevLett.58.1544; SCHWEIZER KS, 1989, J CHEM PHYS, V91, P5059, DOI 10.1063/1.457598; SEMINOV AN, 1985, ZH EKSP TEOR FIZ, V61, P733; STEINER U, 1990, PHYS REV LETT, V64, P1119, DOI 10.1103/PhysRevLett.64.1119; SZWARC M, 1983, ADV POLYM SCI, V49, P1; THOMAS EL, 1988, NATURE, V334, P598, DOI 10.1038/334598a0; WHITMORE MD, 1985, MACROMOLECULES, V18, P2486, DOI 10.1021/ma00154a024; WIGNALL GD, 1987, ENCY POLYM SCI ENG, V10, P112; WILTZIUS P, 1987, PHYS REV A, V36, P2991, DOI 10.1103/PhysRevA.36.2991; [No title captured]; [No title captured]; [No title captured]	60	1256	1327	18	844	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	1991	251	4996					898	905		10.1126/science.251.4996.898	http://dx.doi.org/10.1126/science.251.4996.898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847383				2022-12-28	WOS:A1991EY62900035
J	HIRSCH, RL				HIRSCH, RL			UNITED-STATES OIL AND GAS CONSUMPTION - IS ANOTHER CRISES AHEAD	SCIENCE			English	Letter											HIRSCH, RL (corresponding author), ARCO OIL & GAS CO,RES & TECH SERV,2300 W PLANO PKWY,PLANO,TX 75075, USA.							HIRSCH RL, 1987, SCIENCE, V235, P1467, DOI 10.1126/science.235.4795.1467; 1990, OLIGRAM NEWS    0118, P5	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1280	1280		10.1126/science.247.4948.1280-a	http://dx.doi.org/10.1126/science.247.4948.1280-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843772				2022-12-28	WOS:A1990CU25300003
J	Guccione, E; Bassi, C; Casadio, F; Martinato, F; Cesaroni, M; Schuchlautz, H; Luscher, B; Amati, B				Guccione, Ernesto; Bassi, Christian; Casadio, Fabio; Martinato, Francesca; Cesaroni, Matteo; Schuchlautz, Henning; Luescher, Bernhard; Amati, Bruno			Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive	NATURE			English	Article							RNA-POLYMERASE-II; ARGININE METHYLATION; MOLECULAR RECOGNITION; STRUCTURAL BASIS; PROTEIN WDR5; IN-VIVO; C-MYC; METHYLTRANSFERASE; CHROMATIN; H4	Eukaryotic genomes are organized into active (euchromatic) and inactive (heterochromatic) chromatin domains. Post-translational modifications of histones (or 'marks') are key in defining these functional states, particularly in promoter regions(1,2). Mutual regulatory interactions between these marks-and the enzymes that catalyse them-contribute to the shaping of this epigenetic landscape, in a manner that remains to be fully elucidated(1,2). We previously observed that asymmetric di-methylation of histone H3 arginine 2 (H3R2me2a) counter-correlates with di- and tri-methylation of H3 lysine 4 (H3K4me2, H3K4me3) on human promoters(3). Here we show that the arginine methyltransferase PRMT6 catalyses H3R2 di- methylation in vitro and controls global levels of H3R2me2a in vivo. H3R2 methylation by PRMT6 was prevented by the presence of H3K4me3 on the H3 tail. Conversely, the H3R2me2a mark prevented methylation of H3K4 as well as binding to the H3 tail by an ASH2/WDR5/MLL-family methyltransferase complex(4-7). Chromatin immunoprecipitation showed that H3R2me2a was distributed within the body and at the 39 end of human genes, regardless of their transcriptional state, whereas it was selectively and locally depleted from active promoters, coincident with the presence of H3K4me3. Hence, the mutual antagonism between H3R2 and H3K4 methylation, together with the association of MLL-family complexes with the basal transcription machinery(8), may contribute to the localized patterns of H3K4 tri-methylation characteristic of transcriptionally poised or active promoters in mammalian genomes(1-3,9,10).	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; RWTH Aachen Univ Hosp, Inst Biochem, Div Biochem & Mol Biol, D-52074 Aachen, Germany	IRCCS European Institute of Oncology (IEO); RWTH Aachen University; RWTH Aachen University Hospital	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Amati, Bruno/AAM-3418-2020; guccione, ernesto/G-9874-2011; Luscher, Bernhard/A-7330-2011	Amati, Bruno/0000-0002-2958-1799; Kleine, Henning/0000-0003-2559-6608; Luscher, Bernhard/0000-0002-9622-8709				Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; KIRMIZIS A, NATURE; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06	33	339	349	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					933	U18		10.1038/nature06166	http://dx.doi.org/10.1038/nature06166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17898714				2022-12-28	WOS:000250230600053
J	Beck, M; Lucic, V; Forster, F; Baumeister, W; Medalia, O				Beck, Martin; Lucic, Vladan; Foerster, Friedrich; Baumeister, Wolfgang; Medalia, Ohad			Snapshots of nuclear pore complexes in action captured by cryo-electron tomography	NATURE			English	Article							PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; SYSTEMS-ANALYSIS; VISUALIZATION; NUCLEOPORINS; ARCHITECTURE; REPEATS; BINDING; BETA	Nuclear pore complexes reside in the nuclear envelope of eukaryotic cells and mediate the nucleocytoplasmic exchange of macromolecules(1). Traffic is regulated by mobile transport receptors that target their cargo to the central translocation channel, where phenylalanine-glycine-rich repeats serve as binding sites(2). The structural analysis of the nuclear pore is a formidable challenge given its size, its location in a membranous environment and its dynamic nature. Here we have used cryo-electron tomography(3) to study the structure of nuclear pore complexes in their functional environment, that is, in intact nuclei of Dictyostelium discoideum. A new image-processing strategy compensating for deviations of the asymmetric units (protomers) from a perfect eight-fold symmetry enabled us to refine the structure and to identify new features. Furthermore, the superposition of a large number of tomograms taken in the presence of cargo, which was rendered visible by gold nanoparticles, has yielded a map outlining the trajectories of import cargo. Finally, we have performed single-molecule Monte Carlo simulations of nuclear import to interpret the experimentally observed cargo distribution in the light of existing models for nuclear import.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Baumeister, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de; omedalia@bgu.ac.il	Foerster, Friedrich/D-3710-2009; Beck, Martin/B-5589-2011; Lucic, Vladan/AAA-8128-2020	Foerster, Friedrich/0000-0002-6044-2746; Beck, Martin/0000-0002-7397-1321; Lucic, Vladan/0000-0003-3698-7436; Medalia, Ohad/0000-0003-0994-2937				AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Becskei A, 2005, CURR OPIN CELL BIOL, V17, P27, DOI 10.1016/j.ceb.2004.12.010; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kiseleva E, 1998, J CELL SCI, V111, P223; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Rutherford SA, 1997, EXP CELL RES, V232, P146, DOI 10.1006/excr.1997.3487; SAXTON WO, 1992, ULTRAMICROSCOPY, V46, P287, DOI 10.1016/0304-3991(92)90020-K; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	30	270	275	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					611	615		10.1038/nature06170	http://dx.doi.org/10.1038/nature06170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17851530				2022-12-28	WOS:000249893500048
J	Hurley, M; Smith, C				Hurley, Matthew; Smith, Craig			Patients' blogs: do doctors have anything to fear?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queens Med Ctr, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Neonatal Intens Care Unit, Nottingham, England	University of Nottingham; University of Nottingham	Hurley, M (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.	hurleymn@doctors.org.uk; craig.smith@nuh.nhs.uk		Hurley, Matthew/0000-0002-2439-8522					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					645	646		10.1136/bmj.39343.478403.68	http://dx.doi.org/10.1136/bmj.39343.478403.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901513	Green Published			2022-12-28	WOS:000249989600036
J	O'Dowd, A				O'Dowd, Adrian			How far is too far?	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654	1	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					640	641		10.1136/bmj.39344.638623.AD	http://dx.doi.org/10.1136/bmj.39344.638623.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901509	Green Published			2022-12-28	WOS:000249989600033
J	Goldberg, AL				Goldberg, Alfred L.			On prions, proteasomes, and mad cows	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEIN-DEGRADATION		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051923-12, R01 GM051923] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Prusiner SB, 2004, PRION BIOL DIS; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019	5	15	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1150	1152		10.1056/NEJMcibr073962	http://dx.doi.org/10.1056/NEJMcibr073962			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855677				2022-12-28	WOS:000249387200013
J	Jamison, RL; Hartigan, P; Kaufman, JS; Goldfarb, DS; Warren, SR; Guarino, PD; Gaziano, JM				Jamison, Rex L.; Hartigan, Pamela; Kaufman, James S.; Goldfarb, David S.; Warren, Stuart R.; Guarino, Peter D.; Gaziano, J. Michael		Veterans Affairs Site Invest	Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID SUPPLEMENTATION; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; VITAMIN INTERVENTION; PLASMA HOMOCYSTEINE; RISK-FACTORS; HYPERHOMOCYSTEINEMIA; ATHEROSCLEROSIS; PREVENTION; HOMOCYST(E)INE	Context High plasma homocysteine levels are a risk factor for mortality and vascular disease in observational studies of patients with chronic kidney disease. Folic acid and B vitamins decrease homocysteine levels in this population but whether they lower mortality is unknown. Objective To determine whether high doses of folic acid and B vitamins administered daily reduce mortality in patients with chronic kidney disease. Design, Setting, and Participants Double-blind randomized controlled trial (2001-2006) in 36 US Department of Veterans Affairs medical centers. Median follow-up was 3.2 years for 2056 participants aged 21 years or older with advanced chronic kidney disease (estimated creatinine clearance <= 30 mL/min) (n = 1305) or end-stage renal disease (n = 751) and high homocysteine levels (>= 15 mu mol/L). Intervention Participants received a daily capsule containing 40 mg of folic acid, 100 mg of pyridoxine hydrochloride (vitamin B-6), and 2 mg of cyanocobalamin (vitamin B-12) or a placebo. Main Outcome Measures The primary outcome was all-cause mortality. Secondary outcomes included myocardial infarction (MI), stroke, amputation of all or part of a lower extremity, a composite of these 3 plus all-cause mortality, time to initiation of dialysis, and time to thrombosis of arteriovenous access in hemodialysis patients. Results Mean baseline homocysteine level was 24.0 mu mol/L in the vitamin group and 24.2 mu mol/L in the placebo group. It was lowered 6.3 mu mol/L (25.8%; P < .001) in the vitamin group and 0.4 mu mol/L (1.7%; P = .14) in the placebo group at 3 months, but there was no significant effect on mortality ( 448 vitamin group deaths vs 436 placebo group deaths) (hazard ratio [HR], 1.04; 95% CI, 0.91-1.18). No significant effects were demonstrated for secondary outcomes or adverse events: there were 129 MIs in the vitamin group vs 150 for placebo (HR, 0.86; 95% CI, 0.67-1.08), 37 strokes in the vitamin group vs 41 for placebo (HR, 0.90; 95% CI, 0.58-1.40), and 60 amputations in the vitamin group vs 53 for placebo (HR, 1.14; 95% CI, 0.79-1.64). In addition, the composite of MI, stroke, and amputations plus mortality (P = .85), time to dialysis (P = .38), and time to thrombosis in hemodialysis patients (P = .97) did not differ between the vitamin and placebo groups. Conclusion Treatment with high doses of folic acid and B vitamins did not improve survival or reduce the incidence of vascular disease in patients with advanced chronic kidney disease or end-stage renal disease.	Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Div Nephrol, Dept Med, Stanford, CA 94305 USA; VA Connecticut Healthcare Syst, VA Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; VA Boston Healthcare Syst, Renal Sect, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; New York Harbor Healthcare Syst, Nephrol Sect, New York, NY USA; NYU, Sch Med, New York, NY USA; Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA; Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat MAVERI, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; New York University; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jamison, RL (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, MB3 Room 305,M-C HOST 151,3801 Miranda Ave, Palo Alto, CA 94304 USA.	rjamison@stanford.edu		Goldfarb, David/0000-0002-9215-1273				Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 1999, J AM SOC NEPHROL, V10, P891; Bostom AG, 1996, KIDNEY INT, V49, P147, DOI 10.1038/ki.1996.19; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Finkelstein JD, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P92; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Jamison Rex L, 2004, Clin Trials, V1, P451, DOI 10.1191/1740774504cn038oa; Jungers P, 1999, NEPHROL DIAL TRANSPL, V14, P2903, DOI 10.1093/ndt/14.12.2903; Lentz SR, 2003, ATHEROSCLEROSIS SUPP, V4, P61, DOI 10.1016/S1567-5688(03)00035-7; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Loscalzo J, 2006, NEW ENGL J MED, V354, P1629, DOI 10.1056/NEJMe068060; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; PEDUZZI P, 1987, CONTROL CLIN TRIALS, V8, P190, DOI 10.1016/0197-2456(87)90044-4; Righetti Marco, 2003, Med Sci Monit, V9, pPI19; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; RYAN TJ, 1996, J AM COLL CARDIOL, P1208; Shemin D, 1999, J AM SOC NEPHROL, V10, P1095; SHIPCHANDLER MT, 1995, CLIN CHEM, V41, P991; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; SPENCE JD, 1997, ARTERIOSCLER THROMB, V17, P2554; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; *US REN DAT SYST, 2004, USRDS 2004 ANN DAT R; WAHLGREN N, 1997, CEREBROVASC DIS, P1208; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	37	341	355	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1163	1170		10.1001/jama.298.10.1163	http://dx.doi.org/10.1001/jama.298.10.1163			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848650	Bronze			2022-12-28	WOS:000249374200021
J	HIRSH, R				HIRSH, R			SPACE TECHNOLOGY AND PLANETARY ASTRONOMY - TATAREWICZ,JN	SCIENCE			English	Book Review											HIRSH, R (corresponding author), VIRGINIA POLYTECH INST & STATE UNIV,DEPT HIST,BLACKSBURG,VA 24061, USA.							Tatarewicz Joseph N., 1990, SPACE TECHNOLOGY PLA	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					957	957		10.1126/science.251.4996.957	http://dx.doi.org/10.1126/science.251.4996.957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847393				2022-12-28	WOS:A1991EY62900050
J	OSTRO, SJ; JURGENS, RF; YEOMANS, DK; STANDISH, EM; GREINER, W				OSTRO, SJ; JURGENS, RF; YEOMANS, DK; STANDISH, EM; GREINER, W			RADAR DETECTION OF PHOBOS	SCIENCE			English	Article											OSTRO, SJ (corresponding author), CALTECH,JET PROP LAB,PASADENA,CA 91109, USA.							BURNS JA, 1986, SATELLITES, P14; CAMPBELL MJ, 1969, J GEOPHYS RES, V74, P5867, DOI 10.1029/JB074i025p05867; CARRIER WD, 1973, P LUNAR PLANET SCI C, V4, P2403; GARVIN JB, 1985, J GEOPHYS RES-SOLID, V90, P6859, DOI 10.1029/JB090iB08p06859; GLASS BP, 1982, INTRO PLANETARY GEOL, P101; GOLDSTEIN RM, 1984, ASTRON J, V89, P1745, DOI 10.1086/113683; JURGENS RF, 1976, ICARUS, V28, P1, DOI 10.1016/0019-1035(76)90079-8; OBERG JE, 1982, MISSION MARS, P149; OSTRO SJ, 1984, ICARUS, V60, P391, DOI 10.1016/0019-1035(84)90198-2; OSTRO SJ, 1983, ASTRON J, V88, P565, DOI 10.1086/113345; OSTRO SJ, 1985, SCIENCE, V229, P442, DOI 10.1126/science.229.4712.442; OSTRO SJ, IN PRESS ICARUS; OSTRO SJ, 1985, B AM ASTRON SOC, V17, P729; PANG KD, 1978, SCIENCE, V199, P64, DOI 10.1126/science.199.4324.64; PETTENGILL GH, 1978, ANNU REV ASTRON ASTR, V16, P265, DOI 10.1146/annurev.aa.16.090178.001405; SEKANINA Z, 1988, ASTRON J, V95, P1876, DOI 10.1086/114783; SIMPSON RA, 1982, IEEE T ANTENN PROPAG, V30, P438, DOI 10.1109/TAP.1982.1142803; STEVENSON DJ, 1986, SATELLITES, P369; THOMAS P, 1986, SATELLITES, P831; VEVERKA J, 1980, ANNU REV EARTH PL SC, V8, P527, DOI 10.1146/annurev.ea.08.050180.002523; ZELLNER B, 1976, ICARUS, V28, P149, DOI 10.1016/0019-1035(76)90097-X; Zisk S. H., 1974, Moon, V10, P17, DOI 10.1007/BF00562017	22	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1584	1586		10.1126/science.243.4898.1584	http://dx.doi.org/10.1126/science.243.4898.1584			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847261				2022-12-28	WOS:A1989T795200030
J	Hierro, A; Rojas, AL; Rojas, R; Murthy, N; Effantin, G; Kajava, AV; Steven, AC; Bonifacino, JS; Hurley, JH				Hierro, Aitor; Rojas, Adriana L.; Rojas, Raul; Murthy, Namita; Effantin, Gregory; Kajava, Andrey V.; Steven, Alasdair C.; Bonifacino, Juan S.; Hurley, James H.			Functional architecture of the retromer cargo-recognition complex	NATURE			English	Article							POLYCISTRONIC EXPRESSION; RETROGRADE TRANSPORT; MAMMALIAN RETROMER; REQUIRES RETROMER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MODEL; PROTEINS; DOMAINS; VPS29	The retromer complex(1,2) is required for the sorting of acid hydrolases to lysosomes(3-7), transcytosis of the polymeric immunoglobulin receptor(8), Wnt gradient formation(9,10), iron transporter recycling(11) and processing of the amyloid precursor protein(12). Human retromer consists of two smaller complexes: the cargo recognition VPS26-VPS29-VPS35 heterotrimer and a membrane-targeting heterodimer or homodimer of SNX1 and/or SNX2 (ref. 13). Here we report the crystal structure of a VPS29-VPS35 subcomplex showing how the metallophosphoesterase-fold subunit VPS29 (refs 14, 15) acts as a scaffold for the carboxyterminal half of VPS35. VPS35 forms a horseshoe-shaped, right-handed, alpha-helical solenoid, the concave face of which completely covers the metal-binding site of VPS29, whereas the convex face exposes a series of hydrophobic interhelical grooves. Electron microscopy shows that the intact VPS26-VPS29-VPS35 complex is a stick-shaped, flexible structure, approximately 21 nm long. A hybrid structural model derived from crystal structures, electron microscopy, interaction studies and bioinformatics shows that the alpha-solenoid fold extends the full length of VPS35, and that VPS26 is bound at the opposite end from VPS29. This extended structure presents multiple binding sites for the SNX complex and receptor cargo, and appears capable of flexing to conform to curved vesicular membranes.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Struct Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Univ Montpellier, CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Rojas, Adriana/G-2403-2011; Kajava, Andrey V/E-1107-2014; Hierro, Aitor/F-9998-2011	Rojas, Adriana/0000-0002-7358-3505; Kajava, Andrey V/0000-0002-2342-6886; Hierro, Aitor/0000-0002-7721-1581; Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036128, Z01DK036118] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Martina JA, 2003, J BIOL CHEM, V278, P29376, DOI 10.1074/jbc.M301294200; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708	43	211	217	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1063	U8		10.1038/nature06216	http://dx.doi.org/10.1038/nature06216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17891154	Green Accepted			2022-12-28	WOS:000250395000055
J	Rao, M; Prasad, S; Adshead, F; Tissera, H				Rao, Mala; Prasad, Sunand; Adshead, Fiona; Tissera, Hasitha			The built environment and health	LANCET			English	Editorial Material							OBESITY; PEOPLE		Dept Hlth, London SE1 6LH, England; Royal Inst British Architects, London, England		Rao, M (corresponding author), Dept Hlth, London SE1 6LH, England.	mala.rao@dh.gsi.gov.uk	Tissera, Hasitha/AAQ-2516-2020					Barton H, 2005, BUILT ENV, V31, P339, DOI DOI 10.2148/BENV.2005.31.4.339; Barton H, 2006, J R SOC PROMO HEALTH, V126, P252, DOI 10.1177/1466424006070466; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; CABE, 2006, PHYS ACT BUILT ENV; CAVE B, 2007, TOWN COUNTRY PLAN, V76, P59; Ferriman A, 2007, BRIT MED J, V334, P111, DOI 10.1136/bmj.39097.611806.DB; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Jackson R.J., 2001, CREATING HLTH ENV IM; Jacobs Jane, 1961, DEATH LIFE GREAT AM; Larkin M, 2003, LANCET, V362, P1046, DOI 10.1016/S0140-6736(03)14451-0; Lavin T., 2006, HLTH IMPACTS BUILT E; Office of the Deputy Prime Minister (UK) Scottish Executive Welsh Assembly Government Department of the Environment Northern Ireland, 2005, PRACT GUID STRAT ENV; RAO M, 2006, ED MEET CHOOSING HLT, P6; Royal Commission of Environmental Pollution, 2007, 26 ROYAL COMM ENV PO; Srinivasan S, 2003, AM J PUBLIC HEALTH, V93, P1446, DOI 10.2105/AJPH.93.9.1446; WHITEHEAD M, 1991, LANCET, V338, P1059, DOI 10.1016/0140-6736(91)91911-D; Williams C, 2007, DRAFT GUIDANCE HLTH	17	52	52	2	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1111	1113		10.1016/S0140-6736(07)61260-4	http://dx.doi.org/10.1016/S0140-6736(07)61260-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221YQ	17868821				2022-12-28	WOS:000250263700009
J	Nesbit, J; Bradford, M				Nesbit, Jeff; Bradford, Monica			2007 visualization challenge	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1857	1857		10.1126/science.317.5846.1857	http://dx.doi.org/10.1126/science.317.5846.1857			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901311				2022-12-28	WOS:000249764300012
J	Avram, MM; Gobel, V; Sepehr, A; Buzney, EA				Avram, Mathew M.; Gobel, Verena; Sepehr, Alireza; Buzney, Elizabeth A.			Case 30-2007: A newborn girl with skin lesions - Cutaneous Langerhans'-cell histiocytosis, with single-organ-system involvement	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMPLEX-VIRUS-INFECTIONS; SELF-HEALING RETICULOHISTIOCYTOSIS; HASHIMOTO-PRITZKER; MANAGEMENT; PREGNANCY; VARICELLA; CHILDREN; PERIOD; ZOSTER		Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Avram, MM (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.							BALE JF, 1987, PEDIATR INFECT DIS J, V6, P644, DOI 10.1097/00006454-198707000-00005; Berlin AL, 2002, J AM ACAD DERMATOL, V47, P169, DOI 10.1067/mjd.2002.125949; BONIFAZI E, 1982, ARCH DERMATOL, V118, P267, DOI 10.1001/archderm.118.4.267; DARMSTADT GL, 1994, PEDIATR DERMATOL, V11, P293, DOI 10.1111/j.1525-1470.1994.tb00092.x; Darmstadt GL, 2000, PEDIATRICS, V105, P438, DOI 10.1542/peds.105.2.438; Dobbins J G, 1992, MMWR CDC Surveill Summ, V41, P35; EICHENFIELD L, 2003, PEDIAT DERMATOLOGY; ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2; HASHIMOTO K, 1973, ARCH DERMATOL, V107, P263, DOI 10.1001/archderm.107.2.263; HUTTO C, 1987, J PEDIATR-US, V110, P97, DOI 10.1016/S0022-3476(87)80298-6; KANITAKIS J, 1988, CANCER, V61, P508, DOI 10.1002/1097-0142(19880201)61:3<508::AID-CNCR2820610316>3.0.CO;2-2; Kapur P, 2007, J AM ACAD DERMATOL, V56, P290, DOI 10.1016/j.jaad.2006.09.001; Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Lau L, 2006, PEDIATR BLOOD CANCER, V46, P66, DOI 10.1002/pbc.20479; LOWY G, 1992, PEDIATR DERMATOL, V9, P329, DOI 10.1111/j.1525-1470.1992.tb00619.x; MCKEE PH, 2005, PATHOLOGY SKIN, V2, P1467; Minkov M, 2005, PEDIATR BLOOD CANCER, V45, P802, DOI 10.1002/pbc.20362; PROBER CG, 1990, PEDIATR INFECT DIS J, V9, P865, DOI 10.1097/00006454-199012000-00001; Ricart J, 2004, ACTA PAEDIATR, V93, P426; Stein SL, 2001, ARCH PEDIAT ADOL MED, V155, P778, DOI 10.1001/archpedi.155.7.778; SULLIVANBOLYAI JZ, 1986, PEDIATR INFECT DIS J, V5, P309, DOI 10.1097/00006454-198605000-00007; WEISS L, 2001, WHO CLASSIFICATION T, V3, P280; Weiss T, 2005, J AM ACAD DERMATOL, V53, P838, DOI 10.1016/j.jaad.2005.07.011; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; WHITLEY RJ, 1980, PEDIATRICS, V66, P495	26	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1327	1335		10.1056/NEJMcpc079025	http://dx.doi.org/10.1056/NEJMcpc079025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898103				2022-12-28	WOS:000249711500011
J	Majer, J; Chow, JM; Gambetta, JM; Koch, J; Johnson, BR; Schreier, JA; Frunzio, L; Schuster, DI; Houck, AA; Wallraff, A; Blais, A; Devoret, MH; Girvin, SM; Schoelkopf, RJ				Majer, J.; Chow, J. M.; Gambetta, J. M.; Koch, Jens; Johnson, B. R.; Schreier, J. A.; Frunzio, L.; Schuster, D. I.; Houck, A. A.; Wallraff, A.; Blais, A.; Devoret, M. H.; Girvin, S. M.; Schoelkopf, R. J.			Coupling superconducting qubits via a cavity bus	NATURE			English	Article							QUANTUM; ENTANGLEMENT; PHOTON; STATES	Superconducting circuits are promising candidates for constructing quantum bits (qubits) in a quantum computer; single-qubit operations are now routine(1,2), and several examples(3-9) of two-qubit interactions and gates have been demonstrated. These experiments show that two nearby qubits can be readily coupled with local interactions. Performing gate operations between an arbitrary pair of distant qubits is highly desirable for any quantum computer architecture, but has not yet been demonstrated. An efficient way to achieve this goal is to couple the qubits to a 'quantum bus', which distributes quantum information among the qubits. Here we show the implementation of such a quantum bus, using microwave photons confined in a transmission line cavity, to couple two superconducting qubits on opposite sides of a chip. The interaction is mediated by the exchange of virtual rather than real photons, avoiding cavity-induced loss. Using fast control of the qubits to switch the coupling effectively on and off, we demonstrate coherent transfer of quantum states between the qubits. The cavity is also used to perform multiplexed control and measurement of the qubit states. This approach can be expanded to more than two qubits, and is an attractive architecture for quantum information processing on a chip.	Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University	Majer, J (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	johannes.majer@yale.edu; robert.schoelkopf@yale.edu	Majer, Johannes B/C-1864-2008; Blais, Alexandre/E-3315-2010; Koch, Jens/G-6789-2011; Schoelkopf, Robert J/J-8178-2012; Koch, Jens/GVT-0089-2022; Wallraff, Andreas J/C-2130-2009; Frunzio, Luigi/O-1573-2019	Majer, Johannes B/0000-0002-5192-1809; Blais, Alexandre/0000-0002-0591-2012; Koch, Jens/0000-0002-5047-631X; Koch, Jens/0000-0002-5047-631X; Wallraff, Andreas J/0000-0002-3476-4485; Frunzio, Luigi/0000-0002-0272-5481; schuster, david/0000-0002-0012-3874				Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Blais A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032329; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Devoret MH, 2004, QUANTUM INF PROCESS, V3, P163, DOI 10.1007/s11128-004-3101-5; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; GRANGIER P, 1985, PHYS REV LETT, V54, P418, DOI 10.1103/PhysRevLett.54.418; Hagley E, 1997, PHYS REV LETT, V79, P1, DOI 10.1103/PhysRevLett.79.1; Hime T, 2006, SCIENCE, V314, P1427, DOI 10.1126/science.1134388; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Itano WM, 1998, PHYS REV A, V57, P4176, DOI 10.1103/PhysRevA.57.4176; KOCH J, 2007, IN PRESS PHYS REV A; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Majer JB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090501; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; Osnaghi S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037902; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; van der Ploeg SHW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057004; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757; Zheng SB, 2000, PHYS REV LETT, V85, P2392, DOI 10.1103/PhysRevLett.85.2392	28	982	1009	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					443	447		10.1038/nature06184	http://dx.doi.org/10.1038/nature06184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898763	Green Submitted			2022-12-28	WOS:000249724800036
J	Baker, J				Baker, Joanne			Water, water, not everywhere? Introduction	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1705	1705		10.1126/science.317.5845.1705	http://dx.doi.org/10.1126/science.317.5845.1705			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885124				2022-12-28	WOS:000249585900033
J	Boehringer, D; Ban, N				Boehringer, Daniel; Ban, Nenad			Trapping the ribosome to control gene expression	CELL			English	Editorial Material							TRANSLATION INITIATION COMPLEX; MESSENGER-RNA	Protein synthesis is often regulated by structured mRNAs that interact with ribosomes. In this issue of Cell, Marzi et al. ( 2007) provide insights into the autoregulation of protein S15 by visualizing the folded repressor mRNA on the ribosome stalled in the preinitiation state. These results have implications for our understanding of the mechanism of translation initiation in general.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Boelens R, 2002, CURR PROTEIN PEPT SC, V3, P107, DOI 10.2174/1389203023380765; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; MARZI S, 2007, CELL; Schlax PJ, 2003, MOL MICROBIOL, V48, P1157, DOI 10.1046/j.1365-2958.2003.03517.x; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					983	985		10.1016/j.cell.2007.09.002	http://dx.doi.org/10.1016/j.cell.2007.09.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889642	Bronze			2022-12-28	WOS:000250507500007
J	Dai, C; Whitesell, L; Rogers, AB; Lindquist, S				Dai, Chengkai; Whitesell, Luke; Rogers, Arlin B.; Lindquist, Susan			Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis	CELL			English	Article							PROTEIN-KINASE-A; TRANSCRIPTION FACTOR-1; TARGETED DISRUPTION; IN-VITRO; EXPRESSION; PROTECTION; APOPTOSIS; CELLS; HSF1; THERMOTOLERANCE	Heat shock factor 1 ( HSF1) is the master regulator of the heat shock response in eukaryotes, a very highly conserved protective mechanism. HSF1 function increases survival under a great many pathophysiological conditions. How it might be involved in malignancy remains largely unexplored. We report that eliminating HSF1 protects mice from tumors induced by mutations of the RAS oncogene or a hot spot mutation in the tumor suppressor p53. In cell culture, HSF1 supports malignant transformation by orchestrating a network of core cellular functions including proliferation, survival, protein synthesis, and glucose metabolism. The striking effects of HSF1 on oncogenic transformation are not limited to mouse systems or tumor initiation; human cancer lines of diverse origins show much greater dependence on HSF1 function to maintain proliferation and survival than their nontransformed counterparts. While it enhances organismal survival and longevity under most circumstances, HSF1 has the opposite effect in supporting the lethal phenomenon of cancer.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BISSELL MJ, 1976, SCIENCE, V191, P856, DOI 10.1126/science.175441; Bossis I, 2004, ENDOCR-RELAT CANCER, V11, P265, DOI 10.1677/erc.0.0110265; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; MIVECHI NF, 1995, CANCER RES, V55, P5512; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; SAWAJI Y, 1999, NY ACAD SCI, V878, P707; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; YUSPA SH, 1994, CANCER RES, V54, P1178; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	43	620	642	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1005	1018		10.1016/j.cell.2007.07.020	http://dx.doi.org/10.1016/j.cell.2007.07.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889646	Green Accepted, Bronze			2022-12-28	WOS:000250507500011
J	Malhotra, A				Malhotra, Atul			Low-tidal-volume ventilation in the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED LUNG INJURY; MECHANICAL VENTILATION; DAILY INTERRUPTION; SURVIVING SEPSIS; STRATEGY; TRIAL; HYPERCAPNIA; GUIDELINES; REDUCTION; CAMPAIGN		Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Brigham & Womens Hosp, Sleep Med Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Malhotra, A (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	amalhotra1@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292, R01HL073146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG024837] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Borges JB, 2006, NEW ENGL J MED, V355, P319; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Carvalho CRR, 1997, AM J RESP CRIT CARE, V156, P1458, DOI 10.1164/ajrccm.156.5.9604081; Cho MH, 2006, ANN THORAC SURG, V82, P261, DOI 10.1016/j.athoracsur.2006.02.022; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Dreyfuss D, 1998, INTENS CARE MED, V24, P102, DOI 10.1007/s001340050529; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; FARIDY EE, 1966, J APPL PHYSIOL, V21, P1453, DOI 10.1152/jappl.1966.21.5.1453; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Kacmarek RM, 2006, AM J RESP CRIT CARE, V173, P882, DOI 10.1164/rccm.200508-1196OC; Kacmarek Robert M, 2005, Crit Care Med, V33, pS148, DOI 10.1097/01.CCM.0000156786.43935.A0; Kahn JM, 2005, CRIT CARE MED, V33, P766, DOI 10.1097/01.CCM.0000157786.41506.24; Kallet Richard H, 2002, Respir Care, V47, P898; Kavanagh BP, 2006, MINERVA ANESTESIOL, V72, P567; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; MacIntyre NR, 2005, CHEST, V128, p561S, DOI 10.1378/chest.128.5_suppl_2.561S; Malhotra A, 2002, NEW ENGL J MED, V346, P296; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; MEADE MO, 2007, AM J RESP CRIT CARE, V175, pA506; MERCAT A, 2007, AM J RESP CRIT CARE, V175, pA507; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; SLUTSKY AS, 1993, CHEST, V104, P1833, DOI 10.1378/chest.104.6.1833; SLUTSKY AS, 1994, CHEST, V106, P656; Spragg RG, 2004, NEW ENGL J MED, V351, P884, DOI 10.1056/NEJMoa033181; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Tobin MJ, 2001, NEW ENGL J MED, V344, P1986, DOI 10.1056/NEJM200106283442606; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Villar J, 2005, Minerva Anestesiol, V71, P255; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	47	139	148	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1113	1120		10.1056/NEJMct074213	http://dx.doi.org/10.1056/NEJMct074213			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855672	Green Accepted			2022-12-28	WOS:000249387200007
J	KITCHELL, JA; MACLEOD, N				KITCHELL, JA; MACLEOD, N			ASYMMETRIES OF CLADE SHAPE AND THE DIRECTION OF EVOLUTIONARY TIME - RESPONSE	SCIENCE			English	Article									UNIV MICHIGAN,MUSEUM PALEONTOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	KITCHELL, JA (corresponding author), UNIV MICHIGAN,DEPT GEOL SCI,ANN ARBOR,MI 48109, USA.							GOULD S J, 1977, Paleobiology, V3, P23; GOULD SJ, 1987, SCIENCE, V236, P1437, DOI 10.1126/science.236.4807.1437; KITCHELL JA, 1988, SCIENCE, V240, P1190, DOI 10.1126/science.240.4856.1190	3	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1614	1615		10.1126/science.243.4898.1614	http://dx.doi.org/10.1126/science.243.4898.1614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847264				2022-12-28	WOS:A1989T795200042
J	Holman, RR; Thorne, KI; Farmer, AJ; Davies, MJ; Keenan, JF; Paul, S; Levy, JC				Holman, Rury R.; Thorne, Kerensa I.; Farmer, Andrew J.; Davies, Melanie J.; Keenan, Joanne F.; Paul, Sanjoy; Levy, Jonathan C.		4-T Study Grp	Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTPRANDIAL GLYCEMIC CONTROL; TO-TARGET TRIAL; NPH INSULIN; PLUS METFORMIN; GLARGINE; ROSIGLITAZONE; SULFONYLUREA; COMBINATION; MELLITUS; DETEMIR	Background Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though evidence supporting specific insulin regimens is limited. Methods In an open-label, controlled, multicenter trial, we randomly assigned 708 patients with a suboptimal glycated hemoglobin level (7.0 to 10.0%) who were receiving maximally tolerated doses of metformin and sulfonylurea to receive biphasic insulin aspart twice daily, prandial insulin aspart three times daily, or basal insulin detemir once daily (twice if required). Outcome measures at 1 year were the mean glycated hemoglobin level, the proportion of patients with a glycated hemoglobin level of 6.5% or less, the rate of hypoglycemia, and weight gain. Results At 1 year, mean glycated hemoglobin levels were similar in the biphasic group (7.3%) and the prandial group (7.2%) (P=0.08) but higher in the basal group (7.6%, P<0.001 for both comparisons). The respective proportions of patients with a glycated hemoglobin level of 6.5% or less were 17.0%, 23.9%, and 8.1%; respective mean numbers of hypoglycemic events per patient per year were 5.7, 12.0, and 2.3; and respective mean weight gains were 4.7 kg, 5.7 kg, and 1.9 kg. Rates of adverse events were similar among the three groups. Conclusions A single analogue-insulin formulation added to metformin and sulfonylurea resulted in a glycated hemoglobin level of 6.5% or less in a minority of patients at 1 year. The addition of biphasic or prandial insulin aspart reduced levels more than the addition of basal insulin detemir but was associated with greater risks of hypoglycemia and weight gain.	Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; Univ Oxford, Dept Primary Hlth Care, Oxford, England; Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Oxford; University of Oxford; University of Leicester	Holman, RR (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Paul, Sanjoy K/F-8199-2010	Paul, Sanjoy K/0000-0003-0848-7194; Keenan, Joanne/0000-0003-2558-6688; Martins, Janine/0000-0003-2195-7314; Jaap, Alan/0000-0001-8289-704X; Thorne, Kerensa/0000-0003-1905-5610; Levy, Jonathan/0000-0002-9486-1885; Davies, Melanie/0000-0002-9987-9371				[Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1996, DIABETES; Bastyr EJ, 2000, DIABETES CARE, V23, P1236, DOI 10.2337/diacare.23.9.1236; Bretzel RG, 2004, DIABETES CARE, V27, P1023, DOI 10.2337/diacare.27.5.1023; Christiansen JS, 2003, DIABETES OBES METAB, V5, P446, DOI 10.1046/j.1463-1326.2003.00300.x; Davies M, 2005, DIABETES CARE, V28, P1282, DOI 10.2337/diacare.28.6.1282; de Grauw WJC, 2001, BRIT J GEN PRACT, V51, P527; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Eliaschewitz FG, 2006, ARCH MED RES, V37, P495, DOI 10.1016/j.arcmed.2005.10.015; Haak T, 2005, DIABETES OBES METAB, V7, P56, DOI 10.1111/j.1463-1326.2004.00373.x; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Holman R R, 1985, Diabet Med, V2, P45; Janka HU, 2005, DIABETES CARE, V28, P254, DOI 10.2337/diacare.28.2.254; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kilo C, 2003, J DIABETES COMPLICAT, V17, P307, DOI 10.1016/S1056-8727(03)00076-X; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Kvapil A, 2006, DIABETES OBES METAB, V8, P39, DOI 10.1111/j.1463-1326.2005.00492.x; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Malone JK, 2005, CLIN THER, V27, P1112; Malone JK, 2005, DIABETIC MED, V22, P374, DOI 10.1111/j.1464-5491.2005.01511.x; Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Philis-Tsimikas A, 2006, CLIN THER, V28, P1569, DOI 10.1016/j.clinthera.2006.10.020; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0; Yki-Jarvinen H, 2007, DIABETES CARE, V30, P1364, DOI 10.2337/dc06-1357	40	524	570	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1716	1730		10.1056/NEJMoa075392	http://dx.doi.org/10.1056/NEJMoa075392			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17890232	Green Published, Green Submitted			2022-12-28	WOS:000250355100007
J	Howard, RJ; Juszczak, E; Ballard, CG; Bentham, P; Brown, RG; Bullock, R; Burns, AS; Holmes, C; Jacoby, R; Johnson, T; Knapp, M; Lindesay, J; O'Brien, JT; Wilcock, G; Katona, C; Jones, RW; DeCesare, J; Rodger, M				Howard, Robert J.; Juszczak, Edmund; Ballard, Clive G.; Bentham, Peter; Brown, Richard G.; Bullock, Roger; Burns, Alistair S.; Holmes, Clive; Jacoby, Robin; Johnson, Tony; Knapp, Martin; Lindesay, James; O'Brien, John T.; Wilcock, Gordon; Katona, Cornelius; Jones, Roy W.; DeCesare, Julia; Rodger, Michaela		CALM AD Trial Grp	Donepezil for the treatment of agitation in Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSING-HOME RESIDENTS; DOUBLE-BLIND; NEUROPSYCHIATRIC INVENTORY; BEHAVIORAL DISTURBANCES; CAREGIVER DISTRESS; CONTROLLED TRIALS; LEWY BODIES; DEMENTIA; SYMPTOMS; EFFICACY	Background Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear. Methods We randomly assigned 272 patients with Alzheimer's disease who had clinically significant agitation and no response to a brief psychosocial treatment program to receive 10 mg of donepezil per day (128 patients) or placebo (131 patients) for 12 weeks. The primary outcome was a change in the score on the Cohen-Mansfield Agitation Inventory (CMAI) (on a scale of 29 to 203, with higher scores indicating more agitation) at 12 weeks. Results There was no significant difference between the effects of donepezil and those of placebo on the basis of the change in CMAI scores from baseline to 12 weeks (estimated mean difference in change [the value for donepezil minus that for placebo], -0.06; 95% confidence interval [CI], -4.35 to 4.22). Twenty-two of 108 patients (20.4%) in the placebo group and 22 of 113 (19.5%) in the donepezil group had a reduction of 30% or greater in the CMAI score (the value for donepezil minus that for placebo, -0.9 percentage point; 95% CI, -11.4 to 9.6). There were also no significant differences between the placebo and donepezil groups in scores for the Neuropsychiatric Inventory, the Neuropsychiatric Inventory Caregiver Distress Scale, or the Clinician's Global Impression of Change. Conclusions In this 12-week trial, donepezil was not more effective than placebo in treating agitation in patients with Alzheimer's disease.	Inst Psychiat, Univ London Kings Coll, MRC, Neurogenerat Res Ctr, London SE5 8AF, England; Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford, England; Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; Queen Elizabeth Psychiat Hosp, Birmingham, W Midlands, England; Victoria Hosp, Swindon, Wilts, England; Univ Manchester, Div Psychiat, Manchester, Lancs, England; Univ Southampton, Memory Assessment & Res Ctr, Southampton, Hants, England; Univ Oxford, Dept Psychiat, Oxford, England; Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; Univ Kent, Kent Inst Med & Hlth, Canterbury, Kent, England; Res Inst Care Elderly, Bath, Avon, England; Kings Coll London, Old Age Psychiat Sect, London WC2R 2LS, England	University of London; King's College London; University of Oxford; University of London; King's College London; University of Birmingham; University of Manchester; University of Southampton; University of Oxford; MRC Biostatistics Unit; University of Cambridge; University of Leicester; University of Leicester; Newcastle University - UK; University of Oxford; University of Kent; University of London; King's College London	Howard, RJ (corresponding author), Inst Psychiat, Univ London Kings Coll, MRC, Neurogenerat Res Ctr, De Crespigny Pk, London SE5 8AF, England.	robert.howard@iop.kcl.ac.uk	Knapp, Martin RJ/G-3011-2011; Howard, Robert/E-4890-2010; Brown, Richard G/A-9599-2010	Brown, Richard G/0000-0001-9021-0172; Howard, Robert/0000-0002-3071-2338; Knapp, Martin/0000-0003-1427-0215; Katona, Cornelius/0000-0001-7451-0167; Holmes, Clive/0000-0003-1999-6912; O'Brien, John/0000-0002-0837-5080; Burns, Alistair/0000-0002-9837-0645; Ballard, Clive/0000-0003-0022-5632	MRC [G0100070] Funding Source: UKRI; Medical Research Council [G0100070] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; CohenMansfield J, 1997, J GERONTOL A-BIOL, V52, pM369, DOI 10.1093/gerona/52A.6.M369; Cummings JL, 2004, AM J PSYCHIAT, V161, P532, DOI 10.1176/appi.ajp.161.3.532; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Donaldson C, 1997, BRIT J PSYCHIAT, V170, P62, DOI 10.1192/bjp.170.1.62; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Feldman H, 2001, NEUROLOGY, V57, P2153; Gauthier S, 2002, INT PSYCHOGERIATR, V14, P389, DOI 10.1017/S104161020200858X; Herrmann N, 2005, AM J GERIAT PSYCHIAT, V13, P527, DOI 10.1176/appi.ajgp.13.6.527; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Howard R, 2001, INT J GERIATR PSYCH, V16, P714, DOI 10.1002/gps.418; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Margallo-Lana M, 2001, INT J GERIATR PSYCH, V16, P39, DOI 10.1002/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; *MED HEALTHC PROD, 2004, NEW ADV ISS RISP OL; MOLLOY DW, 1991, AM J PSYCHIAT, V148, P102; RABINS PV, 1982, JAMA-J AM MED ASSOC, V248, P333, DOI 10.1001/jama.248.3.333; Saxton J, 1990, PSYCHOL ASSESS, V2, P298, DOI DOI 10.1037/1040-3590.2.3.298; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Winblad B, 2006, LANCET, V368, P1650; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5; Winblad B, 2006, LANCET, V367, P1980; Wood S, 2000, AM J GERIAT PSYCHIAT, V8, P75, DOI 10.1097/00019442-200002000-00010	35	178	184	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1382	1392		10.1056/NEJMoa066583	http://dx.doi.org/10.1056/NEJMoa066583			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914039	Green Published			2022-12-28	WOS:000249892900004
J	Min, JH; Pavletich, NP				Min, Jung-Hyun; Pavletich, Nikola P.			Recognition of DNA damage by the Rad4 nucleotide excision repair protein	NATURE			English	Article							GROUP-C PROTEIN; ADDUCT OPPOSITE DT; XERODERMA-PIGMENTOSUM; SOLUTION CONFORMATION; BINDING DOMAIN; BASE-PAIRS; CIS-SYN; GROUP-A; COMPLEX; DUPLEX	Mutations in the nucleotide excision repair (NER) pathway can cause the xeroderma pigmentosum skin cancer predisposition syndrome. NER lesions are limited to one DNA strand, but otherwise they are chemically and structurally diverse, being caused by a wide variety of genotoxic chemicals and ultraviolet radiation. The xeroderma pigmentosum C (XPC) protein has a central role in initiating global-genome NER by recognizing the lesion and recruiting downstream factors. Here we present the crystal structure of the yeast XPC orthologue Rad4 bound to DNA containing a cyclobutane pyrimidine dimer (CPD) lesion. The structure shows that Rad4 inserts a beta-hairpin through the DNA duplex, causing the two damaged base pairs to flip out of the double helix. The expelled nucleotides of the undamaged strand are recognized by Rad4, whereas the two CPD-linked nucleotides become disordered. These findings indicate that the lesions recognized by Rad4/XPC thermodynamically destabilize the Watson-Crick double helix in a manner that facilitates the flipping-out of two base pairs.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pavletin@mkscc.org		Min, Jung-Hyun/0000-0002-4221-9321				Anantharaman V, 2001, HUM MOL GENET, V10, P1627, DOI 10.1093/hmg/10.16.1627; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchko GW, 2001, NUCLEIC ACIDS RES, V29, P2635, DOI 10.1093/nar/29.12.2635; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Buterin T, 2000, CANCER RES, V60, P1849; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Chou SH, 2001, J MOL BIOL, V312, P769, DOI 10.1006/jmbi.2001.4964; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cosman M, 1996, BIOCHEMISTRY-US, V35, P9850, DOI 10.1021/bi9605346; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P12488, DOI 10.1021/bi00097a029; COSMAN M, 1995, BIOCHEMISTRY-US, V34, P1295, DOI 10.1021/bi00004a024; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; DELOSSANTOS C, 1992, BIOCHEMISTRY-US, V31, P5245, DOI 10.1021/bi00138a002; Dip R, 2004, DNA REPAIR, V3, P1409, DOI 10.1016/j.dnarep.2004.05.005; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Gao YG, 1999, BIOCHEMISTRY-US, V38, P16452, DOI 10.1021/bi9914614; Geacintov NE, 2002, BIOPOLYMERS, V65, P202, DOI 10.1002/bip.10239; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Mao B, 1999, BIOCHEMISTRY-US, V38, P10831, DOI 10.1021/bi991212f; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; McAteer K, 1998, J MOL BIOL, V282, P1013, DOI 10.1006/jmbi.1998.2062; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; OHANDLEY SF, 1993, BIOCHEMISTRY-US, V32, P2481, DOI 10.1021/bi00061a005; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang M, 2000, BIOCHEMISTRY-US, V39, P6433, DOI 10.1021/bi000472q; Yang A, 2006, BIOCHEMISTRY-US, V45, P3653, DOI 10.1021/bi0524868; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	50	317	333	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					570	U7		10.1038/nature06155	http://dx.doi.org/10.1038/nature06155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17882165				2022-12-28	WOS:000249893500038
J	Alvaro, D; Macarri, G; Mancino, MG; Marzioni, M; Bragazzi, M; Onori, P; Corradini, SG; Invernizzi, P; Franchitto, A; Attill, AF; Gaudio, E; Benedetti, A				Alvaro, Domenico; Macarri, Gianpiero; Mancino, Maria Grazia; Marzioni, Marco; Bragazzi, MariaConsiglia; Onori, Paolo; Corradini, Stefano Ginanni; Invernizzi, Pietro; Franchitto, Antonio; Attill, Adolfo F.; Gaudio, Eugenio; Benedetti, Antonio			Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; DIGITAL IMAGE-ANALYSIS; BREAST-CANCER CELLS; BINDING-PROTEINS; ESTROGEN-RECEPTOR; STEROID-HORMONES; ROUTINE CYTOLOGY; CARCINOMA-CELLS; BRUSH CYTOLOGY; FACTOR (IGF)-I	Background: Cholangiocarcinoma cells express and secrete insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Objective: To measure IGF-I and VEGF in bile and serum of patients with extrahepatic cholangiocarcinoma and to evaluate their performance as diagnostic markers. Design: Cross-sectional study. Setting: Inpatients at the Division of Gastroenterology, University Hospital, Ancona, Italy. Patients: 73 patients who consecutively had endoscopic retrograde cholangiopancreatography (ERCP), including patients with extrahepatic cholangiocarcinoma (n = 29), pancreatic cancer (n = 19), and benign biliary abnormalities (n = 25; bile duct stones, primary sclerosing cholangitis, and cholangitis). Measurements: Diagnosis was based on conventional radiology, ERCP, and follow-up. Insulin-like growth factor I and VEGF were measured by using enzyme-linked immunosorbent assay. Results: The biliary IGF-I concentration was 15- to 20-fold higher (P < 0.001) in extrahepatic cholangiocarcinoma (mean, 84.6 nmol/L [95% Cl, 74.0 to 95.2 nmol/L]) than in pancreatic cancer (5.8 nmol/L [Cl, 4.0 to 7.5 nmol/L]) or benign biliary abnormalities (4.1 nmol/L [Cl, 3.1 to 5.2 nmol/L]). The area under the receiver-operating characteristic curve was 1 when biliary IGF-I values in the extrahepatic cholangiocarcinoma were compared with benign biliary abnormalities or pancreatic cancer. In contrast, biliary VEGF concentration was similar in the 3 groups. Serum IGF-I levels were similar among the groups, whereas serum VEGF levels were higher in the cholangiocarcinoma (0.97 ng/mL [Cl, 0.59 to 1.35 ng/mL]; P = 0.0016) and pancreatic cancer groups (0.66 ng/mL [Cl, 0.43 to 0.88 ng/mL); P < 0.001) compared with patients with benign biliary abnormalities (0.28 ng/mL [Cl, 0.17 to 0.37 ng/mL]). Limitations: Data were obtained in a small sample, the study was performed in a single center, and few patients had a tissue diagnosis. Conclusions: Biliary IGF-I levels in patients undergoing ERCP for biliary obstruction may differentiate extrahepatic cholangiocarcinoma from either pancreatic cancer or benign biliary abnormalities.	Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol, I-00137 Rome, Italy; Polytechn Univ Marche, Ancona, Italy; State Univ Laquila, Laquila, Italy; Univ Milan, Sch Med, San Paolo Hosp, Milan, Italy	Sapienza University Rome; Marche Polytechnic University; San Paolo-Polo Universitaria Hospital; University of Milan	Alvaro, D (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol, Via Roberto Rossellini 51, I-00137 Rome, Italy.	domenico.alvaro@uniromal.it	Invernizzi, Pietro/AAB-8367-2022; Onori, Paolo/J-9394-2013; Mancino, Maria Grazia/AAC-4125-2022; ALVARO, Domenico/J-8600-2018; Franchitto, Antonio/C-8095-2009; Marzioni, Marco/A-8153-2011; Benedetti, Antonio/A-8189-2011	Invernizzi, Pietro/0000-0003-3262-1998; Onori, Paolo/0000-0002-7195-3760; ALVARO, Domenico/0000-0003-3771-9644; Marzioni, Marco/0000-0001-6014-6165; Attili, Adolfo Francesco/0000-0001-7240-7246; FRANCHITTO, Antonio/0000-0003-0822-3690; Ginanni Corradini, Stefano/0000-0002-0839-1961; Benedetti, Antonio/0000-0003-0280-4574; mancino, maria grazia/0000-0003-1771-5056				Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Alvaro D, 2005, J HEPATOL, V43, P875, DOI 10.1016/j.jhep.2005.04.011; Alvaro D, 2006, AM J PATHOL, V169, P877, DOI 10.2353/ajpath.2006.050464; Baron TH, 2004, CLIN GASTROENTEROL H, V2, P214, DOI 10.1016/S1542-3565(04)00006-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blendis Laurie, 2002, Gastroenterology, V122, P237, DOI 10.1016/S0016-5085(02)80088-9; Boberg KM, 2006, J HEPATOL, V45, P568, DOI 10.1016/j.jhep.2006.05.010; Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; CHAURASIA OP, 1994, REGUL PEPTIDES, V50, P113, DOI 10.1016/0167-0115(94)90026-4; Dunger DB, 2003, HORM RES, V60, P131, DOI 10.1159/000074514; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fulcher AS, 2000, RADIOLOGY, V215, P71, DOI 10.1148/radiology.215.1.r00ap2671; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hata H, 1998, ONCOLOGY-BASEL, V55, P35, DOI 10.1159/000055257; Helle SI, 2004, BEST PRACT RES CL EN, V18, P67, DOI 10.1016/S1521-690X(03)00045-9; Hyder SM, 2002, AM J PATHOL, V161, P345, DOI 10.1016/S0002-9440(10)64186-7; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kassem M, 1998, CALCIFIED TISSUE INT, V62, P60, DOI 10.1007/s002239900395; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Kim JH, 2002, RADIOGRAPHICS, V22, P1335, DOI 10.1148/rg.226025060; Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Levy C, 2005, DIGEST DIS SCI, V50, P1734, DOI 10.1007/s10620-005-2927-8; Lin YS, 2004, INT J CANCER, V110, P584, DOI 10.1002/ijc.20147; Malhi H, 2006, ALIMENT PHARM THER, V23, P1287, DOI 10.1111/j.1365-2036.2006.02900.x; Mancino A, 2006, HEPATOLOGY, V44, p389A; Neufeld G, 2006, CANCER METAST REV, V25, P373, DOI 10.1007/s10555-006-9011-5; Park BK, 2006, AM J CLIN ONCOL-CANC, V29, P138, DOI 10.1097/01.coc.0000204402.29830.08; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rumalla A, 2001, MAYO CLIN PROC, V76, P29, DOI 10.4065/76.1.29; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Singh P, 2006, CURR OPIN GASTROEN, V22, P294, DOI 10.1097/01.mog.0000218967.60633.64; Stephen RL, 2001, J BIOL CHEM, V276, P40080, DOI 10.1074/jbc.M105892200; Taylor PC, 2005, RHEUMATOLOGY, V44, P721, DOI 10.1093/rheumatology/keh524; TURLEY SD, 1978, J LIPID RES, V19, P924; Vitellas KM, 2000, RADIOGRAPHICS, V20, P939, DOI 10.1148/radiographics.20.4.g00jl23939; West J, 2006, BRIT J CANCER, V94, P1751, DOI 10.1038/sj.bjc.6603127; WIMALASENA J, 1993, ONCOL RES, V5, P325; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zech CJ, 2004, EUR RADIOL, V14, P1174, DOI 10.1007/s00330-004-2327-z; Zhou J, 2001, J INVEST MED, V49, P47, DOI 10.2310/6650.2001.34090	49	46	50	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					451	459		10.7326/0003-4819-147-7-200710020-00003	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909206				2022-12-28	WOS:000250214700002
J	Page, L; Drife, J				Page, Lesley; Drife, Jim			Do we have enough evidence to judge midwife led maternity units safe?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 9NH, England	University of London; King's College London	Page, L (corresponding author), Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 9NH, England.	Lesley.page@kcl.ac.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					642	643		10.1136/bmj.39343.471227.AD	http://dx.doi.org/10.1136/bmj.39343.471227.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901510	Green Published			2022-12-28	WOS:000249989600034
J	Balen, AH; Rutherford, AJ				Balen, Adam H.; Rutherford, Anthony J.			Management of infertility	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEMEN QUALITY; POPULATION; IVF; AGE		Leeds Gen Infirm, Leeds LS2 9NS, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Balen, AH (corresponding author), Leeds Gen Infirm, Leeds LS2 9NS, W Yorkshire, England.	adam.balen@leedsth.nhs.uk						ABELL A, 1994, LANCET, V343, P1498, DOI 10.1016/S0140-6736(94)92605-0; [Anonymous], 2004, FERT ASS TREATM PEOP; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Cassell JA, 2006, BMJ-BRIT MED J, V332, P332, DOI 10.1136/bmj.38726.404120.7C; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; Homan GF, 2007, HUM REPROD UPDATE, V13, P209, DOI 10.1093/humupd/dml056; *HUM FERT EMBR AUT, 2007, LONGT AN REG DAT 199; *HUM FERT EMBR AUT, 2007, NAT IVF LIV BIRTH RA; Human Fertilisation and Embryology Authority, 2006, ON CHILD TIM RED MUL; Jones GL, 2002, AM J OBSTET GYNECOL, V187, P501, DOI 10.1067/mob.2002.124940; Jorgensen N, 2001, HUM REPROD, V16, P1012, DOI 10.1093/humrep/16.5.1012; Kennedy R, 2006, Hum Fertil (Camb), V9, P181, DOI 10.1080/14647270600908411; Luke B, 2007, HUM REPROD, V22, P1264, DOI 10.1093/humrep/del522; Maheshwari A, 2006, HUM REPROD, V21, P2729, DOI 10.1093/humrep/del188; Meirow D, 2007, FERTIL STERIL, V87, DOI 10.1016/j.fertnstert.2006.05.086; Oktem O, 2007, FERTIL STERIL, V88, pS270, DOI 10.1016/j.fertnstert.2007.07.918; Taylor A, 2003, BRIT MED J, V327, P434, DOI 10.1136/bmj.327.7412.434; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Twisk M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005291.pub2; World Heath Organization (WHO), 2000, WHO LAB MAN EX HUM S	25	30	37	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2007	335	7620					608	611		10.1136/bmj.39324.662049.80	http://dx.doi.org/10.1136/bmj.39324.662049.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884905	Green Published			2022-12-28	WOS:000249832400036
J	Spiegel, DA; Gosselin, RA				Spiegel, David A.; Gosselin, Richard A.			Surgical services in low-income and middle-income countries	LANCET			English	Editorial Material									Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Orthoped Surg, Philadelphia, PA 19104 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California Berkeley	Spiegel, DA (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Orthoped Surg, Philadelphia, PA 19104 USA.	spiegeld@email.chop.edu						[Anonymous], 2003, SURG CAR DISTR HOSP; Cherian Meena Nathan, 2004, World Hosp Health Serv, V40, P24; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P1615; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; PARRY E, 1999, TRAUMA Q, V14, P329; *WHO, WORKSH REP; *WHO, 2003, INT MAN EM ESS SURG; World Health Organization,, WHO CALL RET DECL AL	10	61	62	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2007	370	9592					1013	1015		10.1016/S0140-6736(07)61457-3	http://dx.doi.org/10.1016/S0140-6736(07)61457-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889228				2022-12-28	WOS:000249727900007
J	McEwen, AS; Hansen, CJ; Delamere, WA; Eliason, EM; Herkenhoff, KE; Keszthelyi, L; Gulick, VC; Kirk, RL; Mellon, MT; Grant, JA; Thomas, N; Weitz, CM; Squyres, SW; Bridges, NT; Murchie, SL; Seelos, F; Seelos, K; Okubo, CH; Milazzo, MP; Tornabene, LL; Jaeger, WL; Byrne, S; Russell, PS; Griffes, JL; Martinez-Alonso, S; Davatzes, A; Chuang, FC; Thomson, BJ; Fishbaugh, KE; Dundas, CM; Kolb, KJ; Banks, ME; Wray, JJ				McEwen, A. S.; Hansen, C. J.; Delamere, W. A.; Eliason, E. M.; Herkenhoff, K. E.; Keszthelyi, L.; Gulick, V. C.; Kirk, R. L.; Mellon, M. T.; Grant, J. A.; Thomas, N.; Weitz, C. M.; Squyres, S. W.; Bridges, N. T.; Murchie, S. L.; Seelos, F.; Seelos, K.; Okubo, C. H.; Milazzo, M. P.; Tornabene, L. L.; Jaeger, W. L.; Byrne, S.; Russell, P. S.; Griffes, J. L.; Martinez-Alonso, S.; Davatzes, A.; Chuang, F. C.; Thomson, B. J.; Fishbaugh, K. E.; Dundas, C. M.; Kolb, K. J.; Banks, M. E.; Wray, J. J.			A closer look at water-related geologic activity on Mars	SCIENCE			English	Article							CRATERING RATE; DEPOSITS; MISSION; FATE	Water has supposedly marked the surface of Mars and produced characteristic landforms. To understand the history of water on Mars, we take a close look at key locations with the High-Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter, reaching fine spatial scales of 25 to 32 centimeters per pixel. Boulders ranging up to similar to 2 meters in diameter are ubiquitous in the middle to high latitudes, which include deposits previously interpreted as fine-grained ocean sediments or dusty snow. Bright gully deposits identify six locations with very recent activity, but these lie on steep (20 degrees to 35 degrees) slopes where dry mass wasting could occur. Thus, we cannot confirm the reality of ancient oceans or water in active gullies but do see evidence of fluvial modification of geologically recent mid-latitude gullies and equatorial impact craters.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Delamere Support Syst, Boulder, CO 80304 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Univ Colorado, Boulder, CO 80309 USA; Smithsonian Ctr Earth & Planetary Studies, Washington, DC USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Cornell Univ, Ithaca, NY 14853 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Int Space Sci Inst, Bern, Switzerland	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; Cornell University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	McEwen, AS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	mcewen@lpl.arizona.edu	Seelos, Frank/C-7875-2016; Thomson, Bradley/AAA-3496-2022; Martinez-Alonso, Sara/D-8594-2011; Wray, James J/B-8457-2008; Davatzes, Alexandra/B-1479-2012; Murchie, Scott L/E-8030-2015; Seelos, Kimberly D/F-4647-2015; Bridges, Nathan T/D-6341-2016; Mellon, Michael/C-3456-2016; Byrne, Shane/B-8104-2012; Thomas, Nicolas/G-4693-2015	Seelos, Frank/0000-0001-9721-941X; Thomson, Bradley/0000-0001-8635-8932; Martinez-Alonso, Sara/0000-0001-5185-8670; Wray, James J/0000-0001-5559-2179; Murchie, Scott L/0000-0002-1616-8751; Seelos, Kimberly D/0000-0001-7236-0580; Dundas, Colin/0000-0003-2343-7224; Thomas, Nicolas/0000-0002-0146-0071; Grant, John/0000-0001-8276-1281; Okubo, Chris/0000-0001-9776-8128; Tornabene, Livio Leonardo/0000-0002-1479-6711; Kestay, Laszlo/0000-0003-1879-4331				BarnouinJha OS, 1996, J GEOPHYS RES-PLANET, V101, P21099, DOI 10.1029/96JE01949; Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Heather DJ, 2003, ICARUS, V163, P307, DOI 10.1016/S0019-1035(02)00063-5; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P25617, DOI 10.1029/97JE02582; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Okubo CH, 2007, SCIENCE, V315, P983, DOI 10.1126/science.1136855; Osinski GR, 2006, METEORIT PLANET SCI, V41, P1571, DOI 10.1111/j.1945-5100.2006.tb00436.x; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; Squyres S. W., 1992, MARS, P523; TORNABENE LL, 2004, LUNAR PLANET SCI, V38; Williams KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029507; Williams RME, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025618; WILLIAMS RME, 2004, LUNAR PLANCET SCI, V35; WILLIAMS RME, 2004, AM GEOPH UN FALL M; Zurek RW, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002701	23	122	124	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1706	1709		10.1126/science.1143987	http://dx.doi.org/10.1126/science.1143987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885125				2022-12-28	WOS:000249585900034
J	Puthenveedu, MA; Yudowski, GA; von Zastrow, M				Puthenveedu, Manojkumar A.; Yudowski, Guillermo A.; von Zastrow, Mark			Endocytosis of neurotransmitter receptors: location matters	CELL			English	Editorial Material							MEMBRANE; PROTEINS	Endocytosis of excitatory glutamate receptors from the postsynaptic plasma membrane plays a fundamental role in synaptic function and plasticity. In a recent study published in Neuron, Lu et al. ( 2007) describe protein interactions that link zones of receptor endocytosis directly to the postsynaptic scaffold and propose that local trafficking of receptors facilitated by these endocytic zones is required to maintain synaptic responsiveness.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	; Puthenveedu, Manojkumar/A-3795-2016	Yudowski, Guillermo/0000-0001-5989-4131; Puthenveedu, Manojkumar/0000-0002-3177-4231	NIDA NIH HHS [K99 DA023444-02, K99 DA023444] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023444] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LU J, 2007, NEURON; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679	11	6	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					988	989		10.1016/j.cell.2007.09.006	http://dx.doi.org/10.1016/j.cell.2007.09.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889644	Bronze			2022-12-28	WOS:000250507500009
J	Haines, A; Horton, R; Bhutta, Z				Haines, Andy; Horton, Richard; Bhutta, Zulfiqar			Primary health care comes of age. Looking forward to the 30th anniversary of Alma-Ata: call for papers	LANCET			English	Editorial Material							WORKERS; INTERVENTION; MANAGEMENT; OUTCOMES; GOALS		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; The Lancet, London, England; Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan	University of London; London School of Hygiene & Tropical Medicine; Aga Khan University	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Andy.Haines@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605				[Anonymous], NAT PROGR FAM PLANN; [Anonymous], 1978, DECL ALM AT INT C PR; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Brown TM, 2004, AM J PUBLIC HEALTH, V94, P1851, DOI 10.2105/AJPH.94.11.1851; CHAN M, 2006, COMMUNICATION   1109; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Goni S, 1999, HEALTH POLICY, V48, P107, DOI 10.1016/S0168-8510(99)00036-6; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Jackson S, 2005, CHINA QUART, V181, P137, DOI 10.1017/S0305741005000081; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Peres Ellen M, 2006, Hum Resour Health, V4, P25, DOI 10.1186/1478-4491-4-25; SAUERBORN R, 1989, SOC SCI MED, V29, P1163, DOI 10.1016/0277-9536(89)90359-6; SIDEL VW, 1972, NEW ENGL J MED, V286, P1292, DOI 10.1056/NEJM197206152862404; Sundararaman T, 2007, LANCET, V369, P2058, DOI 10.1016/S0140-6736(07)60326-2; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNICEF, 1980S CAMP CHILD SUR; United Nations, MILL DEV GOALS REP 2; Walker DG, 2005, J COMMUN HEALTH, V30, P221, DOI 10.1007/s10900-004-1960-4; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; WALT G, 1989, SOC SCI MED, V29, P599, DOI 10.1016/0277-9536(89)90179-2; Walt G., 1988, Health Policy and Planning, V3, P1, DOI 10.1093/heapol/3.1.1; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	31	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					911	913		10.1016/S0140-6736(07)61423-8	http://dx.doi.org/10.1016/S0140-6736(07)61423-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211EG	17869618				2022-12-28	WOS:000249506500004
J	Okutsu, T; Shikina, S; Kanno, M; Takeuchi, Y; Yoshizaki, G				Okutsu, Tomoyuki; Shikina, Shinya; Kanno, Megumi; Takeuchi, Yutaka; Yoshizaki, Goro			Production of trout offspring from triploid salmon parents	SCIENCE			English	Article							GERM-CELLS; FISH		Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan; Japan Sci & Technol Agcy, SORST, Chiyoda Ku, Tokyo 1020075, Japan	Tokyo University of Marine Science & Technology; Japan Science & Technology Agency (JST)	Yoshizaki, G (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	goro@kaiyodai.ac.jp	YOSHIZAKI, Goro/O-1937-2014; Wei, Qiwei/B-6928-2014	Wei, Qiwei/0000-0002-6366-1020; Takeuchi, Yutaka/0000-0001-5450-4632				Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624	4	187	207	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1517	1517		10.1126/science.1145626	http://dx.doi.org/10.1126/science.1145626			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872437				2022-12-28	WOS:000249467900032
J	Hattori, D; Demir, E; Kim, HW; Viragh, E; Zipursky, SL; Dickson, BJ				Hattori, Daisuke; Demir, Ebru; Kim, Ho Won; Viragh, Erika; Zipursky, S. Lawrence; Dickson, Barry J.			Dscam diversity is essential for neuronal wiring and self-recognition	NATURE			English	Article							AXON GUIDANCE; DROSOPHILA DSCAM; MOLECULAR DIVERSITY; MORPHOGENESIS; MELANOGASTER; ORGANIZATION; SPECIFICITY; AVOIDANCE; CADHERINS; PATTERNS	Neurons are thought to use diverse families of cell-surface molecules for cell recognition during circuit assembly. In Drosophila, alternative splicing of the Down syndrome cell adhesion molecule (Dscam) gene potentially generates 38,016 closely related transmembrane proteins of the immunoglobulin superfamily, each comprising one of 19,008 alternative ectodomains linked to one of two alternative transmembrane segments(1). These ectodomains show isoform-specific homophilic binding, leading to speculation that Dscam proteins mediate cell recognition(2). Genetic studies have established that Dscam is required for neural circuit assembly(1,3-10), but the extent to which isoform diversity contributes to this process is not known. Here we provide conclusive evidence that Dscam diversity is essential for circuit assembly. Using homologous recombination, we reduced the entire repertoire of Dscam ectodomains to just a single isoform. Neural circuits in these mutants are severely disorganized. Furthermore, we show that it is crucial for neighbouring neurons to express distinct isoforms, but that the specific identity of the isoforms expressed in an individual neuron is unimportant. We conclude that Dscam diversity provides each neuron with a unique identity by which it can distinguish its own processes from those of other neurons, and that this self-recognition is essential for wiring the Drosophila brain.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90049 USA; Inst Mol Pathol, A-1030 Vienna, Austria	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90049 USA.	lzipursky@mednet.ucla.edu; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Newsome TP, 2000, DEVELOPMENT, V127, P851; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Takeichi M, 1997, COLD SPRING HARB SYM, V62, P505; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; WOJTOWICZ WM, IN PRESS CELL; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	28	158	160	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					223	U6		10.1038/nature06099	http://dx.doi.org/10.1038/nature06099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851526	Green Accepted			2022-12-28	WOS:000249394500051
J	Saleska, SR; Didan, K; Huete, AR; da Rocha, HR				Saleska, Scott R.; Didan, Kamel; Huete, Alfredo R.; da Rocha, Humberto R.			Amazon forests green-up during 2005 drought	SCIENCE			English	Article									Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; Univ Sao Paulo, Dept Atmospher Sci, BR-05508090 Sao Paulo, Brazil	University of Arizona; University of Arizona; Universidade de Sao Paulo	Saleska, SR (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	saleska@email.arizona.edu	Saleska, Scott R/K-1733-2016; Mitchard, Edward T A/C-6346-2009; Huete, Alfredo R/C-1294-2008	Saleska, Scott R/0000-0002-4974-3628; Mitchard, Edward T A/0000-0002-5690-4055; Huete, Alfredo R/0000-0003-2809-2376				Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Betts RA, 2004, THEOR APPL CLIMATOL, V78, P157, DOI 10.1007/s00704-004-0050-y; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Makarieva AM, 2007, HYDROL EARTH SYST SC, V11, P1013, DOI 10.5194/hess-11-1013-2007; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0	7	422	433	9	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					612	612		10.1126/science.1146663	http://dx.doi.org/10.1126/science.1146663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17885095	Green Submitted			2022-12-28	WOS:000250409200036
J	Lowe, CJM; Barker, KL; Dewey, M; Sackley, CM				Lowe, Catherine J. Minns; Barker, Karen L.; Dewey, Michael; Sackley, Catherine M.			Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; IMPACT	Objective To evaluate the effectiveness of physiotherapy exercise after elective primary total knee arthroplasty in patients with osteoarthritis. Design Systematic review. Data sources Database searches: AMED, CINAHL, Embase, King's Fund, Medline, Cochrane library (Cochrane reviews, Cochrane central register of controlled trials, DARE), PEDro, Department of Health national research register. Hand searches: Physiotherapy, Physical Therapy, Journal of Bone and joint Surgery (Britain) Conference Proceedings. Review methods Randomised controlled trials were reviewed if they included a physiotherapy exercise intervention compared with usual or standard physiotherapy care, or compared two types of exercise physiotherapy interventions meeting the review criteria, after discharge from hospital after elective primary total knee arthroplasty for osteoarthritis. Outcome measures Functional activities of daily living, walking, quality of life, muscle strength, and range of motion in the knee joint. Trial quality was extensively evaluated. Narrative synthesis plus meta-analyses with fixed effect models, weighted mean differences, standardised effect sizes, and tests for heterogeneity. Results Six trials were identified, five of which were suitable for inclusion in meta-analyses. There was a small to moderate standardised effect size (0.33, 95% confidence interval 0.07 to 0.58) in favour of functional exercise for function three to four months postoperatively. There were also small to moderate weighted mean differences of 2.9 (0.61 to 5.2) for range of joint motion and 1.66 (-1 to 4.3) for quality of life in favour of functional exercise three to four months postoperatively. Benefits of treatment were no longer evident at one year. Conclusions Interventions including physiotherapy functional exercises after discharge result in short term benefit after elective primary total knee arthroplasty. Effect sizes are small to moderate, with no long term benefit.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Nuffield Orthopaed Hosp NHS Trust, Physiotherapy Res Unit, Oxford, England; Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England	University of Birmingham; Nuffield Orthopaedic Centre; University of Oxford; University of Nottingham	Lowe, CJM (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	catherine.minnslowe@nocangtox.nhs.uk	Dewey, Michael E/E-2049-2010	Dewey, Michael E/0000-0002-7522-3677; sackley, catherine/0000-0002-8580-6622				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; COHEN J, 1969, SCI PROG, V57, P23; Critical Appraisal Skills Programme, 10 QUEST HELP YOU MA; Fautrel B, 2005, JOINT BONE SPINE, V72, P235, DOI 10.1016/j.jbspin.2004.08.009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; KNIPSCHILD P, 1994, BRIT MED J, V309, P719, DOI 10.1136/bmj.309.6956.719; MAIN E, 2003, CARDIOPULM PHYS THER, V14, P24; Martin J., 1988, OPCS SURVEYS DISABIL, V1; *NAT AUD OFF, 2003, 956 HC NAT AUD OFF; *NAT AUD OFF, 2003, 956 NAT AUD OFF; *NAT JOINT REG ENG, 2005, 3 NAT JOINT REG ENGL; Naylor J, 2006, PHYSIOTHER RES INT, V11, P35, DOI 10.1002/pri.40; NOBLE PC, 2005, CLIN ORTHOP RELAT R, V431, P157, DOI DOI 10.1097/01.BL0; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; R Development Core Team, 2006, R LANG ENV STAT COMP; Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9; Sultan PG, 2003, CLIN ORTHOP RELAT R, P167, DOI 10.1097/01.blo.0000081937.75404.ed; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa	19	187	190	2	26	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 20	2007	335	7624					812	815		10.1136/bmj.39311.460093.BE	http://dx.doi.org/10.1136/bmj.39311.460093.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17884861	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000250630700038
J	Rohrbach, A; Ballhaus, C; Golla-Schindler, U; Ulmer, P; Kamenetsky, VS; Kuzmin, DV				Rohrbach, Arno; Ballhaus, Chris; Golla-Schindler, Ute; Ulmer, Peter; Kamenetsky, Vadim S.; Kuzmin, Dmitry V.			Metal saturation in the upper mantle	NATURE			English	Article							FERRIC IRON; OXIDATION-STATE; OXYGEN FUGACITY; CATIO3 PEROVSKITE; CORE FORMATION; MINERALS; SOLUBILITY; INCLUSIONS; BAROMETER; GARNETS	The oxygen fugacity (f)(O2) of the Earth's mantle is one of the fundamental variables in mantle petrology. Through ferric-ferrous iron and carbon-hydrogen-oxygen equilibria, (f)(O2) influences the pressure-temperature positions of mantle solidi and compositions of small-degree mantle melts(1-3). Among other parameters, (f)(O2) affects the water storage capacity and rheology of the mantle(4,5). The uppermost mantle, as represented by samples and partial melts, is sufficiently oxidized to sustain volatiles, such as H2O and CO2, as well as carbonatitic melts(6,7), but it is not known whether the shallow mantle is representative of the entire upper mantle. Using high-pressure experiments, we show here that large parts of the asthenosphere are likely to be metal-saturated. We found that pyroxene and garnet synthesized at >7 GPa in equilibrium with metallic Fe can incorporate sufficient ferric iron that the mantle at >250 km depth is so reduced that an (Fe,Ni)-metal phase may be stable. Our results indicate that the oxidized nature of the upper mantle can no longer be regarded as being representative for the Earth's upper mantle as a whole and instead that oxidation is a shallow phenomenon restricted to an upper veneer only about 250 km in thickness.	Univ Bonn, Mineral Petrol Inst, D-53115 Bonn, Germany; Univ Bonn, Museum, D-53115 Bonn, Germany; Univ Munster, Inst Mineral, D-48149 Munster, Germany; ETH, Inst Mineral & Petrog, CH-8092 Zurich, Switzerland; Univ Tasmania, ARC, Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia; Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; SB RAS, Inst Geol & Mineral, Novosibirsk 630090, Russia	University of Bonn; University of Bonn; University of Munster; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tasmania; University of Tasmania; Max Planck Society; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences	Rohrbach, A (corresponding author), Univ Bonn, Mineral Petrol Inst, Poppelsdorfer Schloss, D-53115 Bonn, Germany.	rohrbaa@web.de; ballhaus@uni-bonn.de	Kamenetsky, Vadim S/B-1019-2008; Kamenetsky, Vadim/CAF-7424-2022; Kamenetsky, Vadim/K-2200-2019; Kuzmin, Dmitry/A-3809-2014; Ulmer, Peter/G-4694-2018	Kamenetsky, Vadim S/0000-0002-2734-8790; Ulmer, Peter/0000-0001-9131-0669; Pauldurai, Jona/0000-0002-7217-0872				BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; BALLHAUS C, 1991, CONTRIB MINERAL PETR, V107, P27, DOI 10.1007/BF00311183; BALLHAUS C, 1990, NATURE, V348, P437, DOI 10.1038/348437a0; Bellis A, 2007, J PETROL, V48, P219, DOI 10.1093/petrology/egl054; Canil D, 1996, J PETROL, V37, P609, DOI 10.1093/petrology/37.3.609; Canil D, 2007, J PETROL, V48, P231, DOI 10.1093/petrology/egl067; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Eggler DH., 1982, HIGH PRESSURE RES GE, P237, DOI [10.1007/978-94-009-7867-6_19, DOI 10.1007/978-94-009-7867-6_19]; FROST BR, 1991, REV MINERAL, V25, P1; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; IRIFUNE T, 1987, PHYS EARTH PLANET IN, V45, P324, DOI 10.1016/0031-9201(87)90040-9; Jacob DE, 2004, CONTRIB MINERAL PETR, V146, P566, DOI 10.1007/s00410-003-0518-2; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; Keppler H, 2000, PHYS CHEM MINER, V27, P371, DOI 10.1007/s002699900070; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; LUTH RW, 1990, CONTRIB MINERAL PETR, V104, P56, DOI 10.1007/BF00310646; Matveev S, 1997, GEOCHIM COSMOCHIM AC, V61, P3081, DOI 10.1016/S0016-7037(97)00142-7; McCammon CA, 2003, PHYS CHEM MINER, V30, P206, DOI 10.1007/s00269-003-0309-3; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; Mysen BO, 1987, GEOCHEM SOC SPEC PUB, P121; ONEILL HSC, 1993, AM MINERAL, V78, P456; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; RINGWOOD AE, 1965, NATURE, V207, P701, DOI 10.1038/207701a0; Sinmyo R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025858; Stachel T, 1998, CONTRIB MINERAL PETR, V132, P34, DOI 10.1007/s004100050403; van Aken PA, 1998, PHYS CHEM MINER, V25, P323, DOI 10.1007/s002690050122; van Aken PA, 2002, PHYS CHEM MINER, V29, P188, DOI 10.1007/s00269-001-0222-6; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; WALLACE ME, 1988, NATURE, V335, P343, DOI 10.1038/335343a0; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337; Woodland AB, 2003, EARTH PLANET SC LETT, V214, P295, DOI 10.1016/S0012-821X(03)00379-0	32	221	237	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					456	458		10.1038/nature06183	http://dx.doi.org/10.1038/nature06183			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898766				2022-12-28	WOS:000249724800039
J	Wadman, M				Wadman, Meredith			Copycat consolidation	NATURE			English	News Item																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					393	393		10.1038/449393a	http://dx.doi.org/10.1038/449393a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898741	Bronze			2022-12-28	WOS:000249724800014
J	Zou, YZ; Stastny, P; Susal, C; Dohler, B; Opelz, G				Zou, Yizhou; Stastny, Peter; Suesal, Caner; Doehler, Bernd; Opelz, Gerhard			Antibodies against MICA antigens and kidney-transplant rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT REJECTION; ENDOTHELIAL-CELLS; SURFACE EXPRESSION; HLA ANTIBODY; IDENTIFICATION; CYTOTOXICITY; MOLECULES; FAILURE; RISK	Background Good HLA-A, HLA-B, and HLA-DR matches do not guarantee rejection-free renal transplantation. Some kidney transplants fail despite such matches, suggesting that other antigens might be targets for rejection. Major-histocompatibility-complex (MHC) class I-related chain A (MICA) antigens are polymorphic and can elicit antibody production. We sought to determine whether an immune response to MICA antigens might play a role in the failure of kidney allografts. Methods Pretransplantation serum samples from 1910 recipients of kidney transplants from deceased donors were tested for anti-MICA antibodies with an assay in which single MICA antigens were attached to polystyrene microspheres. Results Antibodies against MICA alleles were detected in 217 of the 1910 patients (11.4%). The presence of MICA antibodies was associated with renal-allograft rejection. The mean (+/-SE) 1-year graft-survival rate was 88.3+/-2.2% among recipients with anti-MICA antibodies as compared with 93.0+/-0.6% among recipients without anti-MICA antibodies (P=0.01). Among recipients of first kidney transplants, the survival rate was even lower among MICA antibody-positive patients (87.8+/-2.4%) than among MICA antibody-negative recipients (93.5+/-0.6%, P=0.005). In addition, the association of MICA sensitization with reduced graft survival was more evident in kidney-transplant recipients with good HLA matching: among 326 recipients who received well-matched kidneys (0 or 1 HLA-A plus HLA-B plus HLA-DR mismatch), sensitization against MICA was associated with poorer allograft survival (83.2+/-5.8% among those with anti-MICA antibodies vs. 95.1+/-1.3% among those without such antibodies, P=0.002). Conclusions Presensitization of kidney-transplant recipients against MICA antigens is associated with an increased frequency of graft loss and might contribute to allograft loss among recipients who are well matched for HLA. N Engl J Med 2007;357:1293-300.	Univ Texas, SW Med Ctr, Dept Internal Med, Transplantat Immunol Div, Dallas, TX 75390 USA; Univ Heidelberg, Dept Transplantat Immunol, Heidelberg, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ruprecht Karls University Heidelberg	Stastny, P (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Transplantat Immunol Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	peter.stastny@utsouthwestern.edu						Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Cardarelli F, 2005, TRANSPLANT INT, V18, P532, DOI 10.1111/j.1432-2277.2005.00085.x; Carter V, 2005, TRANSPLANT P, V37, P654, DOI 10.1016/j.transproceed.2004.12.043; COX DR, 1972, J R STAT SOC B, V34, P187; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Hankey KG, 2002, TRANSPLANTATION, V73, P304, DOI 10.1097/00007890-200201270-00029; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kekomaki S, 2001, TISSUE ANTIGENS, V57, P154, DOI 10.1034/j.1399-0039.2001.057002154.x; KRISTENSEN T, 1976, ACTA PATH MICRO IM C, V84, P304; Lee PC, 2002, TRANSPLANTATION, V74, P1192, DOI 10.1097/00007890-200210270-00025; Menier C, 2002, INT J CANCER, V100, P63, DOI 10.1002/ijc.10460; Mizutani K, 2005, AM J TRANSPLANT, V5, P2265, DOI 10.1111/j.1600-6143.2005.01016.x; Mizutani K, 2006, HUM IMMUNOL, V67, P683, DOI 10.1016/j.humimm.2006.06.002; Mizutani K, 2006, HUM IMMUNOL, V67, P223, DOI 10.1016/j.humimm.2006.02.007; MORAES JR, 1977, J CLIN INVEST, V60, P449, DOI 10.1172/JCI108795; MORAES JR, 1975, 6 INT HIST WORKSH C, P391; Opelz G, 2005, LANCET, V365, P1570, DOI 10.1016/S0140-6736(05)66458-6; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Quiroga I, 2006, TRANSPLANTATION, V81, P1196, DOI 10.1097/01.tp.0000205788.05322.42; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Tinckam K, 2005, TRANSPLANTATION, V79, P836, DOI 10.1097/01.TP.0000155187.81806.DF; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007; Vermehren D, 2002, TRANSPLANTATION, V74, P1479, DOI 10.1097/00007890-200212150-00001; Zhang YZ, 2006, HUM IMMUNOL, V67, P215, DOI 10.1016/j.humimm.2006.02.014; Zou YZ, 2006, HUM IMMUNOL, V67, P230, DOI 10.1016/j.humimm.2006.02.017; Zou YZ, 2002, HUM IMMUNOL, V63, P30, DOI 10.1016/S0198-8859(01)00349-4; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1; Zwirner NW, 2000, HUM IMMUNOL, V61, P917, DOI 10.1016/S0198-8859(00)00162-2	32	318	368	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1293	1300		10.1056/NEJMoa067160	http://dx.doi.org/10.1056/NEJMoa067160			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898098				2022-12-28	WOS:000249711500005
J	Balskus, EP; Jacobsen, EN				Balskus, Emily P.; Jacobsen, Eric N.			Asymmetric catalysis of the transannular Diels-Alder reaction	SCIENCE			English	Article							CHIRAL OXAZABOROLIDINE; ALPHA-DEPROTONATION; STRATEGY; DESYMMETRIZATION	Transannular chemical reactions are unparalleled in their ability to generate high degrees of stereochemical and architectural complexity in a single transformation. However, the successful application of this approach in synthesis depends on the ability to predict and control the outcome of the transannular reaction. Use of a chiral catalyst in this context represents an attractive, yet unused, strategy. This report describes a catalytic, asymmetric transannnular Diels-Alder (TADA) reaction that affords polycyclic products in high enantiomeric excess. This catalyst system can also alter the inherent diastereoselectivity of cyclizations with substrates containing chiral centers. Additionally, the catalytic enantioselective TADA has been used as the key step in a total synthesis of the sesquiterpene 11,12-diacetoxydrimane; this route may provide a general approach to the polycyclic carbon framework shared by many terpene natural products.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NIGMS NIH HHS [GM-59316, R01 GM059316] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059316] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Corey EJ, 2002, J AM CHEM SOC, V124, P3808, DOI 10.1021/ja025848x; DESLONGCHAMPS P, 1992, PURE APPL CHEM, V64, P1831, DOI 10.1351/pac199264121831; Deslongchamps P., 1991, ALDRICHIM ACTA, V24, P43; Evans D.A., 1999, COMPREHENSIVE ASYMME, V3; Fraga BM, 2006, NAT PROD REP, V23, P943, DOI 10.1039/b507870a; Hodgson DM, 1999, CHEM COMMUN, P309, DOI 10.1039/a809105f; Hodgson DM, 1998, J CHEM SOC PERK T 1, P2151, DOI 10.1039/a802434k; Hodgson DM, 2001, ORG LETT, V3, P441, DOI 10.1021/ol006947n; Inoue M, 2007, J ORG CHEM, V72, P3065, DOI 10.1021/jo0700474; Knopff O, 2007, ANGEW CHEM INT EDIT, V46, P1307, DOI 10.1002/anie.200604518; Lu K, 2006, ORG LETT, V8, P1193, DOI 10.1021/ol060221v; Marsault E, 2001, TETRAHEDRON, V57, P4243, DOI 10.1016/S0040-4020(01)00121-1; MASAMUNE S, 1985, ANGEW CHEM INT EDIT, V24, P1, DOI 10.1002/anie.198500013; Montagnac A, 1996, J NAT PROD, V59, P866, DOI 10.1021/np9603737; Myers AG, 1997, J AM CHEM SOC, V119, P6496, DOI 10.1021/ja970402f; NEGI M, 1993, ENZYME MICROB TECH, V15, P483, DOI 10.1016/0141-0229(93)90080-L; Ryu DH, 2003, J AM CHEM SOC, V125, P6388, DOI 10.1021/ja035393r; STORK G, 1992, J AM CHEM SOC, V114, P7578, DOI 10.1021/ja00045a049; TAMAO K, 1983, J ORG CHEM, V48, P2120, DOI 10.1021/jo00160a046; Witter DJ, 1996, J ORG CHEM, V61, P2613, DOI 10.1021/jo952117p; Zhou G, 2003, ORG LETT, V5, P3979, DOI 10.1021/ol035542a	22	83	83	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1736	1740		10.1126/science.1146939	http://dx.doi.org/10.1126/science.1146939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	212HD	17885133				2022-12-28	WOS:000249585900044
J	Engheta, N				Engheta, Nader			Circuits with light at nanoscales: Optical nanocircuits inspired by metamaterials	SCIENCE			English	Review							NEGATIVE-INDEX METAMATERIALS; REFRACTION; FREQUENCIES; FIELD; SUPERLENS; HYPERLENS	A form of optical circuitry is overviewed in which a tapestry of subwavelength nanometer-scale metamaterial structures and nanoparticles may provide a mechanism for tailoring, patterning, and manipulating local optical electric fields and electric displacement vectors in a subwavelength domain, leading to the possibility of optical information processing at the nanometer scale. By exploiting the optical properties of metamaterials, these nanoparticles may play the role of "lumped" nanocircuit elements such as nanoinductors, nanocapacitors, and nanoresistors, analogous to microelectronics. I show that this concept of metamaterial-inspired nanoelectronics ("metactronics") can bring the tools and mathematical machinery of the circuit theory into optics, may link the fields of optics, electronics, plasmonics, and metamaterials, and may provide road maps to future innovations in nanoscale optical devices, components, and more intricate nanoscale metamaterials.	Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu						Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Alu A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1884757; Alu A, 2006, J OPT SOC AM B, V23, P571, DOI 10.1364/JOSAB.23.000571; Alu A, 2006, OPT EXPRESS, V14, P1557, DOI 10.1364/OE.14.001557; Alu A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205436; Alu A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024304; Balmain KG, 2002, IEEE ANTENN WIREL PR, V1, P146, DOI 10.1109/LAWP.2002.807565; Caloz C, 2006, ELECTROMAGNETIC METAMATERIALS: TRANSMISSION LINE THEORY AND MICROWAVE APPLICATIONS: THE ENGINEERING APPROACH, P1; Dolling G, 2007, OPT LETT, V32, P53, DOI 10.1364/OL.32.000053; Dolling G, 2006, OPT LETT, V31, P1800, DOI 10.1364/OL.31.001800; Eleftheriades GV, 2005, NEGATIVE-REFRACTION METAMATERIALS: FUNDAMENTAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471744751; Engheta N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.095504; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Li JJ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.115125; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Meyrath TP, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205102; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Pendry JB, 2006, SCI AM, V295, P60, DOI 10.1038/scientificamerican0706-60; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Ramakrishna SA, 2003, J MOD OPTIC, V50, P1419, DOI 10.1080/0950034021000020824; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Schurig D, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/162; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shalaev VM, 1996, PHYS REP, V272, P61, DOI 10.1016/0370-1573(95)00076-3; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shen JT, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197401; Silveirinha M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157403; Silveirinha MG, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036603; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404; Zhang S, 2006, J OPT SOC AM B, V23, P434, DOI 10.1364/JOSAB.23.000434	37	991	1011	13	569	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1698	1702		10.1126/science.1133268	http://dx.doi.org/10.1126/science.1133268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885123	Green Published			2022-12-28	WOS:000249585900032
J	Zuckerman, S; Lahad, A; Shmueli, A; Zimran, A; Peleg, L; Orr-Urtreger, A; Levy-Lahad, E; Sagi, M				Zuckerman, Shachar; Lahad, Amnon; Shmueli, Amir; Zimran, Ari; Peleg, Leah; Orr-Urtreger, Avi; Levy-Lahad, Ephrat; Sagi, Michal			Carrier screening for Gaucher disease - Lessons for low-penetrance, treatable diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASHKENAZI-JEWISH POPULATION; ENZYME REPLACEMENT THERAPY; TAY-SACHS-DISEASE; ETHNIC-GROUPS; MUTATIONS; ISRAEL; GENE; PREVALENCE; DISORDERS; FREQUENCY	Context The aim of carrier screening is to prevent severe, untreatable genetic disease by identifying couples at risk before the birth of an affected child, and providing such couples with options for reproductive outcomes for affected pregnancies. Gaucher disease (GD) is an autosomal recessive storage disorder, relatively frequent in Ashkenazi Jews. Carrier screening for GD is controversial because common type 1 GD is often asymptomatic and effective treatment exists. However, screening is offered to Ashkenazi Jews worldwide and has been offered in Israel since 1995. Objective To examine the scope and outcomes of nationwide GD screening. Design, Setting, and Participants All Israeli genetic centers provided data on the number of individuals screened for GD, the number of carriers identified, the number of carrier couples identified, and the mutations identified in these couples between January 1, 1995, and March 31, 2003. Carrier couples were interviewed via telephone between January 21, 2003, and August 31, 2004, using a structured questionnaire for relevant outcome measures. Main Outcome Measures Screening scope (number of testing centers, tested individuals, and carrier couples), screening process (type of pretest and posttest consultations), and screening outcomes (utilization of prenatal diagnosis and pregnancy terminations). Results Between January 1, 1995, and March 31, 2003, 10 of 12 Israeli genetic centers (83.3%) offered carrier screening. Carrier frequency was 5.7%, and 83 carrier couples were identified among an estimated 28 893 individuals screened. There were 82 couples at risk for offspring with type 1 GD. Seventy of 82 couples (85%) were at risk for asymptomatic or mildly affected offspring and 12 of 82 couples (15%) were at risk for moderately affected offspring. At postscreening, 65 interviewed couples had 90 pregnancies, and prenatal diagnosis was performed in 68 pregnancies (76%), detecting 16 fetuses with GD (24%). Pregnancies were terminated in 2 of 13 fetuses (15%) predicted to be asymptomatic or mildly affected and 2 of 3 fetuses (67%) with predicted moderate disease. There were significantly fewer pregnancy terminations in couples who in addition to genetic counseling had medical counseling with a GD expert (1 of 13 [8%] vs 3 of 3 with no medical counseling [100%], P = .007). Conclusions In this study of GD screening among Ashkenazi Jewish couples in Israel, most couples did not terminate affected pregnancies, although screening was associated with a few pregnancy terminations. The main possible benefit was providing couples with knowledge and control. The divergence of these outcomes from stated goals of screening programs is likely to confront carrier screening programs for low-penetrance diseases.	Shaare Zedek Med Ctr, Med Genet Unit, IL-91031 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Family Med, IL-91010 Jerusalem, Israel; Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel; Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Tel Aviv sourasky Med Ctr, Inst Genet, IL-69978 Tel Aviv, Israel; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Lahad, A (corresponding author), Shaare Zedek Med Ctr, Med Genet Unit, POB 3235, IL-91031 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Orr-Urtreger, Avi/0000-0001-9305-6203				Allitto BA, 1997, AM J HUM GENET, V61, pA325; Azuri J, 1998, GENET TEST, V2, P297, DOI 10.1089/gte.1998.2.297; Ben-Chetrit E, 2003, ISR MED ASSOC J, V5, P592; BEUTLER E, 1992, BLOOD, V79, P1662; Beutler E, 1997, BAILLIERE CLIN HAEM, V10, P751, DOI 10.1016/S0950-3536(97)80038-8; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Brautbar A, 2003, BLOOD CELL MOL DIS, V31, P187, DOI 10.1016/S1079-9796(03)00126-8; Burke W, 2001, GENET TEST, V5, P201, DOI 10.1089/10906570152742245; Cao A, 1991, CURR OPIN GENET DEV, V1, P48, DOI 10.1016/0959-437X(91)80040-S; Connock M, 2006, HEALTH TECHNOL ASSES, V10, pIII; Ekstein J, 2001, ADV GENET, V44, P297; Elstein D, 2005, GENET TEST, V9, P26, DOI 10.1089/gte.2005.9.26; Elstein D, 1998, QJM-MON J ASSOC PHYS, V91, P483, DOI 10.1093/qjmed/91.7.483; Eng CM, 1997, JAMA-J AM MED ASSOC, V278, P1268, DOI 10.1001/jama.278.15.1268; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Heitner R, 2002, BLOOD CELL MOL DIS, V28, P127, DOI 10.1006/bcmd.2002.0497; Horowitz M, 1998, HUM MUTAT, V12, P240, DOI 10.1002/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J; *ISR MED ASS, 2004, POS PAP CARR SCREEN; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Kannai R, 2006, ISR MED ASSOC J, V8, P347; Kesselman I, 2006, BLOOD CELL MOL DIS, V37, P46, DOI 10.1016/j.bcmd.2006.05.002; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Langlois S, 2006, J OBSTET GYNAECOL CA, V28, P324, DOI 10.1016/S1701-2163(16)32131-4; Lerer I, 2000, AM J MED GENET, V95, P53, DOI 10.1002/1096-8628(20001106)95:1<53::AID-AJMG11>3.0.CO;2-2; Lilani Anjali, 2005, Hum Reprod Genet Ethics, V11, P28; McCabe ERB, 1996, JAMA-J AM MED ASSOC, V275, P548, DOI 10.1001/jama.1996.03530310054033; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Sagi M, 1998, SCI CONTEXT, V11, P419, DOI 10.1017/S0269889700003112; Strom CM, 2004, GENET MED, V6, P145, DOI 10.1097/01.GIM.0000127267.57526.D1; Vallance H, 2003, CRIT REV CL LAB SCI, V40, P473, DOI 10.1080/10408360390247832; Wallerstein R, 2001, GENET TEST, V5, P61, DOI 10.1089/109065701750168789; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wertz DC, 2002, AM J MED GENET, V108, P29, DOI 10.1002/ajmg.10212; WILLIAMS FIB, 1993, J PHYS IV, V3, P3, DOI 10.1051/jp4:1993201; WILSON JMG, 1968, PRINCIPLES PRACTICE, P473; Zimran A, 1997, Harefuah, V133, P107; Zimran A, 2000, ISRAEL MED ASSOC J, V2, P80; ZIMRAN A, 1992, MEDICINE, V71, P337, DOI 10.1097/00005792-199211000-00002; ZIMRAN A, 1994, AM J MED GENET, V50, P74, DOI 10.1002/ajmg.1320500116	43	60	62	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1281	1290		10.1001/jama.298.11.1281	http://dx.doi.org/10.1001/jama.298.11.1281			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878420	Bronze			2022-12-28	WOS:000249524100018
J	Schwarz, EB; Postlethwaite, DA; Hung, YY; Armstrong, MA				Schwarz, Eleanor Bimla; Postlethwaite, Debbie A.; Hung, Yun-Yi; Armstrong, Mary Anne			Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; UNINTENDED PREGNANCY; RISK CLASSIFICATION; DRUG-USE; PRESCRIPTION; INFORMATION	Background: Certain medications are identified by the U.S. Food and Drug Administration (FDA) as class D or X because they increase the risk for birth defects if used during pregnancy. Objective: To assess pregnancy rates and the frequency of contraceptive counseling documented with prescriptions for class D or X drugs filled by women of reproductive age. Design: Description of prescriptions filled in 2001. Setting: A large health maintenance organization in northern California in 2001. Patients: 488 175 women age 15 to 44 years who filled a total of 1 011 658 class A, B, D, or X prescriptions. Measurements: Medications dispensed, contraceptive counseling, and pregnancy testing. Results: A class D or X prescription was filled by 1 of every 6 women studied. Women who filled a prescription for class D or X medications were no more likely than women who filled prescriptions for safer, class A or B medications to have received contraceptive counseling, filled a contraceptive prescription, or been sterilized (48% vs. 51% of prescriptions). There was little variation by clinical indication in rates of contraceptive counseling with class D or X prescriptions, except for isotretinoin. Women who filled a class D or X prescription were only slightly less likely to have a pregnancy documented within 3 months than women filling a class A or B prescription (1.0% vs. 1.4% of prescriptions). Limitations: International Classification of Diseases, Ninth Revision, codes underestimate contraceptive counseling. Documentation of a positive pregnancy test after filling a prescription may overestimate medication use in early pregnancy. Women who filled several prescriptions are overrepresented in prescription analyses. Conclusion: Prescriptions for potentially teratogenic medications are frequently filled by women of childbearing age without documentation of contraceptive counseling.	Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA; Kaiser Permanente No California, Womens Hlth Res Inst, Oakland, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente	Schwarz, EB (corresponding author), Univ Pittsburgh, Ctr Res Hlth Care, 230 McKee Place,Suite 600, Pittsburgh, PA 15213 USA.	schwarzeb@upmc.edu		Schwarz, Eleanor Bimla/0000-0002-9912-8236	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD051585] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R43CA094612, R44CA094612] Funding Source: NIH RePORTER; NCI NIH HHS [R44 CA094612, R43 CA094612] Funding Source: Medline; NICHD NIH HHS [K23 HD051585, K23 HD051585-01, K23 HD051585-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Addis A, 2000, DRUG SAFETY, V23, P245, DOI 10.2165/00002018-200023030-00006; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P117, DOI 10.2307/3038208; Briggs G.C., 2002, DRUGS PREGNANCY LACT; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V54, P1301; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Lee E, 2006, PHARMACOEPIDEM DR S, V15, P537, DOI 10.1002/pds.1241; *METC HUM RES CONS, 2005, WOM HLTH CAR UND COS; PERMANENTE K, 2006, KAISER HLTH PLAN BEN; Pole M, 2000, J CLIN PHARMACOL, V40, P573; Sannerstedt R, 1996, DRUG SAFETY, V14, P69, DOI 10.2165/00002018-199614020-00001; Sanz E, 2001, EUR J OBSTET GYN R B, V95, P127, DOI 10.1016/S0301-2115(00)00375-4; Schwarz EB, 2005, AM J MED, V118, P1240, DOI 10.1016/j.amjmed.2005.02.029; TRUSSEL J, 1999, FAM PLANN PERSPECT, V64, P72; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; Weisman CS, 2002, WOMEN HEALTH ISS, V12, P79, DOI 10.1016/S1049-3867(01)00147-5; WILSON JG, 1981, AM J OBSTET GYNECOL, V141, P567, DOI 10.1016/S0002-9378(15)33279-8; 2006, PHYS DESK REFERENCE	19	63	66	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					370	376		10.7326/0003-4819-147-6-200709180-00006	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876020	Green Accepted			2022-12-28	WOS:000249726200002
J	BRAUMAN, JI				BRAUMAN, JI			POLYMERS	SCIENCE			English	Editorial Material																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					853	853		10.1126/science.251.4996.853	http://dx.doi.org/10.1126/science.251.4996.853			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847364				2022-12-28	WOS:A1991EY62900001
J	CHERFAS, J				CHERFAS, J			GREENPEACE AND SCIENCE - OIL AND WATER	SCIENCE			English	Editorial Material																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1288	1290		10.1126/science.247.4948.1288	http://dx.doi.org/10.1126/science.247.4948.1288			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843783				2022-12-28	WOS:A1990CU25300017
J	KLEIN, GD				KLEIN, GD			THERMAL HISTORY OF SEDIMENTARY BASINS - METHODS AND CASE-HISTORIES - NAESER,NL, MCCULLOH,TH	SCIENCE			English	Book Review											KLEIN, GD (corresponding author), UNIV ILLINOIS,DEPT GEOL,URBANA,IL 61801, USA.							NAESER NL, 1988, THERMAL HIST SEDIMEN	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1619	1619		10.1126/science.243.4898.1619	http://dx.doi.org/10.1126/science.243.4898.1619			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847269				2022-12-28	WOS:A1989T795200048
J	WISE, SP				WISE, SP			NEUROBIOLOGY OF NEOCORTEX - RAKIC,P, SINGER,W	SCIENCE			English	Book Review											WISE, SP (corresponding author), NIMH,NEUROPHYSIOL LAB,POOLESVILLE,MD 20837, USA.							RAKIC P, 1987, NEUROBIOLOGY NEOCORT	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1617	1617		10.1126/science.243.4898.1617	http://dx.doi.org/10.1126/science.243.4898.1617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847266				2022-12-28	WOS:A1989T795200045
J	Kramer, MS; Matush, L; Vanilovich, I; Platt, R; Bogdanovich, N; Sevkovskaya, Z; Dzikovich, I; Shishko, G; MazerS, B				Kramer, Michael S.; Matush, Lidia; Vanilovich, Irina; Platt, Robert; Bogdanovich, Natalia; Sevkovskaya, Zinaida; Dzikovich, Irina; Shishko, Gyorgy; MazerS, Bruce			Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOPIC-DERMATITIS; CHILDHOOD; CHILDREN; METAANALYSIS; DISEASE; PREVALENCE; PROTECT; ECZEMA	Objective To assess whether exclusive and prolonged breast feeding reduces the risk of childhood asthma and allergy by age 6.5 years. Design Cluster randomised trial. Setting 31 Belarussian maternity hospitals and their affiliated polyclinics. Participants A total of 17 046 mother-infant pairs were enrolled, of whom 13 889 (81.5%) were followed up at age 6.5 years. Intervention Breastfeeding promotion intervention modelled on the WHO/UNICEF baby friendly hospital initiative. Main outcome measures International study of asthma and allergies in childhood (ISAAC) questionnaire and skin prick tests of five inhalant antigens. Results The experimental intervention led to a large increase in exclusive breast feeding at 3 months (44.3% v 6.4%; P<0.001) and a significantly higher prevalence of any breast feeding at all ages up to and including 12 months. The experimental group had no reduction in risks of allergic symptoms and diagnoses or positive skin prick tests. In fact, after exclusion of six sites (three experimental and three control) with suspiciously high rates of positive skin prick tests, risks were significantly increased in the experimental group for four of the five antigens. Conclusions These results do not support a protective effect of prolonged and exclusive breast feeding on asthma or allergy.	McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Allergy & Clin Immunol, Montreal, PQ H3H 1P3, Canada; McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Canadian Inst Hlth Res, Inst Human Dev & Child & Youth Hlth, Montreal, PQ, Canada; Belarrusian Minist Hlth, Dept Maternal & Child Hlth, Minsk, BELARUS; Belarrusian Maternal & Child Hlth Res Inst, Minsk, BELARUS; McGill Univ, Hlth Ctr Res Inst, IS IT, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University; Institute for Work & Health; McGill University	Kramer, MS (corresponding author), McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Allergy & Clin Immunol, 2300 Tupper St, Montreal, PQ H3H 1P3, Canada.	michael.kramer@mcgill.ca		Platt, Robert/0000-0002-5981-8443				ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Benn CS, 2004, AM J EPIDEMIOL, V160, P217, DOI 10.1093/aje/kwh208; Bloch AM, 2002, ACTA PAEDIATR, V91, P275, DOI 10.1080/08035250252833914; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Burgess SW, 2006, PEDIATRICS, V117, pE787, DOI 10.1542/peds.2005-1753; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Dell S, 2001, ARCH PEDIAT ADOL MED, V155, P1261, DOI 10.1001/archpedi.155.11.1261; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Gdalevich M, 2001, J PEDIATR-US, V139, P261, DOI 10.1067/mpd.2001.117006; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Golding J, 1997, EARLY HUM DEV, V49, pS121, DOI 10.1016/S0378-3782(97)00058-3; GRULEE C, 1936, J PEDIAT, V72, P411; KRAMER MS, 1988, J PEDIATR-US, V112, P181, DOI 10.1016/S0022-3476(88)80054-4; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036; Lowe AJ, 2006, J ALLERGY CLIN IMMUN, V117, P682, DOI 10.1016/j.jaci.2005.10.027; Muraro A, 2004, PEDIAT ALLERG IMM-UK, V15, P291, DOI 10.1111/j.1399-3038.2004.00127.x; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Oppenheimer J, 2006, ANN ALLERG ASTHMA IM, V96, pS6, DOI 10.1016/S1081-1206(10)60895-2; Purvis DJ, 2005, BRIT J DERMATOL, V152, P742, DOI 10.1111/j.1365-2133.2005.06540.x; Ronchetti R, 2004, INT ARCH ALLERGY IMM, V135, P136, DOI 10.1159/000080656; Rothenbacher D, 2005, CLIN EXP ALLERGY, V35, P1014, DOI 10.1111/j.1365-2222.2005.02298.x; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Takemura Y, 2001, AM J EPIDEMIOL, V154, P115, DOI 10.1093/aje/154.2.115; TAYLOR B, 1984, LANCET, V2, P1255, DOI 10.1016/S0140-6736(84)92805-8; Wegienka G, 2006, ANN ALLERG ASTHMA IM, V97, P78, DOI 10.1016/S1081-1206(10)61374-9; WHO/UNICEF, 1989, PROT PROM SUPP BREAS; Wright AL, 2001, THORAX, V56, P192, DOI 10.1136/thorax.56.3.192	31	187	200	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2007	335	7624					815	B818		10.1136/bmj.39304.464016.AE	http://dx.doi.org/10.1136/bmj.39304.464016.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17855282	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000250630700039
J	Stewart, CE; Stephens, DA; Fielder, AR; Moseley, MJ				Stewart, Catherine E.; Stephens, David A.; Fielder, Alistair R.; Moseley, Merrick J.			Objectively monitored patching regimens for treatment of amblyopia: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OCCLUSION TREATMENT; DOSE-RESPONSE; THERAPY; CHILDREN; EYE	Objectives To compare visual outcome in response to two prescribed rates of occlusion (six hours a day and 12 hours a day). Design Unmasked randomised trial. Setting Research clinics in two London hospitals. Participants 97 children with a confirmed diagnosis of amblyopia associated with strabismus, anisometropia, or both. Interventions 18 week period of wearing glasses (refractive adaptation) followed by occlusion prescribed ("patching") for six or 12 hours a day. Main outcome measures Visual acuity measured by logMAR letter recognition; objectively monitored rate of occlusion (hours a day). Results The mean age of children at study entry was 5.6 (SD 1.5) years. Ninety were eligible for occlusion but 10 dropped out in this phase, leaving 80 children who were randomised to a prescribed dose rate of six (n=40) or 12 (n=40) hours a day. The mean change in visual acuity of the amblyopic eye was not significantly different (P=0.64) between the two groups (0.26 (95% confidence interval 0.21 to 0.31) log units in six hour group; 0.24 (0.19 to 0.29) log units in 12 hour group). The mean dose rates (hours a day) actually received, however, were also not significantly different (4.2 (3.7 to 4.7) in six hour group v 6.2 (5.1 to 7.3) in 12 hour group; P=0.06). The visual outcome was similar for those children who received three to six hours a day or more than six to 12 hours a day, but significantly better than that in children who received less than three hours a day. Children aged under 4 required significantly less occlusion than older children. Visual outcome was not influenced by type of amblyopia. Conclusions Substantial (six hours a day) and maximal (12 hours a day) prescribed occlusion results in similar visual outcome. On average, the occlusion dose received in the maximal group was only 50% more than in the substantial group and in both groups was much less than that prescribed. Younger children required the least occlusion.	City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England; McGill Univ, Dept Math & Stat, Montreal, PQ H3A 2K6, Canada	City University London; McGill University	Moseley, MJ (corresponding author), City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England.	m.j.moseley@city.ac.uk		Stephens, David/0000-0001-9811-7140	National Institute for Health Research [N&AHP/C3/04/PD/015] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; Beck RW, 2003, OPHTHALMOLOGY, V110, P2075, DOI 10.1016/S0161-6420(03)01023-6; BLAKEMORE C, 1978, J PHYSIOL-LONDON, V283, P223, DOI 10.1113/jphysiol.1978.sp012498; Cobb CJ, 2002, BRIT J OPHTHALMOL, V86, P1278, DOI 10.1136/bjo.86.11.1278; Cotter SA, 2006, OPHTHALMOLOGY, V113, P895, DOI 10.1016/j.ophtha.2006.01.068; Daw NW, 2003, ADV INFAN R, P43; FIELDER AR, 1995, BRIT J OPHTHALMOL, V79, P585, DOI 10.1136/bjo.79.6.585; FIELDER AR, 1994, LANCET, V343, P547, DOI 10.1016/S0140-6736(94)91502-4; Flynn J T, 1999, Trans Am Ophthalmol Soc, V97, P373; FULTON AB, 1988, GRAEF ARCH CLIN EXP, V226, P309, DOI 10.1007/BF02172956; HARWERTH RS, 1989, EXP BRAIN RES, V74, P327, DOI 10.1007/BF00248866; HISCOX F, 1992, EYE, V6, P300, DOI 10.1038/eye.1992.59; Hrisos S, 2004, OPHTHALMOLOGY, V111, P1550, DOI 10.1016/j.ophtha.2003.12.059; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kushner BJ, 2005, OPHTHALMOLOGY, V112, P736, DOI 10.1016/j.ophtha.2004.10.006; KUTSCHKE PJ, 1991, OPHTHALMOLOGY, V98, P258; LEA S J H, 1989, Eye (London), V3, P783; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Loudon S E, 2002, Strabismus, V10, P79, DOI 10.1076/stra.10.2.79.8143; MASSIE H, 1965, T OPHTHALMOL SOC AUS, V24, P39; Moseley MJ, 2002, OPHTHAL PHYSL OPT, V22, P296, DOI 10.1046/j.1475-1313.2002.00034.x; Newsham D, 2002, BRIT J OPHTHALMOL, V86, P787, DOI 10.1136/bjo.86.7.787; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Searle A, 2002, EYE, V16, P150, DOI 10.1038/sj/EYE/6700086; Stewart CE, 2007, INVEST OPHTH VIS SCI, V48, P2589, DOI 10.1167/iovs.05-1243; Stewart CE, 2004, BRIT J OPHTHALMOL, V88, P1552, DOI 10.1136/bjo.2004.044214; Stewart CE, 2004, INVEST OPHTH VIS SCI, V45, P3048, DOI 10.1167/iovs.04-0250; Stewart CE, 2003, BRIT J OPHTHALMOL, V87, P1229, DOI 10.1136/bjo.87.10.1229; Stewart CE, 2002, BRIT J OPHTHALMOL, V86, P915, DOI 10.1136/bjo.86.8.915; von Noorden GK, 2004, OPHTHALMOLOGY, V111, P1063, DOI 10.1016/j.ophtha.2004.03.003; Wygnanski-Jaffe T, 2005, J AAPOS, V9, P208, DOI 10.1016/j.jaapos.2004.11.012	32	99	104	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					707	711		10.1136/bmj.39301.460150.55	http://dx.doi.org/10.1136/bmj.39301.460150.55			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17855283	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000250156800032
J	Goldston, D				Goldston, David			Passing the test	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.							Goldston D, 2007, NATURE, V446, P714, DOI 10.1038/446714a	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					391	391		10.1038/449391a	http://dx.doi.org/10.1038/449391a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898740	Bronze			2022-12-28	WOS:000249724800013
J	Xiao, B; Heath, R; Saiu, P; Leiper, FC; Leone, P; Jing, C; Walker, PA; Haire, L; Eccleston, JF; Davis, CT; Martin, SR; Carling, D; Gamblin, SJ				Xiao, Bing; Heath, Richard; Saiu, Peter; Leiper, Fiona C.; Leone, Philippe; Jing, Chun; Walker, Philip A.; Haire, Lesley; Eccleston, John F.; Davis, Colin T.; Martin, Stephen R.; Carling, David; Gamblin, Steven J.			Structural basis for AMP binding to mammalian AMP-activated protein kinase	NATURE			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GAMMA-SUBUNITS; MUTATIONS; SYSTEM; DOMAIN; LIVER; GAUGE; BETA	AMP-activated protein kinase (AMPK) regulates cellular metabolism in response to the availability of energy and is therefore a target for type II diabetes treatment(1). It senses changes in the ratio of AMP/ATP by binding both species in a competitive manner(2). Thus, increases in the concentration of AMP activate AMPK resulting in the phosphorylation and differential regulation of a series of downstream targets that control anabolic and catabolic pathways(1,2). We report here the crystal structure of the regulatory fragment of mammalian AMPK in complexes with AMP and ATP. The phosphate groups of AMP/ATP lie in a groove on the surface of the gamma domain, which is lined with basic residues, many of which are associated with disease-causing mutations. Structural and solution studies reveal that two sites on the gamma domain bind either AMP or Mg center dot ATP, whereas a third site contains a tightly bound AMP that does not exchange. Our binding studies indicate that under physiological conditions AMPK mainly exists in its inactive form in complex with Mg center dot ATP, which is much more abundant than AMP. Our modelling studies suggest how changes in the concentration of AMP ([AMP]) enhance AMPK activity levels. The structure also suggests a mechanism for propagating AMP/ATP signalling whereby a phosphorylated residue from the alpha and/or beta subunits binds to the gamma subunit in the presence of AMP but not when ATP is bound.	Natl Inst Med Res, MRC, London NW7 1AA, England; Imperial Coll, MRC, Ctr Clin Sci, London W12 0NN, England	MRC National Institute for Medical Research; Imperial College London	Martin, SR (corresponding author), Natl Inst Med Res, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	smartin@nimr.mrc.ac.uk; david.carling@csc.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Gamblin, Steve/0000-0001-5331-639X; Leiper, Fiona/0000-0001-6681-681X	MRC [MC_U117584222] Funding Source: UKRI; Medical Research Council [MC_U120027537, MC_U117584222] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	37	422	440	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					496	U14		10.1038/nature06161	http://dx.doi.org/10.1038/nature06161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851531				2022-12-28	WOS:000249724800048
J	Glasziou, P				Glasziou, Paul			Evidence based case report - Do all fractures need full immobilisation?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RADIAL HEAD FRACTURES; TRIAL		Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England	University of Oxford	Glasziou, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				Liow RYL, 2002, INJURY, V33, P801, DOI 10.1016/S0020-1383(02)00164-X; Nash CE, 2004, J FAM PRACTICE, V53, P706; UNSWORTHWHITE J, 1994, INJURY, V25, P165, DOI 10.1016/0020-1383(94)90154-6; Watts BL, 2001, EMERG MED J, V18, P46, DOI 10.1136/emj.18.1.46	4	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					612	613		10.1136/bmj.39272.565810.80	http://dx.doi.org/10.1136/bmj.39272.565810.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884906	Green Submitted, Green Published			2022-12-28	WOS:000249832400037
J	Lin, JF; Vanko, G; Jacobsen, SD; Iota, V; Struzhkin, VV; Prakapenka, VB; Kuznetsov, A; Yoo, CS				Lin, Jung-Fu; Vanko, Gyoergy; Jacobsen, Steven D.; Iota, Valentin; Struzhkin, Viktor V.; Prakapenka, Vitali B.; Kuznetsov, Alexei; Yoo, Choong-Shik			Spin transition zone in Earth's lower mantle	SCIENCE			English	Article							RAY-EMISSION SPECTROSCOPY; THERMODYNAMIC PARAMETERS; IRON; PEROVSKITE; STATE; TEMPERATURE; MAGNESIOWUSTITE; FERROPERICLASE; CONDUCTIVITY; STABILITY	Mineral properties in Earth's lower mantle are affected by iron electronic states, but representative pressures and temperatures have not yet been probed. Spin states of iron in lower-mantle ferropericlase have been measured up to 95 gigapascals and 2000 kelvin with x-ray emission in a laser-heated diamond cell. A gradual spin transition of iron occurs over a pressure-temperature range extending from about 1000 kilometers in depth and 1900 kelvin to 2200 kilometers and 2300 kelvin in the lower mantle. Because low-spin ferropericlase exhibits higher density and faster sound velocities relative to the high-spin ferropericlase, the observed increase in low-spin (Mg, Fe)O at mid-lower mantle conditions would manifest seismically as a lower-mantle spin transition zone characterized by a steeper-than-normal density gradient.	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; European Synchrotron Radiat Facil, F-38043 Grenoble 9, France; Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Consortium Adv Radiat Sources, Chicago, IL 60637 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; European Synchrotron Radiation Facility (ESRF); Northwestern University; Carnegie Institution for Science	Lin, JF (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.		Lin, Jung-Fu/B-4917-2011; Struzhkin, Viktor V/J-9847-2013; Vankó, György/B-8176-2012; Jacobsen, Steven/F-3443-2013; Kuznetsov, Alexei/C-2274-2008	Lin, Jung-Fu/0000-0002-0163-5329; Struzhkin, Viktor V/0000-0002-3468-0548; Vankó, György/0000-0002-3095-6551; Jacobsen, Steven/0000-0002-9746-958X; 				Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; BIRCH F, 1986, J GEOPHYS RES-SOLID, V91, P4949, DOI 10.1029/JB091iB05p04949; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; DAVIES GF, 1975, PHYS EARTH PLANET IN, V10, P336, DOI 10.1016/0031-9201(75)90060-6; Dubrovinsky LS, 2000, SCIENCE, V289, P430, DOI 10.1126/science.289.5478.430; DUFFY TS, 1989, J GEOPHYS RES-SOLID, V94, P1895, DOI 10.1029/JB094iB02p01895; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Hofmeister AM, 2006, EARTH PLANET SC LETT, V243, P44, DOI 10.1016/j.epsl.2005.12.013; Jackson JM, 2005, AM MINERAL, V90, P199, DOI 10.2138/am.2005.1633; Jacobsen SD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000490; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Lin JF, 2005, J SYNCHROTRON RADIAT, V12, P637, DOI 10.1107/S0909049505020741; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lin JF, 2003, P NATL ACAD SCI USA, V100, P4405, DOI 10.1073/pnas.252782399; Lin JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028099; Mattern E, 2005, GEOPHYS J INT, V160, P973, DOI 10.1111/j.1365-246X.2004.02549.x; Matyska C, 2006, PHYS EARTH PLANET IN, V154, P196, DOI 10.1016/j.pepi.2005.10.001; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Naliboff JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025717; Persson K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026621; RINGWOOD AE, 1982, J GEOL, V90, P611, DOI 10.1086/628721; Sturhahn W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022802; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; van Westrenen W, 2005, PHYS EARTH PLANET IN, V151, P163, DOI 10.1016/j.pepi.2005.03.001; Vanko G, 2006, J PHYS CHEM B, V110, P11647, DOI 10.1021/jp0615961; Zhang FW, 2006, EARTH PLANET SC LETT, V249, P436, DOI 10.1016/j.epsl.2006.07.023	31	164	175	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1740	1743		10.1126/science.1144997	http://dx.doi.org/10.1126/science.1144997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885134				2022-12-28	WOS:000249585900045
J	McGuire, AL; Cho, MK; McGuire, SE; Caulfield, T				McGuire, Amy L.; Cho, Mildred K.; McGuire, Sean E.; Caulfield, Timothy			Medicine - The future of personal Genomics	SCIENCE			English	Editorial Material							HEALTH; GENETICS		Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; Stanford Univ, Stanford Ctr Biomed Ethics, Palo Alto, CA 94304 USA; Univ Texas, MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; Univ Alberta, Hlth Law Inst, Edmonton, AB, Canada	Baylor College of Medicine; Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Alberta	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003389] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG004333, P50 HG003389-04, P50 HG003389, P50HG003389] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Carlsten C, 2006, JAMA-J AM MED ASSOC, V296, P2480, DOI 10.1001/jama.296.20.2480; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Grosse SD, 2006, GENET MED, V8, P448, DOI 10.1097/01.gim.0000227935.26763.c6; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; LEI HH, 2007, PERSONAL GENOME CO 2; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Scheuner MT, 2006, GENET MED, V8, P141, DOI 10.1097/01.gim.0000206657.19102.a0; Silversides A, 2007, CAN MED ASSOC J, V176, P315, DOI 10.1503/cmaj.061726; WADE N, 2007, NY TIMES        0601, pA19	11	46	53	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1687	1687		10.1126/science.1147475	http://dx.doi.org/10.1126/science.1147475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885116	Green Accepted			2022-12-28	WOS:000249585900025
J	Schroeder, SA				Schroeder, Steven A.			Shattuck lecture - We can do better - Improving the health of the American people	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; SMOKING; MATTER; INEQUALITIES; MORTALITY; OBESITY; DEATHS		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Suite 430, San Francisco, CA 94143 USA.	schroeder@medicine.ucsf.edu						ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; [Anonymous], 1998, INDEPENDENT INQUIRY; [Anonymous], 2006, TOBACCO CONTROL POLI; Colton CW, 2006, PREV CHRONIC DIS; *DEP HHS, 2001, HLTH PEOPL 2010 UND; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Farrelly MC, 2003, AM J PUBLIC HEALTH, V93, P703; Fiore MC, 2004, AM J PUBLIC HEALTH, V94, P205, DOI 10.2105/AJPH.94.2.205; FIORE MC, 2000, TREATING TOBACCO USE; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gawande Atul, 2007, New Yorker, P50; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P87, DOI 10.1001/jama.297.1.87; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; HOYERT DL, 2007, VITAL HLTH STAT 3, V33, P4; *I MED, 2000, TO ERR IS HUM BUILD; *I MED, 2003, HIDD COSTS VAL LOST; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; ISAACS SL, 2001, AM PROSPECT     0604, P26; *KAIS FAM FDN, 2007, FOOD THOUGHT TEL FOO, P3; Kindig DA, 2006, JAMA-J AM MED ASSOC, V296, P2611, DOI 10.1001/jama.296.21.2611; Koh HK, 2007, NEW ENGL J MED, V356, P1496, DOI 10.1056/NEJMp068279; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; McGinnis JM, 2001, AM J HEALTH PROMOT, V15, P391, DOI 10.4278/0890-1171-15.5.391; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; *NAT CTR HLTH STAT, 2001, INF NEON POSTN DEATH; *NAT CTR HLTH STAT, CHARTB TRENDS HLTH A, P193; Nestle M, 2006, NEW ENGL J MED, V354, P2527, DOI 10.1056/NEJMp068014; *OECD, 2006, OECD HLTH DAT 2006; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; POLLAN M, 2007, NY TIMES SUNDAY 0422, P15; Schroeder SA, 1996, NEW ENGL J MED, V334, P1130, DOI 10.1056/NEJM199604253341713; Schroeder SA, 2005, HEALTH AFFAIR, V24, P1005, DOI 10.1377/hlthaff.24.4.1005; Schroeder SA, 2005, JAMA-J AM MED ASSOC, V294, P482, DOI 10.1001/jama.294.4.482; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; Schroeder SA, 2006, ANN INTERN MED, V145, P784, DOI 10.7326/0003-4819-145-10-200611210-00013; SELDIN DW, 1981, T ASSOC AM PHYSICIAN, V94, pR75; Smith, 2006, DEATHS PRELIMINARY D; *SMOK CESS LEAD CT, PARTN HIGHL; *WHO, WHO COR HLTH IND; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848; Woolf SH, 2007, JAMA-J AM MED ASSOC, V297, P523, DOI 10.1001/jama.297.5.523; ZEIDONIS DM, 2005, VA VANGUARD BUILDING, P141	52	636	639	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1221	1228		10.1056/NEJMsa073350	http://dx.doi.org/10.1056/NEJMsa073350			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881753				2022-12-28	WOS:000249541000007
J	Sigal, RJ; Kenny, GP; Boule, NG; Wells, GA; Prud'homme, D; Fortier, M; Reid, RD; Tulloch, H; Coyle, D; Phillips, P; Jennings, A; Jaffey, J				Sigal, Ronald J.; Kenny, Glen P.; Boule, Normand G.; Wells, George A.; Prud'homme, Denis; Fortier, Michelle; Reid, Robert D.; Tulloch, Heather; Coyle, Douglas; Phillips, Penny; Jennings, Alison; Jaffey, James			Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes - A Randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE; EXERCISE; METAANALYSIS; PLASMA; COMPLICATIONS; INTENSITY; MELLITUS; ADULTS; MUSCLE; WOMEN	Background: Previous trials have evaluated the effects of aerobic training alone and of resistance training alone on glycemic control in type 2 diabetes, as assessed by hemoglobin A(1c) values. However, none could assess incremental effects of combined aerobic and resistance training compared with either type of exercise alone. Objective: To determine the effects of aerobic training alone, resistance training alone, and combined exercise training on hemoglobin A(1c) values in patients with type 2 diabetes. Design: Randomized, controlled trial. Setting: 8 community-based facilities. Patients: 2151 adults age 39 to 70 years with type 2 diabetes. A negative result on a stress test or clearance by a cardiologist, and adherence to exercise during a 4-week run-in period, were required before randomization. Interventions: Aerobic training, resistance training, or both types of exercise (combined exercise training). A sedentary control group was included. Exercise training was performed 3 times weekly for 22 weeks (weeks 5 to 26 of the study). Measurements: The primary outcome was the change in hemoglobin A,, value at 6 months. Secondary outcomes were changes in body composition, plasma lipid values, and blood pressure. Results: The absolute change in the hemoglobin A, value in the combined exercise training group compared with the control group was -0.51 percentage point (95% Cl, -0.87 to -0.14) in the aerobic training group and -0.38 percentage point (Cl, -0.72 to -0.22) in the resistance training group. Combined exercise training resulted in an additional change in the hemoglobin A, value of -0.46 percentage point (Cl, -0.83 to -0.09) compared with aerobic training alone and -0.59 percentage point (Cl, -0.95 to -0.23) compared with resistance training alone. Changes in blood pressure and lipid values did not statistically significantly differ among groups. Adverse events were more common in the exercise groups. Limitations: The generalizability of the results to patients who are less adherent to exercise programs is uncertain. The participants were not blinded, and the total duration of exercise was greater in the combined exercise training group than in the aerobic and resistance training groups. Conclusion: Either aerobic or resistance training alone improves glycemic control in type 2 diabetes, but the improvements are greatest with combined aerobic and resistance training.	Univ Calgary, Calgary, AB T2N 2T9, Canada; Univ Ottawa, Hlth Res Inst, Prevent & Rehabil Ctr, Clin Epidemiol Program, Ottawa, ON, Canada	University of Calgary; University of Ottawa; Ottawa Hospital Research Institute	Sigal, RJ (corresponding author), Univ Calgary, 7th Floor,N Tower,Foothills Med Ctr,140329 St NW, Calgary, AB T2N 2T9, Canada.	rsigal@ucalgary.ca	Sigal, Ron/AAK-7627-2020; Sigal, Ronald/AAU-6081-2020	Coyle, Doug/0000-0003-3492-2268				Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Canadian Diabetes Association, 1999, CAN J DIABETES CARE, V23, P56; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Cuff DJ, 2003, DIABETES CARE, V26, P2977, DOI 10.2337/diacare.26.11.2977; Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Dunstan DW, 1998, DIABETES RES CLIN PR, V40, P53, DOI 10.1016/S0168-8227(98)00027-8; Evans WJ, 1996, GERIATRICS, V51, P46; Eves ND, 2006, DIABETES CARE, V29, P1933, DOI 10.2337/dc05-1981; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Heymsfield SB, 1998, HDB OBESITY, P41; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Ivy J, 2002, HDB EXERCISE DIABETE, V2nd, P23; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Lemieux S, 1996, DIABETES CARE, V19, P983, DOI 10.2337/diacare.19.9.983; PELLETT PL, 1990, AM J CLIN NUTR, V51, P711, DOI 10.1093/ajcn/51.5.711; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Willey KA, 2003, DIABETES CARE, V26, P1580, DOI 10.2337/diacare.26.5.1580; WVANS WJ, 1996, GERIATRICS, V51, P46	25	763	797	4	134	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					357	369		10.7326/0003-4819-147-6-200709180-00005	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876019				2022-12-28	WOS:000249726200001
J	Came, RE; Eiler, JM; Veizer, J; Azmy, K; Brand, U; Weidman, CR				Came, Rosemarie E.; Eiler, John M.; Veizer, Jan; Azmy, Karem; Brand, Uwe; Weidman, Christopher R.			Coupling of surface temperatures and atmospheric CO2 concentrations during the Palaeozoic era	NATURE			English	Article							CARBON ISOTOPIC COMPOSITION; PHANEROZOIC TIME; STABLE-ISOTOPES; COEVAL SEAWATER; REVISED MODEL; OXYGEN; BRACHIOPODS; CLIMATE; CALCITE; PALEOTHERMOMETER	Atmospheric carbon dioxide concentrations seem to have been several times modern levels during much of the Palaeozoic era (543-248 million years ago), but decreased during the Carboniferous period to concentrations similar to that of today(1-3). Given that carbon dioxide is a greenhouse gas, it has been proposed that surface temperatures were significantly higher during the earlier portions of the Palaeozoic era(1). A reconstruction of tropical sea surface temperatures based on the delta O-18 of carbonate fossils indicates, however, that the magnitude of temperature variability throughout this period was small(4), suggesting that global climate may be independent of variations in atmospheric carbon dioxide concentration. Here we present estimates of sea surface temperatures that were obtained from fossil brachiopod and mollusc shells using the 'carbonate clumped isotope' method(5)-an approach that, unlike the delta O-18 method, does not require independent estimates of the isotopic composition of the Palaeozoic ocean. Our results indicate that tropical sea surface temperatures were significantly higher than today during the Early Silurian period (443-423 Myr ago), when carbon dioxide concentrations are thought to have been relatively high, and were broadly similar to today during the Late Carboniferous period (314-300 Myr ago), when carbon dioxide concentrations are thought to have been similar to the present-day value. Our results are consistent with the proposal that increased atmospheric carbon dioxide concentrations drive or amplify increased global temperatures(1,6).	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Ottawa, Ottawa Carleton Geosci Ctr, Ottawa, ON K1N 6N5, Canada; Mem Univ Newfoundland, Dept Earth Sci, St John, NF A1B 3X5, Canada; Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; Waquoit Bay Natl Estuarine Res Reserve, Waquoit, MA 02536 USA	California Institute of Technology; University of Ottawa; Memorial University Newfoundland; Brock University	Came, RE (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	rcame@gps.caltech.edu	Veizer, Jan/ABG-3321-2020					Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Azmy K, 1998, GEOL SOC AM BULL, V110, P1499, DOI 10.1130/0016-7606(1998)110<1499:OACICO>2.3.CO;2; Azmy K, 2006, CAN J EARTH SCI, V43, P281, DOI 10.1139/E05-109; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Bohm F, 2000, GEOCHIM COSMOCHIM AC, V64, P1695, DOI 10.1016/S0016-7037(99)00408-1; Boucot AJ, 2004, PALEONTOL J+, V38, P115; BRAND U, 1989, GEOL SOC AM BULL, V101, P377, DOI 10.1130/0016-7606(1989)101<0377:ACTBOP>2.3.CO;2; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; BRAND U, 1982, SEDIMENTOLOGY, V29, P139, DOI 10.1111/j.1365-3091.1982.tb01715.x; BROCK TD, 1985, SCIENCE, V230, P132, DOI 10.1126/science.230.4722.132; CAPUTO MV, 1985, GEOL SOC AM BULL, V96, P1020, DOI 10.1130/0016-7606(1985)96<1020:MOGCAG>2.0.CO;2; Crowley T. J., 1991, PALEOCLIMATOLOGY; Eiler JM, 2004, GEOCHIM COSMOCHIM AC, V68, P4767, DOI 10.1016/j.gca.2004.05.035; FRAKES LA, 1988, NATURE, V333, P547, DOI 10.1038/333547a0; FRANCOIS LM, 1992, AM J SCI, V292, P81, DOI 10.2475/ajs.292.2.81; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Ghosh P, 2007, GEOCHIM COSMOCHIM AC, V71, P2736, DOI 10.1016/j.gca.2007.03.015; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; LAND LS, 1995, GEOCHIM COSMOCHIM AC, V59, P2843, DOI 10.1016/0016-7037(95)00176-Z; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; Montanez IP, 2007, SCIENCE, V315, P87, DOI 10.1126/science.1134207; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Muehlenbachs K, 1998, CHEM GEOL, V145, P263, DOI 10.1016/S0009-2541(97)00147-2; Royer DL, 2007, NATURE, V446, P530, DOI 10.1038/nature05699; Ruddiman WF, 2001, EARTHS CLIMATE FUTUR; SWART PK, 1991, CHEM GEOL, V86, P89, DOI 10.1016/0168-9622(91)90055-2; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Wallmann K, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000683; Wanamaker AD, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001189; Wang ZG, 2004, GEOCHIM COSMOCHIM AC, V68, P4779, DOI 10.1016/j.gca.2004.05.039; Wenzel B, 2000, GEOCHIM COSMOCHIM AC, V64, P1859, DOI 10.1016/S0016-7037(00)00337-9; YAPP CJ, 1992, NATURE, V355, P342, DOI 10.1038/355342a0; [No title captured]	37	209	222	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					198	U3		10.1038/nature06085	http://dx.doi.org/10.1038/nature06085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851520				2022-12-28	WOS:000249394500045
J	Danzon, PM				Danzon, Patricia M.			At what price?	NATURE			English	Editorial Material							DISCRIMINATION		Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA	University of Pennsylvania	Danzon, PM (corresponding author), Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA.							[Anonymous], 2001, MACR HLTH INV HLTH E; BRITTIN RV, 1992, B COUNCIL RES MUSIC, V113, P1; Danzon P., 2003, HLTH AFFAIRS; Danzon Patricia M, 2003, Int J Health Care Finance Econ, V3, P183, DOI 10.1023/A:1025384819575; Danzon PM, 2005, HEALTH ECON, V14, P269, DOI 10.1002/hec.931; DANZON PM, 1997, INT J EC BUSINESS, V4, P301; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dumoulin J, 2001, INT J BIOTECHNOLOGY, V3, P338; HAUSMAN JA, 1988, RAND J ECON, V19, P253, DOI 10.2307/2555703; Maskus Keith E., 2001, PARALLEL IMPORTS PHA; Ramsey FP, 1927, ECON J, V37, P47, DOI 10.2307/2222721; VARIAN HR, 1985, AM ECON REV, V75, P870; *WORLD TRAD ORG, 2003, WTGCM82 WORLD TRAD O; *WORLD TRAD ORG, 2003, WTL540 WORLD TRAD RO	14	22	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					176	179		10.1038/449176a	http://dx.doi.org/10.1038/449176a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209NF	17851515				2022-12-28	WOS:000249394500039
J	Martinson, BC				Martinson, Brian C.			Universities and the money fix	NATURE			English	Editorial Material							BIOMEDICAL-RESEARCH; NIH		HealthPartners Res Fdn, Minneapolis, MN 55440 USA	HealthPartners Institute for Education & Research	Martinson, BC (corresponding author), HealthPartners Res Fdn, Minneapolis, MN 55440 USA.		Martinson, Brian C/AAX-2860-2020	Martinson, Brian C/0000-0002-4255-5595				Bowman MA, 2007, JAMA-J AM MED ASSOC, V297, P2521, DOI 10.1001/jama.297.22.2521; BRUGGE JS, 2007, OUR GRASP SLIPPING A; KOHN TH, 2004, ACAD HLTH CTR LEADIN; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; Schindler BA, 2006, ACAD MED, V81, P27, DOI 10.1097/00001888-200601000-00008; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	7	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					141	142		10.1038/449141a	http://dx.doi.org/10.1038/449141a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209NF	17851495				2022-12-28	WOS:000249394500021
J	Balter, M				Balter, M			Archaeology - Paintings in Italian cave may be oldest yet	SCIENCE			English	News Item																			0	8	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					419	+		10.1126/science.290.5491.419	http://dx.doi.org/10.1126/science.290.5491.419			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	17844275				2022-12-28	WOS:000089946000002
J	CHIDSEY, CED				CHIDSEY, CED			FREE-ENERGY AND TEMPERATURE-DEPENDENCE OF ELECTRON-TRANSFER AT THE METAL-ELECTROLYTE INTERFACE	SCIENCE			English	Article							MONOLAYER FILMS; GOLD; DIFFRACTION; SURFACES	The rate constant of the electron-electron reaction between a gold electrode and an electroactive ferrocene group has been measured at a structurally well-defined metal-electrolyte interface at temperatures from 1-degree to 47-degrees-C and reaction free energies from -1.0 to +0.8 electron volts (eV). The ferrocene group was positioned a fixed distance from the gold surface by the self-assembly of a mixed thiol monolayer of (eta-5C5H5)Fe(eta-5C5H4)CO2(CH2)16SH and CH3(CH2)15SH. Rate constants from 1 per second (s-1) to 2 x 10(4) s-1 in 1 molar HClO4 are reasonably fit with a reorganization energy of 0.85 eV and a prefactor for electron tunneling of 7 x 10(4) s-1 eV-1. Such self-assembled monolayers can be used to systematically probe the dependence of electron-transfer rates on distance, medium, and spacer structure, and to provide an empirical basis for the construction of interfacial devices such as sensors and transducers that utilize macroscopically directional electron-transfer reactions.			CHIDSEY, CED (corresponding author), AT&T BELL LABS,MURRAY HILL,NJ 07974, USA.							BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Bard A. J., 1980, ELECTROCHEMICAL METH; BRUNSCHWIG BS, 1980, J AM CHEM SOC, V102, P5798, DOI 10.1021/ja00538a017; CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026; CHIDSEY CED, 1989, J CHEM PHYS, V91, P4421, DOI 10.1063/1.456776; CHIDSEY CED, 1990, J AM CHEM SOC, V112, P4301, DOI 10.1021/ja00167a028; CHIDSEY CED, UNPUB; GENNETT T, 1985, J PHYS CHEM-US, V89, P2787, DOI 10.1021/j100259a018; KESTNER NR, 1974, J PHYS CHEM-US, V78, P2148, DOI 10.1021/j100614a017; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Levich VG., 1966, ADV ELECTROCH EL ENG, V4, P249; LI TTT, 1984, J AM CHEM SOC, V106, P6107, DOI 10.1021/ja00332a073; LIANG N, 1990, J AM CHEM SOC, V112, P5353, DOI 10.1021/ja00169a054; MARCUS RA, 1965, J CHEM PHYS, V43, P679, DOI 10.1063/1.1696792; MARCUS RA, 1982, J PHYS CHEM-US, V86, P622, DOI 10.1021/j100394a009; MISHRA AK, 1987, J PHYS CHEM-US, V91, P3417, DOI 10.1021/j100296a062; MORGAN JD, 1987, J PHYS CHEM-US, V91, P874, DOI 10.1021/j100288a023; NEWTON MD, 1984, ANNU REV PHYS CHEM, V35, P437, DOI 10.1146/annurev.physchem.35.1.437; NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012; NUZZO RG, 1990, J CHEM PHYS, V93, P767, DOI 10.1063/1.459528; NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063; PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011; RATNER MA, 1990, J PHYS CHEM-US, V94, P4877, DOI 10.1021/j100375a024; SCHMICKLER W, 1986, J ELECTROANAL CHEM, V204, P31, DOI 10.1016/0022-0728(86)80505-8; SEBASTIAN KL, 1989, J CHEM PHYS, V90, P5056, DOI 10.1063/1.456547; STRONG L, 1988, LANGMUIR, V4, P546, DOI 10.1021/la00081a009; ULSTRUP J, 1975, J CHEM PHYS, V63, P4358, DOI 10.1063/1.431152; ZUSMAN LD, 1987, CHEM PHYS, V112, P53, DOI 10.1016/0301-0104(87)85021-8	28	1337	1365	3	390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					919	922		10.1126/science.251.4996.919	http://dx.doi.org/10.1126/science.251.4996.919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847385				2022-12-28	WOS:A1991EY62900038
J	WALSH, J				WALSH, J			IN PERU, EVEN POTATO RESEARCH IS HIGH-RISK	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1286	1287		10.1126/science.247.4948.1286	http://dx.doi.org/10.1126/science.247.4948.1286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843782				2022-12-28	WOS:A1990CU25300015
J	Dunn, FA; Lankheet, MJ; Rieke, F				Dunn, Felice A.; Lankheet, Martin J.; Rieke, Fred			Light adaptation in cone vision involves switching between receptor and post-receptor sites	NATURE			English	Article							RETINAL GANGLION-CELLS; SLOW CONTRAST ADAPTATION; PRIMATE RETINA; SENSITIVITY REGULATION; BIPOLAR CELLS; OUTER RETINA; PHOTORECEPTORS; DYNAMICS; PHOTOVOLTAGE; SALAMANDER	We see over an enormous range of mean light levels, greater than the range of output signals retinal neurons can produce. Even highlights and shadows within a single visual scene can differ similar to 10,000-fold in intensity-exceeding the range of distinct neural signals by a factor of similar to 100. The effectiveness of daylight vision under these conditions relies on at least two retinal mechanisms that adjust sensitivity in the similar to 200 ms intervals between saccades(1). One mechanism is in the cone photoreceptors (receptor adaptation)(2-5) and the other is at a previously unknown location within the retinal circuitry that benefits from convergence of signals from multiple cones (post-receptor adaptation)(6,7). Here we find that post-receptor adaptation occurs as signals are relayed from cone bipolar cells to ganglion cells. Furthermore, we find that the two adaptive mechanisms are essentially mutually exclusive: as light levels increase the main site of adaptation switches from the circuitry to the cones. These findings help explain how human cone vision encodes everyday scenes, and, more generally, how sensory systems handle the challenges posed by a diverse physical environment.	Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Utrecht, Funct Neurobiol & Helmholtz Inst, NL-3584 CH Utrecht, Netherlands	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utrecht University	Rieke, F (corresponding author), Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA.	rieke@u.washington.edu						Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lee BB, 1999, P NATL ACAD SCI USA, V96, P14611, DOI 10.1073/pnas.96.25.14611; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; VALETON JM, 1983, VISION RES, V23, P1539, DOI 10.1016/0042-6989(83)90167-0; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0	25	124	124	6	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					603	U12		10.1038/nature06150	http://dx.doi.org/10.1038/nature06150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17851533				2022-12-28	WOS:000249893500046
J	Feder, HM; Johnson, BJB; O'Connell, S; Shapiro, ED; Steere, AC; Wormser, GP				Feder, Henry M., Jr.; Johnson, Barbara J. B.; O'Connell, Susan; Shapiro, Eugene D.; Steere, Allen C.; Wormser, Gary P.		Ad Hoc Int Lyme Dis Grp	Current concepts - A critical appraisal of "chronic Lyme disease''	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BORRELIA-BURGDORFERI; ANTIBIOTIC-TREATMENT; CONTROLLED-TRIALS; CHRONIC-FATIGUE; CULTURE; PREVENTION; DIAGNOSIS; URINE; OVERDIAGNOSIS; FIBROMYALGIA		Univ Connecticut, Ctr Hlth, Dept Family Med, Farmington, CT 06030 USA; Connecticut Childrens Med Ctr, Dept Family Med, Hartford, CT USA; Connecticut Childrens Med Ctr, Dept Pediat, Hartford, CT USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Microbiol Lab, Ft Collins, CO USA; Southampton Gen Hosp, Hlth Protect Agcy Microbiol Lab, Lyme Borreliosis Unit, Southampton SO9 4XY, Hants, England; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	University of Connecticut; Connecticut Children's Medical Center; Connecticut Children's Medical Center; Centers for Disease Control & Prevention - USA; University of Southampton; Yale University; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College	Feder, HM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Family Med, Farmington, CT 06030 USA.	hfeder@nso2.uchc.edu	halperin, john/X-6433-2019	halperin, john/0000-0003-1170-1710; Steere, Allen/0000-0002-5268-9853; Dattwyler, Raymond/0000-0002-1983-1301	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000142] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Akin E, 1999, INFECT IMMUN, V67, P173, DOI 10.1128/IAI.67.1.173-181.1999; Alban PS, 2000, MICROBIOL-SGM, V146, P119, DOI 10.1099/00221287-146-1-119; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2005, MMWR; ASCH ES, 1994, J RHEUMATOL, V21, P454; Bayer ME, 1996, INFECTION, V24, P347, DOI 10.1007/BF01716077; BURDGE DR, 1993, CLIN INFECT DIS, V16, P558, DOI 10.1093/clind/16.4.558; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Donta ST, 1997, CLIN INFECT DIS, V25, pS52, DOI 10.1086/516171; DONTA ST, 2003, MED SCI MONITOR, V9, pI136; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; ETTESTAD PJ, 1995, J INFECT DIS, V171, P356, DOI 10.1093/infdis/171.2.356; FALLON B, 2005, 10 INT C LYM BORR OT; Fallon B. A., 1999, Journal of Spirochetal and Tick-borne Diseases, V6, P94; *FOOD DRUG ADM, 2006, FDA CONSUM, V40, P5; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Harvey WT, 2003, MED HYPOTHESES, V60, P742, DOI 10.1016/S0306-9877(03)00060-4; Hellyer TJ, 1996, J INFECT DIS, V173, P934, DOI 10.1093/infdis/173.4.934; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Klempner MS, 2002, VECTOR-BORNE ZOONOT, V2, P255, DOI 10.1089/153036602321653842; Klempner MS, 2001, AM J MED, V110, P217, DOI 10.1016/S0002-9343(00)00701-4; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Kuschak T, 2007, CAN J INFECT DIS MED, V18, P145; LIGHTFOOT RW, 1993, ANN INTERN MED, V119, P503, DOI 10.7326/0003-4819-119-6-199309150-00010; Livengood JA, 2006, MICROBES INFECT, V8, P2832, DOI 10.1016/j.micinf.2006.08.014; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Marques AR, 2000, J CLIN MICROBIOL, V38, P4239, DOI 10.1128/JCM.38.11.4239-4241.2000; Morgen K, 2001, NEUROLOGY, V57, P1980, DOI 10.1212/WNL.57.11.1980; Nieman GF, 2001, CURR MED CHEM, V8, P317, DOI 10.2174/0929867013373570; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Pachner AR, 2002, IMMUNOL REV, V187, P139; Pachner AR, 2001, IMMUNOL REV, V183, P186, DOI 10.1034/j.1600-065x.2001.1830115.x; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; Phillips SE, 1998, INFECTION, V26, P364, DOI 10.1007/BF02770837; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rauter C, 2005, CLIN DIAGN LAB IMMUN, V12, P910, DOI 10.1128/CDLI.12.8.910-917.2005; Reid MC, 1998, ANN INTERN MED, V128, P354, DOI 10.7326/0003-4819-128-5-199803010-00003; RENFRO L, 1989, AM J MED, V86, P165, DOI 10.1016/0002-9343(89)90262-3; Richardson RD, 2004, NEUROLOGIST, V10, P18, DOI 10.1097/01.nrl.0000106921.76055.24; Shapiro ED, 2005, INT J EPIDEMIOL, V34, P1437, DOI 10.1093/ije/dyi241; SIGAL LH, 1992, PEDIATRICS, V90, P523; Sigal LH, 2002, ENVIRON HEALTH PERSP, V110, P607, DOI 10.1289/ehp.02110s4607; SIGAL LH, 1990, AM J MED, V88, P577, DOI 10.1016/0002-9343(90)90520-N; Stanek G, 1996, WIEN KLIN WOCHENSCHR, V108, P741; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Tilton RC, 2001, J CLIN MICROBIOL, V39, P2747, DOI 10.1128/JCM.39.7.2747.2001; Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011; Wessely S, 2001, ANN INTERN MED, V134, P838, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00007; Wormser GP, 2007, CLIN INFECT DIS, V44, P1137, DOI 10.1086/513029; Wormser GP, 2007, LANCET INFECT DIS, V7, P371, DOI 10.1016/S1473-3099(07)70117-2; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; WORMSER GP, 1995, MT SINAI J MED, V62, P188; 1990, MMWR MORB MORTAL WKL, V39, P873	59	316	328	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1422	1430		10.1056/NEJMra072023	http://dx.doi.org/10.1056/NEJMra072023			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914043				2022-12-28	WOS:000249892900008
J	Hadden, JM; Declais, AC; Carr, SB; Lilley, DMJ; Phillips, SEV				Hadden, Jonathan M.; Declais, Anne-Cecile; Carr, Stephen B.; Lilley, David M. J.; Phillips, Simon E. V.			The structural basis of Holliday junction resolution by T7 endonuclease	NATURE			English	Article							4-WAY DNA JUNCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COMPLEX; RUVA; SITE; BACTERIOPHAGE-T7; RECOGNITION; BINDING	The four-way (Holliday) DNA junction is the central intermediate in homologous recombination, a ubiquitous process that is important in DNA repair and generation of genetic diversity(1). The penultimate stage of recombination requires resolution of the DNA junction into nicked-duplex species by the action of a junction-resolving enzyme, examples of which have been identified in a wide variety of organisms(2). These enzymes are nucleases that are highly selective for the structure of branched DNA. The mechanism of this selectivity has, however, been unclear in the absence of structural data. Here we present the crystal structure of the junction-resolving enzyme phage T7 endonuclease I in complex with a synthetic four-way DNA junction. Although the enzyme is structure-selective, significant induced fit occurs in the interaction, with changes in the structure of both the protein and the junction. The dimeric enzyme presents two binding channels that contact the backbones of the junction's helical arms over seven nucleotides. These interactions effectively measure the relative orientations and positions of the arms of the junction, thereby ensuring that binding is selective for branched DNA that can achieve this geometry.	Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Dundee, Canc Res UK, Nucl Acid Struct Res Grp, Dundee DD1 4HN, Scotland	University of Leeds; Cancer Research UK; University of Dundee	Phillips, SEV (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.v.phillips@leeds.ac.uk		Declais, Anne-Cecile/0000-0002-1904-6469	Biotechnology and Biological Sciences Research Council [BB/E001777/1] Funding Source: Medline; Cancer Research UK [11722] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/E001777/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; BHATTACHARYYA A, 1991, J MOL BIOL, V221, P1191, DOI 10.1016/0022-2836(91)90928-Y; CENTER MS, 1970, J BIOL CHEM, V245, P6285; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Declais AC, 2003, EMBO J, V22, P1398, DOI 10.1093/emboj/cdg132; Declais AC, 2006, J MOL BIOL, V359, P1261, DOI 10.1016/j.jmb.2006.04.037; DEMASSY B, 1984, COLD SPRING HARB SYM, V49, P715, DOI 10.1101/SQB.1984.049.01.081; DUCKETT DR, 1995, J MOL BIOL, V246, P95, DOI 10.1006/jmbi.1994.0069; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Evans W, 1997, CHEM BRIT, V33, P22; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Hadden JM, 2002, EMBO J, V21, P3505, DOI 10.1093/emboj/cdf337; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, ESF EAMCB NEWSL PROT, V26; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu J, 2006, BIOCHEMISTRY-US, V45, P3934, DOI 10.1021/bi0523254; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Newman M, 1998, EMBO J, V17, P5466, DOI 10.1093/emboj/17.18.5466; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Parkinson MJ, 1997, J MOL BIOL, V270, P169, DOI 10.1006/jmbi.1997.1128; Pohler JRG, 1996, J MOL BIOL, V260, P678; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; SADOWSKI PD, 1971, J BIOL CHEM, V246, P200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795	32	67	69	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					621	U15		10.1038/nature06158	http://dx.doi.org/10.1038/nature06158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873858				2022-12-28	WOS:000249893500050
J	Florez, JC				Florez, Jose C.			Knowledge is power	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOWN-SYNDROME; PRENATAL-DIAGNOSIS; MOTHERS					jcflorez@partners.org						American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Britt DW, 2000, AM J MED GENET, V93, P410, DOI 10.1002/1096-8628(20000828)93:5<410::AID-AJMG12>3.3.CO;2-6; Caruso TM, 1998, GENET MED, V1, P22; Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B; Skotko B, 2005, PEDIATRICS, V115, P64, DOI 10.1542/peds.2004-0928; Skotko BG, 2005, AM J OBSTET GYNECOL, V192, P670, DOI 10.1016/j.ajog.2004.11.001	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1489	1490		10.1001/jama.298.13.1489	http://dx.doi.org/10.1001/jama.298.13.1489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911487				2022-12-28	WOS:000249860500001
J	Gu, J; Xie, ZG; Gao, ZC; Liu, JH; Korteweg, C; Ye, JX; Lau, LT; Lu, J; Gao, ZF; Zhang, B; McNutt, MA; Lu, M; Anderson, VM; Gong, EC; Yu, ACH; Lipkin, WI				Gu, Jiang; Xie, Zhigang; Gao, Zhancheng; Liu, Jinhua; Korteweg, Christine; Ye, Juxiang; Lau, Lok Ting; Lu, Jie; Gao, Zifen; Zhang, Bo; McNutt, Michael A.; Lu, Min; Anderson, Virginia M.; Gong, Encong; Yu, Albert Cheung Hoi; Lipkin, W. Ian			H5N1 infection of the respiratory tract and beyond: a molecular pathology study	LANCET			English	Article							INFLUENZA-A H5N1; HUMAN AIRWAY EPITHELIUM; AVIAN INFLUENZA; HUMAN-DISEASE; VIRUS INFECTION; IN-VITRO; TRANSMISSION; EXPRESSION; SARS; PATHOGENESIS	Background Human infection with avian influenza H5N1 is an emerging infectious disease characterised by respiratory symptoms and a high fatality rate. Previous studies have shown that the human infection with avian influenza H5N1 could also target organs apart from the lungs. Methods We studied post-mortem tissues of two adults (one man and one pregnant woman) infected with H5N1 influenza virus, and a fetus carried by the woman. In-situ hybridisation (with sense and antisense probes to haemagglutinin and nucleoprotein) and immunohistochemistry (with monoclonal antibodies to haemagglutinin and nucleoprotein) were done on selected tissues. Reverse-transcriptase (RT) PCR, real-time RT PCR, strand-specific RT PCR, and nucleic acid sequence-based amplification (NASBA) detection assays were also undertaken to detect viral RNA in organ tissue samples. Findings We detected viral genomic sequences and antigens in type II epithelial cells of the lungs, ciliated and non-ciliated epithelial cells of the trachea, T cells of the lymph node, neurons of the brain, and Hofbauer cells and cytotrophoblasts of the placenta. Viral genomic sequences (but no viral antigens) were detected in the intestinal mucosa. In the fetus, we found viral sequences and antigens in the lungs, circulating mononuclear cells, and macrophages of the liver. The presence of viral sequences in the organs and the fetus was also confirmed by RT PCR, strand-specific RT PCR, real-time RT PCR, and NASBA. Interpretation In addition to the lungs, H5N1 influenza virus infects the trachea and disseminates to other organs including the brain. The virus could also be transmitted from mother to fetus across the placenta.	Peking Univ, Ctr Infect Dis, Beijing 100083, Peoples R China; Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100083, Peoples R China; Peking Univ, Peoples Hosp, Beijing 100083, Peoples R China; Peking Univ, Neurosci Res Inst, Beijing 100083, Peoples R China; China Agr Univ, Coll Vet Med, Beijing, Peoples R China; SUNY, Hlth Sci Ctr, Dept Pathol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Peking University; Peking University; Peking University; Peking University; China Agricultural University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Community College; SUNY Maritime College; SUNY Optometry; Columbia University	Gu, J (corresponding author), Peking Univ, Ctr Infect Dis, Beijing 100083, Peoples R China.	jianggu@bjmu.edu.cn	Lipkin, W. Ian/ABE-6216-2020; Lau, Lok Ting/C-3866-2013	Lipkin, W. Ian/0000-0002-8768-9386; Gu, Jiang/0000-0002-0706-8329; Lau, Lok Ting/0000-0001-7517-1486				Brown LM, 2005, HISTOCHEM CELL BIOL, V124, P499, DOI 10.1007/s00418-005-0051-7; Cerna A, 2002, ACTA HISTOCHEM, V104, P339, DOI 10.1078/0065-1281-00669; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Farcas GA, 2005, J INFECT DIS, V191, P193, DOI 10.1086/426870; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; GU J, 1994, CELL VISION, V1, P76; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Lau LT, 2004, BIOCHEM BIOPH RES CO, V313, P336, DOI 10.1016/j.bbrc.2003.11.131; Li L, 2005, CLIN INFECT DIS, V41, P815, DOI 10.1086/432720; Lin Y, 2003, CELL RES, V13, P141, DOI 10.1038/sj.cr.7290158; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mori I, 1997, CLIN INFECT DIS, V24, P736; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Normile D, 2006, SCIENCE, V312, P1855; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; *PEK U SCH BAS MED, SOURC DIL INC TIM PR; *PEK U SCH BAS MED, HA SEQ VIR IS CAS 2; RAMPHAL R, 1980, AM J OBSTET GYNECOL, V138, P347, DOI 10.1016/0002-9378(80)90265-3; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; World Health Organization, CUM NUMB CONF HUM CA; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang Qing-ling, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1125; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	42	291	319	1	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1137	1145		10.1016/S0140-6736(07)61515-3	http://dx.doi.org/10.1016/S0140-6736(07)61515-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905166	Green Published, Bronze			2022-12-28	WOS:000250263700028
J	Morrison, HG; McArthur, AG; Gillin, FD; Aley, SB; Adam, RD; Olsen, GJ; Best, AA; Cande, WZ; Chen, F; Cipriano, MJ; Davids, BJ; Dawson, SC; Elmendorf, HG; Hehl, AB; Holder, ME; Huse, SM; Kim, UU; Lasek-Nesselquist, E; Manning, G; Nigam, A; Nixon, JEJ; Palm, D; Passamaneck, NE; Prabhu, A; Reich, CI; Reiner, DS; Samuelson, J; Svard, SG; Sogin, ML				Morrison, Hilary G.; McArthur, Andrew G.; Gillin, Frances D.; Aley, Stephen B.; Adam, Rodney D.; Olsen, Gary J.; Best, Aaron A.; Cande, W. Zacheus; Chen, Feng; Cipriano, Michael J.; Davids, Barbara J.; Dawson, Scott C.; Elmendorf, Heidi G.; Hehl, Adrian B.; Holder, Michael E.; Huse, Susan M.; Kim, Ulandt U.; Lasek-Nesselquist, Erica; Manning, Gerard; Nigam, Anuranjini; Nixon, Julie E. J.; Palm, Daniel; Passamaneck, Nora E.; Prabhu, Anjali; Reich, Claudia I.; Reiner, David S.; Samuelson, John; Svard, Staffan G.; Sogin, Mitchell L.			Genomic minimalism in the early diverging intestinal parasite Giardia lamblia	SCIENCE			English	Article							TRICHOMONAS-VAGINALIS; ENTAMOEBA-HISTOLYTICA; SPLICEOSOMAL INTRON; GENES; EUKARYOTE; ORIGIN; EVOLUTION; DICTYOSTELIUM; MITOCHONDRIA; PROTEINS	The genome of the eukaryotic protist Giardia lamblia, an important human intestinal parasite, is compact in structure and content, contains few introns or mitochondrial relics, and has simplified machinery for DNA replication, transcription, RNA processing, and most metabolic pathways. Protein kinases comprise the single largest protein class and reflect Giardia's requirement for a complex signal transduction network for coordinating differentiation. Lateral gene transfer from bacterial and archaeal donors has shaped Giardia's genome, and previously unknown gene families, for example, cysteine-rich structural proteins, have been discovered. Unexpectedly, the genome shows little evidence of heterozygosity, supporting recent speculations that this organism is sexual. This genome sequence will not only be valuable for investigating the evolution of eukaryotes, but will also be applied to the search for new therapeutics for this parasite.	Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Calif San Diego, Dept Pathol, Div Infect Dis, San Diego, CA 92103 USA; Univ Texas, Dept Biol Sci, El Paso, TX 79968 USA; Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Hope Coll, Dept Biol, Holland, MI 49423 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Penn, Philadelphia, PA 19194 USA; Georgetown Univ, Dept Biol, Washington, DC 20057 USA; Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, S-17182 Solna, Sweden; Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Marine Biological Laboratory - Woods Hole; University of California System; University of California San Diego; University of Texas System; University of Texas El Paso; University of Arizona; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign; Hope College; University of California System; University of California Berkeley; University of Pennsylvania; Georgetown University; University of Zurich; Salk Institute; Swedish Institute for Infectious Disease Control; Boston University; Uppsala University	Morrison, HG (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	morrison@mbl.edu	Reiner, David S./F-6106-2012; Sogin, Mitchell/AAE-7186-2019; Manning, Gerard/C-8308-2009; Chen, Feng/A-4497-2011	Reiner, David S./0000-0002-8289-7311; McArthur, Andrew/0000-0002-1142-3063; Hehl, Adrian/0000-0002-2110-4445; Manning, Gerard/0000-0002-5087-9151; Svard, Staffan/0000-0002-7392-1746; Cipriano, Michael/0000-0001-8163-8812; Samuelson, John/0000-0001-9533-3040; Morrison, Hilary/0000-0003-0281-326X; Dawson, Scott/0000-0002-0843-1759	NHGRI NIH HHS [R01 HG004164, R01 HG004164-01] Funding Source: Medline; NIAID NIH HHS [R01 AI054693, AI42488, AI43273, AI51687, R01 AI048082] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051687, R01AI054693, R01AI042488, R01AI043273, R01AI048082] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BROWN DM, 1995, MOL BIOCHEM PARASIT, V72, P47, DOI 10.1016/0166-6851(95)00065-9; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Davids BJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000044; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elmendorf HG, 2005, INT J PARASITOL, V35, P1001, DOI 10.1016/j.ijpara.2005.03.009; FEELY DE, 1982, EXP PARASITOL, V53, P145, DOI 10.1016/0014-4894(82)90100-X; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; Hlavsa Michele C., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; LEIPE DD, 1993, MOL BIOCHEM PARASIT, V59, P41, DOI 10.1016/0166-6851(93)90005-I; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; McArthur AG, 2001, MOL BIOL EVOL, V18, P1455, DOI 10.1093/oxfordjournals.molbev.a003931; Nagasaki A, 2002, J CELL SCI, V115, P2241; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Simpson AGB, 2002, NATURE, V419, P270, DOI 10.1038/419270a; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Suguri S, 2001, J EUKARYOT MICROBIOL, V48, P493, DOI 10.1111/j.1550-7408.2001.tb00184.x; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102	41	581	622	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1921	1926		10.1126/science.1143837	http://dx.doi.org/10.1126/science.1143837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901334				2022-12-28	WOS:000249764300040
J	Schmith, T; Johansen, S; Thejll, P				Schmith, Torben; Johansen, Soren; Thejll, Peter			Comment on "A semi-empirical approach to projecting future sea-level rise"	SCIENCE			English	Editorial Material									Danish Meteorol Inst, Ctr Ocean & Ice, Copenhagen, Denmark; Univ Copenhagen, Inst Math Sci, Copenhagen, Denmark; Danish Meteorol Inst, Danish Climate Ctr, Copenhagen, Denmark	Danish Meteorological Institute DMI; University of Copenhagen; Danish Meteorological Institute DMI	Schmith, T (corresponding author), Danish Meteorol Inst, Ctr Ocean & Ice, Copenhagen, Denmark.	ts@dmi.dk	Thejll, Peter/K-2959-2012	Schmith, Torben/0000-0003-3442-4381; Thejll, Peter/0000-0002-5074-699X; Johansen, Soren/0000-0002-9285-8236				Hamilton JamesD., 1994, TIME SERIES ANAL, DOI 10.2307/j.ctv14jx6sm; Kim TH, 2004, ECON LETT, V83, P257, DOI 10.1016/j.econlet.2003.10.020; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; vonsStorch H., 1999, STAT ANAL CLIMATE RE, DOI DOI 10.1017/CBO9780511612336; Yule GU, 1926, J R STAT SOC, V89, P1, DOI 10.2307/2341482	5	37	38	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846								10.1126/science.1143286	http://dx.doi.org/10.1126/science.1143286			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901317				2022-12-28	WOS:000249764300018
J	Bornhop, DJ; Latham, JC; Kussrow, A; Markov, DA; Jones, RD; Sorensen, HS				Bornhop, Darryl J.; Latham, Joey C.; Kussrow, Amanda; Markov, Dmitry A.; Jones, Richard D.; Sorensen, Henrik S.			Free-solution, label-free molecular interactions studied by back-scattering interferometry	SCIENCE			English	Article							SURFACE-PLASMON RESONANCE; ISOTHERMAL TITRATION CALORIMETRY; MACH-ZEHNDER INTERFEROMETER; REFRACTIVE-INDEX DETECTION; CONFORMATIONAL-CHANGES; CALMODULIN-BINDING; BIOSENSOR APPLICATIONS; SILICON TECHNOLOGY; COMPACT DISC; REAL-TIME	Free-solution, label-free molecular interactions were investigated with back-scattering interferometry in a simple optical train composed of a helium-neon laser, a microfluidic channel, and a position sensor. Molecular binding interactions between proteins, ions and protein, and small molecules and protein, were determined with high dynamic range dissociation constants (K-d spanning six decades) and unmatched sensitivity (picomolar K-d's and detection limits of 10,000s of molecules). With this technique, equilibrium dissociation constants were quantified for protein A and immunoglobulin G, interleukin-2 with its monoclonal antibody, and calmodulin with calcium ion Ca2+, a small molecule inhibitor, the protein calcineurin, and the M13 peptide. The high sensitivity of back-scattering interferometry and small volumes of microfluidics allowed the entire calmodulin assay to be performed with 200 picomoles of solute.	Vanderbilt Univ, Dept Chem, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA; Tech Univ Denmark, Riso Natl Lab, Opt & Plasma Res Dept, DK-4000 Roskilde, Denmark; Vanderbilt Univ, VIIBRE, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Technical University of Denmark; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bornhop, DJ (corresponding author), Vanderbilt Univ, Dept Chem, Vanderbilt Inst Chem Biol, VU Stn B 351822, Nashville, TN 37235 USA.	darryl.bornhop@vanderbilt.edu			NEI NIH HHS [T32-EY07135] Funding Source: Medline; NIBIB NIH HHS [R-01 EB0003537-01A2] Funding Source: Medline; NIGMS NIH HHS [T32 GM065086] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ababou A, 2007, J MOL RECOGNIT, V20, P4, DOI 10.1002/jmr.803; Abbas AK, 2003, CELLULAR MOL IMMUNOL; Brosinger F, 1997, SENSOR ACTUAT B-CHEM, V44, P350, DOI 10.1016/S0925-4005(97)00226-8; Burke BJ, 2003, ANAL CHEM, V75, P1786, DOI 10.1021/ac026173j; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Elkashef H, 1997, OPT MATER, V8, P175, DOI 10.1016/S0925-3467(97)00015-3; Goh JB, 2005, SENSOR ACTUAT B-CHEM, V106, P243, DOI 10.1016/j.snb.2004.08.003; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; Kerby MB, 2006, ANAL CHEM, V78, P8273, DOI 10.1021/ac061189l; KLEE CB, 1978, BIOCHEMISTRY-US, V17, P120, DOI 10.1021/bi00594a017; La Clair JJ, 2003, ORG BIOMOL CHEM, V1, P3244, DOI 10.1039/b306391g; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; Latham JC, 2006, ANGEW CHEM INT EDIT, V45, P955, DOI 10.1002/anie.200502418; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298; Markov DA, 2004, ELECTROPHORESIS, V25, P3805, DOI 10.1002/elps.200406139; Markov DA, 2004, J AM CHEM SOC, V126, P16659, DOI 10.1021/ja047820m; Maroulis G, 2001, J CHEM PHYS, V115, P7957, DOI 10.1063/1.1410392; MASSOM L, 1990, BIOCHEMISTRY-US, V29, P671, DOI 10.1021/bi00455a012; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; Pan SL, 2003, NANO LETT, V3, P811, DOI 10.1021/nl034055l; Prieto F, 2003, SENSOR ACTUAT B-CHEM, V92, P151, DOI 10.1016/S0925-4005(03)00257-0; Prieto F, 2003, NANOTECHNOLOGY, V14, P907, DOI 10.1088/0957-4484/14/8/312; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; REEM GH, 1985, P NATL ACAD SCI USA, V82, P8663, DOI 10.1073/pnas.82.24.8663; Rich RL, 2001, ANAL BIOCHEM, V296, P197, DOI 10.1006/abio.2001.5314; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; Sakai T, 2004, ANAL SCI, V20, P279, DOI 10.2116/analsci.20.279; Schipper EF, 1997, SENSOR ACTUAT B-CHEM, V40, P147, DOI 10.1016/S0925-4005(97)80254-7; Shekhawat G, 2006, SCIENCE, V311, P1592, DOI 10.1126/science.1122588; Sorensen H. S., 2006, THESIS TU DENMARK; Sorensen HS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356380; Sota H, 1998, ANAL CHEM, V70, P2019, DOI 10.1021/ac9713666; SPEAKER MG, 1983, P NATL ACAD SCI-BIOL, V80, P329, DOI 10.1073/pnas.80.2.329; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Swinney K, 2000, ANAL CHEM, V72, P2690, DOI 10.1021/ac000261r; Swinney K, 2000, REV SCI INSTRUM, V71, P2684, DOI 10.1063/1.1150675; Tarigan HJ, 1996, ANAL CHEM, V68, P1762, DOI 10.1021/ac9511455; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; Torok K, 2002, BIOCHEM SOC T, V30, P55; Torres FE, 2004, P NATL ACAD SCI USA, V101, P9517, DOI 10.1073/pnas.0403573101; TSURUTA H, 1990, BIOPHYS CHEM, V35, P75, DOI 10.1016/0301-4622(90)80062-C; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Wegner GJ, 2003, ANAL CHEM, V75, P4740, DOI 10.1021/ac0344438; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Ymeti A, 2003, APPL OPTICS, V42, P5649, DOI 10.1364/AO.42.005649; Zhao M, 2006, CLIN CHEM, V52, P2135, DOI 10.1373/clinchem.2006.072793	49	160	182	0	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1732	1736		10.1126/science.1146559	http://dx.doi.org/10.1126/science.1146559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885132				2022-12-28	WOS:000249585900043
J	Jaeger, WL; Keszthelyi, LP; McEwen, AS; Dundas, CM; Russell, PS				Jaeger, W. L.; Keszthelyi, L. P.; McEwen, A. S.; Dundas, C. M.; Russell, P. S.			Athabasca Valles, Mars: A lava-draped channel system	SCIENCE			English	Article							SURFACE	Athabasca Valles is a young outflow channel system on Mars that may have been carved by catastrophic water floods. However, images acquired by the High-Resolution Imaging Science Experiment camera onboard the Mars Reconnaissance Orbiter spacecraft reveal that Athabasca Valles is now entirely draped by a thin layer of solidified lava-the remnant of a once-swollen river of molten rock. The lava erupted from a fissure, inundated the channels, and drained downstream in geologically recent times. Purported ice features in Athabasca Valles and its distal basin, Cerberus Palus, are actually composed of this lava. Similar volcanic processes may have operated in other ostensibly fluvial channels, which could explain in part why the landers sent to investigate sites of ancient flooding on Mars have predominantly found lava at the surface instead.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Bern	Jaeger, WL (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	wjaeger@usgs.gov		Kestay, Laszlo/0000-0003-1879-4331; Dundas, Colin/0000-0003-2343-7224				Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Burr DA, 2005, ICARUS, V178, P56, DOI 10.1016/j.icarus.2005.04.012; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Carr M.H, 1996, WATER MARS; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Edgett KS, 1997, J GEOPHYS RES-PLANET, V102, P21545, DOI 10.1029/97JE01685; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002207; Gaidos E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002000; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Harmon JK, 1999, J GEOPHYS RES-PLANET, V104, P14065, DOI 10.1029/1998JE900042; HOFFMAN N, 2002, LUNAR PLANET SCI, V33; LANAGAN PD, 2004, THESIS U ARIZONA TUC; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; MILAZZO MP, 2005, THESIS U ARIZONA TUC; MUHLEMAN DO, 1991, SCIENCE, V253, P1508, DOI 10.1126/science.253.5027.1508; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Page DP, 2006, ICARUS, V183, P46, DOI 10.1016/j.icarus.2006.01.017; PLESCIA JB, 1990, ICARUS, V88, P465, DOI 10.1016/0019-1035(90)90095-Q; Putzig NE, 2005, ICARUS, V173, P325, DOI 10.1016/j.icarus.2004.08.017; RICE JW, 2002, LUNAR PLANET SCI, V33; TANAKA KL, 1986, LUNAR PLANET SCI, V17, P865	22	122	124	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1709	1711		10.1126/science.1143315	http://dx.doi.org/10.1126/science.1143315			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885126				2022-12-28	WOS:000249585900035
J	Nishiyama, T; Yoshizaki, N; Kishimoto, T; Ohsumi, K				Nishiyama, Tomoko; Yoshizaki, Norio; Kishimoto, Takeo; Ohsumi, Keita			Transient activation of calcineurin is essential to initiate embryonic development in Xenopus laevis	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; M-M TRANSITION; CYTOSTATIC FACTOR; EXTRACELLULAR-MATRIX; OOCYTE EXTRACTS; EGG ACTIVATION; FERTILIZATION; CALCIUM; DEGRADATION; ARREST	At fertilization, an increase of cytosolic calciumions (Ca2+) triggers various activation responses in animal eggs(1,2). In vertebrates, these responses include exit from metaphase arrest in meiosis II (MII exit) and cortical remodelling initiated by cortical granule exocytosis. Although the essential requirement of Ca2+/calmodulin-dependent protein kinase II for inducing MII exit has been documented(3), a role of the Ca2+/calmodulin-dependent protein phosphatase calcineurin in egg activation has not been investigated. Here we show, using cell-free extracts from unfertilized eggs of Xenopus laevis, that calcineurin is transiently activated immediately after Ca2+ addition to a concentration that induces MII exit. When calcineurin activation is inhibited, cyclin-dependent kinase 1 (Cdk1) inactivation by means of cyclin B degradation is prevented and sperm chromatin incubated in the extracts remains condensed. Similarly, if calcineurin is inhibited in intact eggs, MII exit on egg activation is prevented. In addition, the activation contraction(4) in the cortex is suppressed whereas cortical granule exocytosis occurs. We further demonstrate that, when a high level of calcineurin activity is maintained after activation, growth of sperm asters is prevented in egg extracts and, consistently, migration of male and female pronuclei towards each other is hindered in fertilized eggs. Thus, both activation and the subsequent inactivation of calcineurin in fertilized eggs are crucial for the commencement of vertebrate embryonic development.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Gifu Univ, Dept Anim Resource Product, United Grad Sch Agr Sci, Gifu 5011193, Japan	Tokyo Institute of Technology; Gifu University	Ohsumi, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kohsumi@bio.titech.ac.jp						BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; CAPCO DG, 1992, J EXP ZOOL, V264, P395, DOI 10.1002/jez.1402640405; CHRISTENSEN K, 1984, NATURE, V310, P150, DOI 10.1038/310150a0; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HEDRICK JL, 1991, J ELECTRON MICR TECH, V17, P319, DOI 10.1002/jemt.1060170306; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; JAFFE LF, 1983, DEV BIOL, V99, P265, DOI 10.1016/0012-1606(83)90276-2; LARABELL C, 1991, J ELECTRON MICR TECH, V17, P294, DOI 10.1002/jemt.1060170305; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohsumi Keita, 2006, V322, P445; PALECEK J, 1978, J EMBRYOL EXP MORPH, V45, P203; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sardet C, 2006, SEMIN CELL DEV BIOL, V17, P223, DOI 10.1016/j.semcdb.2006.03.001; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Sultana F, 2003, J ANAT, V203, P115, DOI 10.1046/j.1469-7580.2003.00197.x; Uto K, 1999, DEV BIOL, V208, P456, DOI 10.1006/dbio.1999.9231; WANGH LJ, 1989, J CELL SCI, V93, P1; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	35	70	70	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					341	+		10.1038/nature06136	http://dx.doi.org/10.1038/nature06136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882220				2022-12-28	WOS:000249557300045
J	Wapner, RJ; Sorokin, Y; Mele, L; Johnson, F; Dudley, DJ; Spong, CY; Peaceman, AM; Leveno, KJ; Malone, F; Caritis, SN; Mercer, B; Harper, M; Rouse, DJ; Thorp, JM; Ramin, S; Carpenter, MW; Gabbe, SG				Wapner, Ronald J.; Sorokin, Yoram; Mele, Lisa; Johnson, Francee; Dudley, Donald J.; Spong, Catherine Y.; Peaceman, Alan M.; Leveno, Kenneth J.; Malone, Fergal; Caritis, Steve N.; Mercer, Brian; Harper, Margaret; Rouse, Dwight J.; Thorp, John M.; Ramin, Susan; Carpenter, Marshall W.; Gabbe, Steven G.		Natl Inst Child Hlth Human	Long-term outcomes after repeat doses of antenatal corticosteroids	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	27th Annual Meeting of the Society-of-Maternal-Fetal-Medicine	FEB 05-10, 2007	San Francisco, CA	Soc Maternal Fetal Med (SMFM)			MATERNAL INJECTIONS; IN-UTERO; SINGLE; BIRTH; EXPOSURE; DEXAMETHASONE; CHILDREN; COURSES; GROWTH; BRAIN	Background Previous trials have shown that repeat courses of antenatal corticosteroids improve some neonatal outcomes in preterm infants but reduce birth weight and increase the risk of intrauterine growth restriction. We report long-term follow-up results of children enrolled in a randomized trial comparing single and repeat courses of antenatal corticosteroids. Methods Women at 23 through 31 weeks of gestation who remained pregnant 7 days after an initial course of corticosteroids were randomly assigned to weekly courses of betamethasone, consisting of 12 mg given intramuscularly and repeated once at 24 hours, or an identical-appearing placebo. We studied the children who were born after these treatments when they were between 2 and 3 years of corrected age. Prespecified outcomes included scores on the Bayley Scales of Infant Development, anthropometric measurements, and the presence of cerebral palsy. Results A total of 556 infants were available for follow-up; 486 children (87.4%) underwent physical examination and 465 (83.6%) underwent Bayley testing at a mean (+/-SD) corrected age of 29.3+/-4.6 months. There were no significant differences in Bayley results or anthropometric measurements. Six children (2.9% of pregnancies) in the repeat-corticosteroid group had cerebral palsy as compared with one child (0.5% of pregnancies) in the placebo group (relative risk, 5.7; 95% confidence interval, 0.7 to 46.7; P=0.12). Conclusions Children who had been exposed to repeat as compared with single courses of antenatal corticosteroids did not differ significantly in physical or neurocognitive measures. Although the difference was not statistically significant, the higher rate of cerebral palsy among children who had been exposed to repeat doses of corticosteroids is of concern and warrants further study.	Columbia Univ, Dept Obstet & Gynaecol, New York, NY 10032 USA; Drexel Univ, Philadelphia, PA 19104 USA; Wayne State Univ, Detroit, MI USA; George Washington Univ, Ctr Biostat, Washington, DC USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Utah, Salt Lake City, UT USA; NICHHD, Bethesda, MD 20892 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ N Carolina, Chapel Hill, NC USA; Univ Texas, Houston, TX USA; Brown Univ, Providence, RI 02912 USA; Vanderbilt Univ, Nashville, TN USA	Columbia University; Drexel University; Wayne State University; George Washington University; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Northwestern University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Wake Forest University; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; Brown University; Vanderbilt University	Wapner, RJ (corresponding author), Columbia Univ, Dept Obstet & Gynaecol, 622W 168th St,PH 16-66, New York, NY 10032 USA.			Peaceman, Alan/0000-0002-4515-4850; caritis, steve/0000-0002-2169-0712	NCRR NIH HHS [M01-RR-000080] Funding Source: Medline; NICHD NIH HHS [HD27860, HD27869, HD27915, HD27917, HD34116, HD34136, HD34208, HD36801, HD40485, HD40500, HD40512, HD40544, HD40545, HD40560, HD21410] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD034116, UG1HD040512, UG1HD027915, UG1HD034208, U10HD027869, U10HD040545, U10HD040485, U10HD034208, U10HD027917, U10HD040544, UG1HD040545, UG1HD040560, UG1HD040544, U10HD034116, UG1HD040500, UG1HD040485, U10HD027915, UG1HD027869, U10HD021410, U10HD040512, U10HD040500, U10HD040560, U10HD036801] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027860, U01HD036801, U10HD034136, U01HD021410] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; BENEDIKTSSON, 1993, LANCET, V341, P572; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Brocklehurst P, 1999, BRIT J OBSTET GYNAEC, V106, P977, DOI 10.1111/j.1471-0528.1999.tb08440.x; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Harding J, 2003, COCHRANE DB SYST REV, V3; Hasbargen U, 2001, EUR J PEDIATR, V160, P552, DOI 10.1007/s004310100804; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; McLaughlin KJ, 2003, AUST NZ J OBSTET GYN, V43, P101, DOI 10.1046/j.0004-8666.2003.00052.x; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P146, DOI 10.1016/j.ajog.2004.06.065; O'Shea TM, 1999, PEDIATRICS, V104, P15, DOI 10.1542/peds.104.1.15; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Quinlivan JA, 2000, EYE, V14, P93, DOI 10.1038/eye.2000.20; Quinlivan JA, 1999, PRENAT NEONAT MED, V4, P47; Quinlivan JA, 1998, AUST NZ J OBSTET GYN, V38, P1, DOI 10.1111/j.1479-828X.1998.tb02947.x; Quinlivan JA, 2000, J PERINAT MED, V28, P26, DOI 10.1515/JPM.2000.004; Rayburn WF, 1998, NEUROTOXICOL TERATOL, V20, P475, DOI 10.1016/S0892-0362(97)00131-1; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROCHE AF, 1987, PEDIATRICS, V79, P706; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; Spinillo A, 2004, AM J OBSTET GYNECOL, V191, P217, DOI 10.1016/j.ajog.2003.12.023; Thom EA, 2005, AM J OBSTET GYNECOL, V193, P619, DOI 10.1016/j.ajog.2005.05.061; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Wapner RJ, 2006, AM J OBSTET GYNECOL, V195, P633, DOI 10.1016/j.ajog.2006.03.087; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; WEI LJ, 1989, CONTROL CLIN TRIALS, V10, P127; Yeh TF, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.5.e7	36	205	213	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1190	1198		10.1056/NEJMoa071453	http://dx.doi.org/10.1056/NEJMoa071453			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	211RM	17881751	Bronze			2022-12-28	WOS:000249541000004
J	Kuritzky, L				Kuritzky, Louis			On knowledge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lkuritzky@aol.com							0	1	1	4	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1137	1137		10.1001/jama.298.10.1137	http://dx.doi.org/10.1001/jama.298.10.1137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848642				2022-12-28	WOS:000249374200001
J	Stott, L; Timmermann, A; Thunell, R				Stott, Lowell; Timmermann, Axel; Thunell, Robert			Southern hemisphere and deep-sea warming led deglacial atmospheric CO(2) rise and tropical warming	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; OXYGEN ISOTOPIC COMPOSITION; PORE FLUID CONSTRAINTS; PACIFIC-OCEAN; SURFACE-TEMPERATURE; CLIMATE-CHANGE; ICE CORE; CYCLE; ANTARCTICA; SALINITY	Establishing what caused Earth's largest climatic changes in the past requires a precise knowledge of both the forcing and the regional responses. We determined the chronology of high- and low-latitude climate change at the last glacial termination by radiocarbon dating benthic and planktonic foraminiferal stable isotope and magnesium/calcium records from a marine core collected in the western tropical Pacific. Deep-sea temperatures warmed by similar to 2 degrees C between 19 and 17 thousand years before the present (ky B.P.), leading the rise in atmospheric CO(2) and tropical-surface-ocean warming by similar to 1000 years. The cause of this deglacial deep-water warming does not lie within the tropics, nor can its early onset between 19 and 17 ky B.P. be attributed to CO(2) forcing. Increasing austral-spring insolation combined with sea-ice albedo feedbacks appear to be the key factors responsible for this warming.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ Hawaii, Int Pacific Res Ctr, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA	University of Southern California; University of Hawaii System; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Stott, L (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	stott@usc.edu	Timmermann, Axel/F-4977-2011; Timmermann, Axel/Y-2799-2019; Stott, Lowell/J-9460-2012	Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; 				Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Adkins JF, 2001, GEOPHYS RES LETT, V28, P771, DOI 10.1029/2000GL011597; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Barrows TT, 2004, QUATERNARY SCI REV, V23, P697, DOI 10.1016/j.quascirev.2003.10.011; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker W, 2004, SCIENCE, V306, P1169, DOI 10.1126/science.1102293; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Gagan MK, 2004, QUATERN INT, V118, P127, DOI 10.1016/S1040-6182(03)00134-4; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Ioualalen M, 2000, GEOPHYS RES LETT, V27, P1243, DOI 10.1029/1999GL002396; Kaiser J, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001146; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; LEVITUS S, 1994, CLIMATOLOGICAL ATLAS; Loulergue L., 2007, CLIM PAST DISCUSS, V3, P435; Martin P, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000914; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Oppo DW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000260; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shemesh A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000599; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stott LD, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001379; Visser K, 2003, NATURE, V421, P152, DOI 10.1038/nature01297	36	164	185	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					435	438		10.1126/science.1143791	http://dx.doi.org/10.1126/science.1143791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17901296				2022-12-28	WOS:000250230400042
J	Flierl, MA; Rittirsch, D; Nadeau, BA; Chen, AJ; Sarma, JV; Zetoune, FS; McGuire, SR; List, RP; Day, DE; Hoesel, LM; Gao, H; Van Rooijen, N; Huber-Lang, MS; Neubig, RR; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Chen, Anthony J.; Sarma, J. Vidya; Zetoune, Firas S.; McGuire, Stephanie R.; List, Rachel P.; Day, Danielle E.; Hoesel, L. Marco; Gao, Hongwei; Van Rooijen, Nico; Huber-Lang, Markus S.; Neubig, Richard R.; Ward, Peter A.			Phagocyte-derived catecholamines enhance acute inflammatory injury	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; LUNG INJURY; NOREPINEPHRINE; PATHOGENESIS; STIMULATION; LYMPHOCYTES; NEUTROPHILS; COMPLEMENT; METABOLISM; ACTIVATION	It is becoming increasingly clear that the autonomic nervous system and the immune system demonstrate cross-talk during inflammation by means of sympathetic and parasympathetic pathways(1,2). We investigated whether phagocytes are capable of de novo production of catecholamines, suggesting an autocrine/paracrine self-regulatory mechanism by catecholamines during inflammation, as has been described for lymphocytes(3). Here we show that exposure of phagocytes to lipopolysaccharide led to a release of catecholamines and an induction of catecholamine-generating and degrading enzymes, indicating the presence of the complete intracellular machinery for the generation, release and inactivation of catecholamines. To assess the importance of these findings in vivo, we chose two models of acute lung injury. Blockade of alpha(2)-adrenoreceptors or catecholamine-generating enzymes greatly suppressed lung inflammation, whereas the opposite was the case either for an alpha(2)-adrenoreceptor agonist or for inhibition of catecholamine-degrading enzymes. We were able to exclude T cells or sympathetic nerve endings as sources of the injury-modulating catecholamines. Our studies identify phagocytes as a new source of catecholamines, which enhance the inflammatory response.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Vrije Univ Amsterdam, Dept Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; Univ Ulm, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-89075 Ulm, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vrije Universiteit Amsterdam; Ulm University	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Van Rooijen, Nico/Z-1578-2019; Huber-Lang, Markus/AAJ-2209-2020	Neubig, Richard/0000-0003-0501-0008; Rittirsch, Daniel/0000-0002-1185-2431				BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 2000, ANN NY ACAD SCI, V917, P281; BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; HOFFMAN BB, 2006, GOODMAN GILMANS PHAR, P845; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kohm AP, 2002, J IMMUNOL, V168, P6314, DOI 10.4049/jimmunol.168.12.6314; Musso NR, 1996, J CLIN ENDOCR METAB, V81, P3553, DOI 10.1210/jc.81.10.3553; Sanders VM, 1997, J IMMUNOL, V158, P4200; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Swanson MA, 2001, J IMMUNOL, V166, P232, DOI 10.4049/jimmunol.166.1.232; Torres KCL, 2005, J NEUROIMMUNOL, V166, P144, DOI 10.1016/j.jneuroim.2005.06.006; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; UELAND PM, 1982, PHARMACOL REV, V34, P223; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 1996, AM J PATHOL, V149, P1079; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	26	324	332	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					721	U8		10.1038/nature06185	http://dx.doi.org/10.1038/nature06185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17914358	Green Published			2022-12-28	WOS:000250045000044
J	Balen, AH; Rutherford, AJ				Balen, Adam H.; Rutherford, Anthony J.			Managing anovulatory infertility and polycystic ovary syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INSULIN-RESISTANCE; METFORMIN; WOMEN; INDUCTION; OVULATION; CLOMIPHENE; FEATURES; PLACEBO; CITRATE		Leeds Gen Infirm, Leeds LS2 9NS, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Balen, AH (corresponding author), Leeds Gen Infirm, Leeds LS2 9NS, W Yorkshire, England.	adam.baten@leedsth.nhs.uk						[Anonymous], 2004, FERT ASS TREATM PEOP; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Balen A, 2002, HUM REPROD, V17, P2219, DOI 10.1093/humrep/17.9.2219; Balen AH, 2006, BRIT MED J, V332, P434, DOI 10.1136/bmj.332.7539.434; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; BALEN AH, 2007, PCOS OBESITY REPROD; Bayram N, 2004, BMJ-BRIT MED J, V328, P192, DOI 10.1136/bmj.328.7433.192; Beck JI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002249.pub3; Costello MF, 2003, FERTIL STERIL, V79, P1, DOI 10.1016/S0015-0282(02)04554-5; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; HAMILTONFAIRLEY D, 1991, HUM REPROD, V6, P1095, DOI 10.1093/oxfordjournals.humrep.a137491; Kousta E, 1997, HUM REPROD UPDATE, V3, P359, DOI 10.1093/humupd/3.4.359; Laven JSE, 2002, OBSTET GYNECOL SURV, V57, P755, DOI 10.1097/00006254-200211000-00022; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2004, OBSTET GYNECOL SURV, V59, P141, DOI 10.1097/01.OGX.0000109523.25076.E2; Lewis G., 2004, WHY MOTHERS DIE 2000; Lord J.M., 2003, COCHRANE DATABASE SY, DOI [10.1002/14651858.Cd003053, DOI 10.1002/14651858.CD003053]; Michelmore KF, 1999, CLIN ENDOCRINOL, V51, P779, DOI 10.1046/j.1365-2265.1999.00886.x; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Norman RJ, 2004, HUM REPROD UPDATE, V10, P267, DOI 10.1093/humupd/dmh018; Proctor ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001896.pub2; Rodin DA, 1998, CLIN ENDOCRINOL, V49, P91, DOI 10.1046/j.1365-2265.1998.00492.x; Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	25	36	40	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2007	335	7621					663	666		10.1136/bmj.39335.462303.80	http://dx.doi.org/10.1136/bmj.39335.462303.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901517	Green Published			2022-12-28	WOS:000249989600043
J	Montori, VM; Gandhi, GY; Guyatt, GH				Montori, Victor M.; Gandhi, Gunjan Y.; Guyatt, Gordon H.			Patient-important outcomes in diabetes - time for consensus	LANCET			English	Editorial Material							ROSIGLITAZONE; COMPLICATIONS; PROGRESSION; METFORMIN; MELLITUS; DEATH		Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON, Canada	Mayo Clinic; McMaster University	Montori, VM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Knowledge & Encounter Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	Montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Guyatt Gordon, 2004, ACP J Club, V140, pA11; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *U DIAB GROUP PROG, 1970, DIABETES S2, V10, pS785	11	38	41	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1104	1106		10.1016/S0140-6736(07)61489-5	http://dx.doi.org/10.1016/S0140-6736(07)61489-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905147				2022-12-28	WOS:000250263700005
J	Convey, P; Stevens, MI				Convey, Peter; Stevens, Mark I.			Antarctic biodiversity	SCIENCE			English	Editorial Material							ICE; DIVERSITY; ECOLOGY; HISTORY		British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Massey Univ, Inst Mol Biosci, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Massey University	Convey, P (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	p.convey@bas.ac.uk; m.i.stevens@massey.ac.nz	Convey, Peter/AAV-5728-2020	Convey, Peter/0000-0001-8497-9903	Natural Environment Research Council [bas010015] Funding Source: researchfish; NERC [bas010015] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams BJ, 2007, POLAR BIOL, V30, P809, DOI 10.1007/s00300-006-0241-3; Allegrucci G, 2006, POLAR BIOL, V29, P320, DOI 10.1007/s00300-005-0056-7; Ashworth AC, 2004, PALAEOGEOGR PALAEOCL, V213, P65, DOI 10.1016/j.palaeo.2004.07.002; Ashworth AC, 2003, NATURE, V423, P135, DOI 10.1038/423135a; Bayly IAE, 2003, ANTARCT SCI, V15, P439, DOI 10.1017/S0954102003001548; Brundin L., 1970, P41; Chown SL, 2007, PHILOS T R SOC LON B, P362; Cromer L, 2006, J BIOGEOGR, V33, P1314, DOI 10.1111/j.1365-2699.2006.01490.x; Gressitt JL, 1967, ANTARCTIC RES SERIES, V10; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Marshall DJ, 2000, ZOOL J LINN SOC-LOND, V129, P111, DOI 10.1111/j.1096-3642.2000.tb00011.x; Maslen NR, 2006, SOIL BIOL BIOCHEM, V38, P3141, DOI 10.1016/j.soilbio.2005.12.007; Pugh P. J. A., 2003, Polar Record, V39, P239; Smellie JL, 2006, PALAEOGEOGR PALAEOCL, V231, P233, DOI 10.1016/j.palaeo.2005.07.035; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Sugden DE, 2006, PHILOS T R SOC A, V364, P1607, DOI 10.1098/rsta.2006.1791; WISE KAJ, 1965, NATURE, V207, P101, DOI 10.1038/207101a0	18	134	139	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1877	1878		10.1126/science.1147261	http://dx.doi.org/10.1126/science.1147261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901323				2022-12-28	WOS:000249764300027
J	Corneo, B; Wendland, RL; Deriano, L; Cui, XP; Klein, IA; Wong, SY; Arnal, S; Holub, AJ; Weller, GR; Pancake, BA; Shah, S; Brandt, VL; Meek, K; Roth, DB				Corneo, Barbara; Wendland, Rebecca L.; Deriano, Ludovic; Cui, Xiaoping; Klein, Isaac A.; Wong, Serre-Yu; Arnal, Suzzette; Holub, Abigail J.; Weller, Geoffrey R.; Pancake, Bette A.; Shah, Sundeep; Brandt, Vicky L.; Meek, Katheryn; Roth, David B.			Rag mutations reveal robust alternative end joining	NATURE			English	Article							STRAND BREAK REPAIR; COMBINED IMMUNE-DEFICIENCY; V(D)J RECOMBINATION; MAMMALIAN-CELLS; ERROR-PRONE; PROTEINS; MICE; CLEAVAGE; REGIONS; SIGNAL	Mammalian cells repair DNA double-strand breaks (DSBs) through either homologous recombination or non-homologous end joining (NHEJ). V(D)J recombination, a cut-and-paste mechanism for generating diversity in antigen receptors, relies on NHEJ for repairing DSBs introduced by the Rag1-Rag2 protein complex. Animals lacking any of the seven known NHEJ factors are therefore immunodeficient(1). Nevertheless, DSB repair is not eliminated entirely in these animals: evidence of a third mechanism, 'alternative NHEJ', appears in the form of extremely rare V(D)J junctions(2-4) and a higher rate of chromosomal translocations(5,6). The paucity of these V(D)J events has suggested that alternative NHEJ contributes little to a cell's overall repair capacity, being operative only (and inefficiently) when classical NHEJ fails. Here we find that removing certain portions of murine Rag proteins reveals robust alternative NHEJ activity in NHEJ-deficient cells and some alternative joining activity even in wildtype cells. We propose a two-tier model in which the Rag proteins collaborate with NHEJ factors to preserve genomic integrity during V(D)J recombination.	NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; CUNY Mt Sinai Sch Med, Dept Gene & Cell Biol, Black Family Stem Cell Inst, New York, NY 10029 USA; Michigan State Univ, Coll Vet Med Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	New York University; New York University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Michigan State University; Baylor College of Medicine	Roth, DB (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	roth@saturn.med.nyu.edu	Brandt, Vicky L/J-5202-2014; Deriano, Ludovic/D-2048-2019	Deriano, Ludovic/0000-0002-9673-9525; Brandt, Vicky/0000-0002-5512-3724; Corneo, Barbara/0000-0001-5189-6749				Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Deriano L, 2006, BRIT J HAEMATOL, V133, P520, DOI 10.1111/j.1365-2141.2006.06071.x; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Posey JE, 2004, NAT IMMUNOL, V5, P476, DOI 10.1038/ni0504-476; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; Schultz HY, 2001, MOL CELL, V7, P65, DOI 10.1016/S1097-2765(01)00155-1; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	24	244	248	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					483	U10		10.1038/nature06168	http://dx.doi.org/10.1038/nature06168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898768				2022-12-28	WOS:000249724800045
J	Zong, Y; Chen, Z; Innes, JB; Chen, C; Wang, Z; Wang, H				Zong, Y.; Chen, Z.; Innes, J. B.; Chen, C.; Wang, Z.; Wang, H.			Fire and flood management of coastal swamp enabled first rice paddy cultivation in east China	NATURE			English	Article							PHYTOLITH EVIDENCE; WILD-RICE; DOMESTICATION; ORIGINS; POLLEN; AGRICULTURE; MONSOON	The adoption of cereal cultivation was one of the most important cultural processes in history, marking the transition from hunting and gathering by Mesolithic foragers to the food-producing economy of Neolithic farmers(1). In the Lower Yangtze region of China, a centre of rice domestication(2), the timing and system of initial rice cultivation remain unclear. Here we report detailed evidence from Kuahuqiao that reveals the precise cultural and environmental context of rice cultivation at this earliest known Neolithic site in eastern China, 7,700 calibrated years before present (cal. yr BP). Pollen, algal, fungal spore and micro-charcoal data from sediments demonstrate that these Neolithic communities selected lowland swamps for their rice cultivation and settlement, using fire to clear alder-dominated wetland scrub and prepare the site for occupation, then to maintain wet grassland vegetation of paddy type. Regular flooding by slightly brackish water was probably controlled by 'bunding' to maintain crop yields. The site's exploitation ceased when it was overwhelmed by marine inundation 7,550 cal. yr BP. Our results establish that rice cultivation began in coastal wetlands of eastern China, an ecosystem vulnerable to coastal change but of high fertility and productivity, attractions maximized for about two centuries by sustained high levels of cultural management of the environment.	Univ Durham, Dept Geog, Durham DH1 3LE, England; E China Normal Univ, Inst Estuarine & Coastal Res, Shanghai 200062, Peoples R China; Fudan Univ, Dept Cultural Heritage, Shanghai 200433, Peoples R China; E China Normal Univ, Dept Geog, Shanghai 200062, Peoples R China	Durham University; East China Normal University; Fudan University; East China Normal University	Zong, Y (corresponding author), Univ Durham, Dept Geog, Durham DH1 3LE, England.	y.q.zong@durham.ac.uk; j.b.innes@durham.ac.uk	Innes, James/AAQ-3317-2021					Bird MI, 2007, ESTUAR COAST SHELF S, V71, P523, DOI 10.1016/j.ecss.2006.07.004; Chen ZY, 2005, HOLOCENE, V15, P915, DOI 10.1191/0959683605hl862rr; CLARKE C, 1994, AASP CONTRIBUTIONS S, V29, P53; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; GLOVER IC, 1996, ORIGINS SPREAD AGR P, P413; Graf MT, 2006, REV PALAEOBOT PALYNO, V141, P139, DOI 10.1016/j.revpalbo.2006.03.018; Higham C, 1998, ANTIQUITY, V72, P867, DOI 10.1017/S0003598X00087500; Huang F, 2000, VEG HIST ARCHAEOBOT, V9, P161, DOI 10.1007/BF01299800; Innes JB, 2000, PALAEOGEOGR PALAEOCL, V164, P151, DOI 10.1016/S0031-0182(00)00184-X; JARVIS DI, 1993, QUATERNARY RES, V39, P325, DOI 10.1006/qres.1993.1039; JIANG L, 2003, HEMUDU NEOLITHIC SIT; Jiang L., 2005, ANTIQUITY, V87, P46; Jiang L. -P., 2004, KUAHUQIAO; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; JIANG QH, 1995, REV PALAEOBOT PALYNO, V89, P481, DOI 10.1016/0034-6667(95)00033-9; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu Tracey L.-D, 1999, BRIT ARCHAEOLOGICAL, V774; Mesleard F, 1999, PLANT ECOL, V145, P101, DOI 10.1023/A:1009803709975; Moore P.D., 1991, BLACKWELL SCI PUBLI; MORTON JF, 1975, ECON BOT, V29, P7, DOI 10.1007/BF02861252; Pei AP, 1998, ANTIQUITY, V72, P878, DOI 10.1017/S0003598X00087512; PIKE AW, 1968, NATURE, V219, P303, DOI 10.1038/219303a0; STUIVER M, 1998, RADIOCARBON, V40, P215; TANG S, 1994, AGR ARCHAEOL, V3, P88; van Geel B, 2006, NOVA HEDWIGIA, V82, P313, DOI 10.1127/0029-5035/2006/0082-0313; VOS PC, 1993, HYDROBIOLOGIA, V269, P285, DOI 10.1007/BF00028027; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Zhao S, 1988, ASIAN PERSPECT, V27, P29; Zhao Z., 1995, ORIGINS RICE AGR, P47; Zhao Z.J., 2000, GEOARCHAEOLOGY, V15, P203, DOI [10.1002/(SICI)1520-6548(200002)15:23.0.CO;2-J, DOI 10.1002/(SICI)1520-6548(200002)15:2]; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zheng XF, 2004, CLIN TRANSPLANT, V18, P119, DOI 10.1046/j.1399-0012.2003.00075.x; Zong YQ, 2004, QUATERN INT, V117, P55, DOI 10.1016/S1040-6182(03)00116-2	35	290	333	14	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					459	U4		10.1038/nature06135	http://dx.doi.org/10.1038/nature06135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898767				2022-12-28	WOS:000249724800040
J	Kim, C; Cheng, CY; Saldanha, SA; Taylor, SS				Kim, Choel; Cheng, Cecilia Y.; Saldanha, S. Adrian; Taylor, Susan S.			PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation	CELL			English	Article							PROTEIN-KINASE-A; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; CYCLIC-AMP; BINDING-SITES; CRYSTAL-STRUCTURE; ALPHA SUBUNIT; ISOFORMS; PHOSPHORYLATION; MUTATIONS	Protein kinase A ( PKA) holoenzyme is one of the major receptors for cyclic adenosine monophosphate ( cAMP), where an extracellular stimulus is translated into a signaling response. We report here the structure of a complex between the PKA catalytic subunit and a mutant RI regulatory subunit, RIa( 91 - 379: R333K), containing both cAMP- binding domains. Upon binding to the catalytic subunit, RI undergoes a dramatic conformational change in which the two cAMP- binding domains uncouple and wrap around the large lobe of the catalytic subunit. This large conformational reorganization reveals the concerted mechanism required to bind and inhibit the catalytic subunit. The structure also reveals a holoenzyme- specific salt bridge between two conserved residues, Glu261 and Arg366, that tethers the two adenine capping residues far from their cAMPbinding sites. Mutagenesis of these residues demonstrates their importance for PKA activation. Our structural insights, combined with the mutagenesis results, provide a molecular mechanism for the ordered and cooperative activation of PKA by cAMP.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54441] Funding Source: Medline; NIGMS NIH HHS [GM08326] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Anand GS, 2003, P NATL ACAD SCI USA, V100, P13264, DOI 10.1073/pnas.2232255100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BUBIS J, 1988, BIOCHEMISTRY-US, V27, P1570, DOI 10.1021/bi00405a026; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Gangal M, 1998, BIOCHEMISTRY-US, V37, P13728, DOI 10.1021/bi980560z; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kapphahn MA, 1997, ARCH BIOCHEM BIOPHYS, V348, P347, DOI 10.1006/abbi.1997.0431; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, J MOL BIOL, V220, P217, DOI 10.1016/0022-2836(91)90005-Q; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OGREID D, 1981, FEBS LETT, V129, P282, DOI 10.1016/0014-5793(81)80184-6; OGREID D, 1981, FEBS LETT, V129, P287, DOI 10.1016/0014-5793(81)80185-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saldanha SA, 2006, ANAL CHEM, V78, P8265, DOI 10.1021/ac061104g; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SYMCOX MM, 1994, J BIOL CHEM, V269, P23025; Vigil D, 2006, PROTEIN SCI, V15, P113, DOI 10.1110/ps.051723606; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503	37	256	265	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1032	1043		10.1016/j.cell.2007.07.018	http://dx.doi.org/10.1016/j.cell.2007.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889648	Bronze			2022-12-28	WOS:000250507500013
J	Seu, R; Phillips, RJ; Alberti, G; Biccari, D; Bonaventura, F; Bortone, M; Calabrese, D; Campbell, BA; Cartacci, M; Carter, LM; Catallo, C; Croce, A; Croci, R; Cutigni, M; Di Placido, A; Dinardo, S; Federico, C; Flamini, E; Fois, F; Frigeri, A; Fuga, O; Giacomoni, E; Gim, YY; Guelfi, M; Holt, JW; Kofman, W; Leuschen, CJ; Marinangeli, L; Marras, P; Masdea, A; Mattei, S; Mecozzi, R; Milkovich, SM; Morlupi, A; Mouginot, J; Orosei, R; Papa, C; Paterno, T; del Marmo, PP; Pettinelli, E; Pica, G; Picardi, G; Plaut, JJ; Provenziani, M; Putzig, NE; Russo, F; Safaeinili, A; Salzillo, G; Santovito, MR; Smrekar, SE; Tattarletti, B; Vicari, D				Seu, Roberto; Phillips, Roger J.; Alberti, Giovanni; Biccari, Daniela; Bonaventura, Francesco; Bortone, Marco; Calabrese, Diego; Campbell, Bruce A.; Cartacci, Marco; Carter, Lynn M.; Catallo, Claudio; Croce, Anna; Croci, Renato; Cutigni, Marco; Di Placido, Antonio; Dinardo, Salvatore; Federico, Costanzo; Flamini, Enrico; Fois, Franco; Frigeri, Alessandro; Fuga, Oreste; Giacomoni, Emanuele; Gim, Yonggyu; Guelfi, Mauro; Holt, John W.; Kofman, Wlodek; Leuschen, Carlton J.; Marinangeli, Lucia; Marras, Paolo; Masdea, Arturo; Mattei, Stefania; Mecozzi, Riccardo; Milkovich, Sarah M.; Morlupi, Antonio; Mouginot, Jeremie; Orosei, Roberto; Papa, Claudio; Paterno, Tobia; del Marmo, Paolo Persi; Pettinelli, Elena; Pica, Giulia; Picardi, Giovanni; Plaut, Jeffrey J.; Provenziani, Marco; Putzig, Nathaniel E.; Russo, Federica; Safaeinili, Ali; Salzillo, Giuseppe; Santovito, Maria Rosaria; Smrekar, Suzanne E.; Tattarletti, Barbara; Vicari, Danilo			Accumulation and erosion of Mars' south polar layered deposits	SCIENCE			English	Article							RADAR; SUBSURFACE; TOPOGRAPHY; FEATURES; MISSION; HISTORY; CAP	Mars' polar regions are covered with ice-rich layered deposits that potentially contain a record of climate variations. The sounding radar SHARAD on the Mars Reconnaissance Orbiter mapped detailed subsurface stratigraphy in the Promethei Lingula region of the south polar plateau, Planum Australe. Radar reflections interpreted as layers are correlated across adjacent orbits and are continuous for up to 150 kilometers along spacecraft orbital tracks. The reflectors are often separated into discrete reflector sequences, and strong echoes are seen as deep as 1 kilometer. In some cases, the sequences are dipping with respect to each other, suggesting an interdepositional period of erosion. In Australe Sulci, layers are exhumed, indicating recent erosion.	Univ Roma La Sapienza, Dept Info Com, I-00184 Rome, Italy; Washington Univ, St Louis, MO 63130 USA; Consorzio Ric Sistemi Telesensori, I-80125 Naples, Italy; Thales Alenia Space Italia, I-00131 Rome, Italy; Smithsonian Inst, Washington, DC 20013 USA; Univ Perugia, I-06123 Perugia, Italy; Agenzia Spaziale Italiana, I-00198 Rome, Italy; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Texas, Austin, TX 78758 USA; CNRS, F-38041 Grenoble, France; Univ Grenoble 1, F-38041 Grenoble, France; Univ Kansas, Lawrence, KS 66045 USA; Int Res Sch Planetary Sci, I-65127 Pescara, Italy; Ist Nazl Astrofis, I-00133 Rome, Italy; Univ Roma Tre, I-00146 Rome, Italy	Sapienza University Rome; Washington University (WUSTL); Thales Group; Smithsonian Institution; University of Perugia; Agenzia Spaziale Italiana (ASI); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Kansas; Istituto Nazionale Astrofisica (INAF); Roma Tre University	Seu, R (corresponding author), Univ Roma La Sapienza, Dept Info Com, I-00184 Rome, Italy.	roberto.seu@uniroma1.it	Smrekar, Suzanne/AAH-8074-2020; Carter, Lynn/D-2937-2012; Frigeri, Alessandro/F-2151-2010; Mouginot, Jeremie/G-7045-2015; Kofman, Wlodek/C-4556-2008; Frigeri, Alessandro/K-9679-2019; Holt, John/C-4896-2009	Smrekar, Suzanne/0000-0001-8775-075X; Carter, Lynn/0000-0002-6245-4142; Frigeri, Alessandro/0000-0002-9140-3977; Mouginot, Jeremie/0000-0001-9155-5455; Kofman, Wlodek/0000-0002-6744-8796; Frigeri, Alessandro/0000-0002-9140-3977; Calabrese, Diego/0000-0002-2598-1111; Putzig, Nathaniel/0000-0003-4485-6321; Cartacci, Marco/0000-0001-9825-1817; MARINANGELI, Lucia/0000-0001-5417-6122; PETTINELLI, Elena/0000-0002-7066-6516				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Byrne S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002267; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; Doute S, 2007, PLANET SPACE SCI, V55, P113, DOI 10.1016/j.pss.2006.05.035; FISHER DA, 1993, ICARUS, V105, P501, DOI 10.1006/icar.1993.1144; Graf JE, 2005, ACTA ASTRONAUT, V57, P566, DOI 10.1016/j.actaastro.2005.03.043; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; HOWARD AD, 1978, ICARUS, V34, P581, DOI 10.1016/0019-1035(78)90047-7; Howard AD, 2000, ICARUS, V144, P267, DOI 10.1006/icar.1999.6305; Kolb E.J., 2006, INT J MARS SCI EXPLO, V2, P1, DOI [10.1038/s41598-021-83329-3, 10.1555/mars.2006.0001, DOI 10.1555/MARS.2006.0001]; Koutnik MR, 2005, ICARUS, V174, P490, DOI 10.1016/j.icarus.2004.09.015; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; Nouvel JF, 2004, RADIO SCI, V39, DOI 10.1029/2003RS002903; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Seu R, 2004, PLANET SPACE SCI, V52, P157, DOI 10.1016/j.pss.2003.08.024; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka KL, 2001, ICARUS, V154, P3, DOI 10.1006/icar.2001.6675; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X	26	64	66	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1715	1718		10.1126/science.1144120	http://dx.doi.org/10.1126/science.1144120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885128				2022-12-28	WOS:000249585900037
J	Ryan, ET; Aquino, SL; Kradin, RL; McDonough, AL				Ryan, Edward T.; Aquino, Suzanne L.; Kradin, Richard L.; McDonough, Allison L.			A 51-year-old man with gastric cancer and lung nodules - Schistosoma mansoni infection with pulmonary involvement.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HELICOBACTER-PYLORI INFECTION; JAPANESE BRAZILIANS; STOMACH-CANCER; RISK-FACTORS; SAO-PAULO; CARCINOMA; PARAGONIMIASIS; DIAGNOSIS; STRAINS; ESOPHAGEAL		Harvard Univ, Sch Med, Div Infect Dis, Massachusetts Gen Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Ryan, ET (corresponding author), Harvard Univ, Sch Med, Div Infect Dis, Massachusetts Gen Hosp, Cambridge, MA 02138 USA.							Ashour AAR, 2002, FEMS IMMUNOL MED MIC, V33, P173, DOI 10.1111/j.1574-695X.2002.tb00588.x; Chow WH, 1998, CANCER RES, V58, P588; DeFrain M, 2002, CHEST, V121, P1368, DOI 10.1378/chest.121.4.1368; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Hamada GS, 2002, JPN J CLIN ONCOL, V32, P284, DOI 10.1093/jjco/hyf061; Jeon K, 2005, CHEST, V128, P1423, DOI 10.1378/chest.128.3.1423; JOHNSON RJ, 1985, REV INFECT DIS, V7, P200; Lambertucci JR, 2005, REV SOC BRAS MED TRO, V38, P536, DOI 10.1590/S0037-86822005000600020; Loffeld RJLF, 2000, DIGESTION, V62, P95, DOI 10.1159/000007801; Lourenco L G, 2001, Gastric Cancer, V4, P103, DOI 10.1007/PL00011722; Nishimoto IN, 2002, JPN J CLIN ONCOL, V32, P277, DOI 10.1093/jjco/hyf060; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; SLEMENDA SB, 1988, AM J TROP MED HYG, V39, P469, DOI 10.4269/ajtmh.1988.39.469; *WHO, 2006, CANC FACT SHEET; ZHANG ZH, 1993, AM J TROP MED HYG, V49, P329, DOI 10.4269/ajtmh.1993.49.329	21	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1239	1246		10.1056/NEJMcpc079023	http://dx.doi.org/10.1056/NEJMcpc079023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881756				2022-12-28	WOS:000249541000011
J	Horton, R				Horton, Richard			Righting the balance: energy for health	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	11	11	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2007	370	9591					921	921		10.1016/S0140-6736(07)61258-6	http://dx.doi.org/10.1016/S0140-6736(07)61258-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17876906				2022-12-28	WOS:000249506500009
J	Herrling, P				Herrling, Paul			Patent sense	NATURE			English	Editorial Material									Novartis Int, Corp Res, Basel, Switzerland	Novartis	Herrling, P (corresponding author), Novartis Int, Corp Res, Basel, Switzerland.								0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					174	175		10.1038/449174a	http://dx.doi.org/10.1038/449174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851514	Bronze			2022-12-28	WOS:000249394500038
J	Service, RF				Service, RF			Chemistry Nobel - Getting a charge out of plastics	SCIENCE			English	News Item																			0	12	13	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					425	+		10.1126/science.290.5491.425	http://dx.doi.org/10.1126/science.290.5491.425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	17844278				2022-12-28	WOS:000089946000009
J	Barter, P; Gotto, AM; LaRosa, JC; Maroni, J; Szarek, M; Grundy, SM; Kastelein, JJP; Bittner, V; Fruchart, JC				Barter, Philip; Gotto, Antonio M.; LaRosa, John C.; Maroni, Jaman; Szarek, Michael; Grundy, Scott M.; Kastelein, John J. P.; Bittner, Vera; Fruchart, Jean-Charles		Treating New Targets Investigators	HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; RISK-FACTORS; PRAVASTATIN; PREVENTION; AVERAGE; TRIGLYCERIDES; ATORVASTATIN; EFFICACY; MEN	Background High-density lipoprotein (HDL) cholesterol levels are a strong inverse predictor of cardiovascular events. However, it is not clear whether this association is maintained at very low levels of low-density lipoprotein (LDL) cholesterol. Methods A post hoc analysis of the recently completed Treating to New Targets (TNT) study assessed the predictive value of HDL cholesterol levels in 9770 patients. The primary outcome measure was the time to a first major cardiovascular event, defined as death from coronary heart disease, nonfatal non-procedure-related myocardial infarction, resuscitation after cardiac arrest, or fatal or nonfatal stroke. The predictive relationship between HDL cholesterol levels at the third month of treatment with statins and the time to the first major cardiovascular event was assessed in univariate and multivariate analyses and was also assessed for specific LDL cholesterol strata, including subjects with LDL cholesterol levels below 70 mg per deciliter (1.8 mmol per liter). Results The HDL cholesterol level in patients receiving statins was predictive of major cardiovascular events across the TNT study cohort, both when HDL cholesterol was considered as a continuous variable and when subjects were stratified according to quintiles of HDL cholesterol level. When the analysis was stratified according to LDL cholesterol level in patients receiving statins, the relationship between HDL cholesterol level and major cardiovascular events was of borderline significance (P=0.05). Even among study subjects with LDL cholesterol levels below 70 mg per deciliter, those in the highest quintile of HDL cholesterol level were at less risk for major cardiovascular events than those in the lowest quintile (P=0.03). Conclusions In this post hoc analysis, HDL cholesterol levels were predictive of major cardiovascular events in patients treated with statins. This relationship was also observed among patients with LDL cholesterol levels below 70 mg per deciliter.	Heart Res Inst, Sydney, NSW, Australia; Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; Pfizer, New York, NY USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; Inst Pasteur, F-59019 Lille, France	University of Sydney; Heart Research Institute; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Pfizer; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Amsterdam; Academic Medical Center Amsterdam; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Barter, P (corresponding author), Heart Res Inst, 145 Missenden Rd, Camperdown, NSW 2050, Australia.	barterp@hri.org.au	Kastelein, John/AAF-7950-2020; Szarek, Michael/ABE-1965-2021	Szarek, Michael/0000-0002-0046-0264; Bittner, Vera/0000-0001-9456-850X				Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; Gillespie MJ, 2006, CIRCULATION, V113, pE805; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Lamarche B, 1996, ATHEROSCLEROSIS, V119, P235, DOI 10.1016/0021-9150(95)05653-X; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; PEDERSEN TR, 1994, LANCET, V344, P1383; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Wang TD, 2001, AM J CARDIOL, V88, P737, DOI 10.1016/S0002-9149(01)01843-4; Waters DD, 2004, AM J CARDIOL, V93, P154, DOI 10.1016/j.amjcard.2003.09.031	24	1153	1211	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1301	1310		10.1056/NEJMoa064278	http://dx.doi.org/10.1056/NEJMoa064278			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898099				2022-12-28	WOS:000249711500006
J	Kavanagh, KD; Evans, AR; Jernvall, J				Kavanagh, Kathryn D.; Evans, Alistair R.; Jernvall, Jukka			Predicting evolutionary patterns of mammalian teeth from development	NATURE			English	Article							EXPRESSION PATTERNS; TOOTH DEVELOPMENT; GENETIC-BASIS; 3RD MOLAR; REDUCTION; DENTITIONS; GROWTH; SIZE; DIFFERENTIATION; MORPHOGENESIS	One motivation in the study of development is the discovery of mechanisms that may guide evolutionary change. Here we report how development governs relative size and number of cheek teeth, or molars, in the mouse. We constructed an inhibitory cascade model by experimentally uncovering the activator-inhibitor logic of sequential tooth development. The inhibitory cascade acts as a ratchet that determines molar size differences along the jaw, one effect being that the second molar always makes up one-third of total molar area. By using a macroevolutionary test, we demonstrate the success of the model in predicting dentition patterns found among murine rodent species with various diets, thereby providing an example of ecologically driven evolution along a developmentally favoured trajectory. In general, our work demonstrates how to construct and test developmental rules with evolutionary predictability in natural systems.	SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; Univ Helsinki, Inst Biotechnol, Evolut & Dev Unit, FIN-00014 Helsinki, Finland	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Helsinki	Kavanagh, KD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	kathryn_kavanagh@yahoo.com; jernvall@fastmail.fm	Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693				Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Bateson W., 1894, MAT STUDY VARIATION; Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007; Brakefield PM, 2006, AM NAT, V168, pS4, DOI 10.1086/509049; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Emlen DJ, 2005, AM NAT, V166, pS42, DOI 10.1086/444599; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; GARN SM, 1963, NATURE, V200, P488, DOI 10.1038/200488a0; GAUNT WA, 1963, ACTA ANAT, V54, P220; Godfrey Laurie R., 2003, P177; GOULD SJ, 1969, EVOLUTION, V23, P276, DOI 10.1111/j.1558-5646.1969.tb03512.x; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; GUTHRIE RD, 1965, EVOLUTION, V19, P214, DOI 10.1111/j.1558-5646.1965.tb01708.x; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; KURTEN BJORN, 1953, ACTA ZOOL FENNICA, V76, P1; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; OSBORN JW, 1978, DEV FUNCTION EVOLUTI; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Polly PD, 2005, EVOL DEV, V7, P29, DOI 10.1111/j.1525-142X.2005.05004.x; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Sahlberg Carin, 2002, Methods Mol Biol, V188, P373; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Silvestri AR, 2003, J AM DENT ASSOC, V134, P450, DOI 10.14219/jada.archive.2003.0194; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SOFAER JA, 1971, EVOLUTION, V25, P509, DOI 10.1111/j.1558-5646.1971.tb01910.x; Sokal RR, 1995, BIOMETRY; Tanaka M, 2005, DEV BIOL, V281, P227, DOI 10.1016/j.ydbio.2005.02.016; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; VANVALEN L, 1962, EVOLUTION, V16, P272; Wagner GP, 2000, AM ZOOL, V40, P819, DOI 10.1668/0003-1569(2000)040[0819:DEAAMS]2.0.CO;2; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; [No title captured]	50	279	286	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					427	U1		10.1038/nature06153	http://dx.doi.org/10.1038/nature06153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898761				2022-12-28	WOS:000249724800033
J	Keller, A; Zhuang, HY; Chi, QY; Vosshall, LB; Matsunami, H				Keller, Andreas; Zhuang, Hanyi; Chi, Qiuyi; Vosshall, Leslie B.; Matsunami, Hiroaki			Genetic variation in a human odorant receptor alters odour perception	NATURE			English	Article							FUNCTIONAL EXPRESSION; ENHANCED SENSITIVITY; ANDROSTENONE; PLASTICITY; ABILITY; PEOPLE	Human olfactory perception differs enormously between individuals, with large reported perceptual variations in the intensity and pleasantness of a given odour. For instance, androstenone (5 alpha-androst-16-en-3-one), an odorous steroid derived from testosterone, is variously perceived by different individuals as offensive ("sweaty, urinous''), pleasant ("sweet, floral'') or odourless(1-3). Similar variation in odour perception has been observed for several other odours(4-6). The mechanistic basis of variation in odour perception between individuals is unknown. We investigated whether genetic variation in human odorant receptor genes accounts in part for variation in odour perception between individuals(7,8). Here we show that a human odorant receptor, OR7D4, is selectively activated in vitro by androstenone and the related odorous steroid androstadienone (androsta-4,16-dien-3-one) and does not respond to a panel of 64 other odours and two solvents. A common variant of this receptor (OR7D4 WM) contains two non-synonymous single nucleotide polymorphisms (SNPs), resulting in two amino acid substitutions (R88W, T133M; hence 'RT') that severely impair function in vitro. Human subjects with RT/WM or WM/WM genotypes as a group were less sensitive to androstenone and androstadienone and found both odours less unpleasant than the RT/RT group. Genotypic variation in OR7D4 accounts for a significant proportion of the valence (pleasantness or unpleasantness) and intensity variance in perception of these steroidal odours. Our results demonstrate the first link between the function of a human odorant receptor in vitro and odour perception.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Rockefeller University; Duke University	Vosshall, LB (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	leslie@mail.rockefeller.edu; hiroaki.matsunami@duke.edu		Vosshall, Leslie/0000-0002-6060-8099; Keller, Andreas/0000-0001-5491-2214				Bremner EA, 2003, CHEM SENSES, V28, P423, DOI 10.1093/chemse/28.5.423; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; DORRIES KM, 1989, DEV PSYCHOBIOL, V22, P423, DOI 10.1002/dev.420220502; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; GOWER DB, 1998, PERFUMERY, P47; GUILLOT M, 1948, CR HEBD ACAD SCI, V226, P1307; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Keller A, 2004, CURR BIOL, V14, pR875, DOI 10.1016/j.cub.2004.09.066; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	28	440	458	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					468	U6		10.1038/nature06162	http://dx.doi.org/10.1038/nature06162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17873857	Green Submitted			2022-12-28	WOS:000249724800042
J	Raty, JY; Schwegler, E; Bonev, SA				Raty, Jean-Yves; Schwegler, Eric; Bonev, Stanimir A.			Electronic and structural transitions in dense liquid sodium	NATURE			English	Article							MOLECULAR-DYNAMICS; PHASE-TRANSITION; HIGH-PRESSURES; ELEMENTS; LITHIUM; CESIUM; ORDER	At ambient conditions, the light alkali metals are free-electron-like crystals with a highly symmetric structure. However, they were found recently to exhibit unexpected complexity under pressure(1-6). It was predicted from theory(1,2)-and later confirmed by experiment(3-5)-that lithium and sodium undergo a sequence of symmetry-breaking transitions, driven by a Peierls mechanism, at high pressures. Measurements of the sodium melting curve(6) have subsequently revealed an unprecedented (and still unexplained) pressure-induced drop in melting temperature from 1,000 K at 30 GPa down to room temperature at 120 GPa. Here we report results from ab initio calculations that explain the unusual melting behaviour in dense sodium. We show that molten sodium undergoes a series of pressure-induced structural and electronic transitions, analogous to those observed in solid sodium but commencing at much lower pressure in the presence of liquid disorder. As pressure is increased, liquid sodium initially evolves by assuming a more compact local structure. However, a transition to a lower-coordinated liquid takes place at a pressure of around 65 GPa, accompanied by a threefold drop in electrical conductivity. This transition is driven by the opening of a pseudogap, at the Fermi level, in the electronic density of states-an effect that has not hitherto been observed in a liquid metal. The lower-coordinated liquid emerges at high temperatures and above the stability region of a close-packed free-electron-like metal. We predict that similar exotic behaviour is possible in other materials as well.	Univ Liege, FNRS, B-4000 Sart Tilman Par Liege, Belgium; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Dalhousie Univ, Dept Phys, Halifax, NS B3H 3J5, Canada	University of Liege; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Dalhousie University	Raty, JY (corresponding author), Univ Liege, FNRS, B-4000 Sart Tilman Par Liege, Belgium.	jyraty@ulg.ac.be; stanimir.bonev@dal.ca	Schwegler, Eric/A-2436-2016; Schwegler, Eric/F-7294-2010	Schwegler, Eric/0000-0003-3635-7418; 				Ackland GJ, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/138; BECKE AD, 1990, J CHEM PHYS, V92, P5397, DOI 10.1063/1.458517; BEISTER HJ, 1990, PHYS REV B, V41, P5535, DOI 10.1103/PhysRevB.41.5535; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BICHARA C, 1993, PHYS REV B, V47, P5002, DOI 10.1103/PhysRevB.47.5002; BOEHLER R, 1986, PHYSICA B & C, V139, P233, DOI 10.1016/0378-4363(86)90565-6; Bonev SA, 2004, NATURE, V431, P669, DOI 10.1038/nature02968; CHATTOPADHYAY T, 1987, J PHYS C SOLID STATE, V20, P1431, DOI 10.1088/0022-3719/20/10/012; Correa AA, 2006, P NATL ACAD SCI USA, V103, P1204, DOI 10.1073/pnas.0510489103; Gaspard JP, 1998, PHILOS MAG B, V77, P727, DOI 10.1080/13642819808214831; GLOTZEL D, 1979, PHYS REV B, V20, P3210, DOI 10.1103/PhysRevB.20.3210; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Gregoryanz E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.185502; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Hanfland M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184109; Hernandez ER, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.055501; JAYARAMAN A, 1967, PHYS REV, V159, P527, DOI 10.1103/PhysRev.159.527; Katayama Y, 2003, J PHYS-CONDENS MAT, V15, P6085, DOI 10.1088/0953-8984/15/36/302; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; Neaton JB, 2001, PHYS REV LETT, V86, P2830, DOI 10.1103/PhysRevLett.86.2830; Raty JY, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235209; STEINHARDT PJ, 1981, PHYS REV LETT, V47, P1297, DOI 10.1103/PhysRevLett.47.1297; SUGINO O, 1995, PHYS REV LETT, V74, P1823, DOI 10.1103/PhysRevLett.74.1823; SYASSEN K, 2002, HIGH PRESSURE PHENOM, P251; WASEDA Y, 1980, STRUCTURE NONCRYSTAL, pCH3; ZHA CS, 1985, PHYS REV B, V31, P3199, DOI 10.1103/PhysRevB.31.3199	28	117	118	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					448	451		10.1038/nature06123	http://dx.doi.org/10.1038/nature06123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898764	Green Submitted			2022-12-28	WOS:000249724800037
J	Sugarman, SD				Sugarman, Stephen D.			Cases in vaccine court - Legal battles over vaccines and austism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sugarman, SD (corresponding author), Univ Calif Berkeley, Sch Law, Boalt Hall, Berkeley, CA 94720 USA.							*DEP HLTH HUM SERV, NAT VACC INJ COMP PR; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	4	28	32	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1275	1277		10.1056/NEJMp078168	http://dx.doi.org/10.1056/NEJMp078168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898095				2022-12-28	WOS:000249711500002
J	Dranovsky, A; Hen, R				Dranovsky, Alex; Hen, Rene			DISC1 puts the brakes on neurogenesis	CELL			English	Editorial Material							HIPPOCAMPAL NEUROGENESIS; SCHIZOPHRENIA	The gene DISC1 ( Disrupted- in- Schizophrenia 1) is a leading candidate gene for schizophrenia. In this issue, Duan et al. ( 2007) present evidence implicating DISC1 in the maturation and integration of newly generated neurons in the adult mouse hippocampus. Surprisingly, DISC1 appears to have opposite effects on neurogenesis during development and in adulthood.	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University	Dranovsky, A (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	ad722@columbia.edu; rh95@columbia.edu	Dranovsky, Alex/P-4357-2018	Dranovsky, Alex/0000-0001-7896-3243	NIMH NIH HHS [K08 MH079088, K08 MH079088-01, K08 MH079088-03, K08 MH079088-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; DUAN X, 2007, CELL; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030	10	13	13	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					981	983		10.1016/j.cell.2007.09.004	http://dx.doi.org/10.1016/j.cell.2007.09.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889641	Bronze			2022-12-28	WOS:000250507500006
J	Pancost, RD; Steart, DS; Handley, L; Collinson, ME; Hooker, JJ; Scott, AC; Grassineau, NV; Glasspool, IJ				Pancost, Richard D.; Steart, David S.; Handley, Luke; Collinson, Margaret E.; Hooker, Jerry J.; Scott, Andrew C.; Grassineau, Nathalie V.; Glasspool, Ian J.			Increased terrestrial methane cycling at the Palaeocene-Eocene thermal maximum	NATURE			English	Article							BOUNDARY; WETLANDS; OCEAN; BASIN	The Palaeocene-Eocene thermal maximum (PETM), a period of intense, global warming about 55 million years ago(1), has been attributed to a rapid rise in greenhouse gas levels, with dissociation of methane hydrates being the most commonly invoked explanation(2). It has been suggested previously that high-latitude methane emissions from terrestrial environments could have enhanced the warming effect(3,4), but direct evidence for an increased methane flux from wetlands is lacking. The Cobham Lignite, a recently characterized expanded lacustrine/mire deposit in England, spans the onset of the PETM5 and therefore provides an opportunity to examine the biogeochemical response of wet-land-type ecosystems at that time. Here we report the occurrence of hopanoids, biomarkers derived from bacteria, in the mire sediments from Cobham. We measure a decrease in the carbon isotope values of the hopanoids at the onset of the PETM interval, which suggests an increase in the methanotroph population. We propose that this reflects an increase in methane production potentially driven by changes to a warmer(1,6) and wetter climate(7,8). Our data suggest that the release of methane from the terrestrial biosphere increased and possibly acted as a positive feedback mechanism to global warming.	Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol Biogeochem Res Ctr, Bristol BS8 1TS, Avon, England; Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Bristol; University of London; Royal Holloway University London; Natural History Museum London; Field Museum of Natural History (Chicago)	Pancost, RD (corresponding author), Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol Biogeochem Res Ctr, Bristol BS8 1TS, Avon, England.	r.d.pancost@bristol.ac.uk	Scott, Andrew C/C-6661-2008	Scott, Andrew C/0000-0002-1998-3508; Pancost, Richard/0000-0003-0298-4026; Grassineau, Nathalie/0000-0001-7958-7104				Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Bujak JP, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P277; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Collinson ME, 2007, J GEOL SOC LONDON, V164, P87, DOI 10.1144/0016-76492005-185; COLLINSON ME, 2003, CAUSES CONSEQUENCES, P333; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; Crouch EM, 2003, PALAEOGEOGR PALAEOCL, V194, P387, DOI 10.1016/S0031-0182(03)00334-1; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; ELLISON R. A., 1996, GEOL SOC LOND SPEC P, V101, P185; Gibson TG, 2000, SEDIMENT GEOL, V134, P65, DOI 10.1016/S0037-0738(00)00014-2; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grassineau NV, 2006, APPL GEOCHEM, V21, P756, DOI 10.1016/j.apgeochem.2006.02.015; Hartner T, 2005, FEMS MICROBIOL LETT, V243, P59, DOI 10.1016/j.femsle.2004.11.039; Inubushi K, 2005, NUTR CYCL AGROECOSYS, V71, P93, DOI 10.1007/s10705-004-5283-8; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KURTZ AC, 2003, PALEOCEANOGRAPHY, V18; Magioncalda R, 2001, B SOC GEOL FR, V172, P349, DOI 10.2113/172.3.349; Maslin MA, 2003, QUATERNARY SCI REV, V22, P1729, DOI 10.1016/S0277-3791(03)00135-5; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pancost RD, 2003, HOLOCENE, V13, P921, DOI 10.1191/0959683603hl674rp; Powell A.J., 1992, P155; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; RUBLE TE, 1994, ORG GEOCHEM, V21, P661, DOI 10.1016/0146-6380(94)90011-6; Schmitz B, 2007, GEOLOGY, V35, P215, DOI 10.1130/G23261A.1; Schouten S, 2001, GEOCHIM COSMOCHIM AC, V65, P1629, DOI 10.1016/S0016-7037(00)00627-X; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; SLOAN LC, 1992, NATURE, V357, P320, DOI 10.1038/357320a0; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Steart David C., 2007, Acta Palaeobotanica, V47, P109; Steurbaut E., 2003, Geological Society of America Special Paper, V369, P291; Xie SC, 2005, NATURE, V434, P494, DOI 10.1038/nature03396; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	35	71	79	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					332	+		10.1038/nature06012	http://dx.doi.org/10.1038/nature06012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882218				2022-12-28	WOS:000249557300043
J	Bhattacharyya, N; Friedlander, RM				Bhattacharyya, Neil; Friedlander, Robert M.			Pneumocephalus associated with pneumosinus dilatans frontalis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Bhattacharyya, N (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	neiloy@massmed.org	Friedlander, Robert M/A-2845-2016	Friedlander, Robert M/0000-0003-4423-9219					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1136	1136		10.1056/NEJMicm062822	http://dx.doi.org/10.1056/NEJMicm062822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855674				2022-12-28	WOS:000249387200009
J	Chipman, A				Chipman, Andrea			A commodity no more	NATURE			English	News Item																			0	87	88	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					131	131		10.1038/449131a	http://dx.doi.org/10.1038/449131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851487				2022-12-28	WOS:000249394500012
J	CHERFAS, J				CHERFAS, J			TRANSGENIC CROPS GET A TEST IN THE WILD	SCIENCE			English	Editorial Material																			0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 22	1991	251	4996					878	878		10.1126/science.251.4996.878	http://dx.doi.org/10.1126/science.251.4996.878			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY629	17847381				2022-12-28	WOS:A1991EY62900032
J	CREIGHTON, TE				CREIGHTON, TE			PREDICTION OF PROTEIN-STRUCTURE AND THE PRINCIPLES OF PROTEIN CONFORMATION - FASMAN,GD	SCIENCE			English	Book Review											CREIGHTON, TE (corresponding author), MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND.							Richardson J. S., 1989, PREDICTION PROTEIN S, P1	1	5	6	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1351	1352		10.1126/science.247.4948.1351-a	http://dx.doi.org/10.1126/science.247.4948.1351-a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843800				2022-12-28	WOS:A1990CU25300044
J	KERR, RA				KERR, RA			OZONE DESTRUCTION CLOSER TO HOME	SCIENCE			English	Editorial Material																		1989, SCIENCE, V239, P1007	1	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1297	1297		10.1126/science.247.4948.1297	http://dx.doi.org/10.1126/science.247.4948.1297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843787				2022-12-28	WOS:A1990CU25300022
J	NORMAN, C				NORMAN, C			SDI HEADS FOR FISCAL CRASH	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1283	1285		10.1126/science.247.4948.1283	http://dx.doi.org/10.1126/science.247.4948.1283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843779				2022-12-28	WOS:A1990CU25300011
J	Konig, M; Wiedmann, S; Brune, C; Roth, A; Buhmann, H; Molenkamp, LW; Qi, XL; Zhang, SC				Koenig, Markus; Wiedmann, Steffen; Bruene, Christoph; Roth, Andreas; Buhmann, Hartmut; Molenkamp, Laurens W.; Qi, Xiao-Liang; Zhang, Shou-Cheng			Quantum spin hall insulator state in HgTe quantum wells	SCIENCE			English	Article							PHASE	Recent theory predicted that the quantum spin Hall effect, a fundamentally new quantum state of matter that exists at zero external magnetic field, may be realized in HgTe/(Hg,Cd)Te quantum wells. We fabricated such sample structures with low density and high mobility in which we could tune, through an external gate voltage, the carrier conduction from n-type to p-type, passing through an insulating regime. For thin quantum wells with well width d < 6.3 nanometers, the insulating regime showed the conventional behavior of vanishingly small conductance at low temperature. However, for thicker quantum wells (d > 6.3 nanometers), the nominally insulating regime showed a plateau of residual conductance close to 2e(2)/h, where e is the electron charge and h is Planck's constant. The residual conductance was independent of the sample width, indicating that it is caused by edge states. Furthermore, the residual conductance was destroyed by a small external magnetic field. The quantum phase transition at the critical thickness, d = 6.3 nanometers, was also independently determined from the magnetic field-induced insulator-to-metal transition. These observations provide experimental evidence of the quantum spin Hall effect.	Univ Wurzburg, Inst Phys, EP 3, D-97074 Wurzburg, Germany; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Wurzburg; Stanford University	Molenkamp, LW (corresponding author), Univ Wurzburg, Inst Phys, EP 3, D-97074 Wurzburg, Germany.	molenkmp@physik.uni-wuerzburg.de	Brüne, Christoph/AAO-2131-2020; Wiedmann, Steffen/F-9701-2015; König, Markus/N-8770-2015; Zhang, Shou-Cheng/B-2794-2010; Wiedmann, Steffen/N-3298-2019	Brüne, Christoph/0000-0002-2491-6414; Wiedmann, Steffen/0000-0002-9122-7117; Molenkamp, Laurens/0000-0003-4833-5179				Becker C. R., 2007, Physica Status Solidi C, V4, P3382, DOI 10.1002/pssc.200775402; Bemevig B. A., 2006, PHYS REV LETT, V96; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Daumer V, 2003, APPL PHYS LETT, V83, P1376, DOI 10.1063/1.1602170; FRADKIN E, 1986, PHYS REV LETT, V57, P2967, DOI 10.1103/PhysRevLett.57.2967; Hinz J, 2006, SEMICOND SCI TECH, V21, P501, DOI 10.1088/0268-1242/21/4/015; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Konig M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076804; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; Novik EG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035321; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pfeuffer-Jeschke A., 2000, THESIS U WURZBURG GE; Schultz M, 1998, PHYS REV B, V57, P14772, DOI 10.1103/PhysRevB.57.14772; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; VOLKOV BA, 1985, JETP LETT+, V42, P178; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wu CJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106401; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Xu CK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045322; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	23	4351	4422	41	1165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					766	770		10.1126/science.1148047	http://dx.doi.org/10.1126/science.1148047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17885096	Green Submitted			2022-12-28	WOS:000250583900033
J	Cornia, PB; Lipsky, BA; Saint, S; Gonzales, R				Cornia, Paul B.; Lipsky, Benjamin A.; Saint, Sanjay; Gonzales, Ralph			Nothing to cough at	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; PERTUSSIS; EPIDEMIOLOGY; INFANTS; ADULTS		Vet Affairs Puget Sound Hlth Care Syst, Primary & Specialty Med Care Serv, Seattle, WA 98108 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Cornia, PB (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Primary & Specialty Med Care Serv, 1660 S Columbian Way S-111, Seattle, WA 98108 USA.	paul.cornia@med.va.gov	Saint, Sanjay/AAF-5126-2019; Lipsky, Benjamin A/B-4645-2013	Lipsky, Benjamin A./0000-0001-9886-5114; Cornia, Paul/0000-0002-4949-9637				BISGARD K, 2002, MANUAL SURVEILLANCE; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; De Serres G, 2000, J INFECT DIS, V182, P174, DOI 10.1086/315648; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; KLASS P, 2004, N ENGL J MED; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Lievano FA, 2002, J CLIN MICROBIOL, V40, P2801, DOI 10.1128/JCM.40.8.2801-2805.2002; Muller FMC, 1997, J CLIN MICROBIOL, V35, P2435; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; Park WB, 2005, EUR J CLIN MICROBIOL, V24, P156, DOI 10.1007/s10096-005-1277-y; Pratter MR, 2006, CHEST, V129, p59S, DOI 10.1378/chest.129.1_suppl.59S; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; 2002, MMWR MORB MORTAL WKL, V51, P73	18	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1432	1437		10.1056/NEJMcps062357	http://dx.doi.org/10.1056/NEJMcps062357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914045				2022-12-28	WOS:000249892900010
J	Tu, JV; Bowen, J; Chiu, M; Ko, DT; Austin, PC; He, YH; Hopkins, R; Tarride, J; Blackhouse, G; Lazzam, C; Cohen, EA; Goeree, R				Tu, Jack V.; Bowen, James; Chiu, Maria; Ko, Dennis T.; Austin, Peter C.; He, Yaohua; Hopkins, Robert; Tarride, Jean-Eric; Blackhouse, Gord; Lazzam, Charles; Cohen, Eric A.; Goeree, Ron			Effectiveness and safety of drug-eluting stents in Ontario	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREMATURE DISCONTINUATION; UNCOATED STENTS; THROMBOSIS; RESTENOSIS; OUTCOMES; INTERVENTIONS; IMPLANTATION; METAANALYSIS; MULTICENTER; PREDICTORS	Background The placement of drug-eluting stents decreases the frequency of repeat revascularization procedures in patients undergoing percutaneous coronary intervention (PCI) in randomized clinical trials. However, there is uncertainty about the effectiveness of drug-eluting stents, and increasing concern about their safety, in routine clinical practice. Methods From the Cardiac Care Network of Ontario's population-based clinical registry of all patients undergoing PCI in Ontario, Canada, we identified a well-balanced cohort of 3751 pairs of patients, matched on the basis of propensity score, who received either bare-metal stents alone or drug-eluting stents alone during an index PCI procedure between December 1, 2003, and March 31, 2005. The primary outcomes of the study were the rates of target-vessel revascularization, myocardial infarction, and death. Results The 2-year rate of target-vessel revascularization was significantly lower among patients who received drug-eluting stents than among those who received bare-metal stents (7.4% vs. 10.7%, P<0.001). Drug-eluting stents were associated with significant reductions in the rate of target-vessel revascularization among patients with two or three risk factors for restenosis (i.e., presence of diabetes, small vessels [<3 mm in diameter], and long lesions [>= 20 mm]) but not among lower-risk patients. The 3-year mortality rate was significantly higher in the bare-metal-stent group than in the drug-eluting-stent group (7.8% vs. 5.5%, P<0.001), whereas the 2-year rate of myocardial infarction was similar in the two groups (5.2% and 5.7%, respectively; P=0.95). Conclusions Drug-eluting stents are effective in reducing the need for target-vessel revascularization in patients at highest risk for restenosis, without a significantly increased rate of death or myocardial infarction.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; St Josephs Healthcare, Hamilton, ON, Canada; Trillium Hlth Sci Ctr, Mississauga, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tu, JV (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca	, Jim/L-3077-2019	, Jim/0000-0002-6457-2337; Ko, Dennis/0000-0001-6840-8051; Austin, Peter/0000-0003-3337-233X; Tu, Jack/0000-0003-0111-722X; Chiu, Maria/0000-0002-3877-1068				Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; BOWEN J, 2005, HTA0020512 ONT MIN H, P170; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; Greenberg D, 2004, J AM COLL CARDIOL, V43, P513, DOI 10.1016/j.jacc.2003.11.020; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Klein JP., 2003, SURVIVAL ANAL TECHNI; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; LAERQVIST B, 2007, NEW ENGL J MED, V356, P1009; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shuchman M, 2007, NEW ENGL J MED, V356, P325, DOI 10.1056/NEJMp068300; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Wilkins R, 1993, Health Rep, V5, P157; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; *WORK GROUP DRUG E, 2002, REP IN UT STRAT FIN, P15	33	302	315	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2007	357	14					1393	1402		10.1056/NEJMoa071076	http://dx.doi.org/10.1056/NEJMoa071076			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216QA	17914040	Bronze			2022-12-28	WOS:000249892900005
J	Steinman, RM; Banchereau, J				Steinman, Ralph M.; Banchereau, Jacques			Taking dendritic cells into medicine	NATURE			English	Review							REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID PREDENDRITIC CELLS; PERIPHERAL LYMPHOID ORGANS; INTERFERON-PRODUCING CELLS; INNATE IMMUNE RECOGNITION; ANTIGEN-PRESENTING CELLS; STEADY-STATE CONDITIONS; VERSUS-HOST-DISEASE; RESPONSES IN-VIVO	Dendritic cells (DCs) orchestrate a repertoire of immune responses that bring about resistance to infection and silencing or tolerance to self. In the settings of infection and cancer, microbes and tumours can exploit DCs to evade immunity, but DCs also can generate resistance, a capacity that is readily enhanced with DC-targeted vaccines. During allergy, autoimmunity and transplant rejection, DCs instigate unwanted responses that cause disease, but, again, DCs can be harnessed to silence these conditions with novel therapies. Here we present some medical implications of DC biology that account for illness and provide opportunities for prevention and therapy.	Rockefeller Univ, New York, NY 10065 USA; Baylor Inst Immunol Res, Dallas, TX 75204 USA	Rockefeller University; Baylor Scott & White Health	Steinman, RM (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	steinma@mail.rockefeller.edu	Steinman, Ralph/F-7729-2012					Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Vries IJM, 2003, CANCER RES, V63, P12; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; O'Rourke MGE, 2003, CANCER IMMUNOL IMMUN, V52, P387, DOI 10.1007/s00262-003-0375-x; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Paczesny S, 2004, J EXP MED, V199, P1503, DOI 10.1084/jem.20032118; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Probst HC, 2005, J IMMUNOL, V174, P3920, DOI 10.4049/jimmunol.174.7.3920; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vicari AP, 2002, SEMIN CANCER BIOL, V12, P33, DOI 10.1006/scbi.2001.0400; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	108	1562	1691	8	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					419	426		10.1038/nature06175	http://dx.doi.org/10.1038/nature06175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898760				2022-12-28	WOS:000249724800032
J	Borch, SJ				Borch, Sarah Jane			Prescription for community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sjborch@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1375	1376		10.1001/jama.298.12.1375	http://dx.doi.org/10.1001/jama.298.12.1375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895448				2022-12-28	WOS:000249698900001
J	Lengeler, C; deSavigny, D				Lengeler, Christian; deSavigny, Don			Programme diversity is key to the success of insecticide-treated bednets	LANCET			English	Editorial Material							MALARIA		Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Lengeler, C (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	Christian.Lengeler@unibas.ch						[Anonymous], 2007, OPERATIONS COSTS COS; [Anonymous], 2003, AFR MAL REP 2003; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; LENGELER C, IN PRESS AM J TROP M; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Roll Back Malaria, 2005, SCAL INS TREAT NETT; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; World Health Organization Global Malaria Programme, 2007, INS TREAT MOSQ NETS	12	23	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2007	370	9592					1009	1010		10.1016/S0140-6736(07)61454-8	http://dx.doi.org/10.1016/S0140-6736(07)61454-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889225				2022-12-28	WOS:000249727900004
J	Winyard, G				Winyard, Graham			Medical immigration: the elephant in the room	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTORS					gwinyard@doctors.org.uk						Delamothe T, 2007, BRIT MED J, V334, P1285, DOI 10.1136/bmj.39252.411192.80; Hawkes N, 2007, BRIT MED J, V334, P724, DOI 10.1136/bmj.39170.469780.59; *HOM OFF BORD IMM, INF HIGHL SKILL MIGR; *INF CTR, NHS HCHS MED DENT ST; Jefferis Tony, 2007, BMJ, V334, P1302, DOI 10.1136/bmj.39238.447338.AD; *MED WORKF STAND A, 1997, 3 DOH MED WORKF STAN; *MMC, 2007, LANCET, V369, P879; *MOD MED CAR, REV MED TRAIN APPL S; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2007, NEW ENGL J MED, V356, P440, DOI 10.1056/NEJMp068267; NEWTON P, 2007, BMA NEWS        0630, P1; WARNER, 2006, UNEMPLOYMENT QUALIFI	12	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					593	595		10.1136/bmj.39330.686840.AD	http://dx.doi.org/10.1136/bmj.39330.686840.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215TR	17884904	Green Published			2022-12-28	WOS:000249832400032
J	Herkenhoff, KE; Byrne, S; Russell, PS; Fishbaugh, KE; McEwen, AS				Herkenhoff, K. E.; Byrne, S.; Russell, P. S.; Fishbaugh, K. E.; McEwen, A. S.			Meter-scale morphology of the north polar region of Mars	SCIENCE			English	Article							LAYERED DEPOSITS; GEOLOGIC HISTORY; STRATIGRAPHY	Mars' north pole is covered by a dome of layered ice deposits. Detailed (similar to 30 centimeters per pixel) images of this region were obtained with the High-Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter (MRO). Planum Boreum basal unit scarps reveal cross-bedding and show evidence for recent mass wasting, flow, and debris accumulation. The north polar layers themselves are as thin as 10 centimeters but appear to be covered by a dusty veneer in places, which may obscure thinner layers. Repetition of particular layer types implies that quasi-periodic climate changes influenced the stratigraphic sequence in the polar layered deposits, informing models for recent climate variations on Mars.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Int Space Sci Inst, CH-3012 Bern, Switzerland	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Bern	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Byrne, Shane/B-8104-2012					BYRNE S, 2002, J GEOPHYS RES, V107; Clifford SM, 2005, ICARUS, V174, P291, DOI 10.1016/j.icarus.2004.12.012; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2003, GEOMORPHOLOGY, V52, P289, DOI 10.1016/S0169-555X(02)00262-3; Fenton LK, 2000, ICARUS, V147, P433, DOI 10.1006/icar.2000.6459; FISHBAUGH K, 2006, J GEOPHYS RES, V111; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; Johnson AM., 1970, PHYS PROCESSES GEOLO; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; MALIN M, 2001, J GEOPHYS RES, V106, P23439; McEwen A.S., 2007, J GEOPHYS RES, V112, pE5, DOI 10.1029/2005JE002605; MILKOVICH S, 2006, MARS, V2, P21, DOI DOI 10.1555/MARS.2006.0003; MILKOVICH SM, 2005, J GEOPHYS RES, V110; MURCHIE S, 2007, LUN PLAN SCI C, V38; PHILLIPS RJ, 2007, LUN PLAN SCI C, V38; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Tanaka KL, 2005, NATURE, V437, P991, DOI 10.1038/nature04065; THOMAS P, 1992, MARS	21	78	79	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1711	1715		10.1126/science.1143544	http://dx.doi.org/10.1126/science.1143544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885127				2022-12-28	WOS:000249585900036
J	Rass, U; Ahel, I; West, SC				Rass, Ulrich; Ahel, Ivan; West, Stephen C.			Defective DNA repair and Neurodegenerative disease	CELL			English	Review							STRAND BREAK REPAIR; HUMAN POLYNUCLEOTIDE KINASE; OCULAR MOTOR APRAXIA; TOPOISOMERASE-I; ATAXIA-TELANGIECTASIA; OXIDATIVE STRESS; GENE-PRODUCT; PHOSPHODIESTERASE TDP1; SPINOCEREBELLAR ATAXIA; TARGETED DISRUPTION	Defects in cellular DNA repair processes have been linked to genome instability, heritable cancers, and premature aging syndromes. Yet defects in some repair processes manifest themselves primarily in neuronal tissues. This review focuses on studies defining the molecular defects associated with several human neurological disorders, particularly ataxia with oculomotor apraxia 1 ( AOA1) and spinocerebellar ataxia with axonal neuropathy 1 ( SCAN1). A picture is emerging to suggest that brain cells, due to their nonproliferative nature, may be particularly prone to the progressive accumulation of unrepaired DNA lesions.	Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk		West, Stephen/0000-0001-8848-9418; Rass, Ulrich/0000-0001-9275-9062; Ahel, Ivan/0000-0002-9446-3756				Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Date H, 2004, BIOCHEM BIOPH RES CO, V325, P1279, DOI 10.1016/j.bbrc.2004.10.162; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Davies DR, 2002, J MOL BIOL, V324, P917, DOI 10.1016/S0022-2836(02)01154-3; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gueven N, 2007, CELL DEATH DIFFER, V14, P1149, DOI 10.1038/sj.cdd.4402116; Gueven N, 2007, NEUROSCIENCE, V145, P1418, DOI 10.1016/j.neuroscience.2006.12.010; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hirano M, 2004, BIOCHEM BIOPH RES CO, V322, P380, DOI 10.1016/j.bbrc.2004.07.135; Hirano M, 2007, ANN NEUROL, V61, P162, DOI 10.1002/ana.21078; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kamsler A, 2001, CANCER RES, V61, P1849; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Lesher DTT, 2002, P NATL ACAD SCI USA, V99, P12102, DOI 10.1073/pnas.192282699; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; McConnell MJ, 2004, J NEUROSCI, V24, P8090, DOI 10.1523/JNEUROSCI.2263-04.2004; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Miao ZH, 2006, DNA REPAIR, V5, P1489, DOI 10.1016/j.dnarep.2006.07.004; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; O'Driscoll M, 2006, CELL CYCLE, V5, P2339, DOI 10.4161/cc.5.20.3358; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Raymond AC, 2004, J MOL BIOL, V338, P895, DOI 10.1016/j.jmb.2004.03.013; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; SARKANDER HI, 1978, EXP BRAIN RES, V31, P317; Seidle HF, 2005, J BIOL CHEM, V280, P20927, DOI 10.1074/jbc.M502889200; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Takahashi T, 2007, NUCLEIC ACIDS RES, V35, P3797, DOI 10.1093/nar/gkm158; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson RB, 2003, J NEUROL SCI, V207, P103, DOI 10.1016/S0022-510X(02)00432-X; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411	84	244	249	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					991	1004		10.1016/j.cell.2007.08.043	http://dx.doi.org/10.1016/j.cell.2007.08.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889645	Bronze			2022-12-28	WOS:000250507500010
J	Bloche, MG				Bloche, M. Gregg			Health care for all?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Washington, DC 20057 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Washington, DC 20057 USA.							Bloche MG, 2006, NEW ENGL J MED, V355, P1756, DOI 10.1056/NEJMp068127; Bobbitt P., 2002, SHIELD ACHILLES WAR; CALABRESE M, 2004, 1 NEW AM FDN; Epstein R., 1997, MORTAL PERIL OUR INA; Putnam RD., 2000, BOWLING ALONE COLLAP	5	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1173	1175		10.1056/NEJMp078132	http://dx.doi.org/10.1056/NEJMp078132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211RM	17881748				2022-12-28	WOS:000249541000001
J	Sung, L; Nathan, PC; Alibhai, SMH; Tomlinson, GA; Beyene, J				Sung, Lillian; Nathan, Paul C.; Alibhai, Shabbir M. H.; Tomlinson, George A.; Beyene, Joseph			Meta-analysis: Effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; NON-HODGKINS-LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; PLACEBO-CONTROLLED TRIAL; CONTROLLED PHASE-III; FACTOR GM-CSF; FACTOR ACCELERATES NEUTROPHIL	Background: Benefits of prophylactic hematopoietic colony-stimulating factors (CSFs) in adults and children receiving cancer chemotherapy or undergoing stem-cell transplantation (SCT) are unclear. Purpose: To determine whether prophylactic CSFs decrease mortality, infections, and febrile neutropenia more than does placebo or no therapy in patients with cancer and in patients undergoing SCT. Data Sources: Electronic searches of Ovid MEDLINE and EMBASE from inception until April 2007 and of the Cochrane Central Register of Controlled Trials until the second quarter of 2006. Study Selection: We selected 148 trials that were reported in any language that randomly assigned patients to CSFs or to either placebo or no therapy. Prophylactic CSFs were given concurrently with or after initiation of chemotherapy. Data Extraction: Two reviewers independently extracted data onto standardized forms. Data Synthesis: Short-term all-cause mortality appeared to be similar between the prophylactic CSF and the control groups (7.6% vs. 8.0%; relative risk, 0.95 [95% Cl, 0.84 to 1.08]; absolute risk reduction, 0.4% [Cl, -0.5% to 1.4%]). Risks for infection-related death with CSFs and placebo or no therapy were 3.1% and 3.8%, respectively (relative risk, 0.82 [Cl, 0.66 to 1.02]; absolute risk reduction, 0.8% [Cl, 0.0% to 1.5%]). Use of CSFs reduced the following more than did placebo or no therapy: documented infections (median rate, 38.9% vs. 43.1 %; rate ratio, 0.85 [Cl, 0.79 to 0.92]), microbiologically documented infections (median rate, 23.5% vs. 28.6%; rate ratio, 0.86 [Cl, 0.77 to 0.96]), and episodes of febrile neutropenia (median rate, 25.3% vs. 44.2%; rate ratio, 0.71 [Cl, 0.63 to 0.80]). Limitations: Trial designs, including assessments of infections, and participants were heterogeneous. Estimates of mortality effects were imprecise. Conclusions: Prophylactic CSFs may have little or no effect on mortality but do decrease rates of infection in patients receiving cancer chemotherapy or those undergoing SCT.	Univ Toronto, Hosp Sick Children, Univ Hlth Network, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University Health Network Toronto	Sung, L (corresponding author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	lillian.sung@sick-kids.ca	Nathan, Paul/GRR-2377-2022; Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399; Alibhai, Shabbir/0000-0001-7815-6046; Nathan, Paul/0000-0003-0334-0871				Adams Jared R, 2002, Expert Opin Pharmacother, V3, P1273; Amadori S, 2005, BLOOD, V106, P27, DOI 10.1182/blood-2004-09-3728; [Anonymous], 1994, J CLIN ONCOL, V12, P2471; AVILES A, 1994, LEUKEMIA LYMPHOMA, V15, P153, DOI 10.3109/10428199409051691; BAJORIN DF, 1995, J CLIN ONCOL, V13, P79, DOI 10.1200/JCO.1995.13.1.79; Berghmans T, 2002, LUNG CANCER-J IASLC, V37, P115, DOI 10.1016/S0169-5002(02)00082-X; Bernasconi C, 1998, BRIT J HAEMATOL, V102, P678, DOI 10.1046/j.1365-2141.1998.00816.x; BIELER GS, 1993, BIOMETRICS, V49, P793, DOI 10.2307/2532200; Bishop MR, 2000, BLOOD, V96, P80, DOI 10.1182/blood.V96.1.80.013k35_80_85; Bohlius J, 2003, BRIT J HAEMATOL, V122, P413, DOI 10.1046/j.1365-2141.2003.04450.x; BOHLIUS J, 2004, COCHRANE DATABASE SY; BUI BN, 1995, J CLIN ONCOL, V13, P2629, DOI 10.1200/JCO.1995.13.10.2629; BUNN PA, 1995, J CLIN ONCOL, V13, P1632, DOI 10.1200/JCO.1995.13.7.1632; Burton C, 2006, BRIT J CANCER, V94, P806, DOI 10.1038/sj.bjc.6602975; CALDERWOOD S, 1994, AM J HEMATOL, V47, P27, DOI 10.1002/ajh.2830470106; CHANNA J, 2002, JCPSP-J COLL PHYSICI, V123, P538; Clarke V, 1999, MED PEDIATR ONCOL, V32, P331, DOI 10.1002/(SICI)1096-911X(199905)32:5<331::AID-MPO4>3.0.CO;2-M; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Dallorso S, 2002, HAEMATOLOGICA, V87, P1274; Dekker A, 2006, J CLIN ONCOL, V24, P5207, DOI 10.1200/JCO.2006.06.1663; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEWITTE T, 1993, TRANSPLANT P, V25, P57; DEWITTE T, 1992, BLOOD, V79, P1359; DOMBRET H, 1995, NEW ENGL J MED, V332, P1678, DOI 10.1056/NEJM199506223322504; Doorduijn JK, 2003, J CLIN ONCOL, V21, P3041, DOI 10.1200/JCO.2003.01.076; Eapen M, 2004, J CLIN ONCOL, V22, P4872, DOI 10.1200/JCO.2004.02.189; Fossa SD, 1998, J CLIN ONCOL, V16, P716, DOI 10.1200/JCO.1998.16.2.716; Fridrik MA, 1997, ANN HEMATOL, V75, P135, DOI 10.1007/s002770050330; Fukuoka M, 1997, BRIT J CANCER, V75, P306, DOI 10.1038/bjc.1997.50; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Geissler K, 1997, BLOOD, V90, P590, DOI 10.1182/blood.V90.2.590.590_590_596; GERHARTZ HH, 1993, BLOOD, V82, P2329; Gisselbrecht C, 1997, LEUKEMIA LYMPHOMA, V25, P289, DOI 10.3109/10428199709114168; GISSELBRECHT C, 1994, LANCET, V343, P696, DOI 10.1016/S0140-6736(94)91579-2; Godwin JE, 1998, BLOOD, V91, P3607, DOI 10.1182/blood.V91.10.3607.3607_3607_3615; GORIN NC, 1992, BLOOD, V80, P1149; Greenberg P, 1996, BONE MARROW TRANSPL, V18, P1057; GULATI SC, 1992, ANN INTERN MED, V116, P177, DOI 10.7326/0003-4819-116-3-177; Harousseau JL, 2000, J CLIN ONCOL, V18, P780, DOI 10.1200/JCO.2000.18.4.780; Heil G, 1997, BLOOD, V90, P4710, DOI 10.1182/blood.V90.12.4710.4710_4710_4718; Hidalgo M, 1998, CANCER-AM CANCER SOC, V83, P719, DOI 10.1002/(SICI)1097-0142(19980815)83:4<719::AID-CNCR13>3.0.CO;2-V; Holowiecki J, 2002, LEUKEMIA LYMPHOMA, V43, P315, DOI 10.1080/10428190290006099; Ifrah N, 1999, CANCER-AM CANCER SOC, V86, P1496, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1496::AID-CNCR16>3.0.CO;2-#; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jones SE, 1996, J CLIN ONCOL, V14, P2976, DOI 10.1200/JCO.1996.14.11.2976; KAPLAN LD, 1991, J CLIN ONCOL, V9, P929, DOI 10.1200/JCO.1991.9.6.929; KHWAJA A, 1992, BRIT J HAEMATOL, V82, P317, DOI 10.1111/j.1365-2141.1992.tb06424.x; KLUMPP TR, 1995, J CLIN ONCOL, V13, P1323, DOI 10.1200/JCO.1995.13.6.1323; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson RA, 1998, BLOOD, V92, P1556; Legros M, 1997, BONE MARROW TRANSPL, V19, P209, DOI 10.1038/sj.bmt.1700640; Lehrnbecher T, 2002, BRIT J HAEMATOL, V116, P28, DOI 10.1046/j.1365-2141.2002.03230.x; Linch DC, 1997, BRIT J HAEMATOL, V99, P933, DOI 10.1046/j.1365-2141.1997.4703274.x; LINCH DC, 1993, BONE MARROW TRANSPL, V11, P307; LINK H, 1992, BLOOD, V80, P2188; Lowenberg B, 1997, J CLIN ONCOL, V15, P3496; Lyman GH, 2002, AM J MED, V112, P406, DOI 10.1016/S0002-9343(02)01036-7; Michel G, 2000, J CLIN ONCOL, V18, P1517, DOI 10.1200/JCO.2000.18.7.1517; Michon JM, 1998, EUR J CANCER, V34, P1063, DOI 10.1016/S0959-8049(98)00061-6; MILES DW, 1994, J CLIN ONCOL, V12, P77, DOI 10.1200/JCO.1994.12.1.77; Milligan DW, 2006, BLOOD, V107, P4614, DOI 10.1182/blood-2005-10-4202; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moreau P, 1997, J CLIN ONCOL, V15, P660, DOI 10.1200/JCO.1997.15.2.660; NEMUNAITIS J, 1991, NEW ENGL J MED, V324, P1773, DOI 10.1056/NEJM199106203242504; NEMUNAITIS J, 1995, BONE MARROW TRANSPL, V15, P949; OHNO R, 1990, NEW ENGL J MED, V323, P871, DOI 10.1056/NEJM199009273231304; OHNO R, 1999, BIOTHERAPY, V13, P701; Ojeda E, 1999, BONE MARROW TRANSPL, V24, P601, DOI 10.1038/sj.bmt.1701972; OTTMANN OG, 1995, BLOOD, V86, P444, DOI 10.1182/blood.V86.2.444.bloodjournal862444; PETTENGELL R, 1992, BLOOD, V80, P1430; Pfreundschuh M, 2001, ANN ONCOL, V12, P471, DOI 10.1023/A:1011108722666; Przepiorka D, 2001, BLOOD, V97, P3405, DOI 10.1182/blood.V97.11.3405; Pui CH, 1997, NEW ENGL J MED, V336, P1781, DOI 10.1056/NEJM199706193362503; Remberger M, 2003, BONE MARROW TRANSPL, V32, P217, DOI 10.1038/sj.bmt.1704108; RIIKONEN P, 1995, STEM CELLS, V13, P289, DOI 10.1002/stem.5530130310; Ringden O, 2004, J CLIN ONCOL, V22, P416, DOI 10.1200/JCO.2004.06.102; ROWE JM, 1995, BLOOD, V86, P457, DOI 10.1182/blood.V86.2.457.bloodjournal862457; Sasse EC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004139.pub2; SCHMITZ N, 1995, BONE MARROW TRANSPL, V15, P261; Schmitz N, 2004, BONE MARROW TRANSPL, V34, P955, DOI 10.1038/sj.bmt.1704724; Seymour AM, 1995, EUR J CANCER, V31A, P2157, DOI 10.1016/0959-8049(95)00197-2; SHAFFER DW, 1993, CANCER RES, V53, P5929; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; STABEL RA, 1994, J CLIN ONCOL, V12, P1931; Steward WP, 1998, J CLIN ONCOL, V16, P642, DOI 10.1200/JCO.1998.16.2.642; STONE RM, 1995, NEW ENGL J MED, V332, P1671, DOI 10.1056/NEJM199506223322503; Sung L, 2004, J CLIN ONCOL, V22, P3350, DOI 10.1200/JCO.2004.09.106; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Takeshita A, 1995, Rinsho Ketsueki, V36, P606; Thomas X, 1999, LEUKEMIA, V13, P1214, DOI 10.1038/sj.leu.2401474; Thomas X, 2007, LEUKEMIA, V21, P453, DOI 10.1038/sj.leu.2404521; Thomas Xavier, 2004, Hematol J, V5, P384, DOI 10.1038/sj.thj.6200536; Usuki K, 2002, BRIT J HAEMATOL, V116, P103, DOI 10.1046/j.1365-2141.2002.03251.x; Vogel CL, 2005, J CLIN ONCOL, V23, P1178, DOI 10.1200/JCO.2005.09.102; Weiss GR, 1996, ANTI-CANCER DRUG, V7, P402, DOI 10.1097/00001813-199606000-00005; Wexler LH, 1996, J CLIN ONCOL, V14, P901, DOI 10.1200/JCO.1996.14.3.901; Witz F, 1998, BLOOD, V91, P2722; WOLL PJ, 1995, J CLIN ONCOL, V13, P652, DOI 10.1200/JCO.1995.13.3.652; Yau JC, 1996, AM J HEMATOL, V51, P289, DOI 10.1002/(SICI)1096-8652(199604)51:4<289::AID-AJH7>3.3.CO;2-O; Zittoun R, 1996, J CLIN ONCOL, V14, P2150, DOI 10.1200/JCO.1996.14.7.2150; Zwierzina H, 2005, LEUKEMIA, V19, P1929, DOI 10.1038/sj.leu.2403934	101	119	126	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					400	411		10.7326/0003-4819-147-6-200709180-00010	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876022				2022-12-28	WOS:000249726200005
J	Lankau, RA; Strauss, SY				Lankau, Richard A.; Strauss, Sharon Y.			Mutual feedbacks maintain both genetic and species diversity in a plant community	SCIENCE			English	Article							COMPETITIVE RELATIONSHIPS; GENOTYPIC DIVERSITY; EVOLUTION; CONSEQUENCES; MAINTENANCE; GAME	The forces that maintain genetic diversity among individuals and diversity among species are usually studied separately. Nevertheless, diversity at one of these levels may depend on the diversity at the other. We have combined observations of natural populations, quantitative genetics, and field experiments to show that genetic variation in the concentration of an allelopathic secondary compound in Brassica nigra is necessary for the coexistence of B. nigra and its competitor species. In addition, the diversity of competing species was required for the maintenance of genetic variation in the trait within B. nigra. Thus, conservation of species diversity may also necessitate maintenance of the processes that sustain the genetic diversity of each individual species.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Lankau, RA (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	ralankau@gmail.com	Dumitrescu, Ovidiu/C-4738-2011; Ion, Rodica-Mariana/B-2839-2008; Ionita, Ionica/P-9456-2017; Lankau, Richard A/B-9760-2008; Strauss, Sharon/J-1827-2012; Somoghi, Raluca/E-8969-2016	Ion, Rodica-Mariana/0000-0002-9842-3321; Ionita, Ionica/0000-0002-6958-234X; Lankau, Richard A/0000-0001-9995-328X; Strauss, Sharon/0000-0002-6117-4085; Somoghi, Raluca/0000-0002-7648-3147				Abrams PA, 2006, EVOLUTION, V60, P427; BULMER MG, 1989, GENOME, V31, P761, DOI 10.1139/g89-135; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1989, J MATH BIOL, V27, P117, DOI 10.1007/BF00276099; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Falconer DS, 1996, INTRO QUANTITATIVE G; FEENY P, 1982, BIOCHEM SYST ECOL, V10, P23, DOI 10.1016/0305-1978(82)90047-3; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kimura M., 1983, NEUTRAL THEORY MOL E; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Laird RA, 2006, AM NAT, V168, P182, DOI 10.1086/506259; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; SCHREINER RP, 1993, NEW PHYTOL, V123, P107, DOI 10.1111/j.1469-8137.1993.tb04536.x; Siemens DH, 2002, ECOLOGY, V83, P505, DOI 10.1890/0012-9658(2002)083[0505:CODITC]2.0.CO;2; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Tilman D., 1982, Monographs in Population Biology, pi; Traw MB, 2002, EVOLUTION, V56, P2196, DOI 10.1111/j.0014-3820.2002.tb00144.x; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2	27	270	274	6	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1561	1563		10.1126/science.1147455	http://dx.doi.org/10.1126/science.1147455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872447				2022-12-28	WOS:000249467900045
J	Oppenheimer, M; O'Neill, BC; Webster, M; Agrawala, S				Oppenheimer, Michael; O'Neill, Brian C.; Webster, Mort; Agrawala, Shardul			Climate change - The limits of consensus	SCIENCE			English	Editorial Material							TECHNOLOGICAL-CHANGE; UNCERTAINTY; MODEL		Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; MIT, MIT Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA; OECD, Paris, France	Princeton University; Princeton University; International Institute for Applied Systems Analysis (IIASA); Brown University; Massachusetts Institute of Technology (MIT); Organisation for Economic Co-operation & Development (OECD)	Oppenheimer, M (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	omichael@princeton.edu	O'Neill, Brian C./E-6531-2013	O'Neill, Brian C./0000-0001-7505-8897; Oppenheimer, Michael/0000-0002-9708-5914				Agrawala S, 1998, CLIMATIC CHANGE, V39, P621, DOI 10.1023/A:1005312331477; Baker E, 2005, RESOUR ENERGY ECON, V27, P19, DOI 10.1016/j.reseneeco.2004.05.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerlagh R, 2003, RESOUR ENERGY ECON, V25, P35, DOI 10.1016/S0928-7655(02)00020-9; Goulder LH, 1999, RESOUR ENERGY ECON, V21, P211, DOI 10.1016/S0928-7655(99)00004-4; Houghton J. T, 1990, SCI ASS CLIM CHANG R, P365; Houghton J. T., 2001, CLIMATE CHANGE 2001; IPCC, 1996, FULL TEXT CLIM CHANG; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; MORGAN G, 1990, UNCERTAINTY GUIDE DE; OPPENHEIMER M, 2006, C LEARN CLIM CHANG I; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Parson E.A., 2003, PROTECTING OZONE LAY; PATT A, 1999, RISK DECISION POLICY, V4, P1; Patt A, 2007, GLOBAL ENVIRON CHANG, V17, P37, DOI 10.1016/j.gloenvcha.2006.10.002; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; ROWLAND FS, 1989, AM SCI, V77, P36; Scambos T., 2001, IMAGES ANTARCTIC ICE; Vaughan DG, 2002, CLIMATIC CHANGE, V52, P65, DOI 10.1023/A:1013038920600; Webster MD, 2002, ATMOS ENVIRON, V36, P3659, DOI 10.1016/S1352-2310(02)00245-5; *WORLD MET ORG, 1991, 25 WORLD MET ORG; *WORLD MET ORG, 1988, 18 WORLD MET ORG; *WORLD MET ORG, 1986, 16 WORLD MET ORG; Zickfeld K, 2007, CLIMATIC CHANGE, V82, P235, DOI 10.1007/s10584-007-9246-3	25	111	112	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1505	1506		10.1126/science.1144831	http://dx.doi.org/10.1126/science.1144831			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872430				2022-12-28	WOS:000249467900025
J	Affolder, R; Rizzo, I; Burgess, C; Bchir, A; Lob-Levyt, J				Affolder, Rebecca; Rizzo, Ivone; Burgess, Craig; Bchir, Abdallah; Lob-Levyt, Julian			A prescription for drug delivery	NATURE			English	Editorial Material									GAVI Alliance, Geneva, Switzerland		Affolder, R (corresponding author), GAVI Alliance, Geneva, Switzerland.								0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					170	172		10.1038/449170a	http://dx.doi.org/10.1038/449170a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851513	Bronze			2022-12-28	WOS:000249394500037
J	Silvotti, R; Schuh, S; Janulis, R; Solheim, JE; Bernabei, S; Ostensen, R; Oswalt, TD; Bruni, I; Gualandi, R; Bonanno, A; Vauclair, G; Reed, M; Chen, CW; Leibowitz, E; Paparo, M; Baran, A; Charpinet, S; Dolez, N; Kawaler, S; Kurtz, D; Moskalik, P; Riddle, R; Zola, S				Silvotti, R.; Schuh, S.; Janulis, R.; Solheim, J.-E.; Bernabei, S.; Ostensen, R.; Oswalt, T. D.; Bruni, I.; Gualandi, R.; Bonanno, A.; Vauclair, G.; Reed, M.; Chen, C. -W.; Leibowitz, E.; Paparo, M.; Baran, A.; Charpinet, S.; Dolez, N.; Kawaler, S.; Kurtz, D.; Moskalik, P.; Riddle, R.; Zola, S.			A giant planet orbiting the 'extreme horizontal branch' star V391 Pegasi	NATURE			English	Article							SUBDWARF-B-STARS; STELLAR EVOLUTION; SYSTEM; DWARF; COMPANION; JUPITER; PULSAR; MODES	After the initial discoveries fifteen years ago(1,2), over 200 extrasolar planets have now been detected. Most of them orbit main-sequence stars similar to our Sun, although a few planets orbiting red giant stars have been recently found(3). When the hydrogen in their cores runs out, main-sequence stars undergo an expansion into red-giant stars. This expansion can modify the orbits of planets and can easily reach and engulf the inner planets. The same will happen to the planets of our Solar System in about five billion years and the fate of the Earth is matter of debate(4,5). Here we report the discovery of a planetary-mass body (Msini = 3.2M(Jupiter)) orbiting the star V 391 Pegasi at a distance of about 1.7 astronomical units (AU), with a period of 3.2 years. This star is on the extreme horizontal branch of the Hertzsprung-Russell diagram, burning helium in its core and pulsating. The maximum radius of the red-giant precursor of V 391 Pegasi may have reached 0.7 AU, while the orbital distance of the planet during the stellar main-sequence phase is estimated to be about 1 AU. This detection of a planet orbiting a post-red-giant star demonstrates that planets with orbital distances of less than 2 AU can survive the red-giant expansion of their parent stars.	Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; Vilnius State Univ, Inst Theoret Phys & Astron, LT-01108 Vilnius, Lithuania; Univ Oslo, Inst Teoret Astrofys, N-0315 Oslo, Norway; Osservatorio Astron Bologna, INAF, I-40127 Bologna, Italy; Katholieke Univ Leuven, Inst Astron, B-3001 Louvain, Belgium; Florida Inst Technol, Dept Phys & Space Sci, Melbourne, FL 32901 USA; Florida Inst Technol, SARA Observ, Melbourne, FL 32901 USA; Osserv Astrofis Catania, INAF, I-95123 Catania, Italy; Univ Toulouse 3, Observ Midi Pyrenees, CNRS, UMR5572, F-31400 Toulouse, France; Missouri State Univ, Dept Phys Astron & Mat Sci, Springfield, MO 65897 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Tel Aviv Univ, Wise Observ, IL-69978 Tel Aviv, Israel; Konkoly Observ Budapest, H-1525 Budapest 12, Hungary; Cracow Pedag Univ, PL-30084 Krakow, Poland; Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; Univ Cent Lancashire, Ctr Astrophys, Preston PR1 2HE, Lancs, England; Copernicus Astron Ctr, PL-00716 Warsaw, Poland; Thirty Meter Telescope Project, Pasadena, CA 91107 USA; Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland	Istituto Nazionale Astrofisica (INAF); University of Gottingen; Vilnius University; University of Oslo; Istituto Nazionale Astrofisica (INAF); KU Leuven; Florida Institute of Technology; Florida Institute of Technology; Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Missouri State University; National Central University; Tel Aviv University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Pedagogical University of Cracow; Iowa State University; University of Central Lancashire; Jagiellonian University	Silvotti, R (corresponding author), Osserv Astron Capodimonte, INAF, Via Moiariello 16, I-80131 Naples, Italy.	silvotti@na.astro.it	Silvotti, Roberto/ABB-7598-2021; Baran, Andrzej/V-1285-2018; Bonanno, Alfio/J-1845-2012	Silvotti, Roberto/0000-0002-1295-8174; Baran, Andrzej/0000-0001-6446-6617; Moskalik, Pawel/0000-0003-3142-0350; Charpinet, Stephane/0000-0002-6018-6180; Reed, Michael/0000-0002-2936-4807; Bonanno, Alfio/0000-0003-3175-9776; Kurtz, Donald/0000-0002-1015-3268; Kawaler, Steven/0000-0002-6536-6367; Bruni, Ivan/0000-0002-1560-4590; Schuh, Sonja/0000-0002-5830-837X				Charpinet S, 2002, ASTROPHYS J SUPPL S, V140, P469, DOI 10.1086/339707; Costa JES, 1999, ASTROPHYS J, V522, P973, DOI 10.1086/307655; DOLLINGER MP, IN PRESS ASTRON ASTR; Duncan MJ, 1998, ICARUS, V134, P303, DOI 10.1006/icar.1998.5962; EGGLETON PP, 1983, ASTROPHYS J, V268, P368, DOI 10.1086/160960; Han Z, 2002, MON NOT R ASTRON SOC, V336, P449, DOI 10.1046/j.1365-8711.2002.05752.x; HANEL RA, 1981, J GEOPHYS RES-SPACE, V86, P8705, DOI 10.1029/JA086iA10p08705; Kepler SO, 2005, ASTROPHYS J, V634, P1311, DOI 10.1086/497002; Kilkenny D., 2007, COMMUN ASTEROSEISMOL, V150, P234; Koen C., 2005, ASP C SER, V335, P25; LIVIO M, 1983, ASTRON ASTROPHYS, V125, pL12; Maxted PFL, 2006, NATURE, V442, P543, DOI 10.1038/nature04987; Mukadam AS, 2003, ASTROPHYS J, V594, P961, DOI 10.1086/377044; Ostensen R, 2001, ASTRON ASTROPHYS, V368, P175, DOI 10.1051/0004-6361:20000488; Rasio FA, 1996, ASTROPHYS J, V470, P1187, DOI 10.1086/177941; Reed MD, 2004, MON NOT R ASTRON SOC, V348, P1164, DOI 10.1111/j.1365-2966.2004.07438.x; Rybicki KR, 2001, ICARUS, V151, P130, DOI 10.1006/icar.2001.6591; Silvotti R, 2006, ASTRON ASTROPHYS, V459, P557, DOI 10.1051/0004-6361:20065314; Silvotti R, 2002, ASTRON ASTROPHYS, V389, P180, DOI 10.1051/0004-6361:20020584; Soker N, 1998, ASTRON J, V116, P1308, DOI 10.1086/300503; Sterken C., 2005, ASP C SER, V335; Stumpff P., 1980, Astronomy & Astrophysics Supplement Series, V41, P1; SWEIGART AV, 1978, ASTROPHYS J SUPPL S, V36, P405, DOI 10.1086/190506; THORSETT SE, 1993, ASTROPHYS J, V412, pL33, DOI 10.1086/186933; Villaver E, 2007, ASTROPHYS J, V661, P1192, DOI 10.1086/516746; Winget DE, 2003, ASTR SOC P, V294, P59; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; ZAHN JP, 1977, ASTRON ASTROPHYS, V57, P383	29	189	189	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					189	191		10.1038/nature06143	http://dx.doi.org/10.1038/nature06143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851517				2022-12-28	WOS:000249394500042
J	Ma, L; Teruya-Feldstein, J; Weinberg, RA				Ma, Li; Teruya-Feldstein, Julie; Weinberg, Robert A.			Tumour invasion and metastasis initiated by microRNA 10b in breast cancer	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; GENE-EXPRESSION; CELLS; RHOC; DROSOPHILA; TWIST; TRANSFORMATION; MORPHOGENESIS	MicroRNAs have been implicated in regulating diverse cellular pathways. Although there is emerging evidence that some microRNAs can function as oncogenes or tumour suppressors, the role of microRNAs in mediating cancer metastasis remains unexplored. Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion. Overexpression of miR-10b in otherwise non-metastatic breast tumours initiates robust invasion and metastasis. Expression of miR-10b is induced by the transcription factor Twist, which binds directly to the putative promoter of mir-10b (MIRN10B). The miR-10b induced by Twist proceeds to inhibit translation of the messenger RNA encoding homeobox D10, resulting in increased expression of a well-characterized pro-metastatic gene, RHOC. Significantly, the level of miR-10b expression in primary breast carcinomas correlates with clinical progression. These findings suggest the workings of an undescribed regulatory pathway, in which a pleiotropic transcription factor induces expression of a specific microRNA, which suppresses its direct target and in turn activates another pro-metastatic gene, leading to tumour cell invasion and metastasis.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Vickers, Michael M/E-4095-2010	Ma, Li/0000-0001-9965-989X				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; ETHIER SP, 1993, CANCER RES, V53, P627; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kleer CG, 2006, CLIN CANCER RES, V12, P4485, DOI 10.1158/1078-0432.CCR-06-0376; Kondo T, 2004, PATHOBIOLOGY, V71, P19, DOI 10.1159/000072958; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makiyama K, 2005, ONCOL REP, V13, P673; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang Wei, 2004, Zhonghua Zhongliu Zazhi, V26, P279; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	48	2059	2269	4	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					682	U2		10.1038/nature06174	http://dx.doi.org/10.1038/nature06174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17898713				2022-12-28	WOS:000250045000035
J	Kenyon, S; Ullman, R; Mori, R; Whittle, M				Kenyon, S.; Ullman, R.; Mori, R.; Whittle, M.		Guideline Dev Grp	Care of healthy women and their babies during childbirth: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; Royal Coll Obstet & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England	University of Leicester	Kenyon, S (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	oracle@le.ac.uk		Kenyon, Sara/0000-0002-0756-9617; Mori, Rintaro/0000-0001-7656-6156				National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO	1	10	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2007	335	7621					667	668		10.1136/bmj.39322.703380.AD	http://dx.doi.org/10.1136/bmj.39322.703380.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901518	Green Published			2022-12-28	WOS:000249989600044
J	Borman, E				Borman, Edwin			Should postgraduate training places be reserved for UK graduates? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp, Coventry & Warwickshire NHS Trust, Coventry CV2 2DX, W Midlands, England	University of Warwick	Borman, E (corresponding author), Univ Hosp, Coventry & Warwickshire NHS Trust, Coventry CV2 2DX, W Midlands, England.	edwin@borman.demon.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					591	591		10.1136/bmj.39302.403021.94	http://dx.doi.org/10.1136/bmj.39302.403021.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884902	Green Published			2022-12-28	WOS:000249832400030
J	Sheikh, A; Wallia, S				Sheikh, Aziz; Wallia, Sunita			10-minute consultation - Ramadan fasting and diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland; Univ Edinburgh, Div Community Hlth Sci Publ Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				*DIAB UK, DIAB RAM; *SCOTT NUTR DIET R, S AS BAL GOOD HLTH	2	8	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2007	335	7620					613	614		10.1136/bmj.39323.573148.BE	http://dx.doi.org/10.1136/bmj.39323.573148.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17884907	Green Published			2022-12-28	WOS:000249832400038
J	Brodsky, I; Medzhitov, R				Brodsky, Igor; Medzhitov, Ruslan			Two modes of ligand recognition by TLRs	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; COMPLEX; MD-2	Toll- like receptors ( TLRs) are membrane- bound sensors that detect and respond to microbial infection. Two studies in Cell, one in this issue, reveal how TLRs recognize their ligands. Kim etal. ( 2007) recently reported the structure of TLR4 bound to the accessory protein MD- 2 and its antagonist, the drug eritoran. In this issue, Jin et al. ( 2007) describe the crystal structure of a complex between TLR1, TLR2, and a lipopeptide ligand.	Yale Univ, Sch Med, Howard Hughes Med Inst & Sect Immunol, New Haven, CT 06520 USA	Yale University	Brodsky, I (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst & Sect Immunol, 333 Cedar St, New Haven, CT 06520 USA.	igor.brodsky@yale.edu; ruslan.medzhitov@yale.edu						Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JIN MS, 2007, CELL; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111	8	56	59	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					979	981		10.1016/j.cell.2007.09.009	http://dx.doi.org/10.1016/j.cell.2007.09.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889640	Bronze			2022-12-28	WOS:000250507500005
J	Michniewicz, M; Zago, MK; Abas, L; Weijers, D; Schweighofer, A; Meskiene, I; Heisler, MG; Ohno, C; Zhang, J; Huang, F; Schwab, R; Weigel, D; Meyerowitz, EM; Luschnig, C; Offringa, R; Friml, J				Michniewicz, Marta; Zago, Marcelo K.; Abas, Lindy; Weijers, Dolf; Schweighofer, Alois; Meskiene, Irute; Heisler, Marcus G.; Ohno, Carolyn; Zhang, Jing; Huang, Fang; Schwab, Rebecca; Weigel, Detlef; Meyerowitz, Elliot M.; Luschnig, Christian; Offringa, Remko; Friml, Jiri			Antagonistic regulation of PIN phosphorylation by PP2A and PINOID directs auxin flux	CELL			English	Article							PROTEIN-KINASE; ARABIDOPSIS; EFFLUX; TRANSPORT; GRADIENTS; GROWTH; PHOSPHOPROTEOMICS; PHOSPHATASE-2A; GRAVITROPISM; ENDOCYTOSIS	In plants, cell polarity and tissue patterning are connected by intercellular flow of the phytohormone auxin, whose directional signaling depends on polar subcellular localization of PIN auxin transport proteins. The mechanism of polar targeting of PINs or other cargos in plants is largely unidentified, with the PINOID kinase being the only known molecular component. Here, we identify PP2A phosphatase as an important regulator of PIN apical- basal targeting and auxin distribution. Genetic analysis, localization, and phosphorylation studies demonstrate that PP2A and PINOID both partially colocalize with PINs and act antagonistically on the phosphorylation state of their central hydrophilic loop, hence mediating PIN apicalbasal polar targeting. Thus, in plants, polar sorting by the reversible phosphorylation of cargos allows for their conditional delivery to specific intracellular destinations. In the case of PIN proteins, this mechanism enables switches in the direction of intercellular auxin fluxes, which mediate differential growth, tissue patterning, and organogenesis.	Univ Tubingen, Zentrum Mole Biol Pfflanzen, Tubingen, Germany; Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; Univ Nat Resources & Appl Life Sci BOKU, Inst Appl Genet & Cell Biol, Vienna, Austria; Wageningen Univ, Biochem Lab, Wageningen, Netherlands; Univ Vienna, Max F Perutz Labs, Vienna, Austria; CALTECH, Div Biol, Pasadena, CA 91125 USA; Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, Gottingen, Germany	Eberhard Karls University of Tubingen; Leiden University; Leiden University - Excl LUMC; University of Natural Resources & Life Sciences, Vienna; Wageningen University & Research; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); California Institute of Technology; Max Planck Society; University of Gottingen	Friml, J (corresponding author), Univ Tubingen, Zentrum Mole Biol Pfflanzen, Tubingen, Germany.	jifri@psb.ugent.be	Meyerowitz, Elliot M/A-7118-2009; Schwab, Rebecca/I-9352-2012; Weigel, Detlef/AAR-3312-2021; heisler, marcus G/B-9738-2015; Weijers, Dolf/A-2076-2010; Friml, Jiri/D-9511-2012; Weijers, Dolf/ABI-1332-2020; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Schwab, Rebecca/0000-0001-9933-9669; heisler, marcus G/0000-0001-5644-8398; Weijers, Dolf/0000-0003-4378-141X; Friml, Jiri/0000-0002-8302-7596; Weijers, Dolf/0000-0003-4378-141X; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schweighofer, Alois/0000-0002-8466-0924; Luschnig, Christian/0000-0003-2099-9280	Austrian Science Fund FWF [P 18840] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shin H, 2005, PLANT J, V42, P188, DOI 10.1111/j.1365-313X.2005.02369.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zhou HW, 2004, PLANT CELL, V16, P709, DOI 10.1105/tpc.018994	37	492	527	3	110	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1044	1056		10.1016/j.cell.2007.07.033	http://dx.doi.org/10.1016/j.cell.2007.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889649	Bronze			2022-12-28	WOS:000250507500014
J	Fonseca, C; Lindahl, GE; Ponticos, M; Sestini, P; Renzoni, EA; Holmes, AM; Spagnolo, P; Pantelidis, P; Leoni, P; McHugh, N; Stock, CJ; Xu, SW; Denton, CP; Black, CM; Welsh, KI; du Bois, RM; Abraham, DJ				Fonseca, Carmen; Lindahl, Gisela E.; Ponticos, Markella; Sestini, Piersante; Renzoni, Elisabetta A.; Holmes, Alan M.; Spagnolo, Paolo; Pantelidis, Panagiotis; Leoni, Patricia; McHugh, Neil; Stock, Carmel J.; Xu, Shi-Wen; Denton, Christopher P.; Black, Carol M.; Welsh, Kenneth I.; du Bois, Roland M.; Abraham, David J.			A polymorphism in the CTGF promoter region associated with systemic sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE GROWTH-FACTOR; SCLERODERMA FIBROBLASTS; EXPRESSION; ANTICENTROMERE; AUTOANTIBODIES; DISEASE; ACTIVATION; GENETICS; BINDING; SCL-70	Background Systemic sclerosis (scleroderma) is a life-threatening autoimmune disease that is characterized by the presence of specific autoantibodies and fibrosis of the skin and major internal organs. Methods We genotyped a polymorphism (G-945C) in the promoter of the connective-tissue growth factor (CTGF) gene in 1000 subjects in two groups: group 1, consisting of 200 patients with systemic sclerosis and 188 control subjects; and group 2, consisting of 300 patients with systemic sclerosis and 312 control subjects. The combined groups represented an estimated 10% of patients with systemic sclerosis in the United Kingdom. We tested the effect of the polymorphism on the transcription of CTGF. Results The GG genotype was significantly more common in patients with systemic sclerosis than in control subjects in both groups, with an odds ratio for the combined group of 2.2 (95% confidence interval [CI], 1.5 to 3.2; P<0.001 for trend). Analysis of the combined group of patients with systemic sclerosis showed a significant association between homozygosity for the G allele and the presence of anti-topoisomerase I antibodies (odds ratio, 3.3; 95% CI, 2.0 to 5.6; P<0.001) and fibrosing alveolitis (odds ratio, 3.1; 95% CI, 1.9 to 5.0; P<0.001). We observed that the substitution of cytosine for guanine created a binding site of the transcriptional regulators Sp1 and Sp3. The C allele has high affinity for Sp3 and is associated with severely reduced transcriptional activity. A chromatin immunoprecipitation assay showed a marked shift in the ratio of Sp1 to Sp3 binding at this region, demonstrating functional relevance in vivo. Conclusions The G-945C substitution represses CTGF transcription, and the -945G allele is significantly associated with susceptibility to systemic sclerosis.	Royal Free & Univ Coll Med, Ctr Rheumatol, London, England; Univ Siena, Inst Resp Dis, I-53100 Siena, Italy; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Clin Genom Grp, London, England; Royal Natl Hosp Rheumat Dis, Ctr Rheumatol, Bath BA1 1RL, Avon, England	University of London; University College London; University of Siena; Imperial College London; Royal National Hospital for Rheumatic Diseases (RNHRD)	Abraham, DJ (corresponding author), UCL, Dept Rheumatol, Hampstead Campus,Rowland Hill St, London NW3 2PF, England.	d.abraham@medsch.ucl.ac.uk	Sestini, Piersante/AAF-8570-2019	Renzoni, Elisabetta/0000-0002-1118-797X; Ponticos, Markella/0000-0001-5957-5851; Stock, Carmel/0000-0003-4090-8761; Sestini, Piersante/0000-0002-8195-0811				[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Assassi S, 2005, CURR OPIN RHEUMATOL, V17, P761, DOI 10.1097/01.bor.0000179943.27777.b1; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; BUNCE M, 1995, TISSUE ANTIGENS, V45, P81, DOI 10.1111/j.1399-0039.1995.tb02422.x; Bunn CC, 1998, BRIT J RHEUMATOL, V37, P15; Chen M, 2005, ARTHRITIS RHEUM-US, V52, P877, DOI 10.1002/art.20962; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Denton CP, 2006, NAT CLIN PRACT RHEUM, V2, P134, DOI 10.1038/ncprheum0115; Fonseca C, 2005, ARTHRITIS RHEUM-US, V52, pS176; Fonseca C, 2006, ARTHRITIS RHEUM-US, V54, P3034, DOI 10.1002/art.22036; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Henault J, 2006, ARTHRITIS RHEUM-US, V54, P963, DOI 10.1002/art.21646; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Hudson LL, 2005, GENES IMMUN, V6, P274, DOI 10.1038/sj.gene.6364180; Ihn H, 2000, ARTHRITIS RHEUM, V43, P2240, DOI 10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Pan LH, 2001, EUR RESPIR J, V17, P1220, DOI 10.1183/09031936.01.00074101; Pearce SHS, 2006, TRENDS MOL MED, V12, P90, DOI 10.1016/j.molmed.2005.12.005; Reveille JD, 2005, J RHEUMATOL, V32, P10; Reveille JD, 2003, ARTHRIT RHEUM-ARTHR, V49, P399, DOI 10.1002/art.11113; Sato H, 2004, ARTHRITIS RHEUM-US, V50, P558, DOI 10.1002/art.20065; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tan FK, 2003, RHEUM DIS CLIN N AM, V29, P211, DOI 10.1016/S0889-857X(03)00015-2; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Xu SW, 1997, ARTHRITIS RHEUM-US, V40, P1237; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P3305, DOI 10.1002/art.21355; Zhou XD, 2003, ARTHRITIS RHEUM-US, V48, P2585, DOI 10.1002/art.11220	39	139	142	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1210	1220		10.1056/NEJMoa067655	http://dx.doi.org/10.1056/NEJMoa067655			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881752	Bronze			2022-12-28	WOS:000249541000006
J	Lordkipanidze, D; Jashashvili, T; Vekua, A; de Leon, MSP; Zollikofer, CPE; Rightmire, GP; Pontzer, H; Ferring, R; Oms, O; Tappen, M; Bukhsianidze, M; Agusti, J; Kahlke, R; Kiladze, G; Martinez-Navarro, B; Mouskhelishvili, A; Nioradze, M; Rook, L				Lordkipanidze, David; Jashashvili, Tea; Vekua, Abesalom; de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.; Rightmire, G. Philip; Pontzer, Herman; Ferring, Reid; Oms, Oriol; Tappen, Martha; Bukhsianidze, Maia; Agusti, Jordi; Kahlke, Ralf; Kiladze, Gocha; Martinez-Navarro, Bienvenido; Mouskhelishvili, Alexander; Nioradze, Medea; Rook, Lorenzo			Postcranial evidence from early Homo from Dmanisi, Georgia	NATURE			English	Article							EAST-RUDOLF; PLIOPLEISTOCENE HOMINID; LATE PLEISTOCENE; BODY-SIZE; PROPORTIONS; FEMUR; KENYA; MORPHOLOGY; SKELETON; HABILIS	The Plio-Pleistocene site of Dmanisi, Georgia, has yielded a rich fossil and archaeological record documenting an early presence of the genus Homo outside Africa. Although the craniomandibular morphology of early Homo is well known as a result of finds from Dmanisi and African localities, data about its postcranial morphology are still relatively scarce. Here we describe newly excavated postcranial material from Dmanisi comprising a partial skeleton of an adolescent individual, associated with skull D2700/D2735, and the remains from three adult individuals. This material shows that the postcranial anatomy of the Dmanisi hominins has a surprising mosaic of primitive and derived features. The primitive features include a small body size, a low encephalization quotient and absence of humeral torsion; the derived features include modern-human-like body proportions and lower limb morphology indicative of the capability for long-distance travel. Thus, the earliest known hominins to have lived outside of Africa in the temperate zones of Eurasia did not yet display the full set of derived skeletal features.	Georgian Natl Museum, GE-0105 Tbilisi, Georgia; Univ Florence, Dipartimento Sci Terra, I-50121 Florence, Italy; Othar Lordkipanidze Ctr Archaeol Res, GE-0102 Tbilisi, Georgia; Senckenberg Res Inst, D-99423 Weimar, Germany; Univ Rovira & Virgili, Inst Human Paleoecol, ICREA, Tarragona, Spain; Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; Univ Autonoma Barcelona, Dept Geol, Bellaterra, Spain; Univ N Texas, Dept Geog, Denton, TX 76203 USA; Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02138 USA; Univ Zurich, Inst Anthropol, CH-8057 Zurich, Switzerland	University of Florence; Senckenberg Gesellschaft fur Naturforschung (SGN); ICREA; Universitat Rovira i Virgili; University of Minnesota System; University of Minnesota Twin Cities; Autonomous University of Barcelona; University of North Texas System; University of North Texas Denton; Washington University (WUSTL); Harvard University; University of Zurich	Lordkipanidze, D (corresponding author), Georgian Natl Museum, GE-0105 Tbilisi, Georgia.	dlordkipanidze@museum.ge	Martinez-Navarro, Bienvenido/L-5950-2014; Lordkipanidze, David/AAH-6472-2020; Oms, Oriol/AAZ-6312-2020; Martínez-Navarro, Bienvenido/ABE-3563-2021; Rook, Lorenzo/D-9675-2011; Rook, Lorenzo/AAA-5014-2019	Martinez-Navarro, Bienvenido/0000-0002-8374-5109; Martínez-Navarro, Bienvenido/0000-0002-8374-5109; Rook, Lorenzo/0000-0001-8923-5428; Rook, Lorenzo/0000-0001-8923-5428; Pontzer, Herman/0000-0003-2397-6543; Oms, Oriol/0000-0001-8355-847X	ICREA Funding Source: Custom	ICREA(ICREA)		Aiello L, 1990, INTRO HUMAN EVOLUTIO; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Day M.H., 1978, EARLY HOMINIDAFRIC, P311; DAY MH, 1975, AM J PHYS ANTHROPOL, V42, P461, DOI 10.1002/ajpa.1330420314; DAY MH, 1974, AM J PHYS ANTHROPOL, V41, P367, DOI 10.1002/ajpa.1330410304; Elton S, 2001, J HUM EVOL, V41, P1, DOI 10.1006/jhev.2001.0475; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Haeusler M, 2004, J HUM EVOL, V46, P433, DOI 10.1016/j.jhevol.2004.01.004; Jashashvili T., 2005, THESIS U FERRARA; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; JOHANSON DC, 1976, NATURE, V260, P293, DOI 10.1038/260293a0; KENNEDY GE, 1983, AM J PHYS ANTHROPOL, V61, P429, DOI 10.1002/ajpa.1330610405; Larson SG, 1996, J HUM EVOL, V31, P239, DOI 10.1006/jhev.1996.0059; LEAKEY LSB, 1964, CURR ANTHROPOL, V6, P424; Leakey R.E., 1989, P167; LEAKEY REF, 1973, AM J PHYS ANTHROPOL, V39, P205, DOI 10.1002/ajpa.1330390211; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; McHenry Henry M., 1992, Evolutionary Anthropology, V1, P15, DOI 10.1002/evan.1360010106; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Pontzer H, 2007, J EXP BIOL, V210, P484, DOI 10.1242/jeb.02662; Reagan KM, 2002, AM J SPORT MED, V30, P354, DOI 10.1177/03635465020300030901; RHOADS JG, 1977, AM J PHYS ANTHROPOL, V46, P29, DOI 10.1002/ajpa.1330460106; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Ruff C, 2007, AM J PHYS ANTHROPOL, V133, P698, DOI 10.1002/ajpa.20568; Senut B., 1981, HUMERUS ARTICULATION; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; Susman RL, 2004, J HUM EVOL, V47, P171, DOI 10.1016/j.jhevol.2004.06.005; SUSMAN RL, 1989, AM J PHYS ANTHROPOL, V79, P451, DOI 10.1002/ajpa.1330790403; Tappen Martha, 2002, P161; TARDIEU C, 1994, AM J PHYS ANTHROPOL, V95, P183, DOI 10.1002/ajpa.1330950206; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; VRBA ES, 1979, AM J PHYS ANTHROPOL, V51, P117, DOI 10.1002/ajpa.1330510114; Walker A., 1993, NARIOKOTOME HOMO ERE; Weidenreich F, 1938, NATURE, V141, P614, DOI 10.1038/141614a0; White T. D., 2000, ENCY HUMAN EVOLUTION, P486	50	408	421	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					305	310		10.1038/nature06134	http://dx.doi.org/10.1038/nature06134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882214				2022-12-28	WOS:000249557300038
J	Gureje, O; Kola, L; Afolabi, E				Gureje, Oye; Kola, Lola; Afolabi, Ebenezer			Epidemiology of major depressive disorder in elderly Nigerians in the lbadan Study of Ageing: a community-based survey	LANCET			English	Article							MENTAL-HEALTH; PREVALENCE; DISABILITY; INVENTORY; LIFETIME; SERVICES; ILLNESS; ADULTS; IMPACT; WORLD	Background The growing populations of elderly people in sub-Saharan Africa are exposed to social changes with potential adverse effects on mental health. Our aim was to estimate the occurrence and effect of major depressive disorder in a large and representative community sample of elderly Africans. Methods Face-to-face interviews with a representative sample of people aged 65 years and older (n=2152) were obtained by a multistage stratified sampling of households in the Yoruba-speaking areas of Nigeria (about 22% of the national population). Major depressive disorder was assessed with the WHO composite international diagnostic interview and diagnosed with the Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Findings Lifetime and 12-month prevalence estimates of major depressive disorder were 26.2% (95% Cl 24.3-28.2) and 7.1% (5.9-8.3) respectively. Female sex (odds ratio [OR] 1.9) and increasing levels of urbanisation of residence (OR 1.4) were associated with this disorder. People with major depressive disorder had impaired quality of life and functioning in home, work, and social roles. Independent ratings of symptom severity confirmed the presence of clinically significant depression in 96.9% of those with diagnosis, and increasing symptom severity was associated with greater disability and poorer quality of life. Only about 37% of lifetime cases had received any treatment, and there was a mean delay of 5 years from onset of depression to receipt of first treatment. Low economic status (0.3) and rural residence (1.0) predicted no treatment. Interpretation Major depressive disorder is common in elderly Nigerians and its occurrence is related to urbanisation. This disorder is a seriously disabling illness in this group but only a few sufferers have ever received treatment. Health-care services need to invest in effective treatment programmes for major depressive disorder.	Univ Ibadan, Coll Med, Ibadan, Nigeria; Univ Coll Hosp, Dept Med Social Serv, Ibadan, Nigeria; Univ Ibadan, Dept Psychiat, Epidemiol & Hlth Serv Res Grp, Ibadan, Nigeria	University of Ibadan; University of Ibadan; University College Hospital, Ibadan; University of Ibadan	Gureje, O (corresponding author), Univ Ibadan, Coll Med, Ibadan, Nigeria.	ogureje@comui.edu.ng	Adewuya, Abiodun/N-4997-2017; Gureje, Oye/J-1183-2014	Adewuya, Abiodun/0000-0002-7611-6953; Gureje, Oye/0000-0003-0094-5947				American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; Beekman ATF, 2002, ACTA PSYCHIAT SCAND, V105, P20, DOI 10.1034/j.1600-0447.2002.10078.x; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gureje O, 2006, SOC PSYCH PSYCH EPID, V41, P44, DOI 10.1007/s00127-005-0001-7; Gureje O, 2005, BRIT J PSYCHIAT, V186, P436, DOI 10.1192/bjp.186.5.436; Gureje O, 2006, J PSYCHOSOM RES, V61, P327, DOI 10.1016/j.jpsychores.2006.07.016; Gureje O, 2006, BRIT J PSYCHIAT, V188, P465, DOI 10.1192/bjp.188.5.465; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; HENDERSON AS, 1993, PSYCHOL MED, V23, P719, DOI 10.1017/S0033291700025496; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kish L, 1965, SURVEY SAMPLING; KLEINMAN AM, 1977, SOC SCI MED, V11, P3, DOI 10.1016/0037-7856(77)90138-X; KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4; Murray C.J, 1996, GLOBAL BURDEN DIS CO; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Naumann VJ, 2004, INT PSYCHOGERIATR, V16, P159, DOI 10.1017/S1041610204000109; Ogunniyi A, 1993, West Afr J Med, V12, P189; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; Stein DJ, 2004, LANCET, V364, P233, DOI 10.1016/S0140-6736(04)16693-2; *UN POP DIV, 2003, POP HLTH HUM WELL BE; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; *WHO, 1999, HLTH FUT; *WHOQOL GROUP, 1996, WHOQOL BREF FIELD TR; Wilson KCM, 1999, BRIT J PSYCHIAT, V175, P549, DOI 10.1192/bjp.175.6.549; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2004, WORLD HLTH REP 2004	38	105	108	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2007	370	9591					957	964		10.1016/S0140-6736(07)61446-9	http://dx.doi.org/10.1016/S0140-6736(07)61446-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211EG	17869636	Green Accepted			2022-12-28	WOS:000249506500028
J	Brown, CD; Johnson, DS; Sidow, A				Brown, Christopher D.; Johnson, David S.; Sidow, Arend			Functional architecture and evolution of transcriptional elements that drive gene coexpression	SCIENCE			English	Article							CIS-REGULATORY MODULES; DE-NOVO DISCOVERY; CIONA-INTESTINALIS; ASCIDIAN EMBRYOS; EXPRESSION; NETWORKS; CONSERVATION; SELECTION; GENOME; TISSUE	Transcriptional coexpression of interacting gene products is required for complex molecular processes; however, the function and evolution of cis-regulatory elements that orchestrate coexpression remain largely unexplored. We mutagenized 19 regulatory elements that drive coexpression of Ciona muscle genes and obtained quantitative estimates of the cis-regulatory activity of the 77 motifs that comprise these elements. We found that individual motif activity ranges broadly within and among elements, and among different instantiations of the same motif type. The activity of orthologous motifs is strongly constrained, although motif arrangement, type, and activity vary greatly among the elements of different co-regulated genes. Thus, the syntactical rules governing this regulatory function are flexible but become highly constrained evolutionarily once they are established in a particular element.	Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	arend@stanford.edu		Brown, Christopher/0000-0002-3785-5008				Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Davidson E. H., 2001, DEV EVOLUTION; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; Johnson DS, 2005, GENOME RES, V15, P1315, DOI 10.1101/gr.4062605; Johnson DS, 2004, GENOME RES, V14, P2448, DOI 10.1101/gr.2964504; Kusakabe T, 2004, DEV BIOL, V276, P563, DOI 10.1016/j.ydbio.2004.09.037; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Oda-Ishii I, 2005, DEVELOPMENT, V132, P1663, DOI 10.1242/dev.01707; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sokal RR, 1995, BIOMETRY; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zeller RW, 2006, DEV DYNAM, V235, P1921, DOI 10.1002/dvdy.20815; Zeller RW, 2004, METHOD CELL BIOL, V74, P713; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	24	95	96	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1557	1560		10.1126/science.1145893	http://dx.doi.org/10.1126/science.1145893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872446				2022-12-28	WOS:000249467900044
J	Kolfschoten, MV; Schuurman, J; Losen, M; Bleeker, WK; Martinez-Martinez, P; Vermeulen, E; den Bleker, TH; Wiegman, L; Vink, T; Aarden, LA; De Baets, MH; van De Winkel, JGJ; Aalberse, RC; Parren, PWHI				Kolfschoten, Marijn van der Neut; Schuurman, Janine; Losen, Mario; Bleeker, Wim K.; Martinez-Martinez, Pilar; Vermeulen, Ellen; den Bleker, Tamara H.; Wiegman, Luus; Vink, Tom; Aarden, Lucien A.; De Baets, Marc H.; van De Winkel, Jan G. J.; Aalberse, Rob C.; Parren, Paul W. H. I.			Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange	SCIENCE			English	Article							MYASTHENIA-GRAVIS; RECEPTOR; MONOVALENCY	Antibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4 antibodies are dynamic molecules that exchange Fab arms by swapping a heavy chain and attached light chain (half-molecule) with a heavy-light chain pair from another molecule, which results in bispecific antibodies. Mutagenesis studies revealed that the third constant domain is critical for this activity. The impact of IgG4 Fab arm exchange was confirmed in vivo in a rhesus monkey model with experimental autoimmune myasthenia gravis. IgG4 Fab arm exchange is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 antibodies.	Genmab, NL-3584 CM Utrecht, Netherlands; Sanquin Res, AMC Landsteiner Lab, Dept Immunopathol, NL-1066 CX Amsterdam, Netherlands; Univ Maastricht, Dept Neurosci, Inst Mental Hlth & Neurosci, Maastricht, Netherlands; Hasselt Univ, Neuroimmunol Grp, Biomed Res Inst, Diepenbeek, Belgium; Univ Med Ctr, Dept Immunol, Immunotherapy Lab, Utrecht, Netherlands	Genmab; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Hasselt University; Utrecht University; Utrecht University Medical Center	Aalberse, RC (corresponding author), Genmab, NL-3584 CM Utrecht, Netherlands.	r.aalberse@sanquin.nl; p.parren@genmab.com	Losen, Mario/C-2676-2008	Losen, Mario/0000-0002-9761-0002; Martinez Martinez, Pilar/0000-0002-5990-3373; Parren, Paul/0000-0002-4365-3859				Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Graus YF, 1997, J IMMUNOL, V158, P1919; JEFFERIS R, 1990, HUMAN IGG SUBCLASSES, P15; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Losen M, 2005, BRAIN, V128, P2327, DOI 10.1093/brain/awh612; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; Nanda A, 2004, J ALLERGY CLIN IMMUN, V114, P1339, DOI 10.1016/j.jaci.2004.08.049; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Scallon BJ, 2006, J IMMUNOTHER, V29, P351, DOI 10.1097/01.cji.0000199196.97845.c3; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415	20	656	754	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1554	1557		10.1126/science.1144603	http://dx.doi.org/10.1126/science.1144603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872445				2022-12-28	WOS:000249467900043
J	Krause, S; Berbil-Bautista, L; Herzog, G; Bode, M; Wiesendanger, R				Krause, S.; Berbil-Bautista, L.; Herzog, G.; Bode, M.; Wiesendanger, R.			Current-induced magnetization switching with a spin-polarized scanning tunneling microscope	SCIENCE			English	Article							MULTILAYER; EXCITATION; FE(110)	Switching the magnetization of a magnetic bit by injection of a spin-polarized current offers the possibility for the development of innovative high-density data storage technologies. We show how individual superparamagnetic iron nanoislands with typical sizes of 100 atoms can be addressed and locally switched using a magnetic scanning probe tip, thus demonstrating current-induced magnetization reversal across a vacuum barrier combined with the ultimate resolution of spin-polarized scanning tunneling microscopy. Our technique allows us to separate and quantify three fundamental contributions involved in magnetization switching (i.e., current-induced spin torque, heating the island by the tunneling current, and Oersted field effects), thereby providing an improved understanding of the switching mechanism.	Univ Hamburg, Inst Phys Appl, D-20355 Hamburg, Germany; Univ Hamburg, Microstruct Res Ctr, D-20355 Hamburg, Germany	University of Hamburg; University of Hamburg	Krause, S (corresponding author), Univ Hamburg, Inst Phys Appl, Jungiusstr 11, D-20355 Hamburg, Germany.	skrause@physnet.uni-hamburg.de	Bode, Matthias/S-3249-2016; Wiesendanger, Roland/P-9726-2016; Krause, Stefan/M-6384-2019; Krause, Stefan/C-8491-2009	Bode, Matthias/0000-0001-7514-5560; Wiesendanger, Roland/0000-0002-0472-4183; Krause, Stefan/0000-0002-0677-8468; 				Acremann Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.217202; Albert FJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.226802; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Bode M, 2005, MICROSC RES TECHNIQ, V66, P117, DOI 10.1002/jemt.20151; Bode M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067201; Bode M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237205; Bode M, 2003, REP PROG PHYS, V66, P523, DOI 10.1088/0034-4885/66/4/203; ELMERS HJ, 1995, PHYS REV LETT, V75, P2031, DOI 10.1103/PhysRevLett.75.2031; ELMERS HJ, 1994, PHYS REV LETT, V73, P898, DOI 10.1103/PhysRevLett.73.898; Fuchs GD, 2004, APPL PHYS LETT, V85, P1205, DOI 10.1063/1.1781769; GOLDENBERG H, 1952, BRIT J APPL PHYS, V3, P296, DOI 10.1088/0508-3443/3/9/307; GRADMANN U, 1990, HYPERFINE INTERACT, V57, P1845, DOI 10.1007/BF02405732; Hauschild J, 1998, PHYS REV B, V57, pR677, DOI 10.1103/PhysRevB.57.R677; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Krivorotov IN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166603; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Sun JZ, 2006, IBM J RES DEV, V50, P81, DOI 10.1147/rd.501.0081; Sun JZ, 1999, J MAGN MAGN MATER, V202, P157, DOI 10.1016/S0304-8853(99)00289-9; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Weisendanger R, 1994, SCANNING PROBE MICRO	23	130	135	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1537	1540		10.1126/science.1145336	http://dx.doi.org/10.1126/science.1145336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872442				2022-12-28	WOS:000249467900038
J	Markowitz, AJ; McPhee, SJ				Markowitz, Amy J.; McPhee, Stephen J.			Lateral sclerosis - "Prepare for the worst and hope for the best"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Mitsumoto H, 2007, JAMA-J AM MED ASSOC, V298, P207, DOI 10.1001/jama.298.2.207	1	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2007	298	10					1208	1208		10.1001/jama.298.10.1208	http://dx.doi.org/10.1001/jama.298.10.1208			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209FK	17848655				2022-12-28	WOS:000249374200026
J	POOL, R				POOL, R			TWEAKING MOLECULES WITH LASER-LIGHT	SCIENCE			English	Editorial Material																		WEINER A, SCIENCE, V247, P1317	1	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1295	1296		10.1126/science.247.4948.1295	http://dx.doi.org/10.1126/science.247.4948.1295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843786				2022-12-28	WOS:A1990CU25300020
J	SUN, M				SUN, M			JAPAN LAYS OUT WELCOME MAT FOR UNITED-STATES SCIENTISTS	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1546	1547		10.1126/science.243.4898.1546	http://dx.doi.org/10.1126/science.243.4898.1546			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847255				2022-12-28	WOS:A1989T795200014
J	Chou, R; Huffman, LH				Chou, Roger; Huffman, Laurie Hoyt			Nonpharmacologic therapies for acute and chronic low back pain: A review of the evidence for an American pain Society/American college of physicians clinical practice guideline	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIALS; ELECTRICAL NERVE-STIMULATION; SPINAL MANIPULATIVE THERAPY; SHORT-WAVE DIATHERMY; LEVEL LASER THERAPY; EXERCISE THERAPY; INTERFERENTIAL THERAPY; MASSAGE THERAPY; DOUBLE-BLIND; NECK PAIN	Background: Many nonpharmacologic therapies are available for treatment of low back pain. Purpose: To assess benefits and harms of acupuncture, back schools, psychological therapies, exercise therapy, functional restoration, interdisciplinary therapy, massage, physical therapies (interferential therapy, low-level laser therapy, lumbar supports, short-wave diathermy, superficial heat, traction, transcutaneous electrical nerve stimulation, and ultrasonography), spinal manipulation, and yoga for acute or chronic low back pain (with or without leg pain). Data Sources: English-language studies were identified through searches of MEDLINE (through November 2006) and the Cochrane Database of Systematic Reviews (2006, Issue 4). These electronic searches were supplemented by hand searching of reference lists and additional citations suggested by experts. Study Selection: Systematic reviews and randomized trials of 1 or more of the preceding therapies for acute or chronic low back pain (with or without leg pain) that reported pain outcomes, back-specific function, general health status, work disability, or patient satisfaction. Data Extraction: We abstracted information about study design, population characteristics, interventions, outcomes, and adverse events. To grade methodological quality, we used the Oxman criteria for systematic reviews and the Cochrane Back Review Group criteria for individual trials. Data Synthesis: We found good evidence that cognitive-behavioral therapy, exercise, spinal manipulation, and interdisciplinary rehabilitation are all moderately effective for chronic or subacute (> 4 weeks' duration) low back pain. Benefits over placebo, sham therapy, or no treatment averaged 10 to 20 points on a 100-point visual analogue pain scale, 2 to 4 points on the Roland-Morris Disability Questionnaire, or a standardized mean difference of 0.5 to 0.8. We found fair evidence that acupuncture, massage, yoga (Viniyoga), and functional restoration are also effective for chronic low back pain. For acute low back pain (< 4 weeks' duration), the only nonpharmacologic therapies with evidence of efficacy are superficial heat (good evidence for moderate benefits) and spinal manipulation (fair evidence for small to moderate benefits). Although serious harms seemed to be rare, data on harms were poorly reported. No trials addressed optimal sequencing of therapies, and methods for tailoring therapy to individual patients are still in early stages of development. Evidence is insufficient to evaluate the efficacy of therapies for sciatica. Limitations: Our primary source of data was systematic reviews. We included non-English-language trials only if they were included in English-language systematic reviews. Conclusions: Therapies with good evidence of moderate efficacy for chronic or subacute low back pain are cognitive-behavioral therapy, exercise, spinal manipulation, and interdisciplinary rehabilitation. For acute low back pain, the only therapy with good evidence of efficacy is superficial heat.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Evidencebased Practice Ctr, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				ABENHAIM L, 1992, CLIN INVEST MED, V15, P527; ANDERSON R, 1992, J MANIP PHYSIOL THER, V15, P181; Ansari N N, 2006, Electromyogr Clin Neurophysiol, V46, P329; Armstrong K, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(00)00263-4; Assendelft W, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000447.PUB2; ASSENDELFT WJ, 1996, N MANIPULATIVE PHYSL, V19, P499; Assendelft WJJ, 1996, J FAM PRACTICE, V42, P475; Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; ASSENDELFT WJJ, 1995, JAMA-J AM MED ASSOC, V274, P1942, DOI 10.1001/jama.274.24.1942; AVERY S, 2004, PHYS THERAPY REV, V9, P146; Baldwin M L, 2001, Spine J, V1, P138, DOI 10.1016/S1529-9430(01)00016-X; Basford JR, 1999, ARCH PHYS MED REHAB, V80, P647, DOI 10.1016/S0003-9993(99)90167-3; BECKERMAN H, 1992, PHYS THER, V72, P483, DOI 10.1093/ptj/72.7.483; BECKERMAN H, 1993, BRIT J GEN PRACT, V43, P73; Bendix A F, 1995, Eur Spine J, V4, P148, DOI 10.1007/BF00298239; Bendix AF, 1996, CLEV CLIN J MED, V63, P62, DOI 10.3949/ccjm.63.1.62; BERGQUISTULLMAN M, 1977, ACTA ORTHOP SCAND, P9; BEURSKENS AJ, 1995, LANCET, V346, P1596, DOI 10.1016/S0140-6736(95)91930-9; Beurskens AJ, 1997, SPINE, V22, P2756, DOI 10.1097/00007632-199712010-00011; Bigos S., 1994, ACUTE LOW BACK PROBL; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Bombardier C, 1997, SPINE, V22, P837, DOI 10.1097/00007632-199704150-00001; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; Brosseau L, 2002, SPINE, V27, P596, DOI 10.1097/00007632-200203150-00007; Brown A, 2005, COSTS OUTCOMES CHIRO; Brox Jens Ivar, 1999, Tidsskrift for den Norske Laegeforening, V119, P2042; Carlsson CPO, 2001, CLIN J PAIN, V17, P296, DOI 10.1097/00002508-200112000-00003; Ceccherelli F, 2002, CLIN J PAIN, V18, P149, DOI 10.1097/00002508-200205000-00003; Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011; CHERKIN DC, 1995, SPINE, V20, P1, DOI 10.1097/00007632-199501000-00001; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; CHOU R, 2007, IN PRESS AM PAIN SOC; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Clare HA, 2004, AUST J PHYSIOTHER, V50, P209, DOI 10.1016/S0004-9514(14)60110-0; Clarke JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003010.pub3; Clarke J, 2006, SPINE, V31, P1591, DOI 10.1097/01.brs.0000222043.09835.72; Cleland J, 2002, J BACK MUSCULOSKELET, V16, P105, DOI 10.3233/BMR-2002-162-309; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN JE, 1994, SPINE, V19, P1214, DOI 10.1097/00007632-199405310-00004; Colle F, 2002, ARCH PHYS MED REHAB, V83, P1745, DOI 10.1053/apmr.2002.35657; DEBIE RA, 1998, PHYS THER REV, V3, P1; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; DEYO RA, 1983, JAMA-J AM MED ASSOC, V250, P1057; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; DIFABIO RP, 1995, PHYS THER, V75, P865, DOI 10.1093/ptj/75.10.865; DIFABIO RP, 1992, PHYS THER, V72, P853, DOI 10.1093/ptj/72.12.853; *ED BOARD BACK REV, 2003, SPINE, V28, P1215; Elders LAM, 2000, INT ARCH OCC ENV HEA, V73, P339, DOI 10.1007/s004200000127; Ernst E, 1997, PAIN, V71, P123, DOI 10.1016/S0304-3959(97)03368-X; Ernst E, 1999, J PAIN SYMPTOM MANAG, V17, P65, DOI 10.1016/S0885-3924(98)00129-8; Ernst E, 1998, ARCH INTERN MED, V158, P2235, DOI 10.1001/archinte.158.20.2235; Ernst E, 2001, J PAIN SYMPTOM MANAG, V22, P879, DOI 10.1016/S0885-3924(01)00337-2; Ernst E, 2001, AM J MED, V110, P481, DOI 10.1016/S0002-9343(01)00651-9; Ernst E, 2001, J PAIN SYMPTOM MANAG, V21, P238, DOI 10.1016/S0885-3924(00)00262-1; Ernst E, 2000, FAM PRACT, V17, P554, DOI 10.1093/fampra/17.6.554; ERNST E, 2003, PHYS THER REV, V8, P85; ERNST E, 2004, PHYS THERAPY REV, V9, P5, DOI DOI 10.1179/108331904225003946; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Faas A, 1996, SPINE, V21, P2874, DOI 10.1097/00007632-199612150-00016; Ferreira ML, 2003, J MANIP PHYSIOL THER, V26, P593, DOI 10.1016/j.jmpt.2003.08.010; Ferreira ML, 2002, AUST J PHYSIOTHER, V48, P277, DOI 10.1016/S0004-9514(14)60167-7; FLOWERDEW M, 1997, COMPLEMENT THER MED, V5, P193; Franke A, 2000, FORSCH KOMP KLAS NAT, V7, P286, DOI 10.1159/000057176; FREBURGER KJ, 2005, SPINE J, V5, P530; French SD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004750.pub2; Fritz Julie M, 2005, BMC Fam Pract, V6, P29, DOI 10.1186/1471-2296-6-29; Furlan A D, 2001, Spine (Phila Pa 1976), V26, pE155, DOI 10.1097/00007632-200104010-00018; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Furlan AD, 2002, SPINE, V27, P1896, DOI 10.1097/00007632-200209010-00017; FURLAN AD, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001929; GADSBY JG, 2000, COCHRANE DB SYST REV; Galantino ML, 2004, ALTERN THER HEALTH M, V10, P56; GAM AN, 1993, PAIN, V52, P63, DOI 10.1016/0304-3959(93)90114-5; Gay RE, 2005, J MANIP PHYSIOL THER, V28, P266, DOI 10.1016/j.jmpt.2005.03.012; GIBSON T, 1985, LANCET, V1, P1258; GODFREY CM, 1984, SPINE, V9, P301, DOI 10.1097/00007632-198404000-00015; Gur A, 2003, LASER SURG MED, V32, P233, DOI 10.1002/lsm.10134; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Guzman J, 2002, COCHRANE DB SYST REV, V1, DOI [DOI 10.1002/14651858.CD000963, DOI 10.1002/14651858.CD000963.PUB2]; Hagen KB, 2005, SPINE, V30, P542, DOI 10.1097/01.brs.0000154625.02586.95; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; Harte AA, 2003, ARCH PHYS MED REHAB, V84, P1542, DOI 10.1016/S0003-9993(03)00294-6; Hayden J A, 2005, Cochrane Database Syst Rev, pCD000335; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Heymans MW, 2005, SPINE, V30, P2153, DOI 10.1097/01.brs.0000182227.33627.15; Heymans MW., 2004, COCHRANE DATABASE SY, DOI [10.1002/14651858.CD000261.pub2, DOI 10.1002/14651858.CD000261.PUB2]; HILDE G, 1998, PHYS THER REV, V3, P107; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; HSIEH CYJ, 1992, J MANIP PHYSIOL THER, V15, P4; Hurley DA, 2004, SPINE, V29, P2207, DOI 10.1097/01.brs.0000142234.15437.da; Hurley DA, 2001, ARCH PHYS MED REHAB, V82, P485, DOI 10.1053/apmr.2001.21934; Hurwitz EL, 2002, SPINE, V27, P2193, DOI 10.1097/00007632-200210150-00002; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jellema P, 2001, SPINE, V26, P377, DOI 10.1097/00007632-200102150-00014; Karjalainen K, 2001, SPINE, V26, P262, DOI 10.1097/00007632-200102010-00011; KEIJSERS J F E M, 1991, Physiotherapy Theory and Practice, V7, P177, DOI 10.3109/09593989109106969; Khadilkar A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003008.pub2; KLEIN RG, 1990, ARCH PHYS MED REHAB, V71, P34; Koes BW, 1996, SPINE, V21, P2860, DOI 10.1097/00007632-199612150-00013; KOES BW, 1991, BRIT MED J, V303, P1298, DOI 10.1136/bmj.303.6813.1298; KOES BW, 1991, BRIT MED J, V302, P1572, DOI 10.1136/bmj.302.6792.1572; KOES BW, 1994, J CLIN EPIDEMIOL, V47, P851, DOI 10.1016/0895-4356(94)90188-0; KOES BW, 1994, EUR J PHYS MED REHAB, V4, P86; Kool J, 2004, J REHABIL MED, V36, P49, DOI 10.1080/16501970310020104; LARSSON U, 1980, ACTA ORTHOP SCAND, V51, P791, DOI 10.3109/17453678008990875; Licciardone JC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-43; Liddle SD, 2004, PAIN, V107, P176, DOI 10.1016/j.pain.2003.10.017; LIND G, 1974, THESIS U LINKOPING; LONGO L, 1988, LASER, V3, P16; Machado LAC, 2006, SPINE, V31, pE254, DOI 10.1097/01.brs.0000214884.18502.93; Maher C, 1999, AUST J PHYSIOTHER, V45, P121, DOI 10.1016/S0004-9514(14)60344-5; Maier-Riehle B, 2001, INT J REHABIL RES, V24, P199, DOI 10.1097/00004356-200109000-00005; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Mayer John M, 2005, Spine J, V5, P395, DOI 10.1016/j.spinee.2005.03.009; McNeely ML, 2003, MANUAL THER, V8, P80, DOI 10.1016/S1356-689X(02)00066-8; Meeker WC, 2002, ANN INTERN MED, V136, P216, DOI 10.7326/0003-4819-136-3-200202050-00010; MELZACK R, 1983, PHYS THER, V63, P489, DOI 10.1093/ptj/63.4.489; MILNE S, 2001, COCHRANE DB SYST REV; MOHSENIBANDPEI MA, 1998, PHYS THERAPY REV, V3, P185; Monticone M, 2004, Eura Medicophys, V40, P263; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nadler SF, 2002, SPINE, V27, P1012, DOI 10.1097/00007632-200205150-00003; Nentwig CG, 1999, ORTHOPADE, V28, P958; NWUGA VCB, 1983, ARCH PHYS MED REHAB, V64, P88; Oliphant D, 2004, J MANIP PHYSIOL THER, V27, P197, DOI 10.1016/j.jmpt.2003.12.023; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; OTTENBACHER K, 1985, SPINE, V10, P833, DOI 10.1097/00007632-198511000-00010; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; PATEL M, 1989, INT J EPIDEMIOL, V18, P900, DOI 10.1093/ije/18.4.900; Pengel HM, 2002, CLIN REHABIL, V16, P811, DOI 10.1191/0269215502cr562oa; PENROSE KW, 1991, SPORTS TRAINING MED, V2, P121, DOI DOI 10.1080/15438629109511908; POPE MH, 1994, SPINE, V19, P2571, DOI 10.1097/00007632-199411001-00013; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; Rasmussen G. G., 1979, MANUAL MED, V17, P8; ROMAN M P, 1960, Phys Ther Rev, V40, P649; SCHEER SJ, 1995, ARCH PHYS MED REHAB, V76, P966, DOI 10.1016/S0003-9993(95)80076-X; Scheer SJ, 1997, ARCH PHYS MED REHAB, V78, P414, DOI 10.1016/S0003-9993(97)90235-5; Schonstein E, 2003, SPINE, V28, pE391, DOI 10.1097/01.BRS.0000092482.76386.97; SCHONSTEIN E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001822; SHEKELLE PG, 1992, ANN INTERN MED, V117, P590, DOI 10.7326/0003-4819-117-7-590; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Smith LA, 2000, PAIN, V86, P119, DOI 10.1016/S0304-3959(00)00234-7; Soriano Fernando, 1998, Laser Therapy, V10, P175; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stevinson C, 2002, AM J MED, V112, P566, DOI 10.1016/S0002-9343(02)01068-9; STRAUSS AJ, 1999, CHIRO J AUSTRAL, V29, P213; SWEETMAN BJ, 1993, J ORTHOP RHEUMATOL, V6, P159; TERRIET G, 1990, J CLIN EPIDEMIOL, V43, P1191, DOI 10.1016/0895-4356(90)90020-P; THOMAS K, 2005, NHS R D HLTH TECHNOL, V9; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thomsen AB, 2001, J PAIN SYMPTOM MANAG, V22, P688, DOI 10.1016/S0885-3924(01)00326-8; Toya Shigeo, 1994, Laser Therapy, V6, P143; Turner JA, 1996, SPINE, V21, P2851, DOI 10.1097/00007632-199612150-00010; TURNER JA, 1988, J CONSULT CLIN PSYCH, V56, P261, DOI 10.1037/0022-006X.56.2.261; Tveito TH, 2004, OCCUP MED-OXFORD, V54, P3, DOI 10.1093/occmed/kqg109; Uhlig T, 2003, CURR OPIN RHEUMATOL, V15, P134, DOI 10.1097/00002281-200303000-00009; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; van der Roer N, 2005, BEST PRACT RES CL RH, V19, P671, DOI 10.1016/j.berh.2005.03.007; van der Windt DAWM, 1999, PAIN, V81, P257, DOI 10.1016/S0304-3959(99)00016-0; van Poppel MNM, 2000, SPINE, V25, P2103, DOI 10.1097/00007632-200008150-00016; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; van Tulder MW, 2001, SPINE, V26, P270, DOI 10.1097/00007632-200102010-00012; van Tulder MW, 1999, SPINE, V24, P1113, DOI 10.1097/00007632-199906010-00011; van Tulder MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335; VANDERHEIJDEN GJM, 1995, PHYSIOTHERAPY, V81, P29; VANDERHEIJDEN GJMG, 1995, PHYS THER, V75, P93, DOI 10.1093/ptj/75.2.93; vanderWeide WE, 1997, SCAND J WORK ENV HEA, V23, P165, DOI 10.5271/sjweh.195; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; VANTULDER MW, 2000, COCHRANE DB SYST REV; VANTULDER MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001823; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; WALKER L, 1982, FYSIOTERAPEUTEN, V49, P161; Werners R, 1999, SPINE, V24, P1579, DOI 10.1097/00007632-199908010-00012; Williams KA, 2005, PAIN, V115, P107, DOI 10.1016/j.pain.2005.02.016; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Wreje Ullacarin, 1992, Scandinavian Journal of Primary Health Care, V10, P310, DOI 10.3109/02813439209014080	185	176	190	1	159	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					492	504		10.7326/0003-4819-147-7-200710020-00007	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909210				2022-12-28	WOS:000250214700006
J	Gold, PB; Waghorn, G				Gold, Paul B.; Waghorn, Geoff			Supported employment for people with severe mental illness	LANCET			English	Editorial Material							TRIAL; WORK		Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; Univ Queensland, Sch Populat Hlth, Richlands, Qld 4076, Australia; Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Richlands, Qld 4076, Australia	Medical University of South Carolina; University of Queensland; Queensland Centre for Mental Health Research	Waghorn, G (corresponding author), Med Univ S Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA.	geoff_waghorn@qcmhr.uq.edu.au	Waghorn, Geoffrey/B-6257-2013					Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Cook JA, 2005, ARCH GEN PSYCHIAT, V62, P505, DOI 10.1001/archpsyc.62.5.505; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; Latimer EA, 2006, BRIT J PSYCHIAT, V189, P65, DOI 10.1192/bjp.bp.105.012641; Mowbray CT, 2005, SOC WORK, V50, P7, DOI 10.1093/sw/50.1.7; ORG. FOR ECON. CO-OPERATION AND DEVELOPMENT, 2006, OECD EMPL OUTL 2006; WHO, 2001, WORLD HLTH REPORT 20	8	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1108	1109		10.1016/S0140-6736(07)61491-3	http://dx.doi.org/10.1016/S0140-6736(07)61491-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221YQ	17905149				2022-12-28	WOS:000250263700007
J	Sillanpaa, MA; Park, JI; Simmonds, RW				Sillanpaeae, Mika A.; Park, Jae I.; Simmonds, Raymond W.			Coherent quantum state storage and transfer between two phase qubits via a resonant cavity	NATURE			English	Article							SINGLE-PHOTON; DYNAMICS; MEMORY	As with classical information processing, a quantum information processor requires bits (qubits) that can be independently addressed and read out, long-term memory elements to store arbitrary quantum states(1,2), and the ability to transfer quantum information through a coherent communication bus accessible to a large number of qubits(3,4). Superconducting qubits made with scalable microfabrication techniques are a promising candidate for the realization of a large-scale quantum information processor(5-9). Although these systems have successfully passed tests of coherent coupling for up to four qubits(10-13), communication of individual quantum states between superconducting qubits via a quantum bus has not yet been realized. Here, we perform an experiment demonstrating the ability to coherently transfer quantum states between two superconducting Josephson phase qubits through a quantum bus. This quantum bus is a resonant cavity formed by an open-ended superconducting transmission line of length 7 mm. After preparing an initial quantum state with the first qubit, this quantum information is transferred and stored as a nonclassical photon state of the resonant cavity, then retrieved later by the second qubit connected to the opposite end of the cavity. Beyond simple state transfer, these results suggest that a high-quality-factor superconducting cavity could also function as a useful short-term memory element. The basic architecture presented here can be expanded, offering the possibility for the coherent interaction of a large number of superconducting qubits.	NIST, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Simmonds, RW (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	simmonds@boulder.nist.gov	Sillanpaa, Mika/A-3554-2013	Simmonds, Raymond/0000-0003-2217-2965				Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; BUISSON O, 2001, MACROSCOPIC QUANTUM, P137; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cleland AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070501; Cooper KB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180401; Grajcar M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047006; HAROCHE S, 2006, EXPLORING QUANTUM AT, pCH5; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Koch RH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127001; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Plastina F, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.224514; SCHLEICH WP, 2007, ELEMENTS QUANTUM INF, pCH1; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Xu HZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.027003; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	30	510	519	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					438	442		10.1038/nature06124	http://dx.doi.org/10.1038/nature06124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898762	Green Submitted			2022-12-28	WOS:000249724800035
J	Murray, CJL; Loakso, T; Shibuya, K; Hill, K; Lopez, AD				Murray, Christopher J. L.; Loakso, Thomas; Shibuya, Kenji; Hill, Kenneth; Lopez, Alan D.			Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015	LANCET			English	Article							CHILD-MORTALITY; MONITORING TRENDS; LATIN-AMERICA; HIV/AIDS; AFRICA; RATES	Background Global efforts have increased the accuracy and timeliness of estimates of under-5 mortality; however, these estimates fail to use all data available, do not use transparent and reproducible methods, do not distinguish predictions from measurements, and provide no indication of uncertainty around point estimates. We aimed to develop new reproducible methods and reanalyse existing data to elucidate detailed time trends. Methods We merged available databases, added to them when possible, and then applied Loess regression to estimate past trends and forecast to 2015 for 172 countries. We developed uncertainty estimates based on different model specifications and estimated levels and trends in neonatal, post-neonatal, and childhood mortality. Findings Global under-5 mortality has fallen from 110 (109-110) per 1000 in 1980 to 72 (70-74) per 1000 in 2005. Child deaths worldwide have decreased from 13.5 (13.4-13.6) million in 1980 to an estimated 9.7 (9.5-10.0) million in 2005. Global under-5 mortality is expected to decline by 27% from 1990 to 2015, substantially less than the target of Millennium Development Goal 4 (MDG4) of a 67% decrease. Several regions in Latin America, north Africa, the Middle East, Europe, and southeast Asia have had consistent annual rates of decline in excess of 4% over 35 years. Global progress on MDG4 is dominated by slow reductions in sub-Saharan Africa, which also has the slowest rates of decline in fertility. Interpretation Globally, we are not doing a better job of reducing child mortality now than we were three decades ago. Further improvements in the quality and timeliness of child-mortality measurements should be possible by more fully using existing datasets and applying standard analytical strategies.	Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; World Health Organization; Harvard University; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA.	cjlm@u.washington.edu	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Shibuya, Kenji/0000-0003-2528-7530	NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adetunji J, 2000, B WORLD HEALTH ORGAN, V78, P1200; Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; AHMAD OB, 1991, J BIOSOC SCI, V23, P313, DOI 10.1017/S0021932000019374; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Castle S E, 1993, Health Transit Rev, V3, P137; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Collumbien M., 2001, BRASS TACKS ESSAYS M, P20; Dreze J., 1989, HUNGER PUBLIC ACTION; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P470, DOI 10.2471/BLT.05.029231; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P225, DOI 10.2471/BLT.05.029744; HILL K, IN PRESS LANCET; Hill K ., 1998, TRENDS CHILD MORTALI; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Korenromp EL, 2004, INT J EPIDEMIOL, V33, P1293, DOI 10.1093/ije/dyh182; MAHY M, 2003, WORKSH HIV AIDS AD M; Morris SS, 2004, INT J EPIDEMIOL, V33, P1302, DOI 10.1093/ije/dyh289; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; MURRAY CJL, 1993, SOC SCI MED, V36, P143, DOI 10.1016/0277-9536(93)90206-J; PALLONI A, 1981, POPUL DEV REV, V7, P623, DOI 10.2307/1972801; SOMOZA JL, 1980, WORLD FERTILITY SURV, P10; STOLNITZ GJ, 1965, POP STUD-J DEMOG, V19, P117, DOI 10.2307/2173184; *UN NAT POP DIV, WORLD POP PROSP 2006; *UNICEF, 2004, PROGR CHILDR CHILD S, V1; UNICEF, 2007, STAT WORLDS CHILDR 2; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; *WHO, 2006, WORLD HLTH REP 200L; *WORLD BANK, 2005, MILL DEV GOALS HLTH; World Health Organization, 2005, HLTH MILL DEV GOALS	30	170	176	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1040	1054		10.1016/S0140-6736(07)61478-0	http://dx.doi.org/10.1016/S0140-6736(07)61478-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214HJ	17889243				2022-12-28	WOS:000249727900028
J	Emanuel, EJ; Fuchs, VR; Garber, AM				Emanuel, Ezekiel J.; Fuchs, Victor R.; Garber, Alan M.			Essential elements of a technology and outcomes assessment initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; INFORMATION		NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; Stanford Univ, Dept Econ, Palo Alto, CA 94304 USA; Stanford Univ, Ctr Hlth Policy, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov	Garber, Alan M/F-1476-2010					Borger C, 2006, HEALTH AFFAIR, V25, pW61, DOI 10.1377/hlthaff.25.w61; BUNKER JP, 1982, NEW ENGL J MED, V306, P687, DOI 10.1056/NEJM198203183061131; Busse R, 2002, INT J TECHNOL ASSESS, V18, P361, DOI 10.1017/S0266462302000284; *COAL HLTH SERV RE, 2005, FED FUND HLTH SERV R; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V297, P2131, DOI 10.1001/jama.297.19.2131; FISCHER S, 1995, AM ECON REV, V85, P201; FUCHS VR, 1990, NEW ENGL J MED, V323, P673, DOI 10.1056/NEJM199009063231011; Gray BH, 2003, HEALTH AFFAIR, V22, pW283; Hailey D., 2006, SMJ Singapore Medical Journal, V47, P187; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; *OR HLTH SCI U, DRUG EFF REV PROJ; Pearson SD, 2005, JAMA-J AM MED ASSOC, V294, P2618, DOI 10.1001/jama.294.20.2618; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P107, DOI 10.1377/hlthaff.23.1.107; Robinson JC, 2005, NEW ENGL J MED, V353, P1199, DOI 10.1056/NEJMp058097; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	17	56	57	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1323	1325		10.1001/jama.298.11.1323	http://dx.doi.org/10.1001/jama.298.11.1323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878424				2022-12-28	WOS:000249524100022
J	Tulloch, L; Rukin, NJ; Creamer, J				Tulloch, Laura; Rukin, Nicholas J.; Creamer, John			Diabetes and a large liver	LANCET			English	Editorial Material							HEMOCHROMATOSIS		Univ Hosp N Staffordshire, Dept Cardiol, Stoke On Trent ST4 6QG, Staffs, England	Keele University	Tulloch, L (corresponding author), Univ Hosp N Staffordshire, Dept Cardiol, Newcastle Rd, Stoke On Trent ST4 6QG, Staffs, England.	lauratulloch@hotmail.com						Cogswell ME, 1999, AM J PREV MED, V16, P134, DOI 10.1016/S0749-3797(98)00141-X; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; Olynyk JK, 2005, J HEPATOL, V43, P9, DOI 10.1016/j.jhep.2005.05.008; Powell LW, 1998, ANN INTERN MED, V129, P925, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00002; Worwood M, 2002, BEST PRACT RES CL HA, V15, P295, DOI 10.1053/beha.2002.0005	5	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2007	370	9591					1006	1006		10.1016/S0140-6736(07)61447-0	http://dx.doi.org/10.1016/S0140-6736(07)61447-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211EG	17869637				2022-12-28	WOS:000249506500032
J	Mills, NL; Tornqvist, H; Gonzalez, MC; Vink, E; Robinson, SD; Soderberg, S; Boon, NA; Donaldson, K; Sandstrom, T; Blomberg, A; Newby, DE				Mills, Nicholas L.; Toernqvist, Hakan; Gonzalez, Manuel C.; Vink, Elen; Robinson, Simon D.; Soederberg, Stefan; Boon, Nicholas A.; Donaldson, Ken; Sandstroem, Thomas; Blomberg, Anders; Newby, David E.			Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARTICULATE AIR-POLLUTION; IMPAIRED ENDOGENOUS FIBRINOLYSIS; ST-SEGMENT DEPRESSION; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; INFLAMMATORY RESPONSES; TERM EXPOSURE; US CITIES; PARTICLES; FINE	Background: Exposure to air pollution from traffic is associated with adverse cardiovascular events. The mechanisms for this association are unknown. We conducted a controlled exposure to dilute diesel exhaust in patients with stable coronary heart disease to determine the direct effect of air pollution on myocardial, vascular, and fibrinolytic function. Methods: In a double-blind, randomized, crossover study, 20 men with prior myocardial infarction were exposed, in two separate sessions, to dilute diesel exhaust (300 microg per cubic meter) or filtered air for 1 hour during periods of rest and moderate exercise in a controlled-exposure facility. During the exposure, myocardial ischemia was quantified by ST-segment analysis using continuous 12-lead electrocardiography. Six hours after exposure, vasomotor and fibrinolytic function were assessed by means of intraarterial agonist infusions. Results: During both exposure sessions, the heart rate increased with exercise (P<0.001); the increase was similar during exposure to diesel exhaust and exposure to filtered air (P=0.67). Exercise-induced ST-segment depression was present in all patients, but there was a greater increase in the ischemic burden during exposure to diesel exhaust (-22+/-4 vs. -8+/-6 millivolt seconds, P<0.001). Exposure to diesel exhaust did not aggravate preexisting vasomotor dysfunction, but it did reduce the acute release of endothelial tissue plasminogen activator (P=0.009; 35% decrease in the area under the curve). Conclusions: Brief exposure to dilute diesel exhaust promotes myocardial ischemia and inhibits endogenous fibrinolytic capacity in men with stable coronary heart disease. Our findings point to ischemic and thrombotic mechanisms that may explain in part the observation that exposure to combustion-derived air pollution is associated with adverse cardiovascular events.	Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; Univ Edinburgh, Ctr Inflammat Res, ELEGI Colt Lab, Edinburgh EH16 4SB, Midlothian, Scotland; Umea Univ, Dept Resp Med & Allergy, Umea, Sweden; Umea Univ, Dept Med, Umea, Sweden	University of Edinburgh; University of Edinburgh; Umea University; Umea University	Mills, NL (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk	Söderberg, Stefan/AAG-3881-2019; Newby, David Ernest/AAB-1364-2019	Söderberg, Stefan/0000-0001-9225-1306; Blomberg, Anders/0000-0002-2452-7347; Vink, Elen/0000-0001-8535-6214; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [RG/10/9/28286] Funding Source: Medline; Medical Research Council [G9900991B] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; Blomberg A, 1997, AM J RESP CRIT CARE, V156, P418, DOI 10.1164/ajrccm.156.2.9612042; BLOMBERG A, 1997, AM J RESP CRIT CARE, V156, P2028; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Geller VD, 2005, ENVIRON SCI TECHNOL, V39, P8653, DOI 10.1021/es050360s; Gold DR, 2005, ENVIRON HEALTH PERSP, V113, P883, DOI 10.1289/ehp.7737; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lanki T, 2006, ENVIRON HEALTH PERSP, V114, P655, DOI 10.1289/ehp.8578; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Nemmar A, 2004, TOXICOL LETT, V149, P243, DOI 10.1016/j.toxlet.2003.12.061; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Newby DE, 1997, THROMB HAEMOSTASIS, V78, P1242; Newby DE, 1999, CIRCULATION, V99, P1411, DOI 10.1161/01.CIR.99.11.1411; Pekkanen J, 2002, CIRCULATION, V106, P933, DOI 10.1161/01.CIR.0000027561.41736.3C; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Stone PH, 2004, NEW ENGL J MED, V351, P1716, DOI 10.1056/NEJMp048245; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; von Klot S, 2005, CIRCULATION, V112, P3073, DOI 10.1161/CIRCULATIONAHA.105.548743; VONKLOT S, 2006, CIRCULATION, V113, pE71; Ware JH, 2000, NEW ENGL J MED, V343, P1798, DOI 10.1056/NEJM200012143432409; *WHO, 1992, 36 WHO; *WHO REG OFF EUR, 2000, AIR QUAL GUID EUR, P173; Witherow FN, 2002, J AM COLL CARDIOL, V40, P961, DOI 10.1016/S0735-1097(02)02061-2; World Health Organization, WORLD HLTH REP 2002; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	36	479	490	3	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1075	1082		10.1056/NEJMoa066314	http://dx.doi.org/10.1056/NEJMoa066314			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855668	Bronze			2022-12-28	WOS:000249387200003
J	WASSERSUG, R				WASSERSUG, R			COMPLEX ORGANISMAL FUNCTIONS - INTEGRATION AND EVOLUTION IN VERTEBRATES - WAKE,DB, ROTH,G	SCIENCE			English	Book Review											WASSERSUG, R (corresponding author), DALHOUSIE UNIV,DEPT ANAT,HALIFAX B3H 4H7,NS,CANADA.							Wake D.B., 1989, COMPLEX ORGANISMAL F	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1350	1351		10.1126/science.247.4948.1350	http://dx.doi.org/10.1126/science.247.4948.1350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	17843799				2022-12-28	WOS:A1990CU25300042
J	KERR, RA				KERR, RA			TREASURING THE MOON FOR 20 YEARS	SCIENCE			English	Editorial Material																		1989, SCIENCE, V243, P1433	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 24	1989	243	4898					1552	1552		10.1126/science.243.4898.1552	http://dx.doi.org/10.1126/science.243.4898.1552			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T7952	17847257				2022-12-28	WOS:A1989T795200022
J	Tuteja, G; Kaestner, KH				Tuteja, Geetu; Kaestner, Klaus H.			SnapShot: Forkhead transcription factors I	CELL			English	Editorial Material									Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Tuteja, G (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Katoh M, 2004, INT J ONCOL, V25, P1495; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387	5	113	120	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6							1160.e1	10.1016/j.cell.2007.09.005	http://dx.doi.org/10.1016/j.cell.2007.09.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889656	Bronze			2022-12-28	WOS:000250507500001
